<SEC-DOCUMENT>0001144204-12-060842.txt : 20121109
<SEC-HEADER>0001144204-12-060842.hdr.sgml : 20121109
<ACCEPTANCE-DATETIME>20121109160609
ACCESSION NUMBER:		0001144204-12-060842
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20120930
FILED AS OF DATE:		20121109
DATE AS OF CHANGE:		20121109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVAVAX INC
		CENTRAL INDEX KEY:			0001000694
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				222816046
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26770
		FILM NUMBER:		121193711

	BUSINESS ADDRESS:	
		STREET 1:		9920 BELWARD CAMPUS DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-268-2000

	MAIL ADDRESS:	
		STREET 1:		9920 BELWARD CAMPUS DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>v326292_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<FONT STYLE="font-size: 12pt">UNITED
STATES SECURITIES AND EXCHANGE COMMISSION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 10-Q</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.2in"></TD><TD STYLE="width: 0.6in"><FONT STYLE="font: 10pt Wingdings">x</FONT></TD><TD><B>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in"><B>For the quarterly period ended September 30, 2012</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OR</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.2in"></TD><TD STYLE="width: 0.6in"><FONT STYLE="font: 10pt Wingdings"><B>&uml;</B></FONT></TD><TD><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in"><B>&nbsp;For the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File No. 0-26770</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>NOVAVAX,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 44%; font-size: 10pt; text-align: center"><B>Delaware</B> </TD>
    <TD STYLE="width: 7%; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 49%; font-size: 10pt; font-weight: bold; text-align: center">22-2816046</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">incorporation or organization)</P></TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>9920 Belward Campus Drive, Rockville,
        MD</B></P></TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>20850</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">(Address of principal executive offices)</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">(Zip code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(240) 268-2000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><FONT STYLE="color: black">Indicate
by check mark whether the </FONT>Registrant<FONT STYLE="color: black">: (1) has filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant
was required to file such reports), and (2) has been subject to such filing requi</FONT>rements for the past 90 days. Yes <FONT STYLE="font-family: Wingdings">x</FONT>
No <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">Indicate by check mark
whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required
to be submitted and posted pursuant to Rule&nbsp;405 of Regulation&nbsp;S-T (&sect;232.405 of this chapter) during the preceding
12&nbsp;months (or for such shorter period that the registrant was required to submit and post such files). Yes <FONT STYLE="font-family: Wingdings">x</FONT>
No <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo;
in Rule 12b-2 of the Exchange Act. (Check one):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 22%; font-size: 10pt; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: black">Large accelerated filer <FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></TD>
    <TD STYLE="width: 18%; font-size: 10pt; text-align: center"><FONT STYLE="color: black">Accelerated filer <FONT STYLE="font-family: Wingdings">x</FONT></FONT></TD>
    <TD STYLE="width: 36%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Non-accelerated filer <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Do not check if a smaller reporting company)</P></TD>
    <TD STYLE="width: 24%; font-size: 10pt; text-align: center"><FONT STYLE="color: black">Smaller reporting company <FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.2in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><FONT STYLE="color: black">Indicate
by check mark whether </FONT>the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <FONT STYLE="font-family: Wingdings">&uml;</FONT>
No <FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">The number of shares
outstanding<FONT STYLE="color: black"> of the Registrant&rsquo;s Common Stock, $0.01 par value, was 147,941,442 as of October 31,
2012.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B>&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOVAVAX, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>PART I. FINANCIAL INFORMATION</B></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom"><B>Page No.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt">Item 1.</TD>
    <TD STYLE="width: 75%; padding-right: 5.4pt; padding-left: 5.4pt">Financial Statements</TD>
    <TD STYLE="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Balance Sheets as of September 30, 2012 (unaudited)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;&nbsp;&nbsp; and December 31, 2011</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">1</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Statements of Operations and Comprehensive Loss for the three
        and nine months ended</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">September 30, 2012 and 2011 (unaudited)</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Statements of Cash Flows for the nine months ended</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">September 30, 2012 and 2011 (unaudited)</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Notes to the Financial Statements (unaudited)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Item 2.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis of Financial</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Condition and Results of Operations</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">15</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Item 3.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Quantitative and Qualitative Disclosures about Market Risk</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">28</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Item 4.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Controls and Procedures</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">29</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-style: normal">PART
II. OTHER INFORMATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt">Item 1A.</TD>
    <TD STYLE="width: 75%; padding-right: 5.4pt; padding-left: 5.4pt">Risk Factors</TD>
    <TD STYLE="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">29</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Item 6.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Exhibits</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">29</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold">SIGNATURES</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; vertical-align: bottom">30</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART I. FINANCIAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 1. Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOVAVAX, INC.</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BALANCE SHEETS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(in thousands, except share and per
share information)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">September 30,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">December 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD COLSPAN="9" STYLE="font-weight: bold; text-align: center">ASSETS</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 74%; text-align: left; padding-left: 9pt">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">10,738</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">14,104</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt">Short-term investments available-for-sale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,672</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,205</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">838</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Accounts receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,469</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,965</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Unbilled receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,725</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,836</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Prepaid expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,807</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,441</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">235</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,558</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,484</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,109</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,815</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,857</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,141</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,141</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">756</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other non-current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">350</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">469</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.25in">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">80,546</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">66,576</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD COLSPAN="9" STYLE="font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,203</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,645</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Accrued expenses and other current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,031</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,528</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">803</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Current portion of capital lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Current portion of notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">769</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Deferred rent</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">421</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">386</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,441</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,579</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Non-current portion of capital lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">252</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Non-current portion of notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">793</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">368</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Deferred rent</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,184</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,980</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">19,170</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,727</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and contingences</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Preferred stock, $0.01 par value, 2,000,000 shares authorized; no shares issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Common stock, $0.01 par value, 200,000,000 shares authorized; and 136,003,676 shares issued and 135,548,246 shares outstanding at September 30, 2012 and 117,480,867 shares issued and 117,025,437 shares outstanding at December 31, 2011</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,360</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,175</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">411,558</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">383,948</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(350,128</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(329,656</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Treasury stock, 455,430 shares, cost basis</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,450</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,450</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Accumulated other comprehensive income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,036</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">832</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">61,376</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">53,849</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.25in">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">80,546</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">66,576</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these financial statements.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOVAVAX, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(in thousands, except per share information)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(unaudited)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>For
                                                                                                         the Three Months</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Ended
                                                                                                                                                                                                                                September
                                                                                                                                                                                                                                30,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>For
                                                                                                         the Nine Months</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Ended
                                                                                                                                                                                                                               September
                                                                                                                                                                                                                               30,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2012</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2012</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD>Revenue:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 52%; text-align: left; padding-left: 9pt">Government contracts</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,583</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,008</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">17,328</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,843</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Research and development collaboration</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">182</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&#8213;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">182</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&#8213;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Total revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,765</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,008</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,510</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,843</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Costs and expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Cost of government contracts revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,838</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,190</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,740</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,763</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,049</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,649</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,474</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">General and administrative</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,381</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,737</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,291</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,926</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Total costs and expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,614</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,976</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">37,680</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">26,163</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,849</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,968</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,170</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,320</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Change in fair value of warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(401</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">736</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(401</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,973</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Loss from operations before income tax</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,217</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,212</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,472</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,247</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income tax expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&#8213;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&#8213;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&#8213;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">412</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(7,217</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,212</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(20,472</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(15,659</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.05</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.16</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.14</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Basic and diluted weighted average number of common shares outstanding</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">134,178</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">115,107</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">127,246</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">113,053</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>For
                                                                                                         the Three Months</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Ended
                                                                                                                                                                                                                                September
                                                                                                                                                                                                                                30,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>For
                                                                                                         the Nine Months</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Ended
                                                                                                                                                                                                                               September
                                                                                                                                                                                                                               30,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2012</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2012</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">Comprehensive loss:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 52%; text-align: left">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(7,217</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(3,212</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(20,472</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(15,659</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Unrealized gain on short-term investments available-for-sale</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">96</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">204</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">141</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Comprehensive loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(7,121</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,209</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(20,268</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(15,518</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these financial statements.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOVAVAX, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">STATEMENTS OF CASH FLOWS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(in thousands)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(unaudited)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>For
                                                                                                         the Nine Months</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Ended
                                                                                                                                                                                                                               September
                                                                                                                                                                                                                               30,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2012</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-weight: bold; text-align: left">Operating Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left; padding-left: 9pt">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(20,472</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(15,659</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Reconciliation of net loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Change in fair value of warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">401</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,973</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,216</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,197</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Amortization of net premiums on short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">317</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Impairment of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Gain on disposal of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(26</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Deferred rent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">436</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(254</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Non-cash stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,668</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,677</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accounts receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(504</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Unbilled receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,848</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Prepaid expenses and other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(271</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,127</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accounts payable and accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(304</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,687</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">803</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Lease incentives received</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,803</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(14,139</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(20,760</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Investing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Capital expenditures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,202</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(414</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Proceeds from disposal of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">318</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&#8213;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Proceeds from maturities of short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,235</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 9pt">Purchases of short-term investments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(15,763</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,082</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Net cash (used in) provided by investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(15,147</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,739</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-weight: bold; text-align: left">Financing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Principal payments of capital lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(90</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Principal payments of notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(60</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Proceeds from notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">650</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,594</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Net proceeds from sales of common stock, net of offering costs of $0.4 million and $0.2 million, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,925</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,182</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Proceeds from the exercise of stock options</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">49</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">156</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">25,920</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,278</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-left: 9pt">Net (decrease) increase in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,366</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,257</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Cash and cash equivalents at beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">14,104</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,061</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Cash and cash equivalents at end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,738</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">14,318</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental disclosure of non-cash activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Equipment acquired under a capital lease</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">399</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Deposit applied towards the purchase of laboratory equipment</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">500</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Property and equipment purchases included in accounts payable and accrued expenses</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,365</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">168</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Settlement of notes receivable</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,522</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOVAVAX, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO FINANCIAL STATEMENTS<BR>
September 30, 2012</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(unaudited)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Note 1 &ndash; Organization</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Novavax, Inc. (the
&ldquo;Company&rdquo;) is a clinical-stage biopharmaceutical company focused on developing recombinant protein nanoparticle vaccines
to address a broad range of infectious diseases. The Company&rsquo;s goal is to become a profitable vaccine company that is aggressively
driving towards development, licensure and commercialization of an important portfolio of vaccines worldwide. The Company&rsquo;s
technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (&ldquo;VLPs&rdquo;)
and recombinant protein micelle vaccines combined with a single-use bioprocessing production system. These vaccine candidates are
genetically engineered three-dimensional nanostructures that incorporate immunologically important recombinant proteins. The Company&rsquo;s
product pipeline targets a variety of infectious diseases and its vaccine candidates are currently in or have completed clinical
trials that target pandemic (H5N1) influenza, seasonal influenza and respiratory syncytial virus (&ldquo;RSV&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2009, the Company
formed a joint venture with Cadila Pharmaceuticals Limited (&ldquo;Cadila&rdquo;) named CPL Biologicals Private Limited (the &ldquo;JV&rdquo;)
to develop and manufacture vaccines, biological therapeutics and diagnostics in India. The JV is owned 20% by the Company and 80%
by Cadila. The Company accounts for its investment in the JV using the equity method.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Note 2 &ndash; Liquidity Matters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s
vaccine candidates currently under development will require significant additional research and development efforts that include
extensive pre-clinical and clinical testing, and regulatory approval prior to commercial use. The Company&rsquo;s research and
development efforts may not be successful and any potential vaccine candidates may not prove to be safe and effective in clinical
trials. Even if developed, these vaccine candidates may not receive regulatory approval or be successfully introduced and marketed
at prices that would permit the Company to operate profitably. The commercial launch of any vaccine is subject to significant risks
including, but not limited to, manufacturing scale-up and market acceptance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since its inception,
the Company has incurred, and continues to incur, significant losses from operations. At September 30, 2012, the Company had cash
and cash equivalents of $10.7 million and short-term investments with a fair value of $17.7 million. In October 2012, the Company
raised $27 million through the sale of common stock to institutional investors (See Note 12).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the Company&rsquo;s
current cash and cash equivalents and short-term investments, including its recent private equity offering, anticipated revenue
under the contract with the Department of Health and Human Services, Biomedical Advanced Research and Development Authority (&ldquo;HHS
BARDA&rdquo;) that was awarded in February 2011, possible proceeds from sales of the Company&rsquo;s common stock under its At
Market Issuance Sales Agreement and its current business operations, the Company believes it has adequate capital resources available
to operate at planned levels that fund the Company beyond 2013. Additional capital will be required in the future to develop its
vaccine candidates through clinical development, manufacturing and commercialization. The Company&rsquo;s ability to obtain such
additional capital is subject to various factors:</P>

<P STYLE="font: 10pt Symbol; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">generating revenue under the HHS BARDA contract is subject to the Company&rsquo;s performance under
the contract, including its ability to collect on delayed reimbursement situations, such as the 205 Trial costs described in Note
5 below; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Symbol; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">raising funds under its At Market Issuance Sales Agreement is subject to both its business performance
and market conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, the Company
may seek additional capital through public or private equity offerings, debt financing, strategic alliance and licensing arrangements,
non-dilutive government contracts, collaborative arrangements, or some combination of these financing alternatives. Any capital
raised by an equity offering, whether public or private, will likely be substantially dilutive to the existing stockholders and
any licensing or development arrangement may require the Company to give up rights to a product or technology at less than its
full potential value. Other than the Company&rsquo;s At Market Issuance Sales Agreement, Equipment Loan (See Note 7) and Improvement
Allowance (See Note 10), the Company has not secured any additional commitments for new financing, nor can the Company provide
any assurance that financing will be available on commercially acceptable terms, if at all. If the Company is unable to perform
under the HHS BARDA contract or obtain additional capital, it will assess its capital resources and will likely be required to
delay, reduce the scope of, or eliminate one or more of its research and development programs, and/or downsize the organization,
including its general and administrative infrastructure.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Note 3 &ndash; Summary
of Significant Accounting Policies</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Basis of Presentation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited
financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (&ldquo;GAAP&rdquo;)
for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The balance sheet as of September
30, 2012, statements of operations for the three and nine months ended September 30, 2012 and 2011 and the statements of cash flows
for the nine months ended September 30, 2012 and 2011 are unaudited, but include all adjustments (consisting of normal recurring
adjustments) that the Company considers necessary for a fair presentation of the financial position, operating results and cash
flows, respectively, for the periods presented. Although the Company believes that the disclosures in these financial statements
are adequate to make the information presented not misleading, certain information and footnote information normally included in
financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the
United States Securities and Exchange Commission (&ldquo;SEC&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Results for any interim
period are not necessarily indicative of results for any future interim period or for the entire year. The accompanying unaudited
financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&rsquo;s
Annual Report on Form 10-K for the year ended December 31, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Use of Estimates</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of
the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Fair Value Measurements
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company applies
Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 820, <I>Fair Value Measurements and Disclosures</I>, for financial
and non-financial assets and liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ASC 820 discusses valuation
techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash
flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The statement utilizes a fair
value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following
is a brief description of those three levels:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets
or liabilities.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Level 2: Inputs other than quoted prices that are observable for the asset or liability, either
directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical
or similar assets or liabilities in markets that are not active.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Level 3: Unobservable inputs that reflect the reporting entity&rsquo;s own assumptions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial assets and
liabilities measured at fair market value on a recurring basis as of September 30, 2012 and December 31, 2011 are summarized below
(in thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="10" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Fair
    Value at September 30, 2012</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="10" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Fair
    Value at December 31, 2011</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Level
    1</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Level
    2</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Level
    3</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Level
    1</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Level
    2</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Level
    3</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-weight: bold; text-decoration: underline; text-indent: -9.45pt; padding-left: 9.45pt"><FONT STYLE="font-size: 9pt">Assets</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 34%; text-align: left; padding-bottom: 2.5pt; text-indent: -9.45pt; padding-left: 9.45pt"><FONT STYLE="font-size: 9pt">Corporate
    debt and auction rate securities</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">17,672</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">4,205</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-weight: bold; text-decoration: underline"><FONT STYLE="font-size: 9pt">Liabilities</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Warrant liability</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">769</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 9pt">368</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
summarizes the activity of Level 3 inputs measured on a recurring basis as of September 30, 2012 (in thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Fair&nbsp;Value&nbsp;Measurements&nbsp;of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Warrants&nbsp;Using
                                                                                                                                                                                                                                                     Significant</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Unobservable&nbsp;Inputs</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>(Level&nbsp;3)</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 82%">Balance at December 31, 2011</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">368</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Change in fair value of Warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">401</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="padding-bottom: 2.5pt">Balance at September 30, 2012</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">769</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The amounts in the Company's balance sheet for accounts receivables, unbilled receivables and accounts payable approximate
fair value due to their short-term nature. Based on borrowing rates available to the Company, the fair value of capital lease
and notes payable approximates their carrying value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Short-Term Investments</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Short-term investments
at September 30, 2012 consist of investments in commercial paper, corporate notes and three auction rate securities. All marketable
securities had original maturities greater than 90 days, but less than one year. The auction rate securities have a par value of
$5.1 million. The Company has classified these securities as available-for-sale since the Company may need to liquidate these securities
within the next year. The available-for-sale securities are carried at fair value and unrealized gains and losses, if determined
to be temporary, on these securities are included in accumulated other comprehensive income (loss) in stockholders&rsquo; equity.
Investments available for sale are evaluated periodically to determine whether a decline in value is &ldquo;other-than-temporary.&rdquo;
The term &ldquo;other-than-temporary&rdquo; is not intended to indicate a permanent decline in value. Rather, it means that the
prospects for a near term recovery of value are not necessarily favorable, or that there is a lack of evidence to support fair
values equal to, or greater than, the carrying value of the security. Management reviews criteria, such as the magnitude and duration
of the decline, as well as the Company&rsquo;s ability to hold the securities until market recovery, to predict whether the loss
in value is other-than-temporary. If a decline in value is determined to be other-than-temporary, the value of the security is
reduced and the impairment is recorded in the statements of operations. The specific identification method is used in computing
realized gains and losses on sale of the Company&rsquo;s securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Short-term investments
classified as available-for-sale as of September 30, 2012 and December 31, 2011 were comprised of (in thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="14" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><FONT STYLE="font-size: 7pt">September
    30, 2012</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="14" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><FONT STYLE="font-size: 7pt">December
    31, 2011</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>Amortized</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>Cost</B></FONT></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>Gross</B><BR>
    <B>Unrealized </B><BR>
    <B>Gains</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>Gross
    </B><BR>
    <B>Unrealized </B><BR>
    <B>Losses</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><FONT STYLE="font-size: 7pt">Fair
    Value</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>Amortized</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>Cost</B></FONT></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>Gross</B><BR>
    <B>Unrealized </B><BR>
    <B>Gains</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><FONT STYLE="font-size: 7pt"><B>Gross
    </B><BR>
    <B>Unrealized </B><BR>
    <B>Losses</B></FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><FONT STYLE="font-size: 7pt">Fair
    Value</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; width: 20%"><FONT STYLE="font-size: 7pt">Auction rate securities</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 7pt">3,373</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 7pt">1,032</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 7pt">4,405</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 7pt">3,373</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 7pt">832</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-size: 7pt">4,205</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">Corporate debt securities</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">13,263</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">4</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">13,267</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 7pt">16,636</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 7pt">1,036</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 7pt">17,672</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 7pt">3,373</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 7pt">832</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 7pt">4,205</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Restricted Cash</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s
noncurrent restricted cash with respect to its new manufacturing, laboratory and office space in Gaithersburg, Maryland functions
as collateral for letters of credit, which serve as security deposits for the duration of the leases. In addition, the Company&rsquo;s
restricted cash includes payments received under the PATH agreement (See Note 5) until such time the Company has paid for the work
performed for the related Phase II RSV clinical trial.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Net Loss per Share</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net loss per share
is computed using the weighted average number of shares of common stock outstanding. All outstanding warrants, stock options and
unvested restricted stock awards totaling 12,951,625 shares and 11,119,476 shares at September 30, 2012 and 2011, respectively,
are excluded from the computation, as their effect is antidilutive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Revenue Recognition</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company performs
research and development for U.S. Government agencies and other collaborators under cost reimbursable and fixed price contracts,
including license and clinical development agreements. The Company recognizes revenue under research contracts when a contract
has been executed, the contract price is fixed and determinable, delivery of services or products has occurred and collection of
the contract price is reasonably assured. Payments received in advance of work performed are recorded as deferred revenue and losses
on contracts, if any, are recognized in the period in which they become known.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under cost reimbursable
contracts, the Company is reimbursed and recognizes revenue as allowable costs are incurred plus a portion of the fixed-fee earned.
The Company considers fixed-fees under cost reimbursable contracts to be earned in proportion to the allowable costs incurred in
performance of the work as compared to total estimated contract costs, with such costs incurred representing a reasonable measurement
of the proportional performance of the work completed. Under its HHS BARDA contract, certain activities must be pre-approved by
HHS BARDA in order for their costs to be deemed allowable direct costs. Direct costs incurred under cost reimbursable contracts
are recorded as cost of government contracts revenue. The Company&rsquo;s government contracts, including its HHS BARDA contract,
provide the U.S. government (or agency) the ability to terminate the contract for convenience or to terminate for default if the
Company fails to meet its obligations as set forth in the statement of work. The Company believes that if the government were to
terminate one of its contracts for convenience, including the HHS BARDA contract, the costs incurred through the effective date
of such termination and any settlement costs resulting from such termination would be allowable costs. Payments to the Company
under cost reimbursable contracts with agencies of the U.S. Government, including its contract with HHS BARDA, are provisional
payments subject to adjustment upon annual audit by the government. No such audit has been completed as of September 30, 2012;
however, management believes that revenue for periods subject to audit has been recorded in amounts that are expected to be realized
upon final audit and settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s
collaborative research and development agreements may include an upfront payment, payments for research and development services,
milestone payments and royalties. Agreements with multiple deliverables are evaluated to determine if the deliverables can be divided
into more than one unit of accounting. A deliverable can generally be considered a separate unit of accounting if both of the following
criteria are met: (1) the delivered item(s) has value to the customer on a stand-alone basis; and (2) if the arrangement includes
a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable
and substantially in control of the Company. Deliverables that cannot be divided into separate units are combined with other units
of accounting, as appropriate. Consideration received is allocated among the separate units of accounting based on the relative
selling price method. Deliverables under these arrangements typically include rights to intellectual property, research and development
services and involvement by the parties in steering committees. Historically, deliverables under the Company&rsquo;s collaborative
research and development agreements have been deemed to have no stand-alone value and as a result been treated as a single unit
of accounting. In addition, the Company analyzes its contracts and collaborative agreements to determine whether the payments received
should be recorded as revenue or as a reduction to research and development expenses. In reaching this determination, management
considers a number of factors, including whether the Company is principal under the arrangement, and whether the arrangement is
significant to, and part of, the Company&rsquo;s core operations. Historically, payments received under its contracts and collaborative
agreements have been recognized as revenue since the Company acts as a principal in the arrangement, and the activities are core
to its operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When the performance
under a fixed price contract can be reasonably estimated, revenue for fixed price contracts is recognized under the proportional
performance method and earned in proportion to the contract costs incurred in performance of the work as compared to total estimated
contract costs. Costs incurred under fixed price contracts represent a reasonable measurement of proportional performance of the
work. Direct costs incurred under collaborative research and development agreements are recorded as research and development expenses.
If the performance under a fixed price contract cannot be reasonably estimated, the Company recognizes the revenue on a straight-line
basis over the contract term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue associated
with upfront payments under arrangements is recognized over the contract term or when all obligations associated with the upfront
payment have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue from the achievement
of research and development milestones, if deemed substantive, is recognized as revenue when the milestones are achieved, and the
milestone payments are due and collectible. If not deemed substantive, the Company would recognize such milestone as revenue upon
its achievement on a straight-line basis over the remaining expected term of the research and development period. Milestones are
considered substantive if all of the following conditions are met: (1) the milestone is non-refundable; (2) there is substantive
uncertainty of achievement of the milestone at the inception of the arrangement; (3) substantive effort is involved to achieve
the milestone and such achievement relates to past performance; and (4) the amount of the milestone appears reasonable in relation
to the effort expended and all of the deliverables and payment terms in the arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>Recent Accounting
Pronouncements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2011, the FASB
issued ASU 2011-05, <I>Comprehensive Income (Topic 220): Presentation of Comprehensive Income</I> (&ldquo;ASU 2011-05&rdquo;).
This guidance is intended to increase the prominence of other comprehensive income in financial statements by presenting it in
either a single-statement or two-statement approach. This ASU was effective for the Company beginning January&nbsp;1, 2012. This
presentation requirement was adopted January 1, 2012 and is reflected on the accompanying statements of operations and comprehensive
loss for the periods ended September 30, 2012 and 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In September 2011,
the FASB issued ASU&nbsp;2011-08, <I>Intangibles &ndash; Goodwill and Other (Topic 350): Testing Goodwill for Impairment </I>(&ldquo;ASU
2011-08&rdquo;)<I>,</I> to give both public and nonpublic entities the option to qualitatively determine whether they can bypass
the two-step goodwill impairment test. Under the new guidance, if an entity chooses to perform a qualitative assessment and determines
that it is more likely than not (a more than 50&nbsp;percent likelihood) that the fair value of a reporting unit is less than its
carrying amount, it would then perform Step&nbsp;1 of the annual goodwill impairment test in ASC&nbsp;350-20 and, if necessary,
proceed to Step&nbsp;2. Otherwise, no further evaluation would be necessary. The decision to perform a qualitative assessment is
made at the reporting unit level, and an entity with multiple reporting units may utilize a mix of qualitative assessments and
quantitative tests among its reporting units. The amended guidance was effective for interim and annual goodwill impairment tests
performed for fiscal years beginning after December&nbsp;15, 2011, although early adoption was permitted.&nbsp;The adoption of
ASU 2011-08 on January 1, 2012 did not have a material effect on the Company&rsquo;s financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 4 &ndash; Stock-Based Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has granted
equity awards under several plans. Under the 2005 Stock Incentive Plan (the &ldquo;2005 Plan&rdquo;), equity awards may be granted
to officers, directors, employees, consultants and advisors to the Company and any present or future subsidiary. The 2005 Plan,
approved in May 2005 and amended in June 2007, June 2011 and June 2012 by the Company&rsquo;s stockholders, currently authorizes
the grant of equity awards for up to 18,312,192 shares of common stock, which included, at the time of approval of the 2005 Plan,
a maximum 5,746,468 shares of common stock subject to stock options outstanding under the Company&rsquo;s 1995 Stock Option Plan
(the &ldquo;1995 Plan&rdquo;) that may revert to and become issuable under the 2005 Plan if such options should expire or otherwise
terminate unexercised. The term of the Company&rsquo;s 1995 Plan has expired. Outstanding stock options remain in existence in
accordance with their terms and no new awards will be made under the 1995 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the 2005 Plan
and the 1995 Plan, incentive stock options, having a maximum term of 10 years, can be or were granted at no less than 100% of the
fair value of the Company&rsquo;s common stock at the time of grant and are generally exercisable over periods ranging from six
months to four years. There is no minimum exercise price for non-statutory stock options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company recorded stock-based compensation expense in the statements of operations and comprehensive loss as follows (in
thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Three
                                                                                                  Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>September
                                                                                                                                                                                                                       30,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Nine
                                                                                                  Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>September
                                                                                                                                                                                                                      30,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 48%; text-align: left">Research and development</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">219</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">176</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">638</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">449</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">General and administrative</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">274</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">366</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,030</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,228</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Total stock-based compensation expense</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">493</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">542</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,668</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,677</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"><B><I>Stock Options Awards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following is a summary of option activity
under the 2005 Plan and the 1995 Plan for the nine months ended September 30, 2012:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2005 Stock Incentive Plan</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">1995 Stock Option Plan</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Stock</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Options</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Weighted-</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Average</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Exercise</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Price</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Stock</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Options</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Weighted-</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Average</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Exercise</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none"><B>Price</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 48%">Outstanding at January 1, 2012</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">7,412,746</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">2.22</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">474,650</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">4.38</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,483,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.29</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD>Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(80,784</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.61</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Canceled</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,546,562</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2.26</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(184,750</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.01</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="padding-bottom: 2.5pt">Outstanding at September 30, 2012</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9,268,400</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1.88</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">289,900</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4.59</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Shares exercisable at September 30, 2012</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,503,043</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2.38</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">289,900</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4.59</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Shares available for grant at&nbsp; September 30, 2012</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,559,536</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of stock
options granted was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 95%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-decoration: none"><B>Three
                                                                                                  Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-decoration: none"><B>September
                                                                                                                                                                                                                       30,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-decoration: none"><B>Nine
                                                                                                  Months Ended</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-decoration: none"><B>September
                                                                                                                                                                                                                      30,</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD NOWRAP STYLE="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt">Weighted-average fair value of stock options granted</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; text-align: center"></TD><TD NOWRAP STYLE="width: 12%; text-align: center">$1.09</TD><TD NOWRAP STYLE="width: 1%; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; text-align: center"></TD><TD NOWRAP STYLE="width: 12%; text-align: center">$0.78</TD><TD NOWRAP STYLE="width: 1%; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; text-align: center"></TD><TD NOWRAP STYLE="width: 12%; text-align: center">$0.71</TD><TD NOWRAP STYLE="width: 1%; text-align: center">&nbsp;</TD><TD NOWRAP STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; text-align: center"></TD><TD NOWRAP STYLE="width: 12%; text-align: center">$1.19</TD><TD NOWRAP STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="text-align: left">Risk-free interest rate</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0.55%</TD><TD NOWRAP STYLE="text-align: center"></TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0.48%-0.68%</TD><TD NOWRAP STYLE="text-align: left">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0.55%-1.54%</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0.48%-1.91%</TD><TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD NOWRAP STYLE="text-align: left">Dividend yield</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0%</TD><TD NOWRAP STYLE="text-align: center"></TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0%</TD><TD NOWRAP STYLE="text-align: left"></TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0%</TD><TD NOWRAP STYLE="text-align: center"></TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0%</TD><TD NOWRAP STYLE="text-align: left"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP>Volatility</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">76.60%-76.71%</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">75.86%-80.40%</TD><TD NOWRAP STYLE="text-align: left">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">75.47%-80.48%</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">73.28%-80.48%</TD><TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD NOWRAP STYLE="text-align: left">Expected term (in years)</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">4.24</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">3.49-4.21</TD><TD NOWRAP STYLE="text-align: left">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">3.34-7.09</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">3.26-4.47</TD><TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="text-align: left">Expected forfeiture rate</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0%-23.15%</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0%-23.15%</TD><TD NOWRAP STYLE="text-align: left">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0%-23.15%</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="text-align: center">0%-23.15%</TD><TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The aggregate intrinsic
value and weighted-average remaining contractual term of stock options outstanding as of September 30, 2012 was approximately $4.6
million and 7.7<B> </B>years, respectively. The aggregate intrinsic value and weighted-average remaining contractual term of stock
options exercisable as of September 30, 2012 was approximately $1.0<B> </B>million and 5.7<B> </B>years, respectively. The aggregate
intrinsic value represents the total intrinsic value (the difference between the Company&rsquo;s closing stock price on the last
trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received
by the option holders had all option holders exercised their options on September 30, 2012. This amount is subject to change based
on changes to the fair value of the Company&rsquo;s common stock. The aggregate intrinsic value of options exercised for the nine
months ended September 30, 2012 and 2011 was less than $0.1 million and $0.2 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"><B><I>Restricted Stock Awards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the 2005 Plan,
the Company has granted restricted stock awards subject to certain performance-based and time-based vesting conditions which, if
not met, would result in forfeiture of the shares and reversal of any previously recognized related stock-based compensation expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a
summary of restricted stock awards activity for the nine months ended September 30, 2012:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; text-decoration: none">
    <TD NOWRAP STYLE="text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.8pt; text-align: center; text-decoration: none"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.8pt; text-align: center; text-decoration: none"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.8pt; text-align: center; text-decoration: none"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.8pt; text-align: center; text-decoration: none"><B>Number
                                                                                                                                                                                                                                                                                                                                                                                                                                                               of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.8pt; text-align: center; text-decoration: none"><B>Shares</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt; text-decoration: none">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; text-decoration: none"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.25pt; text-align: center; text-decoration: none"><B>Per
                                                                                                         Share</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.25pt; text-align: center; text-decoration: none"><B>Weighted-</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.25pt; text-align: center; text-decoration: none"><B>Average</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.25pt; text-align: center; text-decoration: none"><B>Grant-Date</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.25pt; text-align: center; text-decoration: none"><B>Fair
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Value</B></P></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold; text-decoration: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 74%; font-weight: bold">Outstanding at January 1, 2012</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">53,333</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">1.63</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Restricted stock granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">Restricted stock vested</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5.21</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Restricted stock forfeited</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Outstanding at September 30, 2012</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1.39</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of September 30,
2012, there was approximately $3.6<B> </B>million of total unrecognized compensation expense (net of estimated forfeitures) related
to unvested options and restricted stock awards. This unrecognized compensation expense is expected to be recognized over a weighted-average
period of 1.6<B> </B>years. This estimate does not include the impact of other possible stock-based awards that may be made during
future periods.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Note 5 &ndash; U.S.
Government Agreement and Collaborations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><B><I>HHS
BARDA Contract Award for Recombinant Influenza Vaccines</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2011, the
Company was awarded a contract from HHS BARDA valued at $97 million for the 36-month base-period, with an HHS BARDA option for
an additional period of 24 months valued at $82 million, for a total contract value of up to $179 million. The HHS BARDA contract
award provides significant funding for the Company&rsquo;s ongoing clinical development and product scale-up of both its seasonal
and pandemic (H5N1) influenza vaccine candidates. This is a cost-plus-fixed-fee contract in which HHS BARDA will reimburse the
Company for direct contract costs incurred plus allowable indirect costs and a fixed-fee earned in the further development of its
multivalent seasonal and monovalent pandemic (H5N1) influenza vaccines. Billings under the contract are based on approved provisional
indirect billing rates, which permit recovery of fringe benefits, overhead and general and administrative expenses not exceeding
certain limits. These indirect rates are subject to audit by HHS BARDA on an annual basis. When the final determination of the
allowable costs for any year has been made, revenue and billings may be adjusted accordingly. Since the inception of the contract
and during the nine months ended September 30, 2012, the Company has recognized revenue of approximately $31.6 million and $16.9
million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under certain circumstances
HHS BARDA reimbursements may be delayed or even potentially withheld. In March 2012, the Company decided to conduct its Phase II
dose-ranging clinical trial of its trivalent and quadrivalent seasonal influenza vaccine candidates (the &ldquo;205 Trial&rdquo;)
under its existing U.S. investigational new drug application (&ldquo;IND&rdquo;) for its trivalent seasonal influenza vaccine candidate
(&ldquo;Trivalent IND&rdquo;) as opposed to waiting to conduct the 205 Trial under a new IND for its quadrivalent vaccine candidate
(&ldquo;Quadrivalent IND&rdquo;). In July 2012, the Company reported that it expected to launch its next quadrivalent Phase II
clinical trial in 2013 rather than in the second half of 2012; similarly, the filing of the Quadrivalent IND, which the Company
had previously indicated was expected in the second half of 2012 will also be delayed. Based on discussions between HHS BARDA and
the Company, because the 205 Trial includes its quadrivalent seasonal influenza vaccine candidate, the outside clinical trial costs
for the 205 Trial will only be submitted for reimbursement to HHS BARDA and recorded as revenue by the Company after it submits
the 205 Trial data to its Quadrivalent IND. Until then, the outside clinical trial costs of the 205 Trial will be expensed and
included in cost of government contracts revenue. The financial impact of this delay in revenue recognition is based on the outside
clinical trial costs of the 205 Trial that are expected to total approximately $3.1 million, of which $2.8 million was incurred
through September 30, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>License Agreement
with LG Life Sciences, Ltd.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2011, the Company entered into a license agreement with LG Life Sciences, Ltd. ("LGLS") that allows LGLS to use
the Company's technology to develop and commercially sell influenza vaccines exclusively in South Korea and non-exclusively
in certain other specified countries. At its own cost, LGLS is responsible for funding its clinical development of the influenza
VLP vaccines and completing a manufacturing facility in South Korea. Under the license agreement, the Company is obligated
to provide LGLS with information and materials related to the manufacture of the licensed products, provide on-going project
management and regulatory support and conduct clinical trials of its influenza vaccines in order to obtain FDA approval in
the U.S. The term of the license agreement is expected to terminate in 2027. Payments to the Company under the license agreement
include an upfront payment of $2.5 million, reimbursements of certain development and product costs, payments related to the
achievement of certain milestones and royalty payments at a rate between 10% and 20% from LGLS's future commercial sales of
influenza VLP vaccines, which royalty rate is subject to reduction if certain timelines for regulatory licensure are not met.
The upfront payment has been deferred and will be recognized when the previously mentioned obligations in the agreement are
satisfied, which may not occur until the end of the term of the agreement. Payments for milestones under the agreement will
be recognized on a straight-line basis over the remaining term of the research and development period upon achievement of
such milestone. Any royalties under the agreement will be recognized as earned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>PATH Vaccine
Solutions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In July 2012, the Company
entered into a clinical development agreement with PATH Vaccine Solutions (&ldquo;PATH&rdquo;) to develop its vaccine candidate
to protect against RSV through maternal immunization in low-resource countries (the &ldquo;RSV Collaboration Program&rdquo;). The
Company was awarded approximately $2.0 million by PATH for initial funding under the agreement to partially support its Phase II
dose-ranging clinical trial in women of childbearing age, which was launched in October 2012. The agreement would expire July 31,
2013, unless the Company and PATH decide to continue the RSV Collaboration Program. The Company retains global rights to commercialize
the product and has made a commitment to make the vaccine affordable and available in low-resource countries. To the extent PATH
has continued to fund 50% of the Company&rsquo;s external clinical development costs for the RSV Collaboration Program, but the
Company does not continue development, the Company would then grant PATH a fully-paid license to its RSV vaccine technology for
use in pregnant women in such low-resource countries. During the three months ended September 30, 2012, the Company recognized
revenue of approximately $0.2 million under the agreement. Revenue under this arrangement is being recognized under the proportional
performance method and earned in proportion to the contract costs incurred in performance of the work as compared to total estimated
contract costs. Costs incurred under this agreement represent a reasonable measurement of proportional performance of the work.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Note 6 &ndash; Capital
Lease</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">In
August 2012, the Company leased equipment under a capital lease with an effective interest rate of&nbsp;6.5% with an advance payment
and monthly payments of $6,325 starting August 2012 and over the next 59 months. The capital lease is recorded at the present value
of the future minimum lease payments. Future minimum capital lease payments under the capital lease agreement at September 30,
2012 are as follows (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 87%; text-align: left">2012</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">12</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2013</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">44</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">360</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Less &#8213; amounts representing interest</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(51</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">Present value of net minimum lease&nbsp;payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">309</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Less &#8213; current portion of capital lease</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(57</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Non-current portion of capital lease</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">252</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Note 7 &ndash; Notes
Payable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In September 2012,
the Company entered into a Master Security Agreement with General Electric Capital Corporation (&ldquo;GE&rdquo;), whereby the
Company can borrow up to $2.0 million to finance the purchases of equipment (&ldquo;Equipment Loan&rdquo;). Each Equipment Loan
bears interest at the three-year U.S. Government treasury rate plus 11.68%, provided that the rate shall not be less than 12.1%,
and is to be repaid over forty-two (42) months. GE will maintain a security interest in all equipment financed under this facility.
During the three months ended September 30, 2012, the Company financed $0.5 million at an interest rate of 12.1% with monthly principal
payments of $13,089 starting October 2012. Interest accrues on the outstanding balance until paid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Aggregate future minimum
principal payments on the GE Equipment Loan at September 30, 2012 are as follows (in thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 87%; text-align: left">2012</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">39</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2013</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">40</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">550</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Note 8 &ndash; Warrant
Liability</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">In July 2008, the
Company completed a registered direct offering of 6,686,650 units, raising approximately $17.5 million in net proceeds. Each unit
consisted of one share of common stock and a warrant to purchase 0.5 shares of common stock (the &ldquo;Warrants&rdquo;) at a price
of $2.68 per unit. The Warrants represent the right to acquire an aggregate of 3,343,325 shares of common stock at an exercise
price of $3.62 per share and are exercisable between January 31, 2009 and July 31, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"><FONT STYLE="color: black">During
the nine months ended September 30, 2012 and 2011, the Company recorded as other income (expense) </FONT>in its statements of operations
and comprehensive loss <FONT STYLE="color: black">a change in fair value of warrant liability of ($0.4) million and $2.0 million,
respectively. As of September 30, 2012, the warrant liability recorded on the balance sheet was $0.8 million and all Warrants remain
outstanding as of that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Note 9 &ndash; Sales
of Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
of the Company (the &ldquo;Board&rdquo;) has appointed a standing Finance Committee (the &ldquo;Committee&rdquo;) to assist the
Board with its responsibilities to monitor, provide advice to senior management of the Company and approve all capital raising
activities. The Committee has been authorized by the Board to approve all At Market Issuance sales transactions. In doing so, the
Committee sets the amount of shares to be sold, the period of time during which such sales may occur and the minimum sales price
per share. In September 2012, the Company entered into an At Market Issuance Sales Agreement, under which the Company may sell
an aggregate of $50 million in gross proceeds of its common stock. This agreement replaces the previous sales agreement entered
in March 2010, which also allowed for the sale of an aggregate of $50 million in gross proceeds of its common stock, but had recently
met its limitation on sales of shares. The shares of common stock are being offered pursuant to a shelf registration statement
previously filed with the SEC. For the nine months ended September 30, 2012, the Company sold 8.4 million shares at an average
sales price of $1.70 per share, resulting in $14.0 million in net proceeds; this amount excludes $0.8 million received in early
2012 for 0.7 million shares traded in late December 2011. Since entering into the March 2010 sales agreement through November 7,
2012, the Company has sold 24,957,715 shares of its common stock and received gross proceeds of $49.9 million. No sales have occurred
under the September 2012 sales agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2012, the Company
sold 10,000,000 shares of its common stock to two affiliates of RA Capital Management, LLC at a price of $1.22 per share, resulting
in $12.1 million in net proceeds. The shares were offered under an effective shelf registration statement previously filed with
the SEC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Note 10 &ndash;
Manufacturing, Laboratory and Office Facility</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November 2011, the Company entered into lease agreements, under which the Company leases its new manufacturing, laboratory
and office space in Gaithersburg, Maryland. The lease agreements provide that, among other things, as of January 1, 2012,
the Company sublease from the current facility tenant, and subsequently lease directly from the landlord, approximately 74,000
total square feet, with rent payments for such space to the landlord commencing April 1, 2014. Under the terms of the arrangement,
the Landlord will provide the Company with a tenant improvement allowance of $2.5 million and an additional tenant improvement
allowance of $3 million (collectively, the "Improvement Allowance"). The additional tenant improvement allowance is to be
paid back to the Landlord over the remaining term of the lease agreement with an effective interest rate of 8.0%. During the
nine months ended September 30, 2012, the Company was funded $2.8 million under the Improvement Allowance. In addition, the
Company purchased laboratory equipment under an agreement with the then current facility tenant. The Company is currently
renovating the new facility and has started remarketing the Rockville, Maryland facility, which lease term ends January 31,
2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Note 11 <FONT STYLE="font-weight: normal">&ndash;
</FONT>Master Services Agreement with Cadila</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the JV with Cadila, the Company entered into a master services agreement, which the Company and Cadila amended in July 2011 to
extend the term by one year for which services can be provided by Cadila under this agreement. Under the revised terms, if by March
2013, the amount of services provided by Cadila under the master services agreement is less than $7.5 million, the Company will
pay Cadila the portion of the shortfall amount that is less than or equal to $2.0 million and 50% of the portion of the shortfall
amount that exceeds $2.0 million. Through September 30, 2012, the Company has purchased $0.4 million in services from Cadila pursuant
to this agreement. The Company plans to explore with Cadila ways to potentially reduce its financial obligation and/or extend the
time period during which the Company could utilize such services. The Company can provide no assurance, however, that these efforts
will be successful. If the Company fails to negotiate a change in this arrangement, the Company expects that it will be obligated
to spend a significant portion of its available cash and cash equivalents to pay Cadila for our shortfall in services purchased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Note 12 &ndash; Subsequent
Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2012, the
Company sold 12,385,321 shares of its common stock to two affiliates of RA Capital Management, LLC, three affiliates of Camber
Capital Management LLC and three affiliates of Ayer Capital Management LLC at a price of $2.18 per share, resulting in approximately
$26.9 million in net proceeds. The shares were offered under an effective shelf registration statement previously filed with the
SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Item 2.&#9;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain statements
contained or incorporated by reference herein constitute forward-looking statements. In some cases, these statements can be identified
by the use of forward-looking terminology such as &ldquo;expect(s),&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;seeks,&rdquo;
&ldquo;estimates,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; &ldquo;feel(s),&rdquo; &ldquo;believe(s),&rdquo; &ldquo;will,&rdquo;
&ldquo;would,&rdquo; &ldquo;may,&rdquo; &ldquo;can,&rdquo; &ldquo;anticipate(s),&rdquo; &ldquo;potential&rdquo; and similar expressions
or the negative of these terms. Such forward-looking statements are subject to risks and uncertainties that may cause the actual
results, performance or achievements of the Company, or industry results, to be materially different from those expressed or implied
by such forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Forward-looking statements
in this Quarterly Report on Form 10-Q include, without limitation, statements regarding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">potential benefits, regulatory approval and commercialization of our vaccine candidates;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectation that we will have adequate capital resources available to operate at planned levels
for at least the next twenty-four months;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expected 2012 capital expenditures;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectations for future revenue under the contract with the Department of Health and Human
Services, Biomedical Advanced Research and Development Authority (HHS BARDA) and funding requirements and capital raising activity,
including possible proceeds from our At Market Issuance Sales Agreement and funding under the Loan Agreement and Improvement Allowance;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectations on financial or business performance, conditions or strategies and other financial
and business matters, including expectations regarding operating expenses, use of cash, and the fluctuations in expenses and capital
requirements associated with pre-clinical studies, clinical trials and other research and development activities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectations on clinical development and anticipated milestones, including under contracts
with HHS BARDA, LG Life Sciences and PATH, our planned clinical trials and regulatory filings as necessary for our vaccine candidates;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectations that our product candidates will prove to be safe and effective;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectations that our multivalent seasonal influenza virus-like particle (VLP) vaccine could
potentially address an unmet medical need in older adults or children;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectation that our monovalent pandemic (H5N1) influenza vaccine could potentially be developed
without an adjuvant for population segments that are sensitive to adjuvant use;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectations that our RSV vaccine could potentially address unmet medical needs;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectation that we will utilize the amount of services that is required to be provided by
Cadila Pharmaceuticals Limited (Cadila) under the master services agreement and our ability to reduce our financial obligation
and/or extend the period during which we could utilize such services;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectations regarding payments to Wyeth Holdings Corporation, a subsidiary of Pfizer Inc.
(Wyeth);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our expectations concerning payments under existing license agreements; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">other factors referenced herein.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company assumes
no obligation to update any such forward-looking statements, except as specifically required by law. We caution readers not to
place considerable reliance on the forward-looking statements contained in this Quarterly Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Overview</B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Novavax, Inc., a Delaware
corporation (&ldquo;Novavax,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; or &ldquo;us&rdquo;), was incorporated in 1987,
and is a clinical-stage biopharmaceutical company focused on developing recombinant protein nanoparticle vaccines to address a
broad range of infectious diseases. Our goal is to become a profitable vaccine company that is aggressively driving towards development,
licensure and commercialization of an important portfolio of vaccines worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our technology platform
is based on proprietary recombinant vaccine technology that includes VLPs and recombinant protein micelle vaccines combined with
a single-use bioprocessing production system. Our vaccine candidates are genetically engineered three-dimensional nanostructures
that incorporate immunologically important recombinant proteins. Our product pipeline targets a variety of infectious diseases
and our vaccine candidates are currently in or have completed clinical trials that target pandemic (H5N1) influenza, seasonal influenza
and respiratory syncytial virus (RSV).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CPL Biologicals Private
Limited (the JV), our joint venture formed in 2009 between us and Cadila, of which 20% is owned by us and 80% is owned by Cadila.
The JV will develop and manufacture our pandemic (H5N1) influenza and seasonal influenza vaccine candidates and Cadila&rsquo;s
biogeneric products and other diagnostic products for the territory of India. In June 2010, the JV opened its newly constructed
state-of-the-art manufacturing facility, 100% funded by Cadila, to be used to produce pandemic (H5N1) and seasonal influenza vaccines,
as well as other vaccine candidates. The JV is actively developing a rabies vaccine candidate that was genetically engineered by
Novavax; it recently completed initial pre-clinical immunogenicity studies on this vaccine candidate and is now complete with pre-clinical
toxicology studies. Because we do not control the JV, we account for our investment using the equity method. Since the carrying
value of our contribution was nominal and there is no guarantee or commitment to provide future funding, we have not recorded nor
do we expect to record losses related to this investment in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A current summary of
our significant research and development programs and status of development follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; margin-left: 0.5in">
<TR>
    <TD STYLE="width: 45%; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0">Program</TD><TD STYLE="width: 5%; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 45%">Development Phase</TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0">Pandemic (H1N1) Influenza</TD><TD STYLE="font: italic 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif">Phase II (ended)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0">Pandemic (H5N1) Influenza</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Phase I</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0">Seasonal Influenza</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Phase II</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0">Respiratory Syncytial Virus (RSV)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Phase II</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0">Rabies (through JV)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Pre-clinical</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>HHS BARDA Contract
Award for Recombinant Influenza Vaccines</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2011, we
were awarded a contract from HHS BARDA valued at $97 million for the first 36 month base-period, with an HHS BARDA option for an
additional period of 24 months valued at $82 million, for a total contract value of up to $179 million. The HHS BARDA contract
award provides significant funding for our ongoing clinical development and product scale-up of both our seasonal and pandemic
(H5N1) influenza vaccine candidates. This is a cost-plus-fixed-fee contract in which HHS BARDA will reimburse us for direct contract
costs incurred plus allowable indirect costs and a fixed-fee earned in the further development of our multivalent seasonal and
monovalent pandemic (H5N1) influenza vaccines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under certain circumstances
HHS BARDA reimbursements may be delayed or even potentially withheld. In March 2012, we decided to conduct our Phase II dose-ranging
clinical trial of our trivalent and quadrivalent seasonal influenza vaccine candidates (the 205 Trial) under our existing U.S.
investigational new drug application (IND) for our trivalent seasonal influenza vaccine candidate (Trivalent IND) as opposed to
waiting to conduct the 205 Trial under a new IND for our quadrivalent vaccine candidate (Quadrivalent IND). In July 2012, we reported
that we expected to launch our next quadrivalent Phase II clinical trial in 2013 rather than in the second half of 2012; similarly,
the filing of the Quadrivalent IND, which we had previously indicated was expected in the second half of 2012 will also be delayed.
Based on our discussions with HHS BARDA, because the 205 Trial includes our quadrivalent seasonal influenza vaccine candidate,
the outside clinical trial costs for the 205 Trial will only be submitted for reimbursement to HHS BARDA and recorded as revenue
by us after we submit the 205 Trial data to our Quadrivalent IND. Until then, the outside clinical trial costs of the 205 Trial
will be expensed and included in cost of government contracts revenue. The financial impact of this delay in revenue recognition
is based on the outside clinical trial costs of the 205 Trial that are expected to total approximately $3.1 million, of which $2.8
million was incurred through September 30, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Pandemic (H1N1) Influenza</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2009 and 2010, we
dedicated significant resources to demonstrate our ability to develop a recombinant monovalent VLP vaccine against H1N1 influenza,
which had been declared a pandemic. We produced a non-cGMP H1N1 VLP vaccine candidate within 3 weeks after the genetic sequence
of the novel H1N1 influenza virus was announced and manufactured a cGMP vaccine candidate within 11 weeks of the announcement.
We conducted a Phase II clinical trial in Mexico, in collaboration with Laboratorio Avi-Mex S.A. de C.V. and GE Healthcare; we
published the final data results in 2011 and presented at the World Health Organization (WHO) Meeting for the Evaluation of Pandemic
Influenza Vaccines in Clinical Trials. Our results showed that our H1N1 VLP influenza vaccine exceeded the immunogenicity criteria
for seasonal influenza vaccine licensure at all dose levels, including the lowest 5&micro;g dose and that a single administration
of the VLP vaccine induced high levels of hemagglutination-inhibition (HAI) titers in subjects without pre-existing detectable
immunity to H1N1 influenza. Although H1N1 influenza is no longer considered a pandemic and is being addressed as an active strain
in the determination of ongoing seasonal influenza strains, we nevertheless expect that the data from our H1N1 clinical trials
will be used to support our pandemic (H5N1) and seasonal influenza VLP vaccine programs in the U.S. and in other countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Pandemic (H5N1)
Influenza</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have made significant
progress in the development of our monovalent pandemic influenza vaccine that targets the H5N1 influenza strain. In 2007, we released
results from an important pre-clinical study in which ferrets that received our H5N1 vaccine candidate were protected from a lethal
challenge of the H5N1 virus. After filing an IND, we initiated a Phase I/IIa clinical trial. We released interim data from the
first portion of this clinical trial in December 2007. These interim results demonstrated that our pandemic (H5N1) influenza vaccine
can generate a protective immune response. We conducted the second portion of the Phase I/IIa trial in 2008 to gather additional
subject immunogenicity and safety data and determine a final dose through the completion of this clinical trial. In August 2008,
we reported favorable results from this clinical trial, which demonstrated strong neutralizing antibody titers across all three
doses tested. The vaccine was well-tolerated at all dose levels as compared with placebo, and no serious adverse events were reported.
The vaccine also induced robust HAI responses, which have been shown to be important for protection against influenza disease.
In conjunction with our HHS BARDA contract, in May 2012, we launched two Phase I trials of our H5N1 vaccine candidate in combination
with several alternative adjuvant candidates. These trials were designed to evaluate the safety and tolerability of the vaccines
in the presence and absence of adjuvants; the ability of VLP vaccine antigens with and without adjuvants to generate antibody levels
that fulfill the FDA&rsquo;s criteria for accelerated approval, and the ability of these vaccines to provide an expanded number
of doses and possible cross-protection against other virus strains to the U.S. population. In October 2012, we reported positive
results from these clinical trials. The data from the trials demonstrated the safety and immunogenicity of varying dose-levels
of the vaccine, with and without adjuvant, and further demonstrated that statistically significant robust adjuvant effects on the
immune responses were achieved. The vaccine safety was acceptable with no vaccine-related serious adverse events observed. Notably,
in both trials the unadjuvanted vaccine elicited HAI titers &ge; 40 in &gt;82% of subjects at a dose of 45 &micro;g, which would
fulfill FDA criteria for accelerated approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Seasonal Influenza</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are actively developing
our multivalent VLP vaccine that targets the seasonal influenza virus. In April 2010, we reported the final results of our Phase
II trial in older adults (60 years of age or older) in a dose-ranging study comparing our seasonal trivalent (three strain) influenza
VLP vaccine with a commercially available inactivated trivalent influenza vaccine (TIV). The results showed that the vaccine was
both safe and immunogenic against the 2009-2010 seasonal influenza virus strains in older adults. The CDC has indicated that currently
approved seasonal influenza vaccines may be suboptimally effective in preventing hospitalization for pneumonia and influenza in
older adults; however, we believe that some features of our seasonal influenza VLP vaccine have the potential to offer improved
efficacy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
March 2012, we initiated the 205 Trial. We developed a quadrivalent formulation of our seasonal influenza vaccine candidate as
many influenza vaccine manufacturers move from trivalent to quadrivalent formulations, an industry move that has been acknowledged
by WHO and the FDA. In July 2012, topline results for the 205 Trial were reported and demonstrated that the quadrivalent VLP vaccine
candidate achieved its primary endpoints of safety and immunogenicity. The VLP vaccine candidate demonstrated immunogenicity against
all four viral strains based on HAI responses at day 21, was also well-tolerated with no vaccine-related serious adverse events
observed and reactogenicity was considered acceptable.</FONT> <FONT STYLE="font-size: 10pt">We also announced that a secondary
endpoint of the study was to evaluate the potential of the VLP vaccine candidate to fulfill the FDA Center for Biologics Evaluation
and Research (CBER) criteria for accelerated approval, specifically by meeting certain seroconversion rates and seroprotection
rates. The VLP vaccine candidate met the FDA seroprotection rates for all four viral strains; however, the seroconversion rates
were met by three of the four viral strains. The fourth virus, B/Brisbane/60/08, despite fulfilling the seroprotection rates, failed
to meet the seroconversion rates. In addition, we also compared the immunogenicity of the VLP vaccine candidate against that of
a licensed TIV produced in eggs. In general, the results showed the comparator TIV to reach higher levels of HAI than our VLP vaccine
candidate. Finally, we reported that we are evaluating further process development and assay refinements that we believe will further
improve the immunogenicity profile of the VLP vaccine candidate and will delay the start of our next Phase II trial until 2013.
The timing of the launch of our Phase III registration will be coordinated with the completion of the aforementioned Phase II trial
launch in 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Respiratory Syncytial
Virus (RSV)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have developed a
recombinant nanoparticle vaccine to prevent RSV. In pre-clinical studies, we have demonstrated positive results in models designed
to test the safety and efficacy of our RSV vaccine candidate. In December 2010, we initiated a blinded, placebo-controlled, dose-escalating
Phase I trial to assess the safety and tolerability of aluminum phosphate-adjuvanted and unadjuvanted formulations of our RSV vaccine
candidate. A secondary objective of the study was to evaluate total and neutralizing anti-RSV antibody responses and assess the
impact of the adjuvant. The study enrolled 150 healthy adults 18 to 49 years old who were allocated to six cohorts that included
four dose levels of vaccine. The primary safety findings were local pain and tenderness at the site of injection, the majority
of which were mild in nature with no dose-related increase observed. There were no observed vaccine-related serious adverse events
or trends for related systemic side effects. The antibody response to the RSV F protein was significantly increased compared to
placebo (p&lt;0.001) in all groups and increased by 19-fold in the highest-dose adjuvant group at day 60. A significant dose-response
pattern was observed. High rates of seroconversion were seen at all doses including a rate of 100% at the highest-dose-adjuvant
group. In October 2012, we initiated two separate dose-ranging clinical trials, one in women of child bearing age and the other
in elderly adults. The first trial is a randomized, blinded, placebo-controlled Phase II trial that will evaluate the immunogenicity
and safety of two dose levels of our RSV vaccine candidate with and without aluminum phosphate as an adjuvant, enrolling 330 women
of childbearing age. Top-line data is expected to be reported in first quarter of 2013. The second trial is a randomized, blinded,
placebo-controlled Phase I trial that will evaluate the immunogenicity and safety of two doses of our RSV vaccine candidate, also
with and without aluminum phosphate as an adjuvant, enrolling 220 elderly adults. Top-line results are expected to be reported
in the first half of 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>License Agreement
with LG Life Sciences, Ltd. (LGLS)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2011, we
entered into a license agreement with LGLS that allows LGLS to use our technology to develop and commercially sell our influenza
vaccines in South Korea and certain other emerging-market countries. LGLS received an exclusive license to our influenza VLP technology
in South Korea and a non-exclusive license in the other specified countries. At its own cost, LGLS is responsible for funding its
clinical development of the influenza VLP vaccines and completing a manufacturing facility in South Korea. We received an upfront
payment and may receive reimbursements of certain development and product costs, payments related to the achievement of certain
milestones and royalty payments at a rate between 10% and 20% from LGLS&rsquo;s future commercial sales of influenza VLP vaccines,
which royalty rate is subject to reduction if certain timelines for regulatory licensure are not met.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Clinical Development
Agreement with PATH Vaccine Solutions (PATH)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In July 2012, we entered
into a clinical development agreement with PATH to develop our vaccine candidate to protect against RSV through maternal immunization
in low-resource countries (the &ldquo;RSV Collaboration Program&rdquo;). We were awarded approximately $2.0 million by PATH for
initial funding under the agreement to partially support our Phase II dose-ranging clinical trial in women of childbearing age
as described above. The agreement would expire July 31, 2013, unless we and PATH decide to continue the RSV Collaboration Program.
We retain global rights to commercialize the product and have made a commitment to make the vaccine affordable and available in
low-resource countries. To the extent PATH has continued to fund 50% of our external clinical development costs for the RSV Collaboration
Program, but we do not continue development, we would then grant PATH a fully-paid license to our RSV vaccine technology for use
in pregnant women in such low-resource countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Sales of Common
Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2012, the
Company sold 12,385,321 shares of its common stock to two affiliates of RA Capital Management, LLC (RA Capital), three affiliates
of Camber Capital Management LLC and three affiliates of Ayer Capital Management LLC at a price of $2.18 per share, resulting in
approximately $26.9 million in net proceeds. The shares were offered under an effective shelf registration statement previously
filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
of the Company (the &ldquo;Board&rdquo;) has appointed a standing Finance Committee (the &ldquo;Committee&rdquo;) to assist the
Board with its responsibilities to monitor, provide advice to senior management of the Company and approve all capital raising
activities. The Committee has been authorized by the Board to approve all At Market Issuance sales transactions. In doing so, the
Committee sets the amount of shares to be sold, the period of time during which such sales may occur and the minimum sales price
per share. In September 2012, the Company entered into an At Market Issuance Sales Agreement, under which the Company may sell
an aggregate of $50 million in gross proceeds of its common stock. This agreement replaces the previous sales agreement entered
in March 2010, which also allowed for the sale of an aggregate of $50 million in gross proceeds of its common stock, but had recently
met its limitation of sales of shares. The shares of common stock are being offered pursuant to a shelf registration statement
filed with the SEC. For the nine months ended September 30, 2012, the Company sold 8.4 million shares at an average sales price
of $1.70 per share, resulting in $14.0 million in net proceeds; this amount excludes $0.8 million received in early 2012 for 0.7
million shares traded in late December 2011. Since entering into the March 2010 sales agreement through November 7, 2012, the Company
has sold 24,957,715 shares of its common stock and received gross proceeds of $49.9 million. No sales have occurred under the September
2012 sales agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2012, we sold
10,000,000 shares of our common stock to two affiliates of RA Capital at a price of $1.22 per share, resulting in $12.1 million
in net proceeds. The shares were offered under an effective shelf registration statement previously filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Critical Accounting
Policies and Use of Estimates </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">There are no material
changes to the Company&rsquo;s critical accounting policies as described in Item&nbsp;7 of the Company&rsquo;s Annual Report on
Form 10-K for the fiscal year ended December&nbsp;31, 2011, as filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in"><B><I>Recent Accounting
Pronouncements Not Yet Adopted</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">We have considered
the applicability and impact of all Financial Accounting Standards Board&rsquo;s Accounting Standards Updates (ASUs). Recently
issued ASUs were evaluated and determined to be not applicable in this Quarterly Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"><B>Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a
discussion of the historical financial condition and results of operations of the Company and should be read in conjunction with
the financial statements and notes thereto set forth in this Quarterly Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Three Months Ended September 30, 2012
and 2011 </B>(amounts in tables are presented in thousands, except per share information)</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Revenue:</U></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Three Months Ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September 30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: black"><B>Change
    2011 to 2012</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-left: 5.4pt">Revenue:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Total revenue</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">5,765</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">5,008</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">757</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue for the three
months ended September 30, 2012 was $5.8 million as compared to $5.0 million for the same period in 2011, an increase of $0.8 million
or 15%. Revenue for 2012 and 2011 is primarily comprised of services performed under the HHS BARDA contract that was awarded in
February 2011. The increase in revenue relates to increased costs associated with our product development activities and clinical
trials performed under the HHS BARDA contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue for the three
months ended September 30, 2012 was negatively impacted due to the Company electing to conduct the 205 Trial without immediate
HHS BARDA reimbursement of its outside clinical trial costs, which are expected to total approximately $3.1 million, of which $0.4
million was incurred during the three months ended September 30, 2012 (see discussion of the 205 Trial in <I>Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&mdash;Overview</I> on page 17). In July 2012, we reported
that we expected to launch our next quadrivalent Phase II clinical trial in 2013 rather than in the second half of 2012; similarly,
the filing of the Quadrivalent IND, which we had previously indicated was expected in the second half of 2012 will also be delayed.
Until then, we will not record revenue associated with the outside clinical trial costs of our 205 Trial and such costs will be
expensed and included in cost of government contracts revenue. For 2012, we expect to generate significant revenue from conducting
multiple clinical trials, ongoing process development and the manufacture of clinical materials under the HHS BARDA contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Costs and Expenses:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Three Months Ended <BR>September 30,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Change 2011 to 2012</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Costs and Expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Cost of government contracts revenue</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">3,838</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">2,190</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,648</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 5.4pt">Research and development</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,395</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,049</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,346</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">General and administrative</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,381</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,737</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(356</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total costs and expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12,614</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">8,976</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,638</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B><I>Cost
of Government Contracts Revenue</I></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of government
contracts revenue was $3.8 million for the three months ended September 30, 2012 as compared to $2.2 million for the same period
in 2011, an increase of $1.6 million, primarily due to increased costs associated with our product development activities and clinical
trials performed under the HHS BARDA contract that was awarded in February 2011. These costs include direct costs of salaries,
laboratory supplies, consultants and subcontractors and other direct costs associated with our process development, manufacturing,
clinical, regulatory and quality assurance activities under government research contracts.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of government
contracts revenue for the three months ended September 30, 2012 includes $0.4 million of direct clinical trial costs of our 205
Trial (see discussion of the 205 Trial in <I>Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&mdash;Overview</I>
on page 17). For 2012, we expect a significant increase in the cost of government contracts revenue from conducting multiple clinical
trials, ongoing process development and the manufacture of clinical materials under the HHS BARDA contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B><I>Research
and Development Expenses</I></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">Research and development
expenses were $6.4 million for the three months ended September 30, 2012, as compared to $4.0 million for the same period in 2011,
an increase of $2.3 million or 58%, primarily due to increased costs relating to our RSV clinical trials, higher employee-related
costs and expenses associated with our new manufacturing facility. Research and development expenses include salaries, laboratory
supplies, consultants and subcontractors and other expenses associated with our process development, manufacturing, clinical, regulatory
and quality assurance activities for internally funded programs and our collaboration agreements. In addition, indirect costs,
such as fringe benefits and overhead expenses, are also included in research and development expenses. For 2012, we expect a continued
increase in research and development expenses primarily due to two anticipated clinical trials in RSV (an internally funded program
at this time), higher employee-related costs and expenses associated with our new manufacturing facility.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Costs
and Expenses by Functional Area</I></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We track our cost of
contract revenue and research and development expenses by the type of costs incurred in identifying, developing, manufacturing
and testing vaccine candidates. We evaluate and prioritize our activities according to functional area and therefore believe that
project-by-project information would not form a reasonable basis for disclosure to our investors. At September 30, 2012, we had
98 employees dedicated to our research and development programs versus 83 employees as of September 30, 2011. Historically, we
did not account for internal research and development expenses by project, since our employees work time is spread across multiple
programs and our internal manufacturing clean-room facility produces multiple vaccine candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summarizes
our cost of government contracts revenue and research and development expenses by functional area for the three months ended September
30 (in millions).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 72%; font-size: 10pt; padding-left: 40.5pt">Manufacturing</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">5.0</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">3.3</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 40.5pt">Vaccine Discovery</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.9</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.8</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 40.5pt">Clinical &amp; Regulatory</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4.3</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2.1</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 49.5pt">Total cost of government contracts revenue and research and development expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10.2</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6.2</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not provide forward-looking
estimates of costs and time to complete our research programs due to the many uncertainties associated with vaccine development.
As we obtain data from pre-clinical studies and clinical trials, we may elect to discontinue or delay trials in order to focus
our resources on more promising vaccine candidates. Completion of trials may take several years or more, but the length of time
can vary substantially depending upon the phase, size of trial, primary and secondary endpoints and the intended use of the vaccine
candidate. The cost of clinical trials may vary significantly over the life of a project as a result of a variety of factors, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the number of patients who participate in the trials;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the number of sites included in the trials;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if trial locations are domestic, international or both;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the time to enroll patients;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the duration of treatment and follow-up;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the safety and efficacy profile of the vaccine candidate; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the cost and timing of, and the ability to secure, regulatory approvals.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 33pt">As a result of these
uncertainties, we are unable to determine with any significant degree of certainty the duration and completion costs of our research
and development projects or when, and to what extent, we will generate future cash flows from our research projects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>General</I></B></FONT><B><I>
and Administrative Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">General and administrative
expenses were $2.4 million for the three months ended September 30, 2012 as compared to $2.7 million for the same period in 2011,
a decrease of $0.4 million or 13%. The decrease in expenses was primarily due to lower professional fees, partially offset by non-cash
expenses associated with our new office facility. For 2012, we expect a slight decrease in general and administrative expenses
primarily due to lower employee-related costs, including severance expenses, partially offset by non-cash expenses associated with
our new office facility that we leased along with our new manufacturing facility.</P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Other Income
(Expense):</U></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Three Months Ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September 30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: black"><B>Change
    2011 to 2012</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Other Income (Expense):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Interest income</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">39</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">22</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">17</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 5.4pt">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Change in fair value of warrant liability</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(401</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">736</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,137</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total other income (expense)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(365</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">756</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,121</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We had total other
expense of $0.4 million for the three months ended September 30, 2012 compared to total other income of $0.8 million for the same
period in 2011, a change of $1.1 million. We are required to calculate the fair value of our warrant liability at each reporting
period. For the three months ended September 30, 2012 as compared to the same period in 2011, the change in the fair value of the
warrant liability resulted in a $1.1 million decrease in total other income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Net Loss:</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Three Months Ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><B>September 30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Change 2011
to 2012</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Net Loss:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Net loss</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(7,217</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(3,212</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(4,005</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">Net loss per share</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(0.05</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(0.03</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(0.02</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">Weighted shares outstanding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">134,178</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">115,107</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,071</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net loss for the three
months ended September 30, 2012 was $7.2<B> </B>million, or $0.05 per share, as compared to $3.2 million, or $0.03 per share, for
the same period in 2011, an increased net loss of $4.0<B> </B>million, or 125%. The increase in net loss is primarily due to higher
research and development costs and lower other income relating to the change in fair value of our warrant liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The increase in weighted
shares outstanding for the three months ended September 30, 2012 is primarily a result of sales of our common stock under our At
Market Issuance Sales Agreement and to RA Capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nine Months Ended September 30, 2012
and 2011 </B>(amounts in tables are presented in thousands, except per share information)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Revenue:</U></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nine Months Ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September 30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: black"><B>Change
    2011 to 2012</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-left: 5.4pt">Revenue:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Total revenue</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">17,510</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">8,843</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">8,667</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue for the nine
months ended September 30, 2012 was $17.5 million as compared to $8.8 million for the same period in 2011, an increase of $8.7
million or 98%. Revenue for 2012 and 2011 is primarily comprised of services performed under the HHS BARDA contract that was awarded
in February 2011. The increase in revenue relates to increased costs associated with our product development activities and clinical
trials performed under the HHS BARDA contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue for the nine
months ended September 30, 2012 was negatively impacted due to the Company electing to conduct the 205 Trial without immediate
HHS BARDA reimbursement of its outside clinical trial costs, which are expected to total approximately $3.1 million, of which $2.8
million was incurred through September 30, 2012 (see discussion of the 205 Trial in <I>Management&rsquo;s Discussion and Analysis
of Financial Condition and Results of Operations&mdash;Overview</I> on page 17). In July 2012, we reported that we expected to
launch our next quadrivalent Phase II clinical trial in 2013 rather than in the second half of 2012; similarly, the filing of the
Quadrivalent IND, which we had previously indicated was expected in the second half of 2012 will also be delayed. Until then, we
will not record revenue associated with the outside clinical trial costs of our 205 Trial and such costs will be expensed and included
in cost of government contracts revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Costs and Expenses:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nine Months Ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September 30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Change 2011
    to 2012</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Costs and Expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Cost of government contracts revenue</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">12,740</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">3,763</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">8,977</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 5.4pt">Research and development</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,649</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,474</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,175</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">General and administrative</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">8,291</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">8,926</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(635</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total costs and expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">37,680</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">26,163</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">11,517</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B><I>Cost
of Government Contracts Revenue</I></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of government
contracts revenue was $12.7 million for the nine months ended September 30, 2012 as compared to $3.8 million for the same period
in 2011, an increase of $9.0 million, primarily due to increased costs associated with our product development activities and clinical
trials performed under the HHS BARDA contract that was awarded in February 2011. These costs include direct costs of salaries,
laboratory supplies, consultants and subcontractors and other direct costs associated with our process development, manufacturing,
clinical, regulatory and quality assurance activities under government research contracts.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of government
contracts revenue for the nine months ended September 30, 2012 includes $2.6 million of direct clinical trial costs of our 205
Trial (see discussion of the 205 Trial in <I>Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&mdash;Overview</I>
on page 17).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B><I>Research
and Development Expenses</I></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development
expenses were $16.6 million for the nine months ended September 30, 2012 as compared to $13.5 million for the same period in 2011,
an increase of $3.2 million or 24%, primarily due to higher employee-related costs and expenses associated with our new manufacturing
facility, partially offset by higher RSV clinical trial costs in 2011. Research and development expenses include salaries, laboratory
supplies, consultants and subcontractors and other expenses associated with our process development, manufacturing, clinical, regulatory
and quality assurance activities for internally funded programs and our collaboration agreements. In addition, indirect costs,
such as fringe benefits and overhead expenses, are also included in research and development expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Costs
and Expenses by Functional Area</I></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summarizes
our cost of government contracts revenue and research and development expenses by functional area for the nine months ended September
30 (in millions).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 72%; font-size: 10pt; padding-left: 40.5pt">Manufacturing</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">14.2</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">9.5</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 40.5pt">Vaccine Discovery</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.5</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.4</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 40.5pt">Clinical &amp; Regulatory</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12.7</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5.3</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 49.5pt">Total cost of government contracts revenue and research and development expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">29.4</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17.2</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>General</I></B></FONT><B><I>
and Administrative Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify; text-indent: 0.5in">General and administrative
expenses were $8.3 million for the nine months ended September 30, 2012 as compared to $8.9 million for the same period in 2011,
a decrease of $0.6 million or 7%. The decrease in expenses was primarily due to lower employee-related costs, including severance
expenses, partially offset by non-cash expenses associated with our new office facility.</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Other Income
(Expense):</U></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nine Months Ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September 30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: black"><B>Change
    2011 to 2012</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Other Income (Expense):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Interest income</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">111</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">106</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">5</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 5.4pt">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(12</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(6</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(6</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Change in fair value of warrant liability</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(401</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,973</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,374</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total other income (expense)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(302</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,073</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,375</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We had total other
expense of $0.3 million for the nine months ended September 30, 2012 compared to total other income of $2.1 million for the same
period in 2011, a change of $2.4 million. We are required to calculate the fair value of our warrant liability at each reporting
period. For the nine months ended September 30, 2012 as compared to the same period in 2011, the change in fair value of the warrant
liability resulted in a $2.4 million decrease in total other income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Income Tax:</U></B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nine Months Ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September 30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; color: black; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: black"><B>Change
    2011 to 2012</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">Income Tax:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Total income tax expense</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">412</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(412</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income tax expense
for the nine months ended September 30, 2011 was $0.4 million. We incurred a foreign withholding tax related to a payment received
in accordance with a license agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Net Loss:</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nine Months Ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>September 30,</B></P></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Change 2011
to 2012</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Net Loss:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; padding-left: 5.4pt">Net loss</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(20,472</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(15,659</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(4,813</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">Net loss per share</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(0.16</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(0.14</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(0.02</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">Weighted shares outstanding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">127,246</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">113,053</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,193</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net loss for the nine
months ended September 30, 2012 was $20.5<B> </B>million, or $0.16 per share, as compared to $15.7 million, or $0.14 per share,
for the same period in 2011, an increased net loss of $4.8<B> </B>million, or 31%. The increase in net loss is primarily due to
higher research and development costs and lower other income relating to the change in the fair value of our warrant liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The increase in weighted
shares outstanding for the nine months ended September 30, 2012 is primarily a result of sales of our common stock under our At
Market Issuance Sales Agreement and to RA Capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Liquidity Matters
and Capital Resources</B></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future capital
requirements depend on numerous factors including, but not limited to, the commitments and progress of our research and development
programs, the progress of pre-clinical and clinical testing, the time and costs involved in obtaining regulatory approvals, the
costs of filing, prosecuting, defending and enforcing patent claims and other intellectual property rights and manufacturing costs.
We plan to continue to have multiple vaccines and products in various stages of development, and we believe our operating expenses
and capital requirements will fluctuate depending upon the timing of certain events, such as the scope, initiation, rate and progress
of our pre-clinical studies and clinical trials and other research and development activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of September 30,
2012, we had $28.4 million in cash and cash equivalents and short-term investments as compared to $18.3 million as of December
31, 2011, which consists of $10.7 million in cash and cash equivalents and $17.7 million in short-term investments as of September
30, 2012 as compared to $14.1 million and $4.2 million, respectively, at December 31, 2011. The following table summarizes cash
flows for the nine months ended September 30, 2012 and 2011 (in thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Nine Months Ended <BR>September 30,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2011</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Change 2011<BR>

    to 2012</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">Summary of Cash Flows:</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 1.75pt">Net cash (used in) provided by:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 58%; font-size: 10pt; text-align: left; text-indent: 9pt; padding-left: 1.75pt">Operating activities</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(14,139</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(20,760</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">6,621</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: 9pt; padding-left: 1.75pt">Investing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(15,147</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,739</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(32,886</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 9pt; padding-left: 1.75pt">Financing activities</TD><TD STYLE="font-size: 10pt; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">25,920</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">9,278</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">16,642</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 1.75pt">Net (decrease) increase in cash and cash equivalents</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3,366</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,257</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(9,623</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 1.75pt">Cash and cash equivalents at beginning of period</TD><TD STYLE="font-size: 10pt; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">14,104</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">8,061</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">6,043</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 1.75pt">Cash and cash equivalents at end of period</TD><TD STYLE="font-size: 10pt; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">10,738</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">14,318</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; color: black; text-align: right">(3,580</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; color: black; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used in operating
activities decreased to $14.1<B> </B>million for the nine months ended September 30, 2012 as compared to $20.8 million for the
same period in 2011, respectively. The decrease in cash usage was primarily due to the timing of our vendor payments and funds
received under our Improvement Allowance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months
ended September 30, 2012 and 2011, our investing activities included purchases and maturities of short-term investments and capital
expenditures. In the nine months ended September 30, 2012, we primarily purchased short-term investments to increase our rate of
return on our investments. In the same period in 2011, we primarily utilized our short-term investments to fund operations and
increase our cash balances. Capital expenditures for the nine months ended September 30, 2012 and 2011 were $2.2 million and $0.4
million, respectively. The increase in capital expenditures was primarily due to purchase of laboratory equipment and tenant improvements
relating to our new manufacturing facility. For 2012, we expect our level of capital expenditures to increase in connection with
the scale-up of our new manufacturing facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The increase in our
financing activities consists primarily of increased sales of our common stock. We received net proceeds of $26.9 million in the
nine months ended September 30, 2012 as compared to $9.2 million in the same period of 2011 from the sale of our common stock to
RA Capital and through our At Market Issuance Sales Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&nbsp;2011,
we entered into lease agreements, under which we lease our new manufacturing, laboratory and office space in Gaithersburg, Maryland.
The lease agreements provide that, among other things, as of January 1, 2012,&nbsp;we sublease from the current facility tenant,
and subsequently lease directly from the landlord, approximately 74,000 total square feet, with rent payments for such space to
the landlord commencing April 1, 2014. Under the terms of the arrangement, the Landlord will provide us with a tenant improvement
allowance of $2.5 million and an additional tenant improvement allowance of $3 million (collectively, the Improvement Allowance).
The additional tenant improvement allowance is to be paid back to the Landlord over the remaining term of the lease agreement with
an effective interest rate of 8.0%. During the nine months ended September 30, 2012, the Company was funded $2.8 million. In addition,
we purchased laboratory equipment under an agreement with the then current facility tenant and are currently renovating the new
facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into
agreements with outside providers to support our clinical development. As of September 30, 2012, $8.0 million remains unpaid on
certain of these agreements in the event our outside providers complete their services in 2012. However, under the terms of the
agreements, we have the option to terminate for convenience pursuant to notification, but we would be obligated to pay the provider
for all costs incurred through the effective date of termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have licensed certain
rights from Wyeth. The Wyeth license, which provides for an upfront payment, annual license fees, milestone payments and royalties
on any product sales, is a non-exclusive, worldwide license to a family of patent applications covering VLP technology for use
in human vaccines in certain fields; the license may be terminated by Wyeth only for cause and may be terminated by us only after
we have provided ninety (90) days notice that we have absolutely and finally ceased activity, including through any affiliate or
sublicense, related to the manufacturing, development, marketing or sale of products covered by the license. Payments under the
agreement to Wyeth from 2007 through September 30, 2012 totaled $5.5&nbsp;million, of which $0.4 million was paid in the nine months
ended September 30, 2012. We do not expect to make a milestone payment to Wyeth in the next twelve months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
our JV with Cadila, we entered into a master services agreement, which we and Cadila amended in July 2011 to extend the term by
one year for which services can be provided by Cadila under this agreement. Under the revised terms, if by March 2013, the amount
of services provided by Cadila under the master services agreement is less than $7.5 million, the Company will pay Cadila the portion
of the shortfall amount that is less than or equal to $2.0 million and 50% of the portion of the shortfall amount that exceeds
$2.0 million. Through September 30, 2012, we have purchased $0.4 million in services from Cadila pursuant to this agreement. We
plan to explore with Cadila ways to potentially reduce our financial obligation and/or extend the time period during which we could
utilize such services. We can provide no assurance, however, that these efforts will be successful. If we fail to negotiate a change
in this arrangement, we expect that we will be obligated to spend a significant portion of our available cash and cash equivalents
to pay Cadila for our shortfall in services purchased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on our current
cash and cash equivalents and short-term investments, including our recent private equity offering, anticipated revenue under the
contract with HHS BARDA that was awarded in February 2011, possible proceeds from the sales of our common stock under our At Market
Issuance Sales Agreement and our current business operations, we believe we have adequate capital resources available to operate
at planned levels for at least the next twenty-four months. Additional capital will be required in the future to develop our vaccine
candidates through clinical development, manufacturing and commercialization. Our ability to obtain such additional capital is
subject to various factors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">generating revenue under the HHS BARDA contract is subject to our performance under the contract,
including our ability to collect on delayed reimbursement situations, such as the 205 Trial costs; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">raising funds under our At Market Issuance Sales Agreement is subject to both our business performance
and market conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, we may seek
additional capital through further public or private equity offerings, debt financing, additional strategic alliance and licensing
arrangements, non-dilutive government contracts, collaborative arrangements or some combination of these financing alternatives.
Any capital raised by an equity offering will likely be substantially dilutive to the existing stockholders and any licensing or
development arrangement may require us to give up rights to a product or technology at less than its full potential value. Other
than our At Market Issuance Sales Agreement, Equipment Loan and Improvement Allowance, we have not secured any additional commitments
for new financing nor can we provide any assurance that new financing will be available on commercially acceptable terms, if at
all. If we are unable to perform under the HHS BARDA contract or obtain additional capital, we will assess our capital resources
and will likely be required to delay, reduce the scope of, or eliminate one or more of our product research and development programs,
and/or downsize our organization, including our general and administrative infrastructure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 3.&#9;Quantitative and Qualitative
Disclosures About Market Risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The primary objective
of our investment activities is to preserve our capital until it is required to fund operations while at the same time maximizing
the income we receive from our investments without significantly increasing risk. As of September 30, 2012, we had cash and cash
equivalents of $10.7 million, short-term investments of $17.7 million and working capital of $26.0 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our exposure to market
risk is primarily confined to our investment portfolio. As of September 30, 2012, our short-term investments were classified as
available-for-sale. We do not believe that a change in the market rates of interest would have any significant impact on the realizable
value of our investment portfolio. Changes in interest rates may affect the investment income we earn on our investments when they
mature and the proceeds are reinvested into new investments and, therefore, could impact our cash flows and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2007, we invested
in auction rate securities as part of our cash management program. Short-term investments at September 30, 2012 are comprised of
investments in commercial paper, corporate notes and three auction rate securities with a par value of $5.1 million and a fair
value of $4.4 million. At September 30, 2012, we have recorded $1.0 million in unrealized gains on the auction rate securities
included in accumulated other comprehensive income on the balance sheet. These investments are classified within current assets
because we may need to liquidate these securities within the next year to fund our ongoing operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interest and dividend
income is recorded when earned and included in interest income. Premiums and discounts, if any, on short-term investments are amortized
or accreted to maturity and included in interest income. The specific identification method is used in computing realized gains
and losses on the sale of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are headquartered
in the U.S. where we conduct the vast majority of our business activities. Accordingly, we have not had any material exposure to
foreign currency rate fluctuations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not have material
debt and, as such, do not believe that we are exposed to any material interest rate risk as a result of our borrowing activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;4. Controls and Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Evaluation of Disclosure Controls and Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management, with
the assistance of our Chief Executive Officer and Chief Financial Officer, has reviewed and evaluated the effectiveness of our
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended)
as of September 30, 2012. Management recognizes that any controls and procedures, no matter how well designed and operated, can
provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the
cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable
assurance of achieving their control objectives. Based on the evaluation of our disclosure controls and procedures as of September
30, 2012, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and
procedures were effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Changes in Internal Control over Financial Reporting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management, including
our Chief Executive Officer and Chief Financial Officer, has evaluated any changes in our internal control over financial reporting
that occurred during the third quarter of 2012, and has concluded that there was no change that occurred during the third quarter
of 2012 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II. OTHER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;1A. Risk Factors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no material
changes to the Company&rsquo;s risk factors as described in Item&nbsp;1A of the Company&rsquo;s Annual Report on Form 10-K for
the fiscal year ended December&nbsp;31, 2011, as filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;6. Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Exhibits marked with
a single asterisk (*) are filed herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; padding-right: 0.25in; padding-bottom: 12pt; padding-left: 0.25in; text-align: left; vertical-align: top">10.1</TD>
    <TD STYLE="width: 88%; padding-bottom: 12pt; padding-left: 4pt; text-align: justify">At Market Issuance Sales Agreement, dated October 1, 2012, by and between Novavax, Inc. and MLV &amp; Co. LLC (Incorporated by reference to Exhibit 1.1 to the Company&rsquo;s Current Report on Form 8-K, filed October 2, 2012)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.25in; padding-bottom: 12pt; padding-left: 0.25in; text-align: left; vertical-align: top">31.1*</TD>
    <TD STYLE="padding-bottom: 12pt; padding-left: 4pt; text-align: justify">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(e) of the Securities Exchange Act</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.25in; padding-bottom: 12pt; padding-left: 0.25in; text-align: left; vertical-align: top">31.2*</TD>
    <TD STYLE="padding-bottom: 12pt; padding-left: 4pt; text-align: justify">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(e) of the Securities Exchange Act&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.25in; padding-bottom: 12pt; padding-left: 0.25in; text-align: left; vertical-align: top">32.1*</TD>
    <TD STYLE="padding-bottom: 12pt; padding-left: 4pt; text-align: justify">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.25in; padding-bottom: 12pt; padding-left: 0.25in; text-align: left; vertical-align: top">32.2*</TD>
    <TD STYLE="padding-bottom: 12pt; padding-left: 4pt; text-align: justify">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3"><B>NOVAVAX, INC.</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: November 9, 2012</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 23%; border-bottom: Black 1pt solid">/s/ Stanley C. Erck</TD>
    <TD STYLE="vertical-align: top; width: 23%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">President and Chief Executive Officer <BR>
and Director (Principal Executive Officer)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3"></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: November 9, 2012</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 23%; border-bottom: Black 1pt solid">/s/ Frederick W. Driscoll</TD>
    <TD STYLE="vertical-align: top; width: 23%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">Vice President, Chief Financial Officer and <BR>
Treasurer <BR>
(Principal Financial and Accounting Officer)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt"></P>

<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>v326292_31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Stanley C. Erck, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>I have reviewed this Quarterly Report on Form 10-Q of Novavax, Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present
in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a)</TD><TD STYLE="text-align: justify">designed such disclosure controls and procedures, or caused such disclosure controls and procedures
to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being
prepared;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b)</TD><TD STYLE="text-align: justify">designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">c)</TD><TD STYLE="text-align: justify">evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented
in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluations; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">d)</TD><TD STYLE="text-align: justify">disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting
that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case
of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal
control over financial reporting; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or
persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: November 9, 2012</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Stanley C. Erck</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">President and Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>v326292_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL
AND ACCOUNTING OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Frederick W. Driscoll, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>I have reviewed this Quarterly Report on Form 10-Q of Novavax, Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present
in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under
our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report
based on such evaluations; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during
the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial
reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or
persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">

<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: November 9, 2012</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Frederick W. Driscoll</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Vice President, Chief Financial Officer and Treasurer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>v326292_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO 18 UNITED STATES C. &sect;1350<BR>
(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the Quarterly Report of Novavax, Inc. (the &ldquo;Company&rdquo;) on Form 10-Q for the fiscal period ended September 30, 2012 as
filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Stanley C. Erck, President
and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. &sect;1350, as adopted pursuant to Section&nbsp;906
of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company for the dates and periods covered by this Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">

<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: November 9, 2012</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Stanley C. Erck</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">President and Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>v326292_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL
AND ACCOUNTING OFFICER PURSUANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO 18 UNITED STATES C. &sect;1350<BR>
(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the Quarterly Report of Novavax, Inc. (the &ldquo;Company&rdquo;) on Form 10-Q for the fiscal period ended September 30, 2012 as
filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Frederick W. Driscoll, Vice
President, Chief Financial Officer and Treasurer, hereby certify, pursuant to 18 U.S.C. &sect;1350, as adopted pursuant to Section&nbsp;906
of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company for the dates and periods covered by this Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: November 9, 2012</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Frederick W. Driscoll</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Vice President, Chief Financial Officer and Treasurer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>nvax-20120930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Vintage Filings Powered By P3XBRL http://www.p3xbrl.com-->
<!--version 4.1.22 -->
<!--produced on 2012-11-08 @ 9:37 PM-->
<xbrl xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nvax="http://www.novavax.com/20120930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:ISO4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns="http://www.xbrl.org/2003/instance">
  <link:schemaRef xlink:type="simple" xlink:href="nvax-20120930.xsd" />
  <dei:AmendmentFlag id="AmendmentFlag.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate id="CurrentFiscalYearEndDate.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus id="DocumentFiscalPeriodFocus.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">Q3</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus id="DocumentFiscalYearFocus.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">2012</dei:DocumentFiscalYearFocus>
  <dei:DocumentPeriodEndDate id="DocumentPeriodEndDate.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">2012-09-30</dei:DocumentPeriodEndDate>
  <dei:DocumentType id="DocumentType.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">10-Q</dei:DocumentType>
  <dei:EntityCentralIndexKey id="EntityCentralIndexKey.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">0001000694</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding id="EntityCommonStockSharesOutstanding.1291.0.0.0.0.0.0" contextRef="as-of-2012-10-31.1291.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">147941442</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityFilerCategory id="EntityFilerCategory.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityRegistrantName id="EntityRegistrantName.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">NOVAVAX INC.</dei:EntityRegistrantName>
  <dei:TradingSymbol id="TradingSymbol.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">NVAX</dei:TradingSymbol>
  <nvax:AdditionalTenantImprovementAllowance id="AdditionalTenantImprovementAllowance.1343.0.0.0.0.0.0" contextRef="as-of-2011-11-30.1343.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">3000000</nvax:AdditionalTenantImprovementAllowance>
  <nvax:AuctionRateSecuritiesParValue id="AuctionRateSecuritiesParValue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">5100000</nvax:AuctionRateSecuritiesParValue>
  <nvax:AverageSharePrice id="AverageSharePrice.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">1.70</nvax:AverageSharePrice>
  <nvax:CapitalLeaseObligationEquipmentPurchased id="CapitalLeaseObligationEquipmentPurchased.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">399000</nvax:CapitalLeaseObligationEquipmentPurchased>
  <nvax:CapitalLeaseObligationEquipmentPurchased id="CapitalLeaseObligationEquipmentPurchased.1299.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <nvax:CapitalLeasePeriodicPayment id="CapitalLeasePeriodicPayment.1332.0.0.0.0.0.0" contextRef="from-2012-08-01-to-2012-08-31.1332.0.0.0.0.0.0.0" unitRef="USD" decimals="0">6325</nvax:CapitalLeasePeriodicPayment>
  <nvax:CapitalLeasesOfLesseeEffectiveInterestRate id="CapitalLeasesOfLesseeEffectiveInterestRate.1333.0.0.0.0.0.0" contextRef="as-of-2012-08-31.1333.0.0.0.0.0.0.0" unitRef="UPure" decimals="3">0.065</nvax:CapitalLeasesOfLesseeEffectiveInterestRate>
  <nvax:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.1337.0.0.0.0.0.0" contextRef="as-of-2008-07-31.1337.0.0.0.0.0.0.0" unitRef="UPerUnit" decimals="1">0.5</nvax:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <nvax:ClinicalTrialCostsIncurred id="ClinicalTrialCostsIncurred.1298.24606.999.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24606.999.0.0.0.0" unitRef="USD" decimals="-5">2800000</nvax:ClinicalTrialCostsIncurred>
  <nvax:CommonSharesPerUnit id="CommonSharesPerUnit.1337.0.0.0.0.0.0" contextRef="as-of-2008-07-31.1337.0.0.0.0.0.0.0" unitRef="UPerUnit" decimals="0">1.0</nvax:CommonSharesPerUnit>
  <nvax:CommonStockValueAuthorized id="CommonStockValueAuthorized.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">50000000</nvax:CommonStockValueAuthorized>
  <nvax:CommonStockValueAuthorizedPriorAgreement id="CommonStockValueAuthorizedPriorAgreement.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">50000000</nvax:CommonStockValueAuthorizedPriorAgreement>
  <nvax:ContractTerm id="ContractTerm.1328.24606.999.0.0.0.0" contextRef="from-2011-02-01-to-2011-02-28.1328.0.24606.999.0.0.0.0">P36M</nvax:ContractTerm>
  <nvax:ContractTerm id="ContractTerm.1328.24607.999.0.0.0.0" contextRef="from-2011-02-01-to-2011-02-28.1328.0.24607.999.0.0.0.0">P24M</nvax:ContractTerm>
  <nvax:DebtInstrumentTerm id="DebtInstrumentTerm.1334.0.0.0.0.0.0" contextRef="from-2012-09-01-to-2012-09-30.1334.0.0.0.0.0.0.0">P42M</nvax:DebtInstrumentTerm>
  <nvax:DepositsForAcquisitionOfPropertyAndEquipment id="DepositsForAcquisitionOfPropertyAndEquipment.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">500000</nvax:DepositsForAcquisitionOfPropertyAndEquipment>
  <nvax:DepositsForAcquisitionOfPropertyAndEquipment id="DepositsForAcquisitionOfPropertyAndEquipment.1299.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <nvax:ExpectedClinicalTrialCosts id="ExpectedClinicalTrialCosts.1292.24606.999.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24606.999.0.0.0.0" unitRef="USD" decimals="-5">3100000</nvax:ExpectedClinicalTrialCosts>
  <nvax:JointVenturePercentageOwnedByOthers id="JointVenturePercentageOwnedByOthers.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UPure" decimals="1">0.8</nvax:JointVenturePercentageOwnedByOthers>
  <nvax:LeasedFacilitySquareFootage id="LeasedFacilitySquareFootage.1341.0.0.0.0.0.0" contextRef="from-2011-11-01-to-2011-11-30.1341.0.0.0.0.0.0.0" unitRef="UPure" decimals="0">74000</nvax:LeasedFacilitySquareFootage>
  <nvax:LeaseTerm id="LeaseTerm.1332.0.0.0.0.0.0" contextRef="from-2012-08-01-to-2012-08-31.1332.0.0.0.0.0.0.0">P59M</nvax:LeaseTerm>
  <nvax:LiquidityMattersDisclosureTextBlock id="LiquidityMattersDisclosureTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 2 - Liquidity Matters&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company&amp;#39;s vaccine candidates currently under development will require significant additional research and development efforts that include extensive pre-clinical and clinical testing, and regulatory approval prior to commercial use. The Company&amp;#39;s research and development efforts may not be successful and any potential vaccine candidates may not prove to be safe and effective in clinical trials. Even if developed, these vaccine candidates may not receive regulatory approval or be successfully introduced and marketed at prices that would permit the Company to operate profitably. The commercial launch of any vaccine is subject to significant risks including, but not limited to, manufacturing scale-up and market acceptance.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Since its inception, the Company has incurred, and continues to incur, significant losses from operations. At September 30, 2012, the Company had cash and cash equivalents of $10.7 million and short-term investments with a fair value of $17.7 million. In October 2012, the Company raised $27 million through the sale of common stock to institutional investors (See Note 12).&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Based on the Company&amp;#39;s current cash and cash equivalents and short-term investments, including its recent private equity offering, anticipated revenue under the contract with the Department of Health and Human Services, Biomedical Advanced Research and Development Authority ("HHS BARDA") that was awarded in February 2011, possible proceeds from sales of the Company&amp;#39;s common stock under its At Market Issuance Sales Agreement and its current business operations, the Company believes it has adequate capital resources available to operate at planned levels that fund the Company beyond 2013. Additional capital will be required in the future to develop its vaccine candidates through clinical development, manufacturing and commercialization. The Company&amp;#39;s ability to obtain such additional capital is subject to various factors:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 1in; FONT: 10pt Symbol"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 0.75in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; WIDTH: 0.25in"&gt;&amp;middot;&lt;/td&gt; &lt;td style="TEXT-ALIGN: justify"&gt;generating revenue under the HHS BARDA contract is subject to the Company&amp;#39;s performance under the contract, including its ability to collect on delayed reimbursement situations, such as the 205 Trial costs described in Note 5 below; and&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 1in; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 0.75in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; WIDTH: 0.25in"&gt;&amp;middot;&lt;/td&gt; &lt;td style="TEXT-ALIGN: justify"&gt;raising funds under its At Market Issuance Sales Agreement is subject to both its business performance and market conditions.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Further, the Company may seek additional capital through public or private equity offerings, debt financing, strategic alliance and licensing arrangements, non-dilutive government contracts, collaborative arrangements, or some combination of these financing alternatives. Any capital raised by an equity offering, whether public or private, will likely be substantially dilutive to the existing stockholders and any licensing or development arrangement may require the Company to give up rights to a product or technology at less than its full potential value. Other than the Company&amp;#39;s At Market Issuance Sales Agreement, Equipment Loan (See Note 7) and Improvement Allowance (See Note 10), the Company has not secured any additional commitments for new financing, nor can the Company provide any assurance that financing will be available on commercially acceptable terms, if at all. If the Company is unable to perform under the HHS BARDA contract or obtain additional capital, it will assess its capital resources and will likely be required to delay, reduce the scope of, or eliminate one or more of its research and development programs, and/or downsize the organization, including its general and administrative infrastructure.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</nvax:LiquidityMattersDisclosureTextBlock>
  <nvax:LoanAgreementFutureMinimumPaymentsDue id="LoanAgreementFutureMinimumPaymentsDue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">550000</nvax:LoanAgreementFutureMinimumPaymentsDue>
  <nvax:LoanAgreementFutureMinimumPaymentsDueInRollingYearFour id="LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">40000</nvax:LoanAgreementFutureMinimumPaymentsDueInRollingYearFour>
  <nvax:LoanAgreementFutureMinimumPaymentsDueInRollingYearThree id="LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">157000</nvax:LoanAgreementFutureMinimumPaymentsDueInRollingYearThree>
  <nvax:LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo id="LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">157000</nvax:LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo>
  <nvax:LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths id="LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">157000</nvax:LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths>
  <nvax:LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear id="LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">39000</nvax:LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear>
  <nvax:MarketableSecuritiesOriginalMaximumMaturity id="MarketableSecuritiesOriginalMaximumMaturity.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">P1Y</nvax:MarketableSecuritiesOriginalMaximumMaturity>
  <nvax:MarketableSecuritiesOriginalMinimumMaturity id="MarketableSecuritiesOriginalMinimumMaturity.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">P90D</nvax:MarketableSecuritiesOriginalMinimumMaturity>
  <nvax:MasterServiceAgreementPurchases id="MasterServiceAgreementPurchases.2000.0.0.0.0.0.0" contextRef="from-2009-03-31-to-2012-09-30.2000.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">400000</nvax:MasterServiceAgreementPurchases>
  <nvax:MasterServicesAgreementAmountOfServicesToBeProvidedMinimum id="MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.2000.0.0.0.0.0.0" contextRef="from-2009-03-31-to-2012-09-30.2000.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">7500000</nvax:MasterServicesAgreementAmountOfServicesToBeProvidedMinimum>
  <nvax:MasterServicesAgreementTextBlock id="MasterServicesAgreementTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 11 &lt;font style="FONT-WEIGHT: normal"&gt;-&lt;/font&gt; Master Services Agreement with Cadila&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In connection with the JV with Cadila, the Company entered into a master services agreement, which the Company and Cadila amended in July 2011 to extend the term by one year for which services can be provided by Cadila under this agreement. Under the revised terms, if by March 2013, the amount of services provided by Cadila under the master services agreement is less than $7.5 million, the Company will pay Cadila the portion of the shortfall amount that is less than or equal to $2.0 million and 50% of the portion of the shortfall amount that exceeds $2.0 million. Through September 30, 2012, the Company has purchased $0.4 million in services from Cadila pursuant to this agreement. The Company plans to explore with Cadila ways to potentially reduce its financial obligation and/or extend the time period during which the Company could utilize such services. The Company can provide no assurance, however, that these efforts will be successful. If the Company fails to negotiate a change in this arrangement, the Company expects that it will be obligated to spend a significant portion of its available cash and cash equivalents to pay Cadila for our shortfall in services purchased.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</nvax:MasterServicesAgreementTextBlock>
  <nvax:NewFacilityLeaseDisclosureTextBlock id="NewFacilityLeaseDisclosureTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 10 - Manufacturing, Laboratory and Office Facility&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In November 2011, the Company entered into lease agreements, under which the Company leases its new manufacturing, laboratory and office space in Gaithersburg, Maryland. The lease agreements provide that, among other things, as of January 1, 2012, the Company sublease from the current facility tenant, and subsequently lease directly from the landlord, approximately 74,000 total square feet, with rent payments for such space to the landlord commencing April 1, 2014. Under the terms of the arrangement, the Landlord will provide the Company with a tenant improvement allowance of $2.5 million and an additional tenant improvement allowance of $3 million (collectively, the "Improvement Allowance"). The additional tenant improvement allowance is to be paid back to the Landlord over the remaining term of the lease agreement with an effective interest rate of 8.0%. During the nine months ended September 30, 2012, the Company was funded $2.8 million under the Improvement Allowance. In addition, the Company purchased laboratory equipment under an agreement with the then current facility tenant. The Company is currently renovating the new facility and has started remarketing the Rockville, Maryland facility, which lease term ends January 31, 2017.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</nvax:NewFacilityLeaseDisclosureTextBlock>
  <nvax:NumberOfAuctionRateSecuritiesIncludedInInvestments id="NumberOfAuctionRateSecuritiesIncludedInInvestments.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UPure" decimals="0">3</nvax:NumberOfAuctionRateSecuritiesIncludedInInvestments>
  <nvax:PercentOfTheShortfallAmountExceedingTwoMillion id="PercentOfTheShortfallAmountExceedingTwoMillion.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPure" decimals="1">0.5</nvax:PercentOfTheShortfallAmountExceedingTwoMillion>
  <nvax:PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent id="PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.1330.24610.999.0.0.0.0" contextRef="as-of-2012-07-31.1330.0.24610.999.0.0.0.0" unitRef="UPure" decimals="1">0.5</nvax:PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent>
  <nvax:ResearchAndDevelopmentCollaboration id="ResearchAndDevelopmentCollaboration.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">182000</nvax:ResearchAndDevelopmentCollaboration>
  <nvax:ResearchAndDevelopmentCollaboration id="ResearchAndDevelopmentCollaboration.1297.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <nvax:ResearchAndDevelopmentCollaboration id="ResearchAndDevelopmentCollaboration.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">182000</nvax:ResearchAndDevelopmentCollaboration>
  <nvax:ResearchAndDevelopmentCollaboration id="ResearchAndDevelopmentCollaboration.1299.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <nvax:ResearchAndDevelopmentCollaboration id="ResearchAndDevelopmentCollaboration.1296.24610.999.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.24610.999.0.0.0.0" unitRef="USD" decimals="-5">200000</nvax:ResearchAndDevelopmentCollaboration>
  <nvax:RoyaltyPaymentsPercentOfFutureProductSales id="RoyaltyPaymentsPercentOfFutureProductSales.1329.24609.999.3248.4187.0.0" contextRef="as-of-2011-02-28.1329.0.24609.999.3248.4187.0.0" unitRef="UPure" decimals="1">0.1</nvax:RoyaltyPaymentsPercentOfFutureProductSales>
  <nvax:RoyaltyPaymentsPercentOfFutureProductSales id="RoyaltyPaymentsPercentOfFutureProductSales.1329.24609.999.3241.4187.0.0" contextRef="as-of-2011-02-28.1329.0.24609.999.3241.4187.0.0" unitRef="UPure" decimals="1">0.2</nvax:RoyaltyPaymentsPercentOfFutureProductSales>
  <nvax:SaleOfCommonStockDisclosureTextBlock id="SaleOfCommonStockDisclosureTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 9 - Sales of Common Stock&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Board of Directors of the Company (the "Board") has appointed a standing Finance Committee (the "Committee") to assist the Board with its responsibilities to monitor, provide advice to senior management of the Company and approve all capital raising activities. The Committee has been authorized by the Board to approve all At Market Issuance sales transactions. In doing so, the Committee sets the amount of shares to be sold, the period of time during which such sales may occur and the minimum sales price per share. In September 2012, the Company entered into an At Market Issuance Sales Agreement, under which the Company may sell an aggregate of $50 million in gross proceeds of its common stock. This agreement replaces the previous sales agreement entered in March 2010, which also allowed for the sale of an aggregate of $50 million in gross proceeds of its common stock, but had recently met its limitation on sales of shares. The shares of common stock are being offered pursuant to a shelf registration statement previously filed with the SEC. For the nine months ended September 30, 2012, the Company sold 8.4 million shares at an average sales price of $1.70 per share, resulting in $14.0 million in net proceeds; this amount excludes $0.8 million received in early 2012 for 0.7 million shares traded in late December 2011. Since entering into the March 2010 sales agreement through November 7, 2012, the Company has sold 24,957,715 shares of its common stock and received gross proceeds of $49.9 million. No sales have occurred under the September 2012 sales agreement.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In May 2012, the Company sold 10,000,000 shares of its common stock to two affiliates of RA Capital Management, LLC at a price of $1.22 per share, resulting in $12.1 million in net proceeds. The shares were offered under an effective shelf registration statement previously filed with the SEC.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</nvax:SaleOfCommonStockDisclosureTextBlock>
  <nvax:ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock id="ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following is a summary of restricted stock awards activity for the nine months ended September 30, 2012:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 80%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Number of&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Per Share&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Weighted-&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Grant-Date&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Fair Value&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 74%; FONT-WEIGHT: bold"&gt;Outstanding at January 1, 2012&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;53,333&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;1.63&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;Restricted stock granted&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;Restricted stock vested&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;3,333&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;5.21&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;Restricted stock forfeited&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-WEIGHT: bold"&gt;Outstanding at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 50,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 1.39&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</nvax:ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock>
  <nvax:SettlementOfNotesReceivable id="SettlementOfNotesReceivable.1298.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <nvax:SettlementOfNotesReceivable id="SettlementOfNotesReceivable.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1522000</nvax:SettlementOfNotesReceivable>
  <nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.1296.3248.4187.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.3248.4187.0.0.0.0" unitRef="UPure" decimals="2">0</nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate>
  <nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.1297.3248.4187.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.3248.4187.0.0.0.0" unitRef="UPure" decimals="4">0</nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate>
  <nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.1298.3248.4187.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.3248.4187.0.0.0.0" unitRef="UPure" decimals="6">0</nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate>
  <nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.1299.3248.4187.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.3248.4187.0.0.0.0" unitRef="UPure" decimals="8">0</nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate>
  <nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.1296.3241.4187.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.3241.4187.0.0.0.0" unitRef="UPure" decimals="4">0.2315</nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate>
  <nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.1297.3241.4187.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.3241.4187.0.0.0.0" unitRef="UPure" decimals="4">0.2315</nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate>
  <nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.1298.3241.4187.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.3241.4187.0.0.0.0" unitRef="UPure" decimals="4">0.2315</nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate>
  <nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.1299.3241.4187.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.3241.4187.0.0.0.0" unitRef="UPure" decimals="4">0.2315</nvax:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate>
  <nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.1298.24507.3871.3241.4187.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.3241.4187.0.0">P4Y</nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant>
  <nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.1298.24508.3871.3241.4187.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.3241.4187.0.0">P4Y</nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant>
  <nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.1298.24507.3871.3248.4187.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.3248.4187.0.0">P6M</nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant>
  <nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.1298.24508.3871.3248.4187.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.3248.4187.0.0">P6M</nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant>
  <nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.1292.24507.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24507.3871.0.0.0.0" unitRef="UPure" decimals="2">1</nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent>
  <nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.1292.24508.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24508.3871.0.0.0.0" unitRef="UPure" decimals="2">1</nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent>
  <nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.1298.24507.3871.3248.4187.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.3248.4187.0.0">P10Y</nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm>
  <nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.1298.24508.3871.3248.4187.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.3248.4187.0.0">P10Y</nvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm>
  <nvax:ShortfallAmountPayableInFull id="ShortfallAmountPayableInFull.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">2000000</nvax:ShortfallAmountPayableInFull>
  <nvax:StockWarrantsTextBlock id="StockWarrantsTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 8 - Warrant Liability&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.55in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.55in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In July 2008, the Company completed a registered direct offering of 6,686,650 units, raising approximately $17.5 million in net proceeds. Each unit consisted of one share of common stock and a warrant to purchase 0.5 shares of common stock (the "Warrants") at a price of $2.68 per unit. The Warrants represent the right to acquire an aggregate of 3,343,325 shares of common stock at an exercise price of $3.62 per share and are exercisable between January 31, 2009 and July 31, 2013.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.55in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.55in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;font style="COLOR: black"&gt;During the nine months ended September 30, 2012 and 2011, the Company recorded as other income (expense)&lt;/font&gt; in its statements of operations and comprehensive loss &lt;font style="COLOR: black"&gt;a change in fair value of warrant liability of ($0.4) million and $2.0 million, respectively. As of September 30, 2012, the warrant liability recorded on the balance sheet was $0.8 million and all Warrants remain outstanding as of that date.&lt;/font&gt;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</nvax:StockWarrantsTextBlock>
  <nvax:TenantAllowanceInterestRate id="TenantAllowanceInterestRate.1341.0.0.0.0.0.0" contextRef="from-2011-11-01-to-2011-11-30.1341.0.0.0.0.0.0.0" unitRef="UPure" decimals="2">0.08</nvax:TenantAllowanceInterestRate>
  <nvax:TenantImprovementAllowance id="TenantImprovementAllowance.1343.0.0.0.0.0.0" contextRef="as-of-2011-11-30.1343.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">2500000</nvax:TenantImprovementAllowance>
  <nvax:UpfrontLicensePayment id="UpfrontLicensePayment.1329.24609.999.0.0.0.0" contextRef="as-of-2011-02-28.1329.0.24609.999.0.0.0.0" unitRef="USD" decimals="-5">2500000</nvax:UpfrontLicensePayment>
  <us-gaap:AccountsPayableCurrent id="AccountsPayableCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2203000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent id="AccountsPayableCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2645000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsReceivableNetCurrent id="AccountsReceivableNetCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2469000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent id="AccountsReceivableNetCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1965000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments id="AccretionAmortizationOfDiscountsAndPremiumsInvestments.1298.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments id="AccretionAmortizationOfDiscountsAndPremiumsInvestments.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-317000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
  <us-gaap:AccruedLiabilitiesCurrent id="AccruedLiabilitiesCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">6031000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="AccruedLiabilitiesCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4528000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="AccumulatedOtherComprehensiveIncomeLossNetOfTax.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1036000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="AccumulatedOtherComprehensiveIncomeLossNetOfTax.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">832000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AdditionalPaidInCapital id="AdditionalPaidInCapital.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">411558000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital id="AdditionalPaidInCapital.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">383948000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1296.4381.4617.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.4381.4617.0.0.0.0" unitRef="USD" decimals="-3">219000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1297.4381.4617.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.4381.4617.0.0.0.0" unitRef="USD" decimals="-3">176000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1298.4381.4617.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.4381.4617.0.0.0.0" unitRef="USD" decimals="-3">638000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1299.4381.4617.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.4381.4617.0.0.0.0" unitRef="USD" decimals="-3">449000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1296.2354.4617.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.2354.4617.0.0.0.0" unitRef="USD" decimals="-3">274000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1297.2354.4617.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.2354.4617.0.0.0.0" unitRef="USD" decimals="-3">366000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1298.2354.4617.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.2354.4617.0.0.0.0" unitRef="USD" decimals="-3">1030000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1299.2354.4617.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.2354.4617.0.0.0.0" unitRef="USD" decimals="-3">1228000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">493000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">542000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1668000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1677000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">12951625</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">11119476</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AssetImpairmentCharges id="AssetImpairmentCharges.1298.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AssetImpairmentCharges id="AssetImpairmentCharges.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">60000</us-gaap:AssetImpairmentCharges>
  <us-gaap:Assets id="Assets.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">80546000</us-gaap:Assets>
  <us-gaap:Assets id="Assets.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">66576000</us-gaap:Assets>
  <us-gaap:AssetsCurrent id="AssetsCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">36484000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="AssetsCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">26109000</us-gaap:AssetsCurrent>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.1292.1180.3184.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.1180.3184.0.0.0.0" unitRef="USD" decimals="-3">13263000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.1293.1180.3184.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.1180.3184.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.1292.622.3184.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.622.3184.0.0.0.0" unitRef="USD" decimals="-3">3373000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.1293.622.3184.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.622.3184.0.0.0.0" unitRef="USD" decimals="-3">3373000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">16636000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3373000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesCurrent id="AvailableForSaleSecuritiesCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">17672000</us-gaap:AvailableForSaleSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesCurrent id="AvailableForSaleSecuritiesCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4205000</us-gaap:AvailableForSaleSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1292.2024.1894.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.2024.1894.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1293.2024.1894.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.2024.1894.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1292.2026.1894.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.2026.1894.0.0.0.0" unitRef="USD" decimals="-3">17672000</us-gaap:AvailableForSaleSecuritiesFairValueDisclosure>
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1293.2026.1894.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.2026.1894.0.0.0.0" unitRef="USD" decimals="-3">4205000</us-gaap:AvailableForSaleSecuritiesFairValueDisclosure>
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1292.2022.1894.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.2022.1894.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1293.2022.1894.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.2022.1894.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1292.1180.3184.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.1180.3184.0.0.0.0" unitRef="USD" decimals="-3">13267000</us-gaap:AvailableForSaleSecuritiesFairValueDisclosure>
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1292.622.3184.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.622.3184.0.0.0.0" unitRef="USD" decimals="-3">4405000</us-gaap:AvailableForSaleSecuritiesFairValueDisclosure>
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1293.622.3184.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.622.3184.0.0.0.0" unitRef="USD" decimals="-3">4205000</us-gaap:AvailableForSaleSecuritiesFairValueDisclosure>
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">17672000</us-gaap:AvailableForSaleSecuritiesFairValueDisclosure>
  <us-gaap:AvailableForSaleSecuritiesFairValueDisclosure id="AvailableForSaleSecuritiesFairValueDisclosure.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4205000</us-gaap:AvailableForSaleSecuritiesFairValueDisclosure>
  <us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain id="AvailableforsaleSecuritiesGrossUnrealizedGain.1292.1180.3184.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.1180.3184.0.0.0.0" unitRef="USD" decimals="-3">4000</us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain>
  <us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain id="AvailableforsaleSecuritiesGrossUnrealizedGain.1293.1180.3184.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.1180.3184.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain id="AvailableforsaleSecuritiesGrossUnrealizedGain.1292.622.3184.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.622.3184.0.0.0.0" unitRef="USD" decimals="-3">1032000</us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain>
  <us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain id="AvailableforsaleSecuritiesGrossUnrealizedGain.1293.622.3184.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.622.3184.0.0.0.0" unitRef="USD" decimals="-3">832000</us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain>
  <us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain id="AvailableforsaleSecuritiesGrossUnrealizedGain.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1036000</us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain>
  <us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain id="AvailableforsaleSecuritiesGrossUnrealizedGain.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">832000</us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain>
  <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 id="AvailableForSaleSecuritiesGrossUnrealizedLosses1.1292.1180.3184.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.1180.3184.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 id="AvailableForSaleSecuritiesGrossUnrealizedLosses1.1293.1180.3184.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.1180.3184.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 id="AvailableForSaleSecuritiesGrossUnrealizedLosses1.1292.622.3184.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.622.3184.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 id="AvailableForSaleSecuritiesGrossUnrealizedLosses1.1293.622.3184.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.622.3184.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 id="AvailableForSaleSecuritiesGrossUnrealizedLosses1.1292.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 id="AvailableForSaleSecuritiesGrossUnrealizedLosses1.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesTextBlock id="AvailableForSaleSecuritiesTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Short-term investments classified as available-for-sale as of September 30, 2012 and December 31, 2011 were comprised of (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap"&gt;September 30, 2012&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap"&gt;December 31, 2011&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Amortized&lt;/strong&gt;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Cost&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Gains&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Losses&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;Fair Value&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Amortized&lt;/strong&gt;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Cost&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Gains&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Losses&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;Fair Value&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 20%"&gt;Auction rate securities&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;3,373&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;1,032&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;-&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;4,405&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;3,373&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;832&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;-&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;4,205&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; Corporate debt securities&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 13,263&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 4&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 13,267&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 16,636&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 1,036&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 17,672&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 3,373&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 832&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 4,205&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock id="BasisOfAccountingPolicyPolicyTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Basis of Presentation&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The accompanying unaudited financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The balance sheet as of September 30, 2012, statements of operations for the three and nine months ended September 30, 2012 and 2011 and the statements of cash flows for the nine months ended September 30, 2012 and 2011 are unaudited, but include all adjustments (consisting of normal recurring adjustments) that the Company considers necessary for a fair presentation of the financial position, operating results and cash flows, respectively, for the periods presented. Although the Company believes that the disclosures in these financial statements are adequate to make the information presented not misleading, certain information and footnote information normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC").&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Results for any interim period are not necessarily indicative of results for any future interim period or for the entire year. The accompanying unaudited financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&amp;#39;s Annual Report on Form 10-K for the year ended December 31, 2011.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock id="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 3 - Summary of Significant Accounting Policies&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Basis of Presentation&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The accompanying unaudited financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The balance sheet as of September 30, 2012, statements of operations for the three and nine months ended September 30, 2012 and 2011 and the statements of cash flows for the nine months ended September 30, 2012 and 2011 are unaudited, but include all adjustments (consisting of normal recurring adjustments) that the Company considers necessary for a fair presentation of the financial position, operating results and cash flows, respectively, for the periods presented. Although the Company believes that the disclosures in these financial statements are adequate to make the information presented not misleading, certain information and footnote information normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC").&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Results for any interim period are not necessarily indicative of results for any future interim period or for the entire year. The accompanying unaudited financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&amp;#39;s Annual Report on Form 10-K for the year ended December 31, 2011.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Use of Estimates&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these estimates.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Fair Value Measurements&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company applies Accounting Standards Codification ("ASC") Topic 820, &lt;em&gt;Fair Value Measurements and Disclosures&lt;/em&gt;, for financial and non-financial assets and liabilities.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; ASC 820 discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The statement utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="TEXT-ALIGN: justify; WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="TEXT-ALIGN: justify"&gt;Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="TEXT-ALIGN: justify; WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="TEXT-ALIGN: justify"&gt;Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="TEXT-ALIGN: justify; WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="TEXT-ALIGN: justify"&gt;Level 3: Unobservable inputs that reflect the reporting entity&amp;#39;s own assumptions.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Financial assets and liabilities measured at fair market value on a recurring basis as of September 30, 2012 and December 31, 2011 are summarized below (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap"&gt;Fair Value at September 30, 2012&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap"&gt;Fair Value at December 31, 2011&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 1&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 2&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 3&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 1&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 2&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 3&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-LEFT: 9.45pt; TEXT-DECORATION: underline; TEXT-INDENT: -9.45pt"&gt; Assets&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; PADDING-LEFT: 9.45pt; TEXT-ALIGN: left; TEXT-INDENT: -9.45pt; WIDTH: 34%"&gt; Corporate debt and auction rate securities&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; 17,672&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; 4,205&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt; Liabilities&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; Warrant liability&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; 769&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; 368&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following table summarizes the activity of Level 3 inputs measured on a recurring basis as of September 30, 2012 (in thousands):&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Fair Value Measurements of&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Warrants Using Significant&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Unobservable Inputs&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;(Level 3)&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 82%"&gt;Balance at December 31, 2011&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 15%"&gt;368&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;Change in fair value of Warrant liability&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 401&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;Balance at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 769&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The amounts in the Company&amp;#39;s balance sheet for accounts receivable, unbilled receivables and accounts payable approximate fair value due to their short-term nature. Based on borrowing rates available to the Company, the fair value of notes payable and capital lease approximates its carrying value.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"&gt; Short-Term Investments&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Short-term investments at September 30, 2012 consist of investments in commercial paper, corporate notes and three auction rate securities. All marketable securities had original maturities greater than 90 days, but less than one year. The auction rate securities have a par value of $5.1 million. The Company has classified these securities as available-for-sale since the Company may need to liquidate these securities within the next year. The available-for-sale securities are carried at fair value and unrealized gains and losses, if determined to be temporary, on these securities are included in accumulated other comprehensive income (loss) in stockholders&amp;#39; equity. Investments available for sale are evaluated periodically to determine whether a decline in value is "other-than-temporary." The term "other-than-temporary" is not intended to indicate a permanent decline in value. Rather, it means that the prospects for a near term recovery of value are not necessarily favorable, or that there is a lack of evidence to support fair values equal to, or greater than, the carrying value of the security. Management reviews criteria, such as the magnitude and duration of the decline, as well as the Company&amp;#39;s ability to hold the securities until market recovery, to predict whether the loss in value is other-than-temporary. If a decline in value is determined to be other-than-temporary, the value of the security is reduced and the impairment is recorded in the statements of operations. The specific identification method is used in computing realized gains and losses on sale of the Company&amp;#39;s securities.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Short-term investments classified as available-for-sale as of September 30, 2012 and December 31, 2011 were comprised of (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap"&gt;September 30, 2012&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap"&gt;December 31, 2011&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Amortized&lt;/strong&gt;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Cost&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Gains&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Losses&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;Fair Value&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Amortized&lt;/strong&gt;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Cost&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Gains&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Losses&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;Fair Value&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 20%"&gt;Auction rate securities&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;3,373&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;1,032&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;-&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;4,405&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;3,373&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;832&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;-&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;4,205&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; Corporate debt securities&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 13,263&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 4&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 13,267&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 16,636&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 1,036&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 17,672&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 3,373&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 832&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 4,205&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"&gt; Restricted Cash&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company&amp;#39;s noncurrent restricted cash with respect to its new manufacturing, laboratory and office space in Gaithersburg, Maryland functions as collateral for letters of credit, which serve as security deposits for the duration of the leases. In addition, the Company&amp;#39;s restricted cash includes payments received under the PATH agreement (See Note 5) until such time the Company has paid for the work performed for the related Phase II RSV clinical trial.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Net Loss per Share&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Net loss per share is computed using the weighted average number of shares of common stock outstanding. All outstanding warrants, stock options and unvested restricted stock awards totaling 12,951,625 shares and 11,119,476 shares at September 30, 2012 and 2011, respectively, are excluded from the computation, as their effect is antidilutive.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Revenue Recognition&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company performs research and development for U.S. Government agencies and other collaborators under cost reimbursable and fixed price contracts, including license and clinical development agreements. The Company recognizes revenue under research contracts when a contract has been executed, the contract price is fixed and determinable, delivery of services or products has occurred and collection of the contract price is reasonably assured. Payments received in advance of work performed are recorded as deferred revenue and losses on contracts, if any, are recognized in the period in which they become known.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Under cost reimbursable contracts, the Company is reimbursed and recognizes revenue as allowable costs are incurred plus a portion of the fixed-fee earned. The Company considers fixed-fees under cost reimbursable contracts to be earned in proportion to the allowable costs incurred in performance of the work as compared to total estimated contract costs, with such costs incurred representing a reasonable measurement of the proportional performance of the work completed. Under its HHS BARDA contract, certain activities must be pre-approved by HHS BARDA in order for their costs to be deemed allowable direct costs. Direct costs incurred under cost reimbursable contracts are recorded as cost of government contracts revenue. The Company&amp;#39;s government contracts, including its HHS BARDA contract, provide the U.S. government (or agency) the ability to terminate the contract for convenience or to terminate for default if the Company fails to meet its obligations as set forth in the statement of work. The Company believes that if the government were to terminate one of its contracts for convenience, including the HHS BARDA contract, the costs incurred through the effective date of such termination and any settlement costs resulting from such termination would be allowable costs. Payments to the Company under cost reimbursable contracts with agencies of the U.S. Government, including its contract with HHS BARDA, are provisional payments subject to adjustment upon annual audit by the government. No such audit has been completed as of September 30, 2012; however, management believes that revenue for periods subject to audit has been recorded in amounts that are expected to be realized upon final audit and settlement.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company&amp;#39;s collaborative research and development agreements may include an upfront payment, payments for research and development services, milestone payments and royalties. Agreements with multiple deliverables are evaluated to determine if the deliverables can be divided into more than one unit of accounting. A deliverable can generally be considered a separate unit of accounting if both of the following criteria are met: (1) the delivered item(s) has value to the customer on a stand-alone basis; and (2) if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable and substantially in control of the Company. Deliverables that cannot be divided into separate units are combined with other units of accounting, as appropriate. Consideration received is allocated among the separate units of accounting based on the relative selling price method. Deliverables under these arrangements typically include rights to intellectual property, research and development services and involvement by the parties in steering committees. Historically, deliverables under the Company&amp;#39;s collaborative research and development agreements have been deemed to have no stand-alone value and as a result been treated as a single unit of accounting. In addition, the Company analyzes its contracts and collaborative agreements to determine whether the payments received should be recorded as revenue or as a reduction to research and development expenses. In reaching this determination, management considers a number of factors, including whether the Company is principal under the arrangement, and whether the arrangement is significant to, and part of, the Company&amp;#39;s core operations. Historically, payments received under its contracts and collaborative agreements have been recognized as revenue since the Company acts as a principal in the arrangement, and the activities are core to its operations.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; When the performance under a fixed price contract can be reasonably estimated, revenue for fixed price contracts is recognized under the proportional performance method and earned in proportion to the contract costs incurred in performance of the work as compared to total estimated contract costs. Costs incurred under fixed price contracts represent a reasonable measurement of proportional performance of the work. Direct costs incurred under collaborative research and development agreements are recorded as research and development expenses. If the performance under a fixed price contract cannot be reasonably estimated, the Company recognizes the revenue on a straight-line basis over the contract term&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Revenue associated with upfront payments under arrangements is recognized over the contract term or when all obligations associated with the upfront payment have been satisfied.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Revenue from the achievement of research and development milestones, if deemed substantive, is recognized as revenue when the milestones are achieved, and the milestone payments are due and collectible. If not deemed substantive, the Company would recognize such milestone as revenue upon its achievement on a straight-line basis over the remaining expected term of the research and development period. Milestones are considered substantive if all of the following conditions are met: (1) the milestone is non-refundable; (2) there is substantive uncertainty of achievement of the milestone at the inception of the arrangement; (3) substantive effort is involved to achieve the milestone and such achievement relates to past performance; and (4) the amount of the milestone appears reasonable in relation to the effort expended and all of the deliverables and payment terms in the arrangement.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Recent Accounting Pronouncements&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In June 2011, the FASB issued ASU 2011-05, &lt;em&gt;Comprehensive Income (Topic 220): Presentation of Comprehensive Income&lt;/em&gt; ("ASU 2011-05"). This guidance is intended to increase the prominence of other comprehensive income in financial statements by presenting it in either a single-statement or two-statement approach. This ASU was effective for the Company beginning January 1, 2012. This presentation requirement was adopted January 1, 2012 and is reflected on the accompanying statements of operations and comprehensive loss for the periods ended September 30, 2012 and 2011.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In September 2011, the FASB issued ASU 2011-08, &lt;em&gt;Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for Impairment&lt;/em&gt; ("ASU 2011-08")&lt;em&gt;,&lt;/em&gt; to give both public and nonpublic entities the option to qualitatively determine whether they can bypass the two-step goodwill impairment test. Under the new guidance, if an entity chooses to perform a qualitative assessment and determines that it is more likely than not (a more than 50 percent likelihood) that the fair value of a reporting unit is less than its carrying amount, it would then perform Step 1 of the annual goodwill impairment test in ASC 350-20 and, if necessary, proceed to Step 2. Otherwise, no further evaluation would be necessary. The decision to perform a qualitative assessment is made at the reporting unit level, and an entity with multiple reporting units may utilize a mix of qualitative assessments and quantitative tests among its reporting units. The amended guidance was effective for interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, although early adoption was permitted. The adoption of ASU 2011-08 on January 1, 2012 did not have a material effect on the Company&amp;#39;s financial statements.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid id="CapitalExpendituresIncurredButNotYetPaid.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1365000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid id="CapitalExpendituresIncurredButNotYetPaid.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">168000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CapitalLeaseObligationsCurrent id="CapitalLeaseObligationsCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">57000</us-gaap:CapitalLeaseObligationsCurrent>
  <us-gaap:CapitalLeaseObligationsCurrent id="CapitalLeaseObligationsCurrent.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CapitalLeaseObligationsNoncurrent id="CapitalLeaseObligationsNoncurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">252000</us-gaap:CapitalLeaseObligationsNoncurrent>
  <us-gaap:CapitalLeaseObligationsNoncurrent id="CapitalLeaseObligationsNoncurrent.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDue id="CapitalLeasesFutureMinimumPaymentsDue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">360000</us-gaap:CapitalLeasesFutureMinimumPaymentsDue>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive id="CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">44000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive id="CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">76000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour id="CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">76000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree id="CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">76000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo id="CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">76000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments id="CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">51000</us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments id="CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">309000</us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear id="CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12000</us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10738000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">14104000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.1294.0.0.0.0.0.0" contextRef="as-of-2011-09-30.1294.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">14318000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.1295.0.0.0.0.0.0" contextRef="as-of-2010-12-31.1295.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8061000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="CashAndCashEquivalentsPeriodIncreaseDecrease.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-3366000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="CashAndCashEquivalentsPeriodIncreaseDecrease.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">6257000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy id="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"&gt; Restricted Cash&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company&amp;#39;s noncurrent restricted cash with respect to its new manufacturing, laboratory and office space in Gaithersburg, Maryland functions as collateral for letters of credit, which serve as security deposits for the duration of the leases. In addition, the Company&amp;#39;s restricted cash includes payments received under the PATH agreement (See Note 5) until such time the Company has paid for the work performed for the related Phase II RSV clinical trial.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.1337.0.0.0.0.0.0" contextRef="as-of-2008-07-31.1337.0.0.0.0.0.0.0" unitRef="UPerUnit" decimals="2">3.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.1337.0.0.0.0.0.0" contextRef="as-of-2008-07-31.1337.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">3343325</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:CollaborativeArrangementDisclosureTextBlock id="CollaborativeArrangementDisclosureTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 5 - U.S. Government Agreement and Collaborations&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;&lt;br /&gt; &lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;HHS BARDA Contract Award for Recombinant Influenza Vaccines&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In February 2011, the Company was awarded a contract from HHS BARDA valued at $97 million for the 36-month base-period, with an HHS BARDA option for an additional period of 24 months valued at $82 million, for a total contract value of up to $179 million. The HHS BARDA contract award provides significant funding for the Company&amp;#39;s ongoing clinical development and product scale-up of both its seasonal and pandemic (H5N1) influenza vaccine candidates. This is a cost-plus-fixed-fee contract in which HHS BARDA will reimburse the Company for direct contract costs incurred plus allowable indirect costs and a fixed-fee earned in the further development of its multivalent seasonal and monovalent pandemic (H5N1) influenza vaccines. Billings under the contract are based on approved provisional indirect billing rates, which permit recovery of fringe benefits, overhead and general and administrative expenses not exceeding certain limits. These indirect rates are subject to audit by HHS BARDA on an annual basis. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly. Since the inception of the contract and during the nine months ended September 30, 2012, the Company has recognized revenue of approximately $31.6 million and $16.9 million, respectively.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Under certain circumstances HHS BARDA reimbursements may be delayed or even potentially withheld. In March 2012, the Company decided to conduct its Phase II dose-ranging clinical trial of its trivalent and quadrivalent seasonal influenza vaccine candidates (the "205 Trial") under its existing U.S. investigational new drug application ("IND") for its trivalent seasonal influenza vaccine candidate ("Trivalent IND") as opposed to waiting to conduct the 205 Trial under a new IND for its quadrivalent vaccine candidate ("Quadrivalent IND"). In July 2012, the Company reported that it expected to launch its next quadrivalent Phase II clinical trial in 2013 rather than in the second half of 2012; similarly, the filing of the Quadrivalent IND, which the Company had previously indicated was expected in the second half of 2012 will also be delayed. Based on discussions between HHS BARDA and the Company, because the 205 Trial includes its quadrivalent seasonal influenza vaccine candidate, the outside clinical trial costs for the 205 Trial will only be submitted for reimbursement to HHS BARDA and recorded as revenue by the Company after it submits the 205 Trial data to its Quadrivalent IND. Until then, the outside clinical trial costs of the 205 Trial will be expensed and included in cost of government contracts revenue. The financial impact of this delay in revenue recognition is based on the outside clinical trial costs of the 205 Trial that are expected to total approximately $3.1 million, of which $2.8 million was incurred through September 30, 2012.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;&lt;br /&gt; &lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;License Agreement with LG Life Sciences, Ltd.&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In February 2011, the Company entered into a license agreement with LG Life Sciences, Ltd. ("LGLS") that allows LGLS to use the Company&amp;#39;s technology to develop and commercially sell influenza vaccines exclusively in South Korea and non-exclusively in certain other specified countries. At its own cost, LGLS is responsible for funding its clinical development of the influenza VLP vaccines and completing a manufacturing facility in South Korea. Under the license agreement, the Company is obligated to provide LGLS with information and materials related to the manufacture of the licensed products, provide on-going project management and regulatory support and conduct clinical trials of its influenza vaccines in order to obtain FDA approval in the U.S. The term of the license agreement is expected to terminate in 2027. Payments to the Company under the license agreement include an upfront payment of $2.5 million, reimbursements of certain development and product costs, payments related to the achievement of certain milestones and royalty payments at a rate between 10% and 20% from LGLS&amp;#39;s future commercial sales of influenza VLP vaccines, which royalty rate is subject to reduction if certain timelines for regulatory licensure are not met. The upfront payment has been deferred and will be recognized when the previously mentioned obligations in the agreement are satisfied, which may not occur until the end of the term of the agreement. Payments for milestones under the agreement will be recognized on a straight-line basis over the remaining term of the research and development period upon achievement of such milestone. Any royalties under the agreement will be recognized as earned.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;PATH Vaccine Solutions&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In July 2012, the Company entered into a clinical development agreement with PATH Vaccine Solutions ("PATH") to develop its vaccine candidate to protect against RSV through maternal immunization in low-resource countries (the "RSV Collaboration Program"). The Company was awarded approximately $2.0 million by PATH for initial funding under the agreement to partially support its Phase II dose-ranging clinical trial in women of childbearing age, which was launched in October 2012. The agreement would expire July 31, 2013, unless the Company and PATH decide to continue the RSV Collaboration Program. The Company retains global rights to commercialize the product and has made a commitment to make the vaccine affordable and available in low-resource countries. To the extent PATH has continued to fund 50% of the Company&amp;#39;s external clinical development costs for the RSV Collaboration Program, but the Company does not continue development, the Company would then grant PATH a fully-paid license to its RSV vaccine technology for use in pregnant women in such low-resource countries. During the three months ended September 30, 2012, the Company recognized revenue of approximately $0.2 million under the agreement. Revenue under this arrangement is being recognized under the proportional performance method and earned in proportion to the contract costs incurred in performance of the work as compared to total estimated contract costs. Costs incurred under this agreement represent a reasonable measurement of proportional performance of the work.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingencies id="CommitmentsAndContingencies.1292.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommitmentsAndContingencies id="CommitmentsAndContingencies.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommonStockParOrStatedValuePerShare id="CommonStockParOrStatedValuePerShare.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="CommonStockParOrStatedValuePerShare.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="CommonStockSharesAuthorized.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">200000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="CommonStockSharesAuthorized.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">200000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="CommonStockSharesIssued.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">136003676</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="CommonStockSharesIssued.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">117480867</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">135548246</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">117025437</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue id="CommonStockValue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1360000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="CommonStockValue.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1175000</us-gaap:CommonStockValue>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ComprehensiveIncomeNetOfTax.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-7121000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ComprehensiveIncomeNetOfTax.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-3209000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ComprehensiveIncomeNetOfTax.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-20268000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ComprehensiveIncomeNetOfTax.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-15518000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ContractRevenueCost id="ContractRevenueCost.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3838000</us-gaap:ContractRevenueCost>
  <us-gaap:ContractRevenueCost id="ContractRevenueCost.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2190000</us-gaap:ContractRevenueCost>
  <us-gaap:ContractRevenueCost id="ContractRevenueCost.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12740000</us-gaap:ContractRevenueCost>
  <us-gaap:ContractRevenueCost id="ContractRevenueCost.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3763000</us-gaap:ContractRevenueCost>
  <us-gaap:ContractsRevenue id="ContractsRevenue.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5583000</us-gaap:ContractsRevenue>
  <us-gaap:ContractsRevenue id="ContractsRevenue.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5008000</us-gaap:ContractsRevenue>
  <us-gaap:ContractsRevenue id="ContractsRevenue.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">17328000</us-gaap:ContractsRevenue>
  <us-gaap:ContractsRevenue id="ContractsRevenue.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8843000</us-gaap:ContractsRevenue>
  <us-gaap:ContractsRevenue id="ContractsRevenue.1299.24606.999.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.24606.999.0.0.0.0" unitRef="USD" decimals="-5">16900000</us-gaap:ContractsRevenue>
  <us-gaap:ContractsRevenue id="ContractsRevenue.2096.24606.999.0.0.0.0" contextRef="from-2011-02-01-to-2012-09-30.2096.0.24606.999.0.0.0.0" unitRef="USD" decimals="-5">31600000</us-gaap:ContractsRevenue>
  <us-gaap:CostsAndExpenses id="CostsAndExpenses.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12614000</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses id="CostsAndExpenses.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8976000</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses id="CostsAndExpenses.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">37680000</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses id="CostsAndExpenses.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">26163000</us-gaap:CostsAndExpenses>
  <us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock id="DebtAndCapitalLeasesDisclosuresTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 6 - Capital Lease&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"&gt; In August 2012, the Company leased equipment under a capital lease with an effective interest rate of 6.5% with an advance payment and monthly payments of $6,325 starting August 2012 and over the next 59 months. The capital lease is recorded at the present value of the future minimum lease payments. Future minimum capital lease payments under the capital lease agreement at September 30, 2012 are as follows (in thousands):&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;Amount&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 79%"&gt;2012&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 18%"&gt;12&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2013&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;76&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2014&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;76&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2015&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;76&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2016&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;76&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;2017&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 44&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;360&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;Less &amp;#8213; amounts representing interest&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; (51&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;Present value of net minimum lease payments&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;309&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;Less &amp;#8213; current portion of capital lease&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; (57&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;Non-current portion of capital lease&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 252&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock>
  <us-gaap:DebtDisclosureTextBlock id="DebtDisclosureTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 7 - Notes Payable&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In September 2012, the Company entered into a Master Security Agreement with General Electric Capital Corporation ("GE"), whereby the Company can borrow up to $2.0 million to finance the purchases of equipment ("Equipment Loan"). Each Equipment Loan bears interest at the three-year U.S. Government treasury rate plus 11.68%, provided that the rate shall not be less than 12.1%, and is to be repaid over forty-two (42) months. GE will maintain a security interest in all equipment financed under this facility. During the three months ended September 30, 2012, the Company financed $0.5 million at an interest rate of 12.1% with monthly principal payments of $13,089 starting October 2012. Interest accrues on the outstanding balance until paid in full.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Aggregate future minimum principal payments on the GE Equipment Loan at September 30, 2012 are as follows (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold"&gt; Year&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;Amount&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 79%"&gt;2012&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 18%"&gt;39&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2013&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;157&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2014&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;157&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2015&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;157&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;2016&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 40&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 550&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate id="DebtInstrumentBasisSpreadOnVariableRate.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.1168</us-gaap:DebtInstrumentBasisSpreadOnVariableRate>
  <us-gaap:DebtInstrumentFaceAmount id="DebtInstrumentFaceAmount.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">2000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentIncreaseAdditionalBorrowings id="DebtInstrumentIncreaseAdditionalBorrowings.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">500000</us-gaap:DebtInstrumentIncreaseAdditionalBorrowings>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="DebtInstrumentInterestRateDuringPeriod.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="UPure" decimals="3">0.121</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:DebtInstrumentInterestRateStatedPercentageRateRangeMinimum id="DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.1334.0.0.0.0.0.0" contextRef="from-2012-09-01-to-2012-09-30.1334.0.0.0.0.0.0.0" unitRef="UPure" decimals="3">0.121</us-gaap:DebtInstrumentInterestRateStatedPercentageRateRangeMinimum>
  <us-gaap:DebtInstrumentPeriodicPayment id="DebtInstrumentPeriodicPayment.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="0">13089</us-gaap:DebtInstrumentPeriodicPayment>
  <us-gaap:DeferredRentCreditCurrent id="DeferredRentCreditCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">421000</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditCurrent id="DeferredRentCreditCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">386000</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditNoncurrent id="DeferredRentCreditNoncurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5184000</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:DeferredRentCreditNoncurrent id="DeferredRentCreditNoncurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1980000</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:DeferredRevenueCurrent id="DeferredRevenueCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">803000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueCurrent id="DeferredRevenueCurrent.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DeferredRevenueNoncurrent id="DeferredRevenueNoncurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2500000</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredRevenueNoncurrent id="DeferredRevenueNoncurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2500000</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DepreciationAndAmortization id="DepreciationAndAmortization.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1216000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="DepreciationAndAmortization.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1197000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DerivativeLiabilitiesCurrent id="DerivativeLiabilitiesCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">769000</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:DerivativeLiabilitiesNoncurrent id="DerivativeLiabilitiesNoncurrent.1292.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeLiabilitiesNoncurrent id="DerivativeLiabilitiesNoncurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">368000</us-gaap:DerivativeLiabilitiesNoncurrent>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Note 4 - Stock-Based Compensation&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company has granted equity awards under several plans. Under the 2005 Stock Incentive Plan (the "2005 Plan"), equity awards may be granted to officers, directors, employees, consultants and advisors to the Company and any present or future subsidiary. The 2005 Plan, approved in May 2005 and amended in June 2007, June 2011 and June 2012 by the Company&amp;#39;s stockholders, currently authorizes the grant of equity awards for up to 18,312,192 shares of common stock, which included, at the time of approval of the 2005 Plan, a maximum 5,746,468 shares of common stock subject to stock options outstanding under the Company&amp;#39;s 1995 Stock Option Plan (the "1995 Plan") that may revert to and become issuable under the 2005 Plan if such options should expire or otherwise terminate unexercised. The term of the Company&amp;#39;s 1995 Plan has expired. Outstanding stock options remain in existence in accordance with their terms and no new awards will be made under the 1995 Plan.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Under the 2005 Plan and the 1995 Plan, incentive stock options, having a maximum term of 10 years, can be or were granted at no less than 100% of the fair value of the Company&amp;#39;s common stock at the time of grant and are generally exercisable over periods ranging from six months to four years. There is no minimum exercise price for non-statutory stock options.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company recorded stock-based compensation expense in the statements of operations and comprehensive loss as follows (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;table style="WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0" align="center"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;2011&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;2011&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 48%"&gt;Research and development&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;219&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;176&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;638&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;449&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;General and administrative&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 274&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 366&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 1,030&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 1,228&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"&gt; Total stock-based compensation expense&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 493&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 542&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 1,668&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 1,677&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;&lt;br /&gt; &lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Stock Options Awards&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following is a summary of option activity under the 2005 Plan and the 1995 Plan for the nine months ended September 30, 2012:&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;table style="WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="6" nowrap="nowrap"&gt;2005 Stock Incentive Plan&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="6" nowrap="nowrap"&gt;1995 Stock Option Plan&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Stock&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Options&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Weighted-&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Exercise&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Price&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Stock&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Options&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Weighted-&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Exercise&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Price&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 48%"&gt;Outstanding at January 1, 2012&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;7,412,746&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;2.22&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;474,650&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;4.38&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;3,483,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;1.29&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;Exercised&lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;(80,784&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;)&lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;0.61&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;Canceled&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; (1,546,562&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 2.26&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; (184,750&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 4.01&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;Outstanding at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 9,268,400&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 1.88&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 289,900&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 4.59&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"&gt; Shares exercisable at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 3,503,043&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 2.38&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 289,900&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 4.59&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"&gt; Shares available for grant at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 5,559,536&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The fair value of stock options granted was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;table style="WIDTH: 95%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"&gt; &lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"&gt; &lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"&gt; &lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"&gt; &lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap"&gt;2012&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap"&gt;2011&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap"&gt;2012&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap"&gt;2011&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; TEXT-INDENT: -9pt; PADDING-LEFT: 9pt; WIDTH: 40%" nowrap="nowrap"&gt;Weighted-average fair value of stock options granted&lt;/td&gt; &lt;td style="WIDTH: 1%" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"&gt; $1.09&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"&gt; $0.78&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"&gt; $0.71&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"&gt; $1.19&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;Risk-free interest rate&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0.55%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0.48%-0.68%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0.55%-1.54%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0.48%-1.91%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;Dividend yield&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td nowrap="nowrap"&gt;Volatility&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;76.60%-76.71%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;75.86%-80.40%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;75.47%-80.48%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;73.28%-80.48%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;Expected term (in years)&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;4.24&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;3.49-4.21&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;3.34-7.09&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;3.26-4.47&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;Expected forfeiture rate&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%-23.15%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%-23.15%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%-23.15%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%-23.15%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The aggregate intrinsic value and weighted-average remaining contractual term of stock options outstanding as of September 30, 2012 was approximately $4.6 million and 7.7 years, respectively. The aggregate intrinsic value and weighted-average remaining contractual term of stock options exercisable as of September 30, 2012 was approximately $1.0 million and 5.7 years, respectively. The aggregate intrinsic value represents the total intrinsic value (the difference between the Company&amp;#39;s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 30, 2012. This amount is subject to change based on changes to the fair value of the Company&amp;#39;s common stock. The aggregate intrinsic value of options exercised for the nine months ended September 30, 2012 and 2011 was less than $0.1 million and $0.2 million, respectively.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;&lt;br /&gt; &lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Restricted Stock Awards&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Under the 2005 Plan, the Company has granted restricted stock awards subject to certain performance-based and time-based vesting conditions which, if not met, would result in forfeiture of the shares and reversal of any previously recognized related stock-based compensation expense.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following is a summary of restricted stock awards activity for the nine months ended September 30, 2012:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;table style="WIDTH: 80%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;&lt;br /&gt; &lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Number of&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Per Share&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Weighted-&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Grant-Date&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Fair Value&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 74%; FONT-WEIGHT: bold"&gt;Outstanding at January 1, 2012&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;53,333&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;1.63&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;Restricted stock granted&lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;Restricted stock vested&lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;3,333&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;5.21&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;Restricted stock forfeited&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-WEIGHT: bold"&gt;Outstanding at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 50,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 1.39&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; As of September 30, 2012, there was approximately $3.6 million of total unrecognized compensation expense (net of estimated forfeitures) related to unvested options and restricted stock awards. This unrecognized compensation expense is expected to be recognized over a weighted-average period of 1.6 years. This estimate does not include the impact of other possible stock-based awards that may be made during future periods.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:EarningsPerShareBasicAndDiluted id="EarningsPerShareBasicAndDiluted.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">-0.05</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="EarningsPerShareBasicAndDiluted.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">-0.03</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="EarningsPerShareBasicAndDiluted.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="EarningsPerShareBasicAndDiluted.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerSharePolicyTextBlock id="EarningsPerSharePolicyTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Net Loss per Share&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Net loss per share is computed using the weighted average number of shares of common stock outstanding. All outstanding warrants, stock options and unvested restricted stock awards totaling 12,951,625 shares and 11,119,476 shares at September 30, 2012 and 2011, respectively, are excluded from the computation, as their effect is antidilutive.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">3600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:EquityIssuancePerShareAmount id="EquityIssuancePerShareAmount.1336.0.0.0.0.0.0" contextRef="from-2008-07-01-to-2008-07-31.1336.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">2.68</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="EquityMethodInvestmentOwnershipPercentage.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UPure" decimals="1">0.2</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock id="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following table summarizes the activity of Level 3 inputs measured on a recurring basis as of September 30, 2012 (in thousands):&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Fair Value Measurements of&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Warrants Using Significant&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Unobservable Inputs&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;(Level 3)&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 82%"&gt;Balance at December 31, 2011&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 15%"&gt;368&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;Change in fair value of Warrant liability&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 401&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;Balance at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 769&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <us-gaap:FairValueMeasurementPolicyPolicyTextBlock id="FairValueMeasurementPolicyPolicyTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Fair Value Measurements&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company applies Accounting Standards Codification ("ASC") Topic 820, &lt;em&gt;Fair Value Measurements and Disclosures&lt;/em&gt;, for financial and non-financial assets and liabilities.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; ASC 820 discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The statement utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="TEXT-ALIGN: justify; WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="TEXT-ALIGN: justify"&gt;Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="TEXT-ALIGN: justify; WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="TEXT-ALIGN: justify"&gt;Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="TEXT-ALIGN: justify; WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="TEXT-ALIGN: justify"&gt;Level 3: Unobservable inputs that reflect the reporting entity&amp;#39;s own assumptions.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Financial assets and liabilities measured at fair market value on a recurring basis as of September 30, 2012 and December 31, 2011 are summarized below (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap"&gt;Fair Value at September 30, 2012&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap"&gt;Fair Value at December 31, 2011&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 1&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 2&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 3&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 1&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 2&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 3&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-LEFT: 9.45pt; TEXT-DECORATION: underline; TEXT-INDENT: -9.45pt"&gt; Assets&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; PADDING-LEFT: 9.45pt; TEXT-ALIGN: left; TEXT-INDENT: -9.45pt; WIDTH: 34%"&gt; Corporate debt and auction rate securities&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; 17,672&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; 4,205&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt; Liabilities&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; Warrant liability&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; 769&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; 368&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following table summarizes the activity of Level 3 inputs measured on a recurring basis as of September 30, 2012 (in thousands):&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Fair Value Measurements of&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Warrants Using Significant&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Unobservable Inputs&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;(Level 3)&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 82%"&gt;Balance at December 31, 2011&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 15%"&gt;368&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;Change in fair value of Warrant liability&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 401&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;Balance at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 769&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The amounts in the Company&amp;#39;s balance sheet for accounts receivables, unbilled receivables and accounts payable approximate fair value due to their short-term nature. Based on borrowing rates available to the Company, the fair value of capital lease and notes payable approximates their carrying value.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease id="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">401000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">769000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">368000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax id="GainLossOnDerivativeInstrumentsNetPretax.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-401000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax id="GainLossOnDerivativeInstrumentsNetPretax.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">736000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax id="GainLossOnDerivativeInstrumentsNetPretax.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-401000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax id="GainLossOnDerivativeInstrumentsNetPretax.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1973000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="GainLossOnSaleOfPropertyPlantEquipment.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">26000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="GainLossOnSaleOfPropertyPlantEquipment.1299.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:GeneralAndAdministrativeExpense id="GeneralAndAdministrativeExpense.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2381000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="GeneralAndAdministrativeExpense.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2737000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="GeneralAndAdministrativeExpense.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8291000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="GeneralAndAdministrativeExpense.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8926000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:Goodwill id="Goodwill.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">33141000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Goodwill.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">33141000</us-gaap:Goodwill>
  <us-gaap:GovernmentContractReceivable id="GovernmentContractReceivable.1329.24606.999.0.0.0.0" contextRef="as-of-2011-02-28.1329.0.24606.999.0.0.0.0" unitRef="USD" decimals="-5">97000000</us-gaap:GovernmentContractReceivable>
  <us-gaap:GovernmentContractReceivable id="GovernmentContractReceivable.1329.24607.999.0.0.0.0" contextRef="as-of-2011-02-28.1329.0.24607.999.0.0.0.0" unitRef="USD" decimals="-5">82000000</us-gaap:GovernmentContractReceivable>
  <us-gaap:GovernmentContractReceivable id="GovernmentContractReceivable.1330.24610.999.0.0.0.0" contextRef="as-of-2012-07-31.1330.0.24610.999.0.0.0.0" unitRef="USD" decimals="-5">2000000</us-gaap:GovernmentContractReceivable>
  <us-gaap:GovernmentContractReceivable id="GovernmentContractReceivable.1329.0.0.0.0.0.0" contextRef="as-of-2011-02-28.1329.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">179000000</us-gaap:GovernmentContractReceivable>
  <us-gaap:GovernmentContractReceivableUnbilledAmounts id="GovernmentContractReceivableUnbilledAmounts.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1725000</us-gaap:GovernmentContractReceivableUnbilledAmounts>
  <us-gaap:GovernmentContractReceivableUnbilledAmounts id="GovernmentContractReceivableUnbilledAmounts.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1836000</us-gaap:GovernmentContractReceivableUnbilledAmounts>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-7217000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-3212000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-20472000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-15247000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>

 <us-gaap:InvestmentIncomeNet id="InvestmentIncomeNet.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">39000</us-gaap:InvestmentIncomeNet>
  <us-gaap:InvestmentIncomeNet id="InvestmentIncomeNet.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">22000</us-gaap:InvestmentIncomeNet>
  <us-gaap:InvestmentIncomeNet id="InvestmentIncomeNet.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">111000</us-gaap:InvestmentIncomeNet>
  <us-gaap:InvestmentIncomeNet id="InvestmentIncomeNet.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">106000</us-gaap:InvestmentIncomeNet>




 <us-gaap:IncomeTaxExpenseBenefit id="IncomeTaxExpenseBenefit.1296.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxExpenseBenefit id="IncomeTaxExpenseBenefit.1297.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxExpenseBenefit id="IncomeTaxExpenseBenefit.1298.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxExpenseBenefit id="IncomeTaxExpenseBenefit.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">412000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-304000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-3687000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="IncreaseDecreaseInAccountsReceivable.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">504000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="IncreaseDecreaseInAccountsReceivable.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-37000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="IncreaseDecreaseInDeferredRevenue.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">803000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="IncreaseDecreaseInDeferredRevenue.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2500000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities id="IncreaseDecreaseInOtherNoncurrentLiabilities.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2803000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities id="IncreaseDecreaseInOtherNoncurrentLiabilities.1299.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">271000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1127000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInUnbilledReceivables id="IncreaseDecreaseInUnbilledReceivables.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-111000</us-gaap:IncreaseDecreaseInUnbilledReceivables>
  <us-gaap:IncreaseDecreaseInUnbilledReceivables id="IncreaseDecreaseInUnbilledReceivables.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3848000</us-gaap:IncreaseDecreaseInUnbilledReceivables>
  <us-gaap:InterestExpense id="InterestExpense.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">6000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="InterestExpense.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="InterestExpense.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="InterestExpense.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">6000</us-gaap:InterestExpense>
   <us-gaap:Liabilities id="Liabilities.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">19170000</us-gaap:Liabilities>
  <us-gaap:Liabilities id="Liabilities.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12727000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity id="LiabilitiesAndStockholdersEquity.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">80546000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="LiabilitiesAndStockholdersEquity.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">66576000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent id="LiabilitiesCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10441000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="LiabilitiesCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">7579000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesFairValueDisclosure id="LiabilitiesFairValueDisclosure.1292.2024.1894.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.2024.1894.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:LiabilitiesFairValueDisclosure id="LiabilitiesFairValueDisclosure.1293.2024.1894.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.2024.1894.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:LiabilitiesFairValueDisclosure id="LiabilitiesFairValueDisclosure.1292.2026.1894.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.2026.1894.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:LiabilitiesFairValueDisclosure id="LiabilitiesFairValueDisclosure.1293.2026.1894.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.2026.1894.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:LiabilitiesFairValueDisclosure id="LiabilitiesFairValueDisclosure.1292.2022.1894.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.2022.1894.0.0.0.0" unitRef="USD" decimals="-3">769000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:LiabilitiesFairValueDisclosure id="LiabilitiesFairValueDisclosure.1293.2022.1894.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.2022.1894.0.0.0.0" unitRef="USD" decimals="-3">368000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:LongTermNotesPayable id="LongTermNotesPayable.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">793000</us-gaap:LongTermNotesPayable>
  <us-gaap:LongTermNotesPayable id="LongTermNotesPayable.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">300000</us-gaap:LongTermNotesPayable>
  <us-gaap:MarketableSecuritiesAvailableForSaleSecuritiesPolicy id="MarketableSecuritiesAvailableForSaleSecuritiesPolicy.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"&gt; Short-Term Investments&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Short-term investments at September 30, 2012 consist of investments in commercial paper, corporate notes and three auction rate securities. All marketable securities had original maturities greater than 90 days, but less than one year. The auction rate securities have a par value of $5.1 million. The Company has classified these securities as available-for-sale since the Company may need to liquidate these securities within the next year. The available-for-sale securities are carried at fair value and unrealized gains and losses, if determined to be temporary, on these securities are included in accumulated other comprehensive income (loss) in stockholders&amp;#39; equity. Investments available for sale are evaluated periodically to determine whether a decline in value is "other-than-temporary." The term "other-than-temporary" is not intended to indicate a permanent decline in value. Rather, it means that the prospects for a near term recovery of value are not necessarily favorable, or that there is a lack of evidence to support fair values equal to, or greater than, the carrying value of the security. Management reviews criteria, such as the magnitude and duration of the decline, as well as the Company&amp;#39;s ability to hold the securities until market recovery, to predict whether the loss in value is other-than-temporary. If a decline in value is determined to be other-than-temporary, the value of the security is reduced and the impairment is recorded in the statements of operations. The specific identification method is used in computing realized gains and losses on sale of the Company&amp;#39;s securities.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Short-term investments classified as available-for-sale as of September 30, 2012 and December 31, 2011 were comprised of (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap"&gt;September 30, 2012&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap"&gt;December 31, 2011&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Amortized&lt;/strong&gt;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Cost&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Gains&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Losses&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;Fair Value&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Amortized&lt;/strong&gt;&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"&gt; &lt;strong&gt;Cost&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Gains&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;&lt;strong&gt;Gross&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Unrealized&lt;/strong&gt;&lt;br /&gt; &lt;strong&gt;Losses&lt;/strong&gt;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt;Fair Value&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 20%"&gt;Auction rate securities&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;3,373&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;1,032&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;-&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;4,405&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;3,373&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;832&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;-&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%"&gt;4,205&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; Corporate debt securities&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 13,263&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 4&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 13,267&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 16,636&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 1,036&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 17,672&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 3,373&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 832&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"&gt; 4,205&lt;/td&gt; &lt;td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:MarketableSecuritiesAvailableForSaleSecuritiesPolicy>
  <us-gaap:NatureOfOperations id="NatureOfOperations.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; Note 1 - Organization&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Novavax, Inc. (the "Company") is a clinical-stage biopharmaceutical company focused on developing recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The Company&amp;#39;s goal is to become a profitable vaccine company that is aggressively driving towards development, licensure and commercialization of an important portfolio of vaccines worldwide. The Company&amp;#39;s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles ("VLPs") and recombinant protein micelle vaccines combined with a single-use bioprocessing production system. These vaccine candidates are genetically engineered three-dimensional nanostructures that incorporate immunologically important recombinant proteins. The Company&amp;#39;s product pipeline targets a variety of infectious diseases and its vaccine candidates are currently in or have completed clinical trials that target pandemic (H5N1) influenza, seasonal influenza and respiratory syncytial virus ("RSV").&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In 2009, the Company formed a joint venture with Cadila Pharmaceuticals Limited ("Cadila") named CPL Biologicals Private Limited (the "JV") to develop and manufacture vaccines, biological therapeutics and diagnostics in India. The JV is owned 20% by the Company and 80% by Cadila. The Company accounts for its investment in the JV using the equity method.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:NatureOfOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="NetCashProvidedByUsedInFinancingActivities.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">25920000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="NetCashProvidedByUsedInFinancingActivities.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">9278000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="NetCashProvidedByUsedInInvestingActivities.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-15147000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="NetCashProvidedByUsedInInvestingActivities.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">17739000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="NetCashProvidedByUsedInOperatingActivities.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-14139000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="NetCashProvidedByUsedInOperatingActivities.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-20760000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-7217000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-3212000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-20472000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-15659000</us-gaap:NetIncomeLoss>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="NewAccountingPronouncementsPolicyPolicyTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Recent Accounting Pronouncements&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In June 2011, the FASB issued ASU 2011-05, &lt;em&gt;Comprehensive Income (Topic 220): Presentation of Comprehensive Income&lt;/em&gt; ("ASU 2011-05"). This guidance is intended to increase the prominence of other comprehensive income in financial statements by presenting it in either a single-statement or two-statement approach. This ASU was effective for the Company beginning January 1, 2012. This presentation requirement was adopted January 1, 2012 and is reflected on the accompanying statements of operations and comprehensive loss for the periods ended September 30, 2012 and 2011.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In September 2011, the FASB issued ASU 2011-08, &lt;em&gt;Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for Impairment&lt;/em&gt; ("ASU 2011-08")&lt;em&gt;,&lt;/em&gt; to give both public and nonpublic entities the option to qualitatively determine whether they can bypass the two-step goodwill impairment test. Under the new guidance, if an entity chooses to perform a qualitative assessment and determines that it is more likely than not (a more than 50 percent likelihood) that the fair value of a reporting unit is less than its carrying amount, it would then perform Step 1 of the annual goodwill impairment test in ASC 350-20 and, if necessary, proceed to Step 2. Otherwise, no further evaluation would be necessary. The decision to perform a qualitative assessment is made at the reporting unit level, and an entity with multiple reporting units may utilize a mix of qualitative assessments and quantitative tests among its reporting units. The amended guidance was effective for interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, although early adoption was permitted. The adoption of ASU 2011-08 on January 1, 2012 did not have a material effect on the Company&amp;#39;s financial statements.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NotesPayableCurrent id="NotesPayableCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">157000</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesPayableCurrent id="NotesPayableCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">20000</us-gaap:NotesPayableCurrent>
  <us-gaap:OperatingIncomeLoss id="OperatingIncomeLoss.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-6849000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="OperatingIncomeLoss.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-3968000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="OperatingIncomeLoss.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-20170000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="OperatingIncomeLoss.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-17320000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OtherAssetsCurrent id="OtherAssetsCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">235000</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsCurrent id="OtherAssetsCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1558000</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsNoncurrent id="OtherAssetsNoncurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">350000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent id="OtherAssetsNoncurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">469000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">96000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">204000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">141000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherNoncashIncomeExpense id="OtherNoncashIncomeExpense.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-436000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:OtherNoncashIncomeExpense id="OtherNoncashIncomeExpense.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">254000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:PaymentsForProceedsFromTenantAllowance id="PaymentsForProceedsFromTenantAllowance.1341.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">2800000</us-gaap:PaymentsForProceedsFromTenantAllowance>
  <us-gaap:PaymentsOfStockIssuanceCosts id="PaymentsOfStockIssuanceCosts.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">400000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:PaymentsOfStockIssuanceCosts id="PaymentsOfStockIssuanceCosts.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">200000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecurities id="PaymentsToAcquireAvailableForSaleSecurities.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">15763000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecurities id="PaymentsToAcquireAvailableForSaleSecurities.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2082000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
  <us-gaap:PaymentsToAcquireProductiveAssets id="PaymentsToAcquireProductiveAssets.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2202000</us-gaap:PaymentsToAcquireProductiveAssets>
  <us-gaap:PaymentsToAcquireProductiveAssets id="PaymentsToAcquireProductiveAssets.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">414000</us-gaap:PaymentsToAcquireProductiveAssets>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="PreferredStockParOrStatedValuePerShare.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="PreferredStockParOrStatedValuePerShare.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="PreferredStockSharesAuthorized.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">2000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized id="PreferredStockSharesAuthorized.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">2000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="PreferredStockSharesIssued.1292.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UShares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockSharesIssued id="PreferredStockSharesIssued.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UShares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockSharesOutstanding id="PreferredStockSharesOutstanding.1292.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UShares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockSharesOutstanding id="PreferredStockSharesOutstanding.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UShares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockValue id="PreferredStockValue.1292.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockValue id="PreferredStockValue.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PrepaidExpenseCurrent id="PrepaidExpenseCurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2807000</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:PrepaidExpenseCurrent id="PrepaidExpenseCurrent.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2441000</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">26925000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">9182000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.1866.0.0.0.0.0.0" contextRef="from-2012-10-01-to-2012-10-31.1866.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">26900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="ProceedsFromIssuanceOrSaleOfEquity.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">14000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="ProceedsFromIssuanceOrSaleOfEquity.1336.0.0.0.0.0.0" contextRef="from-2008-07-01-to-2008-07-31.1336.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">17500000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="ProceedsFromIssuanceOrSaleOfEquity.1338.0.0.0.0.0.0" contextRef="from-2012-05-01-to-2012-05-31.1338.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">12100000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="ProceedsFromIssuanceOrSaleOfEquity.1344.0.0.0.0.0.0" contextRef="from-2010-03-01-to-2012-11-07.1344.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">49900000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="ProceedsFromIssuanceOrSaleOfEquity.1377.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.1377.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">800000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromNotesPayable id="ProceedsFromNotesPayable.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">650000</us-gaap:ProceedsFromNotesPayable>
  <us-gaap:ProceedsFromNotesPayable id="ProceedsFromNotesPayable.1299.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromRepaymentsOfNotesPayable id="ProceedsFromRepaymentsOfNotesPayable.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-20000</us-gaap:ProceedsFromRepaymentsOfNotesPayable>
  <us-gaap:ProceedsFromRepaymentsOfNotesPayable id="ProceedsFromRepaymentsOfNotesPayable.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-60000</us-gaap:ProceedsFromRepaymentsOfNotesPayable>
  <us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities id="ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-1594000</us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities>
  <us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities id="ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.1299.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities id="ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2500000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities id="ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">20235000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="ProceedsFromSaleOfPropertyPlantAndEquipment.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">318000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="ProceedsFromSaleOfPropertyPlantAndEquipment.1299.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromStockOptionsExercised id="ProceedsFromStockOptionsExercised.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">49000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised id="ProceedsFromStockOptionsExercised.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">156000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:PropertyPlantAndEquipmentNet id="PropertyPlantAndEquipmentNet.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">9815000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="PropertyPlantAndEquipmentNet.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">6857000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="RepaymentsOfLongTermCapitalLeaseObligations.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">90000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="RepaymentsOfLongTermCapitalLeaseObligations.1299.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ResearchAndDevelopmentExpense id="ResearchAndDevelopmentExpense.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">6395000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="ResearchAndDevelopmentExpense.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4049000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="ResearchAndDevelopmentExpense.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">16649000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="ResearchAndDevelopmentExpense.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">13474000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue id="RestrictedCashAndCashEquivalentsAtCarryingValue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">838000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue id="RestrictedCashAndCashEquivalentsAtCarryingValue.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent id="RestrictedCashAndCashEquivalentsNoncurrent.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">756000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
  <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent id="RestrictedCashAndCashEquivalentsNoncurrent.1293.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:RetainedEarningsAccumulatedDeficit id="RetainedEarningsAccumulatedDeficit.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-350128000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="RetainedEarningsAccumulatedDeficit.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-329656000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="RevenueRecognitionPolicyTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Revenue Recognition&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company performs research and development for U.S. Government agencies and other collaborators under cost reimbursable and fixed price contracts, including license and clinical development agreements. The Company recognizes revenue under research contracts when a contract has been executed, the contract price is fixed and determinable, delivery of services or products has occurred and collection of the contract price is reasonably assured. Payments received in advance of work performed are recorded as deferred revenue and losses on contracts, if any, are recognized in the period in which they become known.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Under cost reimbursable contracts, the Company is reimbursed and recognizes revenue as allowable costs are incurred plus a portion of the fixed-fee earned. The Company considers fixed-fees under cost reimbursable contracts to be earned in proportion to the allowable costs incurred in performance of the work as compared to total estimated contract costs, with such costs incurred representing a reasonable measurement of the proportional performance of the work completed. Under its HHS BARDA contract, certain activities must be pre-approved by HHS BARDA in order for their costs to be deemed allowable direct costs. Direct costs incurred under cost reimbursable contracts are recorded as cost of government contracts revenue. The Company&amp;#39;s government contracts, including its HHS BARDA contract, provide the U.S. government (or agency) the ability to terminate the contract for convenience or to terminate for default if the Company fails to meet its obligations as set forth in the statement of work. The Company believes that if the government were to terminate one of its contracts for convenience, including the HHS BARDA contract, the costs incurred through the effective date of such termination and any settlement costs resulting from such termination would be allowable costs. Payments to the Company under cost reimbursable contracts with agencies of the U.S. Government, including its contract with HHS BARDA, are provisional payments subject to adjustment upon annual audit by the government. No such audit has been completed as of September 30, 2012; however, management believes that revenue for periods subject to audit has been recorded in amounts that are expected to be realized upon final audit and settlement.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company&amp;#39;s collaborative research and development agreements may include an upfront payment, payments for research and development services, milestone payments and royalties. Agreements with multiple deliverables are evaluated to determine if the deliverables can be divided into more than one unit of accounting. A deliverable can generally be considered a separate unit of accounting if both of the following criteria are met: (1) the delivered item(s) has value to the customer on a stand-alone basis; and (2) if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable and substantially in control of the Company. Deliverables that cannot be divided into separate units are combined with other units of accounting, as appropriate. Consideration received is allocated among the separate units of accounting based on the relative selling price method. Deliverables under these arrangements typically include rights to intellectual property, research and development services and involvement by the parties in steering committees. Historically, deliverables under the Company&amp;#39;s collaborative research and development agreements have been deemed to have no stand-alone value and as a result been treated as a single unit of accounting. In addition, the Company analyzes its contracts and collaborative agreements to determine whether the payments received should be recorded as revenue or as a reduction to research and development expenses. In reaching this determination, management considers a number of factors, including whether the Company is principal under the arrangement, and whether the arrangement is significant to, and part of, the Company&amp;#39;s core operations. Historically, payments received under its contracts and collaborative agreements have been recognized as revenue since the Company acts as a principal in the arrangement, and the activities are core to its operations.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; When the performance under a fixed price contract can be reasonably estimated, revenue for fixed price contracts is recognized under the proportional performance method and earned in proportion to the contract costs incurred in performance of the work as compared to total estimated contract costs. Costs incurred under fixed price contracts represent a reasonable measurement of proportional performance of the work. Direct costs incurred under collaborative research and development agreements are recorded as research and development expenses. If the performance under a fixed price contract cannot be reasonably estimated, the Company recognizes the revenue on a straight-line basis over the contract term&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Revenue associated with upfront payments under arrangements is recognized over the contract term or when all obligations associated with the upfront payment have been satisfied.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Revenue from the achievement of research and development milestones, if deemed substantive, is recognized as revenue when the milestones are achieved, and the milestone payments are due and collectible. If not deemed substantive, the Company would recognize such milestone as revenue upon its achievement on a straight-line basis over the remaining expected term of the research and development period. Milestones are considered substantive if all of the following conditions are met: (1) the milestone is non-refundable; (2) there is substantive uncertainty of achievement of the milestone at the inception of the arrangement; (3) substantive effort is involved to achieve the milestone and such achievement relates to past performance; and (4) the amount of the milestone appears reasonable in relation to the effort expended and all of the deliverables and payment terms in the arrangement.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:Revenues id="Revenues.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5765000</us-gaap:Revenues>
  <us-gaap:Revenues id="Revenues.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5008000</us-gaap:Revenues>
  <us-gaap:Revenues id="Revenues.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">17510000</us-gaap:Revenues>
  <us-gaap:Revenues id="Revenues.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8843000</us-gaap:Revenues>
  <us-gaap:ScheduleOfDebtTableTextBlock id="ScheduleOfDebtTableTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Aggregate future minimum principal payments on the GE Equipment Loan at September 30, 2012 are as follows (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold"&gt; Year&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;Amount&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 79%"&gt;2012&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 18%"&gt;39&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2013&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;157&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2014&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;157&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2015&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;157&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;2016&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 40&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company recorded stock-based compensation expense in the statements of operations and comprehensive loss as follows (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;/p&gt; &lt;table style="WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0" align="center"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;2011&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;2011&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 48%"&gt;Research and development&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;219&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;176&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;638&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;449&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;General and administrative&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 274&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 366&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 1,030&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 1,228&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"&gt; Total stock-based compensation expense&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 493&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 542&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 1,668&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 1,677&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&lt;br /&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock id="ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Financial assets and liabilities measured at fair market value on a recurring basis as of September 30, 2012 and December 31, 2011 are summarized below (in thousands):&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap"&gt;Fair Value at September 30, 2012&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap"&gt;Fair Value at December 31, 2011&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 1&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 2&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 3&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 1&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 2&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap"&gt;Level 3&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-LEFT: 9.45pt; TEXT-DECORATION: underline; TEXT-INDENT: -9.45pt"&gt; Assets&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; PADDING-LEFT: 9.45pt; TEXT-ALIGN: left; TEXT-INDENT: -9.45pt; WIDTH: 34%"&gt; Corporate debt and auction rate securities&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; 17,672&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; 4,205&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt; Liabilities&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; Warrant liability&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; 769&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; -&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"&gt; 368&lt;/td&gt; &lt;td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock id="ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"&gt; Future minimum capital lease payments under the capital lease agreement at September 30, 2012 are as follows (in thousands):&lt;/p&gt; &lt;p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"&gt;Amount&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 79%"&gt;2012&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 18%"&gt;12&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2013&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;76&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2014&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;76&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2015&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;76&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;2016&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;76&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;2017&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 44&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;360&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;Less &amp;#8213; amounts representing interest&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; (51&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left"&gt;Present value of net minimum lease payments&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;309&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;Less &amp;#8213; current portion of capital lease&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; (57&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;Non-current portion of capital lease&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 252&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following is a summary of option activity under the 2005 Plan and the 1995 Plan for the nine months ended September 30, 2012:&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="6" nowrap="nowrap"&gt;2005 Stock Incentive Plan&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="6" nowrap="nowrap"&gt;1995 Stock Option Plan&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Stock&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Options&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Weighted-&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Exercise&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Price&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Stock&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Options&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Weighted-&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Exercise&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"&gt; &lt;strong&gt;Price&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 48%"&gt;Outstanding at January 1, 2012&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;7,412,746&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;2.22&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;474,650&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%"&gt;4.38&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;3,483,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;1.29&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td&gt;Exercised&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;(80,784&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;)&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;0.61&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;Canceled&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; (1,546,562&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 2.26&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; (184,750&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"&gt; 4.01&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;Outstanding at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 9,268,400&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 1.88&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 289,900&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 4.59&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"&gt; Shares exercisable at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 3,503,043&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 2.38&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 289,900&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 4.59&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"&gt; Shares available for grant at September 30, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"&gt; 5,559,536&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock id="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The fair value of stock options granted was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 95%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"&gt; &lt;td style="TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"&gt; &lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"&gt; &lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"&gt; &lt;p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"&gt; &lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"&gt; &lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap"&gt;2012&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap"&gt;2011&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap"&gt;2012&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap"&gt;2011&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; TEXT-INDENT: -9pt; PADDING-LEFT: 9pt; WIDTH: 40%" nowrap="nowrap"&gt;Weighted-average fair value of stock options granted&lt;/td&gt; &lt;td style="WIDTH: 1%" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"&gt; $1.09&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"&gt; $0.78&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 1%" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"&gt; $0.71&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"&gt; $1.19&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;Risk-free interest rate&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0.55%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0.48%-0.68%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0.55%-1.54%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0.48%-1.91%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;Dividend yield&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td nowrap="nowrap"&gt;Volatility&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;76.60%-76.71%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;75.86%-80.40%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;75.47%-80.48%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;73.28%-80.48%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;Expected term (in years)&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;4.24&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;3.49-4.21&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;3.34-7.09&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;3.26-4.47&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;Expected forfeiture rate&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%-23.15%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%-23.15%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%-23.15%&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center" nowrap="nowrap"&gt;0%-23.15%&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" nowrap="nowrap"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensation id="ShareBasedCompensation.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1668000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ShareBasedCompensation.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1677000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.1298.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UShares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.1298.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPerShare" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.1298.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UShares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.1298.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPerShare" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">53333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">1.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">1.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">3333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">5.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="UPure" decimals="2">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPure" decimals="6">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="UPure" decimals="8">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0">P4Y2M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.1297.3248.4187.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.3248.4187.0.0.0.0">P3Y5M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.1298.3248.4187.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.3248.4187.0.0.0.0">P3Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.1299.3248.4187.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.3248.4187.0.0.0.0">P3Y3M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.1297.3241.4187.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.3241.4187.0.0.0.0">P4Y2M16D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.1298.3241.4187.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.3241.4187.0.0.0.0">P7Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.1299.3241.4187.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.3241.4187.0.0.0.0">P4Y5M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.7671</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="UPure" decimals="3">0.804</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.8048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.8048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="UPure" decimals="3">0.766</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.7586</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.7547</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.7328</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.0055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.0068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.0154</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.0191</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.0048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.0055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="UPure" decimals="4">0.0048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.1292.24507.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24507.3871.0.0.0.0" unitRef="UShares" decimals="0">18312192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.1292.24508.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24508.3871.0.0.0.0" unitRef="UShares" decimals="0">5746468</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">5559536</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.1292.24507.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24507.3871.0.0.0.0" unitRef="UShares" decimals="0">3503043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.1292.24508.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24508.3871.0.0.0.0" unitRef="UShares" decimals="0">289900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.1292.24507.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24507.3871.0.0.0.0" unitRef="UPerShare" decimals="2">2.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.1292.24508.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24508.3871.0.0.0.0" unitRef="UPerShare" decimals="2">4.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.1298.24507.3871.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.0.0.0.0" unitRef="UShares" decimals="0">1546562</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.1298.24508.3871.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.0.0.0.0" unitRef="UShares" decimals="0">184750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.1298.24507.3871.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.0.0.0.0" unitRef="UShares" decimals="0">3483000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.1298.24508.3871.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.0.0.0.0" unitRef="UShares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">1.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">0.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">0.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">1.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1292.24507.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24507.3871.0.0.0.0" unitRef="UShares" decimals="0">9268400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1293.24507.3871.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.24507.3871.0.0.0.0" unitRef="UShares" decimals="0">7412746</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1292.24508.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24508.3871.0.0.0.0" unitRef="UShares" decimals="0">289900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1293.24508.3871.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.24508.3871.0.0.0.0" unitRef="UShares" decimals="0">474650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1292.24507.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24507.3871.0.0.0.0" unitRef="UPerShare" decimals="2">1.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1293.24507.3871.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.24507.3871.0.0.0.0" unitRef="UPerShare" decimals="2">2.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1292.24508.3871.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.24508.3871.0.0.0.0" unitRef="UPerShare" decimals="2">4.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1293.24508.3871.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.24508.3871.0.0.0.0" unitRef="UPerShare" decimals="2">4.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.1298.24507.3871.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.0.0.0.0" unitRef="UPerShare" decimals="2">0.61</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.1298.24508.3871.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.0.0.0.0" unitRef="UPerShare" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice id="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.1298.24507.3871.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.0.0.0.0" unitRef="UPerShare" decimals="2">2.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice id="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.1298.24508.3871.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.0.0.0.0" unitRef="UPerShare" decimals="2">4.01</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.1298.24507.3871.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.0.0.0.0" unitRef="UPerShare" decimals="2">1.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.1298.24508.3871.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.0.0.0.0" unitRef="UPerShare" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:SharePrice id="SharePrice.1291.0.0.0.0.0.0" contextRef="as-of-2012-10-31.1291.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">2.18</us-gaap:SharePrice>
  <us-gaap:SharePrice id="SharePrice.1339.0.0.0.0.0.0" contextRef="as-of-2012-05-31.1339.0.0.0.0.0.0.0" unitRef="UPerShare" decimals="2">1.22</us-gaap:SharePrice>
  <us-gaap:StockholdersEquity id="StockholdersEquity.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">61376000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">53849000</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UShares" decimals="-5">8400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.1336.0.0.0.0.0.0" contextRef="from-2008-07-01-to-2008-07-31.1336.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">6686650</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.1338.0.0.0.0.0.0" contextRef="from-2012-05-01-to-2012-05-31.1338.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">10000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.1344.0.0.0.0.0.0" contextRef="from-2010-03-01-to-2012-11-07.1344.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">24957715</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.1376.0.0.0.0.0.0" contextRef="from-2011-12-01-to-2011-12-31.1376.0.0.0.0.0.0.0" unitRef="UShares" decimals="-5">700000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.1866.0.0.0.0.0.0" contextRef="from-2012-10-01-to-2012-10-31.1866.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">12385321</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="StockIssuedDuringPeriodSharesStockOptionsExercised.1298.24507.3871.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.0.0.0.0" unitRef="UShares" decimals="0">80784</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="StockIssuedDuringPeriodSharesStockOptionsExercised.1298.24508.3871.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.0.0.0.0" unitRef="UShares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:SubsequentEventsTextBlock id="SubsequentEventsTextBlock.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Note 12 - Subsequent Events&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In October 2012, the Company sold 12,385,321 shares of its common stock to two affiliates of RA Capital Management, LLC, three affiliates of Camber Capital Management LLC and three affiliates of Ayer Capital Management LLC at a price of $2.18 per share, resulting in approximately $26.9 million in net proceeds. The shares were offered under an effective shelf registration statement previously filed with the SEC.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:TreasuryStockShares id="TreasuryStockShares.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">455430</us-gaap:TreasuryStockShares>
  <us-gaap:TreasuryStockShares id="TreasuryStockShares.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">455430</us-gaap:TreasuryStockShares>
  <us-gaap:TreasuryStockValue id="TreasuryStockValue.1292.0.0.0.0.0.0" contextRef="as-of-2012-09-30.1292.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2450000</us-gaap:TreasuryStockValue>
  <us-gaap:TreasuryStockValue id="TreasuryStockValue.1293.0.0.0.0.0.0" contextRef="as-of-2011-12-31.1293.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2450000</us-gaap:TreasuryStockValue>
  <us-gaap:UseOfEstimates id="UseOfEstimates.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;&lt;em&gt;Use of Estimates&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these estimates.&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="WeightedAverageNumberOfShareOutstandingBasicAndDiluted.1296.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">134178</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="WeightedAverageNumberOfShareOutstandingBasicAndDiluted.1297.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">115107</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="WeightedAverageNumberOfShareOutstandingBasicAndDiluted.1298.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">127246</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="WeightedAverageNumberOfShareOutstandingBasicAndDiluted.1299.0.0.0.0.0.0" contextRef="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0" unitRef="UShares" decimals="0">113053</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <xbrli:unit id="UShares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USD">
    <xbrli:measure>ISO4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="UPerShare">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>ISO4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="UPerUnit">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>ISO4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>nvax:warrants</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="UPure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>

  <xbrli:context id="from-2012-10-01-to-2012-10-31.1866.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-10-01</xbrli:startDate>
      <xbrli:endDate>2012-10-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-09-01-to-2012-09-30.1334.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-09-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-08-01-to-2012-08-31.1332.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-08-01</xbrli:startDate>
      <xbrli:endDate>2012-08-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2012-09-30.1296.0.4381.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2012-09-30.1296.0.3248.4187.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2012-09-30.1296.0.3241.4187.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2012-09-30.1296.0.24610.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:PathVaccineSolutionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2012-09-30.1296.0.2354.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2012-09-30.1296.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-05-01-to-2012-05-31.1338.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-05-01</xbrli:startDate>
      <xbrli:endDate>2012-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.4381.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.3248.4187.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.3241.4187.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.24606.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:HhsBardaContractAwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.3248.4187.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:OneNineNineFiveStockOptionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.3241.4187.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:OneNineNineFiveStockOptionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.24508.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:OneNineNineFiveStockOptionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.3248.4187.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:TwoZeroZeroFiveStockIncentivePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.3241.4187.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:TwoZeroZeroFiveStockIncentivePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.24507.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:TwoZeroZeroFiveStockIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.2354.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-09-30.1298.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-03-31.1377.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-12-01-to-2011-12-31.1376.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-12-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-11-01-to-2011-11-30.1341.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-11-01</xbrli:startDate>
      <xbrli:endDate>2011-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2011-09-30.1297.0.4381.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2011-09-30.1297.0.3248.4187.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2011-09-30.1297.0.3241.4187.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2011-09-30.1297.0.2354.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2011-09-30.1297.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-02-01-to-2012-09-30.2096.0.24606.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:HhsBardaContractAwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-02-01</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-02-01-to-2011-02-28.1328.0.24607.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:HhsBardaOptionForAdditionalPeriodMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-02-01</xbrli:startDate>
      <xbrli:endDate>2011-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-02-01-to-2011-02-28.1328.0.24606.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:HhsBardaContractAwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-02-01</xbrli:startDate>
      <xbrli:endDate>2011-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-01-01-to-2011-09-30.1299.0.4381.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-01-01-to-2011-09-30.1299.0.3248.4187.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-01-01-to-2011-09-30.1299.0.3241.4187.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-01-01-to-2011-09-30.1299.0.24606.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:HhsBardaContractAwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-01-01-to-2011-09-30.1299.0.2354.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-01-01-to-2011-09-30.1299.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2010-03-01-to-2012-11-07.1344.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-03-01</xbrli:startDate>
      <xbrli:endDate>2012-11-07</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2009-03-31-to-2012-09-30.2000.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-03-31</xbrli:startDate>
      <xbrli:endDate>2012-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2008-07-01-to-2008-07-31.1336.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-07-01</xbrli:startDate>
      <xbrli:endDate>2008-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-10-31.1291.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-10-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-30.1292.0.622.3184.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-30.1292.0.24606.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:HhsBardaContractAwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-30.1292.0.24508.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:OneNineNineFiveStockOptionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-30.1292.0.24507.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:TwoZeroZeroFiveStockIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-30.1292.0.2026.1894.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-30.1292.0.2024.1894.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-30.1292.0.2022.1894.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-30.1292.0.1180.3184.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-30.1292.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-08-31.1333.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-08-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-07-31.1330.0.24610.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:PathVaccineSolutionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-05-31.1339.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-05-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.1293.0.622.3184.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.1293.0.24508.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:OneNineNineFiveStockOptionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.1293.0.24507.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:TwoZeroZeroFiveStockIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.1293.0.2026.1894.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.1293.0.2024.1894.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.1293.0.2022.1894.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.1293.0.1180.3184.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.1293.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-11-30.1343.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-09-30.1294.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-02-28.1329.0.24609.999.3248.4187.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:LicenseAgreementWithLgLifeSciencesLtdMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-02-28.1329.0.24609.999.3241.4187.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:LicenseAgreementWithLgLifeSciencesLtdMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-02-28.1329.0.24609.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:LicenseAgreementWithLgLifeSciencesLtdMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-02-28.1329.0.24607.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:HhsBardaOptionForAdditionalPeriodMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-02-28.1329.0.24606.999.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">nvax:HhsBardaContractAwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-02-28.1329.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2010-12-31.1295.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2008-07-31.1337.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000694</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>nvax-20120930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--P3XBRL-->
<!--version 4.1.22 -->
<!--http://www.p3xbrl.com-->
<!--produced on 2012-11-08 @ 9:38 PM-->
<xsd:schema targetNamespace="http://www.novavax.com/20120930" elementFormDefault="qualified" xmlns:nvax="http://www.novavax.com/20120930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:href="nvax-20120930_cal.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:href="nvax-20120930_def.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="nvax-20120930_lab.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="nvax-20120930_pre.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:roleType roleURI="http://www.novavax.com/role/CapitalLease" id="nvax-cale" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>106 - Disclosure - Capital Lease</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/CapitalLeaseFutureMinimumCapitalLeasePaymentsUnderCapitalLeaseAgreementDetails" id="nvax-calefmclpuclad" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40602 - Disclosure - Capital Lease (Future Minimum Capital Lease Payments Under Capital Lease Agreement)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/CapitalLeaseNarrativeDetails" id="nvax-calend" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40601 - Disclosure - Capital Lease (Narrative)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/NotesPayableAggregateFutureMinimumPrincipalPaymentsOnEquipmentLoanDetails" id="nvax-calenpafmppoeld" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40702 - Disclosure - Notes Payable (Aggregate Future Minimum Principal Payments on Equipment Loan)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/CapitalLeaseTables" id="nvax-caleta" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>306 - Disclosure - Capital Lease (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/BalanceSheets" id="nvax-ccbs" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>002 - Statement - BALANCE SHEETS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/BalanceSheetsParenthetical" id="nvax-ccbsp" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>003 - Statement - BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StatementsOfComprehensiveLoss" id="nvax-ccci" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>005 - Statement - STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StatementsOfCashFlows" id="nvax-ccscf" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>006 - Statement - STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StamentsOfOperations" id="nvax-ccso" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>004 - Statement - STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/DocumentAndEntityInformation" id="nvax-daei" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/LiquidityMatters" id="nvax-lima" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>102 - Disclosure - Liquidity Matters</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/LiquidityMattersDetails" id="nvax-limad" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40201 - Disclosure - Liquidity Matters (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacility" id="nvax-mlof" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>110 - Disclosure - Manufacturing, Laboratory and Office Facility</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacilityDetails" id="nvax-mlofd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>41001 - Disclosure - Manufacturing, Laboratory and Office Facility (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/MasterServicesAgreementWithCadila" id="nvax-msac" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>111 - Disclosure - Master Services Agreement with Cadila</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/MasterServicesAgreementWithCadilaDetails" id="nvax-msacd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>41101 - Disclosure - Master Services Agreement with Cadila (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/NotesPayable" id="nvax-nopa" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>107 - Disclosure - Notes Payable</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/NotesPayableNarrativeDetails" id="nvax-nopand" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40701 - Disclosure - Notes Payable (Narrative)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/NotesPayableTables" id="nvax-nopata" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>307 - Disclosure - Notes Payable (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/Organization" id="nvax-orga" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>101 - Disclosure - Organization</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/OrganizationDetails" id="nvax-orgad" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40101 - Disclosure - Organization (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SalesOfCommonStockDetails" id="nvax-sacsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40901 - Disclosure - Sales of Common Stock (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StockBasedCompensationAssumptionsUsedInEstimationOfFairValueOfStockOptionsGrantedDetails" id="nvax-sbcoauefvsogd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40404 - Disclosure - Stock-Based Compensation (Assumptions Used in Estimation of Fair Value of Stock Options Granted)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" id="nvax-sbcocbced" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40402 - Disclosure - Stock-Based Compensation (Stock-Based Compensation Expense)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StockBasedCompensationNarrativeDetails" id="nvax-sbcond" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40401 - Disclosure - Stock-Based Compensation (Narrative)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StockBasedCompensationSummaryOfRestrictedStockAwardsActivityDetails" id="nvax-sbcosrsaad" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40405 - Disclosure - Stock-Based Compensation (Summary of Restricted Stock Awards Activity)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StockBasedCompensationTables" id="nvax-sbcota" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>304 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StockBasedCompensationSummaryOfOptionActivityDetails" id="nvax-sbcsoad" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40403 - Disclosure - Stock-Based Compensation (Summary of Option Activity)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SalesOfCommonStock" id="nvax-socs" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>109 - Disclosure - Sales of Common Stock</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPolicies" id="nvax-ssap" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>103 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesFinancialAssetsAndLiabilitiesMeasuredAtFairMarketValueOnARecurringBasisDetails" id="nvax-ssapfalmfmvrbd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40302 - Disclosure - Summary of Significant Accounting Policies (Financial Assets and Liabilities Measured at Fair Market Value on a Recurring Basis)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" id="nvax-ssapnd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40301 - Disclosure - Summary of Significant Accounting Policies (Narrative)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesPolicy" id="nvax-ssappo" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>203 - Disclosure - Summary of Significant Accounting Policies (Policy)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfActivityOfLevelThreeInputsMeasuredOnRecurringBasisDetails" id="nvax-ssapsalimrbd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40303 - Disclosure - Summary of Significant Accounting Policies (Summary of Activity of Level 3 Inputs Measured on Recurring Basis)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesShortTermInvestmentsClassifiedAsAvailableForSaleDetails" id="nvax-ssapsticaafsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40304 - Disclosure - Summary of Significant Accounting Policies (Short-term Investments Classified as Available-for-sale)(Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesTables" id="nvax-ssapta" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>303 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StockBasedCompensation" id="nvax-stbaco" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>104 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/StatementsOfCashFlowsParenthetical" id="nvax-stcfpa" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>007 - Statement - STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SubsequentEvents" id="nvax-suev" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>112 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/SubsequentEventsDetails" id="nvax-suevd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>41201 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/USGovernmentAgreementAndCollaboartions" id="nvax-usgac" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>105 - Disclosure - U.S. Government Agreement and Collaborations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/PointsPointGovernmentAgreementAndCollaborationsDetails" id="nvax-usgacd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40501 - Disclosure - U.S. Government Agreement and Collaborations (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/WarrantLiability" id="nvax-wali" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>108 - Disclosure - Warrant Liability</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.novavax.com/role/WarrantLiabilityDetails" id="nvax-walid" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40801 - Disclosure - Warrant Liability (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2012-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2012/elts/us-types-2012-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2012-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2012-01-31" schemaLocation="http://xbrl.sec.gov/invest/2012/invest-2012-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2012-01-31" schemaLocation="http://xbrl.sec.gov/exch/2012/exch-2012-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2012-01-31" schemaLocation="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2012-01-31" schemaLocation="http://xbrl.sec.gov/currency/2012/currency-2012-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2012-01-31" schemaLocation="http://xbrl.sec.gov/country/2012/country-2012-01-31.xsd" />
  <xsd:element name="AdditionalTenantImprovementAllowance" id="nvax_AdditionalTenantImprovementAllowance" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="AdditionalTenantImprovementAllowanceExtended340" id="nvax_AdditionalTenantImprovementAllowanceExtended340" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="AuctionRateSecuritiesParValue" id="nvax_AuctionRateSecuritiesParValue" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="AverageSharePrice" id="nvax_AverageSharePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType" />
  <xsd:element name="CapitalLeaseObligationEquipmentPurchased" id="nvax_CapitalLeaseObligationEquipmentPurchased" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="CapitalLeasePeriodicPayment" id="nvax_CapitalLeasePeriodicPayment" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="CapitalLeasesOfLesseeEffectiveInterestRate" id="nvax_CapitalLeasesOfLesseeEffectiveInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="nvax_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="us-types:perUnitItemType" />
  <xsd:element name="ClinicalTrialCostsIncurred" id="nvax_ClinicalTrialCostsIncurred" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="CommonSharesPerUnit" id="nvax_CommonSharesPerUnit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="us-types:perUnitItemType" />
  <xsd:element name="CommonStockValueAuthorized" id="nvax_CommonStockValueAuthorized" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="CommonStockValueAuthorizedPriorAgreement" id="nvax_CommonStockValueAuthorizedPriorAgreement" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="ContractTerm" id="nvax_ContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="CorporateDebtAndAuctionRateSecuritiesFairValueDisclosure" id="nvax_CorporateDebtAndAuctionRateSecuritiesFairValueDisclosure" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="DebtInstrumentTerm" id="nvax_DebtInstrumentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="DepositsForAcquisitionOfPropertyAndEquipment" id="nvax_DepositsForAcquisitionOfPropertyAndEquipment" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="nvax_DocumentAndEntityInformationAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="ExpectedClinicalTrialCosts" id="nvax_ExpectedClinicalTrialCosts" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="HhsBardaContractAwardMember" id="nvax_HhsBardaContractAwardMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="HhsBardaOptionForAdditionalPeriodMember" id="nvax_HhsBardaOptionForAdditionalPeriodMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="JointVentureOwnershipPercentage" id="nvax_JointVentureOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="JointVenturePercentageOwnedByOthers" id="nvax_JointVenturePercentageOwnedByOthers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="LeasedFacilitySquareFootage" id="nvax_LeasedFacilitySquareFootage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element name="LeaseTerm" id="nvax_LeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="LicenseAgreementWithLgLifeSciencesLtdMember" id="nvax_LicenseAgreementWithLgLifeSciencesLtdMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount" id="nvax_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="LiquidityMattersAbstract" id="nvax_LiquidityMattersAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="LiquidityMattersDisclosureTextBlock" id="nvax_LiquidityMattersDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="LoanAgreementFutureMinimumPaymentsDue" id="nvax_LoanAgreementFutureMinimumPaymentsDue" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="LoanAgreementFutureMinimumPaymentsDueInRollingYearFour" id="nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="LoanAgreementFutureMinimumPaymentsDueInRollingYearThree" id="nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo" id="nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths" id="nvax_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear" id="nvax_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="ManufacturingLaboratoryAndOfficeFacilityAbstract" id="nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="MarketableSecuritiesOriginalMaximumMaturity" id="nvax_MarketableSecuritiesOriginalMaximumMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="MarketableSecuritiesOriginalMinimumMaturity" id="nvax_MarketableSecuritiesOriginalMinimumMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="MasterServiceAgreementPurchases" id="nvax_MasterServiceAgreementPurchases" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="MasterServicesAgreementAmountOfServicesToBeProvidedMinimum" id="nvax_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="MasterServicesAgreementTextBlock" id="nvax_MasterServicesAgreementTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="MasterServicesAgreementWithCadilaAbstract" id="nvax_MasterServicesAgreementWithCadilaAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="MaximumSharesAvailableForSalePriorSalesAgreement" id="nvax_MaximumSharesAvailableForSalePriorSalesAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="NewFacilityLeaseDisclosureTextBlock" id="nvax_NewFacilityLeaseDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="NumberOfAuctionRateSecuritiesIncludedInInvestments" id="nvax_NumberOfAuctionRateSecuritiesIncludedInInvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element name="OneNineNineFiveStockOptionPlanMember" id="nvax_OneNineNineFiveStockOptionPlanMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="PathVaccineSolutionsMember" id="nvax_PathVaccineSolutionsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="PercentOfTheShortfallAmountExceedingTwoMillion" id="nvax_PercentOfTheShortfallAmountExceedingTwoMillion" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation" id="nvax_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent" id="nvax_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="ResearchAndDevelopmentCollaboration" id="nvax_ResearchAndDevelopmentCollaboration" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="RoyaltyPaymentsPercentOfFutureProductSales" id="nvax_RoyaltyPaymentsPercentOfFutureProductSales" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="SaleOfCommonStockDisclosureTextBlock" id="nvax_SaleOfCommonStockDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="SalesOfCommonStockAbstract" id="nvax_SalesOfCommonStockAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock" id="nvax_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="SettlementOfNotesReceivable" id="nvax_SettlementOfNotesReceivable" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate" id="nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant" id="nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent" id="nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm" id="nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="ShortfallAmountPayableInFull" id="nvax_ShortfallAmountPayableInFull" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="StockWarrantsAbstract" id="nvax_StockWarrantsAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="StockWarrantsTextBlock" id="nvax_StockWarrantsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="TenantAllowanceInterestRate" id="nvax_TenantAllowanceInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="TenantImprovementAllowance" id="nvax_TenantImprovementAllowance" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="TwoZeroZeroFiveStockIncentivePlanMember" id="nvax_TwoZeroZeroFiveStockIncentivePlanMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="UpfrontLicensePayment" id="nvax_UpfrontLicensePayment" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="UsGovernmentAgreementAndCollaborationsAbstract" id="nvax_UsGovernmentAgreementAndCollaborationsAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>nvax-20120930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--P3XBRL-->
<!--version 4.1.22 -->
<!--http://www.p3xbrl.com-->
<!--produced on 2012-11-08 @ 9:38 PM-->
<link:linkbase xmlns:nvax="http://www.novavax.com/20120930" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://www.novavax.com/role/DocumentAndEntityInformation" xlink:href="nvax-20120930.xsd#nvax-daei" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/BalanceSheets" xlink:href="nvax-20120930.xsd#nvax-ccbs" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/BalanceSheetsParenthetical" xlink:href="nvax-20120930.xsd#nvax-ccbsp" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StamentsOfOperations" xlink:href="nvax-20120930.xsd#nvax-ccso" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StatementsOfComprehensiveLoss" xlink:href="nvax-20120930.xsd#nvax-ccci" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StatementsOfCashFlows" xlink:href="nvax-20120930.xsd#nvax-ccscf" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StatementsOfCashFlowsParenthetical" xlink:href="nvax-20120930.xsd#nvax-stcfpa" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/Organization" xlink:href="nvax-20120930.xsd#nvax-orga" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/LiquidityMatters" xlink:href="nvax-20120930.xsd#nvax-lima" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="nvax-20120930.xsd#nvax-ssap" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesPolicy" xlink:href="nvax-20120930.xsd#nvax-ssappo" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="nvax-20120930.xsd#nvax-ssapta" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensation" xlink:href="nvax-20120930.xsd#nvax-stbaco" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/USGovernmentAgreementAndCollaboartions" xlink:href="nvax-20120930.xsd#nvax-usgac" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLease" xlink:href="nvax-20120930.xsd#nvax-cale" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayable" xlink:href="nvax-20120930.xsd#nvax-nopa" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/WarrantLiability" xlink:href="nvax-20120930.xsd#nvax-wali" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SalesOfCommonStock" xlink:href="nvax-20120930.xsd#nvax-socs" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacility" xlink:href="nvax-20120930.xsd#nvax-mlof" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayableTables" xlink:href="nvax-20120930.xsd#nvax-nopata" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLeaseTables" xlink:href="nvax-20120930.xsd#nvax-caleta" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationTables" xlink:href="nvax-20120930.xsd#nvax-sbcota" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/OrganizationDetails" xlink:href="nvax-20120930.xsd#nvax-orgad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/LiquidityMattersDetails" xlink:href="nvax-20120930.xsd#nvax-limad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-ssapnd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesFinancialAssetsAndLiabilitiesMeasuredAtFairMarketValueOnARecurringBasisDetails" xlink:href="nvax-20120930.xsd#nvax-ssapfalmfmvrbd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfActivityOfLevelThreeInputsMeasuredOnRecurringBasisDetails" xlink:href="nvax-20120930.xsd#nvax-ssapsalimrbd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:href="nvax-20120930.xsd#nvax-ssapsticaafsd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-sbcond" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:href="nvax-20120930.xsd#nvax-sbcocbced" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationSummaryOfOptionActivityDetails" xlink:href="nvax-20120930.xsd#nvax-sbcsoad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationAssumptionsUsedInEstimationOfFairValueOfStockOptionsGrantedDetails" xlink:href="nvax-20120930.xsd#nvax-sbcoauefvsogd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationSummaryOfRestrictedStockAwardsActivityDetails" xlink:href="nvax-20120930.xsd#nvax-sbcosrsaad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/PointsPointGovernmentAgreementAndCollaborationsDetails" xlink:href="nvax-20120930.xsd#nvax-usgacd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLeaseNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-calend" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLeaseFutureMinimumCapitalLeasePaymentsUnderCapitalLeaseAgreementDetails" xlink:href="nvax-20120930.xsd#nvax-calefmclpuclad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayableNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-nopand" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayableAggregateFutureMinimumPrincipalPaymentsOnEquipmentLoanDetails" xlink:href="nvax-20120930.xsd#nvax-calenpafmppoeld" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/WarrantLiabilityDetails" xlink:href="nvax-20120930.xsd#nvax-walid" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SalesOfCommonStockDetails" xlink:href="nvax-20120930.xsd#nvax-sacsd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacilityDetails" xlink:href="nvax-20120930.xsd#nvax-mlofd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/MasterServicesAgreementWithCadila" xlink:href="nvax-20120930.xsd#nvax-msac" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/MasterServicesAgreementWithCadilaDetails" xlink:href="nvax-20120930.xsd#nvax-msacd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SubsequentEvents" xlink:href="nvax-20120930.xsd#nvax-suev" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SubsequentEventsDetails" xlink:href="nvax-20120930.xsd#nvax-suevd" xlink:type="simple" />
  <link:calculationLink xlink:title="002 - Statement - BALANCE SHEETS" xlink:role="http://www.novavax.com/role/BalanceSheets" xlink:type="extended">
    <link:loc xlink:label="loc_AssetsCurrent.5874.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:loc xlink:label="loc_PrepaidExpenseCurrent.14246.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_PrepaidExpenseCurrent.14246.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6556.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesCurrent.5972.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_AvailableForSaleSecuritiesCurrent.5972.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GovernmentContractReceivableUnbilledAmounts.10338.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GovernmentContractReceivableUnbilledAmounts" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_GovernmentContractReceivableUnbilledAmounts.10338.14.6" order="5.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherAssetsCurrent.13175.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_OtherAssetsCurrent.13175.14.6" order="6.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.14.6" order="7.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccountsReceivableNetCurrent.5451.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_AccountsReceivableNetCurrent.5451.14.6" order="20.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_Assets.5880.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.14697.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5880.14.6" xlink:to="loc_PropertyPlantAndEquipmentNet.14697.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:calculationArc xlink:from="loc_Assets.5880.14.6" xlink:to="loc_AssetsCurrent.5874.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_Goodwill.10311.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5880.14.6" xlink:to="loc_Goodwill.10311.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsNoncurrent.15344.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5880.14.6" xlink:to="loc_RestrictedCashAndCashEquivalentsNoncurrent.15344.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13227.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5880.14.6" xlink:to="loc_OtherAssetsNoncurrent.13227.14.6" order="5.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LiabilitiesCurrent.11668.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:loc xlink:label="loc_NotesPayableCurrent.12933.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_NotesPayableCurrent.12933.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccruedLiabilitiesCurrent.5555.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_AccruedLiabilitiesCurrent.5555.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccountsPayableCurrent.5468.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_AccountsPayableCurrent.5468.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueCurrent.7671.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_DeferredRevenueCurrent.7671.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CapitalLeaseObligationsCurrent.6437.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_CapitalLeaseObligationsCurrent.6437.14.6" order="5.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRentCreditCurrent.7598.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_DeferredRentCreditCurrent.7598.14.6" order="6.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesCurrent.8056.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_DerivativeLiabilitiesCurrent.8056.14.6" order="20.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_Liabilities.11702.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_LiabilitiesCurrent.11668.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesNoncurrent.8124.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_DerivativeLiabilitiesNoncurrent.8124.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueNoncurrent.7662.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_DeferredRevenueNoncurrent.7662.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CapitalLeaseObligationsNoncurrent.6438.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_CapitalLeaseObligationsNoncurrent.6438.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermNotesPayable.12281.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_LongTermNotesPayable.12281.14.6" order="5.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRentCreditNoncurrent.7574.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_DeferredRentCreditNoncurrent.7574.14.6" order="6.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.11731.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquity.16667.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesAndStockholdersEquity.11731.14.6" xlink:to="loc_StockholdersEquity.16667.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CommitmentsAndContingencies.6842.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesAndStockholdersEquity.11731.14.6" xlink:to="loc_CommitmentsAndContingencies.6842.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:calculationArc xlink:from="loc_LiabilitiesAndStockholdersEquity.11731.14.6" xlink:to="loc_Liabilities.11702.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15457.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_RetainedEarningsAccumulatedDeficit.15457.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AdditionalPaidInCapital.5620.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_AdditionalPaidInCapital.5620.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CommonStockValue.6874.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_CommonStockValue.6874.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PreferredStockValue.14123.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_PreferredStockValue.14123.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5602.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5602.14.6" order="5.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_TreasuryStockValue.17060.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_TreasuryStockValue.17060.14.6" order="6.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="004 - Statement - STATEMENTS OF OPERATIONS" xlink:role="http://www.novavax.com/role/StamentsOfOperations" xlink:type="extended">
    <link:loc xlink:label="loc_CostsAndExpenses.7217.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10284.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CostsAndExpenses.7217.14.6" xlink:to="loc_GeneralAndAdministrativeExpense.10284.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15293.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CostsAndExpenses.7217.14.6" xlink:to="loc_ResearchAndDevelopmentExpense.15293.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ContractRevenueCost.7021.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractRevenueCost" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CostsAndExpenses.7217.14.6" xlink:to="loc_ContractRevenueCost.7021.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingIncomeLoss.13080.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" xlink:to="loc_OperatingIncomeLoss.13080.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_InvestmentIncomeInterest.11436.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" xlink:to="loc_InvestmentIncomeInterest.11436.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" xlink:to="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_InterestExpense.11178.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" xlink:to="loc_InterestExpense.11178.14.6" order="4.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_InvestmentIncomeNet.11453.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" xlink:to="loc_InvestmentIncomeNet.11453.14.6" order="60.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeTaxExpenseBenefit.10688.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetIncomeLoss.12771.14.6" xlink:to="loc_IncomeTaxExpenseBenefit.10688.14.6" order="2.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:calculationArc xlink:from="loc_NetIncomeLoss.12771.14.6" xlink:to="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:calculationArc xlink:from="loc_OperatingIncomeLoss.13080.14.6" xlink:to="loc_CostsAndExpenses.7217.14.6" order="1.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_Revenues.15575.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Revenues" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingIncomeLoss.13080.14.6" xlink:to="loc_Revenues.15575.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ContractsRevenue.7028.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Revenues.15575.14.6" xlink:to="loc_ContractsRevenue.7028.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentCollaboration.26647.14.6" xlink:href="nvax-20120930.xsd#nvax_ResearchAndDevelopmentCollaboration" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Revenues.15575.14.6" xlink:to="loc_ResearchAndDevelopmentCollaboration.26647.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="005 - Statement - STATEMENTS OF COMPREHENSIVE LOSS" xlink:role="http://www.novavax.com/role/StatementsOfComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTax.6913.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_ComprehensiveIncomeNetOfTax.6913.14.6" xlink:to="loc_NetIncomeLoss.12771.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13404.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_ComprehensiveIncomeNetOfTax.6913.14.6" xlink:to="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13404.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="006 - Statement - STATEMENTS OF CASH FLOWS" xlink:role="http://www.novavax.com/role/StatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.14.6" xlink:to="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.14.6" xlink:to="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.14.6" xlink:to="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaymentsToAcquireAvailableForSaleSecurities.13806.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" xlink:to="loc_PaymentsToAcquireAvailableForSaleSecurities.13806.14.6" order="1.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14452.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" xlink:to="loc_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14452.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaymentsToAcquireProductiveAssets.13804.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" xlink:to="loc_PaymentsToAcquireProductiveAssets.13804.14.6" order="4.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" xlink:to="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.14.6" order="6.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromStockOptionsExercised.14555.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromStockOptionsExercised.14555.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromNotesPayable.14430.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromNotesPayable.14430.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfNotesPayable.14330.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromRepaymentsOfNotesPayable.14330.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_RepaymentsOfLongTermCapitalLeaseObligations.15248.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_RepaymentsOfLongTermCapitalLeaseObligations.15248.14.6" order="5.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_NetIncomeLoss.12771.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_DepreciationAndAmortization.8044.14.6" order="9.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensation.16244.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_ShareBasedCompensation.16244.14.6" order="10.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.14.6" order="11.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.10853.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInAccountsReceivable.10853.14.6" order="12.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.10871.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.10871.14.6" order="13.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInUnbilledReceivables.11010.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInUnbilledReceivables.11010.14.6" order="2.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.14.6" order="3.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.10850.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInDeferredRevenue.10850.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherNoncurrentLiabilities.10849.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInOtherNoncurrentLiabilities.10849.14.6" order="5.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherNoncashIncomeExpense.13166.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_OtherNoncashIncomeExpense.13166.14.6" order="6.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccretionAmortizationOfDiscountsAndPremiumsInvestments.5479.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_AccretionAmortizationOfDiscountsAndPremiumsInvestments.5479.14.6" order="7.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.14.6" order="8.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AssetImpairmentCharges.5835.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_AssetImpairmentCharges.5835.14.6" order="35.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40304 - Disclosure - Summary of Significant Accounting Policies (Short-term Investments Classified as Available-for-sale)(Details)" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueDisclosure" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6003.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.14.6" xlink:to="loc_AvailableForSaleSecuritiesAmortizedCost.6003.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.14.6" xlink:to="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.14.6" xlink:to="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.14.6" order="3.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40602 - Disclosure - Capital Lease (Future Minimum Capital Lease Payments Under Capital Lease Agreement)(Details)" xlink:role="http://www.novavax.com/role/CapitalLeaseFutureMinimumCapitalLeasePaymentsUnderCapitalLeaseAgreementDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.6375.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments" xlink:type="locator" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.6375.14.6" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.6439.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.6375.14.6" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.6439.14.6" order="2.00" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.6415.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.14.6" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.6415.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.6428.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.14.6" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.6428.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.6416.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.14.6" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.6416.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.6391.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.14.6" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.6391.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.6421.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.14.6" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.6421.14.6" order="5.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.6384.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.14.6" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.6384.14.6" order="6.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40702 - Disclosure - Notes Payable (Aggregate Future Minimum Principal Payments on Equipment Loan)(Details)" xlink:role="http://www.novavax.com/role/NotesPayableAggregateFutureMinimumPrincipalPaymentsOnEquipmentLoanDetails" xlink:type="extended">
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDue.24563.14.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.14.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDue.24563.14.6" xlink:to="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.14.6" order="1.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.14.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDue.24563.14.6" xlink:to="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.14.6" order="2.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.14.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDue.24563.14.6" xlink:to="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.14.6" order="3.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.14.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDue.24563.14.6" xlink:to="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.14.6" order="4.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.14.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDue.24563.14.6" xlink:to="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.14.6" order="5.00" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>nvax-20120930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--P3XBRL-->
<!--version 4.1.22 -->
<!--http://www.p3xbrl.com-->
<!--produced on 2012-11-08 @ 9:38 PM-->
<link:linkbase xmlns:nvax="http://www.novavax.com/20120930" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://www.novavax.com/role/DocumentAndEntityInformation" xlink:href="nvax-20120930.xsd#nvax-daei" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/BalanceSheets" xlink:href="nvax-20120930.xsd#nvax-ccbs" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/BalanceSheetsParenthetical" xlink:href="nvax-20120930.xsd#nvax-ccbsp" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StamentsOfOperations" xlink:href="nvax-20120930.xsd#nvax-ccso" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StatementsOfComprehensiveLoss" xlink:href="nvax-20120930.xsd#nvax-ccci" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StatementsOfCashFlows" xlink:href="nvax-20120930.xsd#nvax-ccscf" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StatementsOfCashFlowsParenthetical" xlink:href="nvax-20120930.xsd#nvax-stcfpa" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/Organization" xlink:href="nvax-20120930.xsd#nvax-orga" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/LiquidityMatters" xlink:href="nvax-20120930.xsd#nvax-lima" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="nvax-20120930.xsd#nvax-ssap" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesPolicy" xlink:href="nvax-20120930.xsd#nvax-ssappo" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="nvax-20120930.xsd#nvax-ssapta" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensation" xlink:href="nvax-20120930.xsd#nvax-stbaco" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/USGovernmentAgreementAndCollaboartions" xlink:href="nvax-20120930.xsd#nvax-usgac" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLease" xlink:href="nvax-20120930.xsd#nvax-cale" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayable" xlink:href="nvax-20120930.xsd#nvax-nopa" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/WarrantLiability" xlink:href="nvax-20120930.xsd#nvax-wali" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SalesOfCommonStock" xlink:href="nvax-20120930.xsd#nvax-socs" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacility" xlink:href="nvax-20120930.xsd#nvax-mlof" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayableTables" xlink:href="nvax-20120930.xsd#nvax-nopata" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLeaseTables" xlink:href="nvax-20120930.xsd#nvax-caleta" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationTables" xlink:href="nvax-20120930.xsd#nvax-sbcota" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/OrganizationDetails" xlink:href="nvax-20120930.xsd#nvax-orgad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/LiquidityMattersDetails" xlink:href="nvax-20120930.xsd#nvax-limad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-ssapnd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesFinancialAssetsAndLiabilitiesMeasuredAtFairMarketValueOnARecurringBasisDetails" xlink:href="nvax-20120930.xsd#nvax-ssapfalmfmvrbd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfActivityOfLevelThreeInputsMeasuredOnRecurringBasisDetails" xlink:href="nvax-20120930.xsd#nvax-ssapsalimrbd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:href="nvax-20120930.xsd#nvax-ssapsticaafsd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-sbcond" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:href="nvax-20120930.xsd#nvax-sbcocbced" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationSummaryOfOptionActivityDetails" xlink:href="nvax-20120930.xsd#nvax-sbcsoad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationAssumptionsUsedInEstimationOfFairValueOfStockOptionsGrantedDetails" xlink:href="nvax-20120930.xsd#nvax-sbcoauefvsogd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationSummaryOfRestrictedStockAwardsActivityDetails" xlink:href="nvax-20120930.xsd#nvax-sbcosrsaad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/PointsPointGovernmentAgreementAndCollaborationsDetails" xlink:href="nvax-20120930.xsd#nvax-usgacd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLeaseNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-calend" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLeaseFutureMinimumCapitalLeasePaymentsUnderCapitalLeaseAgreementDetails" xlink:href="nvax-20120930.xsd#nvax-calefmclpuclad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayableNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-nopand" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayableAggregateFutureMinimumPrincipalPaymentsOnEquipmentLoanDetails" xlink:href="nvax-20120930.xsd#nvax-calenpafmppoeld" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/WarrantLiabilityDetails" xlink:href="nvax-20120930.xsd#nvax-walid" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SalesOfCommonStockDetails" xlink:href="nvax-20120930.xsd#nvax-sacsd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacilityDetails" xlink:href="nvax-20120930.xsd#nvax-mlofd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/MasterServicesAgreementWithCadila" xlink:href="nvax-20120930.xsd#nvax-msac" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/MasterServicesAgreementWithCadilaDetails" xlink:href="nvax-20120930.xsd#nvax-msacd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SubsequentEvents" xlink:href="nvax-20120930.xsd#nvax-suev" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SubsequentEventsDetails" xlink:href="nvax-20120930.xsd#nvax-suevd" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:definitionLink xlink:title="40302 - Disclosure - Summary of Significant Accounting Policies (Financial Assets and Liabilities Measured at Fair Market Value on a Recurring Basis)(Details)" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesFinancialAssetsAndLiabilitiesMeasuredAtFairMarketValueOnARecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.8.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.8.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.6.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.6.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.5.6" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.1894.5.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2024.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:to="loc_FairValueInputsLevel1Member.2024.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2026.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:to="loc_FairValueInputsLevel2Member.2026.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:to="loc_FairValueInputsLevel3Member.2022.7.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.9.6" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.9.6" order="1.00" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueDisclosure" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.7.6" xlink:to="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LiabilitiesFairValueDisclosure.11675.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.7.6" xlink:to="loc_LiabilitiesFairValueDisclosure.11675.7.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40304 - Disclosure - Summary of Significant Accounting Policies (Short-term Investments Classified as Available-for-sale)(Details)" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:type="extended">
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.8.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.8.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.6.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.6.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_CorporateDebtSecuritiesMember.1180.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.7.6" xlink:to="loc_CorporateDebtSecuritiesMember.1180.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AuctionRateSecuritiesMember.622.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AuctionRateSecuritiesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.7.6" xlink:to="loc_AuctionRateSecuritiesMember.622.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.5.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.5.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.9.6" xlink:to="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.9.6" order="1.00" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6003.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.7.6" xlink:to="loc_AvailableForSaleSecuritiesAmortizedCost.6003.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.7.6" xlink:to="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.7.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.7.6" xlink:to="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.7.6" order="4.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueDisclosure" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.7.6" xlink:to="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.7.6" order="5.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40401 - Disclosure - Stock-Based Compensation (Narrative)(Details)" xlink:role="http://www.novavax.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_PlanNameDomain.3870.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.7.6" xlink:href="nvax-20120930.xsd#nvax_TwoZeroZeroFiveStockIncentivePlanMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameDomain.3870.7.6" xlink:to="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OneNineNineFiveStockOptionPlanMember.24508.7.6" xlink:href="nvax-20120930.xsd#nvax_OneNineNineFiveStockOptionPlanMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameDomain.3870.7.6" xlink:to="loc_OneNineNineFiveStockOptionPlanMember.24508.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameAxis.3871.8.6" xlink:to="loc_PlanNameDomain.3870.8.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameAxis.3871.6.6" xlink:to="loc_PlanNameDomain.3870.6.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4187.8.6" xlink:to="loc_RangeMember.4188.8.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4187.6.6" xlink:to="loc_RangeMember.4188.6.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4188.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MinimumMember.3248.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4188.7.6" xlink:to="loc_MinimumMember.3248.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3241.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4188.7.6" xlink:to="loc_MaximumMember.3241.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.5.6" xlink:to="loc_PlanNameAxis.3871.5.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.5.6" xlink:to="loc_RangeAxis.4187.5.6" order="1.50" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.9.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.9.6" order="1.00" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.7.6" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.7.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.7.6" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.7.6" order="4.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.7.6" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.7.6" order="5.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16357.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16357.7.6" order="6.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15611.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15611.7.6" order="7.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15602.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15602.7.6" order="8.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15608.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15608.7.6" order="9.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.16330.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.16330.7.6" order="10.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.7.6" order="11.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40402 - Disclosure - Stock-Based Compensation (Stock-Based Compensation Expense)(Details)" xlink:role="http://www.novavax.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.9.6" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.9.6" order="1.00" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5724.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.7.6" xlink:to="loc_AllocatedShareBasedCompensationExpense.5724.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4381.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.7.6" xlink:to="loc_ResearchAndDevelopmentExpenseMember.4381.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2354.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.7.6" xlink:to="loc_GeneralAndAdministrativeExpenseMember.2354.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.8.6" xlink:to="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.8.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.6.6" xlink:to="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.6.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.5.6" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.5.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40403 - Disclosure - Stock-Based Compensation (Summary of Option Activity)(Details)" xlink:role="http://www.novavax.com/role/StockBasedCompensationSummaryOfOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:label="loc_PlanNameDomain.3870.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.7.6" xlink:href="nvax-20120930.xsd#nvax_TwoZeroZeroFiveStockIncentivePlanMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameDomain.3870.7.6" xlink:to="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OneNineNineFiveStockOptionPlanMember.24508.7.6" xlink:href="nvax-20120930.xsd#nvax_OneNineNineFiveStockOptionPlanMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameDomain.3870.7.6" xlink:to="loc_OneNineNineFiveStockOptionPlanMember.24508.7.6" order="1.50" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameAxis.3871.8.6" xlink:to="loc_PlanNameDomain.3870.8.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameAxis.3871.6.6" xlink:to="loc_PlanNameDomain.3870.6.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.5.6" xlink:to="loc_PlanNameAxis.3871.5.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.16298.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.7.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.16298.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16305.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.7.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16305.7.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.16248.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.7.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.16248.7.6" order="4.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16322.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16322.7.6" order="5.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.9.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.9.6" order="1.00" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.7.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16634.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16634.7.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16342.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16342.7.6" order="4.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16332.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16332.7.6" order="5.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.7.6" order="6.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40404 - Disclosure - Stock-Based Compensation (Assumptions Used in Estimation of Fair Value of Stock Options Granted)(Details)" xlink:role="http://www.novavax.com/role/StockBasedCompensationAssumptionsUsedInEstimationOfFairValueOfStockOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:label="loc_RangeAxis.4187.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4187.8.6" xlink:to="loc_RangeMember.4188.8.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4187.6.6" xlink:to="loc_RangeMember.4188.6.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4188.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MinimumMember.3248.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4188.7.6" xlink:to="loc_MinimumMember.3248.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3241.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4188.7.6" xlink:to="loc_MaximumMember.3241.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeAxis.4187.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.5.6" xlink:to="loc_RangeAxis.4187.5.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.9.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.9.6" order="1.00" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16329.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16329.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.16304.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.16304.7.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.16317.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.16317.7.6" order="4.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.16273.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.16273.7.6" order="5.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.16324.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.16324.7.6" order="6.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.16254.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.16254.7.6" order="7.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.16318.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.16318.7.6" order="8.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.16251.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.16251.7.6" order="9.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.15604.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.15604.7.6" order="10.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.7.6" xlink:href="nvax-20120930.xsd#nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.7.6" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.7.6" order="11.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40501 - Disclosure - U.S. Government Agreement and Collaborations (Details)" xlink:role="http://www.novavax.com/role/PointsPointGovernmentAgreementAndCollaborationsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.9.6" xlink:to="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.9.6" order="1.00" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_GovernmentContractReceivable.10340.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GovernmentContractReceivable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_GovernmentContractReceivable.10340.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ContractsRevenue.7028.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_ContractsRevenue.7028.7.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15308.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15308.7.6" order="4.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ExpectedClinicalTrialCosts.24616.7.6" xlink:href="nvax-20120930.xsd#nvax_ExpectedClinicalTrialCosts" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_ExpectedClinicalTrialCosts.24616.7.6" order="5.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_UpfrontLicensePayment.24620.7.6" xlink:href="nvax-20120930.xsd#nvax_UpfrontLicensePayment" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_UpfrontLicensePayment.24620.7.6" order="6.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.7.6" xlink:href="nvax-20120930.xsd#nvax_RoyaltyPaymentsPercentOfFutureProductSales" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.7.6" order="7.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.7.6" xlink:href="nvax-20120930.xsd#nvax_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.7.6" order="9.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ContractTerm.24751.7.6" xlink:href="nvax-20120930.xsd#nvax_ContractTerm" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_ContractTerm.24751.7.6" order="8.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentCollaboration.26647.7.6" xlink:href="nvax-20120930.xsd#nvax_ResearchAndDevelopmentCollaboration" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_ResearchAndDevelopmentCollaboration.26647.7.6" order="2.25" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClinicalTrialCostsIncurred.27100.7.6" xlink:href="nvax-20120930.xsd#nvax_ClinicalTrialCostsIncurred" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.7.6" xlink:to="loc_ClinicalTrialCostsIncurred.27100.7.6" order="3.75" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember" xlink:type="locator" />
    <link:loc xlink:label="loc_HhsBardaContractAwardMember.24606.7.6" xlink:href="nvax-20120930.xsd#nvax_HhsBardaContractAwardMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.7.6" xlink:to="loc_HhsBardaContractAwardMember.24606.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_HhsBardaOptionForAdditionalPeriodMember.24607.7.6" xlink:href="nvax-20120930.xsd#nvax_HhsBardaOptionForAdditionalPeriodMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.7.6" xlink:to="loc_HhsBardaOptionForAdditionalPeriodMember.24607.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.7.6" xlink:href="nvax-20120930.xsd#nvax_LicenseAgreementWithLgLifeSciencesLtdMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.7.6" xlink:to="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.7.6" order="2.50" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PathVaccineSolutionsMember.24610.7.6" xlink:href="nvax-20120930.xsd#nvax_PathVaccineSolutionsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.7.6" xlink:to="loc_PathVaccineSolutionsMember.24610.7.6" order="3.50" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.8.6" xlink:to="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.8.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.6.6" xlink:to="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.6.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4187.8.6" xlink:to="loc_RangeMember.4188.8.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4187.6.6" xlink:to="loc_RangeMember.4188.6.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4188.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MinimumMember.3248.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4188.7.6" xlink:to="loc_MinimumMember.3248.7.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3241.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4188.7.6" xlink:to="loc_MaximumMember.3241.7.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.5.6" xlink:to="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.5.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.5.6" xlink:to="loc_RangeAxis.4187.5.6" order="1.50" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>nvax-20120930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--P3XBRL-->
<!--version 4.1.22 -->
<!--http://www.p3xbrl.com-->
<!--produced on 2012-11-08 @ 9:38 PM-->
<link:linkbase xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-roles-2012-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/changeLabel2012" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-roles-2012-01-31.xsd#changeLabel2012" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/fragmentDocumentation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-roles-2012-01-31.xsd#fragmentDocumentation" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/fragmentLabel" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-roles-2012-01-31.xsd#fragmentLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/deprecatedLabel" xlink:href="http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd#deprecatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/deprecatedDateLabel" xlink:href="http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd#deprecatedDateLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:label="loc_AmendmentFlag.144.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AmendmentFlag.144.11.6" xlink:to="lab_AmendmentFlag.8" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AmendmentFlag.8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AmendmentFlag.8">Amendment Flag</link:label>
    <link:loc xlink:label="loc_CurrentFiscalYearEndDate.155.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CurrentFiscalYearEndDate.155.11.6" xlink:to="lab_CurrentFiscalYearEndDate.20" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CurrentFiscalYearEndDate.20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CurrentFiscalYearEndDate.20">Current Fiscal Year End Date</link:label>
    <link:loc xlink:label="loc_DocumentAndEntityInformationAbstract.24388.11.6" xlink:href="nvax-20120930.xsd#nvax_DocumentAndEntityInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.11.6" xlink:to="lab_DocumentAndEntityInformationAbstract.158197" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentAndEntityInformationAbstract.158197" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentAndEntityInformationAbstract.158197">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:label="loc_DocumentAndEntityInformationAbstract.24388.11.12" xlink:href="nvax-20120930.xsd#nvax_DocumentAndEntityInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.11.12" xlink:to="lab_DocumentAndEntityInformationAbstract12.158196" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentAndEntityInformationAbstract12.158196" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_DocumentAndEntityInformationAbstract12.158196">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:label="loc_DocumentFiscalPeriodFocus.208.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentFiscalPeriodFocus.208.11.6" xlink:to="lab_DocumentFiscalPeriodFocus.123" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentFiscalPeriodFocus.123" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentFiscalPeriodFocus.123">Document Fiscal Period Focus</link:label>
    <link:loc xlink:label="loc_DocumentFiscalYearFocus.207.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentFiscalYearFocus.207.11.6" xlink:to="lab_DocumentFiscalYearFocus.122" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentFiscalYearFocus.122" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentFiscalYearFocus.122">Document Fiscal Year Focus</link:label>
    <link:loc xlink:label="loc_DocumentPeriodEndDate.161.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentPeriodEndDate.161.11.6" xlink:to="lab_DocumentPeriodEndDate.30" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentPeriodEndDate.30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentPeriodEndDate.30">Document Period End Date</link:label>
    <link:loc xlink:label="loc_DocumentType.212.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentType" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentType.212.11.6" xlink:to="lab_DocumentType.32" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentType.32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentType.32">Document Type</link:label>
    <link:loc xlink:label="loc_EntityCentralIndexKey.188.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityCentralIndexKey.188.11.6" xlink:to="lab_EntityCentralIndexKey.101" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityCentralIndexKey.101" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityCentralIndexKey.101">Entity Central Index Key</link:label>
    <link:loc xlink:label="loc_EntityCommonStockSharesOutstanding.192.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityCommonStockSharesOutstanding.192.11.6" xlink:to="lab_EntityCommonStockSharesOutstanding.105" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityCommonStockSharesOutstanding.105" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityCommonStockSharesOutstanding.105">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:label="loc_EntityFilerCategory.185.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityFilerCategory.185.11.6" xlink:to="lab_EntityFilerCategory.98" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityFilerCategory.98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityFilerCategory.98">Entity Filer Category</link:label>
    <link:loc xlink:label="loc_EntityRegistrantName.187.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityRegistrantName.187.11.6" xlink:to="lab_EntityRegistrantName.100" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityRegistrantName.100" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityRegistrantName.100">Entity Registrant Name</link:label>
    <link:loc xlink:label="loc_TradingSymbol.177.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_TradingSymbol" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TradingSymbol.177.11.6" xlink:to="lab_TradingSymbol.60" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TradingSymbol.60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TradingSymbol.60">Trading Symbol</link:label>
    <link:loc xlink:label="loc_AccountsPayableCurrent.5468.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableCurrent.5468.11.6" xlink:to="lab_AccountsPayableCurrent.421" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayableCurrent.421" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayableCurrent.421">Accounts Payable, Current</link:label>
    <link:loc xlink:label="loc_AccountsPayableCurrent.5468.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableCurrent.5468.11.7" xlink:to="lab_AccountsPayableCurrent.158268" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayableCurrent.158268" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayableCurrent.158268">Accounts payable</link:label>
    <link:loc xlink:label="loc_AccountsReceivableNetCurrent.5451.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsReceivableNetCurrent.5451.11.6" xlink:to="lab_AccountsReceivableNetCurrent.390" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsReceivableNetCurrent.390" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccountsReceivableNetCurrent.390">Accounts Receivable, Net, Current</link:label>
    <link:loc xlink:label="loc_AccountsReceivableNetCurrent.5451.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsReceivableNetCurrent.5451.11.7" xlink:to="lab_AccountsReceivableNetCurrent.174140" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsReceivableNetCurrent.174140" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccountsReceivableNetCurrent.174140">Accounts receivables</link:label>
    <link:loc xlink:label="loc_AccruedLiabilitiesCurrent.5555.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccruedLiabilitiesCurrent.5555.11.6" xlink:to="lab_AccruedLiabilitiesCurrent.550" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccruedLiabilitiesCurrent.550" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccruedLiabilitiesCurrent.550">Accrued Liabilities, Current</link:label>
    <link:loc xlink:label="loc_AccruedLiabilitiesCurrent.5555.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccruedLiabilitiesCurrent.5555.11.7" xlink:to="lab_AccruedLiabilitiesCurrent.158269" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccruedLiabilitiesCurrent.158269" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccruedLiabilitiesCurrent.158269">Accrued expenses and other current liabilities</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5602.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5602.11.6" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.632" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.632" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.632">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5602.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5602.11.7" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.158522" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.158522" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.158522">Accumulated other comprehensive income</link:label>
    <link:loc xlink:label="loc_AdditionalPaidInCapital.5620.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalPaidInCapital.5620.11.6" xlink:to="lab_AdditionalPaidInCapital.673" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdditionalPaidInCapital.673" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdditionalPaidInCapital.673">Additional Paid in Capital</link:label>
    <link:loc xlink:label="loc_AdditionalPaidInCapital.5620.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalPaidInCapital.5620.11.7" xlink:to="lab_AdditionalPaidInCapital.158278" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdditionalPaidInCapital.158278" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AdditionalPaidInCapital.158278">Additional paid-in capital</link:label>
    <link:loc xlink:label="loc_Assets.5880.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Assets.5880.11.6" xlink:to="lab_Assets.1134" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Assets.1134" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_Assets.1134">Assets</link:label>
    <link:loc xlink:label="loc_Assets.5880.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Assets.5880.11.9" xlink:to="lab_Assets.158265" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Assets.158265" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_Assets.158265">Total assets</link:label>
    <link:loc xlink:label="loc_AssetsAbstract.595.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsAbstract.595.11.6" xlink:to="lab_AssetsAbstract.1105" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsAbstract.1105" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AssetsAbstract.1105">Assets [Abstract]</link:label>
    <link:loc xlink:label="loc_AssetsAbstract.595.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsAbstract.595.11.7" xlink:to="lab_AssetsAbstract.158253" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsAbstract.158253" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AssetsAbstract.158253">ASSETS</link:label>
    <link:loc xlink:label="loc_AssetsCurrent.5874.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrent.5874.11.6" xlink:to="lab_AssetsCurrent.1123" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsCurrent.1123" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AssetsCurrent.1123">Assets, Current</link:label>
    <link:loc xlink:label="loc_AssetsCurrent.5874.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrent.5874.11.9" xlink:to="lab_AssetsCurrent.158259" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsCurrent.158259" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_AssetsCurrent.158259">Total current assets</link:label>
    <link:loc xlink:label="loc_AssetsCurrentAbstract.592.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrentAbstract.592.11.6" xlink:to="lab_AssetsCurrentAbstract.1099" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsCurrentAbstract.1099" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AssetsCurrentAbstract.1099">Assets, Current [Abstract]</link:label>
    <link:loc xlink:label="loc_AssetsCurrentAbstract.592.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrentAbstract.592.11.7" xlink:to="lab_AssetsCurrentAbstract.158254" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsCurrentAbstract.158254" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AssetsCurrentAbstract.158254">Current assets:</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesCurrent.5972.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesCurrent.5972.11.6" xlink:to="lab_AvailableForSaleSecuritiesCurrent.1282" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesCurrent.1282" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesCurrent.1282">Available-for-sale Securities, Current</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesCurrent.5972.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesCurrent.5972.11.7" xlink:to="lab_AvailableForSaleSecuritiesCurrent.158483" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesCurrent.158483" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesCurrent.158483">Short-term investments available-for-sale</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationsCurrent.6437.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationsCurrent.6437.11.7" xlink:to="lab_CapitalLeaseObligationsCurrent.158512" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationsCurrent.158512" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationsCurrent.158512">Current portion of capital lease</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationsNoncurrent.6438.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationsNoncurrent.6438.11.7" xlink:to="lab_CapitalLeaseObligationsNoncurrent.158516" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationsNoncurrent.158516" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationsNoncurrent.158516">Non-current portion of capital lease</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.6" xlink:to="lab_CashAndCashEquivalentsAtCarryingValue.2187" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsAtCarryingValue.2187" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsAtCarryingValue.2187">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.7" xlink:to="lab_CashAndCashEquivalentsAtCarryingValue.158255" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsAtCarryingValue.158255" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsAtCarryingValue.158255">Cash and cash equivalents</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingencies.6842.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingencies.6842.11.6" xlink:to="lab_CommitmentsAndContingencies.2677" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommitmentsAndContingencies.2677" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommitmentsAndContingencies.2677">Commitments and Contingencies</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingencies.6842.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingencies.6842.11.7" xlink:to="lab_CommitmentsAndContingencies.158274" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommitmentsAndContingencies.158274" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommitmentsAndContingencies.158274">Commitments and contingencies</link:label>
    <link:loc xlink:label="loc_CommonStockValue.6874.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValue.6874.11.6" xlink:to="lab_CommonStockValue.2730" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValue.2730" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValue.2730">Common Stock, Value, Issued</link:label>
    <link:loc xlink:label="loc_CommonStockValue.6874.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValue.6874.11.7" xlink:to="lab_CommonStockValue.158277" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValue.158277" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValue.158277">Common stock, $0.01 par value, 200,000,000 shares authorized; and 136,003,676 shares issued and 135,548,246 shares outstanding at September 30, 2012 and 117,480,867 shares issued and 117,025,437 shares outstanding at December 31, 2011</link:label>
    <link:loc xlink:label="loc_DeferredRentCreditCurrent.7598.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRentCreditCurrent.7598.11.6" xlink:to="lab_DeferredRentCreditCurrent.3858" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRentCreditCurrent.3858" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRentCreditCurrent.3858">Deferred Rent Credit, Current</link:label>
    <link:loc xlink:label="loc_DeferredRentCreditCurrent.7598.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRentCreditCurrent.7598.11.7" xlink:to="lab_DeferredRentCreditCurrent.138305" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRentCreditCurrent.138305" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRentCreditCurrent.138305">Deferred rent</link:label>
    <link:loc xlink:label="loc_DeferredRentCreditNoncurrent.7574.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRentCreditNoncurrent.7574.11.6" xlink:to="lab_DeferredRentCreditNoncurrent.3813" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRentCreditNoncurrent.3813" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRentCreditNoncurrent.3813">Deferred Rent Credit, Noncurrent</link:label>
    <link:loc xlink:label="loc_DeferredRentCreditNoncurrent.7574.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRentCreditNoncurrent.7574.11.7" xlink:to="lab_DeferredRentCreditNoncurrent.158518" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRentCreditNoncurrent.158518" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRentCreditNoncurrent.158518">Deferred rent</link:label>
    <link:loc xlink:label="loc_DeferredRevenueCurrent.7671.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueCurrent.7671.11.6" xlink:to="lab_DeferredRevenueCurrent.3980" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueCurrent.3980" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueCurrent.3980">Deferred Revenue, Current</link:label>
    <link:loc xlink:label="loc_DeferredRevenueCurrent.7671.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueCurrent.7671.11.7" xlink:to="lab_DeferredRevenueCurrent.158511" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueCurrent.158511" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueCurrent.158511">Deferred revenue</link:label>
    <link:loc xlink:label="loc_DeferredRevenueNoncurrent.7662.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueNoncurrent.7662.11.6" xlink:to="lab_DeferredRevenueNoncurrent.3963" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueNoncurrent.3963" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueNoncurrent.3963">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:label="loc_DeferredRevenueNoncurrent.7662.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueNoncurrent.7662.11.7" xlink:to="lab_DeferredRevenueNoncurrent.160442" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueNoncurrent.160442" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueNoncurrent.160442">Deferred revenue</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesCurrent.8056.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesCurrent.8056.11.6" xlink:to="lab_DerivativeLiabilitiesCurrent.4511" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeLiabilitiesCurrent.4511" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeLiabilitiesCurrent.4511">Derivative Liabilities, Current</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesCurrent.8056.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesCurrent.8056.11.7" xlink:to="lab_DerivativeLiabilitiesCurrent.171371" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeLiabilitiesCurrent.171371" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeLiabilitiesCurrent.171371">Warrant liability</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesNoncurrent.8124.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesNoncurrent.8124.11.6" xlink:to="lab_DerivativeLiabilitiesNoncurrent.4612" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeLiabilitiesNoncurrent.4612" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeLiabilitiesNoncurrent.4612">Derivative Liabilities, Noncurrent</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesNoncurrent.8124.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesNoncurrent.8124.11.7" xlink:to="lab_DerivativeLiabilitiesNoncurrent.158514" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeLiabilitiesNoncurrent.158514" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeLiabilitiesNoncurrent.158514">Warrant liability</link:label>
    <link:loc xlink:label="loc_Goodwill.10311.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Goodwill.10311.11.6" xlink:to="lab_Goodwill.7915" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Goodwill.7915" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_Goodwill.7915">Goodwill</link:label>
    <link:loc xlink:label="loc_Goodwill.10311.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Goodwill.10311.11.7" xlink:to="lab_Goodwill.158505" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Goodwill.158505" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_Goodwill.158505">Goodwill</link:label>
    <link:loc xlink:label="loc_GovernmentContractReceivableUnbilledAmounts.10338.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GovernmentContractReceivableUnbilledAmounts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentContractReceivableUnbilledAmounts.10338.11.6" xlink:to="lab_GovernmentContractReceivableUnbilledAmounts.7956" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GovernmentContractReceivableUnbilledAmounts.7956" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GovernmentContractReceivableUnbilledAmounts.7956">Government Contract Receivable, Unbilled Amounts</link:label>
    <link:loc xlink:label="loc_GovernmentContractReceivableUnbilledAmounts.10338.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GovernmentContractReceivableUnbilledAmounts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentContractReceivableUnbilledAmounts.10338.11.7" xlink:to="lab_GovernmentContractReceivableUnbilledAmounts.158441" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GovernmentContractReceivableUnbilledAmounts.158441" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GovernmentContractReceivableUnbilledAmounts.158441">Unbilled receivables</link:label>
    <link:loc xlink:label="loc_Liabilities.11702.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Liabilities.11702.11.6" xlink:to="lab_Liabilities.10148" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Liabilities.10148" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_Liabilities.10148">Liabilities</link:label>
    <link:loc xlink:label="loc_Liabilities.11702.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Liabilities.11702.11.9" xlink:to="lab_Liabilities.158273" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Liabilities.158273" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_Liabilities.158273">Total liabilities</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.11731.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquity.11731.11.6" xlink:to="lab_LiabilitiesAndStockholdersEquity.10196" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesAndStockholdersEquity.10196" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesAndStockholdersEquity.10196">Liabilities and Equity</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.11731.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquity.11731.11.9" xlink:to="lab_LiabilitiesAndStockholdersEquity.158281" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesAndStockholdersEquity.158281" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesAndStockholdersEquity.158281">Total liabilities and stockholders' equity</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.2940.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.11.6" xlink:to="lab_LiabilitiesAndStockholdersEquityAbstract.10173" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesAndStockholdersEquityAbstract.10173" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesAndStockholdersEquityAbstract.10173">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.2940.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.11.7" xlink:to="lab_LiabilitiesAndStockholdersEquityAbstract.158266" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesAndStockholdersEquityAbstract.158266" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesAndStockholdersEquityAbstract.158266">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrent.11668.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrent.11668.11.6" xlink:to="lab_LiabilitiesCurrent.10094" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesCurrent.10094" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesCurrent.10094">Liabilities, Current</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrent.11668.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrent.11668.11.9" xlink:to="lab_LiabilitiesCurrent.158271" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesCurrent.158271" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesCurrent.158271">Total current liabilities</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.2935.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.11.6" xlink:to="lab_LiabilitiesCurrentAbstract.10147" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesCurrentAbstract.10147" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesCurrentAbstract.10147">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.2935.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.11.7" xlink:to="lab_LiabilitiesCurrentAbstract.158267" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesCurrentAbstract.158267" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesCurrentAbstract.158267">Current liabilities:</link:label>
    <link:loc xlink:label="loc_LongTermNotesPayable.12281.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermNotesPayable.12281.11.6" xlink:to="lab_LongTermNotesPayable.11006" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermNotesPayable.11006" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermNotesPayable.11006">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:label="loc_LongTermNotesPayable.12281.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermNotesPayable.12281.11.7" xlink:to="lab_LongTermNotesPayable.158517" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermNotesPayable.158517" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermNotesPayable.158517">Non-current portion of notes payable</link:label>
    <link:loc xlink:label="loc_NotesPayableCurrent.12933.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NotesPayableCurrent.12933.11.6" xlink:to="lab_NotesPayableCurrent.12132" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NotesPayableCurrent.12132" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NotesPayableCurrent.12132">Notes Payable, Current</link:label>
    <link:loc xlink:label="loc_NotesPayableCurrent.12933.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NotesPayableCurrent.12933.11.7" xlink:to="lab_NotesPayableCurrent.158270" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NotesPayableCurrent.158270" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NotesPayableCurrent.158270">Current portion of notes payable</link:label>
    <link:loc xlink:label="loc_OtherAssetsCurrent.13175.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsCurrent.13175.11.6" xlink:to="lab_OtherAssetsCurrent.12521" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAssetsCurrent.12521" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherAssetsCurrent.12521">Other Assets, Current</link:label>
    <link:loc xlink:label="loc_OtherAssetsCurrent.13175.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsCurrent.13175.11.7" xlink:to="lab_OtherAssetsCurrent.158486" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAssetsCurrent.158486" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherAssetsCurrent.158486">Other current assets</link:label>
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13227.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsNoncurrent.13227.11.6" xlink:to="lab_OtherAssetsNoncurrent.12607" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAssetsNoncurrent.12607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherAssetsNoncurrent.12607">Other Assets, Noncurrent</link:label>
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13227.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsNoncurrent.13227.11.7" xlink:to="lab_OtherAssetsNoncurrent.158504" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAssetsNoncurrent.158504" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherAssetsNoncurrent.158504">Other non-current assets</link:label>
    <link:loc xlink:label="loc_PreferredStockValue.14123.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockValue.14123.11.6" xlink:to="lab_PreferredStockValue.14020" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockValue.14020" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockValue.14020">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:label="loc_PreferredStockValue.14123.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockValue.14123.11.7" xlink:to="lab_PreferredStockValue.158276" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockValue.158276" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockValue.158276">Preferred stock, $0.01 par value, 2,000,000 shares authorized; no shares issued and outstanding</link:label>
    <link:loc xlink:label="loc_PrepaidExpenseCurrent.14246.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PrepaidExpenseCurrent.14246.11.6" xlink:to="lab_PrepaidExpenseCurrent.14227" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PrepaidExpenseCurrent.14227" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PrepaidExpenseCurrent.14227">Prepaid Expense, Current</link:label>
    <link:loc xlink:label="loc_PrepaidExpenseCurrent.14246.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PrepaidExpenseCurrent.14246.11.7" xlink:to="lab_PrepaidExpenseCurrent.158258" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PrepaidExpenseCurrent.158258" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PrepaidExpenseCurrent.158258">Prepaid expenses</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.14697.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentNet.14697.11.6" xlink:to="lab_PropertyPlantAndEquipmentNet.14913" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentNet.14913" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentNet.14913">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.14697.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentNet.14697.11.7" xlink:to="lab_PropertyPlantAndEquipmentNet.158260" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentNet.158260" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentNet.158260">Property and equipment, net</link:label>
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.11.6" xlink:to="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.15967" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.15967" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.15967">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.11.7" xlink:to="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.158485" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.158485" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.158485">Restricted cash</link:label>
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsNoncurrent.15344.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedCashAndCashEquivalentsNoncurrent.15344.11.6" xlink:to="lab_RestrictedCashAndCashEquivalentsNoncurrent.15973" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RestrictedCashAndCashEquivalentsNoncurrent.15973" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RestrictedCashAndCashEquivalentsNoncurrent.15973">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsNoncurrent.15344.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedCashAndCashEquivalentsNoncurrent.15344.11.7" xlink:to="lab_RestrictedCashAndCashEquivalentsNoncurrent.158506" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RestrictedCashAndCashEquivalentsNoncurrent.158506" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RestrictedCashAndCashEquivalentsNoncurrent.158506">Restricted cash</link:label>
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15457.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RetainedEarningsAccumulatedDeficit.15457.11.6" xlink:to="lab_RetainedEarningsAccumulatedDeficit.16146" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RetainedEarningsAccumulatedDeficit.16146" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RetainedEarningsAccumulatedDeficit.16146">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15457.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RetainedEarningsAccumulatedDeficit.15457.11.7" xlink:to="lab_RetainedEarningsAccumulatedDeficit.158279" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RetainedEarningsAccumulatedDeficit.158279" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RetainedEarningsAccumulatedDeficit.158279">Accumulated deficit</link:label>
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.4958.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.11.6" xlink:to="lab_StatementOfFinancialPositionAbstract.158252" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementOfFinancialPositionAbstract.158252" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementOfFinancialPositionAbstract.158252">BALANCE SHEETS [Abstract]</link:label>
    <link:loc xlink:label="loc_StockholdersEquity.16667.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquity.16667.11.6" xlink:to="lab_StockholdersEquity.18029" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquity.18029" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquity.18029">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:label="loc_StockholdersEquity.16667.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquity.16667.11.9" xlink:to="lab_StockholdersEquity.158280" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquity.158280" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquity.158280">Total stockholders' equity</link:label>
    <link:loc xlink:label="loc_StockholdersEquityAbstract.4986.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityAbstract.4986.11.6" xlink:to="lab_StockholdersEquityAbstract.18017" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityAbstract.18017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityAbstract.18017">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityAbstract.4986.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityAbstract.4986.11.7" xlink:to="lab_StockholdersEquityAbstract.158275" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityAbstract.158275" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityAbstract.158275">Stockholders' equity:</link:label>
    <link:loc xlink:label="loc_TreasuryStockValue.17060.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TreasuryStockValue.17060.11.6" xlink:to="lab_TreasuryStockValue.18646" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TreasuryStockValue.18646" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TreasuryStockValue.18646">Treasury Stock, Value</link:label>
    <link:loc xlink:label="loc_TreasuryStockValue.17060.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TreasuryStockValue.17060.11.42" xlink:to="lab_TreasuryStockValue42.158520" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TreasuryStockValue42.158520" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_TreasuryStockValue42.158520">Treasury stock, 455,430 shares, cost basis</link:label>
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.6878.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockParOrStatedValuePerShare.6878.11.6" xlink:to="lab_CommonStockParOrStatedValuePerShare.2741" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockParOrStatedValuePerShare.2741" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockParOrStatedValuePerShare.2741">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.6878.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockParOrStatedValuePerShare.6878.11.7" xlink:to="lab_CommonStockParOrStatedValuePerShare7.158287" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockParOrStatedValuePerShare7.158287" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockParOrStatedValuePerShare7.158287">Common stock, par value per share</link:label>
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.6879.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesAuthorized.6879.11.6" xlink:to="lab_CommonStockSharesAuthorized.2742" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesAuthorized.2742" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesAuthorized.2742">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.6879.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesAuthorized.6879.11.7" xlink:to="lab_CommonStockSharesAuthorized7.158288" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesAuthorized7.158288" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesAuthorized7.158288">Common stock, shares authorized</link:label>
    <link:loc xlink:label="loc_CommonStockSharesIssued.6875.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesIssued.6875.11.6" xlink:to="lab_CommonStockSharesIssued.2734" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesIssued.2734" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesIssued.2734">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:label="loc_CommonStockSharesIssued.6875.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesIssued.6875.11.7" xlink:to="lab_CommonStockSharesIssued7.158289" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesIssued7.158289" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesIssued7.158289">Common stock, shares issued</link:label>
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.6864.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesOutstanding.6864.11.6" xlink:to="lab_CommonStockSharesOutstanding.2714" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesOutstanding.2714" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesOutstanding.2714">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.6864.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesOutstanding.6864.11.7" xlink:to="lab_CommonStockSharesOutstanding.158290" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesOutstanding.158290" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesOutstanding.158290">Common stock, shares outstanding</link:label>
    <link:loc xlink:label="loc_PreferredStockParOrStatedValuePerShare.14166.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockParOrStatedValuePerShare.14166.11.6" xlink:to="lab_PreferredStockParOrStatedValuePerShare.14088" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockParOrStatedValuePerShare.14088" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockParOrStatedValuePerShare.14088">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:label="loc_PreferredStockParOrStatedValuePerShare.14166.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockParOrStatedValuePerShare.14166.11.7" xlink:to="lab_PreferredStockParOrStatedValuePerShare.158283" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockParOrStatedValuePerShare.158283" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockParOrStatedValuePerShare.158283">Preferred stock, par or stated value per share</link:label>
    <link:loc xlink:label="loc_PreferredStockSharesAuthorized.14124.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockSharesAuthorized.14124.11.6" xlink:to="lab_PreferredStockSharesAuthorized.14024" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockSharesAuthorized.14024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockSharesAuthorized.14024">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:label="loc_PreferredStockSharesAuthorized.14124.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockSharesAuthorized.14124.11.7" xlink:to="lab_PreferredStockSharesAuthorized.158284" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockSharesAuthorized.158284" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockSharesAuthorized.158284">Preferred stock, shares authorized</link:label>
    <link:loc xlink:label="loc_PreferredStockSharesIssued.14157.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockSharesIssued.14157.11.6" xlink:to="lab_PreferredStockSharesIssued.14076" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockSharesIssued.14076" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockSharesIssued.14076">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:label="loc_PreferredStockSharesIssued.14157.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockSharesIssued.14157.11.7" xlink:to="lab_PreferredStockSharesIssued.158285" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockSharesIssued.158285" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockSharesIssued.158285">Preferred stock, shares issued</link:label>
    <link:loc xlink:label="loc_PreferredStockSharesOutstanding.14180.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockSharesOutstanding.14180.11.6" xlink:to="lab_PreferredStockSharesOutstanding.14104" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockSharesOutstanding.14104" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockSharesOutstanding.14104">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:label="loc_PreferredStockSharesOutstanding.14180.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockSharesOutstanding.14180.11.7" xlink:to="lab_PreferredStockSharesOutstanding.158286" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockSharesOutstanding.158286" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockSharesOutstanding.158286">Preferred stock, shares outstanding</link:label>
    <link:loc xlink:label="loc_TreasuryStockShares.17065.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockShares" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TreasuryStockShares.17065.11.6" xlink:to="lab_TreasuryStockShares.18653" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TreasuryStockShares.18653" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TreasuryStockShares.18653">Treasury Stock, Shares</link:label>
    <link:loc xlink:label="loc_TreasuryStockShares.17065.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockShares" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TreasuryStockShares.17065.11.7" xlink:to="lab_TreasuryStockShares7.158525" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TreasuryStockShares7.158525" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TreasuryStockShares7.158525">Treasury stock, shares</link:label>
    <link:loc xlink:label="loc_ContractRevenueCost.7021.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractRevenueCost" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ContractRevenueCost.7021.11.6" xlink:to="lab_ContractRevenueCost.2994" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ContractRevenueCost.2994" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ContractRevenueCost.2994">Contract Revenue Cost</link:label>
    <link:loc xlink:label="loc_ContractRevenueCost.7021.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractRevenueCost" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ContractRevenueCost.7021.11.7" xlink:to="lab_ContractRevenueCost.158877" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ContractRevenueCost.158877" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ContractRevenueCost.158877">Cost of government contracts revenue</link:label>
    <link:loc xlink:label="loc_ContractsRevenue.7028.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ContractsRevenue.7028.11.6" xlink:to="lab_ContractsRevenue.3006" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ContractsRevenue.3006" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ContractsRevenue.3006">Contracts Revenue</link:label>
    <link:loc xlink:label="loc_ContractsRevenue.7028.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ContractsRevenue.7028.11.7" xlink:to="lab_ContractsRevenue7.158875" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ContractsRevenue7.158875" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ContractsRevenue7.158875">Government contracts</link:label>
    <link:loc xlink:label="loc_CostsAndExpenses.7217.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CostsAndExpenses.7217.11.6" xlink:to="lab_CostsAndExpenses.3285" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CostsAndExpenses.3285" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CostsAndExpenses.3285">Costs and Expenses</link:label>
    <link:loc xlink:label="loc_CostsAndExpenses.7217.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CostsAndExpenses.7217.11.9" xlink:to="lab_CostsAndExpenses.158530" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CostsAndExpenses.158530" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_CostsAndExpenses.158530">Total costs and expenses</link:label>
    <link:loc xlink:label="loc_CostsAndExpensesAbstract.1204.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CostsAndExpensesAbstract.1204.11.6" xlink:to="lab_CostsAndExpensesAbstract.3279" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CostsAndExpensesAbstract.3279" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CostsAndExpensesAbstract.3279">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:label="loc_CostsAndExpensesAbstract.1204.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CostsAndExpensesAbstract.1204.11.7" xlink:to="lab_CostsAndExpensesAbstract.158528" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CostsAndExpensesAbstract.158528" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CostsAndExpensesAbstract.158528">Costs and expenses:</link:label>
    <link:loc xlink:label="loc_EarningsPerShareBasicAndDiluted.8698.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerShareBasicAndDiluted.8698.11.6" xlink:to="lab_EarningsPerShareBasicAndDiluted.5415" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerShareBasicAndDiluted.5415" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerShareBasicAndDiluted.5415">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:label="loc_EarningsPerShareBasicAndDiluted.8698.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerShareBasicAndDiluted.8698.11.7" xlink:to="lab_EarningsPerShareBasicAndDiluted.158309" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerShareBasicAndDiluted.158309" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerShareBasicAndDiluted.158309">Basic and diluted net loss per share</link:label>
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.11.7" xlink:to="lab_GainLossOnDerivativeInstrumentsNetPretax.158533" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnDerivativeInstrumentsNetPretax.158533" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnDerivativeInstrumentsNetPretax.158533">Change in fair value of warrant liability</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10284.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpense.10284.11.6" xlink:to="lab_GeneralAndAdministrativeExpense.7870" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GeneralAndAdministrativeExpense.7870" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GeneralAndAdministrativeExpense.7870">General and Administrative Expense</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10284.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpense.10284.11.7" xlink:to="lab_GeneralAndAdministrativeExpense.158529" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GeneralAndAdministrativeExpense.158529" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GeneralAndAdministrativeExpense.158529">General and administrative</link:label>
    <link:loc xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.11.6" xlink:to="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.8488" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.8488" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.8488">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest</link:label>
    <link:loc xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.11.9" xlink:to="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.158308" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.158308" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.158308">Loss from operations before income tax</link:label>
    <link:loc xlink:label="loc_IncomeStatementAbstract.2519.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeStatementAbstract.2519.11.6" xlink:to="lab_IncomeStatementAbstract.158291" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeStatementAbstract.158291" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeStatementAbstract.158291">STATEMENTS OF OPERATIONS [Abstract]</link:label>
    <link:loc xlink:label="loc_IncomeTaxExpenseBenefit.10688.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxExpenseBenefit.10688.11.6" xlink:to="lab_IncomeTaxExpenseBenefit.8536" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxExpenseBenefit.8536" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxExpenseBenefit.8536">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:label="loc_IncomeTaxExpenseBenefit.10688.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxExpenseBenefit.10688.11.7" xlink:to="lab_IncomeTaxExpenseBenefit.158296" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxExpenseBenefit.158296" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxExpenseBenefit.158296">Income tax expense</link:label>
    <link:loc xlink:label="loc_InterestExpense.11178.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestExpense.11178.11.6" xlink:to="lab_InterestExpense.9280" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestExpense.9280" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InterestExpense.9280">Interest Expense</link:label>
    <link:loc xlink:label="loc_InterestExpense.11178.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestExpense.11178.11.42" xlink:to="lab_InterestExpense.158532" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestExpense.158532" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_InterestExpense.158532">Interest expense</link:label>
    <link:loc xlink:label="loc_InvestmentIncomeInterest.11436.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestmentIncomeInterest.11436.11.6" xlink:to="lab_InvestmentIncomeInterest.9687" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InvestmentIncomeInterest.9687" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InvestmentIncomeInterest.9687">Investment Income, Interest</link:label>
    <link:loc xlink:label="loc_InvestmentIncomeInterest.11436.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestmentIncomeInterest.11436.11.7" xlink:to="lab_InvestmentIncomeInterest.158531" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InvestmentIncomeInterest.158531" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_InvestmentIncomeInterest.158531">Interest income</link:label>
    <link:loc xlink:label="loc_InvestmentIncomeNet.11453.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestmentIncomeNet.11453.11.6" xlink:to="lab_InvestmentIncomeNet.9715" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InvestmentIncomeNet.9715" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InvestmentIncomeNet.9715">Investment Income, Net</link:label>
    <link:loc xlink:label="loc_InvestmentIncomeNet.11453.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestmentIncomeNet.11453.11.7" xlink:to="lab_InvestmentIncomeNet.134939" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InvestmentIncomeNet.134939" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_InvestmentIncomeNet.134939">Interest income</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.12771.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.12771.11.9" xlink:to="lab_NetIncomeLoss.158297" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetIncomeLoss.158297" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetIncomeLoss.158297">Net loss</link:label>
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.11.6" xlink:to="lab_NonoperatingIncomeExpenseAbstract.12067" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NonoperatingIncomeExpenseAbstract.12067" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NonoperatingIncomeExpenseAbstract.12067">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.11.7" xlink:to="lab_NonoperatingIncomeExpenseAbstract.158304" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NonoperatingIncomeExpenseAbstract.158304" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NonoperatingIncomeExpenseAbstract.158304">Other income (expense):</link:label>
    <link:loc xlink:label="loc_OperatingIncomeLoss.13080.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingIncomeLoss.13080.11.6" xlink:to="lab_OperatingIncomeLoss.12364" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingIncomeLoss.12364" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingIncomeLoss.12364">Operating Income (Loss)</link:label>
    <link:loc xlink:label="loc_OperatingIncomeLoss.13080.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingIncomeLoss.13080.11.9" xlink:to="lab_OperatingIncomeLoss.158293" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingIncomeLoss.158293" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingIncomeLoss.158293">Loss from operations</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentCollaboration.26647.11.6" xlink:href="nvax-20120930.xsd#nvax_ResearchAndDevelopmentCollaboration" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentCollaboration.26647.11.6" xlink:to="lab_ResearchAndDevelopmentCollaboration.171372" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentCollaboration.171372" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentCollaboration.171372">Research And Development Collaboration</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentCollaboration.26647.11.12" xlink:href="nvax-20120930.xsd#nvax_ResearchAndDevelopmentCollaboration" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentCollaboration.26647.11.12" xlink:to="lab_ResearchAndDevelopmentCollaboration.171373" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentCollaboration.171373" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentCollaboration.171373">Research And Development Collaboration</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentCollaboration.26647.11.7" xlink:href="nvax-20120930.xsd#nvax_ResearchAndDevelopmentCollaboration" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentCollaboration.26647.11.7" xlink:to="lab_ResearchAndDevelopmentCollaboration7.171374" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentCollaboration7.171374" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentCollaboration7.171374">Research and development collaboration</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15293.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpense.15293.11.6" xlink:to="lab_ResearchAndDevelopmentExpense.15873" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpense.15873" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpense.15873">Research and Development Expense</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15293.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpense.15293.11.7" xlink:to="lab_ResearchAndDevelopmentExpense.158534" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpense.158534" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpense.158534">Research and development</link:label>
    <link:loc xlink:label="loc_Revenues.15575.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Revenues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Revenues.15575.11.6" xlink:to="lab_Revenues.16307" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Revenues.16307" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_Revenues.16307">Revenues</link:label>
    <link:loc xlink:label="loc_Revenues.15575.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Revenues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Revenues.15575.11.9" xlink:to="lab_Revenues.171375" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Revenues.171375" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_Revenues.171375">Total revenue</link:label>
    <link:loc xlink:label="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.11.6" xlink:to="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.19243" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.19243" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.19243">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:label="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.11.7" xlink:to="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.158306" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.158306" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.158306">Basic and diluted weighted average number of common shares outstanding</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTax.6913.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomeNetOfTax.6913.11.6" xlink:to="lab_ComprehensiveIncomeNetOfTax.2818" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomeNetOfTax.2818" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomeNetOfTax.2818">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTax.6913.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomeNetOfTax.6913.11.9" xlink:to="lab_ComprehensiveIncomeNetOfTax.158315" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomeNetOfTax.158315" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomeNetOfTax.158315">Comprehensive loss</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTaxAbstract.1079.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomeNetOfTaxAbstract.1079.11.6" xlink:to="lab_ComprehensiveIncomeNetOfTaxAbstract.2817" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomeNetOfTaxAbstract.2817" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomeNetOfTaxAbstract.2817">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTaxAbstract.1079.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomeNetOfTaxAbstract.1079.11.7" xlink:to="lab_ComprehensiveIncomeNetOfTaxAbstract.158535" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomeNetOfTaxAbstract.158535" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomeNetOfTaxAbstract.158535">Comprehensive loss:</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.12771.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.12771.11.6" xlink:to="lab_NetIncomeLoss.11860" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetIncomeLoss.11860" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetIncomeLoss.11860">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.12771.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.12771.11.7" xlink:to="lab_NetIncomeLoss.158311" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetIncomeLoss.158311" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetIncomeLoss.158311">Net loss</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13404.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13404.11.6" xlink:to="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.12884" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.12884" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.12884">Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13404.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13404.11.7" xlink:to="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.158312" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.158312" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.158312">Unrealized gain on short-term investments available-for-sale</link:label>
    <link:loc xlink:label="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.11.6" xlink:to="lab_StatementOfIncomeAndComprehensiveIncomeAbstract.158310" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementOfIncomeAndComprehensiveIncomeAbstract.158310" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementOfIncomeAndComprehensiveIncomeAbstract.158310">STATEMENTS OF COMPREHENSIVE LOSS [Abstract]</link:label>
    <link:loc xlink:label="loc_AccretionAmortizationOfDiscountsAndPremiumsInvestments.5479.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccretionAmortizationOfDiscountsAndPremiumsInvestments.5479.11.6" xlink:to="lab_AccretionAmortizationOfDiscountsAndPremiumsInvestments.448" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccretionAmortizationOfDiscountsAndPremiumsInvestments.448" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccretionAmortizationOfDiscountsAndPremiumsInvestments.448">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:label="loc_AccretionAmortizationOfDiscountsAndPremiumsInvestments.5479.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccretionAmortizationOfDiscountsAndPremiumsInvestments.5479.11.42" xlink:to="lab_AccretionAmortizationOfDiscountsAndPremiumsInvestments.158695" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccretionAmortizationOfDiscountsAndPremiumsInvestments.158695" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccretionAmortizationOfDiscountsAndPremiumsInvestments.158695">Amortization of net premiums on short-term investments</link:label>
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.11.6" xlink:to="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.726" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.726">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.11.7" xlink:to="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.158335" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.158335" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.158335">Reconciliation of net loss to net cash used in operating activities:</link:label>
    <link:loc xlink:label="loc_AssetImpairmentCharges.5835.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetImpairmentCharges.5835.11.6" xlink:to="lab_AssetImpairmentCharges.1048" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetImpairmentCharges.1048" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AssetImpairmentCharges.1048">Asset Impairment Charges</link:label>
    <link:loc xlink:label="loc_AssetImpairmentCharges.5835.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetImpairmentCharges.5835.11.7" xlink:to="lab_AssetImpairmentCharges.171376" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetImpairmentCharges.171376" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AssetImpairmentCharges.171376">Impairment of property and equipment</link:label>
    <link:loc xlink:label="loc_CapitalExpendituresIncurredButNotYetPaid.6412.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalExpendituresIncurredButNotYetPaid.6412.11.6" xlink:to="lab_CapitalExpendituresIncurredButNotYetPaid.1947" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalExpendituresIncurredButNotYetPaid.1947" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalExpendituresIncurredButNotYetPaid.1947">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:label="loc_CapitalExpendituresIncurredButNotYetPaid.6412.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalExpendituresIncurredButNotYetPaid.6412.11.7" xlink:to="lab_CapitalExpendituresIncurredButNotYetPaid.158671" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalExpendituresIncurredButNotYetPaid.158671" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalExpendituresIncurredButNotYetPaid.158671">Property and equipment purchases included in accounts payable and accrued expenses</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationEquipmentPurchased.24449.11.6" xlink:href="nvax-20120930.xsd#nvax_CapitalLeaseObligationEquipmentPurchased" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationEquipmentPurchased.24449.11.6" xlink:to="lab_CapitalLeaseObligationEquipmentPurchased.158700" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationEquipmentPurchased.158700" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationEquipmentPurchased.158700">Capital Lease Obligation Equipment Purchased</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationEquipmentPurchased.24449.11.7" xlink:href="nvax-20120930.xsd#nvax_CapitalLeaseObligationEquipmentPurchased" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationEquipmentPurchased.24449.11.7" xlink:to="lab_CapitalLeaseObligationEquipmentPurchased.158706" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationEquipmentPurchased.158706" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationEquipmentPurchased.158706">Equipment acquired under a capital lease</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationEquipmentPurchased.24449.11.12" xlink:href="nvax-20120930.xsd#nvax_CapitalLeaseObligationEquipmentPurchased" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationEquipmentPurchased.24449.11.12" xlink:to="lab_CapitalLeaseObligationEquipmentPurchased.158705" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationEquipmentPurchased.158705" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationEquipmentPurchased.158705">Capital Lease Obligation Equipment Purchased</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.10" xlink:to="lab_CashAndCashEquivalentsAtCarryingValue.158342" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsAtCarryingValue.158342" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsAtCarryingValue.158342">Cash and cash equivalents at beginning of period</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.11" xlink:to="lab_CashAndCashEquivalentsAtCarryingValue.158343" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsAtCarryingValue.158343" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsAtCarryingValue.158343">Cash and cash equivalents at end of period</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.11.6" xlink:to="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.2245" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.2245" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.2245">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.11.9" xlink:to="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.158341" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.158341" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.158341">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:loc xlink:label="loc_DepositsForAcquisitionOfPropertyAndEquipment.24442.11.6" xlink:href="nvax-20120930.xsd#nvax_DepositsForAcquisitionOfPropertyAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DepositsForAcquisitionOfPropertyAndEquipment.24442.11.6" xlink:to="lab_DepositsForAcquisitionOfPropertyAndEquipment.158668" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DepositsForAcquisitionOfPropertyAndEquipment.158668" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DepositsForAcquisitionOfPropertyAndEquipment.158668">Deposits For Acquisition Of Property And Equipment</link:label>
    <link:loc xlink:label="loc_DepositsForAcquisitionOfPropertyAndEquipment.24442.11.7" xlink:href="nvax-20120930.xsd#nvax_DepositsForAcquisitionOfPropertyAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DepositsForAcquisitionOfPropertyAndEquipment.24442.11.7" xlink:to="lab_DepositsForAcquisitionOfPropertyAndEquipment.158670" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DepositsForAcquisitionOfPropertyAndEquipment.158670" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DepositsForAcquisitionOfPropertyAndEquipment.158670">Deposit applied towards the purchase of laboratory equipment</link:label>
    <link:loc xlink:label="loc_DepositsForAcquisitionOfPropertyAndEquipment.24442.11.12" xlink:href="nvax-20120930.xsd#nvax_DepositsForAcquisitionOfPropertyAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DepositsForAcquisitionOfPropertyAndEquipment.24442.11.12" xlink:to="lab_DepositsForAcquisitionOfPropertyAndEquipment.158669" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DepositsForAcquisitionOfPropertyAndEquipment.158669" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_DepositsForAcquisitionOfPropertyAndEquipment.158669">Deposits For Acquisition Of Property And Equipment</link:label>
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DepreciationAndAmortization.8044.11.6" xlink:to="lab_DepreciationAndAmortization.4491" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DepreciationAndAmortization.4491" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DepreciationAndAmortization.4491">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DepreciationAndAmortization.8044.11.7" xlink:to="lab_DepreciationAndAmortization.158317" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DepreciationAndAmortization.158317" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DepreciationAndAmortization.158317">Depreciation and amortization</link:label>
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.11.6" xlink:to="lab_GainLossOnDerivativeInstrumentsNetPretax.7662" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnDerivativeInstrumentsNetPretax.7662" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnDerivativeInstrumentsNetPretax.7662">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.11.42" xlink:to="lab_GainLossOnDerivativeInstrumentsNetPretax.158697" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnDerivativeInstrumentsNetPretax.158697" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnDerivativeInstrumentsNetPretax.158697">Change in fair value of warrant liability</link:label>
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.11.6" xlink:to="lab_GainLossOnSaleOfPropertyPlantEquipment.7730" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnSaleOfPropertyPlantEquipment.7730" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnSaleOfPropertyPlantEquipment.7730">Gain (Loss) on Sale of Property Plant Equipment</link:label>
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.11.42" xlink:to="lab_GainLossOnSaleOfPropertyPlantEquipment42.158319" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnSaleOfPropertyPlantEquipment42.158319" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnSaleOfPropertyPlantEquipment42.158319">Gain on disposal of property and equipment</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.10871.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.10871.11.6" xlink:to="lab_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.8810" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.8810" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.8810">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.10871.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.10871.11.7" xlink:to="lab_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.158325" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.158325" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.158325">Accounts payable and accrued expenses</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.10853.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsReceivable.10853.11.6" xlink:to="lab_IncreaseDecreaseInAccountsReceivable.8785" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccountsReceivable.8785" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccountsReceivable.8785">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.10853.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsReceivable.10853.11.42" xlink:to="lab_IncreaseDecreaseInAccountsReceivable42.158321" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccountsReceivable42.158321" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccountsReceivable42.158321">Accounts receivables</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.10850.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInDeferredRevenue.10850.11.6" xlink:to="lab_IncreaseDecreaseInDeferredRevenue.8782" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInDeferredRevenue.8782" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInDeferredRevenue.8782">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.10850.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInDeferredRevenue.10850.11.7" xlink:to="lab_IncreaseDecreaseInDeferredRevenue.158326" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInDeferredRevenue.158326" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInDeferredRevenue.158326">Deferred revenue</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.11.6" xlink:to="lab_IncreaseDecreaseInOperatingCapitalAbstract.8850" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInOperatingCapitalAbstract.8850" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInOperatingCapitalAbstract.8850">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.11.7" xlink:to="lab_IncreaseDecreaseInOperatingCapitalAbstract.158320" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInOperatingCapitalAbstract.158320" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInOperatingCapitalAbstract.158320">Changes in operating assets and liabilities:</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherNoncurrentLiabilities.10849.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOtherNoncurrentLiabilities.10849.11.6" xlink:to="lab_IncreaseDecreaseInOtherNoncurrentLiabilities.8781" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInOtherNoncurrentLiabilities.8781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInOtherNoncurrentLiabilities.8781">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherNoncurrentLiabilities.10849.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOtherNoncurrentLiabilities.10849.11.7" xlink:to="lab_IncreaseDecreaseInOtherNoncurrentLiabilities.158688" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInOtherNoncurrentLiabilities.158688" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInOtherNoncurrentLiabilities.158688">Lease incentives received</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.11.6" xlink:to="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.8897" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.8897" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.8897">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.11.42" xlink:to="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets42.158323" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets42.158323" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets42.158323">Prepaid expenses and other assets</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInUnbilledReceivables.11010.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInUnbilledReceivables.11010.11.6" xlink:to="lab_IncreaseDecreaseInUnbilledReceivables.9010" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInUnbilledReceivables.9010" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInUnbilledReceivables.9010">Increase (Decrease) in Unbilled Receivables</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInUnbilledReceivables.11010.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInUnbilledReceivables.11010.11.42" xlink:to="lab_IncreaseDecreaseInUnbilledReceivables.158661" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInUnbilledReceivables.158661" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInUnbilledReceivables.158661">Unbilled receivables</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivities.12740.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.11.6" xlink:to="lab_NetCashProvidedByUsedInFinancingActivities.11796" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInFinancingActivities.11796" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInFinancingActivities.11796">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivities.12740.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.11.9" xlink:to="lab_NetCashProvidedByUsedInFinancingActivities.158331" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInFinancingActivities.158331" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInFinancingActivities.158331">Net cash provided by financing activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.11.6" xlink:to="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.11763" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.11763" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.11763">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.11.7" xlink:to="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.158339" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.158339" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.158339">Financing Activities:</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivities.12731.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.11.6" xlink:to="lab_NetCashProvidedByUsedInInvestingActivities.11776" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInInvestingActivities.11776" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInInvestingActivities.11776">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivities.12731.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.11.9" xlink:to="lab_NetCashProvidedByUsedInInvestingActivities.158334" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInInvestingActivities.158334" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInInvestingActivities.158334">Net cash (used in) provided by investing activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.11.6" xlink:to="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.11840" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.11840" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.11840">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.11.7" xlink:to="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.158338" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.158338" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.158338">Investing Activities:</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivities.12778.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.11.6" xlink:to="lab_NetCashProvidedByUsedInOperatingActivities.11871" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInOperatingActivities.11871" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInOperatingActivities.11871">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivities.12778.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.11.9" xlink:to="lab_NetCashProvidedByUsedInOperatingActivities.158336" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInOperatingActivities.158336" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInOperatingActivities.158336">Net cash used in operating activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.11.6" xlink:to="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract.11842" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract.11842" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract.11842">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.11.7" xlink:to="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract7.158337" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract7.158337" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract7.158337">Operating Activities:</link:label>
    <link:loc xlink:label="loc_OtherNoncashIncomeExpense.13166.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherNoncashIncomeExpense.13166.11.6" xlink:to="lab_OtherNoncashIncomeExpense.12505" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherNoncashIncomeExpense.12505" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherNoncashIncomeExpense.12505">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:label="loc_OtherNoncashIncomeExpense.13166.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherNoncashIncomeExpense.13166.11.42" xlink:to="lab_OtherNoncashIncomeExpense.158692" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherNoncashIncomeExpense.158692" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherNoncashIncomeExpense.158692">Deferred rent</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquireAvailableForSaleSecurities.13806.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquireAvailableForSaleSecurities.13806.11.6" xlink:to="lab_PaymentsToAcquireAvailableForSaleSecurities.13557" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsToAcquireAvailableForSaleSecurities.13557" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsToAcquireAvailableForSaleSecurities.13557">Payments to Acquire Available-for-sale Securities</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquireAvailableForSaleSecurities.13806.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquireAvailableForSaleSecurities.13806.11.42" xlink:to="lab_PaymentsToAcquireAvailableForSaleSecurities42.158687" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsToAcquireAvailableForSaleSecurities42.158687" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsToAcquireAvailableForSaleSecurities42.158687">Purchases of short-term investments</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquireProductiveAssets.13804.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquireProductiveAssets.13804.11.6" xlink:to="lab_PaymentsToAcquireProductiveAssets.13554" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsToAcquireProductiveAssets.13554" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsToAcquireProductiveAssets.13554">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquireProductiveAssets.13804.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquireProductiveAssets.13804.11.42" xlink:to="lab_PaymentsToAcquireProductiveAssets42.158684" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsToAcquireProductiveAssets42.158684" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsToAcquireProductiveAssets42.158684">Capital expenditures</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStock.14449.11.6" xlink:to="lab_ProceedsFromIssuanceOfCommonStock.14546" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfCommonStock.14546" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfCommonStock.14546">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStock.14449.11.7" xlink:to="lab_ProceedsFromIssuanceOfCommonStock.158330" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfCommonStock.158330" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfCommonStock.158330">Net proceeds from sales of common stock, net of offering costs of $0.4 million and $0.2 million, respectively</link:label>
    <link:loc xlink:label="loc_ProceedsFromNotesPayable.14430.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromNotesPayable.14430.11.6" xlink:to="lab_ProceedsFromNotesPayable.14515" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromNotesPayable.14515" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromNotesPayable.14515">Proceeds from Notes Payable</link:label>
    <link:loc xlink:label="loc_ProceedsFromNotesPayable.14430.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromNotesPayable.14430.11.7" xlink:to="lab_ProceedsFromNotesPayable.158880" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromNotesPayable.158880" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromNotesPayable.158880">Proceeds from notes payable</link:label>
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfNotesPayable.14330.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromRepaymentsOfNotesPayable.14330.11.6" xlink:to="lab_ProceedsFromRepaymentsOfNotesPayable.14362" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromRepaymentsOfNotesPayable.14362" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromRepaymentsOfNotesPayable.14362">Proceeds from (Repayments of) Notes Payable</link:label>
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfNotesPayable.14330.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromRepaymentsOfNotesPayable.14330.11.7" xlink:to="lab_ProceedsFromRepaymentsOfNotesPayable.158677" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromRepaymentsOfNotesPayable.158677" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromRepaymentsOfNotesPayable.158677">Principal payments of notes payable</link:label>
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.11.6" xlink:to="lab_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14452" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14452" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14452">Proceeds from (Repayments of) Restricted Cash, Financing Activities</link:label>
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.11.7" xlink:to="lab_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.158675" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.158675" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.158675">Restricted cash</link:label>
    <link:loc xlink:label="loc_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14452.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14452.11.6" xlink:to="lab_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14549" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14549" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14549">Proceeds from Sale and Maturity of Available-for-sale Securities</link:label>
    <link:loc xlink:label="loc_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14452.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14452.11.7" xlink:to="lab_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.158686" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.158686" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.158686">Proceeds from maturities of short-term investments</link:label>
    <link:loc xlink:label="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.11.6" xlink:to="lab_ProceedsFromSaleOfPropertyPlantAndEquipment.14631" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromSaleOfPropertyPlantAndEquipment.14631" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromSaleOfPropertyPlantAndEquipment.14631">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:label="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.11.7" xlink:to="lab_ProceedsFromSaleOfPropertyPlantAndEquipment.158333" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromSaleOfPropertyPlantAndEquipment.158333" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromSaleOfPropertyPlantAndEquipment.158333">Proceeds from disposal of property and equipment</link:label>
    <link:loc xlink:label="loc_ProceedsFromStockOptionsExercised.14555.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromStockOptionsExercised.14555.11.6" xlink:to="lab_ProceedsFromStockOptionsExercised.14691" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromStockOptionsExercised.14691" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromStockOptionsExercised.14691">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:label="loc_ProceedsFromStockOptionsExercised.14555.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromStockOptionsExercised.14555.11.7" xlink:to="lab_ProceedsFromStockOptionsExercised.158674" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromStockOptionsExercised.158674" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromStockOptionsExercised.158674">Proceeds from the exercise of stock options</link:label>
    <link:loc xlink:label="loc_RepaymentsOfLongTermCapitalLeaseObligations.15248.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RepaymentsOfLongTermCapitalLeaseObligations.15248.11.6" xlink:to="lab_RepaymentsOfLongTermCapitalLeaseObligations.15813" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RepaymentsOfLongTermCapitalLeaseObligations.15813" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RepaymentsOfLongTermCapitalLeaseObligations.15813">Repayments of Long-term Capital Lease Obligations</link:label>
    <link:loc xlink:label="loc_RepaymentsOfLongTermCapitalLeaseObligations.15248.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RepaymentsOfLongTermCapitalLeaseObligations.15248.11.42" xlink:to="lab_RepaymentsOfLongTermCapitalLeaseObligations.158681" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RepaymentsOfLongTermCapitalLeaseObligations.158681" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_RepaymentsOfLongTermCapitalLeaseObligations.158681">Principal payments of capital lease</link:label>
    <link:loc xlink:label="loc_SettlementOfNotesReceivable.26648.11.6" xlink:href="nvax-20120930.xsd#nvax_SettlementOfNotesReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SettlementOfNotesReceivable.26648.11.6" xlink:to="lab_SettlementOfNotesReceivable.171377" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SettlementOfNotesReceivable.171377" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SettlementOfNotesReceivable.171377">Settlement Of Notes Receivable</link:label>
    <link:loc xlink:label="loc_SettlementOfNotesReceivable.26648.11.12" xlink:href="nvax-20120930.xsd#nvax_SettlementOfNotesReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SettlementOfNotesReceivable.26648.11.12" xlink:to="lab_SettlementOfNotesReceivable.171378" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SettlementOfNotesReceivable.171378" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SettlementOfNotesReceivable.171378">Settlement Of Notes Receivable</link:label>
    <link:loc xlink:label="loc_SettlementOfNotesReceivable.26648.11.7" xlink:href="nvax-20120930.xsd#nvax_SettlementOfNotesReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SettlementOfNotesReceivable.26648.11.7" xlink:to="lab_SettlementOfNotesReceivable7.171379" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SettlementOfNotesReceivable7.171379" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SettlementOfNotesReceivable7.171379">Settlement of notes receivable</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensation.16244.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensation.16244.11.6" xlink:to="lab_ShareBasedCompensation.17402" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensation.17402" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensation.17402">Share-based Compensation</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensation.16244.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensation.16244.11.7" xlink:to="lab_ShareBasedCompensation7.158318" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensation7.158318" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensation7.158318">Non-cash stock-based compensation</link:label>
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.11.6" xlink:to="lab_StatementOfCashFlowsAbstract.158316" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementOfCashFlowsAbstract.158316" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementOfCashFlowsAbstract.158316">STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:loc xlink:label="loc_SupplementalCashFlowInformationAbstract.5043.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.11.6" xlink:to="lab_SupplementalCashFlowInformationAbstract.18204" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SupplementalCashFlowInformationAbstract.18204" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SupplementalCashFlowInformationAbstract.18204">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:label="loc_SupplementalCashFlowInformationAbstract.5043.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.11.7" xlink:to="lab_SupplementalCashFlowInformationAbstract.158344" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SupplementalCashFlowInformationAbstract.158344" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SupplementalCashFlowInformationAbstract.158344">Supplemental disclosure of non-cash activities:</link:label>
    <link:loc xlink:label="loc_PaymentsOfStockIssuanceCosts.13770.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsOfStockIssuanceCosts.13770.11.6" xlink:to="lab_PaymentsOfStockIssuanceCosts.13507" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsOfStockIssuanceCosts.13507" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsOfStockIssuanceCosts.13507">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:label="loc_PaymentsOfStockIssuanceCosts.13770.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsOfStockIssuanceCosts.13770.11.7" xlink:to="lab_PaymentsOfStockIssuanceCosts.158712" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsOfStockIssuanceCosts.158712" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsOfStockIssuanceCosts.158712">Net proceeds from sales of common stock, offering costs</link:label>
    <link:loc xlink:label="loc_NatureOfOperations.12709.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NatureOfOperations.12709.11.6" xlink:to="lab_NatureOfOperations.11734" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NatureOfOperations.11734" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NatureOfOperations.11734">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:label="loc_NatureOfOperations.12709.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NatureOfOperations.12709.11.7" xlink:to="lab_NatureOfOperations7.158717" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NatureOfOperations7.158717" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NatureOfOperations7.158717">Organization</link:label>
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.11.6" xlink:to="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.158715" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.158715" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.158715">Organization [Abstract]</link:label>
    <link:loc xlink:label="loc_LiquidityMattersAbstract.24453.11.6" xlink:href="nvax-20120930.xsd#nvax_LiquidityMattersAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiquidityMattersAbstract.24453.11.6" xlink:to="lab_LiquidityMattersAbstract.158719" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiquidityMattersAbstract.158719" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiquidityMattersAbstract.158719">Liquidity Matters [Abstract]</link:label>
    <link:loc xlink:label="loc_LiquidityMattersAbstract.24453.11.12" xlink:href="nvax-20120930.xsd#nvax_LiquidityMattersAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiquidityMattersAbstract.24453.11.12" xlink:to="lab_LiquidityMattersDisclosureAbstract.158721" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiquidityMattersDisclosureAbstract.158721" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LiquidityMattersDisclosureAbstract.158721">Liquidity Matters Disclosure [Abstract]</link:label>
    <link:loc xlink:label="loc_LiquidityMattersDisclosureTextBlock.24455.11.6" xlink:href="nvax-20120930.xsd#nvax_LiquidityMattersDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiquidityMattersDisclosureTextBlock.24455.11.6" xlink:to="lab_LiquidityMattersDisclosureTextBlock.158726" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiquidityMattersDisclosureTextBlock.158726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiquidityMattersDisclosureTextBlock.158726">Liquidity Matters Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_LiquidityMattersDisclosureTextBlock.24455.11.7" xlink:href="nvax-20120930.xsd#nvax_LiquidityMattersDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiquidityMattersDisclosureTextBlock.24455.11.7" xlink:to="lab_LiquidityMattersDisclosureTextBlock.158730" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiquidityMattersDisclosureTextBlock.158730" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiquidityMattersDisclosureTextBlock.158730">Liquidity Matters</link:label>
    <link:loc xlink:label="loc_LiquidityMattersDisclosureTextBlock.24455.11.12" xlink:href="nvax-20120930.xsd#nvax_LiquidityMattersDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiquidityMattersDisclosureTextBlock.24455.11.12" xlink:to="lab_LiquidityMattersDisclosureTextBlock.158728" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiquidityMattersDisclosureTextBlock.158728" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LiquidityMattersDisclosureTextBlock.158728">Liquidity Matters Disclosure</link:label>
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountingPoliciesAbstract.385.11.6" xlink:to="lab_AccountingPoliciesAbstract.158732" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountingPoliciesAbstract.158732" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccountingPoliciesAbstract.158732">Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:loc xlink:label="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.11.6" xlink:to="lab_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.1457" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.1457" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.1457">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:label="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.11.7" xlink:to="lab_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.158733" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.158733" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.158733">Summary of Significant Accounting Policies</link:label>
    <link:loc xlink:label="loc_BasisOfAccountingPolicyPolicyTextBlock.6086.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BasisOfAccountingPolicyPolicyTextBlock.6086.11.6" xlink:to="lab_BasisOfAccountingPolicyPolicyTextBlock.1458" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BasisOfAccountingPolicyPolicyTextBlock.1458" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BasisOfAccountingPolicyPolicyTextBlock.1458">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_BasisOfAccountingPolicyPolicyTextBlock.6086.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BasisOfAccountingPolicyPolicyTextBlock.6086.11.7" xlink:to="lab_BasisOfAccountingPolicyPolicyTextBlock7.158806" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BasisOfAccountingPolicyPolicyTextBlock7.158806" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_BasisOfAccountingPolicyPolicyTextBlock7.158806">Basis of Presentation</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6562.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6562.11.6" xlink:to="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.2199" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.2199" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.2199">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6562.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6562.11.7" xlink:to="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.158802" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.158802" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.158802">Restricted Cash</link:label>
    <link:loc xlink:label="loc_EarningsPerSharePolicyTextBlock.8704.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerSharePolicyTextBlock.8704.11.6" xlink:to="lab_EarningsPerSharePolicyTextBlock.5427" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerSharePolicyTextBlock.5427" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerSharePolicyTextBlock.5427">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_EarningsPerSharePolicyTextBlock.8704.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerSharePolicyTextBlock.8704.11.7" xlink:to="lab_EarningsPerSharePolicyTextBlock.158800" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerSharePolicyTextBlock.158800" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerSharePolicyTextBlock.158800">Net Loss per Share</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementPolicyPolicyTextBlock.9181.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementPolicyPolicyTextBlock.9181.11.6" xlink:to="lab_FairValueMeasurementPolicyPolicyTextBlock.6214" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementPolicyPolicyTextBlock.6214" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementPolicyPolicyTextBlock.6214">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementPolicyPolicyTextBlock.9181.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementPolicyPolicyTextBlock.9181.11.7" xlink:to="lab_FairValueMeasurementPolicyPolicyTextBlock.158804" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementPolicyPolicyTextBlock.158804" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementPolicyPolicyTextBlock.158804">Fair Value Measurements</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.12483.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MarketableSecuritiesAvailableForSaleSecuritiesPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.12483.11.6" xlink:to="lab_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.11325" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.11325" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.11325">Marketable Securities, Available-for-sale Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.12483.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MarketableSecuritiesAvailableForSaleSecuritiesPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.12483.11.7" xlink:to="lab_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.158803" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.158803" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.158803">Short-Term Investments</link:label>
    <link:loc xlink:label="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.11.6" xlink:to="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.11883" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.11883" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.11883">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.11.7" xlink:to="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.158798" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.158798" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.158798">Recent Accounting Pronouncements</link:label>
    <link:loc xlink:label="loc_RevenueRecognitionPolicyTextBlock.15515.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RevenueRecognitionPolicyTextBlock.15515.11.6" xlink:to="lab_RevenueRecognitionPolicyTextBlock.16231" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RevenueRecognitionPolicyTextBlock.16231" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RevenueRecognitionPolicyTextBlock.16231">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_RevenueRecognitionPolicyTextBlock.15515.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RevenueRecognitionPolicyTextBlock.15515.11.7" xlink:to="lab_RevenueRecognitionPolicyTextBlock.158799" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RevenueRecognitionPolicyTextBlock.158799" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RevenueRecognitionPolicyTextBlock.158799">Revenue Recognition</link:label>
    <link:loc xlink:label="loc_UseOfEstimates.17234.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UseOfEstimates.17234.11.6" xlink:to="lab_UseOfEstimates.18953" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UseOfEstimates.18953" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_UseOfEstimates.18953">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_UseOfEstimates.17234.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UseOfEstimates.17234.11.7" xlink:to="lab_UseOfEstimates.158805" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UseOfEstimates.158805" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_UseOfEstimates.158805">Use of Estimates</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesTextBlock.5982.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesTextBlock.5982.11.6" xlink:to="lab_AvailableForSaleSecuritiesTextBlock.1296" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesTextBlock.1296" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesTextBlock.1296">Available-for-sale Securities [Table Text Block]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesTextBlock.5982.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesTextBlock.5982.11.7" xlink:to="lab_AvailableForSaleSecuritiesTextBlock.158813" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesTextBlock.158813" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesTextBlock.158813">Short-term Investments Classified as Available-For-Sale</link:label>
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.11.6" xlink:to="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.6652" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.6652" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.6652">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.11.7" xlink:to="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.158811" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.158811" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.158811">Summarized Activity of Level 3 Inputs Measured on Recurring Basis</link:label>
    <link:loc xlink:label="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.11.6" xlink:to="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.16543" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.16543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.16543">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.11.7" xlink:to="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.158809" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.158809" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.158809">Summary of Financial Assets and Liabilities Measured at Fair Market Value on Recurring Basis</link:label>
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.8456.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.8456.11.6" xlink:to="lab_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.5017" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.5017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.5017">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.8456.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.8456.11.7" xlink:to="lab_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock7.158735" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock7.158735" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock7.158735">Stock-Based Compensation</link:label>
    <link:loc xlink:label="loc_CollaborativeArrangementDisclosureTextBlock.6814.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CollaborativeArrangementDisclosureTextBlock.6814.11.6" xlink:to="lab_CollaborativeArrangementDisclosureTextBlock.2614" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CollaborativeArrangementDisclosureTextBlock.2614" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CollaborativeArrangementDisclosureTextBlock.2614">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_CollaborativeArrangementDisclosureTextBlock.6814.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CollaborativeArrangementDisclosureTextBlock.6814.11.7" xlink:to="lab_CollaborativeArrangementDisclosureTextBlock.158740" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CollaborativeArrangementDisclosureTextBlock.158740" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CollaborativeArrangementDisclosureTextBlock.158740">U.S. Government Agreement and Collaboration</link:label>
    <link:loc xlink:label="loc_UsGovernmentAgreementAndCollaborationsAbstract.24456.11.12" xlink:href="nvax-20120930.xsd#nvax_UsGovernmentAgreementAndCollaborationsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UsGovernmentAgreementAndCollaborationsAbstract.24456.11.12" xlink:to="lab_CollaborativeArrangementsDisclosureAbstract.158739" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CollaborativeArrangementsDisclosureAbstract.158739" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_CollaborativeArrangementsDisclosureAbstract.158739">Collaborative Arrangements Disclosure [Abstract].</link:label>
    <link:loc xlink:label="loc_UsGovernmentAgreementAndCollaborationsAbstract.24456.11.6" xlink:href="nvax-20120930.xsd#nvax_UsGovernmentAgreementAndCollaborationsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UsGovernmentAgreementAndCollaborationsAbstract.24456.11.6" xlink:to="lab_UsGovernmentAgreementAndCollaborationsAbstract.158738" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UsGovernmentAgreementAndCollaborationsAbstract.158738" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_UsGovernmentAgreementAndCollaborationsAbstract.158738">U.S. Government Agreement and Collaborations [Abstract]</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationsAbstract.800.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.11.6" xlink:to="lab_CapitalLeaseObligationsAbstract.158741" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationsAbstract.158741" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationsAbstract.158741">Capital Lease [Abstract]</link:label>
    <link:loc xlink:label="loc_DebtAndCapitalLeasesDisclosuresTextBlock.7378.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtAndCapitalLeasesDisclosuresTextBlock.7378.11.6" xlink:to="lab_DebtAndCapitalLeasesDisclosuresTextBlock.3542" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtAndCapitalLeasesDisclosuresTextBlock.3542" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtAndCapitalLeasesDisclosuresTextBlock.3542">Debt and Capital Leases Disclosures [Text Block]</link:label>
    <link:loc xlink:label="loc_DebtAndCapitalLeasesDisclosuresTextBlock.7378.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtAndCapitalLeasesDisclosuresTextBlock.7378.11.7" xlink:to="lab_DebtAndCapitalLeasesDisclosuresTextBlock.158742" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtAndCapitalLeasesDisclosuresTextBlock.158742" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtAndCapitalLeasesDisclosuresTextBlock.158742">Capital Lease</link:label>
    <link:loc xlink:label="loc_DebtDisclosureTextBlock.7384.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtDisclosureTextBlock.7384.11.6" xlink:to="lab_DebtDisclosureTextBlock.3550" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtDisclosureTextBlock.3550" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtDisclosureTextBlock.3550">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_DebtDisclosureTextBlock.7384.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtDisclosureTextBlock.7384.11.7" xlink:to="lab_DebtDisclosureTextBlock7.158744" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtDisclosureTextBlock7.158744" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtDisclosureTextBlock7.158744">Notes Payable</link:label>
    <link:loc xlink:label="loc_StockWarrantsAbstract.24457.11.6" xlink:href="nvax-20120930.xsd#nvax_StockWarrantsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockWarrantsAbstract.24457.11.6" xlink:to="lab_StockWarrantsAbstract.158745" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockWarrantsAbstract.158745" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockWarrantsAbstract.158745">Warrant Liability [Abstract]</link:label>
    <link:loc xlink:label="loc_StockWarrantsAbstract.24457.11.12" xlink:href="nvax-20120930.xsd#nvax_StockWarrantsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockWarrantsAbstract.24457.11.12" xlink:to="lab_StockWarrantsAbstract.158746" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockWarrantsAbstract.158746" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_StockWarrantsAbstract.158746">Stock Warrants Abstract.</link:label>
    <link:loc xlink:label="loc_StockWarrantsTextBlock.24458.11.6" xlink:href="nvax-20120930.xsd#nvax_StockWarrantsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockWarrantsTextBlock.24458.11.6" xlink:to="lab_StockWarrantsTextBlock.158747" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockWarrantsTextBlock.158747" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockWarrantsTextBlock.158747">Stock Warrants [Text Block]</link:label>
    <link:loc xlink:label="loc_StockWarrantsTextBlock.24458.11.7" xlink:href="nvax-20120930.xsd#nvax_StockWarrantsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockWarrantsTextBlock.24458.11.7" xlink:to="lab_StockWarrantsTextBlock.158749" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockWarrantsTextBlock.158749" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockWarrantsTextBlock.158749">Warrant Liability</link:label>
    <link:loc xlink:label="loc_StockWarrantsTextBlock.24458.11.12" xlink:href="nvax-20120930.xsd#nvax_StockWarrantsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockWarrantsTextBlock.24458.11.12" xlink:to="lab_StockWarrantsTextBlock.158748" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockWarrantsTextBlock.158748" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_StockWarrantsTextBlock.158748">Stock Warrant Disclosure</link:label>
    <link:loc xlink:label="loc_SaleOfCommonStockDisclosureTextBlock.24461.11.6" xlink:href="nvax-20120930.xsd#nvax_SaleOfCommonStockDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SaleOfCommonStockDisclosureTextBlock.24461.11.6" xlink:to="lab_SaleOfCommonStockDisclosureTextBlock.158759" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SaleOfCommonStockDisclosureTextBlock.158759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SaleOfCommonStockDisclosureTextBlock.158759">Sale Of Common Stock Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_SaleOfCommonStockDisclosureTextBlock.24461.11.7" xlink:href="nvax-20120930.xsd#nvax_SaleOfCommonStockDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SaleOfCommonStockDisclosureTextBlock.24461.11.7" xlink:to="lab_SaleOfCommonStockDisclosureTextBlock.158761" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SaleOfCommonStockDisclosureTextBlock.158761" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SaleOfCommonStockDisclosureTextBlock.158761">Sales of Common Stock</link:label>
    <link:loc xlink:label="loc_SaleOfCommonStockDisclosureTextBlock.24461.11.12" xlink:href="nvax-20120930.xsd#nvax_SaleOfCommonStockDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SaleOfCommonStockDisclosureTextBlock.24461.11.12" xlink:to="lab_SaleOfCommonStockDisclosureTextBlock.158760" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SaleOfCommonStockDisclosureTextBlock.158760" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SaleOfCommonStockDisclosureTextBlock.158760">Sale Of Common Stock Disclosure</link:label>
    <link:loc xlink:label="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.11.6" xlink:href="nvax-20120930.xsd#nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.11.6" xlink:to="lab_ManufacturingLaboratoryAndOfficeFacilityAbstract.158762" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ManufacturingLaboratoryAndOfficeFacilityAbstract.158762" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ManufacturingLaboratoryAndOfficeFacilityAbstract.158762">Manufacturing Laboratory and Office Facility [Abstract]</link:label>
    <link:loc xlink:label="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.11.12" xlink:href="nvax-20120930.xsd#nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.11.12" xlink:to="lab_NewFacilityLeaseDisclosureAbstract.158763" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewFacilityLeaseDisclosureAbstract.158763" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_NewFacilityLeaseDisclosureAbstract.158763">New Facility Lease Disclosure [Abstract]</link:label>
    <link:loc xlink:label="loc_NewFacilityLeaseDisclosureTextBlock.24463.11.6" xlink:href="nvax-20120930.xsd#nvax_NewFacilityLeaseDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NewFacilityLeaseDisclosureTextBlock.24463.11.6" xlink:to="lab_NewFacilityLeaseDisclosureTextBlock.158764" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewFacilityLeaseDisclosureTextBlock.158764" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NewFacilityLeaseDisclosureTextBlock.158764">New Facility Lease Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_NewFacilityLeaseDisclosureTextBlock.24463.11.7" xlink:href="nvax-20120930.xsd#nvax_NewFacilityLeaseDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NewFacilityLeaseDisclosureTextBlock.24463.11.7" xlink:to="lab_NewFacilityLeaseDisclosureTextBlock.158766" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewFacilityLeaseDisclosureTextBlock.158766" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NewFacilityLeaseDisclosureTextBlock.158766">Manufacturing, Laboratory and Office Facility</link:label>
    <link:loc xlink:label="loc_NewFacilityLeaseDisclosureTextBlock.24463.11.12" xlink:href="nvax-20120930.xsd#nvax_NewFacilityLeaseDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NewFacilityLeaseDisclosureTextBlock.24463.11.12" xlink:to="lab_NewFacilityLeaseDisclosureTextBlock.158765" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewFacilityLeaseDisclosureTextBlock.158765" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_NewFacilityLeaseDisclosureTextBlock.158765">New Facility Lease Disclosure</link:label>
    <link:loc xlink:label="loc_ScheduleOfDebtTableTextBlock.15760.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDebtTableTextBlock.15760.11.6" xlink:to="lab_ScheduleOfDebtTableTextBlock.16595" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfDebtTableTextBlock.16595" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfDebtTableTextBlock.16595">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfDebtTableTextBlock.15760.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDebtTableTextBlock.15760.11.7" xlink:to="lab_ScheduleOfDebtTableTextBlock7.158829" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfDebtTableTextBlock7.158829" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfDebtTableTextBlock7.158829">Schedule of Notes Payable</link:label>
    <link:loc xlink:label="loc_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.15769.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.15769.11.6" xlink:to="lab_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.16607" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.16607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.16607">Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.15769.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.15769.11.7" xlink:to="lab_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.158825" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.158825" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.158825">Schedule of Capital Lease Obligation</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.11.6" xlink:to="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16754" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16754" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16754">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.11.7" xlink:to="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.158815" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.158815" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.158815">Stock-Based Compensation Expense</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.24468.11.6" xlink:href="nvax-20120930.xsd#nvax_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.24468.11.6" xlink:to="lab_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.158819" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.158819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.158819">Schedule Of Share Based Compensation Restricted Stock Awards Activity [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.24468.11.7" xlink:href="nvax-20120930.xsd#nvax_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.24468.11.7" xlink:to="lab_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.158822" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.158822" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.158822">Summary of Restricted Stock Awards Activity</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.24468.11.12" xlink:href="nvax-20120930.xsd#nvax_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.24468.11.12" xlink:to="lab_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.158820" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.158820" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.158820">Schedule Of Share Based Compensation, Restricted Stock Awards, Activity</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.15727.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.15727.11.6" xlink:to="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.16559" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.16559" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.16559">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.15727.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.15727.11.7" xlink:to="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.158817" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.158817" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.158817">Summary of Option Activity</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.15758.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.15758.11.6" xlink:to="lab_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.16593" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.16593" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.16593">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.15758.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.15758.11.7" xlink:to="lab_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.158818" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.158818" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.158818">Assumptions used to Estimate Grant Date Fair Value of Stock Options granted using Black-Scholes Option-Pricing Model</link:label>
    <link:loc xlink:label="loc_EquityMethodInvestmentOwnershipPercentage.8943.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityMethodInvestmentOwnershipPercentage.8943.11.6" xlink:to="lab_EquityMethodInvestmentOwnershipPercentage.5790" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityMethodInvestmentOwnershipPercentage.5790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityMethodInvestmentOwnershipPercentage.5790">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:label="loc_EquityMethodInvestmentOwnershipPercentage.8943.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityMethodInvestmentOwnershipPercentage.8943.11.7" xlink:to="lab_EquityMethodInvestmentOwnershipPercentage.159764" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityMethodInvestmentOwnershipPercentage.159764" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EquityMethodInvestmentOwnershipPercentage.159764">Ownership percent of joint venture</link:label>
    <link:loc xlink:label="loc_JointVenturePercentageOwnedByOthers.24478.11.6" xlink:href="nvax-20120930.xsd#nvax_JointVenturePercentageOwnedByOthers" xlink:type="locator" />
    <link:labelArc xlink:from="loc_JointVenturePercentageOwnedByOthers.24478.11.6" xlink:to="lab_JointVenturePercentageOwnedByOthers.158892" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_JointVenturePercentageOwnedByOthers.158892" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_JointVenturePercentageOwnedByOthers.158892">Joint Venture Percentage Owned By Others</link:label>
    <link:loc xlink:label="loc_JointVenturePercentageOwnedByOthers.24478.11.12" xlink:href="nvax-20120930.xsd#nvax_JointVenturePercentageOwnedByOthers" xlink:type="locator" />
    <link:labelArc xlink:from="loc_JointVenturePercentageOwnedByOthers.24478.11.12" xlink:to="lab_JointVenturePercentageOwnedByOthers.158898" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_JointVenturePercentageOwnedByOthers.158898" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_JointVenturePercentageOwnedByOthers.158898">The percentage of the joint venture owned by others.</link:label>
    <link:loc xlink:label="loc_JointVenturePercentageOwnedByOthers.24478.11.7" xlink:href="nvax-20120930.xsd#nvax_JointVenturePercentageOwnedByOthers" xlink:type="locator" />
    <link:labelArc xlink:from="loc_JointVenturePercentageOwnedByOthers.24478.11.7" xlink:to="lab_JointVenturePercentageOwnedByOthers7.158901" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_JointVenturePercentageOwnedByOthers7.158901" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_JointVenturePercentageOwnedByOthers7.158901">Joint venture, percent ownership of Cadila</link:label>
    <link:loc xlink:label="loc_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.24483.11.6" xlink:href="nvax-20120930.xsd#nvax_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.24483.11.6" xlink:to="lab_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.158904" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.158904" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.158904">Period Of Time Current Capital Levels Can Sustain Planned Levels Of Operation</link:label>
    <link:loc xlink:label="loc_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.24483.11.12" xlink:href="nvax-20120930.xsd#nvax_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.24483.11.12" xlink:to="lab_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation12.158905" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation12.158905" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation12.158905">Period of time the current capital levels can sustain planned levels of operation.</link:label>
    <link:loc xlink:label="loc_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.24483.11.7" xlink:href="nvax-20120930.xsd#nvax_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.24483.11.7" xlink:to="lab_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation7.158906" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation7.158906" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation7.158906">Period of time current capital levels can sustain planned levels of operation.</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStock.14449.11.8" xlink:to="lab_ProceedsFromIssuanceOfCommonStock8.171382" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfCommonStock8.171382" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfCommonStock8.171382">Amount raised through the sale of common stock</link:label>
    <link:loc xlink:label="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.11.6" xlink:to="lab_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.1005" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.1005" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.1005">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:label="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.11.7" xlink:to="lab_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.159310" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.159310" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.159310">Number of shares excluded from the computation of net loss per share</link:label>
    <link:loc xlink:label="loc_AuctionRateSecuritiesParValue.24568.11.6" xlink:href="nvax-20120930.xsd#nvax_AuctionRateSecuritiesParValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AuctionRateSecuritiesParValue.24568.11.6" xlink:to="lab_AuctionRateSecuritiesParValue.159299" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AuctionRateSecuritiesParValue.159299" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AuctionRateSecuritiesParValue.159299">Auction Rate Securities Par Value</link:label>
    <link:loc xlink:label="loc_AuctionRateSecuritiesParValue.24568.11.12" xlink:href="nvax-20120930.xsd#nvax_AuctionRateSecuritiesParValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AuctionRateSecuritiesParValue.24568.11.12" xlink:to="lab_AuctionRateSecuritiesParValue.159303" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AuctionRateSecuritiesParValue.159303" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_AuctionRateSecuritiesParValue.159303">Amount of par or stated value of auction rate securities.</link:label>
    <link:loc xlink:label="loc_AuctionRateSecuritiesParValue.24568.11.7" xlink:href="nvax-20120930.xsd#nvax_AuctionRateSecuritiesParValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AuctionRateSecuritiesParValue.24568.11.7" xlink:to="lab_AuctionRateSecuritiesParValue7.159305" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AuctionRateSecuritiesParValue7.159305" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AuctionRateSecuritiesParValue7.159305">Auction rate securities, par value</link:label>
    <link:loc xlink:label="loc_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.24670.11.6" xlink:href="nvax-20120930.xsd#nvax_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.24670.11.6" xlink:to="lab_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.159769" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.159769" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.159769">Likelihood That Fair Value Of AReporting Unit Is Less Than Its Carrying Amount</link:label>
    <link:loc xlink:label="loc_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.24670.11.12" xlink:href="nvax-20120930.xsd#nvax_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.24670.11.12" xlink:to="lab_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.159770" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.159770" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.159770">Likelihood That Fair Value Of A Reporting Unit Is Less Than Its Carrying Amount</link:label>
    <link:loc xlink:label="loc_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.24670.11.7" xlink:href="nvax-20120930.xsd#nvax_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.24670.11.7" xlink:to="lab_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount7.159771" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount7.159771" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount7.159771">Likelihood that fair value of a reporting unit is less than its carrying amount, percent</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesOriginalMaximumMaturity.24567.11.6" xlink:href="nvax-20120930.xsd#nvax_MarketableSecuritiesOriginalMaximumMaturity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesOriginalMaximumMaturity.24567.11.6" xlink:to="lab_MarketableSecuritiesOriginalMaximumMaturity.159296" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesOriginalMaximumMaturity.159296" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesOriginalMaximumMaturity.159296">Marketable Securities Original Maximum Maturity</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesOriginalMaximumMaturity.24567.11.12" xlink:href="nvax-20120930.xsd#nvax_MarketableSecuritiesOriginalMaximumMaturity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesOriginalMaximumMaturity.24567.11.12" xlink:to="lab_MarketableSecuritiesOriginalMaximumMaturity.159297" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesOriginalMaximumMaturity.159297" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesOriginalMaximumMaturity.159297">Marketable Securities Original Maximum Maturity</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesOriginalMaximumMaturity.24567.11.7" xlink:href="nvax-20120930.xsd#nvax_MarketableSecuritiesOriginalMaximumMaturity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesOriginalMaximumMaturity.24567.11.7" xlink:to="lab_MarketableSecuritiesOriginalMaximumMaturity7.159298" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesOriginalMaximumMaturity7.159298" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesOriginalMaximumMaturity7.159298">Marketable securities, original maximum maturity</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesOriginalMinimumMaturity.24566.11.6" xlink:href="nvax-20120930.xsd#nvax_MarketableSecuritiesOriginalMinimumMaturity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesOriginalMinimumMaturity.24566.11.6" xlink:to="lab_MarketableSecuritiesOriginalMinimumMaturity.159293" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesOriginalMinimumMaturity.159293" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesOriginalMinimumMaturity.159293">Marketable Securities Original Minimum Maturity</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesOriginalMinimumMaturity.24566.11.12" xlink:href="nvax-20120930.xsd#nvax_MarketableSecuritiesOriginalMinimumMaturity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesOriginalMinimumMaturity.24566.11.12" xlink:to="lab_MarketableSecuritiesOriginalMinimumMaturity.159294" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesOriginalMinimumMaturity.159294" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesOriginalMinimumMaturity.159294">Marketable Securities Original Minimum Maturity</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesOriginalMinimumMaturity.24566.11.7" xlink:href="nvax-20120930.xsd#nvax_MarketableSecuritiesOriginalMinimumMaturity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesOriginalMinimumMaturity.24566.11.7" xlink:to="lab_MarketableSecuritiesOriginalMinimumMaturity7.159295" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesOriginalMinimumMaturity7.159295" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesOriginalMinimumMaturity7.159295">Marketable securities, original minimum maturity</link:label>
    <link:loc xlink:label="loc_NumberOfAuctionRateSecuritiesIncludedInInvestments.24570.11.6" xlink:href="nvax-20120930.xsd#nvax_NumberOfAuctionRateSecuritiesIncludedInInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NumberOfAuctionRateSecuritiesIncludedInInvestments.24570.11.6" xlink:to="lab_NumberOfAuctionRateSecuritiesIncludedInInvestments.159313" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NumberOfAuctionRateSecuritiesIncludedInInvestments.159313" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NumberOfAuctionRateSecuritiesIncludedInInvestments.159313">Number Of Auction Rate Securities Included In Investments</link:label>
    <link:loc xlink:label="loc_NumberOfAuctionRateSecuritiesIncludedInInvestments.24570.11.12" xlink:href="nvax-20120930.xsd#nvax_NumberOfAuctionRateSecuritiesIncludedInInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NumberOfAuctionRateSecuritiesIncludedInInvestments.24570.11.12" xlink:to="lab_NumberOfAuctionRateSecuritiesIncludedInInvestments.159314" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NumberOfAuctionRateSecuritiesIncludedInInvestments.159314" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_NumberOfAuctionRateSecuritiesIncludedInInvestments.159314">Number of Auction Rate Securities Included In Investments</link:label>
    <link:loc xlink:label="loc_NumberOfAuctionRateSecuritiesIncludedInInvestments.24570.11.7" xlink:href="nvax-20120930.xsd#nvax_NumberOfAuctionRateSecuritiesIncludedInInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NumberOfAuctionRateSecuritiesIncludedInInvestments.24570.11.7" xlink:to="lab_NumberOfAuctionRateSecuritiesIncludedInInvestments7.159315" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NumberOfAuctionRateSecuritiesIncludedInInvestments7.159315" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NumberOfAuctionRateSecuritiesIncludedInInvestments7.159315">Number of auction rate securities</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2024.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel1Member.2024.11.7" xlink:to="FairValueInputsLevel1Member.141121" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="FairValueInputsLevel1Member.141121" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="FairValueInputsLevel1Member.141121">Level 1 [Member]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueDisclosure" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.11.6" xlink:to="lab_AvailableForSaleSecuritiesFairValueDisclosure.1258" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesFairValueDisclosure.1258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesFairValueDisclosure.1258">Available-for-sale Securities, Fair Value Disclosure</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueDisclosure" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.11.7" xlink:to="lab_AvailableForSaleSecuritiesFairValueDisclosure.158947" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesFairValueDisclosure.158947" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesFairValueDisclosure.158947">Corporate debt and auction rate securities</link:label>
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.11.6" xlink:to="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.6333" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.6333" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.6333">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.11.6" xlink:to="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.6255" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.6255" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.6255">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.11.6" xlink:to="lab_FairValueByFairValueHierarchyLevelAxis.6113" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueByFairValueHierarchyLevelAxis.6113" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueByFairValueHierarchyLevelAxis.6113">Fair Value, Hierarchy [Axis]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2024.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel1Member.2024.11.6" xlink:to="lab_FairValueInputsLevel1Member.6601" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel1Member.6601" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel1Member.6601">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2026.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel2Member.2026.11.6" xlink:to="lab_FairValueInputsLevel2Member.6625" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel2Member.6625" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel2Member.6625">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2026.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel2Member.2026.11.7" xlink:to="lab_FairValueInputsLevel2Member.138285" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel2Member.138285" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel2Member.138285">Level 2 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel3Member.2022.11.6" xlink:to="lab_FairValueInputsLevel3Member.6593" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel3Member.6593" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel3Member.6593">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel3Member.2022.11.7" xlink:to="lab_FairValueInputsLevel3Member.141122" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel3Member.141122" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel3Member.141122">Level 3 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.11.6" xlink:to="lab_FairValueMeasurementsFairValueHierarchyDomain.6292" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementsFairValueHierarchyDomain.6292" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementsFairValueHierarchyDomain.6292">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:label="loc_LiabilitiesFairValueDisclosure.11675.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesFairValueDisclosure.11675.11.6" xlink:to="lab_LiabilitiesFairValueDisclosure.10104" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesFairValueDisclosure.10104" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesFairValueDisclosure.10104">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:label="loc_LiabilitiesFairValueDisclosure.11675.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesFairValueDisclosure.11675.11.7" xlink:to="lab_LiabilitiesFairValueDisclosure.158950" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesFairValueDisclosure.158950" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesFairValueDisclosure.158950">Warrant liability</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.9489.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.9489.11.6" xlink:to="lab_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.6650" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.6650" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.6650">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.9489.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.9489.11.7" xlink:to="lab_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.158983" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.158983" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.158983">Change in fair value of Warrant liability</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.11.6" xlink:to="lab_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.6176" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.6176" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.6176">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.11.10" xlink:to="lab_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.158981" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.158981" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.158981">Balance at December 31, 2011</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.11.11" xlink:to="lab_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.158984" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.158984" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.158984">Balance at September 30, 2012</link:label>
    <link:loc xlink:label="loc_AuctionRateSecuritiesMember.622.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AuctionRateSecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AuctionRateSecuritiesMember.622.11.6" xlink:to="lab_AuctionRateSecuritiesMember.1205" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AuctionRateSecuritiesMember.1205" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AuctionRateSecuritiesMember.1205">Auction Rate Securities [Member]</link:label>
    <link:loc xlink:label="loc_AuctionRateSecuritiesMember.622.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AuctionRateSecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AuctionRateSecuritiesMember.622.11.7" xlink:to="lab_AuctionRateSecuritiesMember7.159045" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AuctionRateSecuritiesMember7.159045" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AuctionRateSecuritiesMember7.159045">Auction rate securities [Member]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6003.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesAmortizedCost.6003.11.6" xlink:to="lab_AvailableForSaleSecuritiesAmortizedCost.1331" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesAmortizedCost.1331" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesAmortizedCost.1331">Available-for-sale Securities, Amortized Cost Basis</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6003.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesAmortizedCost.6003.11.7" xlink:to="lab_AvailableForSaleSecuritiesAmortizedCost.145893" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesAmortizedCost.145893" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesAmortizedCost.145893">Amortized Cost</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueDisclosure" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.11.9" xlink:to="lab_AvailableForSaleSecuritiesFairValueDisclosure9.160431" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesFairValueDisclosure9.160431" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesFairValueDisclosure9.160431">Fair Value</link:label>
    <link:loc xlink:label="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.11.6" xlink:to="lab_AvailableforsaleSecuritiesGrossUnrealizedGain.309" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableforsaleSecuritiesGrossUnrealizedGain.309" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableforsaleSecuritiesGrossUnrealizedGain.309">Available-for-sale Securities, Gross Unrealized Gains</link:label>
    <link:loc xlink:label="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.11.7" xlink:to="lab_AvailableforsaleSecuritiesGrossUnrealizedGain.145894" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableforsaleSecuritiesGrossUnrealizedGain.145894" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableforsaleSecuritiesGrossUnrealizedGain.145894">Gross Unrealized Gains</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.11.6" xlink:to="lab_AvailableForSaleSecuritiesGrossUnrealizedLosses1.1304" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesGrossUnrealizedLosses1.1304" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesGrossUnrealizedLosses1.1304">Available-for-sale Securities, Gross Unrealized Losses</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.11.7" xlink:to="lab_AvailableForSaleSecuritiesGrossUnrealizedLosses1.159773" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesGrossUnrealizedLosses1.159773" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesGrossUnrealizedLosses1.159773">Gross Unrealized Losses</link:label>
    <link:loc xlink:label="loc_CorporateDebtSecuritiesMember.1180.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CorporateDebtSecuritiesMember.1180.11.6" xlink:to="lab_CorporateDebtSecuritiesMember.3145" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CorporateDebtSecuritiesMember.3145" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CorporateDebtSecuritiesMember.3145">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:label="loc_CorporateDebtSecuritiesMember.1180.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CorporateDebtSecuritiesMember.1180.11.7" xlink:to="lab_CorporateDebtSecuritiesMember7.159046" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CorporateDebtSecuritiesMember7.159046" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CorporateDebtSecuritiesMember7.159046">Corporate debt securities [Member]</link:label>
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.11.6" xlink:to="lab_MajorTypesOfDebtAndEquitySecuritiesAxis.11217" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MajorTypesOfDebtAndEquitySecuritiesAxis.11217" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MajorTypesOfDebtAndEquitySecuritiesAxis.11217">Major Types of Debt and Equity Securities [Axis]</link:label>
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.11.6" xlink:to="lab_MajorTypesOfDebtAndEquitySecuritiesDomain.11220" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MajorTypesOfDebtAndEquitySecuritiesDomain.11220" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MajorTypesOfDebtAndEquitySecuritiesDomain.11220">Major Types of Debt and Equity Securities [Domain]</link:label>
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.11.6" xlink:to="lab_ScheduleOfAvailableForSaleSecuritiesLineItems.16695" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfAvailableForSaleSecuritiesLineItems.16695" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfAvailableForSaleSecuritiesLineItems.16695">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.11.6" xlink:to="lab_ScheduleOfAvailableForSaleSecuritiesTable.16599" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfAvailableForSaleSecuritiesTable.16599" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfAvailableForSaleSecuritiesTable.16599">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.11.6" xlink:to="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.5607" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.5607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.5607">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.11.7" xlink:to="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.160206" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.160206" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.160206">Unrecognized compensation expense</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.11.6" xlink:to="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.5594" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.5594" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.5594">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.11.7" xlink:to="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.160218" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.160218" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.160218">Unrecognized compensation expense, recognition period</link:label>
    <link:loc xlink:label="loc_OneNineNineFiveStockOptionPlanMember.24508.11.6" xlink:href="nvax-20120930.xsd#nvax_OneNineNineFiveStockOptionPlanMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OneNineNineFiveStockOptionPlanMember.24508.11.6" xlink:to="lab_OneNineNineFiveStockOptionPlanMember.159059" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OneNineNineFiveStockOptionPlanMember.159059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OneNineNineFiveStockOptionPlanMember.159059">One Nine Nine Five Stock Option Plan [Member]</link:label>
    <link:loc xlink:label="loc_OneNineNineFiveStockOptionPlanMember.24508.11.12" xlink:href="nvax-20120930.xsd#nvax_OneNineNineFiveStockOptionPlanMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OneNineNineFiveStockOptionPlanMember.24508.11.12" xlink:to="lab_OneNineNineFiveStockOptionPlanMember.159062" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OneNineNineFiveStockOptionPlanMember.159062" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OneNineNineFiveStockOptionPlanMember.159062">1995 Stock Option Plan [Member]</link:label>
    <link:loc xlink:label="loc_OneNineNineFiveStockOptionPlanMember.24508.11.7" xlink:href="nvax-20120930.xsd#nvax_OneNineNineFiveStockOptionPlanMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OneNineNineFiveStockOptionPlanMember.24508.11.7" xlink:to="lab_OneNineNineFiveStockOptionPlanMember7.159063" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OneNineNineFiveStockOptionPlanMember7.159063" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OneNineNineFiveStockOptionPlanMember7.159063">1995 Stock Option Plan [Member]</link:label>
    <link:loc xlink:label="loc_PlanNameAxis.3871.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PlanNameAxis.3871.11.6" xlink:to="lab_PlanNameAxis.13737" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PlanNameAxis.13737" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PlanNameAxis.13737">Plan Name [Axis]</link:label>
    <link:loc xlink:label="loc_PlanNameDomain.3870.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PlanNameDomain.3870.11.6" xlink:to="lab_PlanNameDomain.13729" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PlanNameDomain.13729" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PlanNameDomain.13729">Plan Name [Domain]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.17523" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.17523" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.17523">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.135582" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.135582" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.135582">Common stock reserved for issuance</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15602.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15602.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.16359" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.16359" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.16359">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15608.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15608.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.16365" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.16365" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.16365">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15608.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15608.11.7" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.159449" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.159449" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.159449">Weighted-average remaining contractual term of stock options exercisable</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.11.6" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.159434" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.159434" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.159434">Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Period From Date Of Grant</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.11.12" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.11.12" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.159442" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.159442" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.159442">Period of time incentive stock options are exercisable, from the date of grant.</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.11.7" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant7.159443" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant7.159443" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant7.159443">Exercise period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.16330.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.16330.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.17514" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.17514" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.17514">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.16330.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.16330.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.159451" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.159451" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.159451">Aggregate intrinsic value of stock options exercised</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.11.6" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.159413" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.159413" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.159413">Share Based Compensation Arrangement By Share Based Payment Award Options Grant Date Exercise Price Minimum Percent</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.11.12" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.11.12" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateSalePriceMinimumPercent.159429" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateSalePriceMinimumPercent.159429" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateSalePriceMinimumPercent.159429">The minimum grant-date exercise price of incentive stock options granted as a percent of the common stock share price.</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.11.7" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateSalePriceMinimumPercent7.159432" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateSalePriceMinimumPercent7.159432" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateSalePriceMinimumPercent7.159432">Minimum grant price, percent of common stock fair value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.11.6" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.159336" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.159336" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.159336">Share Based Compensation Arrangement By Share Based Payment Award Options Maximum Term</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.11.12" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.11.12" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.159409" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.159409" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.159409">Maximum term of incentive stock options.</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.11.7" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm7.159412" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm7.159412" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm7.159412">Maximum term of options</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16357.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16357.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.17557" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.17557" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.17557">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16357.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16357.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.159445" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.159445" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.159445">Aggregate intrinsic value of stock options outstanding</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15611.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15611.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.16368" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.16368" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.16368">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15611.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15611.11.7" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.159446" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.159446" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.159446">Weighted-average remaining contractual term of stock options outstanding</link:label>
    <link:loc xlink:label="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.11.6" xlink:href="nvax-20120930.xsd#nvax_TwoZeroZeroFiveStockIncentivePlanMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.11.6" xlink:to="lab_TwoZeroZeroFiveStockIncentivePlanMember.159049" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TwoZeroZeroFiveStockIncentivePlanMember.159049" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TwoZeroZeroFiveStockIncentivePlanMember.159049">Two Zero Zero Five Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:label="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.11.12" xlink:href="nvax-20120930.xsd#nvax_TwoZeroZeroFiveStockIncentivePlanMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.11.12" xlink:to="lab_TwoZeroZeroFiveStockIncentivePlanMember.159055" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TwoZeroZeroFiveStockIncentivePlanMember.159055" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TwoZeroZeroFiveStockIncentivePlanMember.159055">2005 Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:label="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.11.7" xlink:href="nvax-20120930.xsd#nvax_TwoZeroZeroFiveStockIncentivePlanMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.11.7" xlink:to="lab_TwoZeroZeroFiveStockIncentivePlanMember7.159057" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TwoZeroZeroFiveStockIncentivePlanMember7.159057" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TwoZeroZeroFiveStockIncentivePlanMember7.159057">2005 Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15602.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15602.11.7" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.159447" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.159447" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.159447">Aggregate intrinsic value of stock options exercisable</link:label>
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5724.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AllocatedShareBasedCompensationExpense.5724.11.6" xlink:to="lab_AllocatedShareBasedCompensationExpense.852" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AllocatedShareBasedCompensationExpense.852" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AllocatedShareBasedCompensationExpense.852">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5724.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AllocatedShareBasedCompensationExpense.5724.11.7" xlink:to="lab_AllocatedShareBasedCompensationExpense7.159040" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AllocatedShareBasedCompensationExpense7.159040" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AllocatedShareBasedCompensationExpense7.159040">Stock-based compensation expense</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.11.6" xlink:to="lab_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.5595" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.5595" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.5595">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.11.6" xlink:to="lab_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.5604" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.5604" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.5604">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2354.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpenseMember.2354.11.6" xlink:to="lab_GeneralAndAdministrativeExpenseMember.7876" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GeneralAndAdministrativeExpenseMember.7876" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GeneralAndAdministrativeExpenseMember.7876">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2354.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpenseMember.2354.11.7" xlink:to="lab_GeneralAndAdministrativeExpenseMember7.159042" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GeneralAndAdministrativeExpenseMember7.159042" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GeneralAndAdministrativeExpenseMember7.159042">General and administrative [Member]</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4381.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpenseMember.4381.11.6" xlink:to="lab_ResearchAndDevelopmentExpenseMember.15885" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpenseMember.15885" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpenseMember.15885">Research and Development Expense [Member]</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4381.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpenseMember.4381.11.7" xlink:to="lab_ResearchAndDevelopmentExpenseMember7.159041" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpenseMember7.159041" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpenseMember7.159041">Research and development [Member]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.11.6" xlink:to="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.16736" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.16736" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.16736">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.11.6" xlink:to="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.16738" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.16738" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.16738">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.17518" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.17518" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.17518">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.11.8" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.160437" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.160437" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.160437">Shares available for grant at September 30, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16332.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16332.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.17517" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.17517" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.17517">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16332.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16332.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.159097" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.159097" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.159097">Shares exercisable at September 30, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16322.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16322.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.17506" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.17506" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.17506">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16322.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16322.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.134209" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.134209" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.134209">Options exercisable, September 30, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16342.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16342.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.17531" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.17531" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.17531">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16342.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16342.11.42" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.159074" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.159074" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.159074">Canceled</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.17448" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.17448" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.17448">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.134193" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.134193" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.134193">Granted</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.17577" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.17577" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.17577">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.11.10" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.159077" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.159077" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.159077">Outstanding at January 1, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.159082" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.159082" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.159082">Outstanding at September 30, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.17522" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.17522" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.17522">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward7.134217" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward7.134217" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward7.134217">Number of Shares</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.17554" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.17554" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.17554">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.11.10" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.159079" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.159079" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.159079">Outstanding at January 1, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.159083" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.159083" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.159083">Outstanding at September 30, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.17430" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.17430" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.17430">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.173668" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.173668" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.173668">Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16305.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16305.11.6" xlink:to="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.17487" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.17487" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.17487">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16305.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16305.11.7" xlink:to="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.134206" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.134206" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.134206">Exercised</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.16248.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.16248.11.6" xlink:to="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.17409" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.17409" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.17409">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.16248.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.16248.11.7" xlink:to="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.159076" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.159076" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.159076">Canceled</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.16298.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.16298.11.6" xlink:to="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.17479" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.17479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.17479">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.16298.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.16298.11.7" xlink:to="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.134205" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.134205" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.134205">Granted</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16634.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16634.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.17984" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.17984" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.17984">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16634.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16634.11.42" xlink:to="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.159072" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.159072" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.159072">Exercised</link:label>
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.11.6" xlink:to="lab_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.158734" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.158734" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.158734">Stock-Based Compensation [Abstract]</link:label>
    <link:loc xlink:label="loc_MaximumMember.3241.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumMember.3241.11.6" xlink:to="lab_MaximumMember.11410" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MaximumMember.11410" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MaximumMember.11410">Maximum [Member]</link:label>
    <link:loc xlink:label="loc_MaximumMember.3241.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumMember.3241.11.7" xlink:to="lab_MaximumMember.149646" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MaximumMember.149646" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MaximumMember.149646">Maximum [Member]</link:label>
    <link:loc xlink:label="loc_MinimumMember.3248.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MinimumMember.3248.11.6" xlink:to="lab_MinimumMember.11450" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MinimumMember.11450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MinimumMember.11450">Minimum [Member]</link:label>
    <link:loc xlink:label="loc_MinimumMember.3248.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MinimumMember.3248.11.7" xlink:to="lab_MinimumMember.147963" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MinimumMember.147963" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MinimumMember.147963">Minimum [Member]</link:label>
    <link:loc xlink:label="loc_RangeAxis.4187.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeAxis.4187.11.6" xlink:to="lab_RangeAxis.15198" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RangeAxis.15198" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RangeAxis.15198">Range [Axis]</link:label>
    <link:loc xlink:label="loc_RangeAxis.4187.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeAxis.4187.11.7" xlink:to="lab_RangeAxis.147959" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RangeAxis.147959" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RangeAxis.147959">Range [Axis]</link:label>
    <link:loc xlink:label="loc_RangeMember.4188.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeMember.4188.11.6" xlink:to="lab_RangeMember.15199" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RangeMember.15199" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RangeMember.15199">Range [Domain]</link:label>
    <link:loc xlink:label="loc_RangeMember.4188.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeMember.4188.11.7" xlink:to="lab_RangeMember.147960" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RangeMember.147960" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RangeMember.147960">Range [Domain]</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.11.6" xlink:to="lab_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.16890" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.16890" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.16890">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.11.7" xlink:to="lab_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.154696" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.154696" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.154696">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.16324.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.16324.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.17508" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.17508" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.17508">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.16324.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.16324.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.134186" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.134186" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.134186">Dividend yield</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.11.6" xlink:href="nvax-20120930.xsd#nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.159127" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.159127" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.159127">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.11.12" xlink:href="nvax-20120930.xsd#nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.11.12" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.159135" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.159135" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.159135">Estimated rate of forfeitures.</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.11.7" xlink:href="nvax-20120930.xsd#nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.11.7" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate7.159138" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate7.159138" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate7.159138">Expected forfeiture rate</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.15604.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.15604.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.16361" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.16361" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.16361">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.15604.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.15604.11.7" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm17.159146" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm17.159146" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm17.159146">Expected term (in years)</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.16318.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.16318.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.17502" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.17502" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.17502">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.16318.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.16318.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.134184" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.134184" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.134184">Volatility</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.16251.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.16251.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.17412" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.17412" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.17412">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.16251.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.16251.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.141993" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.141993" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.141993">Volatility, maximum</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.16254.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.16254.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.17415" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.17415" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.17415">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.16254.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.16254.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.141992" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.141992" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.141992">Volatility, minimum</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.16317.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.16317.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.17501" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.17501" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.17501">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.16317.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.16317.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.159144" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.159144" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.159144">Risk-free interest rate</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.16273.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.16273.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.17444" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.17444" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.17444">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.16273.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.16273.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.141988" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.141988" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.141988">Risk-free interest rate, maximum</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.16304.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.16304.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.17486" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.17486" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.17486">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.16304.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.16304.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.141986" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.141986" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.141986">Risk-free interest rate, minimum</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.17450" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.17450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.17450">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16329.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16329.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.17513" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.17513" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.17513">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16329.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16329.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.159140" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.159140" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.159140">Weighted-average fair value of stock options granted</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16252.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16252.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.17413" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.17413" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.17413">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16252.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16252.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.159176" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.159176" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.159176">Restricted stock forfeited</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.16290.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.16290.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.17469" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.17469" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.17469">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.16290.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.16290.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.160309" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.160309" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.160309">Restricted stock forfeited</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16300.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16300.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.17481" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.17481" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.17481">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16300.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16300.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.159170" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.159170" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.159170">Restricted stock granted</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16250.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16250.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.17411" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.17411" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.17411">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16250.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16250.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.159171" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.159171" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.159171">Restricted stock granted</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.17456" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.17456" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.17456">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.159177" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.159177" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.159177">Outstanding at September 30, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.11.10" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.159168" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.159168" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.159168">Outstanding at January 1, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.17399" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.17399" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.17399">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward7.134167" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward7.134167" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward7.134167">Number of Shares</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.17416" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.17416" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.17416">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.11.10" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.159169" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.159169" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.159169">Outstanding at January 1, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.159178" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.159178" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.159178">Outstanding at September 30, 2012</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.17446" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.17446" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.17446">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.159179" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.159179" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.159179">Per Share Weighted-Average Grant-Date Fair Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16286.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16286.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.17464" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.17464" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.17464">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16286.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16286.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.159174" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.159174" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.159174">Restricted stock vested</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.16328.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.16328.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.17512" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.17512" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.17512">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.16328.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.16328.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.159173" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.159173" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.159173">Restricted stock vested</link:label>
    <link:loc xlink:label="loc_ClinicalTrialCostsIncurred.27100.11.6" xlink:href="nvax-20120930.xsd#nvax_ClinicalTrialCostsIncurred" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClinicalTrialCostsIncurred.27100.11.6" xlink:to="lab_ClinicalTrialCostsIncurred.174154" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClinicalTrialCostsIncurred.174154" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClinicalTrialCostsIncurred.174154">Clinical Trial Costs Incurred</link:label>
    <link:loc xlink:label="loc_ClinicalTrialCostsIncurred.27100.11.12" xlink:href="nvax-20120930.xsd#nvax_ClinicalTrialCostsIncurred" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClinicalTrialCostsIncurred.27100.11.12" xlink:to="lab_ClinicalTrialCostsIncurred.174663" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClinicalTrialCostsIncurred.174663" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ClinicalTrialCostsIncurred.174663">Total clinical trial costs incurred.</link:label>
    <link:loc xlink:label="loc_ClinicalTrialCostsIncurred.27100.11.7" xlink:href="nvax-20120930.xsd#nvax_ClinicalTrialCostsIncurred" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClinicalTrialCostsIncurred.27100.11.7" xlink:to="lab_ClinicalTrialCostsIncurred7.174155" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClinicalTrialCostsIncurred7.174155" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClinicalTrialCostsIncurred7.174155">Trial costs incurred</link:label>
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.11.6" xlink:to="lab_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.2624" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.2624" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.2624">Collaborative Arrangements and Non-collaborative Arrangements [Axis]</link:label>
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.11.6" xlink:to="lab_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.2609" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.2609" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.2609">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</link:label>
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.11.6" xlink:to="lab_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.2617" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.2617" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.2617">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Domain]</link:label>
    <link:loc xlink:label="loc_ContractTerm.24751.11.6" xlink:href="nvax-20120930.xsd#nvax_ContractTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ContractTerm.24751.11.6" xlink:to="lab_ContractTerm.160359" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ContractTerm.160359" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ContractTerm.160359">Contract Term</link:label>
    <link:loc xlink:label="loc_ContractTerm.24751.11.12" xlink:href="nvax-20120930.xsd#nvax_ContractTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ContractTerm.24751.11.12" xlink:to="lab_ContractTerm.160368" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ContractTerm.160368" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ContractTerm.160368">Contract Term</link:label>
    <link:loc xlink:label="loc_ContractTerm.24751.11.7" xlink:href="nvax-20120930.xsd#nvax_ContractTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ContractTerm.24751.11.7" xlink:to="lab_ContractTerm7.160369" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ContractTerm7.160369" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ContractTerm7.160369">Contract term</link:label>
    <link:loc xlink:label="loc_ExpectedClinicalTrialCosts.24616.11.6" xlink:href="nvax-20120930.xsd#nvax_ExpectedClinicalTrialCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExpectedClinicalTrialCosts.24616.11.6" xlink:to="lab_ExpectedClinicalTrialCosts.159534" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExpectedClinicalTrialCosts.159534" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ExpectedClinicalTrialCosts.159534">Expected Clinical Trial Costs</link:label>
    <link:loc xlink:label="loc_ExpectedClinicalTrialCosts.24616.11.12" xlink:href="nvax-20120930.xsd#nvax_ExpectedClinicalTrialCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExpectedClinicalTrialCosts.24616.11.12" xlink:to="lab_ExpectedClinicalTrialCosts.159537" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExpectedClinicalTrialCosts.159537" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ExpectedClinicalTrialCosts.159537">Total expected clinical trial costs.</link:label>
    <link:loc xlink:label="loc_GovernmentContractReceivable.10340.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GovernmentContractReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentContractReceivable.10340.11.6" xlink:to="lab_GovernmentContractReceivable.7961" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GovernmentContractReceivable.7961" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GovernmentContractReceivable.7961">Government Contract Receivable</link:label>
    <link:loc xlink:label="loc_GovernmentContractReceivable.10340.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GovernmentContractReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentContractReceivable.10340.11.7" xlink:to="lab_GovernmentContractReceivable7.159497" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GovernmentContractReceivable7.159497" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GovernmentContractReceivable7.159497">Contract receivable</link:label>
    <link:loc xlink:label="loc_HhsBardaContractAwardMember.24606.11.6" xlink:href="nvax-20120930.xsd#nvax_HhsBardaContractAwardMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_HhsBardaContractAwardMember.24606.11.6" xlink:to="lab_HhsBardaContractAwardMember.159498" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_HhsBardaContractAwardMember.159498" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_HhsBardaContractAwardMember.159498">Hhs Barda Contract Award [Member]</link:label>
    <link:loc xlink:label="loc_HhsBardaContractAwardMember.24606.11.12" xlink:href="nvax-20120930.xsd#nvax_HhsBardaContractAwardMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_HhsBardaContractAwardMember.24606.11.12" xlink:to="lab_HhsBardaContractAwardMember.159499" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_HhsBardaContractAwardMember.159499" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_HhsBardaContractAwardMember.159499">HHS BARDA Contract Award [Member]</link:label>
    <link:loc xlink:label="loc_HhsBardaContractAwardMember.24606.11.7" xlink:href="nvax-20120930.xsd#nvax_HhsBardaContractAwardMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_HhsBardaContractAwardMember.24606.11.7" xlink:to="lab_HhsBardaContractAwardMember7.159500" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_HhsBardaContractAwardMember7.159500" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_HhsBardaContractAwardMember7.159500">HHS BARDA Contract Award [Member]</link:label>
    <link:loc xlink:label="loc_HhsBardaOptionForAdditionalPeriodMember.24607.11.6" xlink:href="nvax-20120930.xsd#nvax_HhsBardaOptionForAdditionalPeriodMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_HhsBardaOptionForAdditionalPeriodMember.24607.11.6" xlink:to="lab_HhsBardaOptionForAdditionalPeriodMember.159501" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_HhsBardaOptionForAdditionalPeriodMember.159501" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_HhsBardaOptionForAdditionalPeriodMember.159501">Hhs Barda Option For Additional Period [Member]</link:label>
    <link:loc xlink:label="loc_HhsBardaOptionForAdditionalPeriodMember.24607.11.12" xlink:href="nvax-20120930.xsd#nvax_HhsBardaOptionForAdditionalPeriodMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_HhsBardaOptionForAdditionalPeriodMember.24607.11.12" xlink:to="lab_HhsBardaOptionForAdditionalPeriodMember.159504" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_HhsBardaOptionForAdditionalPeriodMember.159504" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_HhsBardaOptionForAdditionalPeriodMember.159504">HHS Barda Option For Additional Period [Member]</link:label>
    <link:loc xlink:label="loc_HhsBardaOptionForAdditionalPeriodMember.24607.11.7" xlink:href="nvax-20120930.xsd#nvax_HhsBardaOptionForAdditionalPeriodMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_HhsBardaOptionForAdditionalPeriodMember.24607.11.7" xlink:to="lab_HhsBardaOptionForAdditionalPeriodMember7.159508" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_HhsBardaOptionForAdditionalPeriodMember7.159508" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_HhsBardaOptionForAdditionalPeriodMember7.159508">HHS BARDA Option for Additional Period [Member]</link:label>
    <link:loc xlink:label="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.11.6" xlink:href="nvax-20120930.xsd#nvax_LicenseAgreementWithLgLifeSciencesLtdMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.11.6" xlink:to="lab_LicenseAgreementWithLgLifeSciencesLtdMember.159514" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LicenseAgreementWithLgLifeSciencesLtdMember.159514" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LicenseAgreementWithLgLifeSciencesLtdMember.159514">License Agreement With Lg Life Sciences Ltd [Member]</link:label>
    <link:loc xlink:label="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.11.12" xlink:href="nvax-20120930.xsd#nvax_LicenseAgreementWithLgLifeSciencesLtdMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.11.12" xlink:to="lab_LicenseAgreementWithLgLifeSciencesLtdMember.159515" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LicenseAgreementWithLgLifeSciencesLtdMember.159515" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LicenseAgreementWithLgLifeSciencesLtdMember.159515">License Agreement with LG Life Sciences, Ltd. [Member]</link:label>
    <link:loc xlink:label="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.11.7" xlink:href="nvax-20120930.xsd#nvax_LicenseAgreementWithLgLifeSciencesLtdMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.11.7" xlink:to="lab_LicenseAgreementWithLgLifeSciencesLtdMember7.159516" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LicenseAgreementWithLgLifeSciencesLtdMember7.159516" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LicenseAgreementWithLgLifeSciencesLtdMember7.159516">License Agreement with LG Life Sciences, Ltd. [Member]</link:label>
    <link:loc xlink:label="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.11.7" xlink:href="nvax-20120930.xsd#nvax_RoyaltyPaymentsPercentOfFutureProductSales" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.11.7" xlink:to="lab_MilestonesAndRoyaltyPaymentsPercentOfFutureProductSales7.159560" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MilestonesAndRoyaltyPaymentsPercentOfFutureProductSales7.159560" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MilestonesAndRoyaltyPaymentsPercentOfFutureProductSales7.159560">Royalty payments, percent</link:label>
    <link:loc xlink:label="loc_PathVaccineSolutionsMember.24610.11.6" xlink:href="nvax-20120930.xsd#nvax_PathVaccineSolutionsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PathVaccineSolutionsMember.24610.11.6" xlink:to="lab_PathVaccineSolutionsMember.159517" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PathVaccineSolutionsMember.159517" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PathVaccineSolutionsMember.159517">Path Vaccine Solutions [Member]</link:label>
    <link:loc xlink:label="loc_PathVaccineSolutionsMember.24610.11.12" xlink:href="nvax-20120930.xsd#nvax_PathVaccineSolutionsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PathVaccineSolutionsMember.24610.11.12" xlink:to="lab_PathVaccineSolutionsMember.159520" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PathVaccineSolutionsMember.159520" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_PathVaccineSolutionsMember.159520">PATH Vaccine Solutions [Member]</link:label>
    <link:loc xlink:label="loc_PathVaccineSolutionsMember.24610.11.7" xlink:href="nvax-20120930.xsd#nvax_PathVaccineSolutionsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PathVaccineSolutionsMember.24610.11.7" xlink:to="lab_PathVaccineSolutionsMember7.159521" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PathVaccineSolutionsMember7.159521" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PathVaccineSolutionsMember7.159521">PATH Vaccine Solutions [Member]</link:label>
    <link:loc xlink:label="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.11.6" xlink:href="nvax-20120930.xsd#nvax_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.11.6" xlink:to="lab_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.159561" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.159561" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.159561">Potential Provided Funding Of External Clinical Development Costs Percent</link:label>
    <link:loc xlink:label="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.11.12" xlink:href="nvax-20120930.xsd#nvax_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.11.12" xlink:to="lab_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.174153" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.174153" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.174153">The precentage of potential provided fuding of external clinical development costs.</link:label>
    <link:loc xlink:label="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.11.7" xlink:href="nvax-20120930.xsd#nvax_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.11.7" xlink:to="lab_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent7.159566" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent7.159566" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent7.159566">Potential funding of external clinical development costs</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15308.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15308.11.6" xlink:to="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15900" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15900" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15900">Research and Development Arrangement with Federal Government, Costs Incurred, Net</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15308.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15308.11.7" xlink:to="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.159530" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.159530" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.159530">Trial costs incurred</link:label>
    <link:loc xlink:label="loc_ExpectedClinicalTrialCosts.24616.11.7" xlink:href="nvax-20120930.xsd#nvax_ExpectedClinicalTrialCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExpectedClinicalTrialCosts.24616.11.7" xlink:to="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentTotalExpectedCosts7.159540" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentTotalExpectedCosts7.159540" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentTotalExpectedCosts7.159540">Expected costs</link:label>
    <link:loc xlink:label="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.11.6" xlink:href="nvax-20120930.xsd#nvax_RoyaltyPaymentsPercentOfFutureProductSales" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.11.6" xlink:to="lab_RoyaltyPaymentsPercentOfFutureProductSales.159552" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyPaymentsPercentOfFutureProductSales.159552" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyPaymentsPercentOfFutureProductSales.159552">Royalty Payments Percent Of Future Product Sales</link:label>
    <link:loc xlink:label="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.11.12" xlink:href="nvax-20120930.xsd#nvax_RoyaltyPaymentsPercentOfFutureProductSales" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.11.12" xlink:to="lab_RoyaltyPaymentsPercentOfFutureProductSales.159559" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyPaymentsPercentOfFutureProductSales.159559" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyPaymentsPercentOfFutureProductSales.159559">Royalty payments as a percent of future product sales.</link:label>
    <link:loc xlink:label="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.11.6" xlink:to="lab_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.16712" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.16712" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.16712">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</link:label>
    <link:loc xlink:label="loc_UpfrontLicensePayment.24620.11.6" xlink:href="nvax-20120930.xsd#nvax_UpfrontLicensePayment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UpfrontLicensePayment.24620.11.6" xlink:to="lab_UpfrontLicensePayment.159544" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UpfrontLicensePayment.159544" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_UpfrontLicensePayment.159544">Upfront License Payment</link:label>
    <link:loc xlink:label="loc_UpfrontLicensePayment.24620.11.12" xlink:href="nvax-20120930.xsd#nvax_UpfrontLicensePayment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UpfrontLicensePayment.24620.11.12" xlink:to="lab_UpfrontLicensePayment.159547" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UpfrontLicensePayment.159547" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_UpfrontLicensePayment.159547">Upfront License Payment</link:label>
    <link:loc xlink:label="loc_UpfrontLicensePayment.24620.11.7" xlink:href="nvax-20120930.xsd#nvax_UpfrontLicensePayment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UpfrontLicensePayment.24620.11.7" xlink:to="lab_UpfrontLicensePayment7.159549" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UpfrontLicensePayment7.159549" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_UpfrontLicensePayment7.159549">Upfront license payment</link:label>
    <link:loc xlink:label="loc_CapitalLeasePeriodicPayment.24633.11.6" xlink:href="nvax-20120930.xsd#nvax_CapitalLeasePeriodicPayment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasePeriodicPayment.24633.11.6" xlink:to="lab_CapitalLeasePeriodicPayment.159588" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasePeriodicPayment.159588" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasePeriodicPayment.159588">Capital Lease Periodic Payment</link:label>
    <link:loc xlink:label="loc_CapitalLeasePeriodicPayment.24633.11.7" xlink:href="nvax-20120930.xsd#nvax_CapitalLeasePeriodicPayment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasePeriodicPayment.24633.11.7" xlink:to="lab_CapitalLeasePeriodicPayment7.159589" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasePeriodicPayment7.159589" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasePeriodicPayment7.159589">Monthly lease payments</link:label>
    <link:loc xlink:label="loc_LeaseTerm.24635.11.7" xlink:href="nvax-20120930.xsd#nvax_LeaseTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseTerm.24635.11.7" xlink:to="lab_CapitalLeasePeriodicPaymentExtended967.159595" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasePeriodicPaymentExtended967.159595" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasePeriodicPaymentExtended967.159595">Lease term</link:label>
    <link:loc xlink:label="loc_CapitalLeasesOfLesseeEffectiveInterestRate.24630.11.6" xlink:href="nvax-20120930.xsd#nvax_CapitalLeasesOfLesseeEffectiveInterestRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesOfLesseeEffectiveInterestRate.24630.11.6" xlink:to="lab_CapitalLeasesOfLesseeEffectiveInterestRate.159577" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesOfLesseeEffectiveInterestRate.159577" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesOfLesseeEffectiveInterestRate.159577">Capital Leases Of Lessee Effective Interest Rate</link:label>
    <link:loc xlink:label="loc_CapitalLeasesOfLesseeEffectiveInterestRate.24630.11.12" xlink:href="nvax-20120930.xsd#nvax_CapitalLeasesOfLesseeEffectiveInterestRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesOfLesseeEffectiveInterestRate.24630.11.12" xlink:to="lab_CapitalLeasesOfLesseeEffectiveInterestRate.159583" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesOfLesseeEffectiveInterestRate.159583" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesOfLesseeEffectiveInterestRate.159583">Effective interest rate of capital lease.</link:label>
    <link:loc xlink:label="loc_CapitalLeasesOfLesseeEffectiveInterestRate.24630.11.7" xlink:href="nvax-20120930.xsd#nvax_CapitalLeasesOfLesseeEffectiveInterestRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesOfLesseeEffectiveInterestRate.24630.11.7" xlink:to="lab_CapitalLeasesOfLesseeEffectiveInterestRate7.159585" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesOfLesseeEffectiveInterestRate7.159585" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesOfLesseeEffectiveInterestRate7.159585">Effective interest rate on capital lease</link:label>
    <link:loc xlink:label="loc_LeaseTerm.24635.11.6" xlink:href="nvax-20120930.xsd#nvax_LeaseTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseTerm.24635.11.6" xlink:to="lab_LeaseTerm.159592" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeaseTerm.159592" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LeaseTerm.159592">Lease Term</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationsCurrent.6437.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationsCurrent.6437.11.6" xlink:to="lab_CapitalLeaseObligationsCurrent.1990" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationsCurrent.1990" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationsCurrent.1990">Capital Lease Obligations, Current</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationsCurrent.6437.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationsCurrent.6437.11.42" xlink:to="lab_CapitalLeaseObligationsCurrent42.159243" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationsCurrent42.159243" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationsCurrent42.159243">Less - current portion of capital lease</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationsNoncurrent.6438.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationsNoncurrent.6438.11.6" xlink:to="lab_CapitalLeaseObligationsNoncurrent.1991" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationsNoncurrent.1991" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationsNoncurrent.1991">Capital Lease Obligations, Noncurrent</link:label>
    <link:loc xlink:label="loc_CapitalLeaseObligationsNoncurrent.6438.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeaseObligationsNoncurrent.6438.11.8" xlink:to="lab_CapitalLeaseObligationsNoncurrent8.159254" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeaseObligationsNoncurrent8.159254" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeaseObligationsNoncurrent8.159254">Non-current portion of capital lease</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.11.6" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDue.1898" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDue.1898" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDue.1898">Capital Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.11.9" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDue.159230" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDue.159230" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDue.159230">Total</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.6384.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.6384.11.6" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.1904" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.1904" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.1904">Capital Leases, Future Minimum Payments, Due in Rolling after Year Five</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.6384.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.6384.11.7" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.159218" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.159218" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.159218">2017</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.6421.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.6421.11.6" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.1963" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.1963" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.1963">Capital Leases, Future Minimum Payments, Due in Rolling Year Five</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.6421.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.6421.11.7" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.159217" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.159217" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.159217">2016</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.6391.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.6391.11.6" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.1915" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.1915" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.1915">Capital Leases, Future Minimum Payments, Due in Rolling Year Four</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.6391.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.6391.11.7" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.159215" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.159215" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.159215">2015</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.6416.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.6416.11.6" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.1953" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.1953" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.1953">Capital Leases, Future Minimum Payments, Due in Rolling Year Three</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.6416.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.6416.11.7" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.159213" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.159213" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.159213">2014</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.6428.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.6428.11.6" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.1972" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.1972" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.1972">Capital Leases, Future Minimum Payments, Due in Rolling Year Two</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.6428.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.6428.11.7" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.159212" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.159212" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.159212">2013</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.6439.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.6439.11.6" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.1992" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.1992" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.1992">Capital Leases, Future Minimum Payments, Interest Included in Payments</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.6439.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.6439.11.42" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments42.159234" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments42.159234" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments42.159234">Less - amounts representing interest</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.6375.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.6375.11.6" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.1888" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.1888" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.1888">Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.6375.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.6375.11.9" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.159237" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.159237" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.159237">Present value of net minimum lease payments</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.6415.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.6415.11.6" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.1950" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.1950" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.1950">Capital Leases, Future Minimum Payments, Remainder of Fiscal year</link:label>
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.6415.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.6415.11.7" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.159211" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.159211" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.159211">2012</link:label>
    <link:loc xlink:label="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.11.6" xlink:to="lab_DebtInstrumentBasisSpreadOnVariableRate.3585" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentBasisSpreadOnVariableRate.3585" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentBasisSpreadOnVariableRate.3585">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:label="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.11.7" xlink:to="lab_DebtInstrumentBasisSpreadOnVariableRate.159639" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentBasisSpreadOnVariableRate.159639" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentBasisSpreadOnVariableRate.159639">Interest rate in addition to three-year U.S. Government treasury rate</link:label>
    <link:loc xlink:label="loc_DebtInstrumentFaceAmount.7427.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentFaceAmount.7427.11.6" xlink:to="lab_DebtInstrumentFaceAmount.3599" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentFaceAmount.3599" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentFaceAmount.3599">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:label="loc_DebtInstrumentFaceAmount.7427.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentFaceAmount.7427.11.7" xlink:to="lab_DebtInstrumentFaceAmount.159637" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentFaceAmount.159637" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentFaceAmount.159637">Borrowing limit of loan</link:label>
    <link:loc xlink:label="loc_DebtInstrumentIncreaseAdditionalBorrowings.7460.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentIncreaseAdditionalBorrowings" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentIncreaseAdditionalBorrowings.7460.11.6" xlink:to="lab_DebtInstrumentIncreaseAdditionalBorrowings.3636" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentIncreaseAdditionalBorrowings.3636" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentIncreaseAdditionalBorrowings.3636">Debt Instrument, Increase, Additional Borrowings</link:label>
    <link:loc xlink:label="loc_DebtInstrumentIncreaseAdditionalBorrowings.7460.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentIncreaseAdditionalBorrowings" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentIncreaseAdditionalBorrowings.7460.11.7" xlink:to="lab_DebtInstrumentIncreaseAdditionalBorrowings.137218" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentIncreaseAdditionalBorrowings.137218" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentIncreaseAdditionalBorrowings.137218">Debt instrument, increase in borrowings</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateDuringPeriod.7486.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateDuringPeriod.7486.11.6" xlink:to="lab_DebtInstrumentInterestRateDuringPeriod.3669" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateDuringPeriod.3669" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateDuringPeriod.3669">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateDuringPeriod.7486.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateDuringPeriod.7486.11.7" xlink:to="lab_DebtInstrumentInterestRateDuringPeriod.159642" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateDuringPeriod.159642" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateDuringPeriod.159642">Interest rate during period</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.7452.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.7452.11.6" xlink:to="lab_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.3627" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.3627" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.3627">Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.7452.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.7452.11.7" xlink:to="lab_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.159640" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.159640" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.159640">Minimum interest rate</link:label>
    <link:loc xlink:label="loc_DebtInstrumentPeriodicPayment.7459.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentPeriodicPayment.7459.11.6" xlink:to="lab_DebtInstrumentPeriodicPayment.3635" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentPeriodicPayment.3635" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentPeriodicPayment.3635">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:label="loc_DebtInstrumentPeriodicPayment.7459.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentPeriodicPayment.7459.11.7" xlink:to="lab_DebtInstrumentPeriodicPayment.159643" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentPeriodicPayment.159643" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentPeriodicPayment.159643">Monthly principal payments</link:label>
    <link:loc xlink:label="loc_DebtInstrumentTerm.24638.11.6" xlink:href="nvax-20120930.xsd#nvax_DebtInstrumentTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentTerm.24638.11.6" xlink:to="lab_DebtInstrumentTerm.159615" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentTerm.159615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentTerm.159615">Debt Instrument Term</link:label>
    <link:loc xlink:label="loc_DebtInstrumentTerm.24638.11.12" xlink:href="nvax-20120930.xsd#nvax_DebtInstrumentTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentTerm.24638.11.12" xlink:to="lab_DebtInstrumentTerm.159623" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentTerm.159623" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentTerm.159623">Stated term of debt instrument.</link:label>
    <link:loc xlink:label="loc_DebtInstrumentTerm.24638.11.7" xlink:href="nvax-20120930.xsd#nvax_DebtInstrumentTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentTerm.24638.11.7" xlink:to="lab_DebtInstrumentTerm7.159636" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentTerm7.159636" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentTerm7.159636">Repayment term</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDue.24563.11.9" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDue.24563.11.9" xlink:to="lab_CapitalLeasesFutureMinimumPaymentsDue9.159292" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalLeasesFutureMinimumPaymentsDue9.159292" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalLeasesFutureMinimumPaymentsDue9.159292">Total</link:label>
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtDisclosureAbstract.1283.11.6" xlink:to="lab_DebtDisclosureAbstract.158743" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtDisclosureAbstract.158743" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtDisclosureAbstract.158743">Notes Payable [Abstract]</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDue.24563.11.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDue.24563.11.6" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDue.159285" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDue.159285" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDue.159285">Loan Agreement Future Minimum Payments Due</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDue.24563.11.12" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDue.24563.11.12" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDue.159290" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDue.159290" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDue.159290">Amount of minimum loan payments.</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.11.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.11.6" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.159279" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.159279" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.159279">Loan Agreement Future Minimum Payments Due In Rolling Year Four</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.11.12" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.11.12" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.159282" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.159282" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.159282">Amount of minimum loan payments maturing in the fourth rolling twelve months following the latest balance sheet presented.</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.11.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.11.7" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour7.159283" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour7.159283" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour7.159283">2016</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.11.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.11.6" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.159276" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.159276" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.159276">Loan Agreement Future Minimum Payments Due In Rolling Year Three</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.11.12" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.11.12" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.159277" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.159277" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.159277">Amount of minimum loan payments maturing in the third rolling twelve months following the latest balance sheet presented.</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.11.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.11.7" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree7.159278" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree7.159278" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree7.159278">2015</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.11.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.11.6" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.159273" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.159273" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.159273">Loan Agreement Future Minimum Payments Due In Rolling Year Two</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.11.12" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.11.12" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.159274" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.159274" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.159274">Amount of minimum loan payments maturing in the second rolling twelve months following the latest balance sheet presented.</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.11.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.11.7" xlink:to="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo7.159275" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo7.159275" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo7.159275">2014</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.11.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.11.6" xlink:to="lab_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.159269" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.159269" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.159269">Loan Agreement Future Minimum Payments Next Rolling Twelve Months</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.11.12" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.11.12" xlink:to="lab_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.159272" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.159272" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.159272">Amount of minimum loan payments maturing in the next rolling twelve months following the latest balance sheet presented.</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.11.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.11.7" xlink:to="lab_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths7.159271" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths7.159271" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths7.159271">2013</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.11.6" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.11.6" xlink:to="lab_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.159258" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.159258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.159258">Loan Agreement Future Minimum Payments Remainder Of Fiscal Year</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.11.12" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.11.12" xlink:to="lab_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.159264" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.159264" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.159264">Amount of minimum loan payments maturing in the remainder of the fiscal year following the latest fiscal year ended.</link:label>
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.11.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.11.7" xlink:to="lab_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear7.159266" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear7.159266" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear7.159266">2012</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.6" xlink:to="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.2536" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.2536" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.2536">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.7" xlink:to="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.159680" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.159680" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.159680">Exercise price of warrants</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.24643.11.6" xlink:href="nvax-20120930.xsd#nvax_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.24643.11.6" xlink:to="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.159671" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.159671" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.159671">Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.24643.11.12" xlink:href="nvax-20120930.xsd#nvax_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.24643.11.12" xlink:to="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.159675" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.159675" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.159675">The specified number of securities that each warrant or right outstanding gives the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date.</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.24643.11.7" xlink:href="nvax-20120930.xsd#nvax_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.24643.11.7" xlink:to="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight7.159676" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight7.159676" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight7.159676">Shares entitled per warrant</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.6" xlink:to="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.2538" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.2538" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.2538">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.7" xlink:to="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights7.159678" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights7.159678" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights7.159678">Aggregate shares common stock callable by warrants</link:label>
    <link:loc xlink:label="loc_CommonSharesPerUnit.24641.11.6" xlink:href="nvax-20120930.xsd#nvax_CommonSharesPerUnit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonSharesPerUnit.24641.11.6" xlink:to="lab_CommonSharesPerUnit.159665" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonSharesPerUnit.159665" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonSharesPerUnit.159665">Common Shares Per Unit</link:label>
    <link:loc xlink:label="loc_CommonSharesPerUnit.24641.11.12" xlink:href="nvax-20120930.xsd#nvax_CommonSharesPerUnit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonSharesPerUnit.24641.11.12" xlink:to="lab_CommonSharesPerUnit.159667" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonSharesPerUnit.159667" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_CommonSharesPerUnit.159667">Shares included in each equity unit.</link:label>
    <link:loc xlink:label="loc_CommonSharesPerUnit.24641.11.7" xlink:href="nvax-20120930.xsd#nvax_CommonSharesPerUnit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonSharesPerUnit.24641.11.7" xlink:to="lab_CommonSharesPerUnit7.159670" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonSharesPerUnit7.159670" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonSharesPerUnit7.159670">Common shares per unit</link:label>
    <link:loc xlink:label="loc_EquityIssuancePerShareAmount.8955.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityIssuancePerShareAmount.8955.11.6" xlink:to="lab_EquityIssuancePerShareAmount.5807" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityIssuancePerShareAmount.5807" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityIssuancePerShareAmount.5807">Equity Issuance, Per Share Amount</link:label>
    <link:loc xlink:label="loc_EquityIssuancePerShareAmount.8955.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityIssuancePerShareAmount.8955.11.7" xlink:to="lab_EquityIssuancePerShareAmount7.159677" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityIssuancePerShareAmount7.159677" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EquityIssuancePerShareAmount7.159677">Price per unit</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.11.7" xlink:to="lab_ProceedsFromIssuanceOrSaleOfEquity.159663" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOrSaleOfEquity.159663" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOrSaleOfEquity.159663">Proceeds from direct offering</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.7" xlink:to="lab_StockIssuedDuringPeriodSharesNewIssues.159661" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesNewIssues.159661" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesNewIssues.159661">Units issued in direct offering</link:label>
    <link:loc xlink:label="loc_AverageSharePrice.24656.11.6" xlink:href="nvax-20120930.xsd#nvax_AverageSharePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AverageSharePrice.24656.11.6" xlink:to="lab_AverageSharePrice.159723" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AverageSharePrice.159723" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AverageSharePrice.159723">Average Share Price</link:label>
    <link:loc xlink:label="loc_AverageSharePrice.24656.11.12" xlink:href="nvax-20120930.xsd#nvax_AverageSharePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AverageSharePrice.24656.11.12" xlink:to="lab_AverageSharePrice.159732" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AverageSharePrice.159732" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_AverageSharePrice.159732">Average price of a single share of a number of saleable stocks of a company during the period.</link:label>
    <link:loc xlink:label="loc_AverageSharePrice.24656.11.7" xlink:href="nvax-20120930.xsd#nvax_AverageSharePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AverageSharePrice.24656.11.7" xlink:to="lab_AverageSharePrice7.159734" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AverageSharePrice7.159734" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AverageSharePrice7.159734">Average sales price</link:label>
    <link:loc xlink:label="loc_CommonStockValueAuthorized.24650.11.6" xlink:href="nvax-20120930.xsd#nvax_CommonStockValueAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValueAuthorized.24650.11.6" xlink:to="lab_CommonStockValueAuthorized.159700" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValueAuthorized.159700" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValueAuthorized.159700">Common Stock Value Authorized</link:label>
    <link:loc xlink:label="loc_CommonStockValueAuthorized.24650.11.12" xlink:href="nvax-20120930.xsd#nvax_CommonStockValueAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValueAuthorized.24650.11.12" xlink:to="lab_CommonStockValueAuthorized.159702" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValueAuthorized.159702" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValueAuthorized.159702">Common stock authorized for issuance, dolllar amount.</link:label>
    <link:loc xlink:label="loc_CommonStockValueAuthorized.24650.11.7" xlink:href="nvax-20120930.xsd#nvax_CommonStockValueAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValueAuthorized.24650.11.7" xlink:to="lab_CommonStockValueAuthorized7.159707" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValueAuthorized7.159707" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValueAuthorized7.159707">Gross proceeds authorized in sale of stock</link:label>
    <link:loc xlink:label="loc_CommonStockValueAuthorizedPriorAgreement.24654.11.6" xlink:href="nvax-20120930.xsd#nvax_CommonStockValueAuthorizedPriorAgreement" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValueAuthorizedPriorAgreement.24654.11.6" xlink:to="lab_CommonStockValueAuthorizedPriorAgreement.159713" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValueAuthorizedPriorAgreement.159713" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValueAuthorizedPriorAgreement.159713">Common Stock Value Authorized Prior Agreement</link:label>
    <link:loc xlink:label="loc_CommonStockValueAuthorizedPriorAgreement.24654.11.12" xlink:href="nvax-20120930.xsd#nvax_CommonStockValueAuthorizedPriorAgreement" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValueAuthorizedPriorAgreement.24654.11.12" xlink:to="lab_CommonStockValueAuthorizedPriorAgreement.159714" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValueAuthorizedPriorAgreement.159714" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValueAuthorizedPriorAgreement.159714">Common stock authorized for issuance in previous sale agreements.</link:label>
    <link:loc xlink:label="loc_CommonStockValueAuthorizedPriorAgreement.24654.11.7" xlink:href="nvax-20120930.xsd#nvax_CommonStockValueAuthorizedPriorAgreement" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValueAuthorizedPriorAgreement.24654.11.7" xlink:to="lab_CommonStockValueAuthorizedPriorAgreement7.159716" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValueAuthorizedPriorAgreement7.159716" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValueAuthorizedPriorAgreement7.159716">Gross proceeds authorized in sale of stock, prior sales agreement</link:label>
    <link:loc xlink:label="loc_MaximumSharesAvailableForSalePriorSalesAgreement.24655.11.6" xlink:href="nvax-20120930.xsd#nvax_MaximumSharesAvailableForSalePriorSalesAgreement" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumSharesAvailableForSalePriorSalesAgreement.24655.11.6" xlink:to="lab_MaximumSharesAvailableForSalePriorSalesAgreement.159717" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MaximumSharesAvailableForSalePriorSalesAgreement.159717" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MaximumSharesAvailableForSalePriorSalesAgreement.159717">Maximum Shares Available For Sale Prior Sales Agreement</link:label>
    <link:loc xlink:label="loc_MaximumSharesAvailableForSalePriorSalesAgreement.24655.11.12" xlink:href="nvax-20120930.xsd#nvax_MaximumSharesAvailableForSalePriorSalesAgreement" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumSharesAvailableForSalePriorSalesAgreement.24655.11.12" xlink:to="lab_MaximumSharesAvailableForSalePriorSalesAgreement.159720" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MaximumSharesAvailableForSalePriorSalesAgreement.159720" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_MaximumSharesAvailableForSalePriorSalesAgreement.159720">Maximum shares available for sale in prior sales agreement.</link:label>
    <link:loc xlink:label="loc_MaximumSharesAvailableForSalePriorSalesAgreement.24655.11.7" xlink:href="nvax-20120930.xsd#nvax_MaximumSharesAvailableForSalePriorSalesAgreement" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumSharesAvailableForSalePriorSalesAgreement.24655.11.7" xlink:to="lab_MaximumSharesAvailableForSalePriorSalesAgreement7.159722" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MaximumSharesAvailableForSalePriorSalesAgreement7.159722" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MaximumSharesAvailableForSalePriorSalesAgreement7.159722">Limitation of sales, shares, prior sales agreement</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.11.6" xlink:to="lab_ProceedsFromIssuanceOrSaleOfEquity.14589" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOrSaleOfEquity.14589" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOrSaleOfEquity.14589">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.11.8" xlink:to="lab_ProceedsFromIssuanceOrSaleOfEquity8.159699" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOrSaleOfEquity8.159699" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOrSaleOfEquity8.159699">Proceeds from sale of stock</link:label>
    <link:loc xlink:label="loc_SalesOfCommonStockAbstract.24459.11.12" xlink:href="nvax-20120930.xsd#nvax_SalesOfCommonStockAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SalesOfCommonStockAbstract.24459.11.12" xlink:to="lab_SaleOfCommonStockDisclosureAbstract.158758" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SaleOfCommonStockDisclosureAbstract.158758" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SaleOfCommonStockDisclosureAbstract.158758">Sale Of Common Stock Disclosure [Abstract]</link:label>
    <link:loc xlink:label="loc_SalesOfCommonStockAbstract.24459.11.6" xlink:href="nvax-20120930.xsd#nvax_SalesOfCommonStockAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SalesOfCommonStockAbstract.24459.11.6" xlink:to="lab_SalesOfCommonStockAbstract.158750" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SalesOfCommonStockAbstract.158750" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SalesOfCommonStockAbstract.158750">Sales of Common Stock [Abstract]</link:label>
    <link:loc xlink:label="loc_SharePrice.16294.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharePrice.16294.11.6" xlink:to="lab_SharePrice.17475" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharePrice.17475" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharePrice.17475">Share Price</link:label>
    <link:loc xlink:label="loc_SharePrice.16294.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharePrice.16294.11.7" xlink:to="lab_SharePrice.137070" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharePrice.137070" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharePrice.137070">Common stock, price per share</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesNewIssues.17977" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesNewIssues.17977" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesNewIssues.17977">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.8" xlink:to="lab_StockIssuedDuringPeriodSharesNewIssues8.159697" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesNewIssues8.159697" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesNewIssues8.159697">Common stock sold</link:label>
    <link:loc xlink:label="loc_AdditionalTenantImprovementAllowance.24667.11.6" xlink:href="nvax-20120930.xsd#nvax_AdditionalTenantImprovementAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalTenantImprovementAllowance.24667.11.6" xlink:to="lab_AdditionalTenantImprovementAllowance.159754" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdditionalTenantImprovementAllowance.159754" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdditionalTenantImprovementAllowance.159754">Additional Tenant Improvement Allowance</link:label>
    <link:loc xlink:label="loc_AdditionalTenantImprovementAllowance.24667.11.12" xlink:href="nvax-20120930.xsd#nvax_AdditionalTenantImprovementAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalTenantImprovementAllowance.24667.11.12" xlink:to="lab_AdditionalTenantImprovementAllowance.159755" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdditionalTenantImprovementAllowance.159755" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_AdditionalTenantImprovementAllowance.159755">Additional tenant improvement allowance</link:label>
    <link:loc xlink:label="loc_AdditionalTenantImprovementAllowance.24667.11.7" xlink:href="nvax-20120930.xsd#nvax_AdditionalTenantImprovementAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalTenantImprovementAllowance.24667.11.7" xlink:to="lab_AdditionalTenantImprovementAllowance7.159756" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdditionalTenantImprovementAllowance7.159756" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AdditionalTenantImprovementAllowance7.159756">Additional tenant improvement allowance</link:label>
    <link:loc xlink:label="loc_LeasedFacilitySquareFootage.24665.11.6" xlink:href="nvax-20120930.xsd#nvax_LeasedFacilitySquareFootage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeasedFacilitySquareFootage.24665.11.6" xlink:to="lab_LeasedFacilitySquareFootage.159747" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeasedFacilitySquareFootage.159747" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LeasedFacilitySquareFootage.159747">Leased Facility Square Footage</link:label>
    <link:loc xlink:label="loc_LeasedFacilitySquareFootage.24665.11.12" xlink:href="nvax-20120930.xsd#nvax_LeasedFacilitySquareFootage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeasedFacilitySquareFootage.24665.11.12" xlink:to="lab_LeasedFacilitySquareFootage.174157" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeasedFacilitySquareFootage.174157" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LeasedFacilitySquareFootage.174157">Amount of square footage of leased facililty.</link:label>
    <link:loc xlink:label="loc_LeasedFacilitySquareFootage.24665.11.7" xlink:href="nvax-20120930.xsd#nvax_LeasedFacilitySquareFootage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeasedFacilitySquareFootage.24665.11.7" xlink:to="lab_LeasedFacilitySquareFootage7.159753" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeasedFacilitySquareFootage7.159753" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LeasedFacilitySquareFootage7.159753">Leased facility square footage</link:label>
    <link:loc xlink:label="loc_PaymentsForProceedsFromTenantAllowance.13672.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsForProceedsFromTenantAllowance.13672.11.6" xlink:to="lab_PaymentsForProceedsFromTenantAllowance.13363" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsForProceedsFromTenantAllowance.13363" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsForProceedsFromTenantAllowance.13363">Payments for (Proceeds from) Tenant Allowance</link:label>
    <link:loc xlink:label="loc_PaymentsForProceedsFromTenantAllowance.13672.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsForProceedsFromTenantAllowance.13672.11.7" xlink:to="lab_PaymentsForProceedsFromTenantAllowance.159758" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsForProceedsFromTenantAllowance.159758" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsForProceedsFromTenantAllowance.159758">Amount funded from tenant allowance</link:label>
    <link:loc xlink:label="loc_TenantAllowanceInterestRate.26650.11.6" xlink:href="nvax-20120930.xsd#nvax_TenantAllowanceInterestRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TenantAllowanceInterestRate.26650.11.6" xlink:to="lab_TenantAllowanceInterestRate.171384" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TenantAllowanceInterestRate.171384" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TenantAllowanceInterestRate.171384">Tenant Allowance Interest Rate</link:label>
    <link:loc xlink:label="loc_TenantAllowanceInterestRate.26650.11.12" xlink:href="nvax-20120930.xsd#nvax_TenantAllowanceInterestRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TenantAllowanceInterestRate.26650.11.12" xlink:to="lab_TenantAllowanceInterestRate.171385" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TenantAllowanceInterestRate.171385" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TenantAllowanceInterestRate.171385">Tenant Allowance Interest Rate</link:label>
    <link:loc xlink:label="loc_TenantImprovementAllowance.24666.11.6" xlink:href="nvax-20120930.xsd#nvax_TenantImprovementAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TenantImprovementAllowance.24666.11.6" xlink:to="lab_TenantImprovementAllowance.159750" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TenantImprovementAllowance.159750" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TenantImprovementAllowance.159750">Tenant Improvement Allowance</link:label>
    <link:loc xlink:label="loc_TenantImprovementAllowance.24666.11.12" xlink:href="nvax-20120930.xsd#nvax_TenantImprovementAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TenantImprovementAllowance.24666.11.12" xlink:to="lab_TenantImprovementAllowance.159751" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TenantImprovementAllowance.159751" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TenantImprovementAllowance.159751">Tenant Improvement Allowance</link:label>
    <link:loc xlink:label="loc_TenantImprovementAllowance.24666.11.7" xlink:href="nvax-20120930.xsd#nvax_TenantImprovementAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TenantImprovementAllowance.24666.11.7" xlink:to="lab_TenantImprovementAllowance7.159752" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TenantImprovementAllowance7.159752" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TenantImprovementAllowance7.159752">Tenant improvement allowance</link:label>
    <link:loc xlink:label="loc_MasterServicesAgreementTextBlock.26652.11.6" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServicesAgreementTextBlock.26652.11.6" xlink:to="lab_MasterServicesAgreementTextBlock.171389" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServicesAgreementTextBlock.171389" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MasterServicesAgreementTextBlock.171389">Master Services Agreement [Text Block]</link:label>
    <link:loc xlink:label="loc_MasterServicesAgreementTextBlock.26652.11.12" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServicesAgreementTextBlock.26652.11.12" xlink:to="lab_MasterServicesAgreementTextBlock.171390" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServicesAgreementTextBlock.171390" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_MasterServicesAgreementTextBlock.171390">Master Services Agreement [Text Block]</link:label>
    <link:loc xlink:label="loc_MasterServicesAgreementTextBlock.26652.11.7" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServicesAgreementTextBlock.26652.11.7" xlink:to="lab_MasterServicesAgreementTextBlock7.171391" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServicesAgreementTextBlock7.171391" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MasterServicesAgreementTextBlock7.171391">Master Services Agreement with Cadila</link:label>
    <link:loc xlink:label="loc_MasterServicesAgreementWithCadilaAbstract.26651.11.6" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementWithCadilaAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServicesAgreementWithCadilaAbstract.26651.11.6" xlink:to="lab_MasterServicesAgreementWithCadilaAbstract.171387" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServicesAgreementWithCadilaAbstract.171387" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MasterServicesAgreementWithCadilaAbstract.171387">Master Services Agreement with Cadila [Abstract]</link:label>
    <link:loc xlink:label="loc_MasterServicesAgreementWithCadilaAbstract.26651.11.12" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementWithCadilaAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServicesAgreementWithCadilaAbstract.26651.11.12" xlink:to="lab_MasterServicesAgreementWithCadilaAbstract.171388" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServicesAgreementWithCadilaAbstract.171388" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_MasterServicesAgreementWithCadilaAbstract.171388">Master Services Agreement With Cadila [Abstract]</link:label>
    <link:loc xlink:label="loc_MasterServiceAgreementPurchases.26958.11.6" xlink:href="nvax-20120930.xsd#nvax_MasterServiceAgreementPurchases" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServiceAgreementPurchases.26958.11.6" xlink:to="lab_MasterServiceAgreementPurchases.173159" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServiceAgreementPurchases.173159" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MasterServiceAgreementPurchases.173159">Master Service Agreement Purchases</link:label>
    <link:loc xlink:label="loc_MasterServiceAgreementPurchases.26958.11.12" xlink:href="nvax-20120930.xsd#nvax_MasterServiceAgreementPurchases" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServiceAgreementPurchases.26958.11.12" xlink:to="lab_MasterServiceAgreementPurchases.173161" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServiceAgreementPurchases.173161" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_MasterServiceAgreementPurchases.173161">MasterServiceAgreementPurchases</link:label>
    <link:loc xlink:label="loc_MasterServiceAgreementPurchases.26958.11.7" xlink:href="nvax-20120930.xsd#nvax_MasterServiceAgreementPurchases" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServiceAgreementPurchases.26958.11.7" xlink:to="lab_MasterServiceAgreementPurchases7.173163" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServiceAgreementPurchases7.173163" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MasterServiceAgreementPurchases7.173163">Purchases</link:label>
    <link:loc xlink:label="loc_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.26654.11.6" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.26654.11.6" xlink:to="lab_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.171480" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.171480" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.171480">Master Services Agreement Amount Of Services To Be Provided Minimum</link:label>
    <link:loc xlink:label="loc_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.26654.11.12" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.26654.11.12" xlink:to="lab_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.171481" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.171481" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.171481">Master Services Agreement Amount Of Services To Be Provided Minimum</link:label>
    <link:loc xlink:label="loc_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.26654.11.7" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.26654.11.7" xlink:to="lab_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum7.173670" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum7.173670" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum7.173670">Minimum contract services to be provided</link:label>
    <link:loc xlink:label="loc_PercentOfTheShortfallAmountExceedingTwoMillion.26957.11.6" xlink:href="nvax-20120930.xsd#nvax_PercentOfTheShortfallAmountExceedingTwoMillion" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentOfTheShortfallAmountExceedingTwoMillion.26957.11.6" xlink:to="lab_PercentOfTheShortfallAmountExceedingTwoMillion.173156" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PercentOfTheShortfallAmountExceedingTwoMillion.173156" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PercentOfTheShortfallAmountExceedingTwoMillion.173156">Percent Of The Shortfall Amount Exceeding Two Million</link:label>
    <link:loc xlink:label="loc_PercentOfTheShortfallAmountExceedingTwoMillion.26957.11.12" xlink:href="nvax-20120930.xsd#nvax_PercentOfTheShortfallAmountExceedingTwoMillion" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentOfTheShortfallAmountExceedingTwoMillion.26957.11.12" xlink:to="lab_PercentOfTheShortfallAmountExceedingTwoMillion.173157" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PercentOfTheShortfallAmountExceedingTwoMillion.173157" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_PercentOfTheShortfallAmountExceedingTwoMillion.173157">Percent Of The Shortfall Amount Exceeding Two Million</link:label>
    <link:loc xlink:label="loc_PercentOfTheShortfallAmountExceedingTwoMillion.26957.11.7" xlink:href="nvax-20120930.xsd#nvax_PercentOfTheShortfallAmountExceedingTwoMillion" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentOfTheShortfallAmountExceedingTwoMillion.26957.11.7" xlink:to="lab_PercentOfTheShortfallAmountExceedingTwoMillion7.173158" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PercentOfTheShortfallAmountExceedingTwoMillion7.173158" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PercentOfTheShortfallAmountExceedingTwoMillion7.173158">Payable portion of the shortfall amount exceeding two million</link:label>
    <link:loc xlink:label="loc_ShortfallAmountPayableInFull.26900.11.6" xlink:href="nvax-20120930.xsd#nvax_ShortfallAmountPayableInFull" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortfallAmountPayableInFull.26900.11.6" xlink:to="lab_ShortfallAmountPayableInFull.172895" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShortfallAmountPayableInFull.172895" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShortfallAmountPayableInFull.172895">Shortfall Amount Payable In Full</link:label>
    <link:loc xlink:label="loc_ShortfallAmountPayableInFull.26900.11.12" xlink:href="nvax-20120930.xsd#nvax_ShortfallAmountPayableInFull" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortfallAmountPayableInFull.26900.11.12" xlink:to="lab_ShortfallAmountPayableInFull.172896" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShortfallAmountPayableInFull.172896" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ShortfallAmountPayableInFull.172896">Shortfall Amount Payable In Full</link:label>
    <link:loc xlink:label="loc_ShortfallAmountPayableInFull.26900.11.7" xlink:href="nvax-20120930.xsd#nvax_ShortfallAmountPayableInFull" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortfallAmountPayableInFull.26900.11.7" xlink:to="lab_ShortfallAmountPayableInFull7.173155" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShortfallAmountPayableInFull7.173155" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShortfallAmountPayableInFull7.173155">Shortfall amount fully payable</link:label>
    <link:loc xlink:label="loc_SubsequentEventsAbstract.5004.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventsAbstract.5004.11.6" xlink:to="lab_SubsequentEventsAbstract.18085" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventsAbstract.18085" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventsAbstract.18085">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:label="loc_SubsequentEventsTextBlock.16697.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventsTextBlock.16697.11.6" xlink:to="lab_SubsequentEventsTextBlock.18084" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventsTextBlock.18084" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventsTextBlock.18084">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:label="loc_SubsequentEventsTextBlock.16697.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventsTextBlock.16697.11.7" xlink:to="lab_SubsequentEventsTextBlock.134775" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventsTextBlock.134775" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventsTextBlock.134775">Subsequent Events</link:label>
    <link:loc xlink:label="loc_SharePrice.16294.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharePrice.16294.11.8" xlink:to="lab_SharePrice.149855" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharePrice.149855" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharePrice.149855">Price per share</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>nvax-20120930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--P3XBRL-->
<!--version 4.1.22 -->
<!--http://www.p3xbrl.com-->
<!--produced on 2012-11-08 @ 9:38 PM-->
<link:linkbase xmlns:nvax="http://www.novavax.com/20120930" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://www.novavax.com/role/DocumentAndEntityInformation" xlink:href="nvax-20120930.xsd#nvax-daei" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/BalanceSheets" xlink:href="nvax-20120930.xsd#nvax-ccbs" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/BalanceSheetsParenthetical" xlink:href="nvax-20120930.xsd#nvax-ccbsp" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StamentsOfOperations" xlink:href="nvax-20120930.xsd#nvax-ccso" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StatementsOfComprehensiveLoss" xlink:href="nvax-20120930.xsd#nvax-ccci" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StatementsOfCashFlows" xlink:href="nvax-20120930.xsd#nvax-ccscf" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StatementsOfCashFlowsParenthetical" xlink:href="nvax-20120930.xsd#nvax-stcfpa" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/Organization" xlink:href="nvax-20120930.xsd#nvax-orga" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/LiquidityMatters" xlink:href="nvax-20120930.xsd#nvax-lima" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="nvax-20120930.xsd#nvax-ssap" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesPolicy" xlink:href="nvax-20120930.xsd#nvax-ssappo" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="nvax-20120930.xsd#nvax-ssapta" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensation" xlink:href="nvax-20120930.xsd#nvax-stbaco" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/USGovernmentAgreementAndCollaboartions" xlink:href="nvax-20120930.xsd#nvax-usgac" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLease" xlink:href="nvax-20120930.xsd#nvax-cale" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayable" xlink:href="nvax-20120930.xsd#nvax-nopa" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/WarrantLiability" xlink:href="nvax-20120930.xsd#nvax-wali" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SalesOfCommonStock" xlink:href="nvax-20120930.xsd#nvax-socs" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacility" xlink:href="nvax-20120930.xsd#nvax-mlof" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayableTables" xlink:href="nvax-20120930.xsd#nvax-nopata" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLeaseTables" xlink:href="nvax-20120930.xsd#nvax-caleta" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationTables" xlink:href="nvax-20120930.xsd#nvax-sbcota" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/OrganizationDetails" xlink:href="nvax-20120930.xsd#nvax-orgad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/LiquidityMattersDetails" xlink:href="nvax-20120930.xsd#nvax-limad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-ssapnd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesFinancialAssetsAndLiabilitiesMeasuredAtFairMarketValueOnARecurringBasisDetails" xlink:href="nvax-20120930.xsd#nvax-ssapfalmfmvrbd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfActivityOfLevelThreeInputsMeasuredOnRecurringBasisDetails" xlink:href="nvax-20120930.xsd#nvax-ssapsalimrbd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:href="nvax-20120930.xsd#nvax-ssapsticaafsd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-sbcond" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:href="nvax-20120930.xsd#nvax-sbcocbced" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationSummaryOfOptionActivityDetails" xlink:href="nvax-20120930.xsd#nvax-sbcsoad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationAssumptionsUsedInEstimationOfFairValueOfStockOptionsGrantedDetails" xlink:href="nvax-20120930.xsd#nvax-sbcoauefvsogd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/StockBasedCompensationSummaryOfRestrictedStockAwardsActivityDetails" xlink:href="nvax-20120930.xsd#nvax-sbcosrsaad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/PointsPointGovernmentAgreementAndCollaborationsDetails" xlink:href="nvax-20120930.xsd#nvax-usgacd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLeaseNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-calend" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/CapitalLeaseFutureMinimumCapitalLeasePaymentsUnderCapitalLeaseAgreementDetails" xlink:href="nvax-20120930.xsd#nvax-calefmclpuclad" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayableNarrativeDetails" xlink:href="nvax-20120930.xsd#nvax-nopand" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/NotesPayableAggregateFutureMinimumPrincipalPaymentsOnEquipmentLoanDetails" xlink:href="nvax-20120930.xsd#nvax-calenpafmppoeld" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/WarrantLiabilityDetails" xlink:href="nvax-20120930.xsd#nvax-walid" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SalesOfCommonStockDetails" xlink:href="nvax-20120930.xsd#nvax-sacsd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacilityDetails" xlink:href="nvax-20120930.xsd#nvax-mlofd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/MasterServicesAgreementWithCadila" xlink:href="nvax-20120930.xsd#nvax-msac" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/MasterServicesAgreementWithCadilaDetails" xlink:href="nvax-20120930.xsd#nvax-msacd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SubsequentEvents" xlink:href="nvax-20120930.xsd#nvax-suev" xlink:type="simple" />
  <link:roleRef roleURI="http://www.novavax.com/role/SubsequentEventsDetails" xlink:href="nvax-20120930.xsd#nvax-suevd" xlink:type="simple" />
  <link:presentationLink xlink:title="001 - Document - Document and Entity Information" xlink:role="http://www.novavax.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:label="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:href="nvax-20120930.xsd#nvax_DocumentAndEntityInformationAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DocumentType.212.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentType" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_DocumentType.212.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_AmendmentFlag.144.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_AmendmentFlag.144.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentPeriodEndDate.161.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_DocumentPeriodEndDate.161.12.6" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityRegistrantName.187.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_EntityRegistrantName.187.12.6" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityCentralIndexKey.188.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_EntityCentralIndexKey.188.12.6" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_CurrentFiscalYearEndDate.155.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_CurrentFiscalYearEndDate.155.12.6" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentFiscalYearFocus.207.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_DocumentFiscalYearFocus.207.12.6" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentFiscalPeriodFocus.208.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_DocumentFiscalPeriodFocus.208.12.6" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityFilerCategory.185.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_EntityFilerCategory.185.12.6" order="9.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityCommonStockSharesOutstanding.192.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_EntityCommonStockSharesOutstanding.192.12.6" order="10.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_TradingSymbol.177.12.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_TradingSymbol" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.24388.12.6" xlink:to="loc_TradingSymbol.177.12.6" order="5.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="002 - Statement - BALANCE SHEETS" xlink:role="http://www.novavax.com/role/BalanceSheets" xlink:type="extended">
    <link:loc xlink:label="loc_AssetsCurrentAbstract.592.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PrepaidExpenseCurrent.14246.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_PrepaidExpenseCurrent.14246.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsCurrentAbstract.592.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AssetsCurrent.5874.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.9" xlink:to="loc_AssetsCurrent.5874.12.9" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesCurrent.5972.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_AvailableForSaleSecuritiesCurrent.5972.12.7" order="1.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GovernmentContractReceivableUnbilledAmounts.10338.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GovernmentContractReceivableUnbilledAmounts" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_GovernmentContractReceivableUnbilledAmounts.10338.12.7" order="2.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherAssetsCurrent.13175.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_OtherAssetsCurrent.13175.12.7" order="4.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.12.7" order="1.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccountsReceivableNetCurrent.5451.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_AccountsReceivableNetCurrent.5451.12.7" order="2.25" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsAbstract.595.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.7" xlink:to="loc_AssetsCurrentAbstract.592.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.14697.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.7" xlink:to="loc_PropertyPlantAndEquipmentNet.14697.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsAbstract.595.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_Assets.5880.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.9" xlink:to="loc_Assets.5880.12.9" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_Goodwill.10311.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.7" xlink:to="loc_Goodwill.10311.12.7" order="2.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsNoncurrent.15344.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.7" xlink:to="loc_RestrictedCashAndCashEquivalentsNoncurrent.15344.12.7" order="2.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13227.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.7" xlink:to="loc_OtherAssetsNoncurrent.13227.12.7" order="2.88" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AccountsPayableCurrent.5468.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_AccountsPayableCurrent.5468.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccruedLiabilitiesCurrent.5555.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_AccruedLiabilitiesCurrent.5555.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NotesPayableCurrent.12933.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_NotesPayableCurrent.12933.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.2935.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LiabilitiesCurrent.11668.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.9" xlink:to="loc_LiabilitiesCurrent.11668.12.9" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_DeferredRentCreditCurrent.7598.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_DeferredRentCreditCurrent.7598.12.7" order="3.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeaseObligationsCurrent.6437.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_CapitalLeaseObligationsCurrent.6437.12.7" order="2.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DeferredRevenueCurrent.7671.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_DeferredRevenueCurrent.7671.12.7" order="2.25" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesCurrent.8056.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_DerivativeLiabilitiesCurrent.8056.12.7" order="3.25" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_LiabilitiesCurrentAbstract.2935.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_Liabilities.11702.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.9" xlink:to="loc_Liabilities.11702.12.9" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_CommitmentsAndContingencies.6842.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_CommitmentsAndContingencies.6842.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityAbstract.4986.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_StockholdersEquityAbstract.4986.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.11731.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.9" xlink:to="loc_LiabilitiesAndStockholdersEquity.11731.12.9" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesNoncurrent.8124.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_DerivativeLiabilitiesNoncurrent.8124.12.7" order="2.54" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DeferredRevenueNoncurrent.7662.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_DeferredRevenueNoncurrent.7662.12.7" order="1.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermNotesPayable.12281.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_LongTermNotesPayable.12281.12.7" order="2.38" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DeferredRentCreditNoncurrent.7574.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_DeferredRentCreditNoncurrent.7574.12.7" order="2.69" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeaseObligationsNoncurrent.6438.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_CapitalLeaseObligationsNoncurrent.6438.12.7" order="2.06" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_AssetsAbstract.595.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PreferredStockValue.14123.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.7" xlink:to="loc_PreferredStockValue.14123.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockValue.6874.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.7" xlink:to="loc_CommonStockValue.6874.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdditionalPaidInCapital.5620.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.7" xlink:to="loc_AdditionalPaidInCapital.5620.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15457.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.7" xlink:to="loc_RetainedEarningsAccumulatedDeficit.15457.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityAbstract.4986.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquity.16667.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.9" xlink:to="loc_StockholdersEquity.16667.12.9" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StockholdersEquityAbstract.4986.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_TreasuryStockValue.17060.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.42" xlink:to="loc_TreasuryStockValue.17060.12.42" order="4.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5602.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.7" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5602.12.7" order="4.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="003 - Statement - BALANCE SHEETS (Parenthetical)" xlink:role="http://www.novavax.com/role/BalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PreferredStockParOrStatedValuePerShare.14166.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_PreferredStockParOrStatedValuePerShare.14166.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PreferredStockSharesAuthorized.14124.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_PreferredStockSharesAuthorized.14124.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PreferredStockSharesIssued.14157.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_PreferredStockSharesIssued.14157.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PreferredStockSharesOutstanding.14180.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_PreferredStockSharesOutstanding.14180.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.6878.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_CommonStockParOrStatedValuePerShare.6878.12.7" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.6879.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_CommonStockSharesAuthorized.6879.12.7" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockSharesIssued.6875.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_CommonStockSharesIssued.6875.12.7" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.6864.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_CommonStockSharesOutstanding.6864.12.7" order="9.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TreasuryStockShares.17065.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockShares" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_TreasuryStockShares.17065.12.7" order="10.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="004 - Statement - STATEMENTS OF OPERATIONS" xlink:role="http://www.novavax.com/role/StamentsOfOperations" xlink:type="extended">
    <link:loc xlink:label="loc_CostsAndExpensesAbstract.1204.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ContractRevenueCost.7021.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractRevenueCost" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CostsAndExpensesAbstract.1204.12.7" xlink:to="loc_ContractRevenueCost.7021.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15293.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CostsAndExpensesAbstract.1204.12.7" xlink:to="loc_ResearchAndDevelopmentExpense.15293.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10284.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CostsAndExpensesAbstract.1204.12.7" xlink:to="loc_GeneralAndAdministrativeExpense.10284.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CostsAndExpensesAbstract.1204.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CostsAndExpenses.7217.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CostsAndExpensesAbstract.1204.12.9" xlink:to="loc_CostsAndExpenses.7217.12.9" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_IncomeStatementAbstract.2519.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingIncomeLoss.13080.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.9" xlink:to="loc_OperatingIncomeLoss.13080.12.9" order="12.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_IncomeStatementAbstract.2519.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeTaxExpenseBenefit.10688.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_IncomeTaxExpenseBenefit.10688.12.7" order="16.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.9" xlink:to="loc_NetIncomeLoss.12771.12.9" order="17.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" order="12.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.12.7" order="20.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.9" xlink:to="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.12.9" order="15.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_EarningsPerShareBasicAndDiluted.8698.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_EarningsPerShareBasicAndDiluted.8698.12.7" order="19.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ContractsRevenue.7028.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_ContractsRevenue.7028.12.7" order="1.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_CostsAndExpensesAbstract.1204.12.7" order="2.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentCollaboration.26647.12.7" xlink:href="nvax-20120930.xsd#nvax_ResearchAndDevelopmentCollaboration" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_ResearchAndDevelopmentCollaboration.26647.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_Revenues.15575.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Revenues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.9" xlink:to="loc_Revenues.15575.12.9" order="2.25" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_InvestmentIncomeInterest.11436.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" xlink:to="loc_InvestmentIncomeInterest.11436.12.7" order="1.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_InterestExpense.11178.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.42" xlink:to="loc_InterestExpense.11178.12.42" order="1.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" xlink:to="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.12.7" order="1.88" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_InvestmentIncomeNet.11453.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" xlink:to="loc_InvestmentIncomeNet.11453.12.7" order="1.63" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="005 - Statement - STATEMENTS OF COMPREHENSIVE LOSS" xlink:role="http://www.novavax.com/role/StatementsOfComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTaxAbstract.1079.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ComprehensiveIncomeNetOfTaxAbstract.1079.12.7" xlink:to="loc_NetIncomeLoss.12771.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13404.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ComprehensiveIncomeNetOfTaxAbstract.1079.12.7" xlink:to="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13404.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTax.6913.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.12.9" xlink:to="loc_ComprehensiveIncomeNetOfTax.6913.12.9" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.12.7" xlink:to="loc_ComprehensiveIncomeNetOfTaxAbstract.1079.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="006 - Statement - STATEMENTS OF CASH FLOWS" xlink:role="http://www.novavax.com/role/StatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:to="loc_DepreciationAndAmortization.8044.12.7" order="2.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensation.16244.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:to="loc_ShareBasedCompensation.16244.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.42" xlink:to="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.12.42" order="3.63" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:to="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.42" xlink:to="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.12.42" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_AccretionAmortizationOfDiscountsAndPremiumsInvestments.5479.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.42" xlink:to="loc_AccretionAmortizationOfDiscountsAndPremiumsInvestments.5479.12.42" order="3.25" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_OtherNoncashIncomeExpense.13166.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.42" xlink:to="loc_OtherNoncashIncomeExpense.13166.12.42" order="3.81" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_AssetImpairmentCharges.5835.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:to="loc_AssetImpairmentCharges.5835.12.7" order="3.44" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.10853.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.42" xlink:to="loc_IncreaseDecreaseInAccountsReceivable.10853.12.42" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.10871.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" xlink:to="loc_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.10871.12.7" order="2.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInUnbilledReceivables.11010.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.42" xlink:to="loc_IncreaseDecreaseInUnbilledReceivables.11010.12.42" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.42" xlink:to="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.12.42" order="2.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherNoncurrentLiabilities.10849.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" xlink:to="loc_IncreaseDecreaseInOtherNoncurrentLiabilities.10849.12.7" order="2.94" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.10850.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" xlink:to="loc_IncreaseDecreaseInDeferredRevenue.10850.12.7" order="2.84" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.12.7" order="5.88" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivities.12740.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.9" xlink:to="loc_NetCashProvidedByUsedInFinancingActivities.12740.12.9" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfNotesPayable.14330.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromRepaymentsOfNotesPayable.14330.12.7" order="5.38" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromNotesPayable.14430.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromNotesPayable.14430.12.7" order="5.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.12.7" order="5.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromStockOptionsExercised.14555.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromStockOptionsExercised.14555.12.7" order="5.94" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_RepaymentsOfLongTermCapitalLeaseObligations.15248.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.42" xlink:to="loc_RepaymentsOfLongTermCapitalLeaseObligations.15248.12.42" order="5.25" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivities.12731.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.9" xlink:to="loc_NetCashProvidedByUsedInInvestingActivities.12731.12.9" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PaymentsToAcquireProductiveAssets.13804.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.42" xlink:to="loc_PaymentsToAcquireProductiveAssets.13804.12.42" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14452.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.7" xlink:to="loc_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.14452.12.7" order="5.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PaymentsToAcquireAvailableForSaleSecurities.13806.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.42" xlink:to="loc_PaymentsToAcquireAvailableForSaleSecurities.13806.12.42" order="5.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.7" xlink:to="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.12.7" order="4.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.7" xlink:to="loc_NetIncomeLoss.12771.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.7" xlink:to="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivities.12778.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.9" xlink:to="loc_NetCashProvidedByUsedInOperatingActivities.12778.12.9" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.9" xlink:to="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.12.9" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.10" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.10" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_SupplementalCashFlowInformationAbstract.5043.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_SupplementalCashFlowInformationAbstract.5043.12.7" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.11" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.11" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_DepositsForAcquisitionOfPropertyAndEquipment.24442.12.7" xlink:href="nvax-20120930.xsd#nvax_DepositsForAcquisitionOfPropertyAndEquipment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.12.7" xlink:to="loc_DepositsForAcquisitionOfPropertyAndEquipment.24442.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalExpendituresIncurredButNotYetPaid.6412.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.12.7" xlink:to="loc_CapitalExpendituresIncurredButNotYetPaid.6412.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeaseObligationEquipmentPurchased.24449.12.7" xlink:href="nvax-20120930.xsd#nvax_CapitalLeaseObligationEquipmentPurchased" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.12.7" xlink:to="loc_CapitalLeaseObligationEquipmentPurchased.24449.12.7" order="0.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SettlementOfNotesReceivable.26648.12.7" xlink:href="nvax-20120930.xsd#nvax_SettlementOfNotesReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.12.7" xlink:to="loc_SettlementOfNotesReceivable.26648.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="007 - Statement - STATEMENTS OF CASH FLOWS (Parenthetical)" xlink:role="http://www.novavax.com/role/StatementsOfCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PaymentsOfStockIssuanceCosts.13770.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_PaymentsOfStockIssuanceCosts.13770.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="101 - Disclosure - Organization" xlink:role="http://www.novavax.com/role/Organization" xlink:type="extended">
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NatureOfOperations.12709.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfOperations" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.12.7" xlink:to="loc_NatureOfOperations.12709.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="102 - Disclosure - Liquidity Matters" xlink:role="http://www.novavax.com/role/LiquidityMatters" xlink:type="extended">
    <link:loc xlink:label="loc_LiquidityMattersAbstract.24453.12.7" xlink:href="nvax-20120930.xsd#nvax_LiquidityMattersAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LiquidityMattersDisclosureTextBlock.24455.12.7" xlink:href="nvax-20120930.xsd#nvax_LiquidityMattersDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiquidityMattersAbstract.24453.12.7" xlink:to="loc_LiquidityMattersDisclosureTextBlock.24455.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="103 - Disclosure - Summary of Significant Accounting Policies" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="203 - Disclosure - Summary of Significant Accounting Policies (Policy)" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesPolicy" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_BasisOfAccountingPolicyPolicyTextBlock.6086.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_BasisOfAccountingPolicyPolicyTextBlock.6086.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_UseOfEstimates.17234.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_UseOfEstimates.17234.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueMeasurementPolicyPolicyTextBlock.9181.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_FairValueMeasurementPolicyPolicyTextBlock.9181.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.12483.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MarketableSecuritiesAvailableForSaleSecuritiesPolicy" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_MarketableSecuritiesAvailableForSaleSecuritiesPolicy.12483.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6562.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6562.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EarningsPerSharePolicyTextBlock.8704.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_EarningsPerSharePolicyTextBlock.8704.12.7" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RevenueRecognitionPolicyTextBlock.15515.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_RevenueRecognitionPolicyTextBlock.15515.12.7" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.12.7" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="303 - Disclosure - Summary of Significant Accounting Policies (Tables)" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesTextBlock.5982.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_AvailableForSaleSecuritiesTextBlock.5982.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="104 - Disclosure - Stock-Based Compensation" xlink:role="http://www.novavax.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.8456.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:to="loc_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock.8456.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="105 - Disclosure - U.S. Government Agreement and Collaborations" xlink:role="http://www.novavax.com/role/USGovernmentAgreementAndCollaboartions" xlink:type="extended">
    <link:loc xlink:label="loc_UsGovernmentAgreementAndCollaborationsAbstract.24456.12.7" xlink:href="nvax-20120930.xsd#nvax_UsGovernmentAgreementAndCollaborationsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CollaborativeArrangementDisclosureTextBlock.6814.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_UsGovernmentAgreementAndCollaborationsAbstract.24456.12.7" xlink:to="loc_CollaborativeArrangementDisclosureTextBlock.6814.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="106 - Disclosure - Capital Lease" xlink:role="http://www.novavax.com/role/CapitalLease" xlink:type="extended">
    <link:loc xlink:label="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DebtAndCapitalLeasesDisclosuresTextBlock.7378.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_DebtAndCapitalLeasesDisclosuresTextBlock.7378.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="107 - Disclosure - Notes Payable" xlink:role="http://www.novavax.com/role/NotesPayable" xlink:type="extended">
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DebtDisclosureTextBlock.7384.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_DebtDisclosureTextBlock.7384.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="108 - Disclosure - Warrant Liability" xlink:role="http://www.novavax.com/role/WarrantLiability" xlink:type="extended">
    <link:loc xlink:label="loc_StockWarrantsAbstract.24457.12.7" xlink:href="nvax-20120930.xsd#nvax_StockWarrantsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockWarrantsTextBlock.24458.12.7" xlink:href="nvax-20120930.xsd#nvax_StockWarrantsTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_StockWarrantsTextBlock.24458.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="109 - Disclosure - Sales of Common Stock" xlink:role="http://www.novavax.com/role/SalesOfCommonStock" xlink:type="extended">
    <link:loc xlink:label="loc_SalesOfCommonStockAbstract.24459.12.7" xlink:href="nvax-20120930.xsd#nvax_SalesOfCommonStockAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SaleOfCommonStockDisclosureTextBlock.24461.12.7" xlink:href="nvax-20120930.xsd#nvax_SaleOfCommonStockDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SalesOfCommonStockAbstract.24459.12.7" xlink:to="loc_SaleOfCommonStockDisclosureTextBlock.24461.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="110 - Disclosure - Manufacturing, Laboratory and Office Facility" xlink:role="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacility" xlink:type="extended">
    <link:loc xlink:label="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.12.7" xlink:href="nvax-20120930.xsd#nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NewFacilityLeaseDisclosureTextBlock.24463.12.7" xlink:href="nvax-20120930.xsd#nvax_NewFacilityLeaseDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.12.7" xlink:to="loc_NewFacilityLeaseDisclosureTextBlock.24463.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="307 - Disclosure - Notes Payable (Tables)" xlink:role="http://www.novavax.com/role/NotesPayableTables" xlink:type="extended">
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfDebtTableTextBlock.15760.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_ScheduleOfDebtTableTextBlock.15760.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="306 - Disclosure - Capital Lease (Tables)" xlink:role="http://www.novavax.com/role/CapitalLeaseTables" xlink:type="extended">
    <link:loc xlink:label="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.15769.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock.15769.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="304 - Disclosure - Stock-Based Compensation (Tables)" xlink:role="http://www.novavax.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.15727.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:to="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.15727.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.15758.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:to="loc_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock.15758.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.24468.12.7" xlink:href="nvax-20120930.xsd#nvax_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:to="loc_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock.24468.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40101 - Disclosure - Organization (Details)" xlink:role="http://www.novavax.com/role/OrganizationDetails" xlink:type="extended">
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_JointVenturePercentageOwnedByOthers.24478.12.7" xlink:href="nvax-20120930.xsd#nvax_JointVenturePercentageOwnedByOthers" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.12.7" xlink:to="loc_JointVenturePercentageOwnedByOthers.24478.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EquityMethodInvestmentOwnershipPercentage.8943.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.12.7" xlink:to="loc_EquityMethodInvestmentOwnershipPercentage.8943.12.7" order="1.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40201 - Disclosure - Liquidity Matters (Details)" xlink:role="http://www.novavax.com/role/LiquidityMattersDetails" xlink:type="extended">
    <link:loc xlink:label="loc_LiquidityMattersAbstract.24453.12.7" xlink:href="nvax-20120930.xsd#nvax_LiquidityMattersAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiquidityMattersAbstract.24453.12.7" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesCurrent.5972.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiquidityMattersAbstract.24453.12.7" xlink:to="loc_AvailableForSaleSecuritiesCurrent.5972.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.24483.12.7" xlink:href="nvax-20120930.xsd#nvax_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiquidityMattersAbstract.24453.12.7" xlink:to="loc_PeriodOfTimeCurrentCapitalLevelsCanSustainPlannedLevelsOfOperation.24483.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiquidityMattersAbstract.24453.12.8" xlink:href="nvax-20120930.xsd#nvax_LiquidityMattersAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiquidityMattersAbstract.24453.12.8" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.12.8" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40301 - Disclosure - Summary of Significant Accounting Policies (Narrative)(Details)" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_MarketableSecuritiesOriginalMinimumMaturity.24566.12.7" xlink:href="nvax-20120930.xsd#nvax_MarketableSecuritiesOriginalMinimumMaturity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_MarketableSecuritiesOriginalMinimumMaturity.24566.12.7" order="2.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MarketableSecuritiesOriginalMaximumMaturity.24567.12.7" xlink:href="nvax-20120930.xsd#nvax_MarketableSecuritiesOriginalMaximumMaturity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_MarketableSecuritiesOriginalMaximumMaturity.24567.12.7" order="2.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AuctionRateSecuritiesParValue.24568.12.7" xlink:href="nvax-20120930.xsd#nvax_AuctionRateSecuritiesParValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_AuctionRateSecuritiesParValue.24568.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NumberOfAuctionRateSecuritiesIncludedInInvestments.24570.12.7" xlink:href="nvax-20120930.xsd#nvax_NumberOfAuctionRateSecuritiesIncludedInInvestments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_NumberOfAuctionRateSecuritiesIncludedInInvestments.24570.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.24670.12.7" xlink:href="nvax-20120930.xsd#nvax_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_LikelihoodThatFairValueOfAReportingUnitIsLessThanItsCarryingAmount.24670.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40302 - Disclosure - Summary of Significant Accounting Policies (Financial Assets and Liabilities Measured at Fair Market Value on a Recurring Basis)(Details)" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesFinancialAssetsAndLiabilitiesMeasuredAtFairMarketValueOnARecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.6" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.12.6" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.12.6" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2024.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:to="loc_FairValueInputsLevel1Member.2024.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2026.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:to="loc_FairValueInputsLevel2Member.2026.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:to="loc_FairValueInputsLevel3Member.2022.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueDisclosure" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.12.7" xlink:to="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesFairValueDisclosure.11675.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.12.7" xlink:to="loc_LiabilitiesFairValueDisclosure.11675.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40303 - Disclosure - Summary of Significant Accounting Policies (Summary of Activity of Level 3 Inputs Measured on Recurring Basis)(Details)" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfActivityOfLevelThreeInputsMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.10" xlink:to="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.12.10" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.9489.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease.9489.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.11" xlink:to="loc_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.9156.12.11" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40304 - Disclosure - Summary of Significant Accounting Policies (Short-term Investments Classified as Available-for-sale)(Details)" xlink:role="http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.6" xlink:to="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.12.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_CorporateDebtSecuritiesMember.1180.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.12.7" xlink:to="loc_CorporateDebtSecuritiesMember.1180.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AuctionRateSecuritiesMember.622.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AuctionRateSecuritiesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3187.12.7" xlink:to="loc_AuctionRateSecuritiesMember.622.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.12.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3184.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4575.12.6" xlink:to="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.12.7" xlink:to="loc_AvailableforsaleSecuritiesGrossUnrealizedGain.5418.12.7" order="1.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.12.7" xlink:to="loc_AvailableForSaleSecuritiesGrossUnrealizedLosses1.5987.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6003.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.12.7" xlink:to="loc_AvailableForSaleSecuritiesAmortizedCost.6003.12.7" order="1.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueDisclosure" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4603.12.9" xlink:to="loc_AvailableForSaleSecuritiesFairValueDisclosure.5956.12.9" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40401 - Disclosure - Stock-Based Compensation (Narrative)(Details)" xlink:role="http://www.novavax.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.12.7" xlink:href="nvax-20120930.xsd#nvax_TwoZeroZeroFiveStockIncentivePlanMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PlanNameDomain.3870.12.7" xlink:to="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OneNineNineFiveStockOptionPlanMember.24508.12.7" xlink:href="nvax-20120930.xsd#nvax_OneNineNineFiveStockOptionPlanMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PlanNameDomain.3870.12.7" xlink:to="loc_OneNineNineFiveStockOptionPlanMember.24508.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PlanNameAxis.3871.12.6" xlink:to="loc_PlanNameDomain.3870.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4187.12.6" xlink:to="loc_RangeMember.4188.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MinimumMember.3248.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4188.12.6" xlink:to="loc_MinimumMember.3248.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3241.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4188.12.6" xlink:to="loc_MaximumMember.3241.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" xlink:to="loc_PlanNameAxis.3871.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" xlink:to="loc_RangeAxis.4187.12.6" order="1.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.12.7" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm.24575.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.12.7" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent.24593.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.12.7" xlink:href="nvax-20120930.xsd#nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant.24596.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16357.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16357.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15611.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15611.12.7" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15608.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15608.12.7" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15602.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15602.12.7" order="6.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.16330.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.16330.12.7" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.12.7" order="10.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.12.7" order="11.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40402 - Disclosure - Stock-Based Compensation (Stock-Based Compensation Expense)(Details)" xlink:role="http://www.novavax.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.6" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5724.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.12.7" xlink:to="loc_AllocatedShareBasedCompensationExpense.5724.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4381.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.12.7" xlink:to="loc_ResearchAndDevelopmentExpenseMember.4381.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2354.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.12.7" xlink:to="loc_GeneralAndAdministrativeExpenseMember.2354.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.12.6" xlink:to="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.12.6" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.12.6" xlink:to="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40403 - Disclosure - Stock-Based Compensation (Summary of Option Activity)(Details)" xlink:role="http://www.novavax.com/role/StockBasedCompensationSummaryOfOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.12.7" xlink:href="nvax-20120930.xsd#nvax_TwoZeroZeroFiveStockIncentivePlanMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PlanNameDomain.3870.12.7" xlink:to="loc_TwoZeroZeroFiveStockIncentivePlanMember.24507.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OneNineNineFiveStockOptionPlanMember.24508.12.7" xlink:href="nvax-20120930.xsd#nvax_OneNineNineFiveStockOptionPlanMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PlanNameDomain.3870.12.7" xlink:to="loc_OneNineNineFiveStockOptionPlanMember.24508.12.7" order="1.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PlanNameAxis.3871.12.6" xlink:to="loc_PlanNameDomain.3870.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" xlink:to="loc_PlanNameAxis.3871.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.10" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.12.10" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16356.12.11" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.16298.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.7" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.16298.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16305.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.7" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16305.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.16248.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.7" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.16248.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16322.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16322.12.7" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward.4855.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.10" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.12.10" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16369.12.11" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16634.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.42" xlink:to="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16634.12.42" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16342.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.42" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16342.12.42" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16332.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16332.12.11" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.4866.12.8" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.12.8" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40404 - Disclosure - Stock-Based Compensation (Assumptions Used in Estimation of Fair Value of Stock Options Granted)(Details)" xlink:role="http://www.novavax.com/role/StockBasedCompensationAssumptionsUsedInEstimationOfFairValueOfStockOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.7" order="10.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RangeAxis.4187.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4187.12.7" xlink:to="loc_RangeMember.4188.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MinimumMember.3248.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4188.12.7" xlink:to="loc_MinimumMember.3248.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MaximumMember.3241.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4188.12.7" xlink:to="loc_MaximumMember.3241.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4680.12.7" xlink:to="loc_RangeAxis.4187.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16329.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16329.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.16304.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.16304.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.16317.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.16317.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.16273.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.16273.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.16324.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.16324.12.7" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.16254.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum.16254.12.7" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.16318.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.16318.12.7" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.16251.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum.16251.12.7" order="9.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.15604.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1.15604.12.7" order="10.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.12.7" xlink:href="nvax-20120930.xsd#nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.4859.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate.24528.12.7" order="11.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40405 - Disclosure - Stock-Based Compensation (Summary of Restricted Stock Awards Activity)(Details)" xlink:role="http://www.novavax.com/role/StockBasedCompensationSummaryOfRestrictedStockAwardsActivityDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract.1556.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.12.11" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.12.10" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16281.12.10" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16300.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16300.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16286.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16286.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16252.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward.4852.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16252.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.12.10" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.12.10" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.16255.12.11" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16250.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16250.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.16328.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue.16328.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.16290.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward.4858.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue.16290.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40501 - Disclosure - U.S. Government Agreement and Collaborations (Details)" xlink:role="http://www.novavax.com/role/PointsPointGovernmentAgreementAndCollaborationsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_GovernmentContractReceivable.10340.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GovernmentContractReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_GovernmentContractReceivable.10340.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15308.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet.15308.12.7" order="3.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ExpectedClinicalTrialCosts.24616.12.7" xlink:href="nvax-20120930.xsd#nvax_ExpectedClinicalTrialCosts" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_ExpectedClinicalTrialCosts.24616.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ContractsRevenue.7028.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_ContractsRevenue.7028.12.7" order="1.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_UpfrontLicensePayment.24620.12.7" xlink:href="nvax-20120930.xsd#nvax_UpfrontLicensePayment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_UpfrontLicensePayment.24620.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.12.7" xlink:href="nvax-20120930.xsd#nvax_RoyaltyPaymentsPercentOfFutureProductSales" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_RoyaltyPaymentsPercentOfFutureProductSales.24622.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.12.7" xlink:href="nvax-20120930.xsd#nvax_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent.24624.12.7" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ContractTerm.24751.12.7" xlink:href="nvax-20120930.xsd#nvax_ContractTerm" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_ContractTerm.24751.12.7" order="1.25" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentCollaboration.26647.12.7" xlink:href="nvax-20120930.xsd#nvax_ResearchAndDevelopmentCollaboration" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_ResearchAndDevelopmentCollaboration.26647.12.7" order="2.25" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClinicalTrialCostsIncurred.27100.12.7" xlink:href="nvax-20120930.xsd#nvax_ClinicalTrialCostsIncurred" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.7" xlink:to="loc_ClinicalTrialCostsIncurred.27100.12.7" order="3.75" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember" xlink:type="locator" />
    <link:loc xlink:label="loc_HhsBardaContractAwardMember.24606.12.7" xlink:href="nvax-20120930.xsd#nvax_HhsBardaContractAwardMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.12.7" xlink:to="loc_HhsBardaContractAwardMember.24606.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_HhsBardaOptionForAdditionalPeriodMember.24607.12.7" xlink:href="nvax-20120930.xsd#nvax_HhsBardaOptionForAdditionalPeriodMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.12.7" xlink:to="loc_HhsBardaOptionForAdditionalPeriodMember.24607.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.12.7" xlink:href="nvax-20120930.xsd#nvax_LicenseAgreementWithLgLifeSciencesLtdMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.12.7" xlink:to="loc_LicenseAgreementWithLgLifeSciencesLtdMember.24609.12.7" order="2.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PathVaccineSolutionsMember.24610.12.7" xlink:href="nvax-20120930.xsd#nvax_PathVaccineSolutionsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.12.7" xlink:to="loc_PathVaccineSolutionsMember.24610.12.7" order="3.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.12.6" xlink:to="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsMember.994.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4187.12.6" xlink:to="loc_RangeMember.4188.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MinimumMember.3248.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4188.12.6" xlink:to="loc_MinimumMember.3248.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3241.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4188.12.6" xlink:to="loc_MaximumMember.3241.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.12.6" xlink:to="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsAxis.999.12.6" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.12.6" xlink:to="loc_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems.990.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.12.6" xlink:to="loc_RangeAxis.4187.12.6" order="1.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_UsGovernmentAgreementAndCollaborationsAbstract.24456.12.6" xlink:href="nvax-20120930.xsd#nvax_UsGovernmentAgreementAndCollaborationsAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_UsGovernmentAgreementAndCollaborationsAbstract.24456.12.6" xlink:to="loc_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable.4608.12.6" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40601 - Disclosure - Capital Lease (Narrative)(Details)" xlink:role="http://www.novavax.com/role/CapitalLeaseNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CapitalLeasesOfLesseeEffectiveInterestRate.24630.12.7" xlink:href="nvax-20120930.xsd#nvax_CapitalLeasesOfLesseeEffectiveInterestRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_CapitalLeasesOfLesseeEffectiveInterestRate.24630.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeasePeriodicPayment.24633.12.7" xlink:href="nvax-20120930.xsd#nvax_CapitalLeasePeriodicPayment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_CapitalLeasePeriodicPayment.24633.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LeaseTerm.24635.12.7" xlink:href="nvax-20120930.xsd#nvax_LeaseTerm" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_LeaseTerm.24635.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40602 - Disclosure - Capital Lease (Future Minimum Capital Lease Payments Under Capital Lease Agreement)(Details)" xlink:role="http://www.novavax.com/role/CapitalLeaseFutureMinimumCapitalLeasePaymentsUnderCapitalLeaseAgreementDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.6415.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear.6415.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.6428.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo.6428.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.6416.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree.6416.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.6391.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour.6391.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.6421.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive.6421.12.7" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.6384.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.7" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive.6384.12.7" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalLeaseObligationsAbstract.800.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.9" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsDue.6380.12.9" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_CapitalLeaseObligationsAbstract.800.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.6439.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.42" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments.6439.12.42" order="9.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.6375.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.9" xlink:to="loc_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments.6375.12.9" order="10.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_CapitalLeaseObligationsCurrent.6437.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.42" xlink:to="loc_CapitalLeaseObligationsCurrent.6437.12.42" order="11.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_CapitalLeaseObligationsAbstract.800.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CapitalLeaseObligationsNoncurrent.6438.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CapitalLeaseObligationsAbstract.800.12.8" xlink:to="loc_CapitalLeaseObligationsNoncurrent.6438.12.8" order="12.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40701 - Disclosure - Notes Payable (Narrative)(Details)" xlink:role="http://www.novavax.com/role/NotesPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DebtInstrumentFaceAmount.7427.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_DebtInstrumentFaceAmount.7427.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.7452.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum.7452.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentIncreaseAdditionalBorrowings.7460.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentIncreaseAdditionalBorrowings" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_DebtInstrumentIncreaseAdditionalBorrowings.7460.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentInterestRateDuringPeriod.7486.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_DebtInstrumentInterestRateDuringPeriod.7486.12.7" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentPeriodicPayment.7459.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_DebtInstrumentPeriodicPayment.7459.12.7" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentTerm.24638.12.7" xlink:href="nvax-20120930.xsd#nvax_DebtInstrumentTerm" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_DebtInstrumentTerm.24638.12.7" order="3.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40702 - Disclosure - Notes Payable (Aggregate Future Minimum Principal Payments on Equipment Loan)(Details)" xlink:role="http://www.novavax.com/role/NotesPayableAggregateFutureMinimumPrincipalPaymentsOnEquipmentLoanDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.12.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear.24553.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.12.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths.24557.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.12.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo.24558.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.12.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree.24559.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.12.7" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour.24560.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LoanAgreementFutureMinimumPaymentsDue.24563.12.9" xlink:href="nvax-20120930.xsd#nvax_LoanAgreementFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.9" xlink:to="loc_LoanAgreementFutureMinimumPaymentsDue.24563.12.9" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40801 - Disclosure - Warrant Liability (Details)" xlink:role="http://www.novavax.com/role/WarrantLiabilityDetails" xlink:type="extended">
    <link:loc xlink:label="loc_StockWarrantsAbstract.24457.12.7" xlink:href="nvax-20120930.xsd#nvax_StockWarrantsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonSharesPerUnit.24641.12.7" xlink:href="nvax-20120930.xsd#nvax_CommonSharesPerUnit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_CommonSharesPerUnit.24641.12.7" order="2.50" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.24643.12.7" xlink:href="nvax-20120930.xsd#nvax_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.24643.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EquityIssuancePerShareAmount.8955.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_EquityIssuancePerShareAmount.8955.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.12.7" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.12.7" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_GainLossOnDerivativeInstrumentsNetPretax.10156.12.7" order="8.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesCurrent.8056.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockWarrantsAbstract.24457.12.7" xlink:to="loc_DerivativeLiabilitiesCurrent.8056.12.7" order="10.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40901 - Disclosure - Sales of Common Stock (Details)" xlink:role="http://www.novavax.com/role/SalesOfCommonStockDetails" xlink:type="extended">
    <link:loc xlink:label="loc_SalesOfCommonStockAbstract.24459.12.8" xlink:href="nvax-20120930.xsd#nvax_SalesOfCommonStockAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SalesOfCommonStockAbstract.24459.12.8" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.8" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_SalesOfCommonStockAbstract.24459.12.7" xlink:href="nvax-20120930.xsd#nvax_SalesOfCommonStockAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SharePrice.16294.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SalesOfCommonStockAbstract.24459.12.7" xlink:to="loc_SharePrice.16294.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SalesOfCommonStockAbstract.24459.12.8" xlink:to="loc_ProceedsFromIssuanceOrSaleOfEquity.14480.12.8" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_CommonStockValueAuthorized.24650.12.7" xlink:href="nvax-20120930.xsd#nvax_CommonStockValueAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SalesOfCommonStockAbstract.24459.12.7" xlink:to="loc_CommonStockValueAuthorized.24650.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockValueAuthorizedPriorAgreement.24654.12.7" xlink:href="nvax-20120930.xsd#nvax_CommonStockValueAuthorizedPriorAgreement" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SalesOfCommonStockAbstract.24459.12.7" xlink:to="loc_CommonStockValueAuthorizedPriorAgreement.24654.12.7" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MaximumSharesAvailableForSalePriorSalesAgreement.24655.12.7" xlink:href="nvax-20120930.xsd#nvax_MaximumSharesAvailableForSalePriorSalesAgreement" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SalesOfCommonStockAbstract.24459.12.7" xlink:to="loc_MaximumSharesAvailableForSalePriorSalesAgreement.24655.12.7" order="6.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AverageSharePrice.24656.12.7" xlink:href="nvax-20120930.xsd#nvax_AverageSharePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SalesOfCommonStockAbstract.24459.12.7" xlink:to="loc_AverageSharePrice.24656.12.7" order="7.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="41001 - Disclosure - Manufacturing, Laboratory and Office Facility (Details)" xlink:role="http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacilityDetails" xlink:type="extended">
    <link:loc xlink:label="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.12.7" xlink:href="nvax-20120930.xsd#nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LeasedFacilitySquareFootage.24665.12.7" xlink:href="nvax-20120930.xsd#nvax_LeasedFacilitySquareFootage" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.12.7" xlink:to="loc_LeasedFacilitySquareFootage.24665.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TenantImprovementAllowance.24666.12.7" xlink:href="nvax-20120930.xsd#nvax_TenantImprovementAllowance" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.12.7" xlink:to="loc_TenantImprovementAllowance.24666.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdditionalTenantImprovementAllowance.24667.12.7" xlink:href="nvax-20120930.xsd#nvax_AdditionalTenantImprovementAllowance" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.12.7" xlink:to="loc_AdditionalTenantImprovementAllowance.24667.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PaymentsForProceedsFromTenantAllowance.13672.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.12.7" xlink:to="loc_PaymentsForProceedsFromTenantAllowance.13672.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.12.6" xlink:href="nvax-20120930.xsd#nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_TenantAllowanceInterestRate.26650.12.6" xlink:href="nvax-20120930.xsd#nvax_TenantAllowanceInterestRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ManufacturingLaboratoryAndOfficeFacilityAbstract.24462.12.6" xlink:to="loc_TenantAllowanceInterestRate.26650.12.6" order="5.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="111 - Disclosure - Master Services Agreement with Cadila" xlink:role="http://www.novavax.com/role/MasterServicesAgreementWithCadila" xlink:type="extended">
    <link:loc xlink:label="loc_MasterServicesAgreementWithCadilaAbstract.26651.12.7" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementWithCadilaAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_MasterServicesAgreementTextBlock.26652.12.7" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MasterServicesAgreementWithCadilaAbstract.26651.12.7" xlink:to="loc_MasterServicesAgreementTextBlock.26652.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="41101 - Disclosure - Master Services Agreement with Cadila (Details)" xlink:role="http://www.novavax.com/role/MasterServicesAgreementWithCadilaDetails" xlink:type="extended">
    <link:loc xlink:label="loc_MasterServicesAgreementWithCadilaAbstract.26651.12.7" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementWithCadilaAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.26654.12.7" xlink:href="nvax-20120930.xsd#nvax_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MasterServicesAgreementWithCadilaAbstract.26651.12.7" xlink:to="loc_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum.26654.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShortfallAmountPayableInFull.26900.12.7" xlink:href="nvax-20120930.xsd#nvax_ShortfallAmountPayableInFull" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MasterServicesAgreementWithCadilaAbstract.26651.12.7" xlink:to="loc_ShortfallAmountPayableInFull.26900.12.7" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PercentOfTheShortfallAmountExceedingTwoMillion.26957.12.7" xlink:href="nvax-20120930.xsd#nvax_PercentOfTheShortfallAmountExceedingTwoMillion" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MasterServicesAgreementWithCadilaAbstract.26651.12.7" xlink:to="loc_PercentOfTheShortfallAmountExceedingTwoMillion.26957.12.7" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MasterServiceAgreementPurchases.26958.12.7" xlink:href="nvax-20120930.xsd#nvax_MasterServiceAgreementPurchases" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MasterServicesAgreementWithCadilaAbstract.26651.12.7" xlink:to="loc_MasterServiceAgreementPurchases.26958.12.7" order="4.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="112 - Disclosure - Subsequent Events" xlink:role="http://www.novavax.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:label="loc_SubsequentEventsAbstract.5004.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventsTextBlock.16697.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventsAbstract.5004.12.7" xlink:to="loc_SubsequentEventsTextBlock.16697.12.7" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="41201 - Disclosure - Subsequent Events (Details)" xlink:role="http://www.novavax.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_SubsequentEventsAbstract.5004.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventsAbstract.5004.12.8" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.8" order="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_SharePrice.16294.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventsAbstract.5004.12.8" xlink:to="loc_SharePrice.16294.12.8" order="2.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventsAbstract.5004.12.8" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.12.8" order="3.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E2LAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Notes Payable (Narrative)(Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Notes Payable [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Borrowing limit of loan</a></td>
        <td class="nump">$ 2,000,000<span></span></td>
        <td class="nump">$ 2,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate', window );">Interest rate in addition to three-year U.S. Government treasury rate</a></td>
        <td class="nump">11.68%<span></span></td>
        <td class="nump">11.68%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum', window );">Minimum interest rate</a></td>
        <td class="nump">12.10%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_DebtInstrumentTerm', window );">Repayment term</a></td>
        <td class="text">42 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAdditionalBorrowings', window );">Debt instrument, increase in borrowings</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate during period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12.10%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly principal payments</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 13,089<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_DebtInstrumentTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stated term of debt instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_DebtInstrumentTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The percentage points added to the reference rate to compute the variable rate on the debt instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentBasisSpreadOnVariableRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The stated principal amount of the debt instrument at time of issuance, which may vary from the carrying amount because of unamortized premium or discount.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 55<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584090&amp;loc=d3e28878-108400<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 21<br><br> -Paragraph 16, 20<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentFaceAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAdditionalBorrowings">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Increase of additional borrowings on existing and new debt instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(f))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph f<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentIncreaseAdditionalBorrowings</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The average effective interest rate during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentInterestRateDuringPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>When presenting a range of interest rates, the lowest stated (contractual) rate for funds borrowed under the debt agreement as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the required periodic payments including both interest and principal payments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 470<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentPeriodicPayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E1BAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock-Based Compensation (Summary of Option Activity)(Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant at September 30, 2012</a></td>
        <td class="nump">5,559,536<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">2005 Stock Incentive Plan [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at January 1, 2012</a></td>
        <td class="nump">7,412,746<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
        <td class="nump">3,483,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
        <td class="num">(80,784)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled</a></td>
        <td class="num">(1,546,562)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at September 30, 2012</a></td>
        <td class="nump">9,268,400<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares exercisable at September 30, 2012</a></td>
        <td class="nump">3,503,043<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at January 1, 2012</a></td>
        <td class="nump">$ 2.22<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
        <td class="nump">$ 1.29<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
        <td class="nump">$ 0.61<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled</a></td>
        <td class="nump">$ 2.26<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at September 30, 2012</a></td>
        <td class="nump">$ 1.88<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable, September 30, 2012</a></td>
        <td class="nump">$ 2.38<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">1995 Stock Option Plan [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at January 1, 2012</a></td>
        <td class="nump">474,650<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled</a></td>
        <td class="num">(184,750)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at September 30, 2012</a></td>
        <td class="nump">289,900<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares exercisable at September 30, 2012</a></td>
        <td class="nump">289,900<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at January 1, 2012</a></td>
        <td class="nump">$ 4.38<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled</a></td>
        <td class="nump">$ 4.01<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at September 30, 2012</a></td>
        <td class="nump">$ 4.59<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable, September 30, 2012</a></td>
        <td class="nump">$ 4.59<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(c), d(2)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(c)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(f)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(b)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(a)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(a)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance on stock options awarded.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EBG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Organization (Details)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percent of joint venture</a></td>
        <td class="nump">20.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_JointVenturePercentageOwnedByOthers', window );">Joint venture, percent ownership of Cadila</a></td>
        <td class="nump">80.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_JointVenturePercentageOwnedByOthers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The percentage of the joint venture owned by others.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_JointVenturePercentageOwnedByOthers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 159<br><br> -Paragraph 18<br><br> -Subparagraph f<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6382943&amp;loc=d3e33918-111571<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 18<br><br> -Paragraph 20<br><br> -Subparagraph a (1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityMethodInvestmentOwnershipPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EDWAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Sales of Common Stock (Details) (USD $)<br>In Millions, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="4">1 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1">32 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Oct. 31, 2012</div>
        </th>
        <th class="th">
          <div>May 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2008</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Nov. 07, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_SalesOfCommonStockAbstract', window );"><strong>Sales of Common Stock [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock sold</a></td>
        <td class="nump">12,385,321<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">700,000<span></span></td>
        <td class="nump">6,686,650<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,400,000<span></span></td>
        <td class="nump">24,957,715<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Common stock, price per share</a></td>
        <td class="nump">$ 2.18<span></span></td>
        <td class="nump">$ 1.22<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 12.1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 17.5<span></span></td>
        <td class="nump">$ 0.8<span></span></td>
        <td class="nump">$ 14.0<span></span></td>
        <td class="nump">$ 49.9<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_CommonStockValueAuthorized', window );">Gross proceeds authorized in sale of stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50.0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_CommonStockValueAuthorizedPriorAgreement', window );">Gross proceeds authorized in sale of stock, prior sales agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 50.0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_AverageSharePrice', window );">Average sales price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.70<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_AverageSharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average price of a single share of a number of saleable stocks of a company during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_AverageSharePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_CommonStockValueAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock authorized for issuance, dolllar amount.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_CommonStockValueAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_CommonStockValueAuthorizedPriorAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock authorized for issuance in previous sale agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_CommonStockValueAuthorizedPriorAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_SalesOfCommonStockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_SalesOfCommonStockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOrSaleOfEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E5H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Capital Lease (Narrative)(Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Aug. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsAbstract', window );"><strong>Capital Lease [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_CapitalLeasesOfLesseeEffectiveInterestRate', window );">Effective interest rate on capital lease</a></td>
        <td class="nump">6.50%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_CapitalLeasePeriodicPayment', window );">Monthly lease payments</a></td>
        <td class="nump">$ 6,325<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LeaseTerm', window );">Lease term</a></td>
        <td class="text">59 months<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_CapitalLeasePeriodicPayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_CapitalLeasePeriodicPayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_CapitalLeasesOfLesseeEffectiveInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Effective interest rate of capital lease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_CapitalLeasesOfLesseeEffectiveInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LeaseTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LeaseTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeaseObligationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Liquidity Matters<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LiquidityMattersAbstract', window );"><strong>Liquidity Matters [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LiquidityMattersDisclosureTextBlock', window );">Liquidity Matters</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 2 - Liquidity Matters</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company&#39;s vaccine candidates currently under development will require significant additional research and development efforts that include extensive pre-clinical and clinical testing, and regulatory approval prior to commercial use. The Company&#39;s research and development efforts may not be successful and any potential vaccine candidates may not prove to be safe and effective in clinical trials. Even if developed, these vaccine candidates may not receive regulatory approval or be successfully introduced and marketed at prices that would permit the Company to operate profitably. The commercial launch of any vaccine is subject to significant risks including, but not limited to, manufacturing scale-up and market acceptance.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Since its inception, the Company has incurred, and continues to incur, significant losses from operations. At September 30, 2012, the Company had cash and cash equivalents of $10.7 million and short-term investments with a fair value of $17.7 million. In October 2012, the Company raised $27 million through the sale of common stock to institutional investors (See Note 12).</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Based on the Company&#39;s current cash and cash equivalents and short-term investments, including its recent private equity offering, anticipated revenue under the contract with the Department of Health and Human Services, Biomedical Advanced Research and Development Authority ("HHS BARDA") that was awarded in February 2011, possible proceeds from sales of the Company&#39;s common stock under its At Market Issuance Sales Agreement and its current business operations, the Company believes it has adequate capital resources available to operate at planned levels that fund the Company beyond 2013. Additional capital will be required in the future to develop its vaccine candidates through clinical development, manufacturing and commercialization. The Company&#39;s ability to obtain such additional capital is subject to various factors:</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 1in; FONT: 10pt Symbol"> &nbsp;</p> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.75in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; WIDTH: 0.25in">&middot;</td> <td style="TEXT-ALIGN: justify">generating revenue under the HHS BARDA contract is subject to the Company&#39;s performance under the contract, including its ability to collect on delayed reimbursement situations, such as the 205 Trial costs described in Note 5 below; and</td> </tr> </table> <p style="TEXT-ALIGN: justify; TEXT-INDENT: -0.25in; MARGIN: 0pt 0px 0pt 1in; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.75in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; WIDTH: 0.25in">&middot;</td> <td style="TEXT-ALIGN: justify">raising funds under its At Market Issuance Sales Agreement is subject to both its business performance and market conditions.</td> </tr> </table> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Further, the Company may seek additional capital through public or private equity offerings, debt financing, strategic alliance and licensing arrangements, non-dilutive government contracts, collaborative arrangements, or some combination of these financing alternatives. Any capital raised by an equity offering, whether public or private, will likely be substantially dilutive to the existing stockholders and any licensing or development arrangement may require the Company to give up rights to a product or technology at less than its full potential value. Other than the Company&#39;s At Market Issuance Sales Agreement, Equipment Loan (See Note 7) and Improvement Allowance (See Note 10), the Company has not secured any additional commitments for new financing, nor can the Company provide any assurance that financing will be available on commercially acceptable terms, if at all. If the Company is unable to perform under the HHS BARDA contract or obtain additional capital, it will assess its capital resources and will likely be required to delay, reduce the scope of, or eliminate one or more of its research and development programs, and/or downsize the organization, including its general and administrative infrastructure.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LiquidityMattersAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LiquidityMattersAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LiquidityMattersDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Liquidity Matters Disclosure</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LiquidityMattersDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>19
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0D%,04Y#15]32$5%
M5%,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,#(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y"04Q!
M3D-%7U-(14544U]087)E;G1H971I8V%L/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`S+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^4U1!5$5-14Y44U]/1E]/4$52051)3TY3/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U1!5$5-14Y4
M4U]/1E]#3TU04D5(14Y3259%7TQ//"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`U+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^4U1!5$5-14Y44U]/1E]#05-(7T9,3U=3/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`V+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U1!5$5-14Y44U]/
M1E]#05-(7T9,3U=37U!A<F5N/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`W+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^3W)G86YI>F%T:6]N/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`X+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^3&EQ=6ED:71Y7TUA='1E<G,\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,#DN:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=6UM87)Y7V]F7U-I9VYI
M9FEC86YT7T%C8V]U;G0\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3`N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y3=&]C:T)A<V5D7T-O;7!E;G-A=&EO;CPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q
M,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E537T=O=F5R;FUE;G1?06=R965M
M96YT7V%N9%]#;SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,BYH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/D-A<&ET86Q?3&5A<V4\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3,N:'1M;"(O/@T*("`@
M/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@
M("`@/'@Z3F%M93Y.;W1E<U]087EA8FQE/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$T+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^5V%R<F%N=%],:6%B:6QI='D\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,34N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y386QE<U]O9E]#;VUM;VY?
M4W1O8VL\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,38N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y-
M86YU9F%C='5R:6YG7TQA8F]R871O<GE?86YD7T\\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3<N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y-87-T97)?4V5R=FEC97-?06=R965M
M96YT7W=I=&@\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,3@N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y3=6)S97%U96YT7T5V96YT<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q.2YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/E-U;6UA<GE?;V9?4VEG;FEF:6-A;G1?06-C;W5N=#$\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,C`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=6UM87)Y
M7V]F7U-I9VYI9FEC86YT7T%C8V]U;G0R/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(Q+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^4W1O8VM"87-E9%]#;VUP96YS871I;VY?5&%B
M;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#(R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V%P
M:71A;%],96%S95]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C,N:'1M;"(O/@T*("`@
M/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@
M("`@/'@Z3F%M93Y.;W1E<U]087EA8FQE7U1A8FQE<SPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R
M-"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D]R9V%N:7IA=&EO;E]$971A:6QS
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#(U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3&EQ=6ED
M:71Y7TUA='1E<G-?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-BYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/E-U;6UA<GE?;V9?4VEG;FEF:6-A;G1?06-C;W5N=#,\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,C<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=6UM87)Y
M7V]F7U-I9VYI9FEC86YT7T%C8V]U;G0T/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(X+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^4W5M;6%R>5]O9E]3:6=N:69I8V%N=%]!8V-O
M=6YT-3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970R.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-U
M;6UA<GE?;V9?4VEG;FEF:6-A;G1?06-C;W5N=#8\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,S`N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=&]C:T)A<V5D7T-O;7!E;G-A=&EO
M;E].87)R870\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,S$N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y3=&]C:T)A<V5D7T-O;7!E;G-A=&EO;E]3=&]C:T(\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M,S(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=&]C:T)A<V5D7T-O;7!E;G-A
M=&EO;E]3=6UM87(\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,S,N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y3=&]C:T)A<V5D7T-O;7!E;G-A=&EO;E]!<W-U;7`\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,S0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=&]C:T)A<V5D7T-O;7!E
M;G-A=&EO;E]3=6UM87(Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,U+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^55-?1V]V97)N;65N=%]!9W)E96UE;G1?86YD7T-O,3PO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970S-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-A<&ET86Q?3&5A
M<V5?3F%R<F%T:79E1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S-RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/D-A<&ET86Q?3&5A<V5?1G5T=7)E7TUI;FEM=6U?0SPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970S."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5S7U!A
M>6%B;&5?3F%R<F%T:79E1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S.2YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/DYO=&5S7U!A>6%B;&5?06=G<F5G871E7T9U='5R
M93PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970T,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E=A<G)A
M;G1?3&EA8FEL:71Y7T1E=&%I;',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T-#$N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y386QE<U]O9E]#;VUM;VY?4W1O8VM?1&5T86EL<SPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970T,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DUA;G5F86-T
M=7)I;F=?3&%B;W)A=&]R>5]A;F1?3S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T-#,N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y-87-T97)?4V5R=FEC97-?06=R965M96YT7W=I
M=&@Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#0T+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4W5B
M<V5Q=65N=%]%=F5N='-?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T-2YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@(#PO>#I%>&-E;%=O<FMS:&5E
M=',^#0H@(#QX.E-T>6QE<VAE970@2%)E9CTS1")7;W)K<VAE971S+W)E<&]R
M="YC<W,B+SX-"B`@/'@Z06-T:79E4VAE970^,#PO>#I!8W1I=F53:&5E=#X-
M"B`@/'@Z4')O=&5C=%-T<G5C='5R93Y&86QS93PO>#I0<F]T96-T4W1R=6-T
M=7)E/@T*("`\>#I0<F]T96-T5VEN9&]W<SY&86QS93PO>#I0<F]T96-T5VEN
M9&]W<SX-"B`\+W@Z17AC96Q7;W)K8F]O:SX-"CPO>&UL/CPA6V5N9&EF72TM
M/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@
M8F4@;W!E;F5D('=I=&@@36EC<F]S;V9T($5X8V5L(%A0(&]R(&YE=V5R+CPO
M<#X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!A
M96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U86%E.3)D90T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B\P865B-&$X,5]D9F0V7S0V8C5?8C,R9%\U
M9F4T-6%A93DR9&4O5V]R:W-H965T<R]3:&5E=#`Q+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M4$-!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY$;V-U;65N="!A;F0@16YT
M:71Y($EN9F]R;6%T:6]N/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^3V-T+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N="!A;F0@16YT:71Y($EN9F]R;6%T
M:6]N(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&]C=6UE;G0@5'EP93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^,3`M43QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06UE;F1M96YT($9L86<\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/F9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!097)I;V0@16YD
M($1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/E-E<"`S,"P-
M"@D),C`Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^16YT:71Y(%)E9VES=')A;G0@3F%M93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^3D]6059!6"!)3D,N/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@0V5N=')A
M;"!);F1E>"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C`P
M,#$P,#`V.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E1R861I;F<@4WEM8F]L/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#Y.5D%8/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#=7)R96YT($9I<V-A;"!996%R($5N9"!$871E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XM+3$R+3,Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U
M;65N="!&:7-C86P@665A<B!&;V-U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^,C`Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&]C=6UE;G0@1FES8V%L(%!E<FEO9"!&;V-U<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^43,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!&:6QE
M<B!#871E9V]R>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^06-C
M96QE<F%T960@1FEL97(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#;VUM;VX@4W1O8VLL(%-H87)E<R!/
M=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30W
M+#DT,2PT-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U86%E.3)D90T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P865B-&$X,5]D9F0V7S0V8C5?
M8C,R9%\U9F4T-6%A93DR9&4O5V]R:W-H965T<R]3:&5E=#`R+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%43%!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY"04Q!3D-%(%-(
M14544R`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R=VES
M92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^0W5R<F5N="!A<W-E=',Z/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@86YD(&-A
M<V@@97%U:79A;&5N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,3`L-S,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`Q-"PQ,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-H;W)T+71E<FT@:6YV97-T;65N=',@879A
M:6QA8FQE+69O<BUS86QE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-RPV-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT+#(P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4F5S=')I8W1E9"!C87-H/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XX,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S(')E
M8V5I=F%B;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#0V
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L.38U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y5;F)I;&QE9"!R96-E:79A8FQE<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PW,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@S-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E<&%I9"!E>'!E;G-E<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPX,#<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#0T,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H
M97(@8W5R<F5N="!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(S-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L-34X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5&]T86P@8W5R<F5N="!A<W-E=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,V+#0X-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(V+#$P.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R='D@
M86YD(&5Q=6EP;65N="P@;F5T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XY+#@Q-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C8L.#4W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y';V]D=VEL;#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S,L,30Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,S,L,30Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-T<FEC=&5D(&-A<V@\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<U-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3W1H97(@;F]N+6-U<G)E;G0@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XT-CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!A<W-E=',\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C@P+#4T-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8V+#4W-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#=7)R
M96YT(&QI86)I;&ET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!P87EA8FQE/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#(P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-C0U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R=65D(&5X<&5N<V5S
M(&%N9"!O=&AE<B!C=7)R96YT(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV+#`S,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-3(X/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!R979E;G5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,#,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-U<G)E;G0@<&]R=&EO;B!O9B!C87!I=&%L(&QE87-E/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0W5R<F5N
M="!P;W)T:6]N(&]F(&YO=&5S('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$U-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT(&QI86)I;&ET>3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S8Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!R96YT/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,C$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.#8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C
M=7)R96YT(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,"PT-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XW+#4W.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@<F5V96YU93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPU,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#4P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]N+6-U<G)E;G0@
M<&]R=&EO;B!O9B!C87!I=&%L(&QE87-E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO;BUC=7)R96YT('!O<G1I
M;VX@;V8@;F]T97,@<&%Y86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-SDS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y787)R86YT(&QI86)I;&ET>3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S8X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!R
M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#$X-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.3@P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$Y+#$W,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$R+#<R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6ET;65N=',@86YD(&-O;G1I;F=E
M;F-I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,G(&5Q=6ET
M>3H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4')E9F5R<F5D('-T;V-K+"`D,"XP,2!P87(@=F%L=64L(#(L,#`P+#`P,"!S
M:&%R97,@875T:&]R:7IE9#L@;F\@<VAA<F5S(&ES<W5E9"!A;F0@;W5T<W1A
M;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"`D,"XP,2!P87(@=F%L
M=64L(#(P,"PP,#`L,#`P('-H87)E<R!A=71H;W)I>F5D.R!A;F0@,3,V+#`P
M,RPV-S8@<VAA<F5S(&ES<W5E9"!A;F0@,3,U+#4T."PR-#8@<VAA<F5S(&]U
M='-T86YD:6YG(&%T(%-E<'1E;6)E<B`S,"P@,C`Q,B!A;F0@,3$W+#0X,"PX
M-C<@<VAA<F5S(&ES<W5E9"!A;F0@,3$W+#`R-2PT,S<@<VAA<F5S(&]U='-T
M86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$Q/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#,V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L,3<U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!9&1I=&EO;F%L('!A:60M:6X@
M8V%P:71A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#$Q+#4U
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,X,RPY-#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%C8W5M=6QA=&5D(&1E9FEC:70\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#,U,"PQ,C@I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S(Y+#8U-BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1R96%S=7)Y('-T
M;V-K+"`T-34L-#,P('-H87)E<RP@8V]S="!B87-I<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,BPT-3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPT-3`I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-U;75L871E9"!O
M=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PP,S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XX,S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!S=&]C:VAO;&1E<G,G(&5Q
M=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C$L,S<V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3,L
M.#0Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5&]T86P@;&EA8FEL:71I97,@86YD('-T;V-K:&]L9&5R<R<@97%U
M:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#@P+#4T-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M-C8L-3<V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
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M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P14%!044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^0D%,04Y#12!32$5%
M5%,@*%!A<F5N=&AE=&EC86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D)!3$%.
M0T4@4TA%1513(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D('-T;V-K+"!P87(@;W(@<W1A
M=&5D('9A;'5E('!E<B!S:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`P+C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`P+C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R960@<W1O8VLL('-H87)E<R!A
M=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#`P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@<VAA<F5S(&ES<W5E
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y0<F5F97)R960@<W1O8VLL('-H87)E<R!O=71S=&%N
M9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('!A<B!V86QU92!P97(@
M<VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,"XP,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]M;6]N('-T;V-K+"!S:&%R97,@875T:&]R:7IE9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`P+#`P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,#`L,#`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V]M;6]N('-T;V-K+"!S:&%R97,@:7-S=65D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,S8L,#`S+#8W-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q-RPT.#`L.#8W/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM
M;VX@<W1O8VLL('-H87)E<R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3,U+#4T."PR-#8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3<L,#(U+#0S-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5')E87-U
M<GD@<W1O8VLL('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#4U+#0S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0U-2PT,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U86%E
M.3)D90T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P865B-&$X,5]D
M9F0V7S0V8C5?8C,R9%\U9F4T-6%A93DR9&4O5V]R:W-H965T<R]3:&5E=#`T
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%4$Q!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3
M5$%414U%3E13($]&($]015)!5$E/3E,@*%531"`D*3QB<CY);B!4:&]U<V%N
M9',L(&5X8V5P="!3:&%R92!D871A+"!U;FQE<W,@;W1H97)W:7-E('-P96-I
M9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#(^.2!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y397`N(#,P+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY35$%414U%3E13($]&($]015)!5$E/3E,@
M6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y';W9E<FYM96YT(&-O;G1R86-T<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`U+#4X,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-2PP,#@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$W+#,R.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@."PX-#,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E)E<V5A<F-H(&%N9"!D979E;&]P;65N="!C;VQL86)O<F%T:6]N/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#(\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#(\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;"!R979E;G5E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU+#<V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C4L,#`X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<L-3$P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PX-#,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M0V]S=',@86YD(&5X<&5N<V5S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;W-T(&]F(&=O=F5R;FUE;G0@8V]N=')A8W1S
M(')E=F5N=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L.#,X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,BPQ.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,BPW-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#<V,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#,Y-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L,#0Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38L-C0Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3,L-#<T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y'96YE<F%L(&%N9"!A9&UI;FES=')A=&EV93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPS.#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#<S-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@L,CDQ/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PY,C8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4
M;W1A;"!C;W-T<R!A;F0@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$R+#8Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C@L.3<V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S<L-C@P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8L,38S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]S<R!F<F]M
M(&]P97)A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8L
M.#0Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#,L.38X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#(P+#$W,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Q-RPS,C`I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]T:&5R(&EN8V]M
M92`H97AP96YS92DZ/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DEN=&5R97-T(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)E<W0@97AP96YS93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-BD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$R*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#:&%N9V4@
M:6X@9F%I<B!V86QU92!O9B!W87)R86YT(&QI86)I;&ET>3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-#`Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<S-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0P,2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#DW,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO<W,@
M9G)O;2!O<&5R871I;VYS(&)E9F]R92!I;F-O;64@=&%X/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@W+#(Q-RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#(Q,BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,"PT-S(I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,34L,C0W
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^26YC;VUE('1A>"!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@W+#(Q-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#,L,C$R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^)"`H,C`L-#<R*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,34L-C4Y*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S:6,@86YD
M(&1I;'5T960@;F5T(&QO<W,@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B0@*#`N,#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C`S*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XQ-BD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,30I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"
M87-I8R!A;F0@9&EL=71E9"!W96EG:'1E9"!A=F5R86=E(&YU;6)E<B!O9B!C
M;VUM;VX@<VAA<F5S(&]U='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,S0L,3<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3$U+#$P-SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R-RPR-#8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3,L,#4S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
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M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U+04,^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^4U1!5$5-14Y44R!/1B!#3TU04D5(14Y3
M259%($Q/4U,@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE
M<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$Q/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-O;7!R96AE;G-I=F4@
M;&]S<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M-RPR,3<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XD("@S+#(Q,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B0@*#(P+#0W,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$U+#8U.2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N<F5A;&EZ960@
M9V%I;B!O;B!S:&]R="UT97)M(&EN=F5S=&UE;G1S(&%V86EL86)L92UF;W(M
M<V%L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.38\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30Q
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V]M<')E:&5N<VEV92!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#<L,3(Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^)"`H,RPR,#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R,"PR-C@I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q-2PU,3@I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
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M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14$R04<^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^4U1!5$5-14Y44R!/1B!#05-(($9,
M3U=3("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E
M('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0R/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@
M,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P
M+B`S,"P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY/<&5R871I;F<@06-T:79I=&EE<SH\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,C`L-#<R*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,34L-C4Y*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY296-O;F-I;&EA=&EO;B!O9B!N970@;&]S<R!T;R!N970@8V%S
M:"!U<V5D(&EN(&]P97)A=&EN9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#:&%N9V4@:6X@9F%I<B!V
M86QU92!O9B!W87)R86YT(&QI86)I;&ET>3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,2PY-S,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97!R96-I871I;VX@86YD(&%M;W)T
M:7IA=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PR,38\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#$Y-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06UO<G1I>F%T:6]N(&]F(&YE="!P<F5M:75M<R!O;B!S:&]R="UT
M97)M(&EN=F5S=&UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XS,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DEM<&%I<FUE;G0@;V8@<')O<&5R='D@86YD
M(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D=A:6X@;VX@9&ES<&]S86P@;V8@<')O<&5R='D@86YD
M(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C8I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$969E<G)E9"!R96YT/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XT,S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@R-30I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.;VXM8V%S:"!S=&]C:RUB87-E9"!C
M;VUP96YS871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M-C8X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PV-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^0VAA;F=E<R!I;B!O<&5R871I;F<@87-S971S
M(&%N9"!L:6%B:6QI=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^06-C;W5N=',@<F5C96EV86)L97,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#4P-"D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YB:6QL960@<F5C96EV
M86)L97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L.#0X
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4')E<&%I9"!E>'!E;G-E<R!A;F0@;W1H97(@87-S971S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-S$I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PQ,C<I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!P
M87EA8FQE(&%N9"!A8V-R=65D(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@S,#0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,RPV.#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!R979E;G5E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,#,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#4P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&5A<V4@
M:6YC96YT:79E<R!R96-E:79E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,BPX,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@8V%S:"!U<V5D(&EN(&]P
M97)A=&EN9R!A8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q-"PQ,SDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,C`L-S8P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY);G9E<W1I;F<@06-T:79I
M=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V%P:71A;"!E>'!E;F1I='5R97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#(L,C`R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#0Q-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@9&ES<&]S86P@
M;V8@<')O<&5R='D@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S$X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M(&UA
M='5R:71I97,@;V8@<VAO<G0M=&5R;2!I;G9E<W1M96YT<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPU,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PR,S4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!U<F-H87-E<R!O
M9B!S:&]R="UT97)M(&EN=F5S=&UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q-2PW-C,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,BPP.#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&-A<V@@*'5S960@:6XI
M('!R;W9I9&5D(&)Y(&EN=F5S=&EN9R!A8W1I=FET:65S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@Q-2PQ-#<I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<L-S,Y/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9I
M;F%N8VEN9R!!8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<FEN8VEP86P@<&%Y;65N=',@;V8@8V%P:71A
M;"!L96%S93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.3`I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y0<FEN8VEP86P@<&%Y;65N=',@;V8@;F]T97,@<&%Y86)L
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C`I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C`I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C
M965D<R!F<F]M(&YO=&5S('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C8U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')I8W1E9"!C87-H/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#4Y-"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DYE="!P<F]C965D<R!F<F]M('-A;&5S(&]F(&-O;6UO;B!S=&]C:RP@
M;F5T(&]F(&]F9F5R:6YG(&-O<W1S(&]F("0P+C0@;6EL;&EO;B!A;F0@)#`N
M,B!M:6QL:6]N+"!R97-P96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(V+#DR-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/CDL,3@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('1H92!E>&5R
M8VES92!O9B!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$U-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DYE="!C87-H('!R;W9I9&5D(&)Y(&9I;F%N8VEN
M9R!A8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M-2PY,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XY+#(W.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYE="`H9&5C<F5A<V4I(&EN8W)E87-E(&EN(&-A<V@@
M86YD(&-A<V@@97%U:79A;&5N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#,L,S8V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C8L,C4W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S
M(&%T(&)E9VEN;FEN9R!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$T+#$P-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C@L,#8Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE
M;G1S(&%T(&5N9"!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$P+#<S.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$T+#,Q.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=7!P;&5M96YT86P@9&ES
M8VQO<W5R92!O9B!N;VXM8V%S:"!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%<75I<&UE;G0@86-Q=6ER
M960@=6YD97(@82!C87!I=&%L(&QE87-E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<&]S:70@87!P;&EE9"!T
M;W=A<F1S('1H92!P=7)C:&%S92!O9B!L86)O<F%T;W)Y(&5Q=6EP;65N=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y0<F]P97)T>2!A;F0@97%U:7!M96YT('!U<F-H87-E<R!I;F-L=61E9"!I
M;B!A8V-O=6YT<R!P87EA8FQE(&%N9"!A8V-R=65D(&5X<&5N<V5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,V-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V5T=&QE;65N
M="!O9B!N;W1E<R!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-3(R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M
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M<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\3454
M02!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H
M=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S
M8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M
M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE
M(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14=(/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/E-4051%345.5%,@3T8@0T%32"!&3$]74R`H4&%R96YT:&5T:6-A
M;"D@*%531"`D*3QB<CY);B!-:6QL:6]N<RP@=6YL97-S(&]T:&5R=VES92!S
M<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@
M,S`L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^4U1!5$5-14Y44R!/1B!#05-(($9,3U=3(%M!8G-T<F%C=%T\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M('!R;V-E961S(&9R;VT@<V%L97,@;V8@8V]M;6]N('-T;V-K+"!O9F9E<FEN
M9R!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#`N,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,&%E8C1A.#%?9&9D-E\T-F(U7V(S,F1?-69E-#5A864Y,F1E#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D
M7S5F930U86%E.3)D92]7;W)K<VAE971S+U-H965T,#@N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY/<F=A;FEZ871I;VX\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/
M<F=A;FEZ871I;VX@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/<F=A;FEZ871I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M
M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z
M+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA
M;"YD=&0B("TM/@T*/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\
M<"!S='EL93TS1"=415A4+4E.1$5.5#H@,&EN.R!-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(&)O;&0@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^($YO=&4@,2`M($]R9V%N:7IA=&EO;CPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B`\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J
M=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^($YO
M=F%V87@L($EN8RX@*'1H92`B0V]M<&%N>2(I(&ES(&$@8VQI;FEC86PM<W1A
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M<&ER871O<GD@<WEN8WET:6%L('9I<G5S("@B4E-6(BDN/"]P/B`\<"!S='EL
M93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^(#QB<B`O/B`\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@26X@,C`P.2P@=&AE($-O;7!A;GD@9F]R;65D(&$@:F]I;G0@=F5N
M='5R92!W:71H($-A9&EL82!0:&%R;6%C975T:6-A;',@3&EM:71E9"`H(D-A
M9&EL82(I(&YA;65D($-03"!":6]L;V=I8V%L<R!0<FEV871E($QI;6ET960@
M*'1H92`B2E8B*2!T;R!D979E;&]P(&%N9"!M86YU9F%C='5R92!V86-C:6YE
M<RP@8FEO;&]G:6-A;"!T:&5R87!E=71I8W,@86YD(&1I86=N;W-T:6-S(&EN
M($EN9&EA+B!4:&4@2E8@:7,@;W=N960@,C`E(&)Y('1H92!#;VUP86YY(&%N
M9"`X,"4@8GD@0V%D:6QA+B!4:&4@0V]M<&%N>2!A8V-O=6YT<R!F;W(@:71S
M(&EN=F5S=&UE;G0@:6X@=&AE($I6('5S:6YG('1H92!E<75I='D@;65T:&]D
M+CPO<#X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&%E8C1A.#%?9&9D
M-E\T-F(U7V(S,F1?-69E-#5A864Y,F1E#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U86%E.3)D
M92]7;W)K<VAE971S+U-H965T,#DN:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY,:7%U:61I='D@36%T=&5R<SQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DQI<75I9&ET
M>2!-871T97)S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3&EQ=6ED:71Y($UA='1E<G,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#
M("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT
M='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I
M;VYA;"YD=&0B("TM/@T*/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM
M/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,&EN.R!-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(&)O;&0@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^($YO=&4@,B`M($QI<75I9&ET>2!-871T97)S/"]P/B`\<"!S='EL
M93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!
M3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
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M+75P(&%N9"!M87)K970@86-C97!T86YC92X\+W`^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J
M=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(%-I
M;F-E(&ET<R!I;F-E<'1I;VXL('1H92!#;VUP86YY(&AA<R!I;F-U<G)E9"P@
M86YD(&-O;G1I;G5E<R!T;R!I;F-U<BP@<VEG;FEF:6-A;G0@;&]S<V5S(&9R
M;VT@;W!E<F%T:6]N<RX@070@4V5P=&5M8F5R(#,P+"`R,#$R+"!T:&4@0V]M
M<&%N>2!H860@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<R!O9B`D,3`N-R!M
M:6QL:6]N(&%N9"!S:&]R="UT97)M(&EN=F5S=&UE;G1S('=I=&@@82!F86ER
M('9A;'5E(&]F("0Q-RXW(&UI;&QI;VXN($EN($]C=&]B97(@,C`Q,BP@=&AE
M($-O;7!A;GD@<F%I<V5D("0R-R!M:6QL:6]N('1H<F]U9V@@=&AE('-A;&4@
M;V8@8V]M;6]N('-T;V-K('1O(&EN<W1I='5T:6]N86P@:6YV97-T;W)S("A3
M964@3F]T92`Q,BDN/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T
M:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P
M.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM
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M960@4F5S96%R8V@@86YD($1E=F5L;W!M96YT($%U=&AO<FET>2`H(DA(4R!"
M05)$02(I('1H870@=V%S(&%W87)D960@:6X@1F5B<G5A<GD@,C`Q,2P@<&]S
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M('9A<FEO=7,@9F%C=&]R<SH\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`M,"XR-6EN.R!-05)'24XZ(#!P="`P
M<'@@,'!T(#%I;CL@1D].5#H@,3!P="!3>6UB;VPG/B`F;F)S<#L\+W`^(#QT
M86)L92!S='EL93TS1"=-05)'24XM5$]0.B`P<'0[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($U!4D=)3BU"3U143TTZ(#!P
M="<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P
M,"4^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@=&]P)SX@/'1D('-T
M>6QE/3-$)U=)1%1(.B`P+C<U:6XG/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=W:61T:#H@,"XR-6EN.R<^)FUI9&1O=#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@:G5S=&EF>2<^9V5N97)A=&EN9R!R979E;G5E('5N9&5R
M('1H92!(2%,@0D%21$$@8V]N=')A8W0@:7,@<W5B:F5C="!T;R!T:&4@0V]M
M<&%N>28C,SD[<R!P97)F;W)M86YC92!U;F1E<B!T:&4@8V]N=')A8W0L(&EN
M8VQU9&EN9R!I=',@86)I;&ET>2!T;R!C;VQL96-T(&]N(&1E;&%Y960@<F5I
M;6)U<G-E;65N="!S:71U871I;VYS+"!S=6-H(&%S('1H92`R,#4@5')I86P@
M8V]S=',@9&5S8W)I8F5D(&EN($YO=&4@-2!B96QO=SL@86YD/"]T9#X@/"]T
M<CX@/"]T86)L93X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z("TP+C(U:6X[($U!4D=)3CH@,'!T(#!P>"`P<'0@,6EN
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4],T0G34%21TE.+51/4#H@,'!T.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!-05)'
M24XM0D]45$]-.B`P<'0G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@=VED=&@],T0Q,#`E/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ
M('1O<"<^(#QT9"!S='EL93TS1"=724142#H@,"XW-6EN)SXF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G=VED=&@Z(#`N,C5I;CLG/B9M:61D;W0[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GDG/G)A:7-I;F<@9G5N
M9',@=6YD97(@:71S($%T($UA<FME="!)<W-U86YC92!386QE<R!!9W)E96UE
M;G0@:7,@<W5B:F5C="!T;R!B;W1H(&ET<R!B=7-I;F5S<R!P97)F;W)M86YC
M92!A;F0@;6%R:V5T(&-O;F1I=&EO;G,N/"]T9#X@/"]T<CX@/"]T86)L93X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
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M965M96YT+"!%<75I<&UE;G0@3&]A;B`H4V5E($YO=&4@-RD@86YD($EM<')O
M=F5M96YT($%L;&]W86YC92`H4V5E($YO=&4@,3`I+"!T:&4@0V]M<&%N>2!H
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M86YD(&%D;6EN:7-T<F%T:79E(&EN9G)A<W1R=6-T=7)E+CPO<#X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!I;CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B!B;VQD(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#PA+2U%;F1&<F%G;65N
M="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
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M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4W5M
M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5M
M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T
M<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4W5M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#5%E012!H
M=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA
M;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL
M,2UT<F%N<VET:6]N86PN9'1D(B`M+3X-"CQD:78^(#QD:78^/"$M+5-T87)T
M1G)A9VUE;G0M+3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B!B;VQD
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!.;W1E(#,@
M+2!3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@
M,'!T(#!P>"`P<'0@,"XR-6EN.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T(#!P>"`P<'0@,"XR-6EN.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/'-T
M<F]N9SX\96T^0F%S:7,@;V8@4')E<V5N=&%T:6]N/"]E;3X\+W-T<F]N9SX\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL
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M;W)M(#$P+5$@86YD($%R=&EC;&4@,3`@;V8@4F5G=6QA=&EO;B!3+5@N(%1H
M92!B86QA;F-E('-H965T(&%S(&]F(%-E<'1E;6)E<B`S,"P@,C`Q,BP@<W1A
M=&5M96YT<R!O9B!O<&5R871I;VYS(&9O<B!T:&4@=&AR964@86YD(&YI;F4@
M;6]N=&AS(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q,B!A;F0@,C`Q,2!A;F0@
M=&AE('-T871E;65N=',@;V8@8V%S:"!F;&]W<R!F;W(@=&AE(&YI;F4@;6]N
M=&AS(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q,B!A;F0@,C`Q,2!A<F4@=6YA
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M;VX@*")314,B*2X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I
M9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[
M/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.
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M86P@4F5P;W)T(&]N($9O<FT@,3`M2R!F;W(@=&AE('EE87(@96YD960@1&5C
M96UB97(@,S$L(#(P,3$N/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J
M=7-T:69Y.R!-05)'24XZ(#!P="`P<'@@,'!T(#`N,C5I;CL@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]P/B`\
M<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P="`P
M<'@@,'!T(#`N,C5I;CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^(#QS=')O;F<^/&5M/E5S92!O9B!%<W1I;6%T97,\+V5M
M/CPO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S
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M(&UA=&5R:6%L;'D@9G)O;2!T:&5S92!E<W1I;6%T97,N/"]P/B`\<"!S='EL
M93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P="`P<'@@,'!T
M(#`N,C5I;CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T
M:69Y.R!-05)'24XZ(#!P="`P<'@@,'!T(#`N,C5I;CL@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QS=')O;F<^/&5M/D9A
M:7(@5F%L=64@365A<W5R96UE;G1S/"]E;3X\+W-T<F]N9SX\+W`^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T(#!P>"`P
M<'0@,"XR-6EN.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J
M=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(%1H
M92!#;VUP86YY(&%P<&QI97,@06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D:69I
M8V%T:6]N("@B05-#(BD@5&]P:6,@.#(P+"`\96T^1F%I<B!686QU92!-96%S
M=7)E;65N=',@86YD($1I<V-L;W-U<F5S/"]E;3XL(&9O<B!F:6YA;F-I86P@
M86YD(&YO;BUF:6YA;F-I86P@87-S971S(&%N9"!L:6%B:6QI=&EE<RX\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T
M(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
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M(&QE=F5L<SH\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)TU!
M4D=)3BU43U`Z(#!P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@34%21TE.+4)/5%1/33H@,'!T)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X@/'1R('-T>6QE/3-$
M)U9%4E1)0T%,+4%,24=..B!T;W`G/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@:G5S=&EF>3L@5TE$5$@Z(#`N,C5I;B<^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[('=I9'1H.B`P+C(U:6X[)SX@
M)FUI9&1O=#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF
M>2<^3&5V96P@,3H@3V)S97)V86)L92!I;G!U=',@<W5C:"!A<R!Q=6]T960@
M<')I8V5S("AU;F%D:G5S=&5D*2!I;B!A8W1I=F4@;6%R:V5T<R!F;W(@:61E
M;G1I8V%L(&%S<V5T<R!O<B!L:6%B:6QI=&EE<RX\+W1D/B`\+W1R/B`\+W1A
M8FQE/B`\=&%B;&4@<W1Y;&4],T0G34%21TE.+51/4#H@,'!T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!-05)'24XM0D]4
M5$]-.B`P<'0G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED
M=&@],T0Q,#`E/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ('1O<"<^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!724142#H@,"XR
M-6EN)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S
M=&EF>3L@=VED=&@Z(#`N,C5I;CLG/B`F;6ED9&]T.SPO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!J=7-T:69Y)SY,979E;"`R.B!);G!U=',@;W1H
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M05)'24XM5$]0.B`P<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[($U!4D=)3BU"3U143TTZ(#!P="<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT<B!S='EL93TS
M1"=615)424-!3"U!3$E'3CH@=&]P)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&IU<W1I9GD[(%=)1%1(.B`P+C(U:6XG/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!W:61T:#H@,"XR-6EN.R<^
M("9M:61D;W0[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I
M9GDG/DQE=F5L(#,Z(%5N;V)S97)V86)L92!I;G!U=',@=&AA="!R969L96-T
M('1H92!R97!O<G1I;F<@96YT:71Y)B,S.3MS(&]W;B!A<W-U;7!T:6]N<RX\
M+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J
M=7-T:69Y.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@1FEN86YC:6%L(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@
M;65A<W5R960@870@9F%I<B!M87)K970@=F%L=64@;VX@82!R96-U<G)I;F<@
M8F%S:7,@87,@;V8@4V5P=&5M8F5R(#,P+"`R,#$R(&%N9"!$96-E;6)E<B`S
M,2P@,C`Q,2!A<F4@<W5M;6%R:7IE9"!B96QO=R`H:6X@=&AO=7-A;F1S*3H\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\=&%B;&4@
M<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P
M<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS
M1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9"<@;F]W<F%P/3-$;F]W<F%P
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`]
M,T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Y<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0Q,"!N
M;W=R87`],T1N;W=R87`^1F%I<B!686QU92!A="!397!T96UB97(@,S`L(#(P
M,3(\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N;W=R
M87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P="<@;F]W<F%P
M/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@.7!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$,3`@
M;F]W<F%P/3-$;F]W<F%P/D9A:7(@5F%L=64@870@1&5C96UB97(@,S$L(#(P
M,3$\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N;W=R
M87`^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,
M24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/
M3E0M5T5)1TA4.B!B;VQD)R!N;W=R87`],T1N;W=R87`^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O
M;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A<#XF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T
M('-O;&ED.R!&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%
M6%0M04Q)1TXZ(&-E;G1E<B<@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P
M/DQE=F5L(#$\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`]
M,T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P="<@
M;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@.7!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N
M/3-$,B!N;W=R87`],T1N;W=R87`^3&5V96P@,CPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M
M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0
M041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI
M9#L@1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,
M24=..B!C96YT97(G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#Y,979E
M;"`S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P="<@;F]W<F%P/3-$;F]W
M<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@
M1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A
M<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#EP=#L@1D].5"U7
M14E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&-E;G1E<B<@8V]L<W!A;CTS1#(@
M;F]W<F%P/3-$;F]W<F%P/DQE=F5L(#$\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/
M33H@,7!T)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.
M1RU"3U143TTZ(#%P="<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/
M3E0M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@
M8V5N=&5R)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^3&5V96P@,CPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z
M(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A<#XF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N
M;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4
M.B!B;VQD.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R(&YO=W)A
M<#TS1&YO=W)A<#Y,979E;"`S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:
M13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P
M="<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL
M93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU,1494.B`Y+C0U<'0[
M(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!415A4+4E.1$5.5#H@+3DN
M-#5P="<^($%S<V5T<SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP
M="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!4
M15A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP="<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,
M24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%
M.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP="<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L
M969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SXF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#EP="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SXF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#EP="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS
M1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET93L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;2<^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"
M3U143TTZ(#(N-7!T.R!0041$24Y'+4Q%1E0Z(#DN-#5P=#L@5$585"U!3$E'
M3CH@;&5F=#L@5$585"U)3D1%3E0Z("TY+C0U<'0[(%=)1%1(.B`S-"4G/B!#
M;W)P;W)A=&4@9&5B="!A;F0@875C=&EO;B!R871E('-E8W5R:71I97,\+W1D
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-
M.B`R+C5P=#L@5TE$5$@Z(#$E)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%
M.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^("0\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE
M.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`X
M)2<^("T\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E
M)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!0
M041$24Y'+4)/5%1/33H@,BXU<'0[(%=)1%1(.B`Q)2<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B
M;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T.R!724142#H@
M,24G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT.R!724142#H@."4G/B`Q-RPV-S(\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'
M3CH@;&5F=#L@5TE$5$@Z(#$E)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%=)1%1(
M.B`Q)2<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,
M24=..B!L969T.R!724142#H@,24G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@."4G/B`M/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ
M(#(N-7!T.R!724142#H@,24G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z
M(#EP=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX@)#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[
M($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#@E
M)SX@+3PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.
M1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=..B!L969T.R!724142#H@,24G
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!
M1$1)3D<M0D]45$]-.B`R+C5P=#L@5TE$5$@Z(#$E)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L
M93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q
M)2<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@<FEG
M:'0[(%=)1%1(.B`X)2<^(#0L,C`U/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0[(%=)1%1(.B`Q)2<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!724142#H@
M,24G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'
M3CH@;&5F=#L@5TE$5$@Z(#$E)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@.7!T
M.R!415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#@E)SX@+3PO=&0^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T
M.R!415A4+4%,24=..B!L969T.R!724142#H@,24G/B`F;F)S<#L\+W1D/B`\
M+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR
M-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#
M3U)!5$E/3CH@=6YD97)L:6YE)SX@3&EA8FEL:71I97,\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`Y<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R
M:6=H="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T
M.R!415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Y<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4
M+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Y<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#EP=#L@5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=.
M.B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y
M<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@
M5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T
M)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!
M3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:
M13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SXF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0G/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@
M;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T
M.R!415A4+4%,24=..B!R:6=H="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D
M/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@=VAI=&4[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@
M;&5F="<^(%=A<G)A;G0@;&EA8FEL:71Y/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D
M;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SX@)#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D
M;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^("T\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]4
M5$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ(#(N
M-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'
M3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'
M3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@-S8Y/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M
M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L
M93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L
M93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@+3PO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ
M(#(N-7!T.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L
M969T)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R
M:6=H="<^("T\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!
M1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"
M3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@
M5$585"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@
M5$585"U!3$E'3CH@<FEG:'0G/B`S-C@\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'
M3CH@;&5F="<^("9N8G-P.SPO=&0^(#PO='(^(#PO=&%B;&4^(#QP('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[
M/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.
M1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(%1H92!F;VQL;W=I;F<@=&%B
M;&4@<W5M;6%R:7IE<R!T:&4@86-T:79I='D@;V8@3&5V96P@,R!I;G!U=',@
M;65A<W5R960@;VX@82!R96-U<G)I;F<@8F%S:7,@87,@;V8@4V5P=&5M8F5R
M(#,P+"`R,#$R("AI;B!T:&]U<V%N9',I.CPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QT
M86)L92!S='EL93TS1"=724142#H@-S`E.R!"3U)$15(M0T],3$%04T4Z(&-O
M;&QA<'-E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y
M;&4],T0G5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U$14-/4D%424].
M.B!N;VYE)SX@/'1D('-T>6QE/3-$)U1%6%0M1$5#3U)!5$E/3CH@;F]N92<@
M;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/
M4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$58
M5"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/
M4D%424]..B!N;VYE)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!4
M15A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/D9A:7(@5F%L=64@365A
M<W5R96UE;G1S(&]F/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,
M24=..B!C96YT97([($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@5$585"U$14-/4D%424]..B!N
M;VYE)SX@/'-T<F]N9SY787)R86YT<R!5<VEN9R!3:6=N:69I8V%N=#PO<W1R
M;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^56YO
M8G-E<G9A8FQE($EN<'5T<SPO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/
M3CH@;F]N92<^(#QS=')O;F<^*$QE=F5L(#,I/"]S=')O;F<^/"]P/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'
M2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W
M<F%P/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$
M+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M)SX@/'1D('-T>6QE/3-$)U=)1%1(.B`X,B4G/D)A;&%N8V4@870@1&5C
M96UB97(@,S$L(#(P,3$\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$E)SXF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$
M5$@Z(#$E)SXD/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M.R!724142#H@,34E)SXS-C@\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@5TE$5$@Z(#$E)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y
M;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#%P="<^0VAA;F=E(&EN(&9A:7(@=F%L=64@;V8@5V%R
M<F%N="!L:6%B:6QI='D\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#%P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@
M<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX@-#`Q/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G/B9N
M8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2
M.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P="<^0F%L86YC92!A
M="!397!T96UB97(@,S`L(#(P,3(\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!L
M969T)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@-S8Y/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`R+C5P="<^)FYB<W`[/"]T9#X@/"]T<CX@/"]T86)L93X@/'`@<W1Y;&4]
M,T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4
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M(&QE87-E(&%P<')O>&EM871E<R!I=',@8V%R<GEI;F<@=F%L=64N/"]P/B`\
M<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
M,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X(#!P="`P+C(U
M:6X[($9/3E0Z(&)O;&0@:71A;&EC(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B!3:&]R="U497)M($EN=F5S=&UE;G1S/"]P/B`\<"!S
M='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU
M:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B!3:&]R="UT97)M(&EN=F5S=&UE;G1S(&%T(%-E<'1E;6)E<B`S
M,"P@,C`Q,B!C;VYS:7-T(&]F(&EN=F5S=&UE;G1S(&EN(&-O;6UE<F-I86P@
M<&%P97(L(&-O<G!O<F%T92!N;W1E<R!A;F0@=&AR964@875C=&EO;B!R871E
M('-E8W5R:71I97,N($%L;"!M87)K971A8FQE('-E8W5R:71I97,@:&%D(&]R
M:6=I;F%L(&UA='5R:71I97,@9W)E871E<B!T:&%N(#DP(&1A>7,L(&)U="!L
M97-S('1H86X@;VYE('EE87(N(%1H92!A=6-T:6]N(')A=&4@<V5C=7)I=&EE
M<R!H879E(&$@<&%R('9A;'5E(&]F("0U+C$@;6EL;&EO;BX@5&AE($-O;7!A
M;GD@:&%S(&-L87-S:69I960@=&AE<V4@<V5C=7)I=&EE<R!A<R!A=F%I;&%B
M;&4M9F]R+7-A;&4@<VEN8V4@=&AE($-O;7!A;GD@;6%Y(&YE960@=&\@;&EQ
M=6ED871E('1H97-E('-E8W5R:71I97,@=VET:&EN('1H92!N97AT('EE87(N
M(%1H92!A=F%I;&%B;&4M9F]R+7-A;&4@<V5C=7)I=&EE<R!A<F4@8V%R<FEE
M9"!A="!F86ER('9A;'5E(&%N9"!U;G)E86QI>F5D(&=A:6YS(&%N9"!L;W-S
M97,L(&EF(&1E=&5R;6EN960@=&\@8F4@=&5M<&]R87)Y+"!O;B!T:&5S92!S
M96-U<FET:65S(&%R92!I;F-L=61E9"!I;B!A8V-U;75L871E9"!O=&AE<B!C
M;VUP<F5H96YS:79E(&EN8V]M92`H;&]S<RD@:6X@<W1O8VMH;VQD97)S)B,S
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M,SD[<R!S96-U<FET:65S+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F
M;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%
M6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@4VAO<G0M=&5R;2!I
M;G9E<W1M96YT<R!C;&%S<VEF:65D(&%S(&%V86EL86)L92UF;W(M<V%L92!A
M<R!O9B!397!T96UB97(@,S`L(#(P,3(@86YD($1E8V5M8F5R(#,Q+"`R,#$Q
M('=E<F4@8V]M<')I<V5D(&]F("AI;B!T:&]U<V%N9',I.CPO<#X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN
M.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QT86)L92!S='EL93TS1"=7
M24142#H@,3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V5L;'-P86-I
M;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%4E1)0T%,
M+4%,24=..B!B;W1T;VT[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U$14-/4D%424]..B!N;VYE
M)R!N;W=R87`],T1N;W=R87`^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]4
M5$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W
M<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ(&YO
M;F4G(&-O;'-P86X],T0Q-"!N;W=R87`],T1N;W=R87`^4V5P=&5M8F5R(#,P
M+"`R,#$R/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4
M+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U$14-/
M4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@
M4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U$14-/4D%424]..B!N;VYE)R!N
M;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!C96YT97([(%1%6%0M1$5#
M3U)!5$E/3CH@;F]N92<@8V]L<W!A;CTS1#$T(&YO=W)A<#TS1&YO=W)A<#Y$
M96-E;6)E<B`S,2P@,C`Q,3PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[
M(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P
M.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T
M=&]M.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$
M;F]W<F%P/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W
M<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T.R!4
M15A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O
M;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD.R!4
M15A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO
M=W)A<#X@/'`@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@1D].5"U325I%.B`W<'0[($U!4D=)3CH@,'!T(#!P
M>#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ(&YO;F4G
M/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@1D].5"U325I%.B`W<'0[($U!4D=)3CH@
M,'!T(#!P>#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ
M(&YO;F4G/B`\<W1R;VYG/D%M;W)T:7IE9#PO<W1R;VYG/CPO<#X@/'`@<W1Y
M;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@1D].5"U325I%.B`W<'0[($U!4D=)3CH@,'!T(#!P>#L@5$585"U!3$E'
M3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/D-O
M<W0\+W-T<F]N9SX\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[
M(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'
M2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/
M3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:
M13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R
M.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS
M1&YO=W)A<#X\<W1R;VYG/D=R;W-S/"]S=')O;F<^/&)R("\^(#QS=')O;F<^
M56YR96%L:7IE9#PO<W1R;VYG/CQB<B`O/B`\<W1R;VYG/D=A:6YS/"]S=')O
M;F<^/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U$14-/4D%4
M24]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$
M1$E.1RU"3U143TTZ(#%P=#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R
M87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[($9/3E0M
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M;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ
M(#%P=#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!415A4+4%,24=..B!C96YT97([(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@
M8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P/D9A:7(@5F%L=64\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4+41%0T]2051)3TXZ(&YO;F4G
M(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/
M33H@,7!T.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A
M<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4
M.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0R(&YO
M=W)A<#TS1&YO=W)A<#X@/'`@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@1D].5"U325I%.B`W<'0[($U!4D=)
M3CH@,'!T(#!P>#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%0T]2051)
M3TXZ(&YO;F4G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@1D].5"U325I%.B`W<'0[
M($U!4D=)3CH@,'!T(#!P>#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%
M0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/D%M;W)T:7IE9#PO<W1R;VYG/CPO
M<#X@/'`@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@1D].5"U325I%.B`W<'0[($U!4D=)3CH@,'!T(#!P>#L@
M5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\
M<W1R;VYG/D-O<W0\+W-T<F]N9SX\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]4
M5$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W
M<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@
M1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M
M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[
M($9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'
M3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0R
M(&YO=W)A<#TS1&YO=W)A<#X\<W1R;VYG/D=R;W-S/"]S=')O;F<^/&)R("\^
M(#QS=')O;F<^56YR96%L:7IE9#PO<W1R;VYG/CQB<B`O/B`\<W1R;VYG/D=A
M:6YS/"]S=')O;F<^/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$58
M5"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U$14-/4D%424]..B!N
M;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W
M<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!C96YT97([(%1%
M6%0M1$5#3U)!5$E/3CH@;F]N92<@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W
M<F%P/CQS=')O;F<^1W)O<W,\+W-T<F]N9SX\8G(@+SX@/'-T<F]N9SY5;G)E
M86QI>F5D/"]S=')O;F<^/&)R("\^(#QS=')O;F<^3&]S<V5S/"]S=')O;F<^
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U$14-/4D%424].
M.B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.
M1RU"3U143TTZ(#%P=#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`]
M,T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!415A4+4%,24=..B!C96YT97([(%1%6%0M1$5#3U)!5$E/
M3CH@;F]N92<@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P/D9A:7(@5F%L
M=64\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4+41%0T]2051)
M3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\+W1R/B`\
M='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T
M*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#(P)2<^075C
M=&EO;B!R871E('-E8W5R:71I97,\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`W<'0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T.R!724142#H@,24G
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT.R!724142#H@-R4G/C,L,S<S/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T.R!724142#H@,24G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5TE$
M5$@Z(#$E)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO=&0^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0[(%=)
M1%1(.B`W)2<^,2PP,S(\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@
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M+5-)6D4Z(#=P=#L@5TE$5$@Z(#$E)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q
M)2<^)#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U!
M3$E'3CH@<FEG:'0[(%=)1%1(.B`W)2<^-"PT,#4\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q
M)2<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!7
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M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%=)1%1(.B`Q)2<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!415A4+4%,
M24=..B!L969T.R!724142#H@,24G/B0\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@-R4G/C@S
M,CPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'
M3CH@;&5F=#L@5TE$5$@Z(#$E)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`W<'0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T.R!72414
M2#H@,24G/B0\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT.R!724142#H@-R4G/BT\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q
M)2<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!7
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M/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@=VAI=&4[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G/B!#;W)P;W)A=&4@9&5B="!S96-U<FET:65S/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T
M('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F="<^("9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!R:6=H="<^
M(#$S+#(V,SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$
M1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U14
M3TTZ(#%P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!
M3$E'3CH@<FEG:'0G/B`T/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M-W!T.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4+4%,24=..B!L969T)SX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$
M24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@
M5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T
M.R!415A4+4%,24=..B!R:6=H="<^("T\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W
M<'0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:
M13H@-W!T.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U3
M25I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,3,L,C8W/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,7!T
M.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O
M;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@
M<V]L:60[($9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!R:6=H="<^("T\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]4
M5$]-.B`Q<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T
M)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)SX@+3PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$
M1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U14
M3TTZ(#%P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!
M3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M-W!T.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4+4%,24=..B!L969T)SX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$
M24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@
M5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T
M.R!415A4+4%,24=..B!R:6=H="<^("T\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G/B`F;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=2
M3U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;2<^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.
M1RU"3U143TTZ(#(N-7!T)SY4;W1A;#PO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U
M8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U
M8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0G/B`Q-BPV
M,S8\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M
M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ
M(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!
M3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!
M3$E'3CH@<FEG:'0G/B`Q+#`S-CPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=..B!L
M969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M
M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T)SX@)#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M
M4TE:13H@-W!T.R!415A4+4%,24=..B!R:6=H="<^("T\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@
M5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@
M9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F="<^("0\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@
M9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0G/B`Q
M-RPV-S(\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U14
M3TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$58
M5"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G/B`S+#,W,SPO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=.
M.B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M-W!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/
M3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T)SX@)#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/
M3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!R:6=H="<^(#@S,CPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N
M-7!T.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M+C5P="!D;W5B;&4[($9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T
M)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M+C5P="!D;W5B;&4[($9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!R:6=H
M="<^("T\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U14
M3TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$58
M5"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G/B`T+#(P-3PO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=.
M.B!L969T)SX@)FYB<W`[/"]T9#X@/"]T<CX@/"]T86)L93X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X(#!P="`P
M+C(U:6X[($9/3E0Z(&)O;&0@:71A;&EC(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T(#!P>"`P<'0@,"XR-6EN.R!&
M3TY4.B!B;VQD(&ET86QI8R`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@4F5S=')I8W1E9"!#87-H/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/
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M;FEC86P@=')I86PN/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T
M:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P
M.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE.
M.B`P<'0@,'!X(#!P="`P+C(U:6X[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B`\<W1R;VYG/CQE;3Y.970@3&]S<R!P97(@
M4VAA<F4\+V5M/CPO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[
M(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
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M(#$R+#DU,2PV,C4@<VAA<F5S(&%N9"`Q,2PQ,3DL-#<V('-H87)E<R!A="!3
M97!T96UB97(@,S`L(#(P,3(@86YD(#(P,3$L(')E<W!E8W1I=F5L>2P@87)E
M(&5X8VQU9&5D(&9R;VT@=&AE(&-O;7!U=&%T:6]N+"!A<R!T:&5I<B!E9F9E
M8W0@:7,@86YT:61I;'5T:79E+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[
M($U!4D=)3CH@,'!T(#!P>"`P<'0@,"XR-6EN.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/'-T<F]N9SX\96T^4F5V96YU
M92!296-O9VYI=&EO;CPO96T^/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[
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M:6]D(&EN('=H:6-H('1H97D@8F5C;VUE(&MN;W=N+CPO<#X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@
M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
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M<R!B965N(&-O;7!L971E9"!A<R!O9B!397!T96UB97(@,S`L(#(P,3([(&AO
M=V5V97(L(&UA;F%G96UE;G0@8F5L:65V97,@=&AA="!R979E;G5E(&9O<B!P
M97)I;V1S('-U8FIE8W0@=&\@875D:70@:&%S(&)E96X@<F5C;W)D960@:6X@
M86UO=6YT<R!T:&%T(&%R92!E>'!E8W1E9"!T;R!B92!R96%L:7IE9"!U<&]N
M(&9I;F%L(&%U9&ET(&%N9"!S971T;&5M96YT+CPO<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
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M(&%R92!C;W)E('1O(&ET<R!O<&5R871I;VYS+CPO<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
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M+6QI;F4@8F%S:7,@;W9E<B!T:&4@8V]N=')A8W0@=&5R;3PO<#X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN
M.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@4F5V96YU92!A<W-O8VEA=&5D('=I=&@@=7!F<F]N="!P87EM96YT
M<R!U;F1E<B!A<G)A;F=E;65N=',@:7,@<F5C;V=N:7IE9"!O=F5R('1H92!C
M;VYT<F%C="!T97)M(&]R('=H96X@86QL(&]B;&EG871I;VYS(&%S<V]C:6%T
M960@=VET:"!T:&4@=7!F<F]N="!P87EM96YT(&AA=F4@8F5E;B!S871I<V9I
M960N/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4
M+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N
M-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B!2979E;G5E(&9R;VT@=&AE(&%C:&EE=F5M
M96YT(&]F(')E<V5A<F-H(&%N9"!D979E;&]P;65N="!M:6QE<W1O;F5S+"!I
M9B!D965M960@<W5B<W1A;G1I=F4L(&ES(')E8V]G;FEZ960@87,@<F5V96YU
M92!W:&5N('1H92!M:6QE<W1O;F5S(&%R92!A8VAI979E9"P@86YD('1H92!M
M:6QE<W1O;F4@<&%Y;65N=',@87)E(&1U92!A;F0@8V]L;&5C=&EB;&4N($EF
M(&YO="!D965M960@<W5B<W1A;G1I=F4L('1H92!#;VUP86YY('=O=6QD(')E
M8V]G;FEZ92!S=6-H(&UI;&5S=&]N92!A<R!R979E;G5E('5P;VX@:71S(&%C
M:&EE=F5M96YT(&]N(&$@<W1R86EG:'0M;&EN92!B87-I<R!O=F5R('1H92!R
M96UA:6YI;F<@97AP96-T960@=&5R;2!O9B!T:&4@<F5S96%R8V@@86YD(&1E
M=F5L;W!M96YT('!E<FEO9"X@36EL97-T;VYE<R!A<F4@8V]N<VED97)E9"!S
M=6)S=&%N=&EV92!I9B!A;&P@;V8@=&AE(&9O;&QO=VEN9R!C;VYD:71I;VYS
M(&%R92!M970Z("@Q*2!T:&4@;6EL97-T;VYE(&ES(&YO;BUR969U;F1A8FQE
M.R`H,BD@=&AE<F4@:7,@<W5B<W1A;G1I=F4@=6YC97)T86EN='D@;V8@86-H
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M(&%R<F%N9V5M96YT+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#`N,C5I;CL@34%21TE..B`P<'0@,'!X.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S
M<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P+C(U:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QS=')O;F<^/&5M/E)E
M8V5N="!!8V-O=6YT:6YG(%!R;VYO=6YC96UE;G1S/"]E;3X\+W-T<F]N9SX\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL
M93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^($EN($IU;F4@,C`Q,2P@=&AE($9!4T(@:7-S=65D
M($%352`R,#$Q+3`U+"`\96T^0V]M<')E:&5N<VEV92!);F-O;64@*%1O<&EC
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M;W(@=&AE($-O;7!A;GD@8F5G:6YN:6YG($IA;G5A<GD@,2P@,C`Q,BX@5&AI
M<R!P<F5S96YT871I;VX@<F5Q=6ER96UE;G0@=V%S(&%D;W!T960@2F%N=6%R
M>2`Q+"`R,#$R(&%N9"!I<R!R969L96-T960@;VX@=&AE(&%C8V]M<&%N>6EN
M9R!S=&%T96UE;G1S(&]F(&]P97)A=&EO;G,@86YD(&-O;7!R96AE;G-I=F4@
M;&]S<R!F;W(@=&AE('!E<FEO9',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$R
M(&%N9"`R,#$Q+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO
M<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%
M3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!);B!397!T96UB97(@,C`Q,2P@
M=&AE($9!4T(@:7-S=65D($%352`R,#$Q+3`X+"`\96T^26YT86YG:6)L97,@
M+2!';V]D=VEL;"!A;F0@3W1H97(@*%1O<&EC(#,U,"DZ(%1E<W1I;F<@1V]O
M9'=I;&P@9F]R($EM<&%I<FUE;G0\+V5M/B`H(D%352`R,#$Q+3`X(BD\96T^
M+#PO96T^('1O(&=I=F4@8F]T:"!P=6)L:6,@86YD(&YO;G!U8FQI8R!E;G1I
M=&EE<R!T:&4@;W!T:6]N('1O('%U86QI=&%T:79E;'D@9&5T97)M:6YE('=H
M971H97(@=&AE>2!C86X@8GEP87-S('1H92!T=V\M<W1E<"!G;V]D=VEL;"!I
M;7!A:7)M96YT('1E<W0N(%5N9&5R('1H92!N97<@9W5I9&%N8V4L(&EF(&%N
M(&5N=&ET>2!C:&]O<V5S('1O('!E<F9O<FT@82!Q=6%L:71A=&EV92!A<W-E
M<W-M96YT(&%N9"!D971E<FUI;F5S('1H870@:70@:7,@;6]R92!L:6ME;'D@
M=&AA;B!N;W0@*&$@;6]R92!T:&%N(#4P('!E<F-E;G0@;&EK96QI:&]O9"D@
M=&AA="!T:&4@9F%I<B!V86QU92!O9B!A(')E<&]R=&EN9R!U;FET(&ES(&QE
M<W,@=&AA;B!I=',@8V%R<GEI;F<@86UO=6YT+"!I="!W;W5L9"!T:&5N('!E
M<F9O<FT@4W1E<"`Q(&]F('1H92!A;FYU86P@9V]O9'=I;&P@:6UP86ER;65N
M="!T97-T(&EN($%30R`S-3`M,C`@86YD+"!I9B!N96-E<W-A<GDL('!R;V-E
M960@=&\@4W1E<"`R+B!/=&AE<G=I<V4L(&YO(&9U<G1H97(@979A;'5A=&EO
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M9VEN;FEN9R!A9G1E<B!$96-E;6)E<B`Q-2P@,C`Q,2P@86QT:&]U9V@@96%R
M;'D@861O<'1I;VX@=V%S('!E<FUI='1E9"X@5&AE(&%D;W!T:6]N(&]F($%3
M52`R,#$Q+3`X(&]N($IA;G5A<GD@,2P@,C`Q,B!D:60@;F]T(&AA=F4@82!M
M871E<FEA;"!E9F9E8W0@;VX@=&AE($-O;7!A;GDF(S,Y.W,@9FEN86YC:6%L
M('-T871E;65N=',N/"]P/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D
M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-T;V-K+4)A<V5D($-O;7!E
M;G-A=&EO;CQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N
M(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/E-T;V-K+4)A<V5D($-O;7!E;G-A=&EO;B!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T
M;V-K+4)A<V5D($-O;7!E;G-A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$
M(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO
M<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^
M#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QS=')O;F<^
M3F]T92`T("T@4W1O8VLM0F%S960@0V]M<&5N<V%T:6]N/"]S=')O;F<^/"]P
M/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`\<W1R;VYG/CQB<B`O/B`\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@5&AE($-O;7!A;GD@:&%S(&=R86YT960@97%U:71Y(&%W
M87)D<R!U;F1E<B!S979E<F%L('!L86YS+B!5;F1E<B!T:&4@,C`P-2!3=&]C
M:R!);F-E;G1I=F4@4&QA;B`H=&AE("(R,#`U(%!L86XB*2P@97%U:71Y(&%W
M87)D<R!M87D@8F4@9W)A;G1E9"!T;R!O9F9I8V5R<RP@9&ER96-T;W)S+"!E
M;7!L;WEE97,L(&-O;G-U;'1A;G1S(&%N9"!A9'9I<V]R<R!T;R!T:&4@0V]M
M<&%N>2!A;F0@86YY('!R97-E;G0@;W(@9G5T=7)E('-U8G-I9&EA<GDN(%1H
M92`R,#`U(%!L86XL(&%P<')O=F5D(&EN($UA>2`R,#`U(&%N9"!A;65N9&5D
M(&EN($IU;F4@,C`P-RP@2G5N92`R,#$Q(&%N9"!*=6YE(#(P,3(@8GD@=&AE
M($-O;7!A;GDF(S,Y.W,@<W1O8VMH;VQD97)S+"!C=7)R96YT;'D@875T:&]R
M:7IE<R!T:&4@9W)A;G0@;V8@97%U:71Y(&%W87)D<R!F;W(@=7`@=&\@,3@L
M,S$R+#$Y,B!S:&%R97,@;V8@8V]M;6]N('-T;V-K+"!W:&EC:"!I;F-L=61E
M9"P@870@=&AE('1I;64@;V8@87!P<F]V86P@;V8@=&AE(#(P,#4@4&QA;BP@
M82!M87AI;75M(#4L-S0V+#0V."!S:&%R97,@;V8@8V]M;6]N('-T;V-K('-U
M8FIE8W0@=&\@<W1O8VL@;W!T:6]N<R!O=71S=&%N9&EN9R!U;F1E<B!T:&4@
M0V]M<&%N>28C,SD[<R`Q.3DU(%-T;V-K($]P=&EO;B!0;&%N("AT:&4@(C$Y
M.34@4&QA;B(I('1H870@;6%Y(')E=F5R="!T;R!A;F0@8F5C;VUE(&ES<W5A
M8FQE('5N9&5R('1H92`R,#`U(%!L86X@:68@<W5C:"!O<'1I;VYS('-H;W5L
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M+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\8G(@+SX@/"]P/B`\<"!S
M='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU
M:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^(%5N9&5R('1H92`R,#`U(%!L86X@86YD('1H
M92`Q.3DU(%!L86XL(&EN8V5N=&EV92!S=&]C:R!O<'1I;VYS+"!H879I;F<@
M82!M87AI;75M('1E<FT@;V8@,3`@>65A<G,L(&-A;B!B92!O<B!W97)E(&=R
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M<W1A='5T;W)Y('-T;V-K(&]P=&EO;G,N/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^(#QB<B`O/B`\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU
M<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@5&AE
M($-O;7!A;GD@<F5C;W)D960@<W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X
M<&5N<V4@:6X@=&AE('-T871E;65N=',@;V8@;W!E<F%T:6]N<R!A;F0@8V]M
M<')E:&5N<VEV92!L;W-S(&%S(&9O;&QO=W,@*&EN('1H;W5S86YD<RDZ/"]P
M/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QB<B`O/B`\+W`^(#QT86)L92!S
M='EL93TS1"=724142#H@.#4E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$8V5N=&5R
M/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U$
M14-/4D%424]..B!N;VYE)SX@/'1D('-T>6QE/3-$)U1%6%0M1$5#3U)!5$E/
M3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[
M(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T
M('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD
M.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0V(&YO=W)A<#TS
M1&YO=W)A<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^5&AR
M964@36]N=&AS($5N9&5D/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@5$585"U$14-/4D%424].
M.B!N;VYE)SX@/'-T<F]N9SY397!T96UB97(@,S`L/"]S=')O;F<^/"]P/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$
M;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@
M;F]N92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=.
M.B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ
M(&YO;F4G(&-O;'-P86X],T0V(&YO=W)A<#TS1&YO=W)A<#X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#
M3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^3FEN92!-;VYT:',@16YD960\+W-T
M<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/E-E
M<'1E;6)E<B`S,"P\+W-T<F]N9SX\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$
M14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^
M(#PO='(^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,
M24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD)R!C;VQS<&%N/3-$,CXR
M,#$R/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/
M3E0M5T5)1TA4.B!B;VQD)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD)SX\8G(@+SX@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S
M;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9"<@
M8V]L<W!A;CTS1#(^,C`Q,3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&)R("\^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@
M8F]L9"<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5"U7
M14E'2%0Z(&)O;&0G(&-O;'-P86X],T0R/C(P,3(\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/CQB
M<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@
M1D].5"U714E'2%0Z(&)O;&0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C
M96YT97([($9/3E0M5T5)1TA4.B!B;VQD)R!C;VQS<&%N/3-$,CXR,#$Q/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)
M1TA4.B!B;VQD)SX\8G(@+SX@/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!
M0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M5TE$5$@Z(#0X)2<^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT/"]T9#X@/'1D
M('-T>6QE/3-$)U=)1%1(.B`Q)2<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q,"4G/C(Q.3PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/CQB
M<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$E)SX\8G(@+SX@/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^
M)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z
M(#$P)2<^,3<V/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%=)1%1(.B`Q)2<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=724142#H@
M,24G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@5TE$5$@Z(#$E)SXD/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT.R!724142#H@,3`E)SXV,S@\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX\8G(@+SX@/"]T9#X@/'1D('-T
M>6QE/3-$)U=)1%1(.B`Q)2<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!724142#H@,24G/B0\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q,"4G/C0T.3PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/CQB<B`O
M/B`\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@
M=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^1V5N97)A
M;"!A;F0@861M:6YI<W1R871I=F4\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#%P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G
M/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(#(W-#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M,7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`Q<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX\8G(@+SX@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S
M;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/B`S-C8\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^/&)R
M("\^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T)SX\
M8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%
M6%0M04Q)1TXZ(')I9VAT)SX@,2PP,S`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^/&)R("\^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T)SX\8G(@+SX@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)
M1TXZ(')I9VAT)SX@,2PR,C@\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^/&)R("\^(#PO=&0^(#PO
M='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U
M-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$58
M5"U)3D1%3E0Z("TP+C%I;CL@4$%$1$E.1RU,1494.B`P+C%I;B<^(%1O=&%L
M('-T;V-K+6)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG
M:'0G/B`T.3,\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G
M/B`U-#(\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/B`Q
M+#8V.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$
M24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!
M3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^(#$L
M-C<W/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#PO='(^(#PO=&%B;&4^
M(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P:6X[($U!4D=)3CH@,'!T(#!P
M>"`P<'0@,"XR-6EN.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@/'-T<F]N9SX\96T^/&)R("\^(#PO96T^/"]S=')O;F<^
M/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,&EN.R!-05)'24XZ(#!P
M="`P<'@@,'!T(#`N,C5I;CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^(#QS=')O;F<^/&5M/E-T;V-K($]P=&EO;G,@07=A
M<F1S/"]E;3X\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/&)R("\^(#PO<#X@/'`@<W1Y;&4]
M,T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!4:&4@9F]L
M;&]W:6YG(&ES(&$@<W5M;6%R>2!O9B!O<'1I;VX@86-T:79I='D@=6YD97(@
M=&AE(#(P,#4@4&QA;B!A;F0@=&AE(#$Y.34@4&QA;B!F;W(@=&AE(&YI;F4@
M;6]N=&AS(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q,CH\+W`^(#QP('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/'-T<F]N
M9SX\8G(@+SX@/"]S=')O;F<^/"]P/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z
M(#@U)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=.
M.B!B;W1T;VTG/B`\=&0@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z
M(&)O;&0G(&YO=W)A<#TS1&YO=W)A<#X@/&)R("\^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)
M1TXZ(&-E;G1E<CL@1D].5"U714E'2%0Z(&)O;&0G(&-O;'-P86X],T0V(&YO
M=W)A<#TS1&YO=W)A<#XR,#`U(%-T;V-K($EN8V5N=&EV92!0;&%N/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4
M.B!B;VQD)R!N;W=R87`],T1N;W=R87`^(#QB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G
M(&YO=W)A<#TS1&YO=W)A<#X@/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E
M;G1E<CL@1D].5"U714E'2%0Z(&)O;&0G(&-O;'-P86X],T0V(&YO=W)A<#TS
M1&YO=W)A<#XQ.3DU(%-T;V-K($]P=&EO;B!0;&%N/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD)R!N
M;W=R87`],T1N;W=R87`^(#QB<B`O/B`\+W1D/B`\+W1R/B`\='(@<W1Y;&4]
M,T0G5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U$14-/4D%424]..B!N
M;VYE)SX@/'1D('-T>6QE/3-$)U1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W
M<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!
M5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4
M+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2
M051)3TXZ(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%
M6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^/&)R("\^(#PO<W1R;VYG
M/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^/&)R("\^
M(#PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R
M.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O
M;F<^4W1O8VL\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&-E;G1E<CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G
M/B`\<W1R;VYG/D]P=&EO;G,\+W-T<F]N9SX\+W`^(#PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@
M5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^/&)R("\^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4
M+5=%24=(5#H@8F]L9#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`]
M,T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].
M5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@8V]L<W!A
M;CTS1#(@;F]W<F%P/3-$;F]W<F%P/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97([($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE
M)SX@/'-T<F]N9SY796EG:'1E9"T\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2
M051)3TXZ(&YO;F4G/B`\<W1R;VYG/D%V97)A9V4\+W-T<F]N9SX\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!4
M15A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/D5X97)C:7-E/"]S=')O
M;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY0<FEC
M93PO<W1R;VYG/CPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ
M(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!4
M15A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S
M;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9#L@
M5$585"U$14-/4D%424]..B!N;VYE)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N
M;W=R87`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/CQB<B`O
M/B`\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E
M<CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R
M;VYG/CQB<B`O/B`\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&-E;G1E<CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO
M;F4G/B`\<W1R;VYG/E-T;V-K/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@5$585"U$14-/4D%4
M24]..B!N;VYE)SX@/'-T<F]N9SY/<'1I;VYS/"]S=')O;F<^/"]P/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'
M2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W
M<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N
M92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C
M96YT97([($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO
M;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!
M5$E/3CH@;F]N92<^(#QS=')O;F<^5V5I9VAT960M/"]S=')O;F<^/"]P/B`\
M<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T(#!P
M>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY!=F5R86=E/"]S=')O
M;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY%>&5R
M8VES93PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N
M=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS
M=')O;F<^4')I8V4\+W-T<F]N9SX\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$
M14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^
M(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T
M+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE
M/3-$)U=)1%1(.B`T."4G/D]U='-T86YD:6YG(&%T($IA;G5A<GD@,2P@,C`Q
M,CPO=&0^(#QT9"!S='EL93TS1"=724142#H@,24G/CQB<B`O/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!72414
M2#H@,3`E)SXW+#0Q,BPW-#8\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@5TE$5$@Z(#$E)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U=)1%1(.B`Q)2<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!724142#H@,24G/B0\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q,"4G/C(N,C(\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX\8G(@+SX@/"]T
M9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q)2<^/&)R("\^(#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/CQB<B`O/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q
M,"4G/C0W-"PV-3`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@5TE$5$@Z(#$E)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(
M.B`Q)2<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!724142#H@,24G/B0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0[(%=)1%1(.B`Q,"4G/C0N,S@\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX\8G(@+SX@/"]T9#X@/"]T
M<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D/D=R86YT960\+W1D/B`\=&0^/&)R
M("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SX\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SXS+#0X
M,RPP,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^/&)R
M("\^(#PO=&0^(#QT9#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/B0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0G/C$N,CD\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^/&)R("\^(#PO=&0^(#QT9#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0G/BT\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT9#X\8G(@+SX@/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B0\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0G/BT\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^(#PO='(^(#QT<B!S='EL93TS
M1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M)SX@/'1D/D5X97)C:7-E9#PO=&0^(#QT9#X\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/CQB<B`O
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/B@X,"PW
M.#0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^*3PO=&0^
M(#QT9#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/B0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/C`N
M-C$\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^/&)R("\^
M(#PO=&0^(#QT9#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G/BT\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^/&)R("\^(#PO=&0^(#QT9#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/B0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G/BT\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
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M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ
M(')I9VAT)SX@*#$L-30V+#4V,CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,7!T)SXI/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0G/CQB<B`O/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4
M+4%,24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/B`R+C(V
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`Q<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#%P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G
M/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("@Q.#0L-S4P/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]4
M5$]-.B`Q<'0G/BD\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#%P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/B0\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4
M15A4+4%,24=..B!R:6=H="<^(#0N,#$\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^/&)R("\^(#PO
M=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H
M,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P="<^3W5T<W1A;F1I;F<@870@
M4V5P=&5M8F5R(#,P+"`R,#$R/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE
M9G0G/B`\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/B`Y+#(V
M."PT,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/B`Q
M+C@X/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,
M24=..B!L969T)SX@/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT
M)SX@,C@Y+#DP,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@
M5$585"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H
M="<^(#0N-3D\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@/"]T9#X@/"]T<CX@/'1R
M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M+C5P=#L@5$585"U)3D1%3E0Z("TP+C%I;CL@4$%$1$E.1RU,1494.B`P+C%I
M;B<^(%-H87)E<R!E>&5R8VES86)L92!A="!397!T96UB97(@,S`L(#(P,3(\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N
M-7!T(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^(#QB<B`O/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE
M.R!415A4+4%,24=..B!R:6=H="<^(#,L-3`S+#`T,SPO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,BXU<'0G
M/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#(N
M-7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U
M8FQE.R!415A4+4%,24=..B!R:6=H="<^(#(N,S@\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\
M8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P
M="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`\8G(@+SX@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T
M(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/B`R.#DL.3`P/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R
M+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX@
M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P
M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@-"XU.3PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,BXU
M<'0G/CQB<B`O/B`\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.
M1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;2<^(#QT9"!S='EL93TS1"=415A4+4E.1$5.5#H@+3`N,6EN.R!0041$
M24Y'+4Q%1E0Z(#`N,6EN)SX\8G(@+SX@/"]T9#X@/'1D/CQB<B`O/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^/&)R("\^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@
M/'1D/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX\8G(@+SX@/"]T9#X@/'1D/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@/'1D/CQB<B`O/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^/&)R("\^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@
M/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R+C5P=#L@5$585"U)3D1%3E0Z("TP+C%I;CL@4$%$1$E.1RU,
M1494.B`P+C%I;B<^(%-H87)E<R!A=F%I;&%B;&4@9F]R(&=R86YT(&%T(%-E
M<'1E;6)E<B`S,"P@,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T
M)SX@/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@-2PU-3DL
M-3,V/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\
M8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0
M041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\
M8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P
M="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P
M="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R
M+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R
M+C5P="<^/&)R("\^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#QP('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/&)R("\^(#PO
M<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%
M3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!4:&4@9F%I<B!V86QU92!O9B!S
M=&]C:R!O<'1I;VYS(&=R86YT960@=V%S(&5S=&EM871E9"!A="!T:&4@9&%T
M92!O9B!G<F%N="!U<VEN9R!T:&4@0FQA8VLM4V-H;VQE<R!O<'1I;VXM<')I
M8VEN9R!M;V1E;"!W:71H('1H92!F;VQL;W=I;F<@87-S=6UP=&EO;G,Z/"]P
M/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QS=')O;F<^/&)R("\^(#PO<W1R
M;VYG/CPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Y-24[($)/4D1%4BU#
M3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4
M+41%0T]2051)3TXZ(&YO;F4G/B`\=&0@<W1Y;&4],T0G5$585"U$14-/4D%4
M24]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L
M9#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^/&)R
M("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5"U714E'2%0Z(&)O
M;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@8V]L<W!A;CTS1#8@;F]W<F%P
M/3-$;F]W<F%P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!
M4D=)3BU43U`Z(#!P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@34%21TE.+4)/5%1/33H@,'!T.R!415A4+41%0T]2051)
M3TXZ(&YO;F4G/B`\<W1R;VYG/E1H<F5E($UO;G1H<R!%;F1E9#PO<W1R;VYG
M/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XM
M5$]0.B`P<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[($U!4D=)3BU"3U143TTZ(#!P=#L@5$585"U$14-/4D%424]..B!N
M;VYE)SX@/'-T<F]N9SY397!T96UB97(@,S`L/"]S=')O;F<^/"]P/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'
M2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W
M<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N
M92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C
M96YT97([($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO
M;F4G(&-O;'-P86X],T0V(&YO=W)A<#TS1&YO=W)A<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XM5$]0.B`P<'0[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($U!4D=)3BU"3U14
M3TTZ(#!P=#L@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY.:6YE
M($UO;G1H<R!%;F1E9#PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R.R!-05)'24XM5$]0.B`P<'0[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($U!4D=)3BU"3U143TTZ(#!P
M=#L@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY397!T96UB97(@
M,S`L/"]S=')O;F<^/"]P/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/
M3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\+W1R/B`\
M='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!N;W=R
M87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<@;F]W<F%P/3-$;F]W
M<F%P/B`\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%
M24=(5#H@8F]L9"<@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P/C(P,3(\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!0041$24Y'
M+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<@;F]W<F%P/3-$;F]W
M<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N
M=&5R.R!0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<@
M;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT
M97([($9/3E0M5T5)1TA4.B!B;VQD)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N
M;W=R87`^,C`Q,3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<@;F]W<F%P/3-$;F]W<F%P/B`\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/
M3E0M5T5)1TA4.B!B;VQD)R!N;W=R87`],T1N;W=R87`^(#QB<B`O/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED
M.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD)R!C;VQS
M<&%N/3-$,B!N;W=R87`],T1N;W=R87`^,C`Q,CPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!C96YT97([(%!!1$1)3D<M0D]45$]-.B`Q<'0[($9/
M3E0M5T5)1TA4.B!B;VQD)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%!!1$1)3D<M0D]4
M5$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD)R!N;W=R87`],T1N;W=R87`^
M/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5"U714E'2%0Z
M(&)O;&0G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#XR,#$Q/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4
M.B!B;VQD)R!N;W=R87`],T1N;W=R87`^(#QB<B`O/B`\+W1D/B`\+W1R/B`\
M='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T
M*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@+3EP=#L@4$%$1$E.1RU,1494
M.B`Y<'0[(%=)1%1(.B`T,"4G(&YO=W)A<#TS1&YO=W)A<#Y796EG:'1E9"UA
M=F5R86=E(&9A:7(@=F%L=64@;V8@<W1O8VL@;W!T:6]N<R!G<F%N=&5D/"]T
M9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q)2<@;F]W<F%P/3-$;F]W<F%P/CQB
M<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!7
M24142#H@,24G(&YO=W)A<#TS1&YO=W)A<#X@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@5TE$5$@Z(#$R)2<@;F]W<F%P
M/3-$;F]W<F%P/B`D,2XP.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97([(%=)1%1(.B`Q)2<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!724142#H@
M,24G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@5TE$5$@Z(#$E)R!N;W=R87`],T1N;W=R
M87`^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([(%=)1%1(.B`Q,B4G(&YO=W)A<#TS1&YO=W)A<#X@)#`N-S@\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)R!N;W=R
M87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=724142#H@
M,24G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@5TE$5$@Z(#$E)R!N;W=R87`],T1N;W=R
M87`^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([(%=)1%1(.B`Q,B4G(&YO=W)A<#TS1&YO=W)A<#X@)#`N-S$\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!724142#H@,24G(&YO
M=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&-E;G1E<CL@5TE$5$@Z(#$E)R!N;W=R87`],T1N;W=R87`^/&)R
M("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%=)
M1%1(.B`Q)2<@;F]W<F%P/3-$;F]W<F%P/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!724142#H@,3(E)R!N;W=R87`]
M,T1N;W=R87`^("0Q+C$Y/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%=)1%1(.B`Q)2<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D
M/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@=VAI=&4[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@;F]W<F%P/3-$;F]W<F%P/E)I<VLM9G)E92!I;G1E<F5S
M="!R871E/"]T9#X@/'1D(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W
M<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N
M=&5R)R!N;W=R87`],T1N;W=R87`^,"XU-24\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$
M;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M8V5N=&5R)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XP+C0X
M)2TP+C8X)3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!N
M;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!N;W=R87`],T1N;W=R
M87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97(G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/C`N-34E+3$N
M-30E/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W
M<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A
M<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E
M<B<@;F]W<F%P/3-$;F]W<F%P/C`N-#@E+3$N.3$E/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@
M/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G
M8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@;F]W<F%P/3-$;F]W<F%P/D1I
M=FED96YD('EI96QD/"]T9#X@/'1D(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P
M/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^,"4\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P
M/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XP
M)3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!N;W=R87`]
M,T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D(&YO=W)A<#TS1&YO=W)A<#X\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W
M<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^,"4\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W
M<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A
M<#XP)3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!N;W=R
M87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!
M0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M)SX@/'1D(&YO=W)A<#TS1&YO=W)A<#Y6;VQA=&EL:71Y/"]T9#X@/'1D(&YO
M=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R
M87`^-S8N-C`E+3<V+C<Q)3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/CQB
M<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N
M;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XW-2XX-B4M.#`N-#`E
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G(&YO=W)A<#TS
M1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D(&YO=W)A<#TS1&YO=W)A<#X\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W
M<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^-S4N-#<E+3@P+C0X)3PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS
M1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^/&)R
M("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO
M=W)A<#TS1&YO=W)A<#XW,RXR."4M.#`N-#@E/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T
M9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R
M,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@;F]W<F%P/3-$;F]W<F%P/D5X<&5C
M=&5D('1E<FT@*&EN('EE87)S*3PO=&0^(#QT9"!N;W=R87`],T1N;W=R87`^
M/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G
M(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/C0N,C0\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R
M87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97(G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`]
M,T1N;W=R87`^,RXT.2TT+C(Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D(&YO
M=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R
M87`^,RXS-"TW+C`Y/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E
M;G1E<B<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^/&)R("\^
M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A
M<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/C,N,C8M-"XT-SPO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!N;W=R87`],T1N;W=R87`^
M/&)R("\^(#PO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/
M3$]2.B!W:&ET93L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!N;W=R87`],T1N;W=R87`^17AP96-T
M960@9F]R9F5I='5R92!R871E/"]T9#X@/'1D(&YO=W)A<#TS1&YO=W)A<#X\
M8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@
M;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^,"4M,C,N,34E/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$
M;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M8V5N=&5R)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#X\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W
M<F%P/3-$;F]W<F%P/C`E+3(S+C$U)3PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT
M9"!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$
M;F]W<F%P/C`E+3(S+C$U)3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/CQB
M<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N
M;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XP)2TR,RXQ-24\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@;F]W<F%P/3-$;F]W
M<F%P/CQB<B`O/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^(#QB<B`O/B`\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M5&AE(&%G9W)E9V%T92!I;G1R:6YS:6,@=F%L=64@86YD('=E:6=H=&5D+6%V
M97)A9V4@<F5M86EN:6YG(&-O;G1R86-T=6%L('1E<FT@;V8@<W1O8VL@;W!T
M:6]N<R!O=71S=&%N9&EN9R!A<R!O9B!397!T96UB97(@,S`L(#(P,3(@=V%S
M(&%P<')O>&EM871E;'D@)#0N-B!M:6QL:6]N(&%N9"`W+C<@>65A<G,L(')E
M<W!E8W1I=F5L>2X@5&AE(&%G9W)E9V%T92!I;G1R:6YS:6,@=F%L=64@86YD
M('=E:6=H=&5D+6%V97)A9V4@<F5M86EN:6YG(&-O;G1R86-T=6%L('1E<FT@
M;V8@<W1O8VL@;W!T:6]N<R!E>&5R8VES86)L92!A<R!O9B!397!T96UB97(@
M,S`L(#(P,3(@=V%S(&%P<')O>&EM871E;'D@)#$N,"!M:6QL:6]N(&%N9"`U
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M;VYS(&]N(%-E<'1E;6)E<B`S,"P@,C`Q,BX@5&AI<R!A;6]U;G0@:7,@<W5B
M:F5C="!T;R!C:&%N9V4@8F%S960@;VX@8VAA;F=E<R!T;R!T:&4@9F%I<B!V
M86QU92!O9B!T:&4@0V]M<&%N>28C,SD[<R!C;VUM;VX@<W1O8VLN(%1H92!A
M9V=R96=A=&4@:6YT<FEN<VEC('9A;'5E(&]F(&]P=&EO;G,@97AE<F-I<V5D
M(&9O<B!T:&4@;FEN92!M;VYT:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$R
M(&%N9"`R,#$Q('=A<R!L97-S('1H86X@)#`N,2!M:6QL:6]N(&%N9"`D,"XR
M(&UI;&QI;VXL(')E<W!E8W1I=F5L>2X\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`P:6X[($U!4D=)3CH@,'!T(#!P>"`P<'0@,"XR-6EN.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/'-T<F]N
M9SX\96T^/&)R("\^(#PO96T^/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=4
M15A4+4E.1$5.5#H@,&EN.R!-05)'24XZ(#!P="`P<'@@,'!T(#`N,C5I;CL@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QS
M=')O;F<^/&5M/E)E<W1R:6-T960@4W1O8VL@07=A<F1S/"]E;3X\+W-T<F]N
M9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/&)R("\^(#PO<#X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N
M-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B!5;F1E<B!T:&4@,C`P-2!0;&%N+"!T:&4@
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M<W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4N/"]P/B`\<"!S='EL
M93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^(#QB<B`O/B`\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@5&AE(&9O;&QO=VEN9R!I<R!A('-U;6UA<GD@;V8@<F5S=')I8W1E
M9"!S=&]C:R!A=V%R9',@86-T:79I='D@9F]R('1H92!N:6YE(&UO;G1H<R!E
M;F1E9"!397!T96UB97(@,S`L(#(P,3(Z/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^(#QS=')O;F<^/&)R("\^(#PO<W1R;VYG/CPO<#X@/'1A8FQE('-T
M>6QE/3-$)U=)1%1(.B`X,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS1"=6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+41%0T]2051)3TXZ(&YO;F4G
M/B`\=&0@<W1Y;&4],T0G5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`]
M,T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/4D%424].
M.B!N;VYE)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)
M1TXZ(&-E;G1E<CL@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/
M3CH@;F]N92<@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P/B`\<"!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T(#!P>"`P<'0@
M,RXX<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^/&)R("\^(#PO
M<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-
M05)'24XZ(#!P="`P<'@@,'!T(#,N.'!T.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G
M/B`\<W1R;VYG/CQB<B`O/B`\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0@,'!X(#!P="`S+CAP=#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@5$58
M5"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SX\8G(@+SX@/"]S=')O;F<^
M/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@
M,'!T(#!P>"`P<'0@,RXX<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O
M;F<^3G5M8F5R(&]F/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,
M24=..B!C96YT97([($U!4D=)3CH@,'!T(#!P>"`P<'0@,RXX<'0[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#
M3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^4VAA<F5S/"]S=')O;F<^/"]P/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$
M;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@
M;F]N92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=.
M.B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ
M(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@@,'!T(#4N
M,C5P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY097(@4VAA<F4\
M+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@
M34%21TE..B`P<'0@,'!X(#!P="`U+C(U<'0[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N
M92<^(#QS=')O;F<^5V5I9VAT960M/"]S=')O;F<^/"]P/B`\<"!S='EL93TS
M1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T(#!P>"`P<'0@-2XR
M-7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/D%V97)A9V4\+W-T
M<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%2
M1TE..B`P<'0@,'!X(#!P="`U+C(U<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^
M(#QS=')O;F<^1W)A;G0M1&%T93PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@@,'!T(#4N,C5P
M=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY&86ER(%9A;'5E/"]S
M=')O;F<^/"]P/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N
M92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\+W1R/B`\='(@<W1Y
M;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=724142#H@-S0E
M.R!&3TY4+5=%24=(5#H@8F]L9"<^3W5T<W1A;F1I;F<@870@2F%N=6%R>2`Q
M+"`R,#$R/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q)2<^/&)R("\^(#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G
M/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[
M(%=)1%1(.B`Q,"4G/C4S+#,S,SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!724142#H@,24G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5TE$5$@Z(#$E)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$P)2<^,2XV,SPO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/CQB<B`O/B`\
M+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@=VAI
M=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^4F5S=')I8W1E9"!S=&]C:R!G<F%N=&5D/"]T9#X@
M/'1D/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M="<^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SX\8G(@
M+SX@/"]T9#X@/'1D/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SX\
M8G(@+SX@/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],
M3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^4F5S=')I8W1E9"!S
M=&]C:R!V97-T960\+W1D/B`\=&0^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)SXS+#,S,SPO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@/'1D/CQB<B`O/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^)#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^-2XR,3PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@/"]T<CX@/'1R
M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%!!1$1)3D<M0D]45$]-.B`Q<'0G/E)E<W1R:6-T960@<W1O8VL@9F]R9F5I
M=&5D/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0G/CQB
M<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$58
M5"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G/CQB<B`O/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P="<^/&)R("\^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[
M(%1%6%0M04Q)1TXZ(&QE9G0G/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^
M("T\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#%P="<^/&)R("\^(#PO=&0^(#PO='(^(#QT<B!S='EL93TS
M1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R+C5P=#L@1D].5"U714E'2%0Z(&)O;&0G/D]U='-T86YD:6YG(&%T(%-E
M<'1E;6)E<B`S,"P@,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T
M)SX@/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@-3`L,#`P
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=.
M.B!L969T)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,2XS.3PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S
M='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU
M:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B!!<R!O9B!397!T96UB97(@,S`L(#(P,3(L('1H97)E('=A<R!A
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M(&UA9&4@9'5R:6YG(&9U='5R92!P97)I;V1S+CPO<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!I;CL@34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B!B;VQD(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B`\8G(@+SX@/"]P/B`\(2TM16YD1G)A9VUE;G0M+3X\
M+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E4N4RX@1V]V
M97)N;65N="!!9W)E96UE;G0@86YD($-O;&QA8F]R871I;VYS/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^52Y3+B!'
M;W9E<FYM96YT($%G<F5E;65N="!A;F0@0V]L;&%B;W)A=&EO;G,@6T%B<W1R
M86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y5+E,N($=O=F5R;FUE;G0@06=R965M96YT(&%N9"!#;VQL86)O<F%T:6]N
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#5%E012!H
M=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA
M;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL
M,2UT<F%N<VET:6]N86PN9'1D(B`M+3X-"CQD:78^(#QD:78^/"$M+5-T87)T
M1G)A9VUE;G0M+3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B!B;VQD
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!.;W1E(#4@
M+2!5+E,N($=O=F5R;FUE;G0@06=R965M96YT(&%N9"!#;VQL86)O<F%T:6]N
M<SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X(#!P="`P+C(U:6X[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\<W1R;VYG
M/CQE;3X\8G(@+SX@/"]E;3X\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P:6X[($U!4D=)3CH@
M,'!T(#!P>"`P<'0@,"XR-6EN.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@/'-T<F]N9SX\96T^2$A3($)!4D1!($-O;G1R
M86-T($%W87)D(&9O<B!296-O;6)I;F%N="!);F9L=65N>F$@5F%C8VEN97,\
M+V5M/CPO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\8G(@
M+SX@/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4
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M86X@861D:71I;VYA;"!P97)I;V0@;V8@,C0@;6]N=&AS('9A;'5E9"!A="`D
M.#(@;6EL;&EO;BP@9F]R(&$@=&]T86P@8V]N=')A8W0@=F%L=64@;V8@=7`@
M=&\@)#$W.2!M:6QL:6]N+B!4:&4@2$A3($)!4D1!(&-O;G1R86-T(&%W87)D
M('!R;W9I9&5S('-I9VYI9FEC86YT(&9U;F1I;F<@9F]R('1H92!#;VUP86YY
M)B,S.3MS(&]N9V]I;F<@8VQI;FEC86P@9&5V96QO<&UE;G0@86YD('!R;V1U
M8W0@<V-A;&4M=7`@;V8@8F]T:"!I=',@<V5A<V]N86P@86YD('!A;F1E;6EC
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M;6]N;W9A;&5N="!P86YD96UI8R`H2#5.,2D@:6YF;'5E;GIA('9A8V-I;F5S
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M+"`R,#$R+"!T:&4@0V]M<&%N>2!H87,@<F5C;V=N:7IE9"!R979E;G5E(&]F
M(&%P<')O>&EM871E;'D@)#,Q+C8@;6EL;&EO;B!A;F0@)#$V+CD@;6EL;&EO
M;BP@<F5S<&5C=&EV96QY+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\
M8G(@+SX@/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!4
M15A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(%5N9&5R(&-E<G1A
M:6X@8VER8W5M<W1A;F-E<R!(2%,@0D%21$$@<F5I;6)U<G-E;65N=',@;6%Y
M(&)E(&1E;&%Y960@;W(@979E;B!P;W1E;G1I86QL>2!W:71H:&5L9"X@26X@
M36%R8V@@,C`Q,BP@=&AE($-O;7!A;GD@9&5C:61E9"!T;R!C;VYD=6-T(&ET
M<R!0:&%S92!)22!D;W-E+7)A;F=I;F<@8VQI;FEC86P@=')I86P@;V8@:71S
M('1R:79A;&5N="!A;F0@<75A9')I=F%L96YT('-E87-O;F%L(&EN9FQU96YZ
M82!V86-C:6YE(&-A;F1I9&%T97,@*'1H92`B,C`U(%1R:6%L(BD@=6YD97(@
M:71S(&5X:7-T:6YG(%4N4RX@:6YV97-T:6=A=&EO;F%L(&YE=R!D<G5G(&%P
M<&QI8V%T:6]N("@B24Y$(BD@9F]R(&ET<R!T<FEV86QE;G0@<V5A<V]N86P@
M:6YF;'5E;GIA('9A8V-I;F4@8V%N9&ED871E("@B5')I=F%L96YT($E.1"(I
M(&%S(&]P<&]S960@=&\@=V%I=&EN9R!T;R!C;VYD=6-T('1H92`R,#4@5')I
M86P@=6YD97(@82!N97<@24Y$(&9O<B!I=',@<75A9')I=F%L96YT('9A8V-I
M;F4@8V%N9&ED871E("@B475A9')I=F%L96YT($E.1"(I+B!);B!*=6QY(#(P
M,3(L('1H92!#;VUP86YY(')E<&]R=&5D('1H870@:70@97AP96-T960@=&\@
M;&%U;F-H(&ET<R!N97AT('%U861R:79A;&5N="!0:&%S92!)22!C;&EN:6-A
M;"!T<FEA;"!I;B`R,#$S(')A=&AE<B!T:&%N(&EN('1H92!S96-O;F0@:&%L
M9B!O9B`R,#$R.R!S:6UI;&%R;'DL('1H92!F:6QI;F<@;V8@=&AE(%%U861R
M:79A;&5N="!)3D0L('=H:6-H('1H92!#;VUP86YY(&AA9"!P<F5V:6]U<VQY
M(&EN9&EC871E9"!W87,@97AP96-T960@:6X@=&AE('-E8V]N9"!H86QF(&]F
M(#(P,3(@=VEL;"!A;'-O(&)E(&1E;&%Y960N($)A<V5D(&]N(&1I<V-U<W-I
M;VYS(&)E='=E96X@2$A3($)!4D1!(&%N9"!T:&4@0V]M<&%N>2P@8F5C875S
M92!T:&4@,C`U(%1R:6%L(&EN8VQU9&5S(&ET<R!Q=6%D<FEV86QE;G0@<V5A
M<V]N86P@:6YF;'5E;GIA('9A8V-I;F4@8V%N9&ED871E+"!T:&4@;W5T<VED
M92!C;&EN:6-A;"!T<FEA;"!C;W-T<R!F;W(@=&AE(#(P-2!4<FEA;"!W:6QL
M(&]N;'D@8F4@<W5B;6ET=&5D(&9O<B!R96EM8G5R<V5M96YT('1O($A(4R!"
M05)$02!A;F0@<F5C;W)D960@87,@<F5V96YU92!B>2!T:&4@0V]M<&%N>2!A
M9G1E<B!I="!S=6)M:71S('1H92`R,#4@5')I86P@9&%T82!T;R!I=',@475A
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M<VED92!C;&EN:6-A;"!T<FEA;"!C;W-T<R!O9B!T:&4@,C`U(%1R:6%L('1H
M870@87)E(&5X<&5C=&5D('1O('1O=&%L(&%P<')O>&EM871E;'D@)#,N,2!M
M:6QL:6]N+"!O9B!W:&EC:"`D,BXX(&UI;&QI;VX@=V%S(&EN8W5R<F5D('1H
M<F]U9V@@4V5P=&5M8F5R(#,P+"`R,#$R+CPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N,C5I;CL@34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@/'-T<F]N9SX\96T^/&)R("\^(#PO96T^/"]S=')O;F<^/"]P
M/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,"XR-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\<W1R;VYG/CQE;3Y,:6-E;G-E
M($%G<F5E;65N="!W:71H($Q'($QI9F4@4V-I96YC97,L($QT9"X\+V5M/CPO
M<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\8G(@+SX@/"]P
M/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^($EN($9E8G)U87)Y(#(P,3$L('1H
M92!#;VUP86YY(&5N=&5R960@:6YT;R!A(&QI8V5N<V4@86=R965M96YT('=I
M=&@@3$<@3&EF92!38VEE;F-E<RP@3'1D+B`H(DQ'3%,B*2!T:&%T(&%L;&]W
M<R!,1TQ3('1O('5S92!T:&4@0V]M<&%N>28C,SD[<R!T96-H;F]L;V=Y('1O
M(&1E=F5L;W`@86YD(&-O;6UE<F-I86QL>2!S96QL(&EN9FQU96YZ82!V86-C
M:6YE<R!E>&-L=7-I=F5L>2!I;B!3;W5T:"!+;W)E82!A;F0@;F]N+65X8VQU
M<VEV96QY(&EN(&-E<G1A:6X@;W1H97(@<W!E8VEF:65D(&-O=6YT<FEE<RX@
M070@:71S(&]W;B!C;W-T+"!,1TQ3(&ES(')E<W!O;G-I8FQE(&9O<B!F=6YD
M:6YG(&ET<R!C;&EN:6-A;"!D979E;&]P;65N="!O9B!T:&4@:6YF;'5E;GIA
M(%9,4"!V86-C:6YE<R!A;F0@8V]M<&QE=&EN9R!A(&UA;G5F86-T=7)I;F<@
M9F%C:6QI='D@:6X@4V]U=&@@2V]R96$N(%5N9&5R('1H92!L:6-E;G-E(&%G
M<F5E;65N="P@=&AE($-O;7!A;GD@:7,@;V)L:6=A=&5D('1O('!R;W9I9&4@
M3$=,4R!W:71H(&EN9F]R;6%T:6]N(&%N9"!M871E<FEA;',@<F5L871E9"!T
M;R!T:&4@;6%N=69A8W1U<F4@;V8@=&AE(&QI8V5N<V5D('!R;V1U8W1S+"!P
M<F]V:61E(&]N+6=O:6YG('!R;VIE8W0@;6%N86=E;65N="!A;F0@<F5G=6QA
M=&]R>2!S=7!P;W)T(&%N9"!C;VYD=6-T(&-L:6YI8V%L('1R:6%L<R!O9B!I
M=',@:6YF;'5E;GIA('9A8V-I;F5S(&EN(&]R9&5R('1O(&]B=&%I;B!&1$$@
M87!P<F]V86P@:6X@=&AE(%4N4RX@5&AE('1E<FT@;V8@=&AE(&QI8V5N<V4@
M86=R965M96YT(&ES(&5X<&5C=&5D('1O('1E<FUI;F%T92!I;B`R,#(W+B!0
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M;65N=',@870@82!R871E(&)E='=E96X@,3`E(&%N9"`R,"4@9G)O;2!,1TQ3
M)B,S.3MS(&9U='5R92!C;VUM97)C:6%L('-A;&5S(&]F(&EN9FQU96YZ82!6
M3%`@=F%C8VEN97,L('=H:6-H(')O>6%L='D@<F%T92!I<R!S=6)J96-T('1O
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M8F4@<F5C;V=N:7IE9"!A<R!E87)N960N/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^(#QB<B`O/B`\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU
M<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C(U:6X[($U!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QS
M=')O;F<^/&5M/E!!5$@@5F%C8VEN92!3;VQU=&EO;G,\+V5M/CPO<W1R;VYG
M/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\8G(@+SX@/"]P/B`\<"!S
M='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU
M:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^($EN($IU;'D@,C`Q,BP@=&AE($-O;7!A;GD@
M96YT97)E9"!I;G1O(&$@8VQI;FEC86P@9&5V96QO<&UE;G0@86=R965M96YT
M('=I=&@@4$%42"!686-C:6YE(%-O;'5T:6]N<R`H(E!!5$@B*2!T;R!D979E
M;&]P(&ET<R!V86-C:6YE(&-A;F1I9&%T92!T;R!P<F]T96-T(&%G86EN<W0@
M4E-6('1H<F]U9V@@;6%T97)N86P@:6UM=6YI>F%T:6]N(&EN(&QO=RUR97-O
M=7)C92!C;W5N=')I97,@*'1H92`B4E-6($-O;&QA8F]R871I;VX@4')O9W)A
M;2(I+B!4:&4@0V]M<&%N>2!W87,@87=A<F1E9"!A<'!R;WAI;6%T96QY("0R
M+C`@;6EL;&EO;B!B>2!0051((&9O<B!I;FET:6%L(&9U;F1I;F<@=6YD97(@
M=&AE(&%G<F5E;65N="!T;R!P87)T:6%L;'D@<W5P<&]R="!I=',@4&AA<V4@
M24D@9&]S92UR86YG:6YG(&-L:6YI8V%L('1R:6%L(&EN('=O;65N(&]F(&-H
M:6QD8F5A<FEN9R!A9V4L('=H:6-H('=A<R!L875N8VAE9"!I;B!/8W1O8F5R
M(#(P,3(N(%1H92!A9W)E96UE;G0@=V]U;&0@97AP:7)E($IU;'D@,S$L(#(P
M,3,L('5N;&5S<R!T:&4@0V]M<&%N>2!A;F0@4$%42"!D96-I9&4@=&\@8V]N
M=&EN=64@=&AE(%)35B!#;VQL86)O<F%T:6]N(%!R;V=R86TN(%1H92!#;VUP
M86YY(')E=&%I;G,@9VQO8F%L(')I9VAT<R!T;R!C;VUM97)C:6%L:7IE('1H
M92!P<F]D=6-T(&%N9"!H87,@;6%D92!A(&-O;6UI=&UE;G0@=&\@;6%K92!T
M:&4@=F%C8VEN92!A9F9O<F1A8FQE(&%N9"!A=F%I;&%B;&4@:6X@;&]W+7)E
M<V]U<F-E(&-O=6YT<FEE<RX@5&\@=&AE(&5X=&5N="!0051((&AA<R!C;VYT
M:6YU960@=&\@9G5N9"`U,"4@;V8@=&AE($-O;7!A;GDF(S,Y.W,@97AT97)N
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M92!M;VYT:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$R+"!T:&4@0V]M<&%N
M>2!R96-O9VYI>F5D(')E=F5N=64@;V8@87!P<F]X:6UA=&5L>2`D,"XR(&UI
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M+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B!B;VQD(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\8G(@+SX@/"]P/B`\
M(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
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M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/D-A<&ET86P@3&5A<V4\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#87!I=&%L($QE87-E(%M!8G-T
M<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V%P:71A;"!,96%S93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,
M(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O
M>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV
M/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P:6X[($U!4D=)3CH@,'!T
M(#!P>#L@1D].5#H@8F]L9"`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@3F]T92`V("T@0V%P:71A;"!,96%S93PO<#X@/'`@<W1Y;&4]
M,T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M1D].5"U714E'2%0Z(&YO<FUA;#L@34%21TE..B`P<'0@,'!X.R!415A4+4%,
M24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6XG/B`F;F)S<#L\+W`^
M(#QP('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[($9/3E0M5T5)1TA4.B!N;W)M86P[($U!4D=)3CH@,'!T(#!P
M>#L@5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN)SX@
M26X@075G=7-T(#(P,3(L('1H92!#;VUP86YY(&QE87-E9"!E<75I<&UE;G0@
M=6YD97(@82!C87!I=&%L(&QE87-E('=I=&@@86X@969F96-T:79E(&EN=&5R
M97-T(')A=&4@;V8@-BXU)2!W:71H(&%N(&%D=F%N8V4@<&%Y;65N="!A;F0@
M;6]N=&AL>2!P87EM96YT<R!O9B`D-BPS,C4@<W1A<G1I;F<@075G=7-T(#(P
M,3(@86YD(&]V97(@=&AE(&YE>'0@-3D@;6]N=&AS+B!4:&4@8V%P:71A;"!L
M96%S92!I<R!R96-O<F1E9"!A="!T:&4@<')E<V5N="!V86QU92!O9B!T:&4@
M9G5T=7)E(&UI;FEM=6T@;&5A<V4@<&%Y;65N=',N($9U='5R92!M:6YI;75M
M(&-A<&ET86P@;&5A<V4@<&%Y;65N=',@=6YD97(@=&AE(&-A<&ET86P@;&5A
M<V4@86=R965M96YT(&%T(%-E<'1E;6)E<B`S,"P@,C`Q,B!A<F4@87,@9F]L
M;&]W<R`H:6X@=&AO=7-A;F1S*3H\+W`^(#QP('-T>6QE/3-$)T9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($9/3E0M5T5)1TA4
M.B!N;W)M86P[($U!4D=)3CH@,'!T(#!P>#L@5$585"U!3$E'3CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#`N-6EN)SX@)FYB<W`[/"]P/B`\=&%B;&4@<W1Y
M;&4],T0G5TE$5$@Z(#<P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%
M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD
M)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4
M.B!B;VQD)R!C;VQS<&%N/3-$,CY!;6]U;G0\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/B9N8G-P
M.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R
M9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`W.24G/C(P,3(\
M+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$E)SXF;F)S<#L\+W1D/B`\=&0@
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M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/C<V/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#PO
M='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U
M-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/C(P,30\+W1D/B`\=&0^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^-S8\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R
M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/C(P,34\+W1D/B`\=&0^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H="<^-S8\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]5
M3D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^,C`Q-CPO
M=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SXW-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SXF
M;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/
M4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^,C`Q
M-SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!
M3$E'3CH@<FEG:'0G/B`T-#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\+W1R
M/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L
M,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9#XF;F)S<#L\+W1D
M/B`\=&0^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
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M("8C.#(Q,SL@86UO=6YT<R!R97!R97-E;G1I;F<@:6YT97)E<W0\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(')I
M9VAT)SX@*#4Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%!!1$1)3D<M0D]45$]-.B`Q<'0G/BD\+W1D/B`\+W1R/B`\='(@<W1Y;&4]
M,T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SY0<F5S96YT('9A;'5E(&]F(&YE="!M:6YI;75M(&QE87-E('!A>6UE
M;G1S/"]T9#X@/'1D/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G/C,P.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.
M1"U#3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P
M="<^3&5S<R`F(S@R,3,[(&-U<G)E;G0@<&]R=&EO;B!O9B!C87!I=&%L(&QE
M87-E/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4
M+4%,24=..B!R:6=H="<^("@U-SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,7!T)SXI/"]T9#X@/"]T<CX@
M/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P
M-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SY.;VXM8W5R
M<F5N="!P;W)T:6]N(&]F(&-A<&ET86P@;&5A<V4\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4
M+4%,24=..B!L969T)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@
M,C4R/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/"]T<CX@/"]T86)L93X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#!I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B!B;VQD(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#PA+2U%;F1&
M<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
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M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^3F]T97,@4&%Y86)L93QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&5S(%!A>6%B;&4@6T%B<W1R86-T73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.;W1E
M<R!087EA8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM
M1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R
M86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O
M1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X-"CQD:78^(#QD:78^
M/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X.R!&
M3TY4.B!B;VQD(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B!.;W1E(#<@+2!.;W1E<R!087EA8FQE/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!);B!3
M97!T96UB97(@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&$@36%S
M=&5R(%-E8W5R:71Y($%G<F5E;65N="!W:71H($=E;F5R86P@16QE8W1R:6,@
M0V%P:71A;"!#;W)P;W)A=&EO;B`H(D=%(BDL('=H97)E8GD@=&AE($-O;7!A
M;GD@8V%N(&)O<G)O=R!U<"!T;R`D,BXP(&UI;&QI;VX@=&\@9FEN86YC92!T
M:&4@<'5R8VAA<V5S(&]F(&5Q=6EP;65N="`H(D5Q=6EP;65N="!,;V%N(BDN
M($5A8V@@17%U:7!M96YT($QO86X@8F5A<G,@:6YT97)E<W0@870@=&AE('1H
M<F5E+7EE87(@52Y3+B!';W9E<FYM96YT('1R96%S=7)Y(')A=&4@<&QU<R`Q
M,2XV."4L('!R;W9I9&5D('1H870@=&AE(')A=&4@<VAA;&P@;F]T(&)E(&QE
M<W,@=&AA;B`Q,BXQ)2P@86YD(&ES('1O(&)E(')E<&%I9"!O=F5R(&9O<G1Y
M+71W;R`H-#(I(&UO;G1H<RX@1T4@=VEL;"!M86EN=&%I;B!A('-E8W5R:71Y
M(&EN=&5R97-T(&EN(&%L;"!E<75I<&UE;G0@9FEN86YC960@=6YD97(@=&AI
M<R!F86-I;&ET>2X@1'5R:6YG('1H92!T:')E92!M;VYT:',@96YD960@4V5P
M=&5M8F5R(#,P+"`R,#$R+"!T:&4@0V]M<&%N>2!F:6YA;F-E9"`D,"XU(&UI
M;&QI;VX@870@86X@:6YT97)E<W0@<F%T92!O9B`Q,BXQ)2!W:71H(&UO;G1H
M;'D@<')I;F-I<&%L('!A>6UE;G1S(&]F("0Q,RPP.#D@<W1A<G1I;F<@3V-T
M;V)E<B`R,#$R+B!);G1E<F5S="!A8V-R=65S(&]N('1H92!O=71S=&%N9&EN
M9R!B86QA;F-E('5N=&EL('!A:60@:6X@9G5L;"X\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P
M>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M($%G9W)E9V%T92!F=71U<F4@;6EN:6UU;2!P<FEN8VEP86P@<&%Y;65N=',@
M;VX@=&AE($=%($5Q=6EP;65N="!,;V%N(&%T(%-E<'1E;6)E<B`S,"P@,C`Q
M,B!A<F4@87,@9F]L;&]W<R`H:6X@=&AO=7-A;F1S*3H\+W`^(#QP('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4],T0G5TE$
M5$@Z(#<P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,
M24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,7!T('-O;&ED.R!&3TY4+5=%24=(5#H@8F]L9"<^(%EE87(\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z
M(&)O;&0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5"U7
M14E'2%0Z(&)O;&0G(&-O;'-P86X],T0R/D%M;W5N=#PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<^
M)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],
M3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#<Y)2<^
M,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=724142#H@,24G/B9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B0\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q
M."4G/C,Y/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)
M1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'
M4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/C(P,3,\+W1D/B`\=&0^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^,34W
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO
M=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H
M,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/C(P,30\+W1D/B`\=&0^)FYB<W`[
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M1"=415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0G/C$U-SPO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G
M0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@,7!T)SXR,#$V/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(#0P/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]4
M5$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+
M1U)/54Y$+4-/3$]2.B!W:&ET93L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P
M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!
M3$E'3CH@<FEG:'0G/B`U-3`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\
M+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y
M.R!415A4+4E.1$5.5#H@,&EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(&)O
M;&0@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P
M.SPO<#X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&%E8C1A.#%?9&9D
M-E\T-F(U7V(S,F1?-69E-#5A864Y,F1E#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U86%E.3)D
M92]7;W)K<VAE971S+U-H965T,34N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY787)R86YT($QI86)I;&ET>3QB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E=A<G)A;G0@
M3&EA8FEL:71Y(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5V%R<F%N="!,:6%B:6QI='D\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#
M("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT
M='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I
M;VYA;"YD=&0B("TM/@T*/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM
M/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,&EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(&)O;&0@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^($YO=&4@."`M(%=A<G)A;G0@
M3&EA8FEL:71Y/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y
M.R!415A4+4E.1$5.5#H@,"XU-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P+C4U:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^($EN($IU;'D@,C`P."P@=&AE
M($-O;7!A;GD@8V]M<&QE=&5D(&$@<F5G:7-T97)E9"!D:7)E8W0@;V9F97)I
M;F<@;V8@-BPV.#8L-C4P('5N:71S+"!R86ES:6YG(&%P<')O>&EM871E;'D@
M)#$W+C4@;6EL;&EO;B!I;B!N970@<')O8V5E9',N($5A8V@@=6YI="!C;VYS
M:7-T960@;V8@;VYE('-H87)E(&]F(&-O;6UO;B!S=&]C:R!A;F0@82!W87)R
M86YT('1O('!U<F-H87-E(#`N-2!S:&%R97,@;V8@8V]M;6]N('-T;V-K("AT
M:&4@(E=A<G)A;G1S(BD@870@82!P<FEC92!O9B`D,BXV."!P97(@=6YI="X@
M5&AE(%=A<G)A;G1S(')E<')E<V5N="!T:&4@<FEG:'0@=&\@86-Q=6ER92!A
M;B!A9V=R96=A=&4@;V8@,RPS-#,L,S(U('-H87)E<R!O9B!C;VUM;VX@<W1O
M8VL@870@86X@97AE<F-I<V4@<')I8V4@;V8@)#,N-C(@<&5R('-H87)E(&%N
M9"!A<F4@97AE<F-I<V%B;&4@8F5T=V5E;B!*86YU87)Y(#,Q+"`R,#`Y(&%N
M9"!*=6QY(#,Q+"`R,#$S+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-35I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!4
M15A4+4E.1$5.5#H@,"XU-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\9F]N="!S='EL
M93TS1"=#3TQ/4CH@8FQA8VLG/D1U<FEN9R!T:&4@;FEN92!M;VYT:',@96YD
M960@4V5P=&5M8F5R(#,P+"`R,#$R(&%N9"`R,#$Q+"!T:&4@0V]M<&%N>2!R
M96-O<F1E9"!A<R!O=&AE<B!I;F-O;64@*&5X<&5N<V4I/"]F;VYT/B!I;B!I
M=',@<W1A=&5M96YT<R!O9B!O<&5R871I;VYS(&%N9"!C;VUP<F5H96YS:79E
M(&QO<W,@/&9O;G0@<W1Y;&4],T0G0T],3U(Z(&)L86-K)SYA(&-H86YG92!I
M;B!F86ER('9A;'5E(&]F('=A<G)A;G0@;&EA8FEL:71Y(&]F("@D,"XT*2!M
M:6QL:6]N(&%N9"`D,BXP(&UI;&QI;VXL(')E<W!E8W1I=F5L>2X@07,@;V8@
M4V5P=&5M8F5R(#,P+"`R,#$R+"!T:&4@=V%R<F%N="!L:6%B:6QI='D@<F5C
M;W)D960@;VX@=&AE(&)A;&%N8V4@<VAE970@=V%S("0P+C@@;6EL;&EO;B!A
M;F0@86QL(%=A<G)A;G1S(')E;6%I;B!O=71S=&%N9&EN9R!A<R!O9B!T:&%T
M(&1A=&4N/"]F;VYT/CPO<#X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO
M9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,&%E8C1A.#%?9&9D-E\T-F(U7V(S,F1?-69E-#5A864Y,F1E#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D
M7S5F930U86%E.3)D92]7;W)K<VAE971S+U-H965T,38N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY386QE<R!O9B!#;VUM;VX@
M4W1O8VL\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S
M,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY386QE<R!O9B!#;VUM;VX@4W1O8VL@6T%B<W1R86-T73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y386QE<R!O
M9B!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q
M+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH
M=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I=CX@
M/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=415A4+4%,
M24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,&EN.R!-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(&)O;&0@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^($YO=&4@.2`M(%-A;&5S(&]F($-O;6UO;B!3=&]C:SPO<#X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N
M-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@5&AE($)O87)D(&]F($1I<F5C=&]R<R!O9B!T:&4@0V]M<&%N
M>2`H=&AE(")";V%R9"(I(&AA<R!A<'!O:6YT960@82!S=&%N9&EN9R!&:6YA
M;F-E($-O;6UI='1E92`H=&AE(")#;VUM:71T964B*2!T;R!A<W-I<W0@=&AE
M($)O87)D('=I=&@@:71S(')E<W!O;G-I8FEL:71I97,@=&\@;6]N:71O<BP@
M<')O=FED92!A9'9I8V4@=&\@<V5N:6]R(&UA;F%G96UE;G0@;V8@=&AE($-O
M;7!A;GD@86YD(&%P<')O=F4@86QL(&-A<&ET86P@<F%I<VEN9R!A8W1I=FET
M:65S+B!4:&4@0V]M;6ET=&5E(&AA<R!B965N(&%U=&AO<FEZ960@8GD@=&AE
M($)O87)D('1O(&%P<')O=F4@86QL($%T($UA<FME="!)<W-U86YC92!S86QE
M<R!T<F%N<V%C=&EO;G,N($EN(&1O:6YG('-O+"!T:&4@0V]M;6ET=&5E('-E
M=',@=&AE(&%M;W5N="!O9B!S:&%R97,@=&\@8F4@<V]L9"P@=&AE('!E<FEO
M9"!O9B!T:6UE(&1U<FEN9R!W:&EC:"!S=6-H('-A;&5S(&UA>2!O8V-U<B!A
M;F0@=&AE(&UI;FEM=6T@<V%L97,@<')I8V4@<&5R('-H87)E+B!);B!397!T
M96UB97(@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&%N($%T($UA
M<FME="!)<W-U86YC92!386QE<R!!9W)E96UE;G0L('5N9&5R('=H:6-H('1H
M92!#;VUP86YY(&UA>2!S96QL(&%N(&%G9W)E9V%T92!O9B`D-3`@;6EL;&EO
M;B!I;B!G<F]S<R!P<F]C965D<R!O9B!I=',@8V]M;6]N('-T;V-K+B!4:&ES
M(&%G<F5E;65N="!R97!L86-E<R!T:&4@<')E=FEO=7,@<V%L97,@86=R965M
M96YT(&5N=&5R960@:6X@36%R8V@@,C`Q,"P@=VAI8V@@86QS;R!A;&QO=V5D
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M92!M;VYT:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$R+"!T:&4@0V]M<&%N
M>2!S;VQD(#@N-"!M:6QL:6]N('-H87)E<R!A="!A;B!A=F5R86=E('-A;&5S
M('!R:6-E(&]F("0Q+C<P('!E<B!S:&%R92P@<F5S=6QT:6YG(&EN("0Q-"XP
M(&UI;&QI;VX@:6X@;F5T('!R;V-E961S.R!T:&ES(&%M;W5N="!E>&-L=61E
M<R`D,"XX(&UI;&QI;VX@<F5C96EV960@:6X@96%R;'D@,C`Q,B!F;W(@,"XW
M(&UI;&QI;VX@<VAA<F5S('1R861E9"!I;B!L871E($1E8V5M8F5R(#(P,3$N
M(%-I;F-E(&5N=&5R:6YG(&EN=&\@=&AE($UA<F-H(#(P,3`@<V%L97,@86=R
M965M96YT('1H<F]U9V@@3F]V96UB97(@-RP@,C`Q,BP@=&AE($-O;7!A;GD@
M:&%S('-O;&0@,C0L.34W+#<Q-2!S:&%R97,@;V8@:71S(&-O;6UO;B!S=&]C
M:R!A;F0@<F5C96EV960@9W)O<W,@<')O8V5E9',@;V8@)#0Y+CD@;6EL;&EO
M;BX@3F\@<V%L97,@:&%V92!O8V-U<G)E9"!U;F1E<B!T:&4@4V5P=&5M8F5R
M(#(P,3(@<V%L97,@86=R965M96YT+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!
M3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I
M9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@26X@36%Y
M(#(P,3(L('1H92!#;VUP86YY('-O;&0@,3`L,#`P+#`P,"!S:&%R97,@;V8@
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M;&5D('=I=&@@=&AE(%-%0RX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P:6X[($U!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@8F]L9"`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX@)FYB<W`[/"]P/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
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M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DUA;G5F86-T=7)I;F<L($QA8F]R
M871O<GD@86YD($]F9FEC92!&86-I;&ET>3QB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DUA;G5F86-T=7)I;F<@3&%B
M;W)A=&]R>2!A;F0@3V9F:6-E($9A8VEL:71Y(%M!8G-T<F%C=%T\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%N=69A8W1U
M<FEN9RP@3&%B;W)A=&]R>2!A;F0@3V9F:6-E($9A8VEL:71Y/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL(%!50DQ)
M0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H
M='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET
M:6]N86PN9'1D(B`M+3X-"CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M
M+3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%
M3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B!B;VQD(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!.;W1E(#$P("T@36%N=69A
M8W1U<FEN9RP@3&%B;W)A=&]R>2!A;F0@3V9F:6-E($9A8VEL:71Y/"]P/B`\
M<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
M,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^(#QB<B`O/B`\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@26X@3F]V96UB97(@,C`Q,2P@=&AE($-O;7!A;GD@96YT
M97)E9"!I;G1O(&QE87-E(&%G<F5E;65N=',L('5N9&5R('=H:6-H('1H92!#
M;VUP86YY(&QE87-E<R!I=',@;F5W(&UA;G5F86-T=7)I;F<L(&QA8F]R871O
M<GD@86YD(&]F9FEC92!S<&%C92!I;B!'86ET:&5R<V)U<F<L($UA<GEL86YD
M+B!4:&4@;&5A<V4@86=R965M96YT<R!P<F]V:61E('1H870L(&%M;VYG(&]T
M:&5R('1H:6YG<RP@87,@;V8@2F%N=6%R>2`Q+"`R,#$R+"!T:&4@0V]M<&%N
M>2!S=6)L96%S92!F<F]M('1H92!C=7)R96YT(&9A8VEL:71Y('1E;F%N="P@
M86YD('-U8G-E<75E;G1L>2!L96%S92!D:7)E8W1L>2!F<F]M('1H92!L86YD
M;&]R9"P@87!P<F]X:6UA=&5L>2`W-"PP,#`@=&]T86P@<W%U87)E(&9E970L
M('=I=&@@<F5N="!P87EM96YT<R!F;W(@<W5C:"!S<&%C92!T;R!T:&4@;&%N
M9&QO<F0@8V]M;65N8VEN9R!!<')I;"`Q+"`R,#$T+B!5;F1E<B!T:&4@=&5R
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M=F4@:6YT97)E<W0@<F%T92!O9B`X+C`E+B!$=7)I;F<@=&AE(&YI;F4@;6]N
M=&AS(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q,BP@=&AE($-O;7!A;GD@=V%S
M(&9U;F1E9"`D,BXX(&UI;&QI;VX@=6YD97(@=&AE($EM<')O=F5M96YT($%L
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M+"`R,#$W+CPO<#X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&%E8C1A
M.#%?9&9D-E\T-F(U7V(S,F1?-69E-#5A864Y,F1E#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U
M86%E.3)D92]7;W)K<VAE971S+U-H965T,3@N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY-87-T97(@4V5R=FEC97,@06=R965M
M96YT('=I=&@@0V%D:6QA/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^36%S=&5R(%-E<G9I8V5S($%G<F5E;65N="!W
M:71H($-A9&EL82!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DUA<W1E<B!397)V:6-E<R!!9W)E96UE;G0@
M=VET:"!#861I;&$\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA
M+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@
M5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL
M,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I=CX@/&1I
M=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,&EN.R!-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(&)O;&0@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^($YO=&4@,3$@/&9O;G0@<W1Y;&4],T0G1D].5"U714E'2%0Z(&YO<FUA
M;"<^+3PO9F]N=#X@36%S=&5R(%-E<G9I8V5S($%G<F5E;65N="!W:71H($-A
M9&EL83PO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$58
M5"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P
M+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@26X@8V]N;F5C=&EO;B!W:71H('1H92!*
M5B!W:71H($-A9&EL82P@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&$@;6%S
M=&5R('-E<G9I8V5S(&%G<F5E;65N="P@=VAI8V@@=&AE($-O;7!A;GD@86YD
M($-A9&EL82!A;65N9&5D(&EN($IU;'D@,C`Q,2!T;R!E>'1E;F0@=&AE('1E
M<FT@8GD@;VYE('EE87(@9F]R('=H:6-H('-E<G9I8V5S(&-A;B!B92!P<F]V
M:61E9"!B>2!#861I;&$@=6YD97(@=&AI<R!A9W)E96UE;G0N(%5N9&5R('1H
M92!R979I<V5D('1E<FUS+"!I9B!B>2!-87)C:"`R,#$S+"!T:&4@86UO=6YT
M(&]F('-E<G9I8V5S('!R;W9I9&5D(&)Y($-A9&EL82!U;F1E<B!T:&4@;6%S
M=&5R('-E<G9I8V5S(&%G<F5E;65N="!I<R!L97-S('1H86X@)#<N-2!M:6QL
M:6]N+"!T:&4@0V]M<&%N>2!W:6QL('!A>2!#861I;&$@=&AE('!O<G1I;VX@
M;V8@=&AE('-H;W)T9F%L;"!A;6]U;G0@=&AA="!I<R!L97-S('1H86X@;W(@
M97%U86P@=&\@)#(N,"!M:6QL:6]N(&%N9"`U,"4@;V8@=&AE('!O<G1I;VX@
M;V8@=&AE('-H;W)T9F%L;"!A;6]U;G0@=&AA="!E>&-E961S("0R+C`@;6EL
M;&EO;BX@5&AR;W5G:"!397!T96UB97(@,S`L(#(P,3(L('1H92!#;VUP86YY
M(&AA<R!P=7)C:&%S960@)#`N-"!M:6QL:6]N(&EN('-E<G9I8V5S(&9R;VT@
M0V%D:6QA('!U<G-U86YT('1O('1H:7,@86=R965M96YT+B!4:&4@0V]M<&%N
M>2!P;&%N<R!T;R!E>'!L;W)E('=I=&@@0V%D:6QA('=A>7,@=&\@<&]T96YT
M:6%L;'D@<F5D=6-E(&ET<R!F:6YA;F-I86P@;V)L:6=A=&EO;B!A;F0O;W(@
M97AT96YD('1H92!T:6UE('!E<FEO9"!D=7)I;F<@=VAI8V@@=&AE($-O;7!A
M;GD@8V]U;&0@=71I;&EZ92!S=6-H('-E<G9I8V5S+B!4:&4@0V]M<&%N>2!C
M86X@<')O=FED92!N;R!A<W-U<F%N8V4L(&AO=V5V97(L('1H870@=&AE<V4@
M969F;W)T<R!W:6QL(&)E('-U8V-E<W-F=6PN($EF('1H92!#;VUP86YY(&9A
M:6QS('1O(&YE9V]T:6%T92!A(&-H86YG92!I;B!T:&ES(&%R<F%N9V5M96YT
M+"!T:&4@0V]M<&%N>2!E>'!E8W1S('1H870@:70@=VEL;"!B92!O8FQI9V%T
M960@=&\@<W!E;F0@82!S:6=N:69I8V%N="!P;W)T:6]N(&]F(&ET<R!A=F%I
M;&%B;&4@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<R!T;R!P87D@0V%D:6QA
M(&9O<B!O=7(@<VAO<G1F86QL(&EN('-E<G9I8V5S('!U<F-H87-E9"X\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]P/B`\(2TM16YD1G)A9VUE
M;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-U
M8G-E<75E;G0@179E;G1S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4W5B<V5Q=65N="!%=F5N=',@6T%B<W1R86-T
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3
M=6)S97%U96YT($5V96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,
M(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O
M>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV
M/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P:6X[($U!4D=)3CH@,'!T
M(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^(#QS=')O;F<^3F]T92`Q,B`M(%-U8G-E<75E;G0@179E;G1S/"]S=')O
M;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4
M+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N
M-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
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M86P@36%N86=E;65N="!,3$,@870@82!P<FEC92!O9B`D,BXQ."!P97(@<VAA
M<F4L(')E<W5L=&EN9R!I;B!A<'!R;WAI;6%T96QY("0R-BXY(&UI;&QI;VX@
M:6X@;F5T('!R;V-E961S+B!4:&4@<VAA<F5S('=E<F4@;V9F97)E9"!U;F1E
M<B!A;B!E9F9E8W1I=F4@<VAE;&8@<F5G:7-T<F%T:6]N('-T871E;65N="!P
M<F5V:6]U<VQY(&9I;&5D('=I=&@@=&AE(%-%0RX\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P
M/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15='04,^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^4W5M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O=6YT
M:6YG(%!O;&EC:65S("A0;VQI8WDI/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5M;6%R>2!O9B!3:6=N:69I8V%N
M="!!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S:7,@;V8@4')E<V5N
M=&%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#
M5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS
M:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$
M+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X-"CQD:78^(#QD:78^/"$M
M+5-T87)T1G)A9VUE;G0M+3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@34%21TE..B`P<'0@,'!X(#!P="`P+C(U:6X[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\<W1R;VYG/CQE;3Y"
M87-I<R!O9B!0<F5S96YT871I;VX\+V5M/CPO<W1R;VYG/CPO<#X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN
M.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@5&AE(&%C8V]M<&%N>6EN9R!U;F%U9&ET960@9FEN86YC:6%L('-T
M871E;65N=',@:&%V92!B965N('!R97!A<F5D(&EN(&%C8V]R9&%N8V4@=VET
M:"!5;FET960@4W1A=&5S($=E;F5R86QL>2!!8V-E<'1E9"!!8V-O=6YT:6YG
M(%!R:6YC:7!L97,@*")'04%0(BD@9F]R(&EN=&5R:6T@9FEN86YC:6%L(&EN
M9F]R;6%T:6]N(&%N9"!T:&4@:6YS=')U8W1I;VYS('1O($9O<FT@,3`M42!A
M;F0@07)T:6-L92`Q,"!O9B!296=U;&%T:6]N(%,M6"X@5&AE(&)A;&%N8V4@
M<VAE970@87,@;V8@4V5P=&5M8F5R(#,P+"`R,#$R+"!S=&%T96UE;G1S(&]F
M(&]P97)A=&EO;G,@9F]R('1H92!T:')E92!A;F0@;FEN92!M;VYT:',@96YD
M960@4V5P=&5M8F5R(#,P+"`R,#$R(&%N9"`R,#$Q(&%N9"!T:&4@<W1A=&5M
M96YT<R!O9B!C87-H(&9L;W=S(&9O<B!T:&4@;FEN92!M;VYT:',@96YD960@
M4V5P=&5M8F5R(#,P+"`R,#$R(&%N9"`R,#$Q(&%R92!U;F%U9&ET960L(&)U
M="!I;F-L=61E(&%L;"!A9&IU<W1M96YT<R`H8V]N<VES=&EN9R!O9B!N;W)M
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M05`@:&%V92!B965N(&-O;F1E;G-E9"!O<B!O;6ET=&5D('!U<G-U86YT('1O
M('1H92!R=6QE<R!A;F0@<F5G=6QA=&EO;G,@;V8@=&AE(%5N:71E9"!3=&%T
M97,@4V5C=7)I=&EE<R!A;F0@17AC:&%N9V4@0V]M;6ES<VEO;B`H(E-%0R(I
M+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I
M;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
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M;VX@1F]R;2`Q,"U+(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B`S,2P@
M,C`Q,2X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!
M4D=)3CH@,'!T(#!P>"`P<'0@,"XR-6EN.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W`^(#PA+2U%;F1&<F%G
M;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5S92!O9B!%<W1I;6%T97,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"
M3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@
M(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS
M:71I;VYA;"YD=&0B("TM/@T*/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N
M="TM/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ
M(#!P="`P<'@@,'!T(#`N,C5I;CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^(#QS=')O;F<^/&5M/E5S92!O9B!%<W1I;6%T
M97,\+V5M/CPO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F
M;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%
M6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T
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M9&EF9F5R(&UA=&5R:6%L;'D@9G)O;2!T:&5S92!E<W1I;6%T97,N/"]P/B`\
M<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P="`P
M<'@@,'!T(#`N,C5I;CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)FYB<W`[/"]P/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I
M=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y&86ER(%9A;'5E($UE87-U<F5M96YT<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),24,@
M(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T
M<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO
M;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T
M(#!P>"`P<'0@,"XR-6EN.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@/'-T<F]N9SX\96T^1F%I<B!686QU92!-96%S=7)E
M;65N=',\+V5M/CPO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X(#!P="`P+C(U:6X[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\8G(@+SX@
M/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.
M1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(%1H92!#;VUP86YY(&%P<&QI
M97,@06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D:69I8V%T:6]N("@B05-#(BD@
M5&]P:6,@.#(P+"`\96T^1F%I<B!686QU92!-96%S=7)E;65N=',@86YD($1I
M<V-L;W-U<F5S/"]E;3XL(&9O<B!F:6YA;F-I86P@86YD(&YO;BUF:6YA;F-I
M86P@87-S971S(&%N9"!L:6%B:6QI=&EE<RX\+W`^(#QP('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QB<B`O/B`\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@05-#(#@R,"!D:7-C=7-S97,@=F%L
M=6%T:6]N('1E8VAN:7%U97,L('-U8V@@87,@=&AE(&UA<FME="!A<'!R;V%C
M:"`H8V]M<&%R86)L92!M87)K970@<')I8V5S*2P@=&AE(&EN8V]M92!A<'!R
M;V%C:"`H<')E<V5N="!V86QU92!O9B!F=71U<F4@:6YC;VUE(&]R(&-A<V@@
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M<FEE9B!D97-C<FEP=&EO;B!O9B!T:&]S92!T:')E92!L979E;',Z/"]P/B`\
M<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B`\8G(@+SX@/"]P/B`\=&%B;&4@<W1Y;&4],T0G34%21TE.+51/4#H@,'!T
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!-
M05)'24XM0D]45$]-.B`P<'0G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`@=VED=&@],T0Q,#`E/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)
M1TXZ('1O<"<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!7
M24142#H@,"XR-6EN)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@:G5S=&EF>3L@=VED=&@Z(#`N,C5I;CLG/B`F;6ED9&]T.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y)SY,979E;"`Q.B!/
M8G-E<G9A8FQE(&EN<'5T<R!S=6-H(&%S('%U;W1E9"!P<FEC97,@*'5N861J
M=7-T960I(&EN(&%C=&EV92!M87)K971S(&9O<B!I9&5N=&EC86P@87-S971S
M(&]R(&QI86)I;&ET:65S+CPO=&0^(#PO='(^(#PO=&%B;&4^(#QT86)L92!S
M='EL93TS1"=-05)'24XM5$]0.B`P<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($U!4D=)3BU"3U143TTZ(#!P="<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT
M<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@=&]P)SX@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%=)1%1(.B`P+C(U:6XG/B9N8G-P.SPO
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M/"]T<CX@/"]T86)L93X@/'1A8FQE('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P
M=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M34%21TE.+4)/5%1/33H@,'!T)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P('=I9'1H/3-$,3`P)3X@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,
M24=..B!T;W`G/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@
M5TE$5$@Z(#`N,C5I;B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&IU<W1I9GD[('=I9'1H.B`P+C(U:6X[)SX@)FUI9&1O=#L\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>2<^3&5V96P@,SH@
M56YO8G-E<G9A8FQE(&EN<'5T<R!T:&%T(')E9FQE8W0@=&AE(')E<&]R=&EN
M9R!E;G1I='DF(S,Y.W,@;W=N(&%S<W5M<'1I;VYS+CPO=&0^(#PO='(^(#PO
M=&%B;&4^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^(#QB<B`O/B`\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M1FEN86YC:6%L(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@;65A<W5R960@870@
M9F%I<B!M87)K970@=F%L=64@;VX@82!R96-U<G)I;F<@8F%S:7,@87,@;V8@
M4V5P=&5M8F5R(#,P+"`R,#$R(&%N9"!$96-E;6)E<B`S,2P@,C`Q,2!A<F4@
M<W5M;6%R:7IE9"!B96QO=R`H:6X@=&AO=7-A;F1S*3H\+W`^(#QP('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@/&)R("\^(#PO<#X@/'1A8FQE('-T>6QE/3-$)U=)
M1%1(.B`Q,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G5D525$E#04PM
M04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@
M1D].5"U714E'2%0Z(&)O;&0G(&YO=W)A<#TS1&YO=W)A<#X@/&)R("\^(#PO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z
M(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A<#X\
M8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0Q,"!N;W=R87`],T1N
M;W=R87`^1F%I<B!686QU92!A="!397!T96UB97(@,S`L(#(P,3(\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N;W=R87`^/&)R("\^
M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'
M2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A
M<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B
M;VQD.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0Q,"!N;W=R87`]
M,T1N;W=R87`^1F%I<B!686QU92!A="!$96-E;6)E<B`S,2P@,C`Q,3PO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O
M;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A<#X\8G(@
M+SX@/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!B
M;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M5T5)
M1TA4.B!B;VQD)R!N;W=R87`],T1N;W=R87`^(#QB<B`O/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0
M041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L
M:60[($9/3E0M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!
M3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^3&5V
M96P@,3PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U7
M14E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO
M=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P="<@;F]W
M<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#EP=#L@1D].
M5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&-E;G1E<B<@8V]L<W!A;CTS
M1#(@;F]W<F%P/3-$;F]W<F%P/DQE=F5L(#(\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/
M5%1/33H@,7!T)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!
M1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI
M9#L@1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,
M24=..B!C96YT97(G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#Y,979E
M;"`S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P="<@;F]W<F%P/3-$;F]W
M<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R
M87`],T1N;W=R87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@.7!T.R!&3TY4
M+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$
M,B!N;W=R87`],T1N;W=R87`^3&5V96P@,3PO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]4
M5$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$
M1$E.1RU"3U143TTZ(#%P="<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED
M.R!&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)
M1TXZ(&-E;G1E<B<@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P/DQE=F5L
M(#(\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N;W=R
M87`^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@
M1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A
M<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Y<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R
M(&YO=W)A<#TS1&YO=W)A<#Y,979E;"`S/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U14
M3TTZ(#%P="<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\+W1R/B`\
M='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T
M*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M3$5&5#H@
M.2XT-7!T.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%
M3E0Z("TY+C0U<'0G/B!!<W-E=',\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Y<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%
M.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,
M24=..B!L969T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:
M13H@.7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M.7!T.R!415A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^/&)R("\^
M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'
M3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#EP="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP
M=#L@5$585"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@<FEG:'0G/CQB<B`O/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y
M<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX\8G(@+SX@/"]T
M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L
M969T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T
M)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!4
M15A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^/&)R("\^(#PO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F
M="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP="<^
M/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@5$58
M5"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@<FEG:'0G/CQB<B`O/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M/CQB<B`O/B`\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#
M3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@
M4$%$1$E.1RU,1494.B`Y+C0U<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M
M24Y$14Y4.B`M.2XT-7!T.R!724142#H@,S0E)SX@0V]R<&]R871E(&1E8G0@
M86YD(&%U8W1I;VX@<F%T92!S96-U<FET:65S/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%=)1%1(
M.B`Q)2<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,
M24=..B!L969T.R!724142#H@,24G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@."4G/B`M/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^(#QB<B`O/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-
M.B`R+C5P=#L@5TE$5$@Z(#$E)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%
M.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^("0\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE
M.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`X
M)2<^(#$W+#8W,CPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@
M4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=..B!L969T.R!72414
M2#H@,24G/B`\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%=)1%1(.B`Q)2<^/&)R("\^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P
M="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T.R!7
M24142#H@,24G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT.R!724142#H@."4G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^(#QB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5TE$
M5$@Z(#$E)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M
M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^("0\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z
M(#EP=#L@5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`X)2<^("T\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R
M+C5P=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX@/&)R("\^(#PO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U14
M3TTZ(#(N-7!T.R!724142#H@,24G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)
M6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX@)#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B
M;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z
M(#@E)SX@-"PR,#4\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$
M5$@Z(#$E)SX@/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#EP=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!724142#H@,24G/CQB<B`O
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU
M<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F=#L@
M5TE$5$@Z(#$E)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,
M24=..B!R:6=H=#L@5TE$5$@Z(#@E)SX@+3PO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,
M24=..B!L969T.R!724142#H@,24G/B`\8G(@+SX@/"]T9#X@/"]T<CX@/'1R
M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ
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M<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M
M04Q)1TXZ(&QE9G0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Y<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%
M.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX\8G(@
M+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,
M24=..B!L969T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:
M13H@.7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M.7!T.R!415A4+4%,24=..B!L969T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^/&)R("\^
M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'
M3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#EP="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP
M=#L@5$585"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@<FEG:'0G/CQB<B`O/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y
M<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX\8G(@+SX@/"]T
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M3TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M
M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M
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M25I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U3
M25I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@+3PO=&0^(#QT9"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!4
M15A4+4%,24=..B!L969T)SX@/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T
M(&1O=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T
M(&1O=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@
M-S8Y/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'
M+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`\8G(@+SX@/"]T
M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/
M33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$58
M5"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$58
M5"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:
M13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G/B`\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4
M+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4
M+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G/B`\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU
M<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F="<^
M("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU
M<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@<FEG:'0G
M/B`S-C@\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^(#QB<B`O/B`\
M+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@
M,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^(#QB<B`O/B`\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S('1H
M92!A8W1I=FET>2!O9B!,979E;"`S(&EN<'5T<R!M96%S=7)E9"!O;B!A(')E
M8W5R<FEN9R!B87-I<R!A<R!O9B!397!T96UB97(@,S`L(#(P,3(@*&EN('1H
M;W5S86YD<RDZ/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^(#QB<B`O/B`\+W`^(#QT86)L92!S='EL93TS1"=7
M24142#H@-S`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G5D525$E#04PM
M04Q)1TXZ(&)O='1O;3L@5$585"U$14-/4D%424]..B!N;VYE)SX@/'1D('-T
M>6QE/3-$)U1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P
M/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P
M=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@
M;F]W<F%P/3-$;F]W<F%P/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT
M97([($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G
M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/
M3CH@;F]N92<^(#QS=')O;F<^1F%I<B!686QU92!-96%S=7)E;65N=',@;V8\
M+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG
M/E=A<G)A;G1S(%5S:6YG(%-I9VYI9FEC86YT/"]S=')O;F<^/"]P/B`\<"!S
M='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@5$58
M5"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY5;F]B<V5R=F%B;&4@26YP
M=71S/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T
M<F]N9SXH3&5V96P@,RD\+W-T<F]N9SX\+W`^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$58
M5"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^/&)R("\^(#PO
M=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H
M,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T
M>6QE/3-$)U=)1%1(.B`X,B4G/D)A;&%N8V4@870@1&5C96UB97(@,S$L(#(P
M,3$\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$E)SX\8G(@+SX@/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$U
M)2<^,S8X/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)
M1%1(.B`Q)2<^/&)R("\^(#PO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+
M1U)/54Y$+4-/3$]2.B!W:&ET93L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,7!T)SY#:&%N9V4@:6X@9F%I<B!V86QU92!O9B!787)R86YT(&QI86)I
M;&ET>3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T)SX\
M8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^/&)R("\^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%
M6%0M04Q)1TXZ(')I9VAT)SX@-#`Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G/CQB<B`O/B`\+W1D
M/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P
M-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/D)A;&%N8V4@870@4V5P=&5M
M8F5R(#,P+"`R,#$R/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T
M(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/B`W-CD\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T
M)SX\8G(@+SX@/"]T9#X@/"]T<CX@/"]T86)L93X@/'`@<W1Y;&4],T0G34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@/&)R("\^(#PO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P
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M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAO<G0M5&5R;2!);G9E
M<W1M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+41/
M0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N
M<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T14
M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA
M+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU
M<W1I9GD[($U!4D=)3CH@,'!T(#!P>"`P<'0@,"XR-6EN.R!&3TY4.B!B;VQD
M(&ET86QI8R`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M4VAO<G0M5&5R;2!);G9E<W1M96YT<SPO<#X@/'`@<W1Y;&4],T0G5$585"U!
M3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I
M9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@4VAO<G0M
M=&5R;2!I;G9E<W1M96YT<R!A="!397!T96UB97(@,S`L(#(P,3(@8V]N<VES
M="!O9B!I;G9E<W1M96YT<R!I;B!C;VUM97)C:6%L('!A<&5R+"!C;W)P;W)A
M=&4@;F]T97,@86YD('1H<F5E(&%U8W1I;VX@<F%T92!S96-U<FET:65S+B!!
M;&P@;6%R:V5T86)L92!S96-U<FET:65S(&AA9"!O<FEG:6YA;"!M871U<FET
M:65S(&=R96%T97(@=&AA;B`Y,"!D87ES+"!B=70@;&5S<R!T:&%N(&]N92!Y
M96%R+B!4:&4@875C=&EO;B!R871E('-E8W5R:71I97,@:&%V92!A('!A<B!V
M86QU92!O9B`D-2XQ(&UI;&QI;VXN(%1H92!#;VUP86YY(&AA<R!C;&%S<VEF
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M86QU92!I<R`B;W1H97(M=&AA;BUT96UP;W)A<GDN(B!4:&4@=&5R;2`B;W1H
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M<RX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S
M='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU
M:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^(%-H;W)T+71E<FT@:6YV97-T;65N=',@8VQA
M<W-I9FEE9"!A<R!A=F%I;&%B;&4M9F]R+7-A;&4@87,@;V8@4V5P=&5M8F5R
M(#,P+"`R,#$R(&%N9"!$96-E;6)E<B`S,2P@,C`Q,2!W97)E(&-O;7!R:7-E
M9"!O9B`H:6X@=&AO=7-A;F1S*3H\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@
M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX@)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/
M4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M
M.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`W<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W
M<F%P/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4
M+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED
M.R!&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)
M1TXZ(&-E;G1E<CL@5$585"U$14-/4D%424]..B!N;VYE)R!C;VQS<&%N/3-$
M,30@;F]W<F%P/3-$;F]W<F%P/E-E<'1E;6)E<B`S,"P@,C`Q,CPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[
M(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@
M;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-
M.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L
M9#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ(&YO;F4G
M(&-O;'-P86X],T0Q-"!N;W=R87`],T1N;W=R87`^1&5C96UB97(@,S$L(#(P
M,3$\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4+41%0T]2051)
M3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\+W1R/B`\
M='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ(&)O='1O;3L@5$585"U$14-/
M4D%424]..B!N;VYE)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!4
M15A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#X@)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U$14-/4D%424].
M.B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'
M3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/4D%424].
M.B!N;VYE)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QP('-T>6QE
M/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M($9/3E0M4TE:13H@-W!T.R!-05)'24XZ(#!P="`P<'@[(%1%6%0M04Q)1TXZ
M(&-E;G1E<CL@5$585"U$14-/4D%424]..B!N;VYE)SXF;F)S<#L\+W`^(#QP
M('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[($9/3E0M4TE:13H@-W!T.R!-05)'24XZ(#!P="`P<'@[(%1%6%0M
M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N
M9SY!;6]R=&EZ960\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)T9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($9/3E0M4TE:13H@
M-W!T.R!-05)'24XZ(#!P="`P<'@[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$58
M5"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY#;W-T/"]S=')O;F<^/"]P
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4+41%0T]2051)
M3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`W<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$
M24Y'+4)/5%1/33H@,7!T.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A
M<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/4D%4
M24]..B!N;VYE)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^/'-T<F]N
M9SY'<F]S<SPO<W1R;VYG/CQB<B`O/B`\<W1R;VYG/E5N<F5A;&EZ960\+W-T
M<F]N9SX\8G(@+SX@/'-T<F]N9SY'86EN<SPO<W1R;VYG/CPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!
M1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W
M<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q
M<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@
M5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O
M;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X\<W1R;VYG/D=R;W-S/"]S=')O
M;F<^/&)R("\^(#QS=')O;F<^56YR96%L:7IE9#PO<W1R;VYG/CQB<B`O/B`\
M<W1R;VYG/DQO<W-E<SPO<W1R;VYG/CPO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-
M.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].
M5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#
M3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/
M3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@
M8V5N=&5R.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0R(&YO
M=W)A<#TS1&YO=W)A<#Y&86ER(%9A;'5E/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U14
M3TTZ(#%P=#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R
M87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U$
M14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@
M5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$
M14-/4D%424]..B!N;VYE)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^
M(#QP('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[($9/3E0M4TE:13H@-W!T.R!-05)'24XZ(#!P="`P<'@[(%1%
M6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/4D%424]..B!N;VYE)SXF;F)S
M<#L\+W`^(#QP('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[($9/3E0M4TE:13H@-W!T.R!-05)'24XZ(#!P="`P
M<'@[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/4D%424]..B!N;VYE
M)SX@/'-T<F]N9SY!;6]R=&EZ960\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$
M)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($9/
M3E0M4TE:13H@-W!T.R!-05)'24XZ(#!P="`P<'@[(%1%6%0M04Q)1TXZ(&-E
M;G1E<CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY#;W-T/"]S
M=')O;F<^/"]P/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4
M+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[($9/3E0M5T5)1TA4.B!B
M;VQD.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4+41%0T]2051)3TXZ(&YO
M;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P
M=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$58
M5"U$14-/4D%424]..B!N;VYE)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R
M87`^/'-T<F]N9SY'<F]S<SPO<W1R;VYG/CQB<B`O/B`\<W1R;VYG/E5N<F5A
M;&EZ960\+W-T<F]N9SX\8G(@+SX@/'-T<F]N9SY'86EN<SPO<W1R;VYG/CPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z
M(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@
M;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M
M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$
M;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ
M(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X\<W1R;VYG/D=R
M;W-S/"]S=')O;F<^/&)R("\^(#QS=')O;F<^56YR96%L:7IE9#PO<W1R;VYG
M/CQB<B`O/B`\<W1R;VYG/DQO<W-E<SPO<W1R;VYG/CPO=&0^(#QT9"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)
M3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P
M/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[
M(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@
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M87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!
M0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`R,"4G/D%U8W1I;VX@<F%T92!S96-U
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M=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%=)1%1(.B`Q)2<^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!415A4+4%,24=.
M.B!L969T.R!724142#H@,24G/B0\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@-R4G/C$L,#,R
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!415A4+4%,24=.
M.B!L969T.R!724142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#=P=#L@5TE$5$@Z(#$E)SXF;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(
M.B`Q)2<^)#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5$58
M5"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`W)2<^+3PO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E
M)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%=)
M1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M-W!T.R!415A4+4%,24=..B!L969T.R!724142#H@,24G/B0\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT.R!7
M24142#H@-R4G/C0L-#`U/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M-W!T.R!415A4+4%,24=..B!L969T.R!724142#H@,24G/B9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5TE$5$@Z(#$E)SXF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`W)2<^,RPS
M-S,\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@-W!T.R!724142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$
M5$@Z(#$E)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!4
M15A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#<E)SXX,S(\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(
M.B`Q)2<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T
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M<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`W)2<^-"PR
M,#4\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T
M>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$
M24Y'+4)/5%1/33H@,7!T.R!415A4+4%,24=..B!L969T)SX@0V]R<&]R871E
M(&1E8G0@<V5C=7)I=&EE<SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#=P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U3
M25I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4
M+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0G/B`Q,RPR-C,\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`Q
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@
M<V]L:60[($9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T)SX@)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P
M="!S;VQI9#L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@
M-#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"
M3U143TTZ(#%P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#%P
M="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@
M<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0
M041$24Y'+4)/5%1/33H@,7!T.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/
M5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!
M3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!415A4
M+4%,24=..B!R:6=H="<^(#$S+#(V-SPO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@
M;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P
M=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%
M.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)
M6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4
M+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&
M3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[
M($9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!R:6=H="<^("T\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`Q
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@
M<V]L:60[($9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T)SX@)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P
M="!S;VQI9#L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@
M+3PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"
M3U143TTZ(#%P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#%P
M="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@
M<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0
M041$24Y'+4)/5%1/33H@,7!T.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[
M/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G
M8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P
M="<^5&]T86P\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!
M1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%
M.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%
M.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,38L-C,V/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T
M(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T
M(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@
M,2PP,S8\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U14
M3TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$58
M5"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:
M13H@-W!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[
M(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U3
M25I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U3
M25I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,3<L-C<R/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,BXU
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N
M-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N
M-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)SX@,RPS-S,\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!
M1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"
M3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@
M5$585"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@
M5$585"U!3$E'3CH@<FEG:'0G/B`X,S(\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'
M3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&
M3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&
M3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,BXU
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N
M-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N
M-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)SX@-"PR,#4\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!
M1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P
M.SPO=&0^(#PO='(^(#PO=&%B;&4^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&IU<W1I9GD[($U!4D=)3CH@,'!T(#!P>"`P<'0@,"XR-6EN.R!&3TY4.B!B
M;VQD(&ET86QI8R`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX@)FYB<W`[/"]P/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y297-T<FEC=&5D($-A<V@\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-
M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12
M+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I
M=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P="`P<'@@,'!T(#`N,C5I;CL@
M1D].5#H@8F]L9"!I=&%L:6,@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^(%)E<W1R:6-T960@0V%S:#PO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU
M<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@5&AE
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M96EV960@=6YD97(@=&AE(%!!5$@@86=R965M96YT("A3964@3F]T92`U*2!U
M;G1I;"!S=6-H('1I;64@=&AE($-O;7!A;GD@:&%S('!A:60@9F]R('1H92!W
M;W)K('!E<F9O<FUE9"!F;W(@=&AE(')E;&%T960@4&AA<V4@24D@4E-6(&-L
M:6YI8V%L('1R:6%L+CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S
M<#L\+W`^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!,
M;W-S('!E<B!3:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N
M,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT
M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\
M9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T(#!P>"`P<'0@,"XR-6EN.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/'-T<F]N
M9SX\96T^3F5T($QO<W,@<&5R(%-H87)E/"]E;3X\+W-T<F]N9SX\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P
M+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=4
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M;V-K(&%W87)D<R!T;W1A;&EN9R`Q,BPY-3$L-C(U('-H87)E<R!A;F0@,3$L
M,3$Y+#0W-B!S:&%R97,@870@4V5P=&5M8F5R(#,P+"`R,#$R(&%N9"`R,#$Q
M+"!R97-P96-T:79E;'DL(&%R92!E>&-L=61E9"!F<F]M('1H92!C;VUP=71A
M=&EO;BP@87,@=&AE:7(@969F96-T(&ES(&%N=&ED:6QU=&EV92X\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P
M+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\(2TM16YD1G)A9VUE
M;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y2979E;G5E(%)E8V]G;FET:6]N/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL(%!5
M0DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB
M(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N
M<VET:6]N86PN9'1D(B`M+3X-"CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE
M;G0M+3X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE.
M.B`P<'0@,'!X(#!P="`P+C(U:6X[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B`\<W1R;VYG/CQE;3Y2979E;G5E(%)E8V]G
M;FET:6]N/"]E;3X\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@
M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y
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M=VAI8V@@=&AE>2!B96-O;64@:VYO=VXN/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/
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M(%4N4RX@9V]V97)N;65N="`H;W(@86=E;F-Y*2!T:&4@86)I;&ET>2!T;R!T
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M8V]M<&QE=&5D(&%S(&]F(%-E<'1E;6)E<B`S,"P@,C`Q,CL@:&]W979E<BP@
M;6%N86=E;65N="!B96QI979E<R!T:&%T(')E=F5N=64@9F]R('!E<FEO9',@
M<W5B:F5C="!T;R!A=61I="!H87,@8F5E;B!R96-O<F1E9"!I;B!A;6]U;G1S
M('1H870@87)E(&5X<&5C=&5D('1O(&)E(')E86QI>F5D('5P;VX@9FEN86P@
M875D:70@86YD('-E='1L96UE;G0N/"]P/B`\<"!S='EL93TS1"=415A4+4%,
M24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T
M(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
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M;F4@8F%S:7,[(&%N9"`H,BD@:68@=&AE(&%R<F%N9V5M96YT(&EN8VQU9&5S
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M<F4@=&\@:71S(&]P97)A=&EO;G,N/"]P/B`\<"!S='EL93TS1"=415A4+4%,
M24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T
M(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
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M87-I<R!O=F5R('1H92!C;VYT<F%C="!T97)M/"]P/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!2
M979E;G5E(&%S<V]C:6%T960@=VET:"!U<&9R;VYT('!A>6UE;G1S('5N9&5R
M(&%R<F%N9V5M96YT<R!I<R!R96-O9VYI>F5D(&]V97(@=&AE(&-O;G1R86-T
M('1E<FT@;W(@=VAE;B!A;&P@;V)L:6=A=&EO;G,@87-S;V-I871E9"!W:71H
M('1H92!U<&9R;VYT('!A>6UE;G0@:&%V92!B965N('-A=&ES9FEE9"X\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS
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M<F%N9V5M96YT.R`H,RD@<W5B<W1A;G1I=F4@969F;W)T(&ES(&EN=F]L=F5D
M('1O(&%C:&EE=F4@=&AE(&UI;&5S=&]N92!A;F0@<W5C:"!A8VAI979E;65N
M="!R96QA=&5S('1O('!A<W0@<&5R9F]R;6%N8V4[(&%N9"`H-"D@=&AE(&%M
M;W5N="!O9B!T:&4@;6EL97-T;VYE(&%P<&5A<G,@<F5A<V]N86)L92!I;B!R
M96QA=&EO;B!T;R!T:&4@969F;W)T(&5X<&5N9&5D(&%N9"!A;&P@;V8@=&AE
M(&1E;&EV97)A8FQE<R!A;F0@<&%Y;65N="!T97)M<R!I;B!T:&4@87)R86YG
M96UE;G0N/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y.R!4
M15A4+4E.1$5.5#H@,"XR-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO<#X@
M/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5C96YT($%C8V]U
M;G1I;F<@4')O;F]U;F-E;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!8
M2%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G
M+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*
M/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XR-6EN.R!-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`\<W1R;VYG/CQE;3Y296-E;G0@06-C;W5N=&EN9R!0<F]N
M;W5N8V5M96YT<SPO96T^/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!);B!*
M=6YE(#(P,3$L('1H92!&05-"(&ES<W5E9"!!4U4@,C`Q,2TP-2P@/&5M/D-O
M;7!R96AE;G-I=F4@26YC;VUE("A4;W!I8R`R,C`I.B!0<F5S96YT871I;VX@
M;V8@0V]M<')E:&5N<VEV92!);F-O;64\+V5M/B`H(D%352`R,#$Q+3`U(BDN
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M<F5M96YT('=A<R!A9&]P=&5D($IA;G5A<GD@,2P@,C`Q,B!A;F0@:7,@<F5F
M;&5C=&5D(&]N('1H92!A8V-O;7!A;GEI;F<@<W1A=&5M96YT<R!O9B!O<&5R
M871I;VYS(&%N9"!C;VUP<F5H96YS:79E(&QO<W,@9F]R('1H92!P97)I;V1S
M(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q,B!A;F0@,C`Q,2X\+W`^(#QP('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I
M;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@26X@4V5P=&5M8F5R(#(P,3$L('1H92!&05-"(&ES<W5E9"!!4U4@
M,C`Q,2TP."P@/&5M/DEN=&%N9VEB;&5S("T@1V]O9'=I;&P@86YD($]T:&5R
M("A4;W!I8R`S-3`I.B!497-T:6YG($=O;V1W:6QL(&9O<B!);7!A:7)M96YT
M/"]E;3X@*")!4U4@,C`Q,2TP."(I/&5M/BP\+V5M/B!T;R!G:79E(&)O=&@@
M<'5B;&EC(&%N9"!N;VYP=6)L:6,@96YT:71I97,@=&AE(&]P=&EO;B!T;R!Q
M=6%L:71A=&EV96QY(&1E=&5R;6EN92!W:&5T:&5R('1H97D@8V%N(&)Y<&%S
M<R!T:&4@='=O+7-T97`@9V]O9'=I;&P@:6UP86ER;65N="!T97-T+B!5;F1E
M<B!T:&4@;F5W(&=U:61A;F-E+"!I9B!A;B!E;G1I='D@8VAO;W-E<R!T;R!P
M97)F;W)M(&$@<75A;&ET871I=F4@87-S97-S;65N="!A;F0@9&5T97)M:6YE
M<R!T:&%T(&ET(&ES(&UO<F4@;&EK96QY('1H86X@;F]T("AA(&UO<F4@=&AA
M;B`U,"!P97)C96YT(&QI:V5L:6AO;V0I('1H870@=&AE(&9A:7(@=F%L=64@
M;V8@82!R97!O<G1I;F<@=6YI="!I<R!L97-S('1H86X@:71S(&-A<G)Y:6YG
M(&%M;W5N="P@:70@=V]U;&0@=&AE;B!P97)F;W)M(%-T97`@,2!O9B!T:&4@
M86YN=6%L(&=O;V1W:6QL(&EM<&%I<FUE;G0@=&5S="!I;B!!4T,@,S4P+3(P
M(&%N9"P@:68@;F5C97-S87)Y+"!P<F]C965D('1O(%-T97`@,BX@3W1H97)W
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M:71T960N(%1H92!A9&]P=&EO;B!O9B!!4U4@,C`Q,2TP."!O;B!*86YU87)Y
M(#$L(#(P,3(@9&ED(&YO="!H879E(&$@;6%T97)I86P@969F96-T(&]N('1H
M92!#;VUP86YY)B,S.3MS(&9I;F%N8VEA;"!S=&%T96UE;G1S+CPO<#X@/"$M
M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&%E8C1A.#%?9&9D-E\T-F(U7V(S
M,F1?-69E-#5A864Y,F1E#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U86%E.3)D92]7;W)K<VAE
M971S+U-H965T,C$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5+2#X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L
M:6-I97,@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U
M;G1I;F<@4&]L:6-I97,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F($9I;F%N8VEA;"!!
M<W-E=',@86YD($QI86)I;&ET:65S($UE87-U<F5D(&%T($9A:7(@36%R:V5T
M(%9A;'5E(&]N(%)E8W5R<FEN9R!"87-I<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O
M1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW
M,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@
M+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@1FEN86YC:6%L(&%S<V5T<R!A;F0@;&EA8FEL:71I
M97,@;65A<W5R960@870@9F%I<B!M87)K970@=F%L=64@;VX@82!R96-U<G)I
M;F<@8F%S:7,@87,@;V8@4V5P=&5M8F5R(#,P+"`R,#$R(&%N9"!$96-E;6)E
M<B`S,2P@,C`Q,2!A<F4@<W5M;6%R:7IE9"!B96QO=R`H:6X@=&AO=7-A;F1S
M*3H\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\=&%B
M;&4@<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!313H@8V]L
M;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL
M93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9"<@;F]W<F%P/3-$;F]W
M<F%P/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R
M87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Y<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0Q
M,"!N;W=R87`],T1N;W=R87`^1F%I<B!686QU92!A="!397!T96UB97(@,S`L
M(#(P,3(\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N
M;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P="<@;F]W
M<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@.7!T.R!&3TY4
M+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$
M,3`@;F]W<F%P/3-$;F]W<F%P/D9A:7(@5F%L=64@870@1&5C96UB97(@,S$L
M(#(P,3$\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N
M;W=R87`^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,
M+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M($9/3E0M5T5)1TA4.B!B;VQD)R!N;W=R87`],T1N;W=R87`^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z
M(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A<#XF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[
M(%1%6%0M04Q)1TXZ(&-E;G1E<B<@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W
M<F%P/DQE=F5L(#$\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R
M87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:
M13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P
M="<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@.7!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS
M<&%N/3-$,B!N;W=R87`],T1N;W=R87`^3&5V96P@,CPO=&0^(#QT9"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)
M3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`],T1N;W=R87`^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S
M;VQI9#L@1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4
M+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#Y,
M979E;"`S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!&3TY4
M+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P="<@;F]W<F%P/3-$
M;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP
M=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO
M=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#EP=#L@1D].
M5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&-E;G1E<B<@8V]L<W!A;CTS
M1#(@;F]W<F%P/3-$;F]W<F%P/DQE=F5L(#$\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Y<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/
M5%1/33H@,7!T)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$
M1$E.1RU"3U143TTZ(#%P="<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[
M($9/3E0M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'
M3CH@8V5N=&5R)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^3&5V96P@
M,CPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'
M2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G(&YO=W)A<#TS1&YO=W)A
M<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T)R!N;W=R87`]
M,T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Y<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R(&YO
M=W)A<#TS1&YO=W)A<#Y,979E;"`S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ
M(#%P="<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S
M='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!6
M15)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:
M13H@.7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU,1494.B`Y+C0U
M<'0[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!415A4+4E.1$5.5#H@
M+3DN-#5P="<^($%S<V5T<SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#EP="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T
M.R!415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP="<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4
M+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP="<^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=.
M.B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP="<^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T
M)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP="<^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SXF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%
M.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#EP="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL
M93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET93L@5D525$E#04PM04Q)1TXZ
M(&)O='1O;2<^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.
M1RU"3U143TTZ(#(N-7!T.R!0041$24Y'+4Q%1E0Z(#DN-#5P=#L@5$585"U!
M3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z("TY+C0U<'0[(%=)1%1(.B`S-"4G
M/B!#;W)P;W)A=&4@9&5B="!A;F0@875C=&EO;B!R871E('-E8W5R:71I97,\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]4
M5$]-.B`R+C5P=#L@5TE$5$@Z(#$E)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U3
M25I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^("0\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U
M8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(
M.B`X)2<^("T\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!
M1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z
M(#$E)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%=)1%1(.B`Q)2<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D
M;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T.R!72414
M2#H@,24G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT.R!724142#H@."4G/B`Q-RPV-S(\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!
M3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%=)
M1%1(.B`Q)2<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4
M+4%,24=..B!L969T.R!724142#H@,24G/B`D/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%
M.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@."4G/B`M/"]T9#X@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@
M,BXU<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U14
M3TTZ(#(N-7!T.R!724142#H@,24G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)
M6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX@)#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B
M;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z
M(#@E)SX@+3PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$
M1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=..B!L969T.R!724142#H@
M,24G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5TE$5$@Z(#$E)SX@)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O
M=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(
M.B`Q)2<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@
M<FEG:'0[(%=)1%1(.B`X)2<^(#0L,C`U/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!72414
M2#H@,24G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!
M3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SX@)#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@
M.7!T.R!415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#@E)SX@+3PO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ(#(N
M-7!T.R!415A4+4%,24=..B!L969T.R!724142#H@,24G/B`F;F)S<#L\+W1D
M/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P
M-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#EP=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M
M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SX@3&EA8FEL:71I97,\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5"U325I%.B`Y<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F="<^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=.
M.B!R:6=H="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M.7!T.R!415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Y<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H
M="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!4
M15A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Y<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#EP=#L@5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,
M24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%
M.B`Y<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP
M=#L@5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L
M969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@5$58
M5"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SXF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@5$585"U!3$E'
M3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M.7!T.R!415A4+4%,24=..B!R:6=H="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SXF;F)S<#L\
M+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@=VAI
M=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'
M3CH@;&5F="<^(%=A<G)A;G0@;&EA8FEL:71Y/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P
M="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!L969T)SX@
M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P
M="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=..B!R:6=H="<^
M("T\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M
M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U143TTZ
M(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!
M3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP=#L@5$585"U!
M3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[(%!!
M1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%
M.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%
M.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@-S8Y/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O
M=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O
M=6)L93L@1D].5"U325I%.B`Y<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@+3PO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.1RU"3U14
M3TTZ(#(N-7!T.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@.7!T.R!0041$24Y'+4)/5%1/33H@,BXU
M<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=.
M.B!L969T)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R+C5P="!D;W5B;&4[($9/3E0M4TE:13H@.7!T.R!415A4+4%,24=.
M.B!R:6=H="<^("T\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Y<'0[
M(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#EP=#L@4$%$1$E.
M1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP
M=#L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#EP
M=#L@5$585"U!3$E'3CH@<FEG:'0G/B`S-C@\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Y<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!
M3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#PO='(^(#PO=&%B;&4^(#QP('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB
M<W`[/"]P/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM
M87)I>F5D($%C=&EV:71Y(&]F($QE=F5L(#,@26YP=71S($UE87-U<F5D(&]N
M(%)E8W5R<FEN9R!"87-I<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,
M(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O
M>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV
M/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S('1H92!A8W1I
M=FET>2!O9B!,979E;"`S(&EN<'5T<R!M96%S=7)E9"!O;B!A(')E8W5R<FEN
M9R!B87-I<R!A<R!O9B!397!T96UB97(@,S`L(#(P,3(@*&EN('1H;W5S86YD
M<RDZ/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`W
M,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@
M8F]T=&]M.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\=&0@<W1Y;&4],T0G
M5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS
M1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M
M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X]
M,T0R(&YO=W)A<#TS1&YO=W)A<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@
M8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^
M(#QS=')O;F<^1F%I<B!686QU92!-96%S=7)E;65N=',@;V8\+W-T<F]N9SX\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/E=A<G)A;G1S
M(%5S:6YG(%-I9VYI9FEC86YT/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@5$585"U$14-/4D%4
M24]..B!N;VYE)SX@/'-T<F]N9SY5;F]B<V5R=F%B;&4@26YP=71S/"]S=')O
M;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SXH3&5V
M96P@,RD\+W-T<F]N9SX\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/4D%4
M24]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/"]T<CX@
M/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P
M-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5TE$
M5$@Z(#@R)2<^0F%L86YC92!A="!$96-E;6)E<B`S,2P@,C`Q,3PO=&0^(#QT
M9"!S='EL93TS1"=724142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q-24G/C,V.#PO=&0^
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M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4
M15A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@<FEG
M:'0G/B`T,#$\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T
M>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#(N-7!T)SY"86QA;F-E(&%T(%-E<'1E;6)E<B`S,"P@,C`Q,CPO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P
M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!
M3$E'3CH@<FEG:'0G/B`W-CD\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\
M+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S
M<#L\+W`^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H;W)T
M+71E<FT@26YV97-T;65N=',@0VQA<W-I9FEE9"!A<R!!=F%I;&%B;&4M1F]R
M+5-A;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-4
M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I
M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O
M>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I=CX@/&1I=CX\(2TM
M4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T
M:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(%-H;W)T
M+71E<FT@:6YV97-T;65N=',@8VQA<W-I9FEE9"!A<R!A=F%I;&%B;&4M9F]R
M+7-A;&4@87,@;V8@4V5P=&5M8F5R(#,P+"`R,#$R(&%N9"!$96-E;6)E<B`S
M,2P@,C`Q,2!W97)E(&-O;7!R:7-E9"!O9B`H:6X@=&AO=7-A;F1S*3H\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\=&%B;&4@<W1Y
M;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS1"=6
M15)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+41%0T]2051)3TXZ(&YO;F4G
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M1$5#3U)!5$E/
M3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`W<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$
M24Y'+4)/5%1/33H@,7!T.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A
M<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/4D%4
M24]..B!N;VYE)R!C;VQS<&%N/3-$,30@;F]W<F%P/3-$;F]W<F%P/E-E<'1E
M;6)E<B`S,"P@,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P
M=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%
M6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z
M(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@
M;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@
M-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R.R!4
M15A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0Q-"!N;W=R87`],T1N
M;W=R87`^1&5C96UB97(@,S$L(#(P,3$\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/
M33H@,7!T.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A
M<#XF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)
M1TXZ(&)O='1O;3L@5$585"U$14-/4D%424]..B!N;VYE)SX@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@-W!T.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO
M=W)A<#TS1&YO=W)A<#X@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ
M(#%P=#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@
M8F]L9#L@5$585"U$14-/4D%424]..B!N;VYE)R!C;VQS<&%N/3-$,B!N;W=R
M87`],T1N;W=R87`^(#QP('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($9/3E0M4TE:13H@-W!T.R!-05)'24XZ
M(#!P="`P<'@[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/4D%424].
M.B!N;VYE)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($9/3E0M4TE:13H@-W!T.R!-
M05)'24XZ(#!P="`P<'@[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/
M4D%424]..B!N;VYE)SX@/'-T<F]N9SY!;6]R=&EZ960\+W-T<F]N9SX\+W`^
M(#QP('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[($9/3E0M4TE:13H@-W!T.R!-05)'24XZ(#!P="`P<'@[(%1%
M6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T
M<F]N9SY#;W-T/"]S=')O;F<^/"]P/B`\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/
M33H@,7!T.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A
M<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4+41%
M0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&
M3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ
M(&-E;G1E<CL@5$585"U$14-/4D%424]..B!N;VYE)R!C;VQS<&%N/3-$,B!N
M;W=R87`],T1N;W=R87`^/'-T<F]N9SY'<F]S<SPO<W1R;VYG/CQB<B`O/B`\
M<W1R;VYG/E5N<F5A;&EZ960\+W-T<F]N9SX\8G(@+SX@/'-T<F]N9SY'86EN
M<SPO<W1R;VYG/CPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@
M1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M
M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O
M;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N
M92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4
M+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A
M<#X\<W1R;VYG/D=R;W-S/"]S=')O;F<^/&)R("\^(#QS=')O;F<^56YR96%L
M:7IE9#PO<W1R;VYG/CQB<B`O/B`\<W1R;VYG/DQO<W-E<SPO<W1R;VYG/CPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z
M(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@
M;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M
M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$
M;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%0T]2051)3TXZ
M(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#Y&86ER(%9A;'5E
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U$14-/4D%424].
M.B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.
M1RU"3U143TTZ(#%P=#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`]
M,T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4
M+5=%24=(5#H@8F]L9#L@5$585"U$14-/4D%424]..B!N;VYE)R!C;VQS<&%N
M/3-$,B!N;W=R87`],T1N;W=R87`^(#QP('-T>6QE/3-$)T9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($9/3E0M4TE:13H@-W!T
M.R!-05)'24XZ(#!P="`P<'@[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$
M14-/4D%424]..B!N;VYE)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)T9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($9/3E0M4TE:
M13H@-W!T.R!-05)'24XZ(#!P="`P<'@[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@
M5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY!;6]R=&EZ960\+W-T
M<F]N9SX\+W`^(#QP('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($9/3E0M4TE:13H@-W!T.R!-05)'24XZ(#!P
M="`P<'@[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/4D%424]..B!N
M;VYE)SX@/'-T<F]N9SY#;W-T/"]S=')O;F<^/"]P/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`W<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$
M24Y'+4)/5%1/33H@,7!T.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A
M<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%
M.B`W<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!0041$24Y'+4)/5%1/33H@,7!T
M.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T
M('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%
M6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U$14-/4D%424]..B!N;VYE)R!C;VQS
M<&%N/3-$,B!N;W=R87`],T1N;W=R87`^/'-T<F]N9SY'<F]S<SPO<W1R;VYG
M/CQB<B`O/B`\<W1R;VYG/E5N<F5A;&EZ960\+W-T<F]N9SX\8G(@+SX@/'-T
M<F]N9SY'86EN<SPO<W1R;VYG/CPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q
M<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!
M5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M
M4TE:13H@-W!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N
M=&5R.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A
M<#TS1&YO=W)A<#X\<W1R;VYG/D=R;W-S/"]S=')O;F<^/&)R("\^(#QS=')O
M;F<^56YR96%L:7IE9#PO<W1R;VYG/CQB<B`O/B`\<W1R;VYG/DQO<W-E<SPO
M<W1R;VYG/CPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].
M5"U714E'2%0Z(&)O;&0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#
M3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@1D].5"U714E'2%0Z(&)O;&0[
M(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@
M;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+41%
M0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#Y&
M86ER(%9A;'5E/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U$
M14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@
M/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L
M,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`R
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M5$@Z(#$E)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W
M<'0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T.R!724142#H@,24G/B0\+W1D
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT.R!724142#H@-R4G/C$L,#,R/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T.R!724142#H@,24G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5TE$5$@Z(#$E
M)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`W
M)2<^+3PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U!
M3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T.R!7
M24142#H@,24G/B0\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@-R4G/C0L-#`U/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!L969T.R!7
M24142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z
M(#=P=#L@5TE$5$@Z(#$E)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@
M<FEG:'0[(%=)1%1(.B`W)2<^,RPS-S,\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!724142#H@
M,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@
M5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SXD/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z
M(#<E)SXX,S(\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/'1D('-T
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M(#=P=#L@5TE$5$@Z(#$E)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@
M<FEG:'0[(%=)1%1(.B`W)2<^-"PR,#4\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)FYB
M<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z
M('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4+4%,
M24=..B!L969T)SX@0V]R<&]R871E(&1E8G0@<V5C=7)I=&EE<SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#%P
M="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@
M<FEG:'0G/B`Q,RPR-C,\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W
M<'0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)
M3D<M0D]45$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!4
M15A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)SX@-#PO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@
M;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P
M=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%
M.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)
M6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4
M+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&
M3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[
M($9/3E0M4TE:13H@-W!T.R!415A4+4%,24=..B!R:6=H="<^(#$S+#(V-SPO
M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U14
M3TTZ(#%P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG
M:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$
M24Y'+4)/5%1/33H@,7!T.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/
M33H@,7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'
M3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!415A4+4%,
M24=..B!R:6=H="<^("T\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W
M<'0[(%!!1$1)3D<M0D]45$]-.B`Q<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)
M3D<M0D]45$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[($9/3E0M4TE:13H@-W!T.R!4
M15A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`W<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)SX@+3PO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@
M;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P
M=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%
M.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!&3TY4+5-)
M6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@,7!T.R!415A4
M+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$
M)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[
M(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^5&]T86P\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N
M-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N
M-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)SX@,38L-C,V/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0
M041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M
M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)SX@,2PP,S8\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U!
M3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE
M.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE
M.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T.R!0041$24Y'+4)/5%1/33H@
M,BXU<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`W<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)SX@,3<L-C<R/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`W
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`W
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,RPS-S,\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$58
M5"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U
M8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@;&5F="<^("0\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U
M8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'3CH@<FEG:'0G/B`X,S(\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]4
M5$]-.B`R+C5P=#L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#=P=#L@4$%$1$E.1RU"3U143TTZ(#(N
M-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'
M3CH@;&5F="<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,BXU<'0@9&]U8FQE.R!&3TY4+5-)6D4Z(#=P=#L@5$585"U!3$E'
M3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@-W!T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`W<'0[(%!!1$1)
M3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`W
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@1D].5"U325I%.B`W
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SX@-"PR,#4\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`W<'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$58
M5"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#PO='(^(#PO=&%B;&4^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[($U!4D=)3CH@,'!T(#!P
M>"`P<'0@,"XR-6EN.R!&3TY4.B!B;VQD(&ET86QI8R`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\(2TM16YD1G)A
M9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
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M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P13%!04,^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^4W1O8VLM0F%S960@0V]M<&5N<V%T:6]N("A486)L97,I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O8VLM
M0F%S960@0V]M<&5N<V%T:6]N(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VLM0F%S960@0V]M<&5N
M<V%T:6]N($5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q
M+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH
M=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I=CX@
M/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=415A4+4%,
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M9',I.CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$58
M5"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\8G(@+SX@/"]P/B`\
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M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4
M.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A
M<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(
M5#H@8F]L9#L@5$585"U$14-/4D%424]..B!N;VYE)R!C;VQS<&%N/3-$-B!N
M;W=R87`],T1N;W=R87`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E
M<CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R
M;VYG/E1H<F5E($UO;G1H<R!%;F1E9#PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#
M3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^4V5P=&5M8F5R(#,P+#PO<W1R;VYG
M/CPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO
M=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2
M051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#X\8G(@+SX@/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$58
M5"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/
M4D%424]..B!N;VYE)R!C;VQS<&%N/3-$-B!N;W=R87`],T1N;W=R87`^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!4
M15A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/DYI;F4@36]N=&AS($5N
M9&5D/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T
M<F]N9SY397!T96UB97(@,S`L/"]S=')O;F<^/"]P/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[
M(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/CQB<B`O
M/B`\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ(&)O
M='1O;2<^(#QT9#X\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD)SX\8G(@+SX@/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@
M5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9"<@8V]L<W!A
M;CTS1#(^,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&)R("\^(#PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<^
M/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5"U714E'2%0Z
M(&)O;&0G(&-O;'-P86X],T0R/C(P,3$\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/CQB<B`O/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U7
M14E'2%0Z(&)O;&0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([
M($9/3E0M5T5)1TA4.B!B;VQD)R!C;VQS<&%N/3-$,CXR,#$R/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B
M;VQD)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD)SX\8G(@+SX@/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!
M3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9"<@8V]L<W!A;CTS1#(^
M,C`Q,3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&
M3TY4+5=%24=(5#H@8F]L9"<^/&)R("\^(#PO=&0^(#PO='(^(#QT<B!S='EL
M93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%=)1%1(.B`T."4G/E)E<V5A<F-H(&%N9"!D979E;&]P;65N=#PO
M=&0^(#QT9"!S='EL93TS1"=724142#H@,24G/CQB<B`O/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SXD/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@,3`E)SXR
M,3D\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z
M(#$E)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q)2<^/&)R
M("\^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!72414
M2#H@,24G/B0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[
M(%=)1%1(.B`Q,"4G/C$W-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!724142#H@,24G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5TE$5$@Z(#$E)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$P)2<^-C,X/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^/&)R("\^(#PO=&0^
M(#QT9"!S='EL93TS1"=724142#H@,24G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SXD/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@,3`E)SXT-#D\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E
M)SX\8G(@+SX@/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M
M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G
M/D=E;F5R86P@86YD(&%D;6EN:7-T<F%T:79E/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`Q<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=.
M.B!L969T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/B`R-S0\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#%P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,S8V/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q
M<'0G/CQB<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#%P="<^/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/CQB<B`O/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O
M;&ED.R!415A4+4%,24=..B!R:6=H="<^(#$L,#,P/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G/CQB
M<B`O/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P="<^
M/&)R("\^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/CQB<B`O/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4
M15A4+4%,24=..B!R:6=H="<^(#$L,C(X/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G/CQB<B`O/B`\
M+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B
M*#(P-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,BXU
M<'0[(%1%6%0M24Y$14Y4.B`M,"XQ:6X[(%!!1$1)3D<M3$5&5#H@,"XQ:6XG
M/B!4;W1A;"!S=&]C:RUB87-E9"!C;VUP96YS871I;VX@97AP96YS93PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@
M9&]U8FQE.R!415A4+4%,24=..B!L969T)SX@)#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(')I9VAT)SX@-#DS/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U
M8FQE.R!415A4+4%,24=..B!L969T)SX@)#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ
M(')I9VAT)SX@-30R/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE
M.R!415A4+4%,24=..B!L969T)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I
M9VAT)SX@,2PV-C@\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SX\8G(@+SX@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P="<^/&)R("\^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG
M:'0G/B`Q+#8W-SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/CQB<B`O/B`\+W1D/B`\+W1R/B`\
M+W1A8FQE/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM
M87)Y(&]F($]P=&EO;B!!8W1I=FET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$
M(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO
M<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^
M#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@5&AE(&9O;&QO
M=VEN9R!I<R!A('-U;6UA<GD@;V8@;W!T:6]N(&%C=&EV:71Y('5N9&5R('1H
M92`R,#`U(%!L86X@86YD('1H92`Q.3DU(%!L86X@9F]R('1H92!N:6YE(&UO
M;G1H<R!E;F1E9"!397!T96UB97(@,S`L(#(P,3(Z/"]P/B`\<"!S='EL93TS
M1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]P
M/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z(#@U)3L@0D]21$52+4-/3$Q!4%-%
M.B!C;VQL87!S93L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R
M('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@;F]W<F%P
M/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<@;F]W<F%P/3-$;F]W<F%P
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4
M.B!B;VQD)R!C;VQS<&%N/3-$-B!N;W=R87`],T1N;W=R87`^,C`P-2!3=&]C
M:R!);F-E;G1I=F4@4&QA;CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<@;F]W<F%P/3-$;F]W<F%P
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P
M=#L@1D].5"U714E'2%0Z(&)O;&0G(&YO=W)A<#TS1&YO=W)A<#X@)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S
M;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9"<@
M8V]L<W!A;CTS1#8@;F]W<F%P/3-$;F]W<F%P/C$Y.34@4W1O8VL@3W!T:6]N
M(%!L86X\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@
M1D].5"U714E'2%0Z(&)O;&0G(&YO=W)A<#TS1&YO=W)A<#X@)FYB<W`[/"]T
M9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[
M(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QT9"!S='EL93TS1"=415A4+41%
M0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z
M(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5"U714E'2%0Z
M(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@8V]L<W!A;CTS1#(@;F]W
M<F%P/3-$;F]W<F%P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SXF;F)S<#L\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B9N8G-P.SPO<#X@/'`@<W1Y
M;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M
M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^4W1O8VL\+W-T<F]N9SX\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0@
M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/D]P=&EO;G,\+W-T
M<F]N9SX\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/4D%424]..B!N;VYE
M)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%
M0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4
M15A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%
M0T]2051)3TXZ(&YO;F4G(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^5V5I9VAT960M/"]S
M=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY!
M=F5R86=E/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C
M96YT97([($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SX@
M/'-T<F]N9SY%>&5R8VES93PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/
M3CH@;F]N92<^(#QS=')O;F<^4')I8V4\+W-T<F]N9SX\+W`^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO
M=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([
M($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O
M;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/'`@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@
M;F]N92<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SXF;F)S
M<#L\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/E-T;V-K
M/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N
M9SY/<'1I;VYS/"]S=')O;F<^/"]P/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#
M3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5=%24=(5#H@
M8F]L9#L@5$585"U$14-/4D%424]..B!N;VYE)R!C;VQS<&%N/3-$,B!N;W=R
M87`],T1N;W=R87`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG
M/E=E:6=H=&5D+3PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N
M92<^(#QS=')O;F<^079E<F%G93PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!
M5$E/3CH@;F]N92<^(#QS=')O;F<^17AE<F-I<V4\+W-T<F]N9SX\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!4
M15A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/E!R:6-E/"]S=')O;F<^
M/"]P/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@
M1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W
M<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="
M04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U=)1%1(.B`T."4G/D]U='-T
M86YD:6YG(&%T($IA;G5A<GD@,2P@,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=7
M24142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!724142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$P)2<^-RPT,3(L-S0V/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$P
M)2<^,BXR,CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!7
M24142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=724142#H@,24G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!7
M24142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H=#L@5TE$5$@Z(#$P)2<^-#<T+#8U,#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=724142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q,"4G/C0N,S@\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E)SXF
M;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/
M4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0^1W)A;G1E
M9#PO=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)SXS+#0X,RPP,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SXQ+C(Y/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SXM/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9#XF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^)#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^+3PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y
M;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9#Y%>&5R8VES960\+W1D/B`\=&0^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N
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M.SPO=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)SXM/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/B9N8G-P.SPO=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#
M3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P="<^0V%N8V5L960\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT
M)SX@*#$L-30V+#4V,CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@,7!T)SXI/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0G/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(#(N,C8\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ
M(#%P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`Q<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O
M;&ED.R!415A4+4%,24=..B!R:6=H="<^("@Q.#0L-S4P/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G
M/BD\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P
M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^)#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ
M(')I9VAT)SX@-"XP,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\+W1R/B`\
M='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T
M*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,BXU<'0G/D]U='-T86YD:6YG(&%T(%-E<'1E;6)E<B`S
M,"P@,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU
M<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@
M9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^(#DL,C8X+#0P,#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T
M(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/B`Q+C@X/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R+C5P
M="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^("9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P
M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@,C@Y+#DP,#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T
M(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/B`T+C4Y/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R+C5P
M="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M
M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P=#L@5$585"U)3D1%3E0Z("TP
M+C%I;CL@4$%$1$E.1RU,1494.B`P+C%I;B<^(%-H87)E<R!E>&5R8VES86)L
M92!A="!397!T96UB97(@,S`L(#(P,3(\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=.
M.B!L969T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/B`S
M+#4P,RPP-#,\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4
M+4%,24=..B!L969T)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@
M,BXS.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$
M24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(&QE9G0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^
M(#(X.2PY,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4
M+4%,24=..B!L969T)SX@)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@
M-"XU.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$
M24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL
M93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`M,"XQ:6X[(%!!1$1)3D<M3$5&5#H@,"XQ:6XG/B9N8G-P.SPO=&0^(#QT
M9#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SXF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^)FYB
M<W`[/"]T9#X@/'1D/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SXF;F)S<#L\+W1D/B`\=&0^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9#XF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/"]T
M<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R+C5P=#L@5$585"U)3D1%3E0Z("TP+C%I;CL@4$%$1$E.1RU,1494
M.B`P+C%I;B<^(%-H87)E<R!A=F%I;&%B;&4@9F]R(&=R86YT(&%T(%-E<'1E
M;6)E<B`S,"P@,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
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M3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]4
M5$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R+C5P="<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/
M5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^
M(#PO='(^(#PO=&%B;&4^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I
M;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\(2TM16YD1G)A9VUE;G0M
M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!<W-U;7!T:6]N<R!U<V5D('1O($5S=&EM871E
M($=R86YT($1A=&4@1F%I<B!686QU92!O9B!3=&]C:R!/<'1I;VYS(&=R86YT
M960@=7-I;F<@0FQA8VLM4V-H;VQE<R!/<'1I;VXM4')I8VEN9R!-;V1E;#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M
M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO
M+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M
M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R
M86=M96YT+2T^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%
M6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@5&AE(&9A:7(@=F%L
M=64@;V8@<W1O8VL@;W!T:6]N<R!G<F%N=&5D('=A<R!E<W1I;6%T960@870@
M=&AE(&1A=&4@;V8@9W)A;G0@=7-I;F<@=&AE($)L86-K+5-C:&]L97,@;W!T
M:6]N+7!R:6-I;F<@;6]D96P@=VET:"!T:&4@9F]L;&]W:6YG(&%S<W5M<'1I
M;VYS.CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$58
M5"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO<#X@/'1A
M8FQE('-T>6QE/3-$)U=)1%1(.B`Y-24[($)/4D1%4BU#3TQ,05!313H@8V]L
M;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL
M93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M.R!415A4+41%0T]2051)3TXZ
M(&YO;F4G/B`\=&0@<W1Y;&4],T0G5$585"U$14-/4D%424]..B!N;VYE)R!N
M;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2
M051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4
M+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2
M051)3TXZ(&YO;F4G(&-O;'-P86X],T0V(&YO=W)A<#TS1&YO=W)A<#X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XM5$]0.B`P<'0[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($U!
M4D=)3BU"3U143TTZ(#!P=#L@5$585"U$14-/4D%424]..B!N;VYE)SX@/'-T
M<F]N9SY4:')E92!-;VYT:',@16YD960\+W-T<F]N9SX\+W`^(#QP('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.+51/4#H@,'!T.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!-05)'24XM
M0D]45$]-.B`P<'0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS=')O;F<^
M4V5P=&5M8F5R(#,P+#PO<W1R;VYG/CPO<#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4
M+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'
M2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W
M<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5"U714E'
M2%0Z(&)O;&0[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@8V]L<W!A;CTS1#8@
M;F]W<F%P/3-$;F]W<F%P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([($U!4D=)3BU43U`Z(#!P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@34%21TE.+4)/5%1/33H@,'!T.R!415A4+41%
M0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/DYI;F4@36]N=&AS($5N9&5D/"]S
M=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!
M4D=)3BU43U`Z(#!P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@34%21TE.+4)/5%1/33H@,'!T.R!415A4+41%0T]2051)
M3TXZ(&YO;F4G/B`\<W1R;VYG/E-E<'1E;6)E<B`S,"P\+W-T<F]N9SX\+W`^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4
M+5=%24=(5#H@8F]L9#L@5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`]
M,T1N;W=R87`^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)
M0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@;F]W<F%P/3-$;F]W<F%P/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4
M+5=%24=(5#H@8F]L9"<@;F]W<F%P/3-$;F]W<F%P/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4
M15A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD)R!C;VQS<&%N
M/3-$,B!N;W=R87`],T1N;W=R87`^,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([(%!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M
M5T5)1TA4.B!B;VQD)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@4$%$1$E.1RU"3U143TTZ
M(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G(&YO=W)A<#TS1&YO=W)A<#XF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T
M('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD
M)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^,C`Q,3PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L
M9"<@;F]W<F%P/3-$;F]W<F%P/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G(&YO=W)A
M<#TS1&YO=W)A<#X@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&
M3TY4+5=%24=(5#H@8F]L9"<@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P
M/C(P,3(\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!0
M041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<@;F]W<F%P
M/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97([(%!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B
M;VQD)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@
M8V5N=&5R.R!&3TY4+5=%24=(5#H@8F]L9"<@8V]L<W!A;CTS1#(@;F]W<F%P
M/3-$;F]W<F%P/C(P,3$\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G(&YO=W)A<#TS1&YO=W)A<#X@
M)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],
M3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z
M("TY<'0[(%!!1$1)3D<M3$5&5#H@.7!T.R!724142#H@-#`E)R!N;W=R87`]
M,T1N;W=R87`^5V5I9VAT960M879E<F%G92!F86ER('9A;'5E(&]F('-T;V-K
M(&]P=&EO;G,@9W)A;G1E9#PO=&0^(#QT9"!S='EL93TS1"=724142#H@,24G
M(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R.R!724142#H@,24G(&YO=W)A<#TS1&YO=W)A<#X@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@
M5TE$5$@Z(#$R)2<@;F]W<F%P/3-$;F]W<F%P/B`D,2XP.3PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!C96YT97([(%=)1%1(.B`Q)2<@;F]W<F%P
M/3-$;F]W<F%P/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!724142#H@,24G(&YO=W)A<#TS1&YO=W)A<#X@)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@5TE$5$@Z
M(#$E)R!N;W=R87`],T1N;W=R87`^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!C96YT97([(%=)1%1(.B`Q,B4G(&YO=W)A<#TS1&YO
M=W)A<#X@)#`N-S@\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@5TE$5$@Z(#$E)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U=)1%1(.B`Q)2<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%=)1%1(.B`Q
M)2<@;F]W<F%P/3-$;F]W<F%P/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@8V5N=&5R.R!724142#H@,3(E)R!N;W=R87`],T1N;W=R
M87`^("0P+C<Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E
M<CL@5TE$5$@Z(#$E)R!N;W=R87`],T1N;W=R87`^("9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%=)1%1(.B`Q)2<@;F]W
M<F%P/3-$;F]W<F%P/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R.R!724142#H@,24G(&YO=W)A<#TS1&YO=W)A<#X@)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@5TE$
M5$@Z(#$R)2<@;F]W<F%P/3-$;F]W<F%P/B`D,2XQ.3PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G(&YO=W)A<#TS1&YO
M=W)A<#XF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.
M1"U#3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@;F]W<F%P/3-$;F]W<F%P/E)I
M<VLM9G)E92!I;G1E<F5S="!R871E/"]T9#X@/'1D(&YO=W)A<#TS1&YO=W)A
M<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R
M)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/C`N-34E/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W
M<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97(G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$
M;F]W<F%P/C`N-#@E+3`N-C@E/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@;F]W
M<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^
M,"XU-24M,2XU-"4\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N
M=&5R)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS
M1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M8V5N=&5R)R!N;W=R87`],T1N;W=R87`^,"XT."4M,2XY,24\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@;F]W<F%P/3-$;F]W<F%P/B9N
M8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2
M.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G(&YO=W)A<#TS1&YO=W)A
M<#Y$:79I9&5N9"!Y:65L9#PO=&0^(#QT9"!N;W=R87`],T1N;W=R87`^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W
M<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XP)3PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R
M87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XP
M)3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!N;W=R87`]
M,T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D(&YO=W)A<#TS1&YO=W)A<#XF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R
M87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/C`E/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A
M<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/C`E
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G(&YO=W)A<#TS
M1&YO=W)A<#XF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=2
M3U5.1"U#3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\
M=&0@;F]W<F%P/3-$;F]W<F%P/E9O;&%T:6QI='D\+W1D/B`\=&0@;F]W<F%P
M/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^-S8N
M-C`E+3<V+C<Q)3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97(G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$
M;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C
M96YT97(G(&YO=W)A<#TS1&YO=W)A<#XW-2XX-B4M.#`N-#`E/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G(&YO=W)A<#TS1&YO=W)A<#XF
M;F)S<#L\+W1D/B`\=&0@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A
M<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R
M)R!N;W=R87`],T1N;W=R87`^-S4N-#<E+3@P+C0X)3PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R
M87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XW
M,RXR."4M.#`N-#@E/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y
M;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!N;W=R87`],T1N;W=R87`^17AP96-T960@=&5R;2`H:6X@>65A
M<G,I/"]T9#X@/'1D(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@
M;F]W<F%P/3-$;F]W<F%P/C0N,C0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G
M(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^,RXT.2TT+C(Q/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G(&YO=W)A<#TS1&YO
M=W)A<#XF;F)S<#L\+W1D/B`\=&0@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS
M1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M8V5N=&5R)R!N;W=R87`],T1N;W=R87`^,RXS-"TW+C`Y/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97(G(&YO
M=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P
M/C,N,C8M-"XT-SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE
M/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@
M8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G(&YO=W)A
M<#TS1&YO=W)A<#Y%>'!E8W1E9"!F;W)F96ET=7)E(')A=&4\+W1D/B`\=&0@
M;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R
M87`^,"4M,C,N,34E/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E
M;G1E<B<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`]
M,T1N;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&-E;G1E<B<@;F]W<F%P/3-$;F]W<F%P/C`E+3(S+C$U)3PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!N;W=R87`],T1N;W=R87`^)FYB
M<W`[/"]T9#X@/'1D(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N;W=R87`^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<B<@
M;F]W<F%P/3-$;F]W<F%P/C`E+3(S+C$U)3PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R)R!N;W=R87`],T1N
M;W=R87`^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E
M;G1E<B<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!C96YT97(G(&YO=W)A<#TS1&YO=W)A<#XP)2TR,RXQ
M-24\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@;F]W<F%P
M/3-$;F]W<F%P/B9N8G-P.SPO=&0^(#PO='(^(#PO=&%B;&4^(#PA+2U%;F1&
M<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-U;6UA<GD@;V8@4F5S=')I8W1E
M9"!3=&]C:R!!=V%R9',@06-T:79I='D\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T14
M1"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM
M/@T*/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS
M1"=415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6X[($U!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^(%1H92!F;VQL;W=I;F<@:7,@82!S=6UM87)Y(&]F(')E
M<W1R:6-T960@<W1O8VL@87=A<F1S(&%C=&EV:71Y(&9O<B!T:&4@;FEN92!M
M;VYT:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$R.CPO<#X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(
M.B`X,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'
M3CH@8F]T=&]M.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\=&0@<W1Y;&4]
M,T0G5$585"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&YO=W)A
M<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/
M3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)3TXZ(&YO;F4G(&-O;'-P
M86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@@,'!T(#,N.'!T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2
M051)3TXZ(&YO;F4G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@@,'!T(#,N.'!T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2
M051)3TXZ(&YO;F4G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@@,'!T(#,N.'!T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2
M051)3TXZ(&YO;F4G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@@,'!T(#,N.'!T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2
M051)3TXZ(&YO;F4G/B`\<W1R;VYG/DYU;6)E<B!O9CPO<W1R;VYG/CPO<#X@
M/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P
M<'@@,'!T(#,N.'!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R;VYG/E-H
M87)E<SPO<W1R;VYG/CPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+41%0T]2051)
M3TXZ(&YO;F4G(&YO=W)A<#TS1&YO=W)A<#XF;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0[
M(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@;F]W<F%P/3-$;F]W<F%P/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@
M<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5"U714E'2%0Z(&)O;&0[
M(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<@8V]L<W!A;CTS1#(@;F]W<F%P/3-$
M;F]W<F%P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)
M3CH@,'!T(#!P>"`P<'0@-2XR-7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\
M<W1R;VYG/E!E<B!3:&%R93PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@@,'!T(#4N,C5P=#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@5$58
M5"U$14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY796EG:'1E9"T\+W-T<F]N
M9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@34%21TE.
M.B`P<'0@,'!X(#!P="`U+C(U<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(%1%6%0M1$5#3U)!5$E/3CH@;F]N92<^(#QS
M=')O;F<^079E<F%G93PO<W1R;VYG/CPO<#X@/'`@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R.R!-05)'24XZ(#!P="`P<'@@,'!T(#4N,C5P=#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@5$585"U$
M14-/4D%424]..B!N;VYE)SX@/'-T<F]N9SY'<F%N="U$871E/"]S=')O;F<^
M/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($U!4D=)3CH@
M,'!T(#!P>"`P<'0@-2XR-7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!415A4+41%0T]2051)3TXZ(&YO;F4G/B`\<W1R
M;VYG/D9A:7(@5F%L=64\+W-T<F]N9SX\+W`^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$58
M5"U$14-/4D%424]..B!N;VYE)R!N;W=R87`],T1N;W=R87`^)FYB<W`[/"]T
M9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R
M,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y
M;&4],T0G5TE$5$@Z(#<T)3L@1D].5"U714E'2%0Z(&)O;&0G/D]U='-T86YD
M:6YG(&%T($IA;G5A<GD@,2P@,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=72414
M2#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!724142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$P)2<^-3,L,S,S/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$P)2<^,2XV
M,SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@
M,24G/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$
M+4-/3$]2.B!W:&ET93L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SY297-T<FEC=&5D('-T;V-K(&=R
M86YT960\+W1D/B`\=&0^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H="<^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SXF;F)S<#L\+W1D/B`\=&0^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/B0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G/BT\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]5
M3D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^4F5S=')I
M8W1E9"!S=&]C:R!V97-T960\+W1D/B`\=&0^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H="<^,RPS,S,\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D/B9N8G-P.SPO
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M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$58
M5"U!3$E'3CH@<FEG:'0G/B`M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4
M15A4+4%,24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/B`M
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="
M04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M+C5P=#L@1D].5"U714E'2%0Z(&)O;&0G/D]U='-T86YD:6YG(&%T(%-E<'1E
M;6)E<B`S,"P@,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^(#4P+#`P,#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N
M-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/B`Q+C,Y/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R
M+C5P="<^)FYB<W`[/"]T9#X@/"]T<CX@/"]T86)L93X@/"$M+45N9$9R86=M
M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?,&%E8C1A.#%?9&9D-E\T-F(U7V(S,F1?-69E-#5A
M864Y,F1E#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!A96(T83@Q
M7V1F9#9?-#9B-5]B,S)D7S5F930U86%E.3)D92]7;W)K<VAE971S+U-H965T
M,C,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#
M87!I=&%L($QE87-E("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%P:71A;"!,96%S92!;06)S=')A
M8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-C:&5D=6QE(&]F($-A<&ET86P@3&5A<V4@3V)L:6=A=&EO;CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),
M24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B
M:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I
M=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT
M+2T^(#QP('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[($9/3E0M5T5)1TA4.B!N;W)M86P[($U!4D=)3CH@,'!T
M(#!P>#L@5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN
M)SX@1G5T=7)E(&UI;FEM=6T@8V%P:71A;"!L96%S92!P87EM96YT<R!U;F1E
M<B!T:&4@8V%P:71A;"!L96%S92!A9W)E96UE;G0@870@4V5P=&5M8F5R(#,P
M+"`R,#$R(&%R92!A<R!F;VQL;W=S("AI;B!T:&]U<V%N9',I.CPO<#X@/'`@
M<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@1D].5"U714E'2%0Z(&YO<FUA;#L@34%21TE..B`P<'0@,'!X.R!4
M15A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,"XU:6XG/B`F;F)S
M<#L\+W`^(#QT86)L92!S='EL93TS1"=724142#H@-S`E.R!"3U)$15(M0T],
M3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P
M/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9#XF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@
M1D].5"U714E'2%0Z(&)O;&0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E
M;G1E<CL@1D].5"U714E'2%0Z(&)O;&0G(&-O;'-P86X],T0R/D%M;W5N=#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%
M24=(5#H@8F]L9"<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!
M0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,
M24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M5TE$5$@Z(#<Y)2<^,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=724142#H@,24G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!7
M24142#H@,24G/B0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0[(%=)1%1(.B`Q."4G/C$R/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T
M>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'
M3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/C(P
M,3,\+W1D/B`\=&0^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<^-S8\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M
M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^,C`Q-#PO=&0^
M(#QT9#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)SXW-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SXF;F)S
M<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@
M=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^,C`Q-3PO=&0^(#QT9#XF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SXW-CPO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@
M<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SXR,#$V/"]T9#X@/'1D/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
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M0D]45$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(#0T/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G
M/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/
M3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M)SX@/'1D/B9N8G-P.SPO=&0^(#QT9#XF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)SXS-C`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$
M)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`Q<'0G/DQE<W,@)B,X,C$S.R!A;6]U;G1S(')E<')E<V5N=&EN
M9R!I;G1E<F5S=#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,7!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI
M9#L@5$585"U!3$E'3CH@<FEG:'0G/B`H-3$\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^*3PO=&0^
M(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T
M+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/E!R97-E;G0@=F%L=64@;V8@;F5T(&UI
M;FEM=6T@;&5A<V4@<&%Y;65N=',\+W1D/B`\=&0^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^,S`Y/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S
M='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET93L@5D525$E#04PM04Q)
M1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0
M041$24Y'+4)/5%1/33H@,7!T)SY,97-S("8C.#(Q,SL@8W5R<F5N="!P;W)T
M:6]N(&]F(&-A<&ET86P@;&5A<V4\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#%P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX@*#4W/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q
M<'0G/BD\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/
M4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,BXU<'0G/DYO;BUC=7)R96YT('!O<G1I;VX@;V8@8V%P:71A;"!L96%S
M93PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`D/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$58
M5"U!3$E'3CH@<FEG:'0G/B`R-3(\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D
M/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T
M:69Y.R!415A4+4E.1$5.5#H@,&EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(&)O;&0@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N
M8G-P.SPO<#X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&%E8C1A.#%?
M9&9D-E\T-F(U7V(S,F1?-69E-#5A864Y,F1E#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U86%E
M.3)D92]7;W)K<VAE971S+U-H965T,C0N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E<R!087EA8FQE("A486)L97,I/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M3F]T97,@4&%Y86)L92!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F($YO=&5S(%!A>6%B
M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%
M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO
M;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT
M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I=CX@/&1I=CX\(2TM4W1A
M<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y
M.R!415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^($%G9W)E9V%T
M92!F=71U<F4@;6EN:6UU;2!P<FEN8VEP86P@<&%Y;65N=',@;VX@=&AE($=%
M($5Q=6EP;65N="!,;V%N(&%T(%-E<'1E;6)E<B`S,"P@,C`Q,B!A<F4@87,@
M9F]L;&]W<R`H:6X@=&AO=7-A;F1S*3H\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z(#<P)3L@
M0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T
M;VTG/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O
M;&ED.R!&3TY4+5=%24=(5#H@8F]L9"<^(%EE87(\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5"U714E'2%0Z(&)O
M;&0G(&-O;'-P86X],T0R/D%M;W5N=#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)FYB<W`[/"]T
M9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R
M,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#<Y)2<^,C`Q,CPO=&0^
M(#QT9"!S='EL93TS1"=724142#H@,24G/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B0\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q."4G/C,Y/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^
M)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],
M3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/C(P,3,\+W1D/B`\=&0^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^,34W/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#PO='(^
M(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR
M,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/C(P,30\+W1D/B`\=&0^)FYB<W`[/"]T9#X@/'1D
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M24=..B!L969T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G/C$U-SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.
M1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'
M+4)/5%1/33H@,7!T)SXR,#$V/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`Q<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(#0P/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`Q<'0G
M/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/
M3$]2.B!W:&ET93L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0G/B9N8G-P.SPO=&0^(#PO='(^
M(#PO=&%B;&4^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
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M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%0D<^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0Q/CQS=')O;F<^3W)G86YI>F%T:6]N("A$971A:6QS*3QB
M<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N
M(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D]R9V%N:7IA=&EO;B!;06)S=')A8W1=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]W;F5R<VAI<"!P97)C
M96YT(&]F(&IO:6YT('9E;G1U<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(P+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^2F]I;G0@=F5N='5R92P@<&5R8V5N="!O=VYE<G-H
M:7`@;V8@0V%D:6QA/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX
M,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
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M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%5DY!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY,:7%U:61I='D@36%T
M=&5R<R`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S
M<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXY($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y/8W0N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,3QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3&EQ=6ED:71Y($UA
M='1E<G,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$P+#<S.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,30L,S$X/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M-"PQ,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#@L,#8Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3:&]R="UT97)M(&EN=F5S=&UE;G1S(&%V86EL86)L
M92UF;W(M<V%L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<L
M-C<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-"PR,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%M;W5N="!R86ES960@=&AR;W5G:"!T:&4@<V%L92!O9B!C
M;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,C8L.3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`R-BPY,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#DL,3@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
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M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P13)(04,^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^4W5M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S
M("A.87)R871I=F4I*$1E=&%I;',I("A54T0@)"D\8G(^26X@36EL;&EO;G,L
M(&5X8V5P="!3:&%R92!D871A+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE
M9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0R/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q
M,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,@
M6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y.=6UB97(@;V8@875C=&EO;B!R871E('-E8W5R:71I97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA<FME=&%B;&4@<V5C
M=7)I=&EE<RP@;W)I9VEN86P@;6EN:6UU;2!M871U<FET>3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^.3`@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%R:V5T86)L92!S96-U
M<FET:65S+"!O<FEG:6YA;"!M87AI;75M(&UA='5R:71Y/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XQ('EE87(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%U8W1I;VX@<F%T92!S96-U
M<FET:65S+"!P87(@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-2XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y.=6UB97(@;V8@<VAA<F5S(&5X8VQU9&5D(&9R;VT@=&AE
M(&-O;7!U=&%T:6]N(&]F(&YE="!L;W-S('!E<B!S:&%R93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L.34Q+#8R-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q+#$Q.2PT-S8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!A96(T83@Q
M7V1F9#9?-#9B-5]B,S)D7S5F930U86%E.3)D90T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\P865B-&$X,5]D9F0V7S0V8C5?8C,R9%\U9F4T-6%A
M93DR9&4O5V]R:W-H965T<R]3:&5E=#(X+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-E!!13X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT
M($%C8V]U;G1I;F<@4&]L:6-I97,@*$9I;F%N8VEA;"!!<W-E=',@86YD($QI
M86)I;&ET:65S($UE87-U<F5D(&%T($9A:7(@36%R:V5T(%9A;'5E(&]N(&$@
M4F5C=7)R:6YG($)A<VES*2A$971A:6QS*2`H55-$("0I/&)R/DEN(%1H;W5S
M86YD<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1F%I
M<B!686QU92P@07-S971S(&%N9"!,:6%B:6QI=&EE<R!-96%S=7)E9"!O;B!2
M96-U<G)I;F<@86YD($YO;G)E8W5R<FEN9R!"87-I<R!;3&EN92!)=&5M<UT\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]R
M<&]R871E(&1E8G0@86YD(&%U8W1I;VX@<F%T92!S96-U<FET:65S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$W+#8W,CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-"PR,#4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE
M=F5L(#$@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY&86ER(%9A;'5E+"!!<W-E=',@86YD($QI86)I;&ET:65S
M($UE87-U<F5D(&]N(%)E8W5R<FEN9R!A;F0@3F]N<F5C=7)R:6YG($)A<VES
M(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#;W)P;W)A=&4@9&5B="!A;F0@875C=&EO;B!R871E('-E
M8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N="!L:6%B:6QI='D\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3&5V96P@,B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@5F%L=64L($%S<V5T<R!A;F0@3&EA
M8FEL:71I97,@365A<W5R960@;VX@4F5C=7)R:6YG(&%N9"!.;VYR96-U<G)I
M;F<@0F%S:7,@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-O<G!O<F%T92!D96)T(&%N9"!A=6-T:6]N
M(')A=&4@<V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3<L-C<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-"PR,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G0@;&EA8FEL:71Y/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DQE=F5L(#,@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E+"!!<W-E=',@86YD($QI86)I;&ET
M:65S($UE87-U<F5D(&]N(%)E8W5R<FEN9R!A;F0@3F]N<F5C=7)R:6YG($)A
M<VES(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;W)P;W)A=&4@9&5B="!A;F0@875C=&EO;B!R871E
M('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N="!L:6%B:6QI='D\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-S8Y/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S-C@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
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M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%54@^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^4W5M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O
M=6YT:6YG(%!O;&EC:65S("A3=6UM87)Y(&]F($%C=&EV:71Y(&]F($QE=F5L
M(#,@26YP=71S($UE87-U<F5D(&]N(%)E8W5R<FEN9R!"87-I<RDH1&5T86EL
M<RD@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@
M<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S
M,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L
M:6-I97,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y"86QA;F-E(&%T($1E8V5M8F5R(#,Q+"`R,#$Q/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,V.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VAA;F=E(&EN
M(&9A:7(@=F%L=64@;V8@5V%R<F%N="!L:6%B:6QI='D\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!397!T96UB97(@
M,S`L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-S8Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
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M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15%4
M044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P
M86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^4W5M;6%R>2!O9B!3:6=N:69I
M8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A3:&]R="UT97)M($EN=F5S=&UE
M;G1S($-L87-S:69I960@87,@079A:6QA8FQE+69O<BUS86QE*2A$971A:6QS
M*2`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R=VES92!S
M<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4V-H961U;&4@;V8@079A:6QA8FQE+69O<BUS
M86QE(%-E8W5R:71I97,@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IE9"!#;W-T/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$V+#8S-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,RPS-S,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R
M;W-S(%5N<F5A;&EZ960@1V%I;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L,#,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.#,R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!5;G)E86QI>F5D($QO<W-E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1F%I<B!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3<L-C<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-"PR,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%U8W1I;VX@<F%T92!S96-U<FET:65S(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4V-H961U;&4@;V8@079A:6QA8FQE+69O<BUS86QE(%-E8W5R:71I97,@
M6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%M;W)T:7IE9"!#;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#,W,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L,S<S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!5;G)E86QI>F5D($=A:6YS
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`S,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@S,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)O
M<W,@56YR96%L:7IE9"!,;W-S97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@5F%L=64\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-#`U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PR,#4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O
M<G!O<F%T92!D96)T('-E8W5R:71I97,@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY38VAE9'5L92!O9B!!=F%I
M;&%B;&4M9F]R+7-A;&4@4V5C=7)I=&EE<R!;3&EN92!)=&5M<UT\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F5D
M($-O<W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S+#(V,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1W)O<W,@56YR96%L:7IE9"!'86EN<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)O<W,@56YR
M96%L:7IE9"!,;W-S97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@5F%L=64\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3,L,C8W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P151804<^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^4W1O8VLM0F%S960@0V]M<&5N<V%T:6]N("A.87)R
M871I=F4I*$1E=&%I;',I("A54T0@)"D\8G(^26X@36EL;&EO;G,L(&5X8V5P
M="!3:&%R92!D871A+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R
M/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,3QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R
M92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S
M960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06=G<F5G871E(&EN=')I;G-I
M8R!V86QU92!O9B!S=&]C:R!O<'1I;VYS(&]U='-T86YD:6YG/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0N-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960M879E<F%G
M92!R96UA:6YI;F<@8V]N=')A8W1U86P@=&5R;2!O9B!S=&]C:R!O<'1I;VYS
M(&]U='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XW
M('EE87)S(#@@;6]N=&AS(#$R(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%G9W)E9V%T92!I;G1R:6YS:6,@
M=F%L=64@;V8@<W1O8VL@;W!T:6]N<R!E>&5R8VES86)L93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960M879E<F%G92!R96UA
M:6YI;F<@8V]N=')A8W1U86P@=&5R;2!O9B!S=&]C:R!O<'1I;VYS(&5X97)C
M:7-A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XU('EE87)S
M(#@@;6]N=&AS(#$R(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%G9W)E9V%T92!I;G1R:6YS:6,@=F%L=64@
M;V8@<W1O8VL@;W!T:6]N<R!E>&5R8VES960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C`N,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`N,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^56YR96-O9VYI>F5D(&-O;7!E;G-A=&EO
M;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^56YR96-O9VYI>F5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E+"!R96-O9VYI
M=&EO;B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C$@
M>65A<B`W(&UO;G1H<R`V(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/C(P,#4@4W1O8VL@26YC96YT:79E(%!L
M86X@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@
M8GD@4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N
M('-T;V-K(')E<V5R=F5D(&9O<B!I<W-U86YC93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3@L,S$R+#$Y,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36EN:6UU;2!G<F%N="!P<FEC
M92P@<&5R8V5N="!O9B!C;VUM;VX@<W1O8VL@9F%I<B!V86QU93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P+C`P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^,C`P-2!3=&]C:R!)
M;F-E;G1I=F4@4&QA;B!;365M8F5R72!\($UI;FEM=6T@6TUE;6)E<ET\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB
M87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@
M4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%X:6UU;2!T97)M(&]F(&]P=&EO
M;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C$P('EE87)S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M>&5R8VES92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/C8@;6]N=&AS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#XR,#`U(%-T;V-K($EN8V5N=&EV92!0;&%N(%M-96UB97)=
M('P@36%X:6UU;2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO;B!!<G)A
M;F=E;65N="!B>2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET
M96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y%>&5R8VES92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/C0@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/C$Y.34@4W1O8VL@3W!T:6]N(%!L86X@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R
M92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S
M960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K(')E<V5R
M=F5D(&9O<B!I<W-U86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-2PW-#8L-#8X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y-:6YI;75M(&=R86YT('!R:6-E+"!P97)C96YT(&]F
M(&-O;6UO;B!S=&]C:R!F86ER('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#XQ.3DU(%-T;V-K($]P=&EO;B!0;&%N(%M-
M96UB97)=('P@36EN:6UU;2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO
M;B!!<G)A;F=E;65N="!B>2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y-87AI;75M('1E<FT@;V8@;W!T:6]N<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^,3`@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E('!E<FEO9#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-B!M;VYT:',\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/C$Y.34@
M4W1O8VL@3W!T:6]N(%!L86X@6TUE;6)E<ET@?"!-87AI;75M(%M-96UB97)=
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA
M<F4M8F%S960@0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E+6)A
M<V5D(%!A>6UE;G0@07=A<F0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E('!E<FEO9#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-"!Y96%R<SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&%E8C1A.#%?9&9D
M-E\T-F(U7V(S,F1?-69E-#5A864Y,F1E#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U86%E.3)D
M92]7;W)K<VAE971S+U-H965T,S(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$573T%%/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,CX\<W1R;VYG/E-T;V-K+4)A<V5D($-O;7!E;G-A=&EO;B`H
M4W1O8VLM0F%S960@0V]M<&5N<V%T:6]N($5X<&5N<V4I*$1E=&%I;',I("A5
M4T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I
M9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#(^.2!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y397`N(#,P+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY%;7!L;WEE92!397)V:6-E(%-H87)E+6)A
M<V5D($-O;7!E;G-A=&EO;BP@06QL;V-A=&EO;B!O9B!296-O9VYI>F5D(%!E
M<FEO9"!#;W-T<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N
M(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-#DS
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`U-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$L-C8X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`Q+#8W-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT
M(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^16UP;&]Y964@4V5R=FEC92!3:&%R92UB87-E9"!#;VUP96YS871I
M;VXL($%L;&]C871I;VX@;V8@4F5C;V=N:7IE9"!097)I;V0@0V]S=',@6TQI
M;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-T;V-K+6)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,3D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-S8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,S@\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-#D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=E;F5R
M86P@86YD(&%D;6EN:7-T<F%T:79E(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^16UP;&]Y964@4V5R=FEC92!3
M:&%R92UB87-E9"!#;VUP96YS871I;VXL($%L;&]C871I;VX@;V8@4F5C;V=N
M:7IE9"!097)I;V0@0V]S=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K+6)A<V5D(&-O;7!E
M;G-A=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#(W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,S8V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`Q+#`S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,2PR,C@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S!A96(T83@Q7V1F9#9?-#9B-5]B,S)D
M7S5F930U86%E.3)D90T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P
M865B-&$X,5]D9F0V7S0V8C5?8C,R9%\U9F4T-6%A93DR9&4O5V]R:W-H965T
M<R]3:&5E=#,S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%,4)!1SX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY3=&]C:RU"87-E9"!#;VUP96YS871I;VX@*%-U;6UA<GD@;V8@
M3W!T:6]N($%C=&EV:71Y*2A$971A:6QS*2`H55-$("0I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3G5M8F5R(&]F
M(%-H87)E<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3:&%R97,@879A:6QA8FQE(&9O<B!G<F%N="!A="!397!T96UB97(@
M,S`L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-34Y
M+#4S-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^,C`P-2!3=&]C:R!);F-E;G1I=F4@4&QA;B!;365M8F5R73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYU;6)E<B!O
M9B!3:&%R97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3W5T<W1A;F1I;F<@870@2F%N=6%R>2`Q+"`R,#$R/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#0Q,BPW-#8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R86YT960\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-#@S+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I
M<V5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X,"PW.#0I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M86YC96QE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PU-#8L
M-38R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3W5T<W1A;F1I;F<@870@4V5P=&5M8F5R(#,P+"`R,#$R/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#(V."PT,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!E
M>&5R8VES86)L92!A="!397!T96UB97(@,S`L(#(P,3(\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,L-3`S+#`T,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY796EG:'1E
M9"!!=F5R86=E($5X97)C:7-E(%!R:6-E/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG(&%T($IA;G5A<GD@
M,2P@,C`Q,CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+C(R
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y'<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N
M,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5X97)C:7-E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`P+C8Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#86YC96QE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`R+C(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!A="!397!T96UB97(@,S`L(#(P,3(\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2XX.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N
M<R!E>&5R8VES86)L92P@4V5P=&5M8F5R(#,P+"`R,#$R/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#(N,S@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/C$Y.34@4W1O8VL@3W!T:6]N
M(%!L86X@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY.=6UB97(@;V8@4VAA<F5S/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG(&%T($IA;G5A
M<GD@,2P@,C`Q,CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#<T
M+#8U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1W)A;G1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%>&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%N8V5L960\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$X-"PW-3`I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!A="!3
M97!T96UB97(@,S`L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(X.2PY,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-H87)E<R!E>&5R8VES86)L92!A="!397!T96UB97(@
M,S`L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(X.2PY
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^5V5I9VAT960@079E<F%G92!%>&5R8VES92!0<FEC93PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=71S
M=&%N9&EN9R!A="!*86YU87)Y(#$L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@-"XS.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1W)A;G1E9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES960\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%N8V5L
M960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-"XP,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T
M<W1A;F1I;F<@870@4V5P=&5M8F5R(#,P+"`R,#$R/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#0N-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@97AE<F-I<V%B;&4L
M(%-E<'1E;6)E<B`S,"P@,C`Q,CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`T+C4Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P159/04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4W1O8VLM
M0F%S960@0V]M<&5N<V%T:6]N("A!<W-U;7!T:6]N<R!5<V5D(&EN($5S=&EM
M871I;VX@;V8@1F%I<B!686QU92!O9B!3=&]C:R!/<'1I;VYS($=R86YT960I
M*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXY($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E+6)A
M<V5D($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!B>2!3:&%R92UB87-E9"!0
M87EM96YT($%W87)D(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"UA=F5R86=E(&9A:7(@
M=F%L=64@;V8@<W1O8VL@;W!T:6]N<R!G<F%N=&5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$N,#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N-S@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N-S$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N,3D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)I
M<VLM9G)E92!I;G1E<F5S="!R871E+"!M:6YI;75M/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XP+C0X)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C`N-34E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XT."4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)I<VLM9G)E92!I
M;G1E<F5S="!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP
M+C4U)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4FES:RUF<F5E(&EN=&5R97-T(')A=&4L(&UA>&EM=6T\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N-C@E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XU-"4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+CDQ)3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&EV
M:61E;F0@>6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N
M,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XP+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y6;VQA=&EL:71Y+"!M:6YI;75M/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-BXV,"4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-2XX-B4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-2XT-R4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M,RXR."4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E9O;&%T:6QI='DL(&UA>&EM=6T\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C<V+C<Q)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C@P+C0P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@P+C0X)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@P+C0X)3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T
M960@=&5R;2`H:6X@>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XT('EE87)S(#(@;6]N=&AS(#(W(&1A>7,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUI;FEM=6T@6TUE;6)E
M<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3
M:&%R92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M
M8F%S960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T960@=&5R;2`H
M:6X@>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XS('EE
M87)S(#4@;6]N=&AS(#(W(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XS('EE87)S(#0@;6]N=&AS(#(@9&%Y<SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C,@
M>65A<G,@,R!M;VYT:',@-"!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>'!E8W1E9"!F;W)F96ET=7)E(')A
M=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP
M+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y-87AI;75M(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F4M8F%S960@0V]M<&5N<V%T
M:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E+6)A<V5D(%!A>6UE;G0@07=A<F0@
M6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D5X<&5C=&5D('1E<FT@*&EN('EE87)S*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^-"!Y96%R<R`R(&UO;G1H<R`Q-B!D87ES
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M-R!Y96%R<R`Q(&UO;G1H(#(@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/C0@>65A<G,@-2!M;VYT:',@,3D@9&%Y
M<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^17AP96-T960@9F]R9F5I='5R92!R871E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR,RXQ-24\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR,RXQ-24\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,RXQ-24\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,RXQ-24\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
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M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%,TQ!0SX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY3=&]C:RU"87-E9"!#;VUP96YS871I;VX@
M*%-U;6UA<GD@;V8@4F5S=')I8W1E9"!3=&]C:R!!=V%R9',@06-T:79I='DI
M*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY.=6UB97(@;V8@4VAA<F5S/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG
M(&%T($IA;G5A<GD@,2P@,C`Q,CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-3,L,S,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y297-T<FEC=&5D('-T;V-K(&=R86YT960\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')I
M8W1E9"!S=&]C:R!V97-T960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C,L,S,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y297-T<FEC=&5D('-T;V-K(&9O<F9E:71E9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=71S=&%N
M9&EN9R!A="!397!T96UB97(@,S`L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY097(@4VAA<F4@5V5I9VAT
M960M079E<F%G92!'<F%N="U$871E($9A:7(@5F%L=64\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A;F1I;F<@870@
M2F%N=6%R>2`Q+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#$N-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E)E<W1R:6-T960@<W1O8VL@9W)A;G1E9#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-T<FEC=&5D
M('-T;V-K('9E<W1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`U+C(Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y297-T<FEC=&5D('-T;V-K(&9O<F9E:71E9#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=71S=&%N9&EN
M9R!A="!397!T96UB97(@,S`L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,2XS.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?,&%E8C1A.#%?9&9D-E\T-F(U7V(S,F1?-69E-#5A864Y
M,F1E#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!A96(T83@Q7V1F
M9#9?-#9B-5]B,S)D7S5F930U86%E.3)D92]7;W)K<VAE971S+U-H965T,S8N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$5$-$)'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E4N
M4RX@1V]V97)N;65N="!!9W)E96UE;G0@86YD($-O;&QA8F]R871I;VYS("A$
M971A:6QS*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^.2!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0R/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^,C`@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,3$\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q,3QB<CY(
M2%,@0D%21$$@0V]N=')A8W0@07=A<F0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CY(2%,@0D%2
M1$$@0V]N=')A8W0@07=A<F0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,3QB<CY(2%,@0D%21$$@0V]N
M=')A8W0@07=A<F0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CY(2%,@0D%21$$@0V]N=')A8W0@
M07=A<F0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1F5B+B`R."P@,C`Q,3QB<CY(2%,@0D%21$$@3W!T:6]N(&9O<B!!9&1I
M=&EO;F%L(%!E<FEO9"!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y&96(N(#(X+"`R,#$Q/&)R/DQI8V5N<V4@06=R965M96YT
M('=I=&@@3$<@3&EF92!38VEE;F-E<RP@3'1D+B!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#(X+"`R,#$Q/&)R/DQI
M8V5N<V4@06=R965M96YT('=I=&@@3$<@3&EF92!38VEE;F-E<RP@3'1D+B!;
M365M8F5R73QB<CY-:6YI;75M(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,3$\8G(^3&EC96YS92!!9W)E
M96UE;G0@=VET:"!,1R!,:69E(%-C:65N8V5S+"!,=&0N(%M-96UB97)=/&)R
M/DUA>&EM=6T@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CY0051((%9A8V-I;F4@4V]L=71I;VYS
M(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;"X@,S$L(#(P,3(\8G(^4$%42"!686-C:6YE(%-O;'5T:6]N<R!;365M8F5R
M73QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY#;VQL86)O<F%T:79E($%R<F%N9V5M96YT<R!A;F0@3F]N+6-O;&QA8F]R
M871I=F4@07)R86YG96UE;G0@5')A;G-A8W1I;VYS(%M,:6YE($ET96US73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYT
M<F%C="!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#$W.2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Y-RPP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`X,BPP,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#`P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-O;G1R86-T('1E<FT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/C,V(&UO;G1H<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/C(T(&UO;G1H<SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]V97)N;65N="!C;VYT<F%C
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-3@S+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L
M,#`X+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$W+#,R."PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XX+#@T,RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-BPY,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$L-C`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&-O;&QA8F]R871I;VX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X,BPP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ.#(L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T960@8V]S=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,3`P+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,3`P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5')I86P@8V]S=',@:6YC=7)R960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L.#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^57!F<F]N="!L:6-E;G-E('!A>6UE
M;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPU,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y2;WEA;'1Y('!A>6UE;G1S+"!P97)C96YT/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!O=&5N=&EA;"!F=6YD:6YG
M(&]F(&5X=&5R;F%L(&-L:6YI8V%L(&1E=F5L;W!M96YT(&-O<W1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"XP,"4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
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M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-4@^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^0V%P:71A;"!,96%S92`H3F%R<F%T:79E*2A$971A:6QS
M*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D%U
M9RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^0V%P:71A;"!,96%S92!;06)S=')A8W1=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5F9F5C=&EV92!I
M;G1E<F5S="!R871E(&]N(&-A<&ET86P@;&5A<V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8N-3`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-;VYT:&QY(&QE87-E('!A>6UE;G1S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8L,S(U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,96%S
M92!T97)M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XU.2!M;VYT
M:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!A
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M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M041!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#87!I=&%L($QE87-E("A&
M=71U<F4@36EN:6UU;2!#87!I=&%L($QE87-E(%!A>6UE;G1S(%5N9&5R($-A
M<&ET86P@3&5A<V4@06=R965M96YT*2A$971A:6QS*2`H55-$("0I/&)R/DEN
M(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^0V%P:71A;"!,96%S92!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/C(P,3(\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/C(P,3,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C<V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#XR,#$T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^,C`Q-3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/C(P,38\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#XR,#$W/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O
M=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-C`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE<W,@
M+2!A;6]U;G1S(')E<')E<V5N=&EN9R!I;G1E<F5S=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH-3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E<V5N="!V86QU92!O9B!N970@
M;6EN:6UU;2!L96%S92!P87EM96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y,97-S("T@8W5R<F5N="!P;W)T:6]N(&]F(&-A<&ET
M86P@;&5A<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4W*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F]N+6-U<G)E;G0@<&]R=&EO;B!O9B!C87!I=&%L(&QE
M87-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(U,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?,&%E8C1A.#%?9&9D-E\T-F(U7V(S,F1?-69E-#5A864Y,F1E#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!A96(T83@Q7V1F9#9?-#9B-5]B
M,S)D7S5F930U86%E.3)D92]7;W)K<VAE971S+U-H965T,SDN:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$4R3$%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&5S(%!A>6%B
M;&4@*$YA<G)A=&EV92DH1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q
M,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.;W1E<R!087EA8FQE(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F]R<F]W:6YG(&QI;6ET(&]F(&QO
M86X\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPP,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`R+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DEN=&5R97-T(')A=&4@:6X@861D:71I;VX@=&\@=&AR
M964M>65A<B!5+E,N($=O=F5R;FUE;G0@=')E87-U<GD@<F%T93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$N-C@E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$N-C@E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-:6YI;75M
M(&EN=&5R97-T(')A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$R+C$P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4F5P87EM96YT('1E<FT\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/C0R(&UO;G1H<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&5B="!I;G-T<G5M96YT+"!I;F-R96%S
M92!I;B!B;W)R;W=I;F=S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);G1E<F5S="!R871E(&1U<FEN9R!P97)I;V0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+C$P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36]N=&AL>2!P<FEN
M8VEP86P@<&%Y;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,3,L,#@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT
M4&%R=%\P865B-&$X,5]D9F0V7S0V8C5?8C,R9%\U9F4T-6%A93DR9&4-"D-O
M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&%E8C1A.#%?9&9D-E\T-F(U
M7V(S,F1?-69E-#5A864Y,F1E+U=O<FMS:&5E=',O4VAE970T,"YH=&UL#0I#
M;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#
M;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-
M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P135$04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^3F]T97,@4&%Y
M86)L92`H06=G<F5G871E($9U='5R92!-:6YI;75M(%!R:6YC:7!A;"!087EM
M96YT<R!O;B!%<75I<&UE;G0@3&]A;BDH1&5T86EL<RD@*%531"`D*3QB<CY)
M;B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q
M,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.;W1E<R!087EA8FQE(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^,C`Q,CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`S.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^,C`Q,SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,34W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#XR,#$T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/C(P,34\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$U-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^,C`Q-CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y4;W1A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U
M-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!A
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M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M,EA!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY787)R86YT($QI86)I;&ET
M>2`H1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$-#XQ($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0S/C,@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#(^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XS,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^3V-T
M+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-
M87D@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6PN(#,Q+"`R,#`X/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y397`N(#,P+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y.;W8N(#`W+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E=A<G)A;G0@3&EA8FEL:71Y
M(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^56YI=',@:7-S=65D(&EN(&1I<F5C="!O9F9E<FEN9SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L,S@U+#,R,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`P,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XW,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-BPV.#8L-C4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^."PT,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C0L.34W+#<Q-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N
M('-H87)E<R!P97(@=6YI=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4')O8V5E9',@9G)O;2!D:7)E8W0@;V9F97)I;F<\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3(L,3`P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3<L-3`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@.#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,30L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-#DL.3`P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S(&5N
M=&ET;&5D('!E<B!W87)R86YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XP+C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!R:6-E('!E<B!U;FET/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#(N-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%G9W)E9V%T92!S:&%R97,@8V]M;6]N('-T
M;V-K(&-A;&QA8FQE(&)Y('=A<G)A;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#,T,RPS,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E('!R:6-E(&]F('=A<G)A
M;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C8R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#:&%N
M9V4@:6X@9F%I<B!V86QU92!O9B!W87)R86YT(&QI86)I;&ET>3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#`Q+#`P,"D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,S8L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#`Q+#`P
M,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#DW,RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E=A<G)A;G0@;&EA8FEL:71Y/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#<V.2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#<V.2PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
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M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%1%=!13X-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY386QE<R!O9B!#;VUM;VX@4W1O8VL@*$1E=&%I
M;',I("A54T0@)"D\8G(^26X@36EL;&EO;G,L(&5X8V5P="!3:&%R92!D871A
M+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0T/C$@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C,R($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y/8W0N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DUA>2`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DIU;"X@,S$L(#(P,#@\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^36%R+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DYO=BX@,#<L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4V%L97,@;V8@0V]M;6]N(%-T
M;V-K(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]M;6]N('-T;V-K('-O;&0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$R+#,X-2PS,C$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PP,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L
M-C@V+#8U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C@L-#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(T+#DU-RPW,34\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<')I
M8V4@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#(N,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$N,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@<V%L92!O9B!S=&]C:SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,BXQ/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-RXU/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`T.2XY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y'<F]S<R!P<F]C965D<R!A=71H;W)I>F5D(&EN('-A;&4@
M;V8@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'
M<F]S<R!P<F]C965D<R!A=71H;W)I>F5D(&EN('-A;&4@;V8@<W1O8VLL('!R
M:6]R('-A;&5S(&%G<F5E;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^079E<F%G92!S86QE<R!P<FEC93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Q+C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
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M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%44A!0SX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY-86YU9F%C='5R:6YG+"!,86)O<F%T;W)Y(&%N9"!/9F9I8V4@1F%C
M:6QI='D@*$1E=&%I;',I("A54T0@)"D\8G(^26X@36EL;&EO;G,L('5N;&5S
M<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y.;W8N(#,P+"`R,#$Q/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^36%N=69A8W1U<FEN
M9R!,86)O<F%T;W)Y(&%N9"!/9F9I8V4@1F%C:6QI='D@6T%B<W1R86-T73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,96%S
M960@9F%C:6QI='D@<W%U87)E(&9O;W1A9V4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C<T+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&5N86YT(&EM<')O=F5M96YT(&%L;&]W
M86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+C4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%D
M9&ET:6]N86P@=&5N86YT(&EM<')O=F5M96YT(&%L;&]W86YC93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO=6YT(&9U;F1E9"!F<F]M
M('1E;F%N="!A;&QO=V%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,BXX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y496YA;G0@06QL;W=A;F-E($EN=&5R97-T(%)A=&4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@N,#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15)&04,^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^36%S=&5R(%-E<G9I8V5S($%G<F5E;65N="!W:71H
M($-A9&EL82`H1&5T86EL<RD@*%531"`D*3QB<CY);B!-:6QL:6]N<RP@=6YL
M97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C0R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^36%S=&5R(%-E
M<G9I8V5S($%G<F5E;65N="!W:71H($-A9&EL82!;06)S=')A8W1=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUI;FEM=6T@
M8V]N=')A8W0@<V5R=FEC97,@=&\@8F4@<')O=FED960\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@-RXU/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&]R=&9A;&P@86UO=6YT(&9U
M;&QY('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E!A>6%B;&4@<&]R=&EO;B!O9B!T:&4@<VAO<G1F86QL(&%M;W5N="!E>&-E
M961I;F<@='=O(&UI;&QI;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4P+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4'5R8VAA<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`N-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?,&%E8C1A.#%?9&9D-E\T-F(U7V(S,F1?-69E-#5A864Y,F1E
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!A96(T83@Q7V1F9#9?
M-#9B-5]B,S)D7S5F930U86%E.3)D92]7;W)K<VAE971S+U-H965T-#4N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$571T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-U8G-E
M<75E;G0@179E;G1S("A$971A:6QS*2`H55-$("0I/&)R/DEN(%1H;W5S86YD
M<RP@97AC97!T(%-H87)E(&1A=&$L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF
M:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#0^,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,R($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y/8W0N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA>2`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DIU;"X@,S$L(#(P,#@\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$Q/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DYO=BX@,#<L(#(P,3(\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5B<V5Q=65N
M="!%=F5N=',@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@<V]L9#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L,S@U+#,R,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-BPV.#8L-C4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^."PT,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,C0L.34W+#<Q-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')I8V4@<&5R('-H
M87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(N,3@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N
M,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%M;W5N="!R86ES960@=&AR;W5G:"!T:&4@<V%L92!O9B!C;VUM;VX@
M<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C8L.3`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`R-BPY,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#DL,3@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M5V]R:V)O;VLN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`Q+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P,BYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,#,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#`T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P-2YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#8N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#`W+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970P."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#DN
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$P+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970Q,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,3(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$S
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-"YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,34N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#$V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q
M-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3@N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$Y+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970R,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,C$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(R+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970R,RYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,C0N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#(U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R-BYH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C<N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#(X+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970R.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S`N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,Q+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970S,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,S,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,T+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S-2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,S8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#,W+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S."YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,SDN:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#0P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970T,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#(N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0S+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970T-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T-#4N:'1M;"(O/@T*/"]X;6P^#0HM+2TM+2T]7TYE>'1087)T7S!A
F96(T83@Q7V1F9#9?-#9B-5]B,S)D7S5F930U86%E.3)D92TM#0H`
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EQHAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Manufacturing, Laboratory and Office Facility (Details) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Nov. 30, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract', window );"><strong>Manufacturing Laboratory and Office Facility [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LeasedFacilitySquareFootage', window );">Leased facility square footage</a></td>
        <td class="nump">74,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_TenantImprovementAllowance', window );">Tenant improvement allowance</a></td>
        <td class="nump">$ 2.5<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_AdditionalTenantImprovementAllowance', window );">Additional tenant improvement allowance</a></td>
        <td class="nump">3.0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromTenantAllowance', window );">Amount funded from tenant allowance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2.8<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_TenantAllowanceInterestRate', window );">Tenant Allowance Interest Rate</a></td>
        <td class="nump">8.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_AdditionalTenantImprovementAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Additional tenant improvement allowance</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_AdditionalTenantImprovementAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LeasedFacilitySquareFootage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of square footage of leased facililty.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LeasedFacilitySquareFootage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_TenantAllowanceInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tenant Allowance Interest Rate</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_TenantAllowanceInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_TenantImprovementAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tenant Improvement Allowance</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_TenantImprovementAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromTenantAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net cash outflow or inflow from monetary allowance granted by the landlord to a tenant to entice tenant to move into landlords building which will enable the tenant to prepare the leased premises for tenants occupancy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3179-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 16<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsForProceedsFromTenantAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EUH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Summary of Activity of Level 3 Inputs Measured on Recurring Basis)(Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31, 2011</a></td>
        <td class="nump">$ 368<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value of Warrant liability</a></td>
        <td class="nump">401<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at September 30, 2012</a></td>
        <td class="nump">$ 769<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) of liabilities measured at fair value on a recurring basis using unobservable inputs (level 3) which have taken place during the period. Such increase (decrease) may be comprised of changes in fair value (gains or losses) whether realized or unrealized that have been included in earnings, changed net asset value, or other comprehensive income (a separate component of shareholders' equity); purchases, sales, issues, or settlements of assets; and net transfers in to or out of this category within the fair value hierarchy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 157<br><br> -Paragraph 32<br><br> -Subparagraph c(1), c(2), c(3)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents a liability measured at fair value using significant unobservable inputs (Level 3) which is required for reconciliation purposes of beginning and ending balances.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E6PAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Financial Assets and Liabilities Measured at Fair Market Value on a Recurring Basis)(Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueDisclosure', window );">Corporate debt and auction rate securities</a></td>
        <td class="nump">$ 17,672<span></span></td>
        <td class="nump">$ 4,205<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 1 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueDisclosure', window );">Corporate debt and auction rate securities</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Warrant liability</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 2 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueDisclosure', window );">Corporate debt and auction rate securities</a></td>
        <td class="nump">17,672<span></span></td>
        <td class="nump">4,205<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Warrant liability</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 3 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueDisclosure', window );">Corporate debt and auction rate securities</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Warrant liability</a></td>
        <td class="nump">$ 769<span></span></td>
        <td class="nump">$ 368<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7534914&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 12<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Available-for-Sale Securities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505594<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the aggregate of the liabilities reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ERFAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Master Services Agreement with Cadila (Details) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1">42 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_MasterServicesAgreementWithCadilaAbstract', window );"><strong>Master Services Agreement with Cadila [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum', window );">Minimum contract services to be provided</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 7.5<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ShortfallAmountPayableInFull', window );">Shortfall amount fully payable</a></td>
        <td class="nump">2.0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_PercentOfTheShortfallAmountExceedingTwoMillion', window );">Payable portion of the shortfall amount exceeding two million</a></td>
        <td class="nump">50.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_MasterServiceAgreementPurchases', window );">Purchases</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.4<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_MasterServiceAgreementPurchases">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>MasterServiceAgreementPurchases</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_MasterServiceAgreementPurchases</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Master Services Agreement Amount Of Services To Be Provided Minimum</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_MasterServicesAgreementAmountOfServicesToBeProvidedMinimum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_MasterServicesAgreementWithCadilaAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_MasterServicesAgreementWithCadilaAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_PercentOfTheShortfallAmountExceedingTwoMillion">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percent Of The Shortfall Amount Exceeding Two Million</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_PercentOfTheShortfallAmountExceedingTwoMillion</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ShortfallAmountPayableInFull">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Shortfall Amount Payable In Full</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ShortfallAmountPayableInFull</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EQTAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Short-term Investments Classified as Available-for-sale)(Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">$ 16,636<span></span></td>
        <td class="nump">$ 3,373<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain', window );">Gross Unrealized Gains</a></td>
        <td class="nump">1,036<span></span></td>
        <td class="nump">832<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1', window );">Gross Unrealized Losses</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueDisclosure', window );">Fair Value</a></td>
        <td class="nump">17,672<span></span></td>
        <td class="nump">4,205<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Auction rate securities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">3,373<span></span></td>
        <td class="nump">3,373<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain', window );">Gross Unrealized Gains</a></td>
        <td class="nump">1,032<span></span></td>
        <td class="nump">832<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1', window );">Gross Unrealized Losses</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueDisclosure', window );">Fair Value</a></td>
        <td class="nump">4,405<span></span></td>
        <td class="nump">4,205<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Corporate debt securities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">13,263<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain', window );">Gross Unrealized Gains</a></td>
        <td class="nump">4<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1', window );">Gross Unrealized Losses</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueDisclosure', window );">Fair Value</a></td>
        <td class="nump">$ 13,267<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS115-1/124-1<br><br> -Paragraph 7<br><br> -Footnote 2<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 19<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7534914&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 12<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Available-for-Sale Securities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505594<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the gross unrealized gains for securities, at a point in time, which are categorized neither as held-to-maturity nor trading securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 133<br><br> -Paragraph 22<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6872113&amp;loc=d3e27161-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 13, 19<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGain</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the gross unrealized losses for securities, at a point in time, which are categorized neither as held-to-maturity nor trading securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLosses1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ETXAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock-Based Compensation (Narrative)(Details) (USD $)<br>In Millions, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of stock options outstanding</a></td>
        <td class="nump">$ 4.6<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual term of stock options outstanding</a></td>
        <td class="text">7 years 8 months 12 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of stock options exercisable</a></td>
        <td class="nump">1.0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term of stock options exercisable</a></td>
        <td class="text">5 years 8 months 12 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of stock options exercised</a></td>
        <td class="nump">0.1<span></span></td>
        <td class="nump">0.2<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
        <td class="nump">$ 3.6<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, recognition period</a></td>
        <td class="text">1 year 7 months 6 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">2005 Stock Incentive Plan [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance</a></td>
        <td class="nump">18,312,192<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent', window );">Minimum grant price, percent of common stock fair value</a></td>
        <td class="nump">100.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">2005 Stock Incentive Plan [Member] | Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm', window );">Maximum term of options</a></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant', window );">Exercise period</a></td>
        <td class="text">6 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">2005 Stock Incentive Plan [Member] | Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant', window );">Exercise period</a></td>
        <td class="text">4 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">1995 Stock Option Plan [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock reserved for issuance</a></td>
        <td class="nump">5,746,468<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent', window );">Minimum grant price, percent of common stock fair value</a></td>
        <td class="nump">100.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">1995 Stock Option Plan [Member] | Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm', window );">Maximum term of options</a></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant', window );">Exercise period</a></td>
        <td class="text">6 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">1995 Stock Option Plan [Member] | Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant', window );">Exercise period</a></td>
        <td class="text">4 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period of time incentive stock options are exercisable, from the date of grant.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodFromDateOfGrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum grant-date exercise price of incentive stock options granted as a percent of the common stock share price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateExercisePriceMinimumPercent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum term of incentive stock options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the aggregate unrecognized cost of equity-based awards made to employees under equity-based compensation awards that have yet to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph h<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total accumulated difference between fair values of underlying shares on dates of exercise and exercise price on options which were exercised (or share units converted) into shares during the reporting period under the plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph c(2)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph d(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Organization<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 1 - Organization</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Novavax, Inc. (the "Company") is a clinical-stage biopharmaceutical company focused on developing recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The Company&#39;s goal is to become a profitable vaccine company that is aggressively driving towards development, licensure and commercialization of an important portfolio of vaccines worldwide. The Company&#39;s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles ("VLPs") and recombinant protein micelle vaccines combined with a single-use bioprocessing production system. These vaccine candidates are genetically engineered three-dimensional nanostructures that incorporate immunologically important recombinant proteins. The Company&#39;s product pipeline targets a variety of infectious diseases and its vaccine candidates are currently in or have completed clinical trials that target pandemic (H5N1) influenza, seasonal influenza and respiratory syncytial virus ("RSV").</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In 2009, the Company formed a joint venture with Cadila Pharmaceuticals Limited ("Cadila") named CPL Biologicals Private Limited (the "JV") to develop and manufacture vaccines, biological therapeutics and diagnostics in India. The JV is owned 20% by the Company and 80% by Cadila. The Company accounts for its investment in the JV using the equity method.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 94-6<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NatureOfOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EWOAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock-Based Compensation (Stock-Based Compensation Expense)(Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
        <td class="nump">$ 493<span></span></td>
        <td class="nump">$ 542<span></span></td>
        <td class="nump">$ 1,668<span></span></td>
        <td class="nump">$ 1,677<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and development [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
        <td class="nump">219<span></span></td>
        <td class="nump">176<span></span></td>
        <td class="nump">638<span></span></td>
        <td class="nump">449<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">General and administrative [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
        <td class="nump">$ 274<span></span></td>
        <td class="nump">$ 366<span></span></td>
        <td class="nump">$ 1,030<span></span></td>
        <td class="nump">$ 1,228<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph g(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>28
<FILENAME>0001144204-12-060842-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001144204-12-060842-xbrl.zip
M4$L#!!0````(`,N`:4'K7P*Q2Z$``*[Z!@`1`!P`;G9A>"TR,#$R,#DS,"YX
M;6Q55`D``TUPG5!-<)U0=7@+``$$)0X```0Y`0``[%WK=]LVLO^^Y^S_@.JF
M/<TYUMN.++OI7OF5J->VO+::MA\A$I*PH0B5#\GJ7W]G!B`)ZF4JEI-T3W8W
MFYC$XS>#P<Q@9D#_]*_'B<=F(@BE\M^6ZI5:B0G?4:[T1V]+OSZ4.P_GW6Z)
MA1'W7>XI7[PM^:KTKY__^8^?OBN7/T@_XB/!KJ0''4)VI^8B$"X[6["[YN]G
M]]=L'$73DVIU/I]7ILW'0>!5'#4IETU_,S$[K-0KC09+GT\#Y<8.#`3O&K5Z
MHUROEVO'[']9^Z398G<WNB$.QP"_'Y[`]!_?EJS):"H5C*J-6JU9Q=<#'HJ2
M:>[/^&.NN:]F')XAN"I.6&LW:TEC'$IN&5SZR!TG'?QQ'$V\7/MYDUK7V^UV
ME=ZF35=PYYKBVZ2I*S(,-'\HG,I(S:KP@B"7:_5RLYXTC\/RB/-IVF7(PP&-
M;%ZLZ=)]Z!TVZJUME(8*6Z1<C"?K&[M14(T64U&%%B*0C@4*'X=K4=&;55A%
M&`_"P-A/R*V3T!F+";\70T;<.\%1WY9".9EZN$#T;!R((8@QK'<Y6>O*8^B6
M6%4/!!P]Z4R$[\*?Z,KC(R;=MZ7<DTJ]T3ZNU++_EIBC_$@\1O<X]C``(4](
M@?]%ROS4+L-<RWVA]\]#[H7BI^K*U!FB\S@(\*$,'>[](7APZ;L7/!($;M/+
MO>,LE^%ULZZ1;IHU`WVAG'B2-KD#85#N%3P+"?7&MWN'_>^F1KQQQDV0D:I-
M@--W>X>+K]<!3F=<A:MIL65B[9L7@:I?YP'G9EV%VX=]F4.)#_8.KEXK_SL/
M"Z?)T%SZD8P6Y_`\X%[7=\7C_XD%P5K[9N_X:K5:'?Z\:1]JE&MG78&K)A/E
M/T3*^?@PYH$(>W%$]AE,L(U]2S,$4]],"`_+:JBQ`P>;]97FV"'VI6[]JQZ^
MQ%SAR`GHL;<E9/UAJWU8/SQLY"C;@FF93/`I1'`.PC-2@;TFN>=[7Y&.XP@8
M'X9W&<UDP\]-O8SW7HQD".OF1[=\(BS`^1=[1WS;^]#YT/F==6_/*S;8_+09
MVG[`D=T/B\E`>00S]V3_^`"<QI6;1P-"(WS2<5T9@1O(O;[P`6]W`O[?3.!V
M[7B>FJ.-UR:X0,-*O7G8+"#:=?0I$?)2\R71OK#%NGQ4^KE9H__\5"T,W:8T
M=K#U/8C0@W#B`/J*\(X''[@7&Q*WM4#^-@IMVW0Y&KO0=E3/T;8-BDT4>/%P
M"*`-?0?>GB%D^>F^!<NB!&P-S6/3TP`55&FEM"RCL?"?\ZF,N'<MX(#0&WAR
MQ)'LRS]C.25#%@?.&%ZYVM$JV/@%J5U:MR;(9+N=+5M1A)^#`^T\#8^A//$E
MG(VB(!;K&5+/,:2>,:2]G2'F/!7*=:<I."W4J[_?7#_0X:"<'=BJ&YB@G1?I
MW/$%TK1"]])[4"+-+?O26NSCW&(?DVU=ZKMML4&=OFDVCM:L]!*B#72%O>&U
M"$,A+H=#`;M[)KH`$^QP=)^>)`HW1^1%-*U%Z!9-"W*3V[\@UM#BS3I:M\.R
M2?=X"(U_XP&:P5YP+T?CZ#:>#$30&V8Z[9Q[GG#/%I?<&>?;:HX\=Q2DO/4T
MHU`X6H91K2V,$L&O\(/-JSKR*N74<^'F&"A]">>.?B"Y=Z["*.SZ#A[ZC"K8
M^%JKL,;AF]J;2CO;NY^@!->,L<V$-8YM$[89H$VD=DK)'S7,U=2M/G_QE43'
MN9*B7P6P"AM]:;+(G3@:JT#^E:S-QM<O[D74<B[29B"%B`%KK8+.*!`BT\0%
M&W\UA.9AY<C&DYX3]44P,:1E#T!Z&H7W$&R@1LYN-LK0F498MX=^OFN^N4EQ
M9W/NCJVU!VRM)6R-PR>P78A!U`4K'N@S?8)P]3'NP,-"EKF]1@,M]25LAXT$
MV^IL.813%<HHO(*%=\`W"NF8T!O>!6HJ@FC1\=W493+8BW?XK,[ED2WCNZ#\
MG-SX.SF:EX]3\%J$NVJ<=-!@XVNMH)Y0")NTVHYVM)D["F[&9-'UBY)^]`$6
M!#PY,%>.H-Q0;^ZCF]&+QB+0!!9HMU_-O>Q:DKMT;$@K@,:BD?Q/]XH[TI/1
MXN'/&&SSE5*4!$/:MKS'2,.6F%LFE_6<7*91BBT!N&4"04^U#K/5VP)JF;14
ME:8_[?ML\_/=4?O&!K:D.*\E[&L7<-[P")SZ\$*&CJ="H+`/<YYY8%TUP*?;
M[3V4]8,7G7Y7+E_TSOM_W%TRS.2QNU_/KKOGK%2N5G]KGE>K%_T+]OO[_LTU
M@P5C??"K0Q,AJE8O;TMLC=;HW^NL8!T[FW^6(ZMGQ8W<$BN7?QA%I__\!Z)P
MY0Q_8-:_#;B'B`?15<!'J!IU%VHU96&T\,3;4O_R]WZY>WMQ>=L_837IG[*;
MSOV[[BW\,(W@S^,IN^KANX'R7%;'AWTY$2&[%7-VKR;</]`/#M@#'#J')9KB
M5L'YL<'*+%T79A8&)Z].-^#H7'??P<S_B<-(#A>G+`^N<K0%7E%D/_#)]-0?
MA-/3+XVD/Q8,G,0I]Q<$ZG^:[=.0S;CC2%\P!\/@+AQ@0^;HO)JW@#WNB@!V
M]DQX2EO'N?0\%@A@<B!8*$>^'()&AA<\#47"ZU#PP!DS&#+760R'*@`[$XTY
MV%G?\6)7,-@/`D1M)M@T$&7'J'CJF_X`J"+ICP[H:2!&L<<C#,OS*<8[H<$4
M75P6*=AADPFH4;`/+`Y%90/13R*<\`7S5<0&0&3L.'#<'\8:$PS$IB!M?H1S
MK.%>TI4BL0@)Q^!#0;U%$C(`\BWRT)Z%%78Y$SZ3PP21<`^`50!UVS2!<`2.
MMXXKP)(<`;"B8&V2X@;$,^'!1X')!HZ`);33BS-7,>P^\'4F<!J-,AXB/>@"
M8;@&)AG*B`^\A6:SQ7J/QSYP5PV)70EZ&0*6P7^``3B,+3R!##^&1B)HG0=Q
M1-1Y$@``O$@=`%8_'H(S'@>8:<)\I"C'4XL,!O.(*;D\E2^]V;Z>;?\@*7\1
M$7^!/;!'#W)+.N;TBN(2>H>AF9)^C,*@]*N#W'*!H0OA)5HP(PTP*,AO)X*)
MIY'`8`]KU@ZH>&9Y,AB>AWKGT3]0EX"PPH8*46!>U6N5%IN`FL'*'&P5PC$V
M*D?D&O@ST`03:CN7$8S"AEP&(&&8P*#>K:QWA75]UG,BA7!6H01<8E#Y52.;
M+AH'*AZ-J5D(F'!(A\[5L&IH^HD?L%91;'2=1J3`M_SQ00AMA^J-U]_D+T5R
M1J%[8NXZ56R,S1:AV"P#!YG*(`%'7>B3(INA@L)!P!%0H',#8STBZ<@I95<#
MT+$@XL;$1:2_]&%?2Q8^@6,@>#-D&$`0W@ON11KC^QB(12)GJ#(/V)E4$^&2
M+N^X,U1`+KNW;<R%96-,8`:0_5AZ__Z!G77N+SJEUT;QPF;D<QZX&$?SV948
M!.`O+U!\ZP=@>,)0#CS2O8X0KMF#**JT>3:PV)9@32]R"W;KC=:;W3",*<OY
M0`-EX2Z$CDV311K$(2CR,+1V?7Y/#80G@510*!'I%>["(N!:.#J`CI97Q0':
M&3[CTN-(C&53T`QYW(?3#_.09<8<#0'UTCP+!8^`*TU0.YGKD4Q#;LI`))X*
M\1+[#V,\:.&,QL82>6O,:Z()4AMM>0G+IDBKS,3XR;^(,9M<#SZ@8Q`1/8@X
MX`+[/+;=IX2&O+F<<7!Q8EAPF!;4S<FG;^LRG,;7;6SZNXXOK`VNL^5/Z)2(
MEM$`T*.6^[T[&KFXND@`E<]Z_7[OAGK#D4EX7CB%PR-6A-;TSU/DEOEY+MUH
M#(?J6NW[4@8H2-!\N+SO=\\[UPE+(C6UFKE)L]^Z%_WWJ/%:P!EJL$1LY*[I
MA925KSHWW>L_3@RG3EDZ5",WU$2ZKHJV#+9FX:CW2/BTUT#05G56JC\R[947
MF_4:`78;^+D3VO.K"G!9K5HBZRC/PY%!G;C"XPM2I'(RB(-0:PPX,\:)8M""
M'=+8C=H1H[`-#(&A)E>$3B`'>F>2U3Q"Y:'FI[B=EKE4C0+KWRAM+R[XS[&Q
MW_;#"^X'=-M0,M$FA+N9L_S6&"BPYM@SM6KVMK".%;`OM'(.*R\CF/]M+M]5
M'&#D,N\:X($U%.+C.E.76-MI//"D@^?6#3X<S..*`3@$TH=5(J<.B\PB,8)N
M')SX=.U@'`PKH'G&[/)(&(_15W[9E5Y,A_`1'-$#GV0C47[0!)4<'RA4NM`F
MWQV@A>#KH;T?``:DPSA><$Q/40$4\%5]&@#/14!^Z@#I4\<`CNG^JH<Z'POD
MW"HC#K1+X\F/PEOH4_T`H_L8A8`'*45&Y8M'21$3[?2-E>=B^#N)7V2\4?GH
MCD4KK5<2Z%F*`(QP)CAZ!YBOIT,B9_K.1(0C1L(9^\I3HP7Z<Q[N+/#B?-IK
M&(7(Q4^PKHQ1H%LW6F^PGM[<!RQ+X5PK&"@[C[5>$^56<1S+"ONL8UOM]>K!
M&(,0(58M",TZ6WC!Y9/F,`IJ@_FP)2RY].&1DR>(8D+2%7HD("0@"-K%364G
M\5TS!QED+/,O8;5-G(-\9S@2X3EHB*R&EW#FS1T#4.?%?N)F&P6WW8$`W,8S
M7=VI!^C8$T".(8!0GPY6?7M@]Y*\IIXX^=[@.AS`(PQ$Z<.V`R<`V`>TP01&
M?7S<_0J<<G@P40$=Q?49;T/H#G@["C@R`]Y44;#5'(3\+SV!"D;<-Z[YLG^C
M/2P3WG-A:BI<-5&Z8<`QQXJ^_K.B2ON*=&_4\M^5RY>^FP^]4Q,[6)_\D&1`
MGLYBV+D1V%;I?KNBD]0-,&L23TS95WAARD@+M7S1^@C,'!]9*<1"B':EM>O?
M@ZD`,=(7(^*@./$K75^:&X>[,F,%X;.XTQ]#ZT]D#_5]:?[4CUK/81!A?!Z'
MYNI3^3-77SMWYFHGWMPB<-V]/Q?>3-P`,>.P('\V]/[*>+0!Y4Y\NA<3L-,N
MEE9F-[0*<FEMWY?F4;.]"XO60K08I%U"=&ZRPM(>.*7@/'@W_!&'`L,64ZP5
MF;)#^[TG[^_J?QBZ=T!1E%;-MN*TYMOOG]9V[:((L7D8.6)#<$=,?#V5D:2V
M/S0$;FU3:8"D/4D4UMTUR\UEHI;[/E6N=&A7*ST!;!.98=JT,U&Q'V&UM'[1
M5V?B3I\<7,.S50[LU/VS,J=UM)$[.X%^FG'Y$IVG&GVKS]E8G_-YCC+ZU%VG
M^8<*@\=6&/&WR^Z[]S"BCP$YG8`HTPD&6U)WO;YI%LZ*\U$"[YR[<'S^TJ&P
MKR<HU\4@@N\+NE67Y3A_^6"S*Q\`$72O!4/T%.*9:(:'"<-Y%GN9CZ4SSO7%
MP[0>DW'\HH".]/\2>SJ7B6$`JOS1>3W*[`X6=.!?H`^#`14]:#H=!E,&(HFA
M4`C-3)"$,Z2%J<)^38,<@9A1T"T+E@RP/@RC")A!U$1STD`89DAGW#*5V,P-
M#+ED0:]7K<I14E^0YRX%2*8\'1K?355@A11UVGO(,=RBT>G**7M\C)?\&6,,
M5;%7X(OE2B>.:M\G0Q4:63SJK+(]$"8R=73VZ=H.8%EZ6>]5K7*8@L$T9\(H
M2ED;FJ$YAO-,JBJ_?GT[<.:!NM,R,_4P&F3)+)OS!;U+PXK>(HDM4<A11]:P
M'BJ]+YC$B&P1A!V#`3*I7.;JQ.ZJ5#M4%Q5'TL/`$B6X$KKR@%%8DVB?K[)@
MWP$;J[F8Z>`XCTS@."D[2T)_6<G62CQOR*5'U/IBI(!83)HS8+D_$CK)C4S,
MPKA+&YH*J9,"O"B=SS!&1^?"*;*$YRI^+.FAC&`:FMQ<MH$+D@DW[F<,D&1R
M9XM$*C4O%&$KJ"/W&EM[ROVPW!G`E)1'4TWRIJ+C`NV^.35?A5-38V4P,%:1
MR`&[UBDE*M"$_=(;#O&N>K*>7]H[P$D'`:MFTOQE795;S-28NKWZ%J_$PWV0
M60T81UOH5=5-+77"`C,UD_SJ>/G547IU,-%.:O4=EW078Q`'T!A<AP48)%>K
M_&4(J=Y'+7N`]A43;2;#I7.8G*JU?@$(6-M57V=,PWB@!R9S2>49I@AK:$0&
MW!G\YH,NV<1T(&A?7;:M.[HR`&4//Z8C(&:PGECEB27"CW!(BS`]TSH\@`,:
M:&S,XH1T08,-A4"_#LTLS3HU,1G2Y-KP$7-,PC$96B>J="*K,PVD9Z@[M/TQ
M\L,23V3%6%TG0VD'*66F[3E1Z:>FGTDKK\?3O!X6@S8RU\OD/NV4UI/=FVGG
M'TW=BYP!NS3*TMIT8NFUEHFBT\C05(A/N00WD^L2TQP7,$5MO%B,AB%CR5LV
M[%N2/L,;/U=IKF^G,ZJP@VZ@X[^OL`OMX^`8/A:_372(5;OJ3[EZ6*:(!1A4
M/ULY3AF5N<=KV4,5N0EO\B-FCJ.U%46:TM4#XP+F*25Q&@M_T^[(>V72OMP`
M?ZF9+JPB)F#Z-NF,TH+N;(B6A8J<="U(TO@>3.T,:!:9,D@[)Z<AO3*T5@)+
M59+MWM0[HK7LZWR*DU'`([#]#',-?^VG5;KZ/H;;];M6E36Y'3MW>]D+=."5
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M=D'!%[P7FK^6QWZDX`&U*[W6=^2F4_P(B*"8>_(AW2M*6E"WB8PB(4S']&>\
M,$AY!1GJ&]IZ:CH4FSK9J0+9H[L[4E_EA463@.D@JT-V,3A-07_AXPUZ((V;
M^N\EW!0_F>I+[1B^M^O9J>(=@PTT4WKD-L"1QH&`(SK//A$V6%B8D0YKY#6U
MWOJ"(VTF[IC+QEV?N8I*W%4:23`SAB(*EW-Z]!FSY#H^B+_N8_(]2"NF?W)Y
M'QWDHIFQ%EXY<*XD-E#VS]1AZ/=T=1X'T_,0N"R$LAH^R2=6_4+E[9OBFOI>
M!2;R,#@"[4<FS//JJ&;GWT:!"L/LXJC)Y-AW0W'A[!0<R-#4X_J;`/1UAAG=
M0-0D9ZTR8K*<:BT)@H!%43K>!2TP=&A?K7XV8OVA`+Q3KJ_^>L`.$5$S^G*`
MN9_A9S=DM1QH$34RL7S'&Z.?`T&W(_!>!N"VLY2P1\?"&^+W%DR9.'4$"DP5
MNN82AEVE)]PL2O5P>5YA5X8#NT?<4&;9L952->BQ[!_8J#\PFQ-'N@Y?:=4R
MN<22^S#V*(H%_'U5/ZSD&.Z+*&7WJ4DEZATD'BF4$F)6-XOVF6]/T-*#`ZE3
M^PU:9OL2?[+W`FZJ`#Q<[POHG$;X*^8S!21+&IZ)@V8BM2)XR:VA-%?0VI25
M)N8U#@_:1ZV#5OW(6OEEB3)?&#%TK4K@JT/PIK+4^*TRJ,:P`EI%H,!D8="\
M%E@FX=MG`NR<SPU?;!)\4"AP7*$LQ9:U0Y&9PQ8=PM:3=(T;6MUWF/EZ*V;D
M>))IN+X^I[V3VRR-QI;-TJC4-VV6G#[!WT&3JHXT;IW%XY^A/_[;[I\4\?_M
M<P6<RMT8N]!72>G+$B@F`MP""O\*X*C$+\718!W\CD+8T8[)HH_U"DO'C_V-
M]^V4\HFGE+VYWD.%7@;MUA"M=#R98+9%X59+EC'1\;20B<NZ2/V2(E;Y&1]>
MV`NMQ2Z=FTO7Q[7O3]E9[_[B\KY\WKN^[MP]7)[H^ZW34.PP\U/7S@O<-!^H
M*%(3PY*+R_/>?:??[=UBA:<OUMU!7]\0_G\>X&^6TG\7OIM^U[FXZ-Z^2R_3
MUY.K^&FE*:K!3?`^=5;#^V32@8<97I@:K9I,9C,,<LCYV044+"2LB8^_;6`=
MP,WRF4RU[D,(S<KQ;E\IV+R@NWD7WT!]9:`(`*A.Y8_P1YUK!85*$+/G7R]B
M_>WR[7"_)FWQ34<5%)FC2N/HA63F#J\4H-SL6<I?$/)O`K_#(-SRWP>R^84X
M?Q_`[_`W5)3QE\G]?3!?X:<1Z7<!_'][W];<-I*D^[X1\Q^P.NT3=@1)$;S3
MO=T1LB2[-2-;.I+</;UO$%$4,0T"'`"4S/GU)S.K<"5``B0`@A)V9\8B"53E
MK;*RJK*^K+H+#,+H^!'DI[/S?WRYN_G^[0*#UYN[CY+U]/B^T^XU.OU^`_[]
M\+,4'V5N@#0:]M[%L$$O!`O9*4XT/3-94J)E^5UJEQLT#IU-'0\E:<<V"(C%
M;T1`/_6[C6ZW6RP5^?/^TSXLRZU!(0RG-="7F>:P+%89)8F>N8LN6)_0^[`U
M6#3^YRY"W]W*`C?Q\NEI+Q:R&$O.E)?AL])9!^8V5L@X,GJ=BAD(S,=RZ3:R
MM]OX68J9KN.M96I:4Z;%&LR&J;^0U80GP>BN\MXM^_J4,HSX9"GNN'HK5FH;
M;+N:LBK#94:IZK3ZL8%K7,2WOMN;7MO4SW[ZIB8DU<2;/[D/E.3&`_KOTQ';
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M8INJ=9/'N$FZ<;W#N!D%=3/X6NMFWW&SMVYBFSI"W5![V+37(5[B<='C`U`T
M973$T8L"IA\;,B1A'L6]MW%+4<Y)5VE8>_TJ&^VHLNA[KU%EHAC!`U7=S4$S
M@?;*G'GD=EYA08"!8Q-S\9-(\6(.`9G!>WA@=65\QHIR7&[)#Y2'JN1AZ_@[
MF<ED!=G#$]8_"`S3L2/7%&-_JF\<5@$7920U):$:Z5H3E7+3Y(0G7A&LT+7N
MG.YU"]#_]BA\L7L"_^J,XY[PV]!T8YK#UGHU,?$"YZ`Q&,%_^VT:=M"^!SH2
M@K']20Y@[:]?T;Y4)C-J`,<)PJ8P`O[`D@-T<WL="()@T%^$=A'/7&"4HFR2
MT",X3(L[6D\^1"^9=UJ#$5TR1TKXO7'W8<3;P/*&!@=TH=P2@IR8\"J<4;B,
M;J/;@_]V$FGAV!!,!`L!(KJM0>"F.V?48NZ3E+[PR)P7!&T)HY:VQ_0P:53@
MF';W`S%X9>:.O09KF8B,-LHCHB<RPNZ2N-<QL&&(F!:^@4C2!"VM&1.L2_L>
M(?X-FWT@27BU4C1>?=7#&2!;,1>,XP_8;@E[,+\95H9]9I*.R!=;N0F6'ICB
M=1,JZ(J-N\-&=YTB?OD>BT)\"&$R!TM-$.3"PL59;DEG1&82,LIZ#YY43%YV
M]5'1.7S0C($G0,SB$'P)F3T$#X'QAPC+DAG,"A0`3C"45-P=#HDU8FT[I6#%
MSNV!N."!8(P]!.4K`>;L;8EO^+TE=WOR]@A!;LJA36SX#T8(D7>WI[JTVB/!
MU`::UC@+X$3[17E]QN)^1MJZR7P%H/`\5KK)K,3$;Z&"5<ET!'CYO@!I&LXU
M%59F(J8E-F)_B0+[;>,C`=)O!VYBR>&,+.WFDZ(L/IY-)ABHVB)2/1?`VLA,
M_$]%%PWL=-I=XF`SA3EPD=*J.@0W''E\*Q>#7G]G+OP,O6_,B>,E[H'"]=(;
MC&,YBB,F9[Z*U)0\'L1K*A5?%J/5[APKYO!ZTS=3A+6A%LX,]19F&6TYMZ,H
MZ[N]>D09LP>546FIMF!PPZCQ[$#SNLB63'47F!JS(V,E_M>B'<"@W977>(VE
M)#=VBASWO7YGM",[R_D20>W4&XS%SX.!]!7%Y=<038//N)D^*#]<)K.\4WCM
MXG9W$&4]"WT'$4B1MC#J=G*4AU<-YE;1U"O#Q:,CON-_*[P<O"SW^Q%KCZ<D
M%U:*5%5WU!WW=F$%XO@)*C1^O_J2+Z0Y9ZD>Y8F3O>Y(;O4&\CZIES%M;`S$
MY$@<EHK<$J0Q3"N-C8F,&:4A#P?5E,8H@VTDAV<9I3'HCJHIC7$&VTB.RS)*
MH]>KZ$@9M#K=?F]?OQ'3QD:_,>Q54QK#M-+8Z#<R2J,[J*S?2&\;&XYNLTE#
MICV7*HICG,$XDAU'5G%THFN#JHBCM-)0O7&WFA(8;I?`KJ6APA+H]SK5E$!Y
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ME>X7>-K"<LP;XM96N]-KR:-QQHDM>H=KO952)[;<!-+=52`1(WDU`B$+&418
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MX,R7OH9]5'1K4V'Z,1`CIYA)^6"D$1FV8YG&$W[TDJ&(4/_[JM.-N5N;2:[R
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MQWNEC1Q?9IK#]@D7DV/?`-V\H7/36I@4-:KLT=DI=(SIK;"51SP31?=$9L.[
MDKN-SB"#Z\Z@BEW&R9N2?:\6^R'$GF$RJ<6>LZ<9UK*O3;X6>RWV6NRUV/<4
M^R$VKJ.$=UI]H=('TU'TW27@-[2SQJ@)2367CSI+:QX;UIU[]A&<^0>-07>P
MIVR*'):O6OB-=BW[`\E^#X]8RWT?FQ\V!L,,&ZRU\',4?L:S@%KV.<H^T[%"
M+?G:U1^]W#,>=N0D^^#2XY2N$WL?-U]SCB2G\G];';KNS%->,=M'PF*<VF3_
MF\[_W6Q>&FKX4CH]$KS&[GY(`XOF7?$/8P=\4FS-OIF*.N":\70+*\?)BO]O
M&#X@W:,U@D!J!('M)I7:C/1@_B%^8G/\BU2&%_QO+68#:53_ABR'_TY_;D_I
MCJ6>OBSIWG_IE#S,F*1,$"-!,59@ZM+24):JYC!5FFJ&8DPT10>:%(=QB(:9
M\LRD1\8,:6&QA6+!<YI!+5@J8G9(+YHSD[X;U,(]OF=+7YC!+$775Q(,*;R3
MKDK^V`*-:=#+0H<'WY]\.3N[/?D@34T+FG6`S'F`#,V`[^>D6@)\<(!VQ`JQ
M>":>+3FF!.Y@#LPW_Q\]<68YVD1G\`7:QAU[PO+/^/I]\Y\MXOU1T8EL>\:8
MDX@OT0B*`)XP%\`0[Q-)14*<F<48=6IH!I/FX`IFML0,%>40#UA!&!4N(^$.
M)HH]DZ:Z^>)WD+%9B_FJ;$B/2P=$156B)-"$I*AH5+R[]^"V8/20,J!K`V6L
M2Q8Z5`N_"SS[`2A1'"+GG)N,1"^KS+(E@TV8;2O6BDA6I"EFE2X"XQ%;QU=]
MC2Y,[H0:KD2A.WAAJ0-9R(HOA@9^OV`3+'REKQJ>5.`US51MMQ^FMJ0S'1$^
MGF8A,A^9KK%GL#&/`=5#S;0E0@6!!N)M'F6IJ.S?2SRS!QN;*W\Q87R^07H$
M@``=::[9.E,03Z,A39CE$`Y<Q'RGING`L^%FN/1AJ`AMT?"*I6K3^,-A%!BJ
MH",5"]BI$DC-G&L.DKE86O92,1SD")FQEC@$D3#+&R>VJ[+P@/8G6WK^\L=D
MIAA/)&Q@W$8^WI_<7YZ??&@=VK]5Q]/>";NFP6&L//_&+9B,#"W''44:V8"J
M310T>=2#%6E@NG0(PC;<#OSHC@TP$PT>6#'%:F5V]#:,(0CS'L$PP)#1R,"*
M_K4T>-(S65EX+`<'C$&C@$8;LQ@86-":`\.2M/-_NN.?;>G,,);0RAU;F)8C
M01>N)_^'QP\R(ES?&BA&-D/++2#).ZQ-%WK&1K;!R.?,4.^U)T.;@OD83J2U
M-;BL?1JHH^`=<;0V>!1:7Z5U*]]P!NE*3>E^.9_CY(L!C*^Z4*0EE%>QH5*O
M'8YT1JO7#O7:H5X[U&N'>NU0KQWJM</K"8B^VV0SE]#A',=L'0NEBX6X5TV8
MK@(FSL<#^FW-606<K@73A(93"O2A/-'#WI3!7&70`%%L>SE?B,`%)R5E.H7Y
MC?MB&@4(H4O%WLD-*[PN-[ZJ:\JCIOL.V)_**'8P*;#"GI/>$3,@SF>;F'1C
MDSAR+)A-C26/>-B/!4XOMJ0N*6+PW\%/W#'!O#QQEA18<#<V(?^B:L"U):%8
M+(TF/EQNBMG8$U@]NL.CV[_L+WUE"BJ>%);3(,^1_DJ-;3<65!8+'8=!8!$"
M@8VA*A8$DN>F2LMNAT<Q9_<0Q4@/YD*;2*,.A-E;E<!QK/W@,J`4'K;Z0XW/
MDT8S\$WL@-W+_(]79R![E#FYMR6BE$C/(&VN&8=-9H;V[R6^8B\G,URZH=N9
M*]9?N)!;+"Q3@:_?4\1C$12W^&UA:1!B?6B($!X>8('G11Q/79%W],(L>A#T
MYRU*/G@.<H)EH8-]VN3UP0?JRH2O%6QF/4._\#9B=CNTQZ,87.'8JGB6)@Q\
M_P,/V3QO+"T=#:%=;'=EQ0F<:;!NLB:S%9]#@#<3(_/_\-@+J%XL'5H8QXE.
M6N*:`*<G;K_!AB&L-,6B]A'8`GL$AZ_;G*JIJ0/_.'`TI.?1TMA44ID]L;2%
M/W6:MKLLYN]F@VHO!9:==])\N+FECM)WXM+GI7C`&ULQV2%.4)W9+R>(`A](
M`T]$6G;,``R<GVT2*RYQFY;[Z6P7B#^??;VZ_O.C=+^:/YIZ.$UE0_M<Q'--
M5<U-B$$QK='KUV@3DOQ1NGG$L4%:$>;J#NA_+TU:J=*`E=[#BH6V(ICZ@2]Z
M:67$1S5?%FDJKGDFOB.%[];\:+H$F]I,JF0FG8_2%;<-$Y>4Z.R,B'GP&!I#
M8-^>W)6CYV5=8U@U)*912RI$ZQ,'XD[:<G0_D9NSF;=G%NX*F[6UN:;#>C36
MT&+,$Z>*]59\@TW3I-N6QRIN&/!^:M,^5M/N?I2^&^::#R0=6VRJA]>$..>B
MR3C!O1/SQ0@N)[/8PAL))3]OB;#="$C%M3%%02)8%&$@R#>P(_Y(ITT9"]G@
M>+7I?`\!^G!#VGRI:]GD6\MFR]VZ<2SH72Z5)^*;CK^:60+>8!(Y04/B>(/!
MXB7M+<B".#AV+$A3AGS>HCIVJRQ3G'BRE)"I1^L^YA$/`RI65961PAL2>NT(
M#R#T=%<`:Z'7[N78A5Z[ES?H7DH&']G&R/7E9_ANW.KYUQF#L.!+0V66KADL
MLCAM\C?$J0XMP-/*=6>CC+UKN6]#_HW0`Y)TZ/YKD=0BJ452B^3(15(&K/!X
M`QC`ACDU!),<-Y-ZAQ'=GCA&B0`24X+9'L4M-A$>QFW>'?HM$8@A5IMK_>:&
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M<#8Z4P-?"E`]]^F%LJ*X@$"9?A"*7-!SJ4LF<$_A*WMF6DX3HH"Y9"@(]M22
M/BDV7RP]FI;%EUP61^YS:Q:YL*F"!XXF%?:-!D%@>I00GNT":RZ!R4#[0=I`
M)`B)!\Z4L#FIB6/%3BVF^-0]*>D!E71E/#,!2'RD(BJ`DGO?B#5?/O$.7!*(
MSVBDP8<)U'(^9Q8'9U86S&K`-VYF,;=GCGE&8-?Q"<:(P*P+_`R^6/?A@F<*
M(M1J3YJAX"..^_V3Q1`!DN/ZC-N2JJQLCEH-(]OF7T,8&\2RC>^<HQXK0'Q@
M(/[4;\G2'#P&O-`*00'.%!AUNF+;L.1AJH"=#+2F!$9\$]Q1TU:0(<T0J&YN
M.W-E)1F,@ZGIVK^7&F%KKC6'.*'"]QGLAQ-D)Z:7`!D6(^>@!0!*.'>HC:4!
MTM,)5>1)T0P!;F(B8EY#TA"8#<U",SAYCT`7FZ-*+?!:IA'#M,5"@+W@5)=S
M1(1&ETB@20BJ9[$9`RMZ]J#QWF.7A,QE.^;DKQD,<F;9GG.7$!G56;6"PS?@
M3@E3"=G&WAE'JT.L)`(/180D?874>[Q`L,N(%@6^FV`"$?8LL.MLZ80(;:+A
M-#UV6R<D:QHDL0^<X*M@Y@2J3$##A%U,*,QD5?"F8B`:7[3/EG2G8(,@<`=W
MVXP`TCAX>8(N%]#-H'HP3B("IB_SF?&"#T*?,3#04^79M/C$1WA6O%F+<?`]
MBFC@??:,8%(3FICLY8)@E'U#L5'\,.8<DQH)CC<^=87G'A<65E@%:.VKCV=K
M05?L!08._(*HK5$$QB=#<PAH'J%IEV$P72&W!C[]PA")WDX(!<1Z`ME!4PJ2
M@T:*P)VNE_'DV,"GP3)!88YG(/@BFF;(/F+-0[J:)IC3VA"*>Y\+,E9^V`:0
MM9S@`'9+%P#'FD42I5\1PMU'R$XJ."!@(<&><)=&`(AY@*5S8-E4L3V"=N0.
M?;$4P/H)3@*=``T]0?2Z+@+._=#S7.5GW,!T$C][9,2->L&13@Y7HYAT6H-&
M'6RO/G"XY5>+3;77ME.%W717RLO>S$]!9=P&Z[;-?;D72_&.>%,'E%\UJ*B6
M%G>#J2I=?%G0JVJW4=DSP/1'-U'1K4V%Z<=`C)QB)N6#D18YBCJ;(Y@H1(,I
MC\RJ0O>Y:6\YEZSR&*D&%0>:&N)';EB]7V"I''>*^VA)I[%'P.ZB)OT[7W#U
M$V="%=98-:AXVW9S36OEVG".W7#\1)VJBZT:5-1Q71W7U7'=:QBIKWM^KN.Z
MVF[JN.[M&D[5X[J2`3C\C<:XE-..*+]SM@=&W'`=RF47T]TC(7=34^$$W:'(
MSVUTA^D@?5.1M@N[QR4PN='N9CAPJ066[DYB+2QJJ]?HI42NJ@56^Z]=!#:J
MO5?MO0KS7FEQ]_846!DP-,.XN]IR'-V\H0C>\"ZA8Y'W@;8)/[_[05O-AG<E
M=QN=00;7G4$5NXR3-R7[7BWV0X@]PV12BSUG3S.L95^;?"WV6NRUV&NQ[RGV
M0VQ<)]^F?C`=1=]=`D7B<FTPC]QPN3;._(/&H#O84S9%#LM7+?Q&NY;]@62_
MAT>LY;Z/S:>OME,+/V_A9SP+J&6?H^PS'2O4DJ]=_='+/>-A1]FHK^5@T%0*
M$.>.V8ZE31`DXURQ9YDHHB]?Z[W\AU@(`\,T$/26XU=XDIN`Y`B5!;]$C`X"
M_'#@<>@!VE].E0F"U!A/#4E7'O'$R[16=%/?G$XU1*I:*!/"BOBB:(@)83\N
M+7CXJV*M='QLNC0HQ8JP9.B:N\,L12<H$)TY\('@`"8(6N$T\`QO,I,0UI*`
M`CS\")4M3%L3$"($I!$!UB!(*1O1522\`X\_-1+0'*+\"ZP7@JKB&`8<5HNI
MO#H3-7-[]O";I#Q9C&.`O+]G3/IF.DSJ?Q!8'`0"XH`Z0L@XB+"S4#35(_S%
MM/Y"(!7X/&?^UQ;C`#.W,X3&NKJ2[NY_EQ"(`[%?)*!7T8\5>V+[^$]-@![,
M7,5/;(Y_?6..A'FL*%?I?J98/`>2_TA_9@-%K:`0"Z`$I::[4K-G"D?4X8`I
M:/N$ATLFRW`B1$"/9QB[3TPREG29'88>O<9'L#F?FP+[2#*7CNW`\(<6.!Q6
MX`OI12#N-MR'%\)!$)83(HD0LITW2/E3"KRFVN"?<)J`5N1.8]R7&X-.WR4"
MWY?EABR/&[WAP/LV%@$,G\5[^`W7\<%PUU<-CK[T0V`_32USSL&!2"8*=RH<
ML4>S)#:=HL=$%")P`*JF+[&5>I0FC=([]LR,)8.9>V(B1A)(LQZFF>9S=]Z@
M.8PI%J).(<@4PBJ;"YJ8<#[YWKIO25\0$<J@[V#(&A--C!`7P4SWYG-;3',3
MT\;@0)O#%&Y[F(U3[0?BD%DXV4],P[$@(D!<-9HT<2!"T,8,6P`\NA-6D"1O
MUK3#X',6MP.$[[>$:7!"/.:\_A#,"I'[W2]H6GUD\!W[`2$">`F!XN7^SNF%
MH<G)YU+B&%8<24QENN9"CV&X`8_;B`RVL$QUB3UB#^:$8B;^/HJ,38(QQWIO
M%D0A)O8`,9)-%0=:TNU:5(&8<NHS`7U"2Y&``#V0!X:E(/36E!$-KHS"P%5!
ME4PE0N)T6R#9>H!:'$D./_$8"[Y;@0@)NNXOPWPQCM5Q%4#)]X3Q$!!V,,8C
MQ?/'A*W$F#:"86'Y"M&0[7A`@]S$%OH2X>P0MRY@8F2^S2D$FS`B##2GX`@B
M'$M$&?2?2Q[,_F#B$&Z\030(L'FW6X'J&J74HQ*?YJ;JFJ\7TRH\=E`L#A)'
M$[4$LS@!O*K^8*$6&WS503%SI`N++=`!&`3:IOA#BKE5/,BIB)Y]TA&Q,X$R
M)`O6&B@]KEE<2/SVV[WTZ>SNXLRCK"%-F.4HA/A(E4309<[!S%!:0%.3`&MQ
M`#^N`J_#\SA8+3>4URS!$1>SBKY/#4A4U2SFBJ$E700^^3+8KL.HFZ!G@>DG
MW^W[#PL;;"6L#>/>"7KX)'&A-,#\2-`TYP0:>H]0CSCOK#YPB_+A#(4;Y@"A
MOEV@^.`#4*H1CB-*,_@P_@[.4%GJ#KJZX`"<*II.\IXC;#*2:S[JVI/B+3QM
MCJ;LS-;@!5T/'!Y8CS`[@,P$B*7H+<`=@=*%J$-T5H23100\3^X1EH(RQ0;C
M9,I%$C(&9V:9RR?RV"+F1-110EC%R8N6G8(.',*$`PT\`,^.SH16;;("&V2'
MG5-@N_;BB[G45339R.@/3&%AT.<49DJCW(L_Q*",Q"=14_,L@E[VA,0G-K(Y
M6XQWERQ[^?@OL7FAJ#@Q$-?+!4G#0-Q/!9IW<-R&%=F"-;Q`[Z0'O+#"<QF)
M<(4_2S/S!6S$:N!&B8L-&C8<U_>C'?#Y-TQKN,\@!*:+%$[-\$4)KE(\_$T/
MS)*8G!*>,&\.U>^KOI[4M^R+^8$P#JK$L-J/80GK6&P9P6.@`!A-\(0PQH9O
ME:CUQ`;=F+.!P,PP2Z+_\-ZD$,)<*;K`D_8[IR$QQV&\P*F$![$"_ST$'!S"
M"M9<\-G`XQ.@':<G#5TXVARZ3Q/=F@LVO80U&MJ^`)7G:_E@(]0&C&W<T-/1
M:7H!"8X;8!&"`?12ZPTA18^P$O'"'*^REPNJ2^S,F?-1>B]_"%*/M,)0?&]_
MH)'#X6:%7YJ`^4`\:_$R7[3AT%1TY(4*??U,@GW?^>`*A#8BQ,CU=@$5ER6^
M_X\D6LQ96@;?HT,S$=VM411<5EAQX0@ZS"@7M.?BB0W\VZ.W]@)?@4PX&LE7
M$]&^J4>0:B&*"&J6?`:HQC"=-0V'="*`M<WY(R'[DFWQY2'_-:0RVOB@"`A6
M.]!""WKG5//9PU_=\$!W0F8(?DQ,=I&>P^;PZ-8;\+9"4<PVTVFKAR^O.+9O
MA%=O@]8.:1.$L%H(U&QWK)(V;8YH[3!:R^',@`Q!V+=J;!^K](-F/)OZL_#V
M?#X!QBA6).AOQJBR'&Z':0Y\@O'[FP9F:7%R&N%1Z&\PY^&:"/R=YA(1=2)X
M-'YGF*'1X&.GHTY%8,!?=`@96_R`.X!ZO"-(VF>'5A5]]1^WHH,?KXH5M,]0
M@.Y88',NV>C:V9ZY44HP^G4G6@PZ.4>JN-D-32=*#N=4PSTU`+XG,QZ9!0"O
MQ9Y?8(;WUUQ*8!\4STE,*Q0U!_D(K!3!F"$86H#E^;H/6&Z#J`R^&W)2$#_X
M!<H(S1P?1P,$*I(./";HUH,0VF&#3#KVR*!`W_`"&P\!O:Q7#.!MTHK7$XB(
MS=>D$2CNZ%4#,'D`3J[$Y^S0,49UHIT_<,-,[/MXLQ#7JQ*[I^<&!($M+&_Q
MW@A%LK$[@BZ&N]"];]N)*W2!U8X*WK05$=XWR'\G`N>QF+5W/)/>WL3&C8DT
MFQ+;5OY977]T/R"-TYMF-A`14L3;2'!X!S;`^)0N_#./RRP%Y^(FE1G@)5AQ
M1196-_K?0P^BZ@SG.V\7T38G&IDQA6N1U8<;4(1"H?#(C)<TSIQ\CQT/ZT*;
M)^$.*8H-=QKP_C:\92/V?^V)UU3GG29BG,&>/6^1.%*]A:%;QH9".F]-\(S[
M27;"A/OBNG^_$7(1HF_5GUCCEI\6KQ`6//4`-T<>`SU`'"7!P<\WDCS"^`:+
MWT^`3-J]H(5(4"9;G02X6D4S,,CRMT7(B*?BYP2)\CV8EO0U+)3`\BO`$YVG
MZ'K,$M4T>.!KKR]2?2ZIDH[1M-@4AJ1"N6:X\O0JUP1[6AIBYYD7KXX82+A=
M450'`ZI%\*0@,.2AI^Z'4`=LBKN?V*U8OM#$*/J)=D`+3Y1>@`R>GD*1^D*Q
MG>"D(5;5/;'/2QM7,60O%J`3.SAK:NZ*VI_L!9TT1ZGB+"6@@_!^!P6^W`.A
M]NV8^'$O-]3)8?3GXX;RH&3#L3P"CTEG_FK\%AXRT2;]&G/U&?U&2F#]^/<E
M6#E/*4$C_'QV_PG&F[T$*SZ[_TZ_--O]AN0+_CQ41>Q*5!%[,!?:1.ITVA\^
M@B(HV/02W>+>"*A'>G\2Z.KD`YYIP)!_PG)L!C^@#A?VFEA4B%&$Z;CZ%E'J
MAC)G&M]N-JA&7J!*T^-*"IS;:;BA)C%-E"CC&PG-P*D+./(7,_`%[2R!QQ$T
M(Q\O,%'XYQUNHIQ_1/.D&30'_%TQEHJUDGAIC8YH81&4G87%UT2`CLTJJKG`
M62/R*M_@02<UU?FT(K:D<.>#NL7^DDI3B?DR*#-*KW(I=T\`N`(V)"4=.GBJ
MU+CRY;1M<(V"@^L*5&\\:313-*4OIJF^:%AN#41\0T8I!EJWCP/M`9<QH%KO
M.=39E5>@+&F,C4X^^#TV@D_!\'I"`Z!-[L7R$3.;L6\("<0G'"BTG8$,\10X
M?`NKU&F.PO/1XG?%5GRIOH*)F+_-1Q);2$\N^8'::C!K.^ZYMT.%%U\\CR!R
M1C@MT.S,-&TQR?/Y'89N@"!<###;YN,UD%'CG9-2A$&'"+KV%])/9PD8,KY7
M`H<+_3:V3[,./:=!O^H'OV!@N(PLKK1I.0WZH9U(Z,.OBAFJ&\N##ZI!R&-0
M!\-@EY=[%)'LQ4O\8#!)9.B^SN[/T3Z:G3:R2\)RZQ*NZ/1[(DI>4LO@>,BR
M7C0;!&N8TG1ID<K$H4SHB-5KAY\[JVQ"AYJI1(\R5E0O$HQ(1\=XMR%.@5W-
MAH^-PF_P$ZVEH^&!(O0ZUWZ@C.([YTX.?L-VQ6$(HUP6VNC7^!Y)L'51WW/.
MO9XW%ZT[=YR:+&TN*-^H'#N20#W5;$PZ6U&$Z4\,RA1K/'JUE^1^0_@01<?Z
M<4\SW'C"5"U5C#\D"FM<XL:]2+7Q?@.1!`8^3@S1R4/55+)U48(5=T4P;=O-
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M#?LCM/G+R<QQ%A]/3U]>7EHOW99I/9UVVFWY])]?K^\G,S97FIJ!^P`3Z/0T
M%9O?_*M"&SCUGRI:D9U^)XTF?8(*X_*X5&I_7N)@_JH9VGPY=W.X+K"B;X3A
MQ">+5FUWT$Y4;2)1.W!\9=R9E$MPAB'!GS#M?Z8E;5HYQ+]?M'1ZO>S"B:=T
M'Y'M(:VR!#4<["&HW&1D+JU=902O5E]&0.2^,GJ866Q70Z)W*R\EHG)O,;V8
MNPKIQ:R^B%[,K`*ZPK4A+/RN>"Z7>F5X*<GIY)3<0.%AJ)Q17,FD9I6:6/91
M49";Z3?F1'Y/*;MMS10>)+3'&46XC>*L@KRC\T:563?3S[35@&:<4GJQ[Q8M
M,CDY8LY`951,]NS,4/&?RW\OM6=%QQ?/G'.Q^T;2%D))\63A(F@/N]%U;@JR
M"N>YFX+G](N&",\]N1V-&:O`<R\5SYZ>>]EX[LI5U',_!<]M7\_]+#R/VH/H
MK)(3R[=T1G4E3@8OF#@A3.8\_H52-_::W>X@&I.D)[5DJ92VRS?HK&V`Y2L4
M'X`GH67<4%YM$%*Z!O(VI5_%=OK%S?G#G[>7TLR9Z]+M]T_75^?22?/T](_N
M^>GIQ<.%],_?'KY>2W*K+3U8BF%K/)_S]/3RVXD4LT/S<'?Z`]N2\67Q9],)
MO-E2'?5$XEOW?_LOI"*X=R_^%L3=.XKEA'?[:Z"EJB5]U$!+-=!2R3:^XS'@
M/OXW,A7HBFW?3/_@$#XWUAWF:%[^8-9$L]DMYHM[/]KB5[',W.'%EMSM#K>'
M4>U1LSVD,"KR>'B*A)GN.WP(SI,=6%RV!IV`H':@,H6`OM$]H9OIO5<FZ%S1
M=:9^6J675?HV\A4;P6G90:G!'-KM]KK=3G^+X-*3')%A\/;#F9_->0$K4]W$
MFQ;>(3675_KGZV@B=301]FL;O!H%%:E!Q\B52\TUD"+ODC-->@&5FJ*L]6[^
M.(;N`J"M\*]0?>7<$V;+X<-'I#AW;X><(>X:S9Z(VX57A?'FX94QA16E\1]%
M^EV93#`%K,)IPFO*.6Q&XV?V:%'BD)_0Z-V<P-Q4%#A=H/>A4?#JB*\;2HU3
M,?_KI_$0<^QUC,_<`*<[:,[AQ1E=JF[RI%,!MZ,8@59$7A.^IOBQ'+^QADA1
M$.]U>A(U90>[''7<+AO\97'!SJ/6R]Q;+C#*_4D>CMTW>$[5.NX)9]H%E`E?
M<L7[$P1:8B9=E`8[,^EB1BSZF*&ZH%X2;FRR)I!E"O@!#'1M?B-!%Q<*(!"=
MP^KH_6_];_('"%E=.W_F=HZYEZJ&X"NV2#3&^^YTBZ^)$$Y-'[')8\[#W/(9
MIZPV#S0J#&:#.#?NW<#XNX\<*\I#:=&,(*803Z!;0XYR;T>X68E!&0G@&DH0
MY,%?6"I@!*;X?JN`0"R?-#KK"=YN]Q5M,?^VOP>H%$1U\;AYY,U0<6[;7;'P
M]#RZ7.3"MTUQV807T`PVU1"Y"'^9,85?'W'!'$@JZAPL!*\6\5LQXBHD9>VQ
M'YC-268D4*!T;>[F+]H!(1,YQ,<:E$L(%XK`9]Q,1KK`U/)OY7+$EM`M<R\Q
M-8*]Q0?HBK(;?;`8S`#UK^4B<X^NU#&=$U%\"`D'!^T$KX5B!OZJ)=U[-['7
M;A#Y.L+<7EJ,\HQA-'OA!Y)RUQMK:['`O33O]N>4:_P'W1C55])/$'T./`>&
MW?XD#UICW[\$P3D/ORJKTCPB(.J$J4XT:[*<\YR@(%:7YV%\Z!J")-.5%8Y`
MS$W&!&F(R5R0$9PG9DQ7:8'_E6[1K>L7UP+B$@E>AD/7BO[#6U*K)LP\&(:'
MO#*MK5U?`Q^$1Q$)Q:JUYGHV.5_I/1)TTFGW(:"&=D\^!%`+V`^-Y_-3D*D1
MIJS(Z()F<<M%M99/:(RPPN6#[_T)Z`<:H4SD$'UIR('7'[P7>$.(&[58F#87
MTXNB$4$!B2']'OG>S6LD#AKPZ`A))J[?_Q=\@+IN\>M(^BI&<SPYFT#%>,)^
M$%=*5Y;&9":VI7XXX;X]Y4;T"=8'W731+?+["9B4+T#6&/(*WD"?4C1!J%DV
M>%4=TZX;PA&2CQ<N*,I,PP>K##@7G"_8LV8N;8)W436.-4,IY2X[R23PN1=6
MLF9@+,"DY4Y**JP:E[9-6VF/S'E!;^N/*/?:K*"F@1":RE),X;XZO:VN-1VF
M,2<N&L1,1GB]B,#]62'<);%E&AR(":8FGL4N4*@";@`U'>8G#DE%0-MX<!V4
M2@_VPANV(WT#T8J[HQG5(5X^P6T[O(N1@C%A"1&^'KW96A4H/`*CF4"1TD(?
M^IGV>*%@(JZI$MR+3JA>'ON6CU&,`5X(GR@;^;$(;CQBCDZ&+=F?^1"6D$S_
MITYKY$V1:.)KN(#KL_'!K[T><*%<+/W7`NS8WZV@A=7U%^E:FS+I?D)`C]#6
MM2,P$.HE\7Y+8D;I4`*^3/'1IM,H`*;'ZR_7]R?B;AE%UK:$7^$@7(877H$%
MI<,F,\/4S:<5AZ:BE9)[O7..N\$4*R$^6<P"B`/(V_P&'_B4>W`8,^D?IL44
M]PY@,_*(&\?Q>[<8\VJ(HB'1Y1R+@P`*8-,7[O`:G`VZK&HO$,``5PQT&4JL
ME^EF7-R*6+@HG_#?KV]]XMU+K#H3`+RATRD$NN)`KF'&@C<,UU2TAI8L`$:X
M+W119(D?4B90AM@"'IJI>Y/*]@YO!%R`3YJ'K2,Z]];\M@]3"V+G^P3P!:W;
M`JA>?!I\6NK\W,U>+C!.$L+@\5K8W=MN(!NC?P\1&,@T'TFQGW&JI=6NCW-%
MP2E.2T'LBG7[UNSPU.%!SE+DU1EN@V=-:#41P1(I@4FG'UR%A581>(HH[#5I
MHT5@/`?.^4)ZBP!<N*T%L4H\!,Q5`)>$8)>0=3<ND]OOQ*WI=WR3#(TH>+6.
M<MT"HU:R%9T#T<:;OQMPNGU3;UH(M=7'EM-\TO$X4B?E\WC+LR0N>20"8P#<
M:)@SAZM]'4;'=L'[!.0[0<&)\">PGO;`70)A,+8`-&&4$D#O<1$Q_+UUW+9P
M07I<9G%9B)01W+TX9"4T#CI]YE>,`R;JM1:P/.0ZH+X`M%W`3Z\QD@7I)0/`
MBT#^#1M9&(0&_"FNAER,U;0$XPJ#X[`?>M+,;08O-%RBPWQQ0@#3!59(<8]S
MZK@H%:A(["H^$A-MKKK!Y]1X34"`A#]@@.3'.3BKK>\T\)G:02>H/"EX`8TR
M)]Q%",W1M*R=SY<P6/CLC;NHYDL3QJNYM`A+3L0S8OL&6P@=]2'VS).ES#EX
M2<+!2'C9U&FUO?41K%J)47Z?7,,]+2\>BAOB!&=DB:TO=])/O96%^_HFM$-S
MV$S3U4=P#A0T/3'7MR+A?%^%+U9O)HXIP"PZXH:YKRA"!X#)7@,O3:KO\KOE
MW090+S`/@DBK*N>6;\>)O26(VI8\KDT4;K0,"\Y@MO2DFX\NZ+'-&W-G300&
M$"`Q-+TKM*7BPA`(K%M7H'/E+_ZT:T,*@CJI'JBQ\JQHN@L`%6\=0*#`@_KA
MT-X3<CE3;(\_BB10L5(?9OXP&G)@^L?7R2AC1TAX(R516@WI<>F$MS]-<6;@
MB3O0;!P4&L%0/&'&@TAO`MK!XIJ4K^3&9F+[!.EP)1=8AR"92SJ&P%G_B0YA
MN?$AZC#.;4FBO/!W\AVZ?I5I*S_5-C[,(MX0C!EF+0\#S_T1S\S"L+:/C(YZ
M7A&"*.?2&]PY0H?FFT:P4QK'IHERUR2U]%D\T70AU_W8F,1&8]*M.,'3@Q)_
MC[F$DN92=_H[*?E<ZMZ/P2.XM4ZU`^^QSM^M8MU8]XB#HM*EA5MFW?/2A(+1
M+<_E>ZW(;362-`A/R4'#W4I5H>SF=Z.H<'9Y,N'9$ORVQ8N3A=F,_I[S);&X
M5$:\*=>.H!`D$Y0K9SE>!2N<LRN.MA;+%?^M!%W)B!?1'0P'&SCBQ.3"3<'Z
MD>5A;]0>#8;[<G,3**X:RU+@@5*TU._W1IW>)BT%*,J9N>*5UN[T>]U-2DO#
M7.!&8>3+PB_&KH&N1`C8D>9"+[;*PWXVFGT03@Z3^HTY-],'Y8=+?M+O2-H@
MF9-`@O@P-D%\D(6MYE#NR%&^DBC+E<4-]P,"UQ"'L=<0-UT6B+F<V8E>WR^)
MQ?+NGW;:G2BD6DD\EG:;M"GW^]%KUNEYY*MEL0F`BV7!V]KWI8Z^[B@*$+!.
MT%Z<E#;(.O(XZM+SY:0\D,;.L%<L*Z4-F>YPT-V-$]O=+@NRX7Y9ZA#I]T?Q
M/+C4[,A`:2,#HH;X,;XG`^4-B&&W4P@'I8V#T:A7B`V-6[#$:`]:8Y^<'=B(
M:2.1F3YBIX[7EM3[<P,ATB`#-YUULZ(6,G/3E0<9N;%IB_'2O3C!N0E_6:J#
MDCL#.8)X$R%G1PY*\U"C<110+1\&2O-0,,^-HD:4"P>E>2BPH;6I>A,'%^S1
MH>OR`50M_Y3"1]`FSM(^7-],KL+-Y('4E(2J)-)5TEE;VE0.3DKSC\NK+[_!
M"P:>Y^DQ!*=,*DF+@7)0\JX,Z6SY!$_%G"<3?(@J83T6?@KO7GR9"*G3`]YU
M5;]$@"9@$7E*GCF5!JW^.^\Y17VF8U(WET[<6G1F>B!_$!,;!XUNIX]`^[Q$
M08!.#K;R[)7)^.%(_;$X+.<9$V$21>TUGI+BN/EX-K^G(V[`\@N7E(,XYX![
MXF67II;T.?QSN(](63]GC8A`9I\36U+&(G@77KS,EMY30J"YM(%7^\/'2EI/
MHG$[=&`N2/SCZN+AMX_2L/WN9^G3S=W%Y5WS_.;Z^NSV_O(CA[]9V"Q#QI4T
M8;J.&#M@%;C12Y\7>"N:?_:IL%P2?K^\>[@Z/[MV.7LT'<><!YY48XKI\"_%
M[VY+MV<7%U??OC0_W3P\W'P%>A=.1+3HR>)J\\0V)^3AMO:H*S`709N2;>J:
M&E;'A'+)XGI#*8)`##P"Q$[.J+A*P4R<.E:,I#^=G?_CR]W-]V\7J.2;NX^2
M]?3XOM/N-3K]?@/^_?"SM%T;<7.*SJ98+%<8T_@=/8\C)YE/\;#\+K4^$CL4
M;?R4[E7*S/+?'?&7-Y&ZK>/]]?`RTQRVC_!=@7?7N=A5O#OIA81+;PX'N75U
M"&MV!=I[RP+-S2S[;UF*19AE#!=O1Z![F^7/4LPLZXIVF&EN+B2:\&05C>+V
M;MG7F]2+<6W9!7:8X;%-Z`<:"]U!^S4-AFM,E>=YX*..W/U9%`:T_21<RB81
M*\HW,FS>]^4\QLV'RLPFM]'5ML&<A&5V=09:>_RJ!YH+?>NFX./-F."&Q9L9
M:QLFXR,;:^OD=5I]0>`WTVCFIW*_W9U50TU(JKE\U%F2WC<LMS.V&=!XIY]I
M';X+ZT'EG])FF/?Q(%=`<@8I3GM0LGX6DX0+F_!;?=)2A9.6H=2D/VR\1$[&
M'+:BZH!N'[SJ^>;;OU\5&[&9[ET$]P@TS1>!?WB)%>TM;>(=;YV;UL*]ZOC^
MY,OER0>\LPHM1Z"?J-BX:5GFBPOH&;QQB_<P"55)W!!=6A.\.DN'+?XAS_N3
M2^_O:U,Q\'KOI3*92>&OI4>JX.P=]8AC%;JVV"3\PRAJL&/1_3D!U$"XF++<
M&HS>>;`?JE]7G)ZQ9XJNT^W-1Q:H(RYW6O([7C9;H]NO=/&?+FC2F=`49K=5
MTWDQI?>]S@?O6.C+)8<)0)0"`H)0?"A]CPW\&I[QQ2$D%KHIZ`*K['MATVO[
MI[:/X4'0&<;Z&1IQ+:J#NZ=ET/E$6^#UP^"YF=QMM$=C_^`L?(_YRM/89&(M
M4?L^5):;O/^HZ&0F'%^")`N"P8NPAP=3J,S0/WN"T8O0.-%CPSBU<!F#"49&
M49Y'@0=7P?&=^J5=.\2?C4E8>2W3,JD^*JR/"E,=%78S[#W41X4I=G/D+,O\
M"IIS]<X*#R'15WA8>.R&N?&<:\.YW:O:1.QE.),I\IPK\_C8;U_O->T*]OM[
MZ;#>%4S:WUO?!+PR;,=:8MN?$$+P?F$Q1;TQ?E<L#85R1T".8E,PQ;,YXX@L
MPZ`:/035D.7!*,QH"KHV,?Y9F3`>>L=PZO]8Z`7SOH<[D<2:3\@F7MR*I&=>
M79I/M`=%%2[6N=OT>'D74OITX6P#[YO(W"P-OK^"%L"WAWC=UEA)Q#]:H!2B
MUMTEZ^[(R5*()S&M!#CB#+R#*U+EB<;%'<)%B:+F6Z2R[74LB+>A8G5`4N,8
M247>S4]2V\C>)#TN7VTB\%IC!!1YHK0Q0W@A[=$X20(1NJ),<J#<._CEG`J;
MGHO#2,Y@PJ]%(VST(J`.B83DQDV1V!O=T2`?;K[YE7'C&?(?*%I#?7G4V\*4
M3TS.?!6*DS(>1:>?['SQV^FQ'`5_*EI'HW8W@94@%3DP47U\O`CMB087^;5H
M#776@YT$2G)CI\C!LSL[$*=/-#I)/3-4B&TMQP-`)H82?R\96T..>O)$PG+E
ML+2+O+(\'N[*(98LPHN&U[#4PH-8K%8<LLKD!XH>9\/!.,)5,BTIV%H;;QN?
M.0Z(U)P8+32.BF!$;2$GPI^W!7(SQ9-^9MADQ7>\L`;=5R?P.2ICYI9EB*1#
M[==&G3:5.FTJUVH*E"W5DYH2H=TU>9VZH/YHXVS'&@JYUWT(@T)7I[)#$/$>
MD>0)C5U<1'=6O+:`>\W:AOD>4Z86.AA-L+(1>*,^5X-T9>`R'"^FW\)37C5*
M^!T_8RY5N&51>M/M%BL#3:?:A%E`)B\L:^*?;+[0S15#XF%PV4L=W)U;TE=]
MUFQX*%KEAWXS5M[E<RH!1;DC]O+1UE1-L5;\_KI'7L.OO*MAE<\5_XE:FO,T
M(PV+3QCTSK#A_BG+](S[J1.I$AA`WK=12#-35XE!X=)T(-;%F^6E##@FOD@5
M\X5%8/>4:R:/&EVYTY#''4S<LGA>V83`'WD?;IT%MR!@PTL:`Q/PH.J?>>%1
M)R($T,H/VC#J-X:]0:,W&"7T$JS_P[_@U;/M4(:3?TE_72#R>.R:S@VONANP
M&_J1VPW/5D-K0;A]BQ<7QNJ^6'P=00?L)27$+,-&28UIHLJ-2YL]"Q:4`)E2
M>;$7S6:!*E*@RQ]8Y<'&(IC1:E0)?%!O,UYN$YJ&%X,HK6$!\0H^:$]4E16K
MLU%"'!4EIH0P2C^#WC2+^K9%D30JA2H,PBW%0P4G?-8]8@Z?0;;F^@Y>&SAL
M&V[=4D]D#2H`S5U82&,-T.RS6_J-#P_7).0V5:'&$4W)FFA3+\SRW1J8+B@N
MD%79]LMS3!50<`@98]VZ0F,N,I"YKR`?A3WRM%9P*<)\:510JB8O`@66)ZJV
M4&$P6_OAYE%BRJJYM#@K9/,6H7D`Y6ZVG3LD,.UNPLOJ8=4^,'%GR0O$!256
M6U_23.L!I)"\FKR,ZB00N[A57;UZO;C)[66=FJ!*4<G,+4OH(8Y*$,K:54YH
MW*"3N)S&4;^DG$9)T;4GXY<3GLZ7/L512.GB\OSF[NSAZN8;`KX8+#&=8^U!
M^-\72UG\<L+_/8D/&?=(&$RB<(^.<\F/3*3+2YL<Q-*8;+AN5SO;Z%9E^I'[
M`^6@?^6^\Q*#PQU"^S()#N4^;Z:U8M96F_GAK.8;%MRJK;PP8XO/-DN)F)#G
M\"E]7*REQV].&L^?BR.2RP:(@C<ME]I>#F8O![UGTA-7-^X2*AXGLQ^YOI%.
M3\5</VF+NS+R/O=/TC%0/:[E+#A3KX;K07?T!KGN]8JR\`I@O;@7R?E9!.Z4
M8>5VW#_,Y(.+FC;\FRSYMQW$^1CF@SZV\TQ\Y/+K#C*YPUI^$?G)C78WGWM!
M;U>"G4ZFR6DG$53CUAQ=((IL;S?;+1GWM]UGKR\_TZ:W[`)P/U"UZVT[]NE-
M)G"+:0_%'NP.5V\<<^%XISM<NXVX(Q=?OY<7,-:;%)_<&`SV\E:U``?#O<#X
M4O*?^A[FIBN7_-]6APX@]TW%8O-XHOWOTVYOETQR,$W&ELXH!61?RDL^9\__
M2)T?<Q-NK8TH4\OY7+%6_)2<YF4%ZZ1@$E5<:M!:^@?E-%"A$SSWV((PM?DP
M/7\9[Y12>-!#]9A8+T4<5_1)8?)QVP'V;.,/_Q)3*@_*^ZL1;WS:X0$8SW+\
M5V>:%'<$WZGP$7P&9U_3FB55`,=_Q6D4T=YF*BLV9&M?<3A[^8/A$H^IS8K;
M]1E>)7EB%:?R4N0[5YS,6\S&KEU$[2)>W11]3+36X43M*UZ;KZC#B3J<J*R+
M*.,L.9)O&+S/J3C2WQ5CB;O-,M\/3I9,(3E9.S03GY\U;/3D#E[U+9R6ZN6F
M=5J=?2H%'Y#MW-3?&_8:@VR(K-61PGZ)B:W"\C%SSTS$/[_P^\3K).\AT+UL
MB5[N-GJC;J/=SEPK<W.G^_*4Q3+XH4"KD[D*8;$L[*669K5XR:R.7.DONGBM
M&]I5;6R^'[4;PU&&W%QZ:ZW`X@'4WVX-,A1FK4?C:QR->T/LNSFIYXBHHL>-
MSM>;T/M>;O1[@T9_L%>B86+-U<.*+FM.7(H;#*U.G8*_G[V->HWA?I4=WHRU
M]5KM7,J.'RSHV9X6&]DK64^?2Z_C\G)MBVD_H/AQHS,8-7I9%DMU\O):\G)K
M]%:2OPLWR,YHW!C7YKC759A6/],%UQQ2Z8LO3)7U>M0]1X@,PL[57M^[WMGH
MM[N-=J^^,K6/I\JX6WO$\JN]?O7-L6)>?^\;LVD]_19E9=!G_KML!79<\U7S
M=7B^CB(&5)X53:<($&_3"8#B.A9T;WXW^OUQH]_=:[>Q_,FW`)IB#NBK2&85
M::I%]SI%E_VZ_.M$2@^CXH=+)[BH^B]8:0'(F"L"8Q_O;:M8O,&#Q5_:N/N,
MWW]"!]V\G\Q,'>M84%--A+''!^:FRG2OX$+@3KEBV\LY[[82R.FYW0`?5^X&
M>'V[M:H`T\V'FUNRVBS9QN)5E[.V%TP>"%N]?":.#8FZ`AW7PZ$D#/9Z-.RV
MT*[!2Z*`T_'@)9N6]G%][,'Z#A%Z>;V6)N_]`;_?&"Y,;;D5D?<A+/<P**3A
MO=3QPHGNI-)7[HVS]KM8QKP;F0J_\IAFI9PL8?]"2\X&NKEAB6K;&8_VXN?=
MFNTDM/N3W&JG/)1+1VEA(CA"V;9;PQUO2^TA@-<HQ929G[6%9A_]N];2*.SR
M\=Z5!V))N]/LOYI3W"314#3,=B1+<>+`I_-4;+YF$MM:N]7OO]N?IIT,K`3V
M\A96;_2NV6X-1BE%EFA/V^@Z.L&`%37E5K^7@RU5F,\BS$ENC>5"S>D0P7<L
ME1?:LZ8R0Y56&M/C@N1CTU_M.'.65+*!;Y+3*Q5&;38%FDW^X61,][^;NN)H
MNN:LCM]JAX/6H/VN"?\,TTY71VIU.<NMWQH-WC5',-GO;\ZO*VH$T?2&7#1I
M`^HC-8*<Y=9M=4;9Y';DD>/ECP6;8-(1B&0NO=<,:<44RXZ[M7QDNNRU.BG!
M0H[46/-MK=OJC9L@LRQ()6_`DW9;W5YSF'$K_NB4G[?,.@,PI5Z&HDS'MFOI
MN<VI:4V9YBPM]EJV+=\U.]V6G,?6986Y/*C,WHKOK$VIHJ:4.C6_I%SP2N7K
M*T]/%GO"W'O-<"S-L+6)2$K`$FLOT:0%B\T5S<`,^XD)SRL39ZGH/)I>2V(P
M@S@R-OZ^?I&,[@(HBX5E_J#K`/I*^JG7&DAS3=>I"!P0,6P->9C>@.YMG(FT
M9WBP533](42$#/3+K7:(_OYN]%ML`8_#V+'I;H-#56RC#[VGJQ/:=,HL9DR8
M],B<%\8,>N/<G"\48T5[5_^G._[9EB:Z2?<J.)]XB8)))G]85VQ'`H&0ME2%
M"O'A]PLP%U/UZNT)F3#^<D.:+W5'6^@:Q`:/*UY_;TD"@M<UHPE?-.>FP5:N
M4#_`,XHCO9A+795FH!6@&,BUV(2!4+Q&1`G`F:FKS++A0:!`UZ-?N\00:9KE
M&YX1HRD4-U8:G)M+P\&:@_;R\5^@"Q"L-)DI!A@'+PX,;_//-O[DK-UI21"M
M.0=&N62W:=:K<1AD(4O]0E('IF"1^>G,1A-1#,Q1D$.F!U]TW"\BUK?1^=0U
M/;>1?,?@6XV"8EZ.;J^RGF]MYOF^7M*S$1Q8,.+]ZV*6+VKNN!02=6@`,\L!
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M7&))-Y`8@^>0E!&R-`*GC'$GBM)[@SGXO`^YZ9]GVA^\DTG'A+9X!.>E)_#S
MS=A3-I%/L;U[S:8_)Z*/1Q8\%C6?@75E/4]'I)T`U;"TXMDSHD.7"S!N$#$>
MV6K&1%^JC$[ZM/E"F1"W)HI16IBVK?'C,?_<51P34B;*7%DA27,%&E"7%KK8
MZ9).>CD)]CX'LAO,!)U[+F>R_]UL7AKJ9Y#:G!E.L^D.QU-5>_:?%Q_^YW1I
M-Y\49?'Q0K,Q&P@8O9F>!]1VQZWAW+0=F[8G/Z'(;I45MFX_L!_.)QTD^>O?
M_DN2_L=M[%*Q,*?*OF66^XXV.3/4"TU?HMHU]9>3+<^TY,YXT&K[_W]"&5K0
MWQV;_G(RM<QY$X='LSULMN6F8XI/XV:WO?8NOKTT-/[J=[?'$TEE$[`=W<9-
MXE^;\%C?%\@6^@IA>+B=83G$L.PS/-R)X>YA&1ZETK`<J^'1+@S+@\,R/$ZE
M83E6P^.=&.[EQ/`M1.&3E3?@8QF./).WAG\5_NWBYOSAS]M+:>;,=>GV^Z?K
MJW/II'EZ^D?W_/3TXN%"^N=O#U^O)<R[?+`4PZ;$'D4_/;W\=B*=S!QG\?'T
M].7EI?72;9G6T^G#W>D/;$O&E\6?32?P9DMUU!.)^]*__1=2$72FXF]!W+VC
M6$[8_::8)XI/4/L&D_XUS'XXCP4.FJJ9FU:9J`REIKM2HR0OC%\PKJ%1[\.2
MNQ&+Y$8L?MZKR`V#OX))H<%TZ)9TAMFL@64=1"2XT0K$A'.0,0#SHK*D?"<*
M!+$5B!['?;DQZ/2#"6JRW)#E<:,W''C?QBTBO:32<*)H0T(AL!\48T'H"(.8
M!,!E0C%#`].C>0HNFTXQ)0\SM0Q'4]'10"N'3VI+,K`=HZ<MCC#B6><+W5PQ
M!O0\:Q/F1U7!N.N;*;3,\T@?4*7!WS$@^V8Z?S+PI5[T3#ZYJ-;1(W>2O;EB
M-\UIQ(%WDF>L^XO@7-7LG_S:';3Q_P)"+8J3DM1Q2PN&SZ8EOL+GY&)U%-ME
M[M/PK?SG\.O@H@1-Q?(34=^_EYJSNK+M)6;YN@/P3*3UH[`W/-"2N]WMJXSV
M*!AT\T]=>>W=5"%9IS48!02W@;8X-K\R9V:J5R1(=%`W+P:S[)FV@%?QL!\G
M'I_G%$_G.ZAOEV%^Y9-?(8B)LIN"K##OF$]`Z037FO*(L"<:L[\R!1>KZ@VL
M4"=+"Q?J&,[:WPWST08SQ&VE*P-F)+0<8P)OD9&%X]<B&JZ#WM1!;^$)XB(3
MFC+$P9WPBU->-C@$9-<,0AJI*VFH4%N:"]WCG1\%MZ6X_O$B$$8P27>^$#<"
M3'II0\1D?]B<.%Y2'!.7`SY\(SG@*3"L"L@Q2M'K<24\%IP:)@E'2_N(N:;X
M%I/K*!9DTG=:\MUK$(U,M0E\57'"@_.61!/7EO3D@U/\7GCE#YOI//S(+C%U
M<-3AJ6&?%!TC15RQ7[")F(=XEN"&A)!(>EE&D+_\LN/Z_.7N8$?X\7S446`2
MRSF_.(Q7!$-WA(7WD'019\;A]FW+RLAY@@F<S.?<<K"T=CM#FM*&](R##L'D
M8^[`:,PI"6-751PL9V`XR"ME()6.D_(%*K8?6,3",F%-'`BC^*YCW$%-ZJ?K
MU6N%CFP2@N6<SFWRI;]25\1=U`!E@5`DMG0VF>".&@7N>,)"IR3GIDH1/"6G
MO#\YNS\_^2`]F`MM`M$6^/"M>J`#$C]O(JB7!ETUGVH&3`^:HM.3$&`V`]_8
M-A--Z+Z/R'8P\IIN]H/X4>R2"O)<@FQL"IZX<APVF1G:OY?XBKV<S,3QDC17
MK+^8P[.B%/CZ/9Y!*1:M=,1O!$MC?^!@$IH!#[#`\P)0QX_31*J/>!!4.%'L
MF335S9</'N3-Q+3#?=H$.6&Q!<R:/.O(YOO@\#9NDO"M)L7@.L=6Q;-H1=3<
M!XX08SN*P[]<(KHS;E@IP4!RIC%+L2:S%4]5`MY,"\S&W=@2FUA`2YSHI*7-
M$Z[$)E>P8<T@9!LL0_((;(%)X@K,;L7A+3Q:&IM**K,GEL;A=P@"P[29:(&_
MFPT^H4!+#NV$Y5HT<^L^F/2BJ<[LEQ.Y+:X%;=D4<\S%MN6')S&Q*.(..W7L
M2`OASV=?KZ[__"C=K^:P%@Y'=AO:YT'27%-5TTFY<A2MT>M\42]_E&[\[0AA
ML>Z8_O?2Q+-L/F:E]TM#4;$%IG[`%17MV[H#VR8'BU4?''#AGCN%[]:\:;I(
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M<98OHC>JE`S'0&5)*'Y3OAZ\1=E)_(&_6'!521!O2_2U=SR8Z#?@.]2BKQW.
M*Q5][7#>LL,I(Q4B`R_7EY_ANW&K1T`6:^E62T3\UC6#15:U3?Z&>R<>5^YI
M1;N/=>X#];*I+3]3XN"$58.*6CRU>&KQU.)YD^(I+$,U2EH"G-2&N3F4I1<W
M(WL'(MV>.,HY-ZV%:1'T"GMT:`]<64XH)8"^M7'WG/;:T\LT@?"=$#Y3)#5N
M4VFTYSUS*+>:H]??2/2W`=TLI>BVLK2C]=>:"FM*'C8&PPPKL%I=]<"J-55K
MZA5IJM?HM/NUMHY$6X<>5Q79KTK>F>(-!FYPU*N=>C%8BZ<63RV>6CS'+9Y#
M;T3%7U#-<$LZ53\E1W2EA'%%Q6[YA]:U]&OI%R']C3?.:_G7UE]+OY9^0=+?
MB%Q3G/Q37^AY,Z7?7S^RWP;9OV5POW1>I:YI7$/\U1!_U:6X:A!_>>R55`WE
M+YW#VG:&<T"@OX-L8*U3=0BLO_PGFY+J5^8%^'?H`5DFYE]N"Z4B%D:[;,)L
MUW..E0)?VQI'(?!_PO]P?"BS`/K#HS!`>\:80Z@B"H<WLW%=PS0*`Z#=I0'N
M1Z<R,=ZW/$G3?7RAK"AD")05#/HR%?Y+N%!8R,6>F9;3A`!A+AD*@F2U)*KP
M@`NJ1].R^+(,\SZADV=%TZEE_KK+!$?A"GO+B;+0L&RA#J$B$SAIV$8,;6Y-
MF0DXV!7V1HU$(=/V16S<AI"X'8;Q#\V9K8$ZVF%4QS`$I)MCL.+U+JZ,B87B
M@+F?_DV$<,R]IP)KLD4*OG1/?H6Y(E3OI10.\U&?G=`G7_;LHZZ-+1=:@@<T
M`EX]%XUL9.+H-=!-H0&Y"4KHRFN/;],`1,QE:^"+HAE8&.[&N(`1\ZP@O-25
M`6NR):W;OS'GUF*.\H.$FO;A`LMWK@NM&?4D::DL21`%E?6,&;]40ZNR<BAM
M9JFZ0114!71=$/)XV,U5$/>*SFZFMY:Y8!9,L1").EC4:4&HI6$Q;'JT5&OH
M)`V*3126(("(%?RPM8^&IO]R`LI@^1K%C[ENV!^A@U]BH+0[[;9\^L^OU_>3
M&9LK3<W`(I03H.`T(@-F,$O1SPSU3)UKA@9&0^9SZ=;U1N8W/U/JK-#ICB).
M8#-QA7!;FNOO#+O#@W-;VI`>=<:'UVUI7GPTCKJP3-R:IOJBZ3IG2WPH>B71
M[<J]B(9$SRF)*S3(3DW<,[,,=-?GT+VE3+`T@]A*$00G/]"2NYUQJ],;M`>M
ML:_O1%;:G69GQ%]JQ[VVJ73J>-B.U$[=1%DA3`YW8W*8GLE1YW!,=HE:N9V"
MR8Y?';3=BGUM$Y,'Y+&SP9\EJ3#=D`.^Y.&X&,Z^BUW.,W?;=`NCD>>+]H/R
ML--/S76$ME*%4*2_E4?1=>FN0KBBP@P87G^&&19?UHRE9CS=0(C-]ST^L:EI
M,?[<@_*#V5\U`ZLDK*[P=)O9#DR:X5;BB])R(9;87[D[)L..'`X72^3T3:FT
MM`5`L]N1.[5*2U!I>=M8G79O6.NT#)V6MI9KROU.[Z"N%_X3T*K[$W_]&W.$
M]->^+W5^ZHXC$EHC)VJ=F?@H;U<F.GKSY:,T3R3+<J&,E+<AWAZD8,3]_ZC[
M@[$GME@^,8---2?@JM9^BQDP*;9X=QT_N6SQ[LCE,#.7NXZN0W(YVD67.XV]
M0W)9VDCLQ4:K:S2M,17*YK@R1&E'^Y;G"^&6Z&0"&E&O@[64.,\[O%INO-=M
M]Z(RV8'F"HBLO'"J.QBM15,%RBRRI9;FP5)-J)_:@I(VVW+GO41;2&L)Z7F_
M8%-F64R]8\_,6"8Q'GFJW*.P=G<+UQ'J"F.Y-$73EFJN/-]@;<!OIH$Y4Q`+
M;G>$R2^4F]JP7?O)E)8LE"-+=UAG[]9B"T537=,2<0I,)\0WQZI/D$R:5\LU
MG&%T0;<+R1606'DK1[FS;7K)0V3N\<==(&D_7D(Q3Y8;K:YO"J0@L7#^2S.(
M[J@WVI]_OG\7S#R)?%?JOEMT<R1$R4ZDE[?5ECOIY>VNY4][::-@N\7XM$<C
MB$B`4.@Y_)C..P.D)@9"6Z@L]*"\,XQ,,FFHA`GFWC$G?\U,7666S;?^HZ3'
M/E2TU$?M?F^0Q$\L104Q6:32!H/^,"<FSWG@'&5+?%WX&&GW(FEQZS3L07J1
M.ACVA^-=*?>NV%QH]D0W\99-E(N81[AT.^U.KR6/QCV?S`WKFB0-Q;12P((F
M%Y:[N[(<T>P1L4Q:'N2BY6@K566YNRO+ZUH^%I9)RYT(L2G5&GTMRQ7+S905
MI=M4C*XK,PNCT9N,F1@UC:<'9LV_X55PL6W/V8OYH?!+L>/P%EL<#7N27VBR
M>V2O=#OY7Q7K+T9H"_=>!:<S]TK_9]/">TW^+_QZ/+&WRXMY+[1^%1@`%S?G
M#W_>7DHS9ZY+M]\_75^=2R?-T],_NN>GIQ</%](_?WOX>BW)K;;T8"F&K6&B
MC:*?GEY^.Y%BG-'#W>D/;$O&E\6?32?P9DMUU!.)XPW\[;^0BB#@@/A;$'?O
M*)83ABA(`3@1`9?@_[8Z!#S!<280]TA".`5MDAISXIZ`'=`BI$"BT*&1,`CO
MPGBT%ZF@JXJDY-X'OM`".6JQ\"]HNK9F.PAL$7Q8,^"7^9Q9$TW1I86R8%8#
MOG'+IW'$"\2^<&868TE5U%K2F:Y+<V^0!7Z29HHJF9;VI($EPB..^_V3Q:`1
M"QI6#&G<EE1E!>P]+AU)9[;-OS8-)JV88K4X_DA\Y]##,_P(Q`?`.W[JMV1I
MKNDZO,#?%D@?\+0M373%MK6IQI`O9H=:4P(H(<VI:35M!1G2$-@D@!@"K*PD
M@V$+IJ1KL'I2D:RUYEXT9R8`4PQP'4%V8GH)D`'3)L*)((V@T0`T"6IC:8#T
M=.T_\..3`N$'?0GSE8TFHDW!T:)9:`8G[Q'H8G-4J;5J("S*.M,X21L3?:G"
M&T"N,IDLYTL=.`+EX18Q6LG"8C,&5O1,SYIS)KW'+C_@"W9@*>DAPDB,+W.#
MPS<`P8(`,<0V]LZ0.>IO0>@8VD31]152[_$BO<P8T:+@1()U4+!G+A3-EDZ(
MT"8:3M-CMW5"LJ9!$OO`";X*9@Y-.<Q0N<`T`_MWR*K@3<7`]6.TSY9TIV"#
M('`'43P-,EJ'5+VP3'O!)L`NH>"`ZL$XB0B+3?"*`2&!"GU:-,[@F0D8OF)I
MP/94>0;J0$B@+LMKUB(^%8G`D.!]]JRIC.S2E.SE`A@*&HJ-XH<QYYC42'"\
M<;B;,%H--HC?"JL`K7U5#.6)<!V`ZF>-O<#`@5]`/4H#^IO,<*S@*W/E":9Y
ML!TR0W7)<T/=!H7<&OCT"P,_(=Y:QP\22!#(#II2D!PTTJ7A:*Z7\>38P*?!
M,D%ACF<@^"*:9L@^8LU#NIHFF-/:$(I[GPLR5G[8!I"UG.``-C@S&G"L6?Q"
M-F$BF988</2F`PIR$2DET\NQY>X"[0E!'R74N4/PCR3E.6728GM+F[>%0W7I
M$.A1DI-`)T!#3Q"]KHN`<S_T/%?Y&3<PG<3/'HDHOJB1-1Q%&"7H_-'A:H1C
M-<V$]GM(C<3A_\KM8P8`#D!G#V/+Q2="=T:EM`V9>[BE;'T(5#0#@F@**K9!
M*J:@,@ZO=1M6L-R+I3@+>&$UY%<-*JJEQ0SPL(<47SQD9^TV\C"X$B'%TR-!
M1T6W-A6F'P,Q<HJ9E`]&6@39^FP.P0M&@RD1N*M"][EI;X$YK_(8J085!YH:
MXD=N6+U?8*D<!PH?@KX-(LJ[BYKT[R#P52SN?(4U5@TJWK;=7--:N3:<8S<<
MO^Y'U<56#2KJN*Z.Z^JX[C6,U-<]/]=Q76TW=5SW=@VGZG%=&>6`8C<:XVI7
M==J\>-59?!9%>@E&:F'M8+I[5/;:U%2XTM=0%/IJ=(?=_$C;A=WC$IC<:'<S
M'+C4`DM7][@6%K75:_3:_5I@M?\J3&"CVGO5WJLP[]4IQWL55D0T2F)R[+M6
MK?'<RPI6V:.S4^B86%2S@)5'0C'[@GL*%**4NXW.((/KSJ"*7<;)FY)]KQ;[
M(<2>83*IQ9ZSIQG6LJ]-OA9[+?9:[+78]Q3[(3:NDPNQ/YB.HN\N@4!%]UTU
M%BX\G\X\]BMNGW;F'S0&W<&>LBER6+YJX3?:M>P/)/L]/&(M]WUL?M@8##-L
ML-;"SU'X&<\":MGG*/M,QPJUY&M7?_1RSWC8D9/L@TN/4[I.['T\!`9-8AKP
M?S>;EX8:1LJA1X+8.NX''^-H%R"B,`;2-X1083=3OP87(1RM?UWC%R7B%WFW
MX3?<A2=K26LFWTR'2;+4E&ZL)\70_D,:B%A,^;?T]4@&Y"&)^68^*\_*CX9T
M94Q:TGL$G3@1J!,G'SBL"6)P(.Q+TW:4)R8]:N9BIEAS9<*6#GY/D`@(O3,U
M)X1U81J2RIZ9;BXXV`7\_J@9BN$@_HK#-$."#^8"+$*;Z`C3,9EH!A#JF)*B
MJA;"#"G2HV4JJ@3F]L0X.-*488+<TI94S4:P;#N$'Q2`R'@R@2;-YO`@A(>C
M8,=3C:,@B.X\J@G%!1E]>L*N-2!\):F6]HS$.^:+8JFVRP]:;T."P<\,`M!#
MG`@?ITG8%Y*K&`@J8EH.<0W_3L%EF!Q<1G#[8EJZ^J*I+(D/ATUFAJF;3RMI
MH2O0`L);V-*C(F0,/"TL#;R6M0H)V64P\#[GD0,)V=*S9H'7TK6_F.0JP9;>
MG_Q^?6N#SI&G.)W--81U"*B+/P*T()82R-@&@>FL"29`-F*9B)N#0H0_59'=
M:*]LA\V)8SN@"NB3<)HXXM$3,Y@C@(:8\01/,(L)J*NF"B8,+@@=$)F1[5C0
M-BC#]KCT#L2U^7Q)$A"-^2J)83#1G@3YTD);,(*C`8D_81T"!1A`!:P2#)1$
MJ<&#"7R*JA=(F(%00`28A6:I,P1<<L>=Y%A@7"Z*$?4->C-4!AJ1WO_6_R8C
MU--47S+C/X@`!'V3=+SOA$KMA092,<%:[)4Q63F(+$:F`+J_N__]Y,/A$66J
MY!FO#*G3;H\;(70Q'(0()R/]R]1PJ('ZT`_0"#A75(@7I-N0<[2E:VVNH3K?
MG_`'8(@9"C9R?GLM?=)<\[2E6_`Y:+7>"^2,_PZ*X7!;Y(%(ET#Q<JJ0U7O#
ML8&#3K1%H%3*@DC@5JAJRA..%?P,QG8%=JAP>__[[P3"]((#N=-^)SVN0@SC
MRR/^-2<_C-JFB/I(A*>E$7"=B[_CPB=!!TMR`_B!(X\)<*2HO>T8NZV'6)'(
MC#GGBCV[M4S$Y5(_K;Z#`[TR/N/H1\B:,QBVSSYZ>_K'RZV_TA]WPKB<Z0DM
M41ZEE1$8=X:C(L7!L?%2BR/F\9)KJ_3E2)7@])26*)#RJN\,AY&:P#G+0[B;
MM/*(>;QD`^G)Z0020VF)`BFO^%^G3548\A&(7TS;Y=G_IM2"/,UA1U[S`SXM
MF0DOK1Q/L]N)E+79C_#R1E:GW1OF27F9I>4'_36?D$SYBRB'"4,!QH@!?TXX
M,";?$./_^P"T?M+-R5^"N6POU;MCJ=&](VN>3EXKL/#=6S;'O[`>&83TOBJE
ML"XI,N>/TI_;X0Y*6U-6!J44%I1_7QJ,0/?XJO+SV?TG6'W92UA[G=U_E_A0
M[C<D7_#G(7SG*X'O_&`N8.W?Z;0_?`1%,!M4X&T]Q;T14`^L0P-=P:(?UG.P
M`'Q"H&S$+-;L".0R+TWGPB<C\BX^ADBXR0#4L/2;\K@;%J,!_%Q812XXN6A"
M&JT1F2;`H\7^D?<X02R_F($OE`50H$QF@F;DXT6Q)3:EK9=G#ET=7+T^LB?-
M,+"OO\.2&3?*..AA1[2P",K.PL6IQ7O"9A757.`Z//(JW]5!F."I#MWRO3CL
M%-?"U"WVEP0:[&X9!F1&B,@NY1QE&W@B!21`TZ+R#KU94ZEQY<MIV^`:!0?7
M%:C>>-*H9&13^F*:ZHN&0-@@8BK`Z0ZT;A\'V@-?)OC/H<ZN/.CHI#$V.OG@
M]]@(/@7#ZPD-X!%&DK18/N(!&/9MF(;XA`.%XFAD"*P1S13>0OQP#:V6[U6O
M`;'#_ZQPLQ'&VT*Q^=M\)+&%].22'T"]=H"UEO0=;,X2D/@OGD<@X'IHBVB!
M9F>F:?/->K!5VI16@@1)"H(XV'R\XLZ32YV[/TN;[7/3`L/7_D+ZJ:2`83K2
M>X5_3U_TV]@^S3KTG`;]JA]\*/<`\C[NM\-PQ+U=U`]&/-B'7Z\`-Z8\5'5E
MCE,8H<._F$L.9VYXO-RCB&07?ULQ#(1J3Q(9NJ^S^W.T#PA#D%T2EHL8OVI(
MM`O./2FU#(Z'+.M%LT&PABE-EQ:I3.#LHX(Y58_,;X?ON6'L9@L+V"IZE+&"
MR.]<6A'IZ+B9V"#]^)JE3<SY4G>TA1Y]PZ:Z"DM'0T@/Z'6N_4`9Q7?.G1S\
MANWR'U%:-HJ>W+X=;5U47IASK^?-1>O.':<F2YL+RC<JQW:%!"WBJU/-QJU1
M+/1@!R8&98KH^QXJKMQO"!^BZ(CL_323X`6P4IH-2#T*M3S7'/#]@G#W-Q!)
M8.#CQ!"=/%1-)5L7Q3'F"N'VZX)-=RI9/X2(FT[SVC_-&*)'5@6!JD#!DGXQ
MWQ=>CK`?6?BND[`7[44678KN[6XCW=N3B"PF8[XO=_MA,.J%5Y0Q%.W%2HD;
M$N-(1;*\62ESBR):S39O7DK<M!AV.UEY\<NI!\?Y^M=%NZ@.A`HARM<HV(/P
M0@L-]_NC72G_9AJ3>.+]7XH6/,D]GGR?B+TY*%(#O4@=R+0<A/8#^`#QP=E^
M,W6LTH&(?3AJ;HQ`^INEX8K\`CY"6$#+TF_,N9D^*#]\(130>*G3U7BP+M,"
M>'HE:BEMZNW66DFOE?)2$-J]6B_I]5+>47>D"'N)>L&91[%GO/W+'POHCOF"
MC?NUW+BWUXUQ\'%DY<9;:5KO]&-&XW;68%%)2_O/IG7+-Z?LST#7`\-<R#-=
M-U_X,0#PF>[1EMSMR:4HM`],CR+%B=/1&"^"F^D]EL>\LNTE/H3`UW:(\;@'
MRK-?8+>7P&T<83GS6(X=]\7.QUX\/IAG$SJZ2;ZQ$6(YQ?.E>BFY/QQT8V60
M@M)215*><VN/.@5)Y%9DHS\SOGB*ET/TJ7(#K4Y["_=1\@KCN32-]^3>7BQ;
M;,I@":R2T[A5K!OK'C?*5<*AACCF?D;%E)'O5(_FNR'AMAKDNG/R*SPE!UA.
M15@)?.>WC5$2W_2`?;9T9J9%A777^8T^DO.&$[4>Y++MSFSM)$:C%!7`8([[
M4:4P>,6/ZY.8XS_':.Z'K7TT-/V7$\=:LEP4^6.N&_9':/>7F.0OX%L^_>?7
MZ_O)C,V5IF;8#H8H)])ICBQVL[.8396%L7BS=/!IE7)\$O@,/'/<^MR!V6/4
M[.^\_OH:@_1]L1J\.`Q#Q6DI1X86BJ:*97[P?"CVE\+/MD;M870V6*=B;Q8*
M/87O1;;24K'@;SNXB]6;Z;DYGYL&691@9\M3Y2XP!N-./\+H%OH*8[J\&V-R
M=$UY()Y'@U3G6W([J&CXA`8=>7?KY@H=&N;--"VX;Z:7_#)G(M>AQTK=-Y-[
MZY'I-@(+X[O;W:[N]BAX;L8_H;HC[V[E>]BO$M_I]-T/Z;LO^,ZF[XY<(;Y[
MO>U\P]CNAH8W'IRNO;MU?WB<:GB7Q/<PQ?GPVOCN<GT/TY\/`]]KIP![<!U,
MM5OC-?ACJ3/TH)_,89"HG/B*3,(;@MU]Y^2<(E^?E3N(T-P3@XT\)SU8=B9>
MHEZ3""R8]_(R]P9%\7[';,?2\#(.WM]-0C+8^>VR;_*/>ZGDM)7NR@COB-T+
M3B)GAOH5049@'KF9;CM1V^W=DK%$-LR?&8BNA-1*/).,9N\6(K:;*7RS8):S
MNM4QA\%0,8)9S/V-D=3/EVI477FT43@;Z"Q5(,?LBW!]?D-7C>S+'P@Z9WM'
M"5N>*M44(C=`MA)7&,?EI>#U!WNR'&^PWYAGXXD/%+VO.Q[):VXOD9B<^2IR
MLW<PZD?WJ]/R%0R`KDWCZ8%9\W-E@2"VUWA;_N91UYX"*+`9GB]UH([#84`&
M,DN5QY&Y;`B)F6)-9F!"%SYN:#"#=.,3I5Z`&'3'_8@-;"`M=SY+NU'0:T<F
MI7+Y+"^7<#`X**/ES;C=WK"W!Z.!12N\@/^@NW^&^!&\TIES+N`"_&/BC.\4
M/2N/NJ,H]UG(.X@\JG^DOHVIR$7`](\7;0[#2`":GK(2!7`,^G<4Q+2^5"Q$
MA[#/)I/E?*EC,N(%FVH3S65[VV-%Z[O9[</+41>PC:H"F2TR4F]V(:I9,_"L
MS#XS8\GNV,1\,@BC+0ZN;NM3>4_FKQB?;GOEC_U1Z4A;4D!=-1#==DJ"`-X"
M(P<1>7CT)$";O/B)L'.^M^Y;TA?SF5D&!W9Z8L9$$PCW+@Z<KBN/)B',VS":
M5?K.1JA];?ZXM&PZE\+GI]H/IDH+F#88C1U+F3A`("]/@&F4O+Z"J*[@@N`'
M25*>+"8@<$+,6-P._L.0'6X:G!"/.:\_Q,HRL+B%^$*:*8@*!-^Q'VRR!"_"
M4<2\WSF]FBW(#T);(6<-^*1K("`J!F`SZQD>MQ'"3I0/L*D'<T+3H2I@X'2=
M35S@H/C>+([F_X@(1#;6G%!;DGLU`OEET*>*.%2*^JP(8+X7T_HK`'Z$^?\H
M&0NQE12L9<'3'3T9(2T(0H?T&B&5(/#7JN&U0+)576!W#E6'GUYF&LB64,=$
MQ8V_#//%.#1$786&W/>$\1`0=A"WD!3/'Q.V$F/:"%%(%QQY0P2P91$$(S>Q
MA;[$&A4$M.6;&)EO<\H8XEH9+H*5VS'08VM`JNT_ESR8_<%$I59$@V@06)I$
M=`L_$9):A%*/2LW#7G/-%Q\G$U9L7J3%X@!J#M:;E1"$#U&S5'^P4(L-CE]F
M+VF4A[JP6`!T4O&'%)/F\.=20#Z*GGW2H;,DRKPB'2YH'F*:_?;;O?3I[.[B
MS*.L(4V8A6&*I/B'J7,P,Y06T-0D0$L<P(^KP.M4#01;%:"0FB4XXF)6T?>I
M`8FJFL5<,;2DB\`G7P;;=1AU$_0L,/WDNWW_86&#R25XUM\)>O@D<2TX\C8)
MFN:<0$/O01@T[ZP^<(MZU'1,3T++X&[886$GBN*##T"IQC%+K?##^#LX0V6I
M.^CJ0G4^%$TG><\9[E0CBF=@"Q.D8S-J'RQ.>,,`;"GWP.&!]0BS`\C,!4'D
MO06X>V$(?!BDSC1XX2/$+O3D'F$I*%-L,$ZF7"0A8W!F%B';444.#U]/I5ZG
M?`BY=.`0YF![*^39T9G0JDU68"-<('2.<>_ZBQZ2863T!Z8PX1Y<,6TW4UYL
MR(T_Q*",Q"=14_,L@E[VA,0G-K(Y45#(W94&5A[_A:.(2E+AQ$!<+Q<D#8(=
M5*!YQZV6XBNR)7TSN2#X`UY8X=?U48CL=6C7GZ69^0(V8C6PP`NP2'V&#<?U
M_6@'+E1LD-9PG]YP1@\TYX5:J!GDF_U8</A:[E5<:`C.),(-NCRB^GW5UY-Z
M7!P=\'U^((R#*C&L]F-8@M84Q;D0CG.Y@-&$=:FX,39\JT2M)S;HQIQ@/9H.
MLR3Z#^]-"B',E:)3UH1TYG<>1OT40:Q"D+AD)1R7E)N)CS0K'%CH<0*<Q=F(
MBB<@5*<9P'-%<@A[%-%:/;A)("78"+6!Y;\LJM?UR+R`A(HNV0R"`?12ZPTA
M182CZX8Y)KH<_&%B:82Q2>S,F?-1>B]_"%*/M,)0?&]_H)'#,66%7YJ`^4`\
M:V%@K$ATB:NIZ,C+HV)K]L\DV/>=#ZY`%(LJUHGZ1Z+>FN*RQ,MX(HD6<Y86
M#E!=X*.:\10%EQ567#B"#C/*A68'Q0;^[=%;>X&O0":P]A<O.T:NT=3=YH0Y
M0Q01U"SY#%`-`I=&-1S2B:AK%BH,QY>'_->0RAH4P2YX&3MHH06]<ZI=/&YW
M=<,#W0F9(<>0I1DWW'/8'+PJ>1S]5HC99KK.*]+A\DI4H0KSNG1!D.V0-D$(
MJX5;1DZ,5=*FS5'2'49K.9P9%N(8N;%]K'(L<>/9U)^%M^?S"97E8U2JRW88
ML\B.S3EASN+X_4T#L[0X.8WP*/3HS\4U$4PMS24BZ@1FZ3O##(T&/F@H4+`I
MQ,;`@+_HP,PBICT7XSW6$5SA&E:E39SP8@CF0GV%"Y]P*.2NH'V&`G2'G%4`
M%MOWB)YUV3,W2@E&O^Y$BT$GY\@M80A-)TJ.\<,FF[@!OB<S'IEIMK]9P!D,
MS/#^FDN1C"6%!"`:K.]F6J&H.<A'8*4(Q@S!T`(LS]=]P'(YS'/PW9"3@OA!
M@X7E%(P)@9--_C@:(%#12#0DBP5`[:,&N2[DI;=*2JE`W_`"&P\!O8`A35C8
M3*A-6O%Z`A&Q^9HT.%R_MR3C3HL'X.1*?,X.'6-4)]KY`S?,Q+Z/-PMQO2JQ
M>WIN0!#8PO(6[XU0)!N[(\@W03S=^[:=N$+G_IP4O&DK(KQOD/].!,YC,6OO
M>":]O8F-&Q-I-B6VK?RSNO[H?D`:IS?-;"`BI(BWD>#P#FR`\2E=^&<>EUD*
MSL5-*L]*D9F$*[*PNM'_'GH056<XWWF[B+8YT<B,*5R+K#[<@"(4"H5'9KRD
M<>;D>^RZ'MD\"7=(46RXTX#WM^$M>ZJQM6*AM>KXI@N?RF:X1^!ZB\21ZBT,
M^=Z^".F\-<$S[B?9"1/NB^O^_4;(18B^57]BC5M^PH/JDH5./?#V$7H,]`!Q
ME`0'/]](\@CC&RQ^/P$R:?>"%B)!F6QU$N!J%8WJ0?C;(F3$4_%S@D3Y'DQ+
M^AH62F#Y%>")SE-T/6:):AH\\+77%ZD^ET"O81I-BTUA2.(L\3.M/#&LHQ^#
M/6$%!]IYYL6I(P82;E>4",&`:A$\*0@,>>BI^R'4`9OB[B>O%D7+%YH813_1
M#FCAB=(+D$%K,E%'1K&=X*0A5M4]L<]+&U<Q9"\65,HC,&MJ[HK:G^P%G31'
MJ>(L):"#\'X'!;XK44$$#T77X\>]W%`>)=H2W=".U3^V9CS$IE'8P6R)<BM,
M](>#:,8JIR(EH:6EG`*5T?R<3(26ES,Z[,O11/!,E):6]#D:];HI",4L+W6)
M-X$NV*/S@*,[G.:SZ8$ZPV?7"I1YQ#9G3[`">:+3N275MY_#M#Q?S@.+>B^J
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MWR[0,F[N/DK6T^/[3KO7Z/3[#?CWP\]2>A4&V=?9%+>!A`6.W]'S.+*2^10/
MR^]2ZR.Q0]'&3^E>I:UY_]T1?[D[WKWC_?7P,M,<MH_P78%WU[G85;P[Z86$
M2V_*_6%N?1W"G%V)]MZT1',SS/Z;%F.^?C9FBG#%/,@TL10R%7IBB\8M>[?L
MZU#JM;.XZ^RL%S8^HJ1T6OU,Q)Q2S+?ORG[3(B=IO70Y7^CFBK%[?D!-@+*?
M\"@==^*88=/>RAD_C(>_$/[%W2SDM6+HZ"-IL95SZ_5*[9`KM6CB/9T3V8AU
MT.3)%Y.`4MU#HK5LR93ET2N\;H-.'RWIU!^(FY=NHWY)2S=)T;4G6)'P54OZ
ME9R0TL7E^<W=V</5#?Q@F`9+G+76'H3_?;&4Q2\G_-\3UWC#4MIC791$X1X=
MY[(,3*3+6QT.8FE,-ERWJYUM=*LR_?M1#S.+,>DK.-"9+5WB9CF)*]L%JC()
M#FWQ;*:U8M96F_GAK.8;GO[55EZ8L<4'U=MCY]R'3^GC8FT7<//>6/Y<')%<
MY%HNM;U4RUX.NIW>$SO4=PF))LGL1W:IT^FIF%WVMC@2D/?99D_'0/6XEH<;
MMN5>+=>#[N@-<MWK%67AI6W9)^^7?A%WE2A32L7C=\R<PZ2O3#ZXJ&G#W[#/
MO^W`WG-G&',FM,/F\\XS\9'+KSO(Y`YK^47D)S?:W7R./]ZN!#N=3)/33B*H
MQN$@'3!%MK>;[9:,^]ONL]>7GVG3&[X4&_ATBV7;CGUZDPF<<NVA6&I%4LTE
M)3C'GSENF+PSMAD\;1S'Y%5D5,$^(^[(Q=?O;5B[UN+;)CZY,1CLY:UJ`0Z&
M&7(^=A9@D>?T.9^/)QWR?U8TBS!9>2'U,T.]UCB:CL;LK_SFH7ICW&'!"KQZ
M_@GORFS,HLZAQ?HP_Y"'^:)N#R[[2(,<$\[7H7LA5<7<ZBEH6YHKUE_,$1?_
MZ8*5Y6I77*Y*PKFAMB_81'PKT[<RI6?;RSFT2U?/'IENOE3NL#]+DK;</HHL
M;=HJO;_Z7R!M'+]U&G^8ER+O:VO3\4%W[)E3#FEF*<A9WZ`.[$;+[5C2T/E)
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M^%KNM=QSD7MWTTVN@B2_X5I2^)9$21<B]KX+E<.5HL3[3U19X"LO+'`-33&W
M'/5GTSI7%IJCZ/3UEDM/.S93WW2*N^F4UNXBNV8&U@S28^PXY94@;L:?P[4F
M)EQY,/!`>]%*:%3I+/2`5S0OU\(3!Q7(*ZI&D7:.J0M+9%W6UX4EW,(2FTC=
MB@=4'?S^ZA26R`*F54%K=@5:G;H2!Q#H*RPK\4K,,H:+MR/0`J'30+0;("A>
M5VV.?.#1#C(\M@G]0&.A.\@`^%7]P7#-;)M;X/\9=>3NSZ*0:Z#D.4)%:!CY
M,CM;2'N\P^9]?\/=P/2R_5"9V>165*\7."!3R6".MXX.KY^K,]#:&>`[CW"@
MX8X8%:<V+;>><VC#XLV,M;WPH"HUUC9MH'\SC69^*L]]8[Z(C?@$C7?Z>6'0
M[;_/OGFG;</6.V[05&'_?<?=[:1-]W@PLWM$G[RALO/VV<31GC5GM7'3?==F
MZDWW1'BQ_,N"\9UN"N]L21&H7BM>Z8O<DR)T%-A2[[3;?>E6Q^K-ADK?R..Q
M^&9J\F<,K-TRY[5;&-9NB=EMWXP1EBNOF3;)2ZO[%3,WI9AW=L0>2+G?O#,F
M4=Z[Z/&5B<CVR(=(5P8V@W7GT/(.Q_CK$"P-82Y8[IT/(M4LF%M)=9"2`HIT
M!9-R4W@2>45AAZ0R@T2BMD"()$=-A1;82G3;;YH4ZC90=@P'+1%5W=)H(N#;
M3&651EL]Q@]D*7\P7"0RM5EQBSY[9A"MLXI3>?F#61/-KCJ9MY8VV4)CE89I
M[1S>X*Q;(5+J`*`>XZ]GC-<!0!T`'$4`4,9I4J3(Z,W2L1W%P`U#S%C^NV(L
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M+"]'$;(ISXJF4\"&5[2>"':Y#MU^EOJ-?G_<Z'?WVNHK<^K,FYJ8`^UJ$5@M
M:FIQO09QO3H,UETO6V^_`R[NDI^]*)8:;`\17ZF3,]M>SOEW*>^#[]YD?3<\
M\6ZX&!,;\$+SN3"N:)8/(6/3A5%^5=SF4053I1?%EAB0,5?P$T09>"-<Q=J=
M\`H//98VG@G@]Y]PKFZ"F9@Z],^;:BXL#2]-2W-39;KTHCDS>M:_K:[X%K+Y
M&GGQ8LETMWQ<N;OE]37:(C+LXR]9)]MG.-FZ^7!S2^:8)=E:O.IRUHZM:Y^4
M@/TPLQB3OG+`ADL$;"`1[I,Q7CX3H<7,9OJK9)+U0*B0#7U#X))Z'!SZ5D6-
M@[+YKM;FG9JX/O;@.^NZK*0N2Y/TAAR=&ERFMM:W;JV'05D,[X*'"O3P/?!Q
MH#YSK_TNEBOOLJG";W.F6=XFB]>_R9.G76YN-=4HW]1L)Z'=G^166O#5DB@]
MKF83Y=IN#7>\'[:K5;TNNP3YI4R:/6X#*G^\RYFR(':UJO**4L31=:?9?S6G
MN-GAXIE+EN+$H>[F-E1R''6Q3;5;_?Z[*A%4S:;:K=[H7;/=&HQ2"BO1AC82
M=43R`+-IRJU^KS:>E,8CM\9R<<9SD,H`<21>:,^:R@Q56FE,CXMWCT=MM6GG
M)J/7[@YK4SFDJ>0?%<9T_[NI*PX6IET=LZ4.!ZU!^UT3_AFFG8V.SM+R%%>_
M-1J\:XY@"J]=G2N1WI!+)&TL?'1:SU-<W59GE$U<QQS]7?Y8L`DF[H`\YE0"
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MAJ;_<@*-L!S-BZY=0O-SW;`_0B>_Q%P3Z;3;\ND_OU[CF)LK3<U`M*0)4'%:
MLD8@H+'=7!@!;$[(L!<0Y'Q6-.MWRH@I15FI2"E/CV`WQ$_E-4E"LDL:6.'.
MZE&U43R''E@9J:G'UIH$OYG&,[-!:-^6E%9?K+XBO:$0.\D!@V(WS6E$YIWM
M(\B/$]HGO_;;*8*$`EA[,_KKIM"?W`05=N6UQ]/HKPO_]Q;T=VA7FIZ0?$>M
M[RE]O7<@O&]UQZ6J?2O;M45LM(C\_$"B10S*=025L8C?B9R2XM]P9T7N4L2Y
M^[*\?9C+PRCRT.,[(S4%FD+"B.^W.G+YQE#6L/?:"^PPNJ<Q;IKB'2)+[&4%
M:7M!#0U2:7<8J]W!!NTNUS2;1T2>EK-7JZ[A=G7)(74%MEJ'Z=75J]65B[J*
M\IT1=0UJ=>6BKH(.,J+J&AU<78_;NWO,TMT#L^:RKZ="FL][MOKUMO=GYVMG
M>!%112'$OR(=#%O=3F_4ZLFCX=:ADCP1K;?QZVWWSWZMC\SZ&*75Q\:9)EX?
MO:^=6AW9U#'.,#R29Y)X=72_]FIU[."MY!R\E1Q5!\X>\J#6QP[>*HT^MGFK
M-7T,_Y1K;[63MTHY/#9ZJYCAT?\JCP^EC[SC:?^J%4;47Y4?VGPY+VYA$MM=
MB=LUN/YO#0?#/+;B,O/YAM19TG9.%]4Y:O=J;1:JS9)V>WI"FZ-:G86JLZ3=
MH#>F3LTH59V\NQ*GSBZ?.@?E:I.S^8:T6>)!2&O8']7J+%:=94Z=PWYO6*NS
M4'66.74.NYV2I\["U8FH;I\MQJX$IELQIV!QO92]QFRW^_V"E!?'7LDZ*RQV
MW=!9V9-CNSTH:OAMX/*-*++,:;$M]XO:(*@56>:$V);'1>W;54B11<4V&SHK
MW[46MBFP@<LWHLA276NY4<[;4F2IKO681R2_Y"2`$.RSI3,S+>T_;,_+!4FM
M\BM`G5Z_/6QU1T,Y7D-)%X?BWMMRC4`>=>6./.[DH)\DGHY<$:,=%1%];]OU
MO6%OT,ME45"N'MR2TI]-BRX`Y*J.:.-E7(/M]\?];AX[EUMXR2D?XL;==&'6
M1+.Q`_"%EF;8VH2<Y9[Y$%N;SUDE8?22/CBH=COF8G(AK.0T0-;[R>/&<5*K
MI<\8W7Z[V^[E<?<LB:4CUT-)$T9G-![G<F&_=#5$[HV)7]BMI4WVW+#-UE>1
M0R?AHEX'7BA$99OX?$.*S'_L)2BRU^KG<>M^;T7F,Q%&.KUC<P464<;3.8C/
M4B;.4M%SR*W<O=_<2[[?]O\<?95S27S=G:M"QB7S0'X>3$?1PR%.GH-R8T?E
M8?9Y(6+NHW$C@Z]<=^6`$X+N.D>ONP!D73[`$\GM\I&Q+6!)-;AVV2KJ]P;]
M01X[1<D<O@+5;`I!4JLFXUI`'O6&_1Q'4>&:"</1?;%,V\Y%,S'M'G;0='NC
M;JX.+H;#5Z":J+WO"S:8;@P=%G'P$#B1NZ-!%I7?E`1AU<YQ>961W3>IWZ*.
MZ./UB_6/:_V6J=]R`:FP/G.MWS+U6]2!?I)_EE^+?[Y9.CBSJYKQ5,"".['U
MHL_->H.<5]:)G!2FCAR/:]9:+?W8;-P9C'H%Z:.(\YH2]=!-KX<(+NH.>ACV
MY,ZPE\?Y_JO3PU$?7[X>-733JR%F.&140P_&0IX[1^6IH?##QY1]'>`466Z-
M<EP]I>3S32BRJ*DH,1V@D^-^>JW(5Y(.4"LR.B+SGPT3%9EG@L[NBMPC$R&Y
MTZ1,A$XN>1T[])M_7L<P[[R.';C*."[MK$?:^P_/7+LL[8`M<:]QD&6O,5?>
MWZRJRSVP*[M(V#:AQ9R/%Z^IC)T>>EA"!)9EER5G[M^TP@M.04D,G=IY^N'#
M*GSCD40!ND[?WZ''M=SJ9%GJY,?X&]3P\<^R$0%Z_'D$;%R8RVVQG@L]GG+Z
MD:,+N20KBJ>QV]UPI!K</.@3C9''TPZEZ/9/'(U8;'UFZBJS;%ZAB=.Z]G6A
M1XK=DU\'<G<X")\IKM&P!^DYUL=<([W?'?7&V4F_LNTE4R^6%JSR^+CEF^C?
MV`O]9/OL;'VTR)3XM9U]/`'&X\9UEK?26;@8NMWMN63M43#7B'_BHVQ#+EGL
M`<=@,!J$3SBJ(H5TQM`/&8/K:[)6"Q2W:"LHAEYONQC:S78W*`;*1%M[-\VA
M8V_<'P[E?O7$,$R17TG.+Y"_(UQAY-TTKF%836.`D9IF3*`]!(R!QPB1=].,
MB4YWU.^&"B?F+0;Z,;+1HFX72>QKA\UC'[6'HUY*2<62?W"I'7.*^?+19O]>
MPH+B\AE7&@]`Z"<=N.5"2?HU]]WU_ZL[/_]WLWEQ<_[PY^VE-'/FNG3[_=/U
MU;ETTCP]_:-[?GIZ\7`A_?.WAZ_7$LA%>H!%CZVA2A3]]/3RVXD4(X:'N],?
MV):,+XL_FT[@S9;JJ"=2L_E_GYR?__9?2(6J/>,'*?"W(.[>42SG,ZRI</W%
M7Z&G%I+MK'3VR\G#Y3\?FF?75U^^?93^M;0=;;KZ6:(OK[Y=7'Y[^"BU->-G
MZ>O9W9<K>*2]<."_/WZ6/M_@;S)^?M#FX-G`(4AWYEPQ&OR+AG0/UC@]\;JT
M'<LTGO#C-]-ADMR1FI*O+(EK"Q\\]9^DCXN=J&[U\Z!;F2]^-A[MQ<$IN3*D
MFXEC8JH-FF5#<F9,PK6W8JPD&P)W$&@#/'@#7+ADTW"3S*FD.398^7QN&D`P
M#A''E)P74U*F4TW7%(<_=7<FG2L+S5%TZ:MB*'P%WY"NK\^Q'XNQR//G"N7\
MK+^#KTB*H<:^=;;:\(XC*=*"5I[PY$^X7)46\#AQTI"`FZ7N@(>3-$-2%@O+
M_`'.V&'Z"IX=M,;27--U&!SXL\$<:,F<,*;:+>D!Q"3$\<(L;'T*_ZC@FV"I
M`Z1*#+Z8.-HS/L;T*73UI($!TGX&R`PZ(2(7%GO6S*4-/0)/T,"+YLQ("?>7
MYZV-UE&22<)HOS34\%BG1X+>P?T0F+N2_&78Z3Y83+&7UHJF%>[.R=W&?%\"
M+%&OW^]U`Q%;#!5[D9_CXCM_\OUT[/6OB][TP&D^%"NOD[`'Y47N>62F_+O-
M;J:7X-'GY,"0ZO!7=4"1.J"(^#S^;ZM#_G"?2`(_L3G^!:K!F<-3#CD[_E,=
M4R10@G,CS&L+1<QV(#^<T*::`7&W!I.T-_W9.+&"<4]-:X[;EC3Y?3D[NX7I
M\M]+#;WIW)_0(<:8*W\QB7F#!T,"Q<>IA&YPPJ>9E[H$(DS+@5E5F9M+[`Y(
M@>>9PU^%&.(1H?,UT92JV1/=A,%+.L=!!Z$!]IST#N]%10C\34SRR"6>')C_
MF0'>"Y]A/_#(`QI6:=D5>`<_+?@5>.F,<F!$[()AV%)'TC$`D5`L%O2.X03X
M"6S!#@AL<T!1V.C*.[8(^\NP>XT<^83@`0-91I\46YN<&>J%IB\=L>[=[=4"
MK^W&;ZAT>W+P6N=N5%=`:`7=A8T7FMR7V\-7(+32SC9HZV[8"=[A.5JA%86S
M$V]IW7:_FX_0?CQ:NO81.^1AHNB0?O1^GE.XR7[EG_B:]'].P[]1:Z=^<PG-
M7R0T?75_T^O(PX_PQ&XM>R>SX?;!L6LJ$]^%7@,Q@;@<T_)^S$H4O7&ZJ<5`
M=Q?,,.<P<V_L<)N`HSVN-^K^&N`[E>R^PX>C%IWQK/SX^*)8E)Q1INR6:S87
MUN8"_DQETH'FA?N@'C(?EX2)@:#'/1(/?`O\P?=3#?>I<,^:A7:U;39I/9G/
MI^=7_SCY%5:>>.@X&/=<BOV7(X(+]25Z6OB@0X%O;5R+X5WP7WW.W%;\WR(O
M,?!=P5>ZLM^Q&GC!_3;0M?N5$.RO6V4-SGE]?NMVH^>41RAKXBR;K(G]`F4]
M"LEZ)([&H[L[QRCK4799CXJUZ^050J\[DEN]@3P\H,1]03):KT7]O0ID_%CH
MVD1SOC+:R5=A)6C8L#3_Y<3;%P8ZU*6."[CY0C=7C,$Z\5F;L(34/UTW)_37
MS?2.3<PG`T'V^8'DN6EC/N`=K9"O-8.=_=#\PT`BR.,7/[JG@8-3_N/)KRY1
M=[!*5JS)#`,P6(_KY@+YN^3+<<[+_YS&LK@V>X5EL[^1#BOG$)*-M-OIC5H]
M>73T1GJ'Z:8[6Y,HC5+;30:[D6N[^2BJE=5VD]9N.C`AMEMC?XU^K'9S;NJZ
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M/G%_PR?NQV2FQWX*7'59=P4D5_0:X!N1=;?`$_?4\&=')VO!6199"_8+E'7H
MTB'\AVZR]*)`K,<HZZQV+=@O3M8;KA+7F21O,9-$SIY:)A<[T6TTTCJ3I"+;
M3L=G-W4F216V;X[,;NJU]MM<:Q^9F1YYG%Q!67?6]S4Z;??"59U<]JJ2RX2Z
M*[39$S9`^M09P:*XXV8W#FL#S,$`><+"9],Z4U6!U\BGN.,R1F$?!S/&VAN^
M<6]8O`$FXY+5VU9O=-LJ^]YJT5-VLI'6VU;5V;8Z,KNIMZTJLFUU3'931V6O
M,"H[*@.L]TW?ZK[I,9GIL>^;5DS6J:LG'IVL!6?9M@B)_8)DC2"IF`*UMD?=
M;A^YK%W.JK,=F[Y$[-')>I3Y[,5E/V]9IZG%?0SBY:45G1@,:/>7'"45*C0U
MZ'1:77G4.Z"X<@FYOBK_,JV'U8+9-],+]NA`F,/+9M^SR=*BJC,[1TYG2UH4
MW('%^JV5&R^%#"3DMHHVD'I5^`I6A8<TG_KJ<]6N/A_6&NJ+;96[V'9`@VAW
M!BUY-#[Z^..SHEE4L_+3ROOS-^@#S\%6UW@*MG/XX;5W92R6CDV-==Z0@?1J
M`\EN(/(;,I!.;2#9#:3[5@Q$ED?M>HF[Q4+.36N!:Q^&#;^]1>Y1[Q<5+BFW
M=%6TO/?Q26I4\,Z:N\7;;M4U-EY#C8VP]0P+MAX7#O\8#QG#DNH7*2GO:GUG
MW*UWL(]P!SL"#E"T@=1;D)7>@CR`-=1;D%7>@BS;(.HMR"/;@BS?0.HMR*/:
M@BS?0.HMR*/:@BS90.HMR"/<@BS91HYXP5^"I%Q\M^.7E%SD9FT@4_T8LZ=#
MDBIV6SMP(]V]^S2FS=I7`:A_L"W;:VV"ETG.GBQ&+?ZA.;/KIVMMRNXG&H/E
MI7WMI,Q]R\+O$=XP#=MZ\"9\J;9^_&#ZM:UGLO5#W(JM@JT?>>3]&JS\=9A3
MC:+TBE"4#FM*];V*UW.OHF3S.>ZE7:&2:OL;*_WCEE2[V(V5X*748P0$]245
MO5^Z@Z3X-_#'_P=02P,$%`````@`RX!I028)`<PI$@``2>0``!4`'`!N=F%X
M+3(P,3(P.3,P7V-A;"YX;6Q55`D``TUPG5!-<)U0=7@+``$$)0X```0Y`0``
MY5U;<^)(LGX_$><_Z'A?9A_`B#L=TV</[4L/$=@0QM[9?=HHBQ(H1I38*@FW
MY]=OEI"$`(%*0B54??JA;8.@OOPR*RLSZ_;KWWZL;&V#*;,<\O5&KS=N-$P,
M9VZ1Q=>;MUEM.+L;C6XTYB(R1[9#\-<;XMS\[7__^[]^_9]:;=KZQ[>7<:T6
M_!E\C]:NZ_5F4XM>7[KN^LOM[<?'1WW=^O%.[;KAK*)WU]29>P:>:_#)9D-O
MUG2]UNAK_Z<-OK3ZVO1I^Z!MD3^^\/_>$<,:H";L"]F@'U]O8M].G`V"U_C7
MW_*O:@Q:(-#V8=[NW(T>]V$X=`'/-3JWVS>C1WD[>U_\T?*?U0>#P:W_;O0H
MLY(>A"_5;__Q-)X92[Q"-8MP`@T,GV+6%^:_.'8,Y/JLQSX>1]6ZC<0]^03_
MJQ8^5N,OU8#`EE[_P>8AQ"-ADANY`98U;<LS=6S\@DV-_WQ[&9WDF+]_>^\8
MW@H3=TCF#\2UW,\1,1VZ\H4##/X7+BDVP7+@<[50+QSB7_Q7Y@A;X8/NYQI,
MC%FKM0ULW>;%]`W9G._9$F.7"8$PC'<F$\044>!HB5W+0+8PHG7!D&8NXJIB
M$W.RQM17D2@]S"D>BXL#-'?.:DWQ$A-F;?#88:*@C*(-9P\48LM'V_D09L@P
MRT"3W9*8:YAK5#"V"5T@8OTIWLW!XQ2-86S]V[/FX'*>D.O"X".$P[961>.8
M>:L5HI\3<V8MB&6"8L`=&H;C@3\DBZEC6X:%Q=`QA@KO]$+H_)^?PAC7A;L#
M(92OZ-W.P*1;N*9=Q_CC&PR7<^ZRP%^)VS]SWY%1-&MOL^\.A%W$'X`7%.-@
M)+YS;!N].XB*NWB/+9!1,+P[M+9<9(\Q#S"$O"BR<<$8GAT7K!M]<LL1PD"<
MPIWE[XA2L.>QA=XM&_R5$(X/9!<^O`&]V^%VY1#?EL5,US&*#HZ>$/%,9+@>
MA=X]!E.%:,2AGV"Z$Q,Z/WY$ACA3*]LI>NB-6TT&I\-MIW"G$^]%&;#POE22
M`\SBEM\-IW!4\6#D'H2V;#$P/":92PY*LN#AL4G1>,0&UF?NH5R(OK/`Y4,L
MN0[>1XM`<F4A>\@8I%?@-T+G"F\^04_Q*)X/W4=DT2=$_\#NWY'MX0D9OF##
MH]SI@!%;F93#I361O3)7&_I^':FCIX8&Z`IL;&*.\0;;KP`<C\C:<R/9)^0R
M21F,/JNKR;ETJ/N*Z6I$-IBY?@IT9R/&X!.@5C;<@"S<YSPZE(]IF87CR1,R
M6>'2)7K'?'T+_&3Q?2L17_*K#S_XKYDQ&^\&+@EV:$J3-?\S[!(9`3.G>(^;
M"!<<E;?RD;(W>&M$'L`*MV6RB<G]U-9#F?ZGMR*Q[SQJQ/.L.D`>-C?,692L
MAQ?HJM0R`+#_X/`#T3G+J1:'488*U\S4L<"3^/^?S9N"TE@6S'[Z5#3>>.27
MRXOP&+!P+Q)']>A!"(^?+&*MO%7\#8B=?;?]1N:8QM^(Z,XJA[DR[+5GV(5;
M13S6S\4RC_H+9SF.:K@`TA;(W:=["H.[8:V1'7(](0\0>Z[Y[V,'98J$?4-9
M(W.U7CO8+EJ6P_PW"S*>!A?NR([RX$SN"1F%1PZB^7`6G#PM+AXG@Z1FAND&
M0+&H+_]NN<L[-(>@3`P9*[S4E`HL$W.L>%\^\]X9_K<'F!XVO+.*F9J'-Y)Q
M9+)\@"/`"S@3P[/],70,?X?/6ZX-'V@TFEI-BZ8VX/=OP_'P^>Y!F_WV\/`Z
M"[^>@\TQR[=%A7^X,.Y!(.JC"G'9CA$\!8,\MK_>P`O_VB:0=Y`J`9IZI]]K
MU_5VO;O/1WS6V$3LW9\_]5AM@=#:GVJ^Q;;+PE=\YFH-/9B)_4OP\GY3^X!M
M/AWLT)#'LXBG%*^1-0\"]!"YWFZVN]*@)[8I)$+,&(8TE,:DSDJ(?M<1E=FA
M$&CX:Q@:-]H'MA9+-_QK32V'@O,$X[O1/`98'3^^WLV?(6H<V=O^/'GPQ"WC
MT2[_<,T"`]YG`)X14B"?R^/!)OS@`_:&C[TN&[IW,$Q^@O_W,X%ZM].1IT\A
M""7J-S,E@;I;"JC[L%HQXX49OU`5T3+H->5YG;3F2U1S)BH"%;<54/$NF[QS
MB$LAD'O!!@8S!E'?"`2]-IX/5[S*Q>IZH]7J2]-V!B0EZCTO/X$)=!0P@8F[
MQ'2?#KVE]SK2-'W<8(D*39$VT%M7`;WMJE9B8Y#>:;4;TI2:$4V)&K^$I\`<
M>@J80S`9P7;^Z1F[$3GMCBYOG#[3<IE#M"`!@4Z;#164ZHL.,O?E]=QM&Y=D
M=<X:4_=S:J/M8MJPE`?T`^CNH"<QN3O=='&6=TS_+KD3%+V:.=Z%TI_LEV$/
MJY:T)^)?9_X!41P/WG1Y+C)LI@RC3!1)H:PS;;Q^=H@11FXP5,NK>HD#*4.M
M.6E1*!>-A>9Q85K-IKP1)+'-,M29+JQ"*61L"5.45.G=KKQBP7&#^>.7^'QE
MA+XY:+6DH4]HL0B3$])":']I4E<S8CF5^5`/SQ/$[\`_F6E/<K.EZU*(`(6"
MLC"3.S#/3ENB1TEN\QJJ3!%=H4CN'IL8\,]?\`83+Q*FU^W)B[23VRQ=C^FB
M*Q28Q5=!3=YM:[%=918*U6VWY`5HY]LN7:_B5"@4ONV,E;AW\-.*RF:]SD">
MRSW9[!5[ZQD"%)H:N,<4TD*^&C"!AGY#XO3\N9:OH%8Q&E2J",<D`<E[#7G3
M[[&6"M9<`O!092GZ52@K232^6*K?UYOR2E<IC9>GSPPL*)2@'$1W,7EZW:Z\
M'GFRV3+U*2"Y0BG*B7@N)A>$=/)"H-3FR]-L)B842E[&#EGP'7GQ@E==;S;[
M\G+0I"9+'$+3!%8Z,XE[G([$)<_G6KZ&NSTOOT*Y24SP(=ENN%LZ-L!G?#++
M_>1LM"3VS93F\\\C)(G2[7;EE49R@A<W3%']A-::PH!"P3O?8&5MMV_[FRO]
M3=Z8\"W>]6Z_+2_$.]/PE94K2$DUHWAYM)SRXPK%P"]\(Q7!\P=$">B4#0W#
M6W&V^`9NTS(LOJ*@W9'GR-(!%&'[0OYYM]HB$R<*N;;A'*((O_TILN8C$L3]
M]4ZW*7&-87*CI:M50/AJ.K"3HU2P#3C89B1S$^!A:Z4K[YRX"KG;*0V"^I@D
M>EMOREMODM!BZ<I+DUJABD)L+/!7<>T=`CLBAK/RCX)]QN[$?$4_P+E(K-)G
M!%.^Q\U/ED)UBE?JGU[U&3?N7J,K;T`];K!TS:;(G%B2J%U-?;_>'A(PAK_%
M]_ZW#_;^SUZ'KP]/#\^O,VWRJ$VF#R_#U]'D.<,I`.?.M,Y\&,"=P_R\+-AG
MSNJ]IBYQ4<9!:_F+)M\Q`=EM^*[A?&41B[G;4VR";Z[KC69?7DB3TGH172I=
M,=&Z_0Q4*)1OO&"&X5F^8OV>'_GG^!MD(J$ZS8&\P.=LV^5J5YP&I1*0<$_T
M=I4;L%'O-9KRJK<)#9:KQA2)%4I#=K'7(_"PK>=Y%EGL!J-OV'1H$*-!:(;9
MDT5\$4;$Q10SON-M_UNV,<,3=I?./'8")KBN;F<@S2A*E"3_0!>`(8M=.W6]
MU9"XKS.AQ2+ZRG7M)MH^DT*G0@/D3N"M+"%+=5UOM^2MU#O5[,]C(T+$*C3:
M?D<6X6Q,R&Y5U8A`F.A?8\13Z"G%+J08>D.7N,13%,;/8TBYB%<J%-A2%46C
MNMZ3M^;IH+6?QTS.T9A8WKQ>-233@.0?9J"W._+RM(06?R:S.$]G6"A38?4Y
M8(\'7,V>Q)U<>VWE#[PCY0;=\ALFV.33MXUN7Z:32VRU"*M.T\'.[M(%3XQ^
MKN^6"F6@_/Y?S>0CA52Q!'57!SE=,4D4__I&=:(ZZ==Q0-1.1^*1=V$S1?3_
M;(I*%%"AV#0LN+%`$%YMD[@>_Z"U(O1UQL0.JXI)0E;3F60H]>]=35%O=KOM
MI(FIY(.[1;ZR)!UE%:Y:A85+IS\[9Z<_[R9/TY>'WQZ>9Z._/VCCR2S;-&CZ
M=;HYYD./EAE$2PRZ`UU>*G.FX?PQ;+7#[M3)E0RJB(ZG.2FQ0O[PU(*7-T(Q
MLJT_\?PWQ^97UN\*3+MSI8?48O#6O7^QQA2#:/.(-KW5;LB;%9<%^VK&5(H>
M?BY_WSWO[X>SW[3'\>3WO'[^\(;R[/X]\0R\K7I`N7QI$K['VY_U;J<O;_8Q
M"Y*+1@#>PI0Z&PL8^O:YO8HMR@6"V\K\70C@+.5%R.)`"NGN%ZDY-ICD(4^A
MD>:$A-L"Q9&$$K?7B0.IO'FDD5<MAY_'/(*[:`\EE'A*O#B0RIM'&GD*+6@/
MK^%[=88&\$3QZ=M.(.3I-R3>UB2.I*!2>GZW&>ULR,F>2F528,C`>.Y7P+E(
MT*N>$+_SC]_D?$[>=KLC;^]#3E35L9P"6%6HE'O444#^N<>)PL%IR;Q[R,MK
M4]NOCF%D8DJEM06')C\Q3]ZA`-)U&E+OCA!%4AV[R,F>0J%J7,018QZ_*'/O
MPEON_=KRTOG4]B4:@U@\GF0,Z4PI=$+,GI7'+I5_^(&I80%3W+8E'NR=VGXE
M32"=*87J&7'!7O`ZO";<W+\$(Y&L=DOBLI[<N"II,OF9571`V3\2K=UNR:MT
MG&JVDH9PDA>5LHL3AGT@6ZLDG9^"4$G]"_&E4$$K+D]X'.*)\RWYULNVO`$C
M`Y+*6$9>]A+/:ZAH'JKTBHJ+)@-_JA46]WA-L6%MF2+\)F;J6G]N%V/U&Q+O
MACO3<&4T+$A.H.Z!`NJ>+1'%W\`%S?EJ#DS85AB]VY2HZN1&*Z-E`4["#JW"
M#I/8$ISC`E>LNM70!V5L<3P'HC(FD(.ST"24F'TZG*L=D>.[GD&ZOM0=:ND0
M*F,/F?D*K:%J^X`R6D.0M?"Q[NA&/"ZOQ!@O'R@%+$:8T]"&5*@5'(O[1D`H
MFQ^T'G80?IQO0Y=7+!#"4&$#26.LHEL+!>UA2B$)MN;A^?O!-C?H!;%[>\'\
M!RUYJQOR@:JPQ63F-+'ZJ(P)'5R5XP^X9;J3@_8K;!CGF%*HZG@LF&_8NQL[
M#H9.B;/86:!4V#`$^5/HH-A((F!K6WZ+3@MIZ5UY&>W)=BNC?3%F*G:J;-HY
MT13[G,4J;Q/SWF+;T!I&/A@25Y:W8O&3!#KMGCS'D`]398SD<DH#`^JI8$#_
M#P_\*K@>EOV\KKX*AN''RJ,51-/4WX2^1'0!C'3Z+7FKHI+;K(S.TRD)LXF*
MA`F7[=!L-UK^D>3<\]D.\RCFFS1YR_13<TQM9BV(95H&(JX6E'*`26WJV!:_
ML4G[9;8$!UIS,5UI,4^IW=F(,?@@GFN(:=$:])KIT!I#-O[K+_?\9AR;_344
M3&#GYQ;6Q(R!VF$*(?F`^%1S#,X.S9`=KH</<.SSFV$'Z>GU]8]@0_YY]CMR
MZYV!1`>;"8I0C\LH<3":\BDDYM:[8,U7D'4/1!%^Y4(-1YXE.VT*S:!'TD$/
M9WO2?:<PA.ZVR/-!%0(I7=Y:F4Q0JF@@62E4:!7E::H.9.1Q%V8ZL-67MW<C
M*YHJ&DL.(BM6#[TT@NDVFH<13+#,3//7F6F_/'HN?_W)(M;*6QV\&VZ2TMY@
MQ*<';PX7%/NG3>0)6.*+W;80`@3Q-\+F_=;C;T1-7QJAQ+^4[>$(VX8TAL%/
MW_@F)L31!^_7NRV)A]I=CB]_+)/>]CV_(*XE\7Q](0A%>!X9=I!TZ[L0CPJ%
M-NFRA:=\CHAA>W.>=.X8:[=DGAF3'YGZ%B7&NDKSQ^DRO^`5!'\@T<1\A`$/
MV?_$B(*X^C7=<R*H<NPKT3N+FU`JG3^5FP*R1N3%L>&3"R[HZX<#LLH\!C4/
M)"4,)X5*A3*R'+*"B6#>2>15LG*"4M-T#NE4:+-<=FD?'0\<;&L@\6ZW7)B4
M-)U#,A5:Y))#6&O#NXG,6P%S85+3<@[(5&CI2S9AAR8D"3N)6Q)O@;T`F'(V
M=)+6:IT/<FEIL7=<6O3W-6O!<G;ME^%B0?$"N5@[*#).J44,:XWL78'1(5JT
MBT8;.XCD*2K&]U5'C>_K*VPY;'A"HF9YJY?6$_EW1,7)DX;6;'>Z2=-_)P[H
M%_K2_'6^]*]/3@5!BL3=0+FED)8KY]5*V/^+8$BA;#E=W&?H$H&W>_W`]@8_
M.<1=,E_@##=/Y&Y(#:,084FA;%B(L*/,GPN;5$6YQ-?)*(O(-X<T=A3*;7,(
MZV?R7-RDDG]QQE!4J>,*YG#$D$(I:W9Q_?R<\Y<T>UB8/115OBC?'([XJ58:
M>C)["-[@_[U#N@2O_`=02P,$%`````@`RX!I0461PS$1%```KD,!`!4`'`!N
M=F%X+3(P,3(P.3,P7V1E9BYX;6Q55`D``TUPG5!-<)U0=7@+``$$)0X```0Y
M`0``[5U;=^*XEGZ?M>8_>')>^CQ`,+>$6EUSADHE=;(6"5FY=)^9EUG"%N!I
MVZ(EFTKZUX\D7S#!)K*10"8\5"HQQO[VWI^VMK2WI%__\>JYQA)BXB#_ZYG9
M;)T9T+>0[?BSKV<O3XWAT]7M[9E!`N#;P$4^_'KFH[-__.>__]NO_]%H/'3^
M]>UQU&C$?\;/,;I-L]EN&^GU>1`LOIR?__SYL[GHO$ZPV[20EWZZP,@.+6@;
M])OMEMENF&:C=6G\ES'XTKDT'NZB&UW'_^,+^S$!!!H4M4^^^$OP^O4L\W0?
M+0&]QAY_SA[5&G2H0-'-[+UVD-[.82`\H_>U>N?1A^FM[#UK#_[9X?>:@\'@
MG'^:WDJ<O!OI0\WS?]V-GJPY]$##\9D"+4B_19POA%\<(0L$7.N9KV=1=<Y3
M<0OO8'\UDML:[%*#*K!C-E^)G4#<$";_)6=4RX81Z1DC%S["J<'^?WF\+=0Q
M^_S\.[)"#_K!T+>O_<`)WF[]*<(>%XYBX`^<8SBES*'?:R1V81#_QJ_8`#K)
MC<';@E*,.-["I=HZKXKI&W"9OI_F$`9$"(1E38A*$`\`4QW-8>!8P!5&M)`,
MZ2D`S%1D/!TO(.8F$E4/0?*Q!#!&<X6\!89SZ!-G"4>(B(*R9!-G#10@\QL7
M_136D#7=!YKR3"*!-5T`R=C&>`9\YR_Q9DX]CFP,(^?/T+&IR[D#04`['R$<
MKN/)QO$4>A[`;^/IDS/SG2DU#'6'EH5"Z@_]V0-R'<N!8N@(`=(;O1`Z_O^;
M,,:%='<@A/(93-P2F@RD6SI`UA_?:'=I,Y=%_94X_TDP`99LK;T\_4`T[/)Y
M!SS#$,8]\15R73!!`(N[^)#,@"49WA58.`%P1Y`%&$)>%+A0,H9[%%!V@S?&
M'"$,/I+N+'\'&%,^CQPP<5SJKX1P_`2N].Z-JC?J;CWD<RZ+41=9LH.C.^"'
M4V`%(::M>T2I2J,1A-\H=<=3VOCA#;#$->6Y2';7FV5-":?#N"/=Z61;40DL
MK"WMR0&6<<L3"TE'E0U&OE.A'5<,#(M);,5!21D\+#:1C4>L8[UG'BJ@T7<9
MN*R+]0^#]\;QZ>#*`>Z0$#J\HGXC<:[TPSO:4D(,[6%P`QQ\!_`?,/@-N"$<
M^\-':(68.1U*8J>4<9BT4^!Z4V^))X>1.KUK:%%;48Z-IR.XA.XS!0YO_448
MI+*/_=TD);3W\0XFYQSAX!EB[]9?0A+P(="5"PBAWZ!F)<,EE87YG!N$69]6
M6C@V>`)3(EVZ7.]8K6U1/RF_;>7BR[]Z_<I^+8W9FEAP3[`3*HT7[,^D290$
M3)!\CYL+ESJJT.-(R0O]Z-:_IBR,ILG&4^:G(@\UY=^.1"(_6-0([;(V`"&<
M+@F:[=D.C[2I8L>B@/F-PY\`VZ2B61#!!$BWS`-RJ"?A/[>.F^*IL3*8^?!)
M-MYLY%?)B[`84+H7R:*Z"6D(#^\<W_%"+_L!C9VYVW[Q;8BS'Z3J+BO'U+/<
M16BYTEF1C?4K:9E%_=*UG$4UG%&ES4"PKNX'VKE;S@*XB:['_C6-/1?L]Q$"
MI2)A3I0%F'J+!8*N;%G>CW_+(&/#8.F.;&,<7,H]`4MZY"`Z'BZ#DPV+Y>,D
M=%#S!/&2@B)I6_[=">97P*9!F1@R(GVJZ4-@I31'Y/ORIW!"X)\AQ72]9(U5
MC&HA7"K&48KY%(Z`7@"V$DCQKUE4:?Z1]L+GMN.=Q_><`_==/J,@:9GD:UG"
ML\?!9;XI'96/@F%E8.M?EHYM3A^(K7`"&_0JRYZ]GXL6!KKE2=)1IV]HV,@#
M3E7(18^1CY<_ON%!;P)Q5;!YSU"I63@%H1OLKMKUYQ0CIC?2J(2%S2/Z9W*[
M$[CT_FZKTVH;#>.[0RP7L>D)^D<\;##0U,C,!1BKR0`CF0TP?DEG>XQHNL>@
MX9:1F?`QDED/`P0&&TL9T:2/P<=4K+($&.ETB,'G0_[^2^SX_I[(QC2H[]14
MI'GX&M!XG@ZPN>83W;O(BN^B@Q?H?CVC%_XW'5)^>TM__:<#,>7*_(W/&@U?
M'=(T+P?=YF6SG\L4SI(I(!-.E9`T9@`L>&G-.70#DESA/46C9<:5)W^++PM"
M6)?0974Q""?D$A,QUBH/@C??])VWO:8YZ%PHEU0$B9#`J_8TQ(GH4XR\G8P;
MH-T4AS`=S/$ZL=:9L<`.PC0D_7I&_P@)%07Q68M554+LEG;P6Y&*Z&WE^""@
ME?ZGH;QJ236D?%\*Y?L9RK<54CY'0Z49OZVOR:0"Z`WWR,=K'0U/WE&)V]UF
M3S%5=D4IH=T(L$>U%G9W#8(M13HI-AJ3J#95=1P?#EM*-R1Q]W!1%[^Z7>`H
M;<B-9M[QX4FSW:)F5RW>YGME4K^2&3?HO54WRH*AXJ%B:39G!&BO!.COT[CM
M&AAW4S?*NGTUQNVL!&COT[B=&AAW4S>Q<3LZ&W>'OGOD^/`V@![M@`?=07.@
M;U"7(I70C\D)=C16EG@$K#X\+*;81DN4:)>U'C>:L_S")A2A_?4LP"%<741^
M`%^#:Y>[D:]G!,[8+U(;^T;.X8!-7+7'/VP3?U_M]<1>P#&D`%<SR\W>H*<L
MOBF%1,^FFM-I5M6OQC%21DUY,IAF_Z*GBB3;WUT;5HBK\+#AU*_G.?FG$HFI
M[BZ)*5ZHV@@@]HQ,J:JQJE4U`#'2]M68(MP@M(6I2S[M6#E;.LMT!_X/X6?Z
M+3*>?H<3O@KXSY#:?^5$^%10Q[Q4EF82Q%"]`Q)X03PNH6(JRS$)HY#@8JJ:
M-7$>532F>7*IE$H4Y5QT8_KAQ#P,TW/R2E4TIG=.J:1$BJ(HN1S(%?0*X06K
MLX3L^:O'QM-%IGG94B7<UC?OA]0%)DQH+:H;C2?!AZ'%7OY(A=@0H*]NFG3+
M:[6PK)!:-![:L3UU[-"%XVGQN#6:..KVZ`A%43)7&(72OGC5,RD24V;`L9W8
MU<U:HB=^IR_ML](B2EF-Y+O]5D?5!'8I)-4Y7Y(%!Q16UFS\;B9.N%]%;\<Q
MFUY!?XHZ_CTUD>*'#SV$`^<OMCJ3!,U^2YVH@A@.TSQ*S7`7Z4SC`"@59HHP
M61/F!T:$O/@8`I>)](.%@;VN>:F<!B)(]"-#2?UI7#50K(YW(K&]]2`QF[V!
MNI%[63#Z$:.\%F-N=&O%C6//GJIFA5!VM%?'K%BW96YDQ=@JZ0;?_,'([OY@
M_)(NF:^4U2JU8TKI]-2#"^C#/)C,B5Q>*)O36W]5]?CN^2?Z'XCYOQNJ`:Z@
M6]^B`3?]B[TD*6?K]EHY/CQ_Y:[H4R6TN@]4GC2K"F)J/-<X]N&]$_U+I8GV
M<'DG2DXL5F`QD4?NSUQE!=0X?DXDCB:#+B],50G;[(NJ^X,\`RD&+"VYME75
M";4*!=0\(;PIG*)TJ#H>*0:LD$<YF=A"`?5.MSX"?Q8)UE58/)*^I3J!^"-B
M3T^A7BJ%*JU_*U9OPIM\N31W/N_$4M205;!&)515K,GQ-OERU<#59#$K&@J5
MM45^^C/:Y"R&VVEWE<%=>Y,L\A2H.4U6%DBG\1CG#KRN0S;5U?Z\[M\@!=)I
M/)!9S6\]S0&&FSN.LDWW9M%*NF]OJWOB[0+Y_IQQ4K!_V5)?*;$CRMU#WU7X
MJ$C6TI&ZZ`2F;`._CYG?:4;[PHAW_;,B<Y8+?PYMRSR=I(;L:6K(#Y51I(O1
M:N+^LJ=LD>ON\&34PDAAC/):F7VX]P_:F'PR;1;8R#/&D13@2%*ZJJJ<0[;@
MJN^^#UE4&'.-#,-@3LW\%[2;9K^C;N<9Z7`U:M(Y$;]2Z^@\;*@J=WPH03Q2
M8HL,6<8G;R%M04I+XIN/E%K;5:QQ!=*N$O.3+KZ#`%Z_TL#2(?`!.U:ZT3V]
M1.]GJACDU#0J8IL(I..F85FC:%P%M:LJ4@U`*I9]0ZW']#*><A5Q'>2432DB
MYE8LQ\U(83,<MOI**17'8<#/8W?\V:T?8(>.OBU>AL;BCYY^T>%'L(^;L4+6
MBMG:UY6MDX_EGWPL_^_0F<T#:`^7$(,9?(0,'+U^18>WF)U]`EP6\;2;9J]O
M*DLN'$"@&C#\<!:.N7]QA-R/>RLV[;/>]DVF@):R)<CJ<!\WD\7L%1/V\K@)
M*]B4(\TH2\T?0*!/0_$J%HZY/]"5^Q*&%N36CT87SR@`[F;,UE&V@F`?$M2`
MW7NT89*!:6G(YVMOX:(W".,C[?)5<X_X-F^T$?/#5KFXV<_9JM9[%/PW#!ZA
MA68^GZ:^O&PKX[`RU'H3=Q_&2LAZH-JP75>4;1X`5KBBK/"3^$QJ>0O-RAQ]
M77KQF1`IAB[GLL-.@5Z9/?)>C!#9G3HO3&5I?,E8950]R(&4)-W-2_45$!(1
M2W!WJNFW61JAQF+'42:AQ!J'[,3WX0SB=T`['T+LIYN]"W7GU8A!T+6YYJUG
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M$4Z;$)TV(:K+)D02EX:]J\5>6V_[B%QWBC#[(JL_5):9WK\X.\Q][`<K7Z.G
M[#R$/0EQR,I9>4Q7L!Y3U/(:#]RJN^3L$O^T7/X#C;0':A?Z[$>03]8>U#!`
MYWJ$736RL8KD(T?1.ER?+%664\N0PX,Z[]/SD5)N$)Y")PBQL%H4[MR\;VE.
M#406%XY_JZ"<);8;#D/=*>1[$N*3-0CYEC_&?8I&IZUY3UOSRFKEQ60Z;<U[
MVII7APE$UK/<I#U+OP[3A1G(&K5MM;-]^6;28Q[C&/1;/OBJ\S!97"_1;M$L
MYNOKYTF+X.H5UV_SL`J8O&FQ.F<`2DW_\H/.V3@];U=O/;B:`_CSL?4#J^G1
MJ^7SE5=*$A)"^WN(J;HB$;BT)%.7E\Z^LFWU^QUEZTO+XZDAVW;2^1%WTSD3
MF,SM=[6=ELL!7$,ZJK7:YYA:7@4I'6W9N@'W\W%UJ\6.<?+WW>$X2^"X3'BJ
MYVB/?B9^SAD>>IU@]![U)^)M"?L==M?Z75>0=<57D`UIZ.1%9C!>V,>.;UR3
MP/&BS]'4N`$.-OCVHNPO_J1XL1DQN-Z@+6^Q608.0W/KK[",IPP)!T)-F(GL
M8A"[+DA[=\;DZ;#ZS'LD.(EB]9X.JS\=5B_(FM-A]4IMD0OV=%B]9O'KZ;!Z
MS0QR6B=6I@\Z'6V^V7\5'6U^=,O#1J?ZJ5/]E*SI@V(RG>JG3O53!ZN?VKKJ
M*#UW-IW,X"6S^BFRFC`:N0/EJ>E2EM4Y?*VJE530S*S=HT/^N,&0'3(',23!
M(U5(/,;BRXC4);OW),61,GP'6QYC$EU4'4P/IG[G$HO"_^1DSEKO&%/KPHTZ
MFG/A95;Z)3!+2O').9UCRV/,Q>>I@QTP8+%,H+-T;.C;21-7=X*.<OB?B,P?
M64_W@^1EZ^$WY-+'N%3(];BKK>Y`DOW)\0EY_:$]=3\M7JU">"QVN-T4=A?@
MTU,Z:T'=#Y)7W+A7,5A/67)V?W)\>F;GV%/WT^(G'RMD4D8ASQ![9M/L]17/
MX"G!70,"*[>7SN?!*]'`:BD%[YS:W5Y;?(OW/2#ZA*0L-DFM#X#OM<SW!=<O
MS:>F\0,M(?:99HSA#$.N-@/XK`3;I>Q'&$15U!6JIQ\0%93PGZNWI"\9^O;Z
M*W:MC<X\;0FS27/ZIGOD6P4?/]/?"+`XA!7E!@-E90TR<<HH`9&`)RD_:.WA
MD'=9<"6X-I6,VZP.46"GXR@3D6X&1;&C'@U_Y8JOJ%$Q??`CM*"SY-0P6YVN
M,OFWO5G'UIAW;+"@\C2NI$B`DT>XA'X(FQ>MO)A3%N777U83,V_1D<:%!/FG
MGF=T\+L3S&^@S0Z^SA*9L'(A*\08VO<PH..Q3MXY4RJ/FR^+L28TDF\0C0L`
MDO'3%?W`L8#[C!W@<EGH&*IOYFS+5C"L+7Y03<PNI@F-$]XO"ZHP/Q@Y%AU3
MPWC@S+"W<V*#`BOF/J,F!OQ0?HW3O(_H#;C!6PR:/$#,#D4<3V]"-J7Q@)$=
M6L$3<"$G8]X&R`4&%7]P3:Q<35,:)T`?4$`%H+Z&8F?E"?9-R/<K&$^O7P/:
MN5`G%'ND3&_$_5(L.Y<S9^J\@!$[OZ\F1)&J5XUS,DG4RZ;E*>2+O+1@`16R
M7ZV)58NDU3@KG!]/KLVB-MO]?E?\7%^!)];$G"5UDP[0VSW=K+P9-B:#@6;[
MPFR)AV#%#ZJ)3<4TD8[(+_0SY>Y*BM>8#P;*4MK20%:?D_SGG'P#V`:)3^9)
MNO14Z'Y+?/"XY4EZD#[?G@GC!16A\<8/B031:K0;A(>V[41PHA5I&6G$^RG!
MI];)Q"44I/%L<CQ&3K.Z;$9K-!LY4_AD.="W(!D%68ERUI`6F+S$D^M@]HJ*
M2DW?T\[T#R"8_P8LB_;B3\@-LSI@TUSB<4KQ@^I@6#$UI$&*?G:4H"&^-<A@
M,%"URYLDB-4#%+DLTE=+.C6[/%*M!N_2[:'Y'GXR%:IH5[TC:Z7Z:DG+5IJS
M[:$">]1@S\33]JRG[5E/V[-JRYK3]JRG[5E/V[.>MF?5RR"JRKR5[].ZUW)\
MY2,C1>K:Y\A(=*]893R3&/VOVT7['6??11JUVCI8.1WRE)-:5/*L:!F+%BVK
MBZ^S'VS](+WR_U!+`P04````"`#+@&E!2XJ3Z-%_``!2:`@`%0`<`&YV87@M
M,C`Q,C`Y,S!?;&%B+GAM;%54"0`#37"=4$UPG5!U>`L``00E#@``!#D!``#M
MO7MSW#BV)_C_1NQWP-9.Q*V.D%7)?&?OO9R5;;E:=VRGUE)53V_%Q`:5B91X
M*Y/,)IFRU9]^`?"=?.%-4';$S&V7$H_?`7_GX``X./CW__[ML`?/,`A=W_N/
MGZS+T4\`>AM_ZWJ/__'3;W=OKN[>W=S\!,+(\;;.WO?@?_SD^3_]=_M__]_^
M_?]X\^9V\C_??OGXYDWRGTD[8'II78['(/O[4Q0=__K++U^_?KT\3KX]!/O+
MC7_(?CT&_O:T@5N`:HY'UOB-9;T9+<'_#59_G2S![:>XX-[U_OPK_C\/3@@!
M0NV%?\5-;:/_^"EIG[3L!X^_C$>CV2_QCS^E17'5K"1&\G5"REJKU>H7\FM6
M-'3K"J)&K5_^YZ>/=YLG>'#>N!X>DPU$M4+WKR'YXT=_XT1D(`O5BZ@FOV02
M-);`__4F+?8&_^D-&I.)=?DMW*80*\+4=_(3&C@`XJ$+_#W\`G<`_^]O7VZR
MVCLG?"`U3^&;1\<Y_H(+_+)W'N#^%^>;&[Z'.^>TQ^-(FGD*X*X\X)4&\#?\
M!>ZC$/\%MQ:^(9]U9"52_)\U[48O1T2MT#T<]VA(?Q$$OGERO$?X$?\;=RT5
M?$/;<@78!<[C`7K1>W]SPO]+:"55C-8>U`A#QDR)$*66V<&?:]`J1K^%QP`B
MC8;;9N2EJOL@.*^)%7B%%=B:$\0-;2K`_![]'Q6X*^U*P^[!1Y[!3JJ=(ZYK
M33;46QBX_O;:DXRYOEDUX.\B)VC13'[XU89E"W#O1\Y>+O1JD[)!?X:21_N\
M0>FCC)PZ9D/2,<J5)B6"YAC>J(J3=DS)#/<1_2LIB5ML\<SB63%V-@LMPV\1
M]+9P&SML6=O^)BE%>OF/G]`?_K\K--]M\9SW8>\\7EI3Y&M;E_/F636$F\M'
M_QF9=C>>4-$_SJ=1]*=RNV5T>^S6^D$J>$GTJR#%N`O\`PW$R$>EG(>S4LN?
M@!]L88#6(#^!([(?@1N]_,=/:#ER"A$$_XC=$R?[($ZPZ1CII,0O&Q\YZ<?H
MS;[Z/5&16IG.!KT.*\/'KO8;P-`_!63I<-BC;O!2"WIO?KO[";C;^@[M[`\`
M_^7??\D1=E/FW2D(<%-NN''V_X!.@&86/(M?6K.9)/8T=2%&)&K@*:<:*XQ'
M1O.K%;=JKK5U;B<_@OA7@'\&Z'>`"["Q,%UH7'G(LXG0Z-]X.S\XD'7'U4,8
M!<XFNAQ/)\ME#2>]9^<;X=UH-1G%)AK]A:I-,0IRHDX)257=FBVMU<)H@C+)
MH9JP+&#LM#!P$&OCXJ!0'OR1UOA?*NE\O@<Q$#X7MC<8"&V-X]&?#Y[2!4GH
M2;UMWE&11.X<EG)ZQW8_7M%]0'\+T:Q09Z!YG(;&/N10O!OZ.:FK-:SQ9!`D
M;D"NRQ+7=Y^3,_$>X@*`E!"A(_9"TB^Z4$+&K`>95&R&74_$O+PU'@^(AF>X
M]9*PW'F%@L2!%2!@MC47KT/FEF3ZE=J70[YVR.?4*Y>>F+UN:@:MBW25GG/&
M)=9.;+5TCP!=CO&$+Y5FN%DY[*H%>$XJ4F@R#!N68=5%H;3#G#GX+VQTB3V_
M=ZARX.QOO"W\]C_@RZ55NY;FX4UM^V($HH.<,JFA],@RFE,MJ%6SJ[EK.UDF
M)+\!\B-`OW)1SC\<?.\N\C=_WCTY"-?Z%)%@$==[O+16LNQ6=V=2R,@BS!DS
M6ZN.9D.@::<(FCC;A2,C,"D(2,D+$)<%A<(\?/[@[F'P#DW7CWZ`K9&L#?*:
MUF4PMAUNF:+ELBNS3UR:(.NA8*7?E'+D!Y#^PD.P+_#1Q3LR7O39.2!W?"EK
M`5O7O`R*=0`N<^R\\,CL]4,S:#T\J^DY95K^$\"_L5'M/G"P`;Q[.3SX^TMK
M(8MCI7;%R-4.,655N=3<;#95P:IF4:5'._D+B/_$QIJKS<8_>5%XZ[PX#WN8
M'/U=SJ;SKF5$>^@>_LLYFY(_-_0I&']`*4<6B5!??CHV>W'1!ELU\5KZMM/?
M0/+C!4A^ELK&Q2MAXX*2C=9L.9Z;[;-U(*?G9-00'\9/S`1#SLUC_#L?);_`
M#72?<?W/,,H_Z*QK,UB<F'4]RZ$GG4SG)*VM-5F9/4]W@]=E/AL1Y$3-BUP`
M5$C0F+9^9:4FM2?F-IK7VEK68FI-!TS>%+]64]N&).=QD)5B/'E#+00GN/WH
M.@_NWHU<&&;?>-89ORC$V_INA4E+*TV!L8U5C.=J&W(-5K:E>SOY&11^Y[>N
M'1]5E6GMAZ)U1K6A"G&\5@-E:0I>ESEMAY$1%GX[0B^$(8GY\J,G&(!-$J:[
MSVLS4_AT..WQ[8PU;O&=?S@&\`GUXS[#&V_C'^!'/PR1A5_O[IUOE[/YJ.ML
M1XC8+&"$Z2XF>4$)F!J:&WX@SB6/!IO.#,HN5`*D%BA5`W$]\#.N^1?B9@-_
M!U!U/3JD:G(P7X?J)A*FAI!IG!D>&\<KDJY)AP=<2:.2&:BD42ZIRJ@^VZT;
M?ZE;Q]W>>.^<HQLY>T26\4C=5%/?J:`ZT$J2T;ZAPGQA=OAQ*V[E4T%+YW;^
M(\"_(D*"Y'>YI%1CN_L@9=46-U3`[NC"\)WH#NAZ;&L[B")%CZC`&T31#1=%
MPQ!&X>5LN51H)DD?@@1LP)GQ+?[=LB93L\E5Q*G<R!4ZL^/_$&+':B#L6#6Q
M`Z^%S8ZF.T/*8&L:DD\PT"3NTR9I+(##39?L)N!LI7"'M=25#/8TPBZ3*+\C
M:GI@9BU>/2:GW&EB>KBO$]9_'S7.DW):53VELQ%#6C@SW'&O1ZS'+ZKMV[ZZ
MN[N^O^.A5;8]O5QT94,1I96<#?9VU&5699O`IE]%K8.KQU25^DPL%>])3NVG
M4>@T*214@PM5/%68&7XR4PM8HT-UUG7B5Z6'+?S^5=)N86)1>)A2UZ-$OC4*
M44N[W.R/5@,BWQELK7:MW/>Y?1-TR1H^HD+/3!\3&_RTRK!BY1["ED,3<(U>
M6P.$+$U4;!+_RLC$9\?=X\B@#WYPY^SA'406MAQXL%HH-)!=W0M2E%VZC*^=
M5:WQTO#3+TH1E%M4.AQV5N[-S@_>A*@DR(OR.I74#%!C=DWA=]4>=W^4V7*Z
M-'S=0RV$'CM-"\>^>_*#Z`WJZ@!<[QF&$<X]$`*GH@&,V2;C,XR/T`GA^F'O
M/I)$5%GO\^EDH8SJ[7V+\9Q5KBPG97L]?*)NF6W#*2700F\Z+)D_<D04QVG0
M_%UZM@;VN*H42G]&@YM_?76WDCJ[5T+L-NDZN%VH2CZ(V8D`Z87HD^%5.#;Z
MTYN-9**'3U?>%O_/]3]/[C,R_FA*N(K>.4'PXGJ/OSO[$[R<SV9S9=XX%011
MPG-)F9.>IOK86IJ=TI5%#-7>.0,6&Q<BD<_D'X7B%\")0%H#D"HJV:_(U!O&
M_AJ33U.=[`N8?;;*)H@FT\\`*5>$#?X'S"LPLMX_'-S8]\=]^UZ$>H+>!JT8
M+N?+J;I]EY:.!1G.(E'&ZY9*X_G"<%O>"5ZY!>]"8!=*Q.:[6$8^9=68YSXI
M6S7%+95(D*'9F]HT\/68W6X@%?9NQ-B;Y#=+YEJ5<0OGO8GSM!U[D9REDN.%
MX<ED&Q#KL)S5;NUR<CORRP6X"<,3W$JBFS(+J8%NM;:P5)(HKOFS=BUF;5:O
MKO>4>6',O/\VNAQ9X.@$X#GF(.K\8A3_?Q#&.1>=4_2$AO9?</M_$>-H3>;H
MY\G%?#%/B[B$N<FOLXO9='DQGF:_^GG21KR(NT-#"P\/,`"3T05Y$S:N:"TN
MILO1Q7*^J&L6_3H:SRZFDT5#L^_A)FG5(JU:C"F9X0X&`=Q^09/`._2_;I;L
M8#%;J<N0U=BMF&HQ2)-E<VZL,EG.S+X0T@5=M9'OZ-].?P>X`(A+<)XV=G]8
M)8:_-YI6IH+F*M9D.3$\XKL;O);)H1-&SE@9#"UL;B]F"IWAMIYE\[1-IF:J
M%FI-EI;9)]\4Z/7;U7,(#:8U+Z:`NYH,K%;N4IC9\R.JH;D$-?A[,K95)'+L
M[3/T3EE.Q,5\H2YA87V?LGC:+D>5H:7RD]72[(V(5MSZ+&JU\Z(M);\*NZBU
M'U*Q^=1&R!:362I/5-SL7,,=R#6;R3H,10-)?A>B9'$"G,_5G8$U=BN5F&W2
M-'"SZ$:MYD/Q0^NA:S:9Y_W76$UQ[[/IN^JPG?I8VF5!BW[2?#2=FAU'V0V^
M#SM:A2%L2@/WV8G<9UB3RW`Y4A@[UM:S*%599,K9VE)K:OZ<WXE>O67M@F#G
M120D<J7ZS(I,;*_4K3&T+;6LA359#)B\*7Y-YK8;B?UW)R!/_:3Y6QF?EJKM
MHV#8E]98Y:9J:^<*V-LF62N!"Q6G<\-O7=`)T(L%/D?1:(3Y_5RZKZ[/%.OF
M,YU!/M\G-#O@BU:$_LQR%8RH9?[5][=?W?W^TAI-+'7;K6DW8N1L`9O2,"NR
M6%EFGZ2>(55M*,O=V>E_BK)%B853Q9:*T<J+(&TR_.2]@E6+&3KOE9LXSS#P
M<'@J#E_%J1GR5UE^\Y#AVL/MU8&\Q((_UT1=N!(#$E'ZB8B<,Y2^E<5J9O9-
M1G9AU%M%1D1V7@.D54IO8*6U0%)-@YXHLL$FZTF-)6=H9;:<3LW>'N`11]-\
MP`S,SE2"^XVM@@N,OOY"X=,NA9[$:-T..:5MJ=3(FIH=DE*#5K6!KG9I%_XD
M@45*<B>J95$E<6*I%(Z2-_L\M`XN@_'B3YI8TW&2,I'[7:I"DU?>EMQ6>/+W
M:.A#?$,V>L%?;:)N7=W5O33VT0I70\F&JB-K9;:W2BN"1A/8AJ-H%\F%D_A7
M5716;3=[I7.;A6VHBLS)TFR?DEH&W;:X%4W50!-RAX4*_T:2"\BF>I9#<KR:
MJGNXA!:%6N8WRTJK`(4DL-9PW`\J4?JV[V=X&NP\=YY=9FXHV6XP5`\J^PST
M'PL_=3)L!Z<BBY8=!E94]L>;J[<W'V_N;Z[OP-7G]^#N?OWN?_QM_?']]9>[
M?P/7_\]O-_?_X%:)+!#"FL_5;4K+CJFA$J"&TEGAT6AE]EEM,VB-YKK<<]$P
M<\9WM7TWU0ZW<N*U.=6%8/FQX9%;+:AU.\YG_9\]_R!C3^/=63[U\6JB[L&M
MYGYED[)9GF9N%MVPJ=F).[K!ZS>29PAJC:4,'[;I"ZOV6G4SMLTSK0PY]I2&
M2]D$O6[OLP%'EKNY8%\9'Y3XZ'N/]S`X?/8C&-XZ+_A$[-(:CY<*-XIKNA3D
M*)T0&3UKBR//R?`U4@MLY4:TN6^;_`TD?^0/9&W_B&ILIF8F5@UE;7$<3FFX
MB6S#K<<XMB!HRO;M$:(>X\)LY"QVD[FZ:/Z;*+.2-3V*49-.A)29]:6MB=D7
M`5I0J[:0S5V?&TBNY7CKUU-B'/42L&(::TOCQ:79"2G:8&LQC"T`ZI[Z$+")
MZ^@)!F>//TZLA;I%>;5#,4)2"9#RL:[P>#8V>X.H&;1J<]C8LTU^`4)/S[9]
M."6V4"?S*I:PKC!^E\KLU4H+:BUVL+G_A(&I@\CS-&VA\>(]J,EXO-!A_63=
ML*,5HX:)Q?+C^<CLY4HK;HV6L-+YF3'D73IW?$?5)E$3'=L,X]EMQ)'9)X;M
MP'6;QRJ$A)9>81G-8R5O@R0Y2C%S]M0:JULTU_0H1DDZ$5)"UI<>C<U>LK2@
M5FT;F[NVLY\DY/5O_8I*K*->(E8L8VUIO`@TVV=L@ZW%*K8`*!"R,=U_6[)_
MSZ])Q%_(NL_,Z*/C;J^_':$7YNO\Z7BJ+F54;9_"K*82H\#K^O)CLQW05MP:
MC&QCYW;R(TA^Y5R0=WQ'5296,QWKS&Q=>?SHG-FWY]J!ZS*US1`R6L+X9V;'
MTS_"('JY13U'5]X61VL>\471SQ!_SOE*W2J]K6M1<C()E7.TM=K*\,3Y-/#5
M&]!.#'9:Y@*04EDT/"F'5O:0V:+2?&U%AK5?"M>8V;9J.!3&]`46!7Y-1K<;
M249EPF&8<]ACY?`7&$:!NXG@EO:UUHG"ZTV,:,28+BYZ2G[VEE:&Q]=Q2J3:
MRO/!LO-JH.6Y;2ZOFIM$2J:%8>A/9?)@;VDY79J=?HM7)"U3#">XHA[A1[KE
M:DIIBWLR59?@E1Z(6OUH%9A6-4J-K`R_2LLN3-\32@41Y5S">TK(PYE>9I(^
ME81Y_C@_/3-[AYU#&B-FC2HNT0DC<EP/;J^=P$-347BUV9P.I[V#6GL/=^[&
MQ?U,9^KVB;H!B'*?0\"<\]V5YVB];CC5:850/Q%0(K'3DB`M"GXN%`9)Z;^H
MX[HB>V\.UVOL.T7EY7BQ&CS9$RDTV7-:/':1X-OX-S9^WT6H+MZB6N\^N)[C
M;5QG?^N'+OX@V8VYZ6JF+F<"#0(QBO/)F'*<JC8Y>C'[>@>3'*JM.@L8^^W5
MQZO/[Z[!W=^NK^_ON"\7U^6FFL_GZMP4V7G/J`3(:5LMO!R-S;;$S:#5$[*A
M9[OXR[^E29JN(N0^/YPB?/$#1#ZX==B7E&V?4TF2$)U\K"0):<H,9_;I4PMJ
M!E>`/TE(<_])DA#Q_'DMF9FFJZ6ZB"A5N<%8Y&DF9SX)+4>&WR?N!J_?>)XA
M8#&B$N?WRH=7LD+KD<B5!5E'FK6%V6<S%.BU+,"Z<9P1.K:[C-E#[@/HA*?@
MI1@NNQC-U1WB5SL4(RB5`"DSZPHOYX9O@S6#5FU2&WNVTU]*H?WRF)<_#SQ4
MZN42-'-O.B9;X89?+FG%3<'`5<Q`#S[B#2(^6]B&(>=B$M4_G<TNII,TA/\"
M;/PP`@].Z#+&H+[S#P??(UTBIV`=D.V"+>G]%@9WN/7+^7*A;E.*`H`8@;DD
M3/E,4WF\,/QI''HA5-M::B1V7#*UO*@P&F`0%X_M,$`5`*FACO!*G%BC"%]Q
M:RDJ+^*%L=E+-28YM+BZ+(A2^B?&/KN\!8Z(]*$0Z4E'X55VY0M38:7#NI]W
M+(WDW1+5D+M2"9D=LT\5NL%KM-[U",ZL=EP(Y*7DDU:UA=9/VC:+?%XIL1=F
M7^*BPJ_;`C<B.;.\E1NR@A2.KX7CCZTN_U1#IY*IVR1)(VV3"N/%Q.RL%^W`
MM=O88N^U]I4OUT#7]]1C6'4PL]N@QA42$V#VL6TG]GX,Z1F*>B/JRJ#I.D]%
M@+[P7%V(?%O/D@G;*E,C:XNUQ@MK8$:UBEZ[9:U`:#"O:][L%U0?6H^AU4O>
M;I-;K(6-QLKL[6$J_/V8WAHD]>97)(E+(=M,XY:2-;7F2K.Z4(`0XS:WH/7Y
MC%H:&!F^9F,31+7E9D)3S<@E<?.8E2$:DG:9H0H=J;V:&\`.H]DW]A@ET3(+
ML&&JY@0[QBH1QBHAM+5<AE+9UL+)W]0YZ>V=RU0!"L'JJ5]3<30VVUFG$T"O
MU6]`4;7V@IO.M%]=@V7OA\X=EKQ:$=N88?,YD:`'R]V$I6JQ!3>BZ[I-]LG0
MEU=X@;2Y8_ET;A2HC<I9I=&@LH[6@>_#(I<0-%IC\6RX]5]8FQ7615DJZYM6
MPK;"[#!C"O2]6=TRCD:+R[-K7===:9]F:BW5!1]W]"Z?Q.VBM3'YK*;A^?`I
M)>C##%=A--IB[NULZD^OS2KK9S65?3[?DC7\"1Q:$7JSU#5@&LTU]RYW*?HZ
M[I<$NJN+TZCI48S%="+4ANJGI9?SF=F[<2VH5=O=YJXK-T7B7R424(E)U4O`
MBNFL*;V([SN8[=2VXM9B)-L05&Z*A!Q<?.=[Y!+>%_@,O1-\YX?1Y6(T5O?8
M=DV'HN?4%!+DQ]/5PN/5RFQOM!FT^DB*AI[M]!>0_`3P;_*HIRA60B/U:B(C
MJH61)B\7IE^O:(:M*0ZB$8"-_P,_&OOH/\/`P[EOP"8I'H(@KL!'RC#I#G]/
ME5?BRKW)H6,S]G,N9B4G(\/S1#8@UF4`R]UFUB],S9\DDBDU>XI)UFCPTI*+
M6&W-=OF:06LU=I7N[5]K3!PKZ\(HQ&\L)$_87"[&EKKCH//>1%G7A3UGW5G)
MB>E;YPV(U9NVNF[)E!K&K\5P/774^*64I-_2Q+)*YJU*2;PFFY@>VMJ`F<&R
M\6?=:NH]R;FUR6C']\+6>?-Y<IGQ2.75@?I>Y=*P698F.F8U)J;GB>U`KML(
MEKNO,8;<F;0Z/ZHBWZ\7@M;X@DTU\%Z6V2'2G=@U>8;M*`I<32TH8^ZL-#5R
M&E3ZU@G=#>KQO;L_17![N9ROU*V$.SH7XRNS9"EMNRK.II;9OB6=`*JM+!4*
M.TLQGX7L7P!2DI`Z*:N&TDILKQ&4KECBKHK(G$Q&9OL,M")HL<N48.R<R=OX
M%_Q\(=C[8<@;C_^KXWH?4?VU]QX&[K,3N<_PQD.SPNE`7BB!T6T`(^?;I36R
M9NHNJ=#"$..[@+`I\^F;P"L3LP_'F671H@NLJ.QW3Z@9"%P/[!PWS7SD[\!7
M)PCPH[5[UWEP]\SIEW^%'@R</=+"J^W!]5SL*6$LB>^$.#)>JEL4=O0NJ`?,
MHF7T[ZBY6"[,WK^@$T"U+T.%PDY*$7M?+I>N)!4Q6HV)-X+158/>51.OC,QV
M96A%T&.^Z<"4R.V42K*1^L;;^`>()XP/B`WXZ,/U3LB76B.'R,&?)7P+=WX`
MXW+WSC<8?G(]\@%O/"0G#/&3T>56XM32GV#TY*-?GE$1,O4@%LUGZI+?:91$
M3-GZ'?)4<76B6$X-OX&O?S!43Y':);+CLN!G7/HO`-,=Y-V"O%_P0#I.'TN(
MFP.%]BY`TA1!=8$F:V39$'E<SPE>P$T$#\E[I_@(UM_O<?,IY@$8/R5G<#^,
M']60]V'\R.;##_-W/AQ:#CQ[$,S&Y6+SYU=LGAL;-K3\YC%4V>-RV;G#>&:I
M=J@JG<K0?PI)RJI:K4"R+YF=";X+NAX?H+%_^^[^ZO[ZT_7G^SNP_@#6M]=?
MKNYOUI_Y7R+,U"A9K;Q%BY0=?M5S-%^J.[9JZ%4&3VE$*1.U6F,YFY@=UMD.
M7`])&WJW<T\PW;,!/R<E&!\\[OR@2G9M^N%F99>FL0:V!,-D9PI=RZY,!XB4
MIFA>3P_^6<D9.QO9+H]E*7P$YJPW43)V0<])6"ZY,OV1S'K`Z@UB3:]V^E>^
MK>O&CZ3F52P]!*N^AU4IBH^XS'YGH@DR!<MDO(+5T'U.-TYSEBZ+8L.8MH:^
MVG2B+FMI4[>B_*,6)N=A0Y75W/"'?#J0J[=];=W;^<_)%N$%]\9?US=5Y`WV
M0]`:?["I"M9_TU?5'=@U>83M*'(+&N_YB/'S,R1?<S;19CM1CW)962]"$R%Q
MZ=7"\,#.9M"Z[636<YV)1#]*9)\6PZB6?9WFD)2>3%<3LP,7VF#W8@0+`,3L
M'VHHWW2_M,:+A:7LZ*S4EQCKNF"G?#LKAS<1S'8+ZP%K.<*I[=K^G,3M,M+*
M]Y(S&>\Q;C19]^17CJ:SL;(YMK-[0?:Q2Y<1LK.J-1[-#><HK0RJ)V=:(':Q
M8!KS\'-2]B_<AS#T-%`RE1M#\LHL3_%=\!&NV7F(Z(70X@%0P['7T1,,T@/P
MGY-MI;\P7H];E_N*IX3)2&%ZUYH>Q0A,)T+*V=K2X\G<;)*VH%9M?)N[MM<5
M6TM"U20R4(E_JI>!%5^UMC3VPLR^G-,&6XO?V@*@-D2(C89?8`C18#SA2V[P
M&>[](UZ%O?/WJ(P?MW@YGL^G=;EEO&?G&R';:#49$:KAO]`T*<8[/LPI#VEJ
M6PMKLC#[O(=%#-6VD@&+G98%5_@><%X:E(HK)+$U'B"+K<H1)?68FVU>6<2@
MI_'6WY!;BC6?22:=)P;0>3%`-E=65!2U%_&0F^VO,LFA95W%@B@G,[G97B#S
M1C:9\S`!Y,<H6W.U]JV"[\UBM3.]$#4Q2'M]AK\??Z,,HDSFHF7F"GRB_-Y*
M=L+ZIS&EP2X%_PS14I\+T*.)/H/2:)M9:4PRD>(5Y&RA[HV,M!M1<C:"S7F8
M%IE/1F8?*YQ#56\D2_W9Z7^+$D;)WI0JPE1VH?(BV.<Q.RRD@E7+?M-YKTE.
M3ZX$['^'[N-3!+=7SS!P'N'GT^$!!NL=R:U4>!ZHDF9I,5FI,TY\H,28*6T@
M4A[S-K@:3\UV,,4$4VU4A=#9:6V05`=Q?9PDJ?K*FW"^/%'.*?%EAZA\%>^7
MMT%\@FGV)2E!R;3XRV(8:W+W?4W5TDG4TLO4<N,?#KXG_$K=._]P#.`3<NA)
M$K4DQ&V]NW>^7<Y7EKH=D):.Q72*2:(\<7!SI?'2,CNW03=XU9-/)P*[5*)\
M.DW"=S&E4>D+<!5%@?MPBIR'/021#VX1OUG7DC044/1.0(^DKGD]H+D2MCF&
MQY[3P->R[J``<L9O]KC-EC[R.*/10ETJ#`H`RBC<+"$%E?/\&DO+['T6>B%Z
MM-=E)*)V6^`=`WJV*'K2P"!]J'GH@*(RWI\=K(FOB*'%@V<`5&/R&4,]&^Y2
MJ`G,5WX%I!IQ7RYG+>=FYT*HQ:O:$M=U2JY^E$RM%*^XX;NI"9%73K=J[/OY
M+9J)9?8MWWK`6LQ<;=><-XY(U'N-W?S-"Z"S=_\%MW_S]WAC(D_;?@<W)_0I
M7!A>!6Z(?GJ/_M-[O(7H$VUSUWHR5?BFEBK8@H'+^@8SBWY6UN5XN33[J%VU
MZ*HG#\7XDPLMK4N`O"N0]`5P9^F\Y7L@[Q$D78*X3Q!W6EQ&F&9YE,R-WZOE
MJ<S8ZKK$$YK90?+*9=?B1ZB6PBZ8ET=L5LB)AQ]$;Q#H`W#SW+3`>7;</7:/
MW^S\X$WH[!D#`K(<HNM=+,.5MZV1+%L%3E=S=5?R&,&(:;ZPY*D^LS9$/K+9
M:T)>D53/_)RXSO+AOEM_NOUR_;?KSW<WOU^#C^L[_KRX5YM-`/&GNCH@]73_
M1>*QU[OW;KCQ3QYY4O(V@`?W=`B+&:5G4X5;VGR8Q)1)UCBD.L79WG1J]I&E
MB%BJ=4L`FYW5!3\7:_\%^[=9`^2(/VWBHO@NA%:=4Y,8<X!*5\VRR=D@LK+S
ME=D[[H*24>B>C)R=8BCM8BVL>?@)S&-2OMF%9%2^[7^=DHKW_A>(/XZ[AZ6-
MM7O_G1,^W0;^L[N%V[<OOX5P>^-EMZ:O-I'[''O"F6NE,,V#"L"":JMC"#.5
M5M'98FQVT)PZH95/PJJ0VX66\4E*UC:HGKJ@GW$7(.T#/+R`GW$WR&S\!>3)
M-O*N^/UGA;J@9!?K^S(GE;TK)9WA59KA)_9*Y=:R9Z52`CMMSRWY'N3Y;61,
M\+\WV*"<8AL"LL12P,G:9`PBN`I#!/UP=-R`W)]^<H)'B'S;Y43=/97Z/@6U
MEU*.3`'KRULCTU>^;;B5SZHMG=OD1Y#_"I*?I?)1S5RDGX_5":%A:/%5-<.=
MQ';D>HQR*P:[0$ID4H\!MIO1"]E'@?\\N1S7C=\Y1S=R]N0N\]:-3@@CLO^G
M($#V_A1]]J-_P.C6<;>7\ZFE+ETJ+0K!2$-N6;-P0]H6K-74\!A<-DE4&V0V
M.'92'!3+@[0">#A%`%4!+\B,XTJ*-4)-V*V9&E$-P*7^<+/E?&%V(!JS+%JF
M!%94]FWMM`".J)\G)T2*XGJ;_6D;>][.)MF+/SHO)*B2O#*_V00G]'N2NI7U
M"D<,^"-$G:T?]NXC60-<IT!N$QS;R_%T.JT[]6K(D$7;KA25X$%_IA/=3>`\
M.".S#WZ99=$T4U`#RN8*4@/D54!6!V255!.=+A6<J41O,OZ4W\)L[Y]9%IW&
MGQJ5G9/:V:!_8G?HY*%!!P[8)(JPQXVI9CIE#D]3J5[-YLGV)<S>O&26A9[K
M8GD]68$I->XASO>%_P>W]>SL\4[I5?3."8(7UWO\W=F?X.5\-B//KN6Q3G(7
M`1081%6#3\Q<+6CJXVWAJ=F!J&R"T"O$D01TWD5.$/%.`0S`;').AWUXLK\.
M\PK`B<`#?'0]#V^SX]TC`DRI4EC?AU)8`DIA=JHG-D%8E>+:XPR+88+5KA)H
M32U7&>(`;K1"#_"4]![&_XO(LE28LX`!B0K-H)6Y73\:6AF/IZ9[4\S2J%\D
MLT+*M83\HU#K(KF?!-**X.>T*N.#*ESD49.?QFR%J6:P86F%V#W3=UHYY&%8
M<`ODN.%`1BX,_[Q-E0+OK\:*XGKQG%,W^;"ISGMX]$,W"C_XP15>UZ-_DTC0
M=*\70<Y6/&056W=6U[`&9VE;3!D$I4BU@:D9O"L^-SL4@DL>U5,(#R@[K010
M+5"H!M8[D!U+X'<XLJHZU(!NU]5T-:CLOC)_H8791PU<\FC9A>5!ENH"<(['
MO0NW(/*_.L$V!-$3S,[B\-)C'S_;X0<OO#$<?'RBW*$U72VJ.[7LELOLM[^Y
MY-&U8\L#3L<T$<!-''N*FBE>@[E<CJ;JDJFT="RL&_02%12AL=)TNC)[B=`-
M7H,'U([`+I:X`.B_]O&=1^SO%XM?@,^^=PS\[6G#_CP3S:=7$H+4*YGKO)W&
M2N16M]GQ=C3P=?DR74!*O(X#@@JEV-B;)[QXC];0SZ@%?"<_C`(RYX1HY7P;
MP`AGNAA9\7:Z$L-,"T.,V`+"IC2G;F(QGYM]H,8HB6IKS@;'/DO>E-<!A4HD
M9=,%B"NJU@LUU]1-58SJ773Z-O#M9[-G`V99*+1#QGUS5ESVNR?4#-GHW#EN
M`)[QP1M>U**E;N!X$=B[SH.[1T//JQUWSA[FJXE;A#HJK"=&UDK'G-$&0I9B
M,`I:U8K6!A:+B=F;/TQRZ)LKNL&<SQ2X!M:`;!U+*O&N9%GYH7J2,$<3VB:(
MMA;PKA%V<\W>\V&61?L$08<KU@ZD%ELW//JALY=U;^W\+.[&NTIN,MS&%QGP
MVB:^QO`QF8-<<L-SJ3"Y.!\H,;V1-A"I&G$VN%P:GL).2"[5,XX(.+LF,`-[
M9&D+X+9PM2=I!!1:T:MX2K:JAJAXE1TNW@:1I1V;'2$E*)F6?3$QC/:5_'MT
MS8B^P`U$JS/4#:;33-WC=#005&E1JY#=.E.HOEPLAZH?%2GZFXC.H71..WD%
ME;Q7L^(QC?C5U0Y-_<0/'YM]TL<HB::5#ANJW/X'V:_"YOX]W$%\S3MY[YNP
M05U>Q,[^9?.]6[QFKI_711;)[-,06A'TV_=:'$W&/2T,OO`\-L_``4W+A+XH
M3N'\5^IB2V/V'6IZ(7IRZ1O@V!FM`SFTSE+D)?=3\\<DYY:Z`PMZ'+)Y3B]O
M,]\;VU@BG1D8[3MDT6_DVP$U6?L\LVMZSYHWK2L'933-`,:H",64T-@&L6.O
M1DE2:7J:)+IP)8?>X5GB4IRY+W[28)_O#S$F,:T!@U\6^NS'"9^\Z&PGL39]
MDC)-:80B75=8A&Y1E^9FD),[M$5QIS0]S"H=D!KG%?*>7EY1YFD$#7=T32U&
M*0S-_-+2S&PY7YI]C8Y+GK[FF$YD=IS2QD4#X^$PK'1GB36/3;7OVP`>'7>;
MKGFNX\.)*V]+0)$,M)@VJXFZ?*]\H&1K#>=`-.L/58/+I>'!B4)RZ9^$Z,$U
M34=)"R"I2GRX>(J*:^M5.%T'&N9K',VA!TV+Z3:]V;EVA&7K[6"$#:>=JEMZ
M*D[TS2?ZYDC1M]\\-)GN\2Y?=A2#Z#2R=)Z=U&"0K4QT8C:K3EW]U6AP45S-
M8NB?BQJQ-$T]:87"8;E:^NN:7?KF/\W<4=L`OJ(\M*V!-D%ZFQ5:0-D9[;E/
MRS_#J.YMH@^NYWB;TMM$E]9X,55G^NF!B/%?2.!4!U@:L18KLT\;V851/2$P
M(R*9HUJ>ULMJ%I[64Z\G2E*NF:PGE7QK+(W@%\_,GC`XI&'8%N//M<:.B^@+
MR:1V+.C++M,21[F69(=!D\E<W<-R['AT*4VS_.RZDQ^L68NYV8MS?J',F7/.
MD/',/=SG_P($4W)8,R`%JYS;\'QQ;#[-OO$H()66,QQ^?':=)C$&!C3T'C_Z
M7O%J)NJN.-(#4:(P=`)W:$IM(];"\.<IV87I:>II1M0UY60U92]W6FFC<[EC
MA)[0+G=J&\$V;?IJ%"61IL_E3@NN?+GS\RG5D>+"Q\WT1?+"IP93P2]9:E_X
MM.#1I3[-\K-K4<$37T[-/F_A%\J<V><,&<\L)'OA0T,PG0L?$Q6,=N'3^L6Q
M(34[;$U`JCX7/A3X[#I-DK/PR6*TR_[-8JE[9JH!HD1AZ`3NT)3:1JREX<\R
MLPO3T]33C*AKRLDOVDA>^+321N?"QP@]H5WXU#:";=H@=PC:I.ESX=."*U_X
M).N>XD4;Y1I2]$34W=9DQZ-+89KE9]>;DN]M]A5]?J',F6_.D/',.[*7.C0$
MT[G4,5'!:)<Z+6TM8MMI]M4"$;'Z7.S0`+3KE(EQM9-="T(8;KR-?X!),/6E
M-;'FZN:BQG[%-()%G)3Y+77&,\/?5>_$KGJBZ`)@YS<O\:00%P$_)X48G_.D
M^+IJHHW[8VLUJKBE$DZ1;K;'TPV>@K`RHH<[@10SM+"F"KYU7DCV^GN?/#45
MP*MGQ]WCF.,/?H#3&-_!S2E(UA^3Y4B=F65`(D9E,9%3;K.U,IN9[7MP2*/:
M7+-#LM,J(/)!4@EDM=[L_.!-B!/0YQ4UZ(H:*V^VLE1G`H9FXLMP\^6K49B"
M0)IF#"YP]FWR[F:(T]"'3WX0O4&+A4-RD'Y@?Y>Y`N,V>>7M&::W61%CU#TX
MV-F_9-6@$*]1'VKJSF9FAY)0RZ!]IF@`4CL_Y&6Y+K0SD$#33-`;R2FL_GGE
MU/H,G.@%,?JR\,V0[#0]';E2OG6C4\#L^`3^!L)M^`'1XB8,3PX:U/7NG7\X
M^-Y=Y&_^O+2F4X7IMCK[%^0XAW@9Q2GJSJ9F'XU1RZ#<D%,"L=."`']$D!;%
M?DM<&)#2RDBN9$?>'))7-MPIZN)M7K.#]>B%T+*93@V''%,=2X3'JUCBI6]B
MMH>X_`7P4$'T1W^W@P'>:=_X842*_;?1Y10<W/T^?;(6_6&<_N$"(+1'2.:.
M/>-3A$4A/OL13)\#P5R:J+M6WM2M/`WI$*9.,<ZJS"RSM^.[H.NT]37]GYEX
M4B)]JTDV1Y6;<YT<;37>Y2JSY7(Y')M=BUV[J:Y#<<95CW#U*,K5+_"8./GK
MW=FGGFBRK4T0Y'&80<@Z/K=5-_P%<!8Q=-KB#BQG7/\Y+XX<C;_(LM/=M%!N
MLTW@?JLM;ZZ.UOT+PW?/6>30;N.[$"$=<+V->W3VH$!^%7;_"PRCP-U$<(L#
M;VIS?TPG2W5Q_=RXU&@)SW!TJ0Y-F]/9,.<2:MGZFF!H`7;,.GDS))[S0D)J
M*`D4U#I%F:^1U),919O8#@]G><TG7*_3'C5,NZ![.$")7\OPN?25M_WD1/AH
M^F6]:XLTP%9!RZS'@$J>AHD-19U^L;4XFYJ=#D=0,IVS'3N\L[D.ER%[MFD3
MV-64&=0DRCOET]QP5+!UBF-J$1_=#N?0D$<T[=,;!\@S53S$55V)$5)G^-8[
M])<C#**76R1/A.!>__/D'G'+V#J,%MKFO!8D<I6,3>0FQ6IO96YX#E(.:73/
M8=V0ZN8MI"9IM0M`*EZ0N2RKJT%=M,Q/9JE+YSS4V@H^=C8[X2B/.+W,-Q3`
MSM1FZX9''SET6'6.25VB,E""RN`P@37Y=.'U-QALW!!N,6MFZG)6=?8O43TH
MQ:M5BH:Z\]6`9HXV&;3.%RU`SF<)7!0D94%66!G'U4\&O7*\W?#7U\7[.(;'
MWU(+H=_(M\$YXWKT!`%,RI`%!.%^/+:,ZX;B5MU'WWN\1ZN0),R7O(RX?MB[
MCPYI&($93]6=$#$@$=,",9%3?6!K96F9[0=Q2*-Z'F"'9)<.<P"N%*^JT[CU
M^*W/0D4-NJ+FKH;9RE*]O\'X,>>&/QO-(PZ%OLBXS\$!K2$*89-HS1Y78].4
M.QA%>XA;2N(>\M>I+L?S>>TLXCT[WPC=1ZO)B)`=_Z6M*3%FLV%,B=Q6RUI8
M$\/#96C@JS;L%!CLO`Q8[Y)8L+R8`C):XP&PT:K8U<ZQ-#LI*PU\>CIN_<T)
MMT6LFWQ:+GN@Y6(`K*PL%5MJ+>*A-/M0F`J_E@4B#9(B*;/8P8"7E$].`-^B
M^7[[SC_@U#!$ERZM^7BJ[G9]?:>"S*45)"-M0X7%=&1VR%X[<.63>5OO-OGU
MS0/^&11_ETM*)5MQ?9"R:DEK*\2Y\"S#I_8.Z'KL9SL(^[/OO2$IVL@.6D+4
M#3]1D>N16&L2[+;WO^9)**<KA8<C;3T+<I9)IHRX;;7(Z)L=DT*%7[EMI0!A
MW]U?W5]_NOY\?P?6'\"[J[N_@0\?UW^_X\XO>W<Z'F-WPMFGW=YX.S\X$(W(
M`,Q&TXDZ/M.!$*0VKZ09RRD;L);CD=D'(XR2*&<^$QR[6#S.PXPK@$(-;=J@
MQA<Q41NJS@KM1T.6:_I*U"$118\SPP:JK!5;-]SL_?`4P'B1F/@]#F\*Y=ML
MDYD<7*9Y)][A1!&7>`]/X;WBEJX%S\?9A#I/3M50;38R>T^8!K[RH(]N#'G.
M-43@.-HC2]=#RJD@L)HHCYX)7(WM:*TV6RXLL[=`J/#KB>B@0$*?AJ><?X?Q
MF0@<8@[7NR1=/CGN&R]&ZE*K53L4XS*5`-E##C6%K87I+Z@V@E9M;AM[MN-?
M,!7SW\`?]_!;!-ZBK_(GZV,E+1]1S6LD&EE8?4ZD4G@1*[W9#D`;;"U6LP6`
MO0X>'<_]%\=N7+'F.]2FOW>WL:?L;6\1JO2D<+U+;J4Z^VS'I?!VS&RN[N1#
M"D0Q@BL:I>SA!BG-$S*8?4U;KJ"J)P"I:$LZRKW3\M']Y\G=HD_ZR8FP+<EZ
M&4^GL[J=QH;#\*9VQ-2$`5U*_<8J9-C,/@+OQ*Z:H%T`[*P`2$HH)!YE<%!?
MS*N&!9W7>9_M_I3&<6QVE"6#%/1T%`L2HH=40]"\L#2NYDUB%YUXZ(07=2>-
ME*RM:5(N@>DP=U,YKTV&W.P#118Q=-O6%BP=+.9>%S)Q@BX(SBP>5]:&M(-N
M>.YK%C&TK!T9`%7)K)"TG#Y#OZQE\23.;(79T4@L8O3O2U0PM9IA-A)?;3;^
MR</OI]ZB1=^F]$SN4EV`4G.W8O1F$">E=$L58BC,/NN@0*_:?^B&8-^=#@<G
M(!FF[MQ'S]VY&\>+0%X3I%6Y7>&W3NB&."U"OEMQY6T+O55AYGHU'RGDN@@R
M,6V0.R:IP@BU:DT-?[!2@G2J%4X<HDV:B+/HY(V0=""=^LGMY$MAHY)3HH%K
M:&5Q(480;+/-OIXN13XMRQ$92!EF3RZ%/(/P$O_?$LW4/<Y,AT&*DC'+>:9.
M7?61935[U<,DAZ9)C`I,/EWEQ2]BTK^`/Y+_%9V7:.FA<@8R20V:9I6.^N2H
M?CDR>_N5512=<P4MJ'H?CHWZ.&X8S4?X?W#^N&=GCP]TRSFZJ[_'B"[GL[FZ
M5-DBR,341.Z8I,HCU.K86IE]/BQ!.M7SC3A$FUPEP6LD\H]"J8OSAR(:2LF:
ML:105,D\-G"UK<QY0JT20VWV]J$4^;3,CC*0VF=JRJ9UUT[@H5DYO(4!N4A\
M[C@M%R-UH8$=G8OI#K-DJ7IT59Q-QV;O]M$)H'INHD)AIZ4`*@9(.7DS"BT#
ME$P:1G"[8OJ[*A*;8O;I/*T(6@PX)1AR'>:C'X;@F-*<C<H?'#?XW=F?X"?H
MX/-0?");O])=64M+F<&FAB%&;P%I4Z+3-S$?6V9?H6$51;5A9\1CX_*`5`"%
M&O+,/#M;E!A\8W6C,@G0-T',UVO1CE08+1,#,ZP&-6$\_?CD!'_"".=$R]_G
M:7ZY)UU(C*=+=6E.>"")J8BD04C5A:\Y:S(V^S*/B%BJIQ@!;'9>M_#*VT7[
M(W#R)B,Q[BF9F(:F@)7YBJ\Y;%;-/O$7DDO++":"T+XC3[[AW-S@AO?)M\_P
M:^'H*/`]],]-/#$VS*;CA<*H-U8X8FHD0?CLUC9S4]9R:;;V\(JD>N[BQ&6C
M>J7HEU)->1,4/ZG4Y#(8B$95\R`P-S5;+E9FQ])PRZ1E,N)%9^.$TF>A9:7:
MK"^D/$/O!%&C_J/GXN]5[7=FJ9N#.OL74Q$>\?(74#KKSL>&ORY*+8/J>806
MB)T4!(62\J8+!CHHF1_,87ME!J"IBPR0V4$N]$)HL?'4<.I8S\;LWT*XWEV'
MD7MP(OR(]6(\47?27>Y,C+.=P%."GA=<KF9FN_3U@%4;VMI>[=_B9P>SO\LS
MJ4W?3XG]U$&\BF4\+X@W!,S>#&U`K,7FU?==(2#C%=C&79I"!,9JJ2[6E0*`
M&!NY),SNQU)4ML8KLP.^Z850;4*ID=BMV_#@CWNR;\]M6EDXH<3<&L7ZBEVF
M^DS(_!C^D"N+&%HL.`.@9%<\.ML5!^_V3ABZ.Q=N@1,6#JM0BV]PDYPA$1]=
MY\'=$RC)H?)V[7W!\'#.77+9XC?/?PAA0![2NO&.IPA[U-X&U2)W+PKQ!-.5
MNH3G*A!+"K10.H:5F`R9O<WG,[,CM15*K2T*2CKT0B3(!2BTGH:%;('O@:P#
M0'JX`,4^`.D$E'L1GER5*H3:D*SOPZ@T!WK)[(U,9&;OX2J56V_XF`()DJOW
M[K^0);F*WT8AU_`_PF<TF)/8>+1:&\;GA39/<'O:HT5N)M55&,(HO/*V%.(1
MJU448F$MU+W))1.KF*E0/6S9DT9R^YG/IF:O'I3(J]K;4`':3AO%RE_T.>*6
MR75/2O=#V+=01'8U+Y6]>AM1??9,<C_+Y<CL8S$U`FMQ'91`+Z;KR;+E=QH*
M)XKM2AQ&F`2WB[H3>5+(]:[XXNT7N'?PE5G\C%#^)F[Z6%'A;MQTIB[SCR`X
M,6L@?612]1=M>#8R_'48.0*J=@*DH+3?EUY)++8#DH;BI^8N0/%E\^QA.OY4
M>;+HJ612?Q6*6YFW!1N.7RB:F'UT*TU&+;.S++0V>7OO#2E54F+&I"O^'OV7
MCU^D>H9708`@DYC(NCS-\Z6E+D"&`8B8K@E)G&5086AD/#?\?C&[,*HG.F9$
M=JD&*%21\Y0##VG4I"(R64VJB888&L%V;6IVY@D><;1,*AS`[-\N[R[!K_XS
M##RB)U>/`8PUAJ3YREMDCZO,6\T:Q4F,BDV67WB:,SPFP=:\:,";J"A=FM#T
MN-+$[.T1'G'H-4'LR0D.;,W31\.#5I=Z5(+N<:LA:$1-;#)30^1#F7UYBE,B
MU;X4'RR6Z8'_>8MWSM&-G/U'B%8QZX>]^W@&9CE2%W#4T;>@]\0H6)Z9L;T>
MF;S-/GNG%4'Y&H(.AYV4`Z0@-Y/?PP>B5(5."_--8:MF,5DLU>T^4Z(0W*WB
MEC7;EJ)M83*;FAW`QBB)\AUB)C@V+IYD]2TH0='G$=KO9>6)FHU=,W6BNE5+
MVP(Q7*]$*U)9]&R],J(J3PWLW*];?2/?2MT>:D.GXLRFDJ1(Y+H*D]G,[.V=
M=N`Z3'=C[[&EEK*5V?4]E1EA[<RL-;$U%>(SE:G9F_2=V+69T#84]F<_0C[#
MK?."HT@80\#P@=;?';SW$I5W$.K"/1OV0FH;$8RQHL25Q4K5EB<#9/9!:CMP
MU?:OM7<[^2$+,WKA7JEU?$[*76C]/*ON*;>,F-GW5MN!Z]HG;D41'Z^#]&>0
M_2Y`ML*9)?JH=;L`-&23%3E*BZR6;6>^LMG!71W(M1JV2O?G1.-W[+J^Z,)8
MKE7#C5N&S.R#L0[D6IRT=@S5J50NS7@F4$T\ZYA"SX;*[-.F#N2]3*(5&&7C
M5EB_,E+.V<?1<@??(RW6Q@%-I_.ZAR^:^$?1IB`;^5!GU*2ICL=Y9KA%9)%#
M^5S,`,;&A<&:A$BCXB#FLI0]&#9J4$[<AA&Z.JG3COW<[`-.)CGT3/@,B`BK
MPR3R/Z.U2OK2.@2&\;?&6:`>9K/WN9GDT.9(,(#JLLRL+S9XIQU:VI_PA;2/
M<52+'[Q<>=OU;N=NX`=G0]SDXI9,[1O!#<1F;5^,Y!*DR9]=8&R*?!ZS3R:Y
M95+MF?`"LTL505Z3G.O'=4%:F7O3E)]5E-9_*$I2G14^PZ]I<7).W!!E.C<[
M*0*#%+IF!'I(Y.F$C.-Q(%=MV"[S2PD-`,KN0MW360TTIVA2C-E\F+NY?#8'
MFWU6RB*&:KO.@*6+QMS+3292T*TVS2)RW>,<=*-N]D$9BQA:5IH,@,J.R46'
M9Z*0T)0>B%F,9O$SSH;>["`#%C'Z]S0JF-IM-&_.(QQ64\W%,U=W^:&M:\%-
M%C:AJ@F&ZJK-9RNS64T#7_G>=C>&4L8O$E(H+V]7V^=6G(:K'PZW),FJ5B,1
M<LNQX4<U5`+HV=*F@5*BLTCD89XQZX3<%?C)]=S#Z4"L>YJ!XX,?E`+':UBQ
MTI&5DA.@+(60.$`UN>6X&Y_/1X;'($D34M\T(HBTG%Z2M`62QA+'*<LIM?.#
M\RM($A-*"E-6=1;)P>MT6[Y(_L:1C1^*UR<LI>9)511O2;?+-VCSN[:\"GM]
M..[]%PCO8/#L;F">#:N8YNIJ3PB/_K7>)4_`_0MN;R'B2)Q$JX19R]PL&;<L
M]58_G%6ME][G?#$S>\]9N>SZYGTU`I1,1MH%2/HHI9HL=G,!\HYPQ;PK$/<5
MYZJ4Z"XH4Q?%7L3W9GU:?`X%?2ZMH;@BJH37[*$H$J,Q;2:X_H;_S;US4`_P
M"PRCP-U$<$OZO?KJ!-LP?7/CS+7">_\LEX+D=2U+UU6,056[Q7LA7!C*5IP\
M<?5Y$-(PYT[#>A?["*!&=?.&DU#`N.G\<1MYWH%$BE.&=;]J-6^9Q.5P:&QV
M.*(*<35/U-*`%Y^8Z-)H`]27-JS]5>MO39"\;&(8'DNO0%Q=80\*L%/-UQ=-
MZGVA2+])'^MCG/^O"?]BK.-5.5Z`:G6?:X!H-9ZF\?G,]%N,TH3LVPNG1EK:
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MLWA</4VD'G6S5QDL8N@Z_6/`9-\_P=068QHC<XQ^+YMDX!-N/[P`/ZZKD-QT
MD3-F<;OB>U#4)A<=5R.STR$RR:'%XV!!E-CJA,07N<>1^2#D@LO6W3MLA(Z#
M4->[>_<`WYV"`#6:W:MYAOOPG>/=G<+(<;U;)`2"%O]YO5LC"$2C,7>6#+F%
MQ'L44P<E$J?:(J%Q\L7-=N$E2JG:'Y('U4XN<JQW`#<&DM8*U\IP1?2?'DA:
M!$F3Z4]K?(8%>=ZJELE92I?K-:EIU6$3;]T:Q\0P^[Z%5#EUN7PR0:=:BWU!
MK+78(=PDFKM)-'<?J^<&:6Z8:.XQT=SD)U3;SVC5G^K2.92O27,K[JAXXXE/
M979&-9EB:G%F)0(^5UF]ZAKX&PBWX0=$YYLP/#GH8Y;R/5]:T^F4W.Q;EK51
MSJ9T9_^"NLDA7J9Z7771`G)A399F;]8Q2$&O.,\P>/"Y58<:D7UU\$]($P+'
M)0>>3X%_>GPB<UKHQ,$3FSC5>,B>+?_*BURT?CQ%[C.\@TCIW,B%X?6WS?ZT
MA5L,#H=PG:+D'N.U$WBN]Q@B927'NC&TR]G2FBL[R90"44R!%(U2JF-RFK=&
MAKNE,L54O8*4B-4NM@7RQD#:&L!$`X7V2!*"I$6\0Q\'1UV`N-4^%5S)D>RK
M4_"*_RJ)3;/5Q#([`$*NH%I\6*F0[<^GPP-26*3`(?XU!+"DY&0A6E9T#T9@
M[X<AWMV-*S$J^&E#[D,Y40'^K1.0X">TIIJQW-MO;4Q0Q1AQ9KK36@^-^WAE
M]NT<.@&43V@T*.RD%,#%BE,5*AA'TRGA)N7F9/_DK&XI=@[K9&1V/#J=`+HV
M`:G0I`LB9#R/B)<^,INH.V1BG]-X3R>A<8!I'&8-,>X*4)*";G^N?_)6O9*V
M>HMXM`U?4=!)H,>/H,*26=@S:EX0*C^SF]B/[I]P[S[Y_O;^R8EPV#/I<+V[
M^@*/?A`A7^4WSXUNPH\P#%$1[R8*WSE!\()^2'R7\72^J,OFWL!D\1[%Z*Y$
MXE0G)#1.(@7-=DDD2JG:;Y$'U<Z;`KBMXAV!]0[D[0'<(+@)`6X2%_4`:A2D
MK7(MPV62EM)=>DUZ6G6\)/%B8?9Z6J*4NEPX>9"[%!8,1F/I7,37I+`59U.\
M\47,"[,##F6*J<5ME0BXJ*\1UM<=UM=\40:"3%]/6%_=$.RQOD987]T('^XF
M^NJ0AK.`1];G0(,_882O#^9^^#IP'UW$BD_.-YQ4_).#'_Z*7LCBJ"ZS3N-#
MH-1-BZFBF`SY&[GTK9`=(+/#(WC$4>V><F"R\SK%+;:T%DBJ@;2>!O93OX-K
M,OVK/B+SQS$[(0R/.+J\/@YL!NH!G9]FMAI4/"^&5A;QMS'[OA*7/%I\*1YD
M12TH;@?ZJ1H<$C4XR%>#^(65$H7JPGAXU*#<M$(UZ)2!2@W.6B'?QNQS&QYQ
M>G6&ZC%U3@+)FUP*)H$FYLAPAGJG/Z,S5/=QS+Z-Q"..$<Y0/38#]4"",]2[
M&K`Y0^56DBG:[!-0+GGZ=X8:D'4[0XD:\#E#<7#6>E=[5'OCQ8%:-UZ>"`1?
MD9ZQG(VR]R"F%%(DRAYQ9V^,A+V9[2@)2*7:7^*'EL89XF.0AI"MM#[Z1R&3
M$V-:#Q%^4?I10U*9JE?%^PG-=JX$I-+E8_%#+,3H&JL[=+[7D%2GXHFQ-Q8'
M41G^UIV(6%K\,@&`!<UIB+!DTY#LM/'&.YZBD%P.M3Y!W,?E>#2>*KMQTM*Q
MF(8P280UH:V"-;6LL;G'W330E3.:`H1-_@@L\$?\=\;$T%?/CKO'*Y(/?G#G
M%%<S6=_OW7"S]\-3`"]GJYG"FY`L4`1CBL6DSD*,F9JQQC.SCQYXQ%&]B.#`
M9&=UWNS\X`VY17Q76&X7XJSRJCJT1LWU0M.UIAJ8S_9)9\O5U.R3:SZ!M+A#
M7-#L=WYP](GOLX4/$7"\K62/Z"H,811>>=N/KO/@[DE3GZ"#06S7WA?<?(`C
ML+SM9]\+TO]\ZX1N^-'UX$T$#VC!LXJ3.BB9C*1"E>1UJ1FU5"WE=C.?3,S>
M.%,AKNK)4`%F.Y\-+T#<+-'W0L,@;1F0]WZ3QDBI8NN`-`_^P!T`T@.C*RI#
M.O*N`N)XO!8QUC(0F/U;A8;1DFD1XB[FXYG9^QJR11V")2C@+5B!5-O)WLA%
MF[[';Q+Q*OG;E^R??W-A@#[5TPM9REY]<]$LA1P1]1K<BD&2>C+*6=&]]OIS
MR_#S*28YM&D-!9C2Q)@5`G_@$KR<;]DV4TOT/C8"FRE=4VD^-SS5=C=X;>1M
M0E!B;%SH`HCM#M;U.<Z_L[J]P):.Y3.W4:(VYHZSH1\/Q+5I!-\'<TL(6I@[
M5LA<;8<OVIA;V6MKJX33+RZ'R]T4OI9]-`H@MGS"3O+/.]9J:B>J"-LH41MA
MTTK&OW[;#;X/4UM"T&)J)PJ9J\W4:F,NE:E-*Y&S6K-S"-/`[\W4G@&Q)1&V
MN-5171"^]P^.ZUU:JTG='6K)%*:!(HG4?%)7:$[5S'QL^#MW/.)H,^+TF$IF
MO;R#5]C:*VQCQ)49%:>PQUA[?&C-%S-EJM+>N9AN,`N6Y_UHKSBR#'_VB$X`
MU8RG0F$72DF)XJ#]ZDJ<%Q/H7)/&IKWB;+F:F9Y2BDH"+9X,'1;[[TY`7G;?
M)\49K_W4S19_=Z.GWSS_(83!,SZDB5VI+Q`/,>J"Q*1_.3L63CJ/'RJY\38!
M:@Z^A_'_7JZF2PW!%BI%D.\]:1CE-J]+?O?SN>':K7,8^O#R%,G2Y!V"KZ@_
M4.PPV1(`Y2Z+Q\"DUXLL/N3E`B1/&Z5=@Y_3SO]BLB%3NR/QPY"=C;)>0X:G
MUN5`]@JU#(3>G1L=(MGOGA`&"%SO+!%?3^Y4V"`%:>MR92F\.*$$<C]6AG$4
M1:U*>W=S:V%VRD"58IOJ_E!@%W5WPC9_A^>A$+7:D+\E],.H2!E&M5:%S%\#
M"792(CB]93D2#^`N<H)(KT=")8C]UMGC=RV!$P'DG9"3*#"Q+@#2*,LH`V']
M,!!2AU&#@3#[U$"MX*P&XMK;&F<>IB7S<(=&/+$/(V(?QA+>:DK#.A3&!K7T
M*Z:I+`*U/NB4!@:,A_B64PF\:H>[$T'C\WB<F06Z/[&:"]$]<I;N$;*X#LD[
M,IH.EK8Y?BV;2S1(FIX?DYX;X^J`7WKX%]R^\\/H<H[DZR$K1@F$(+5Y)>V^
MTU]NP)I,S%[ZL`FBW&:SH.G*>Y%5`;A.O+&A5B$T)[SH42$8DER<?;DI\A;-
M/JE@%47/=,`&RBZ37T>VEY5>\AN2[65%KP@US:PNK?EH.M@IHE4B!K7P(V<O
M6RW:L!4VS#DU`TTX8:F[7P,_#'_S`NCLL=;]BB-59U.K[K%VR9I!`T629O!)
M7=$,JF8F([,?7>601IOW1`VIRX4B]4!>$>":O$X4$WO4NE*FZDRS6T75#)G\
MS=Y)Y1-(KXO%`LV6JB*56>RLYX_HOV!H(>]CJ>Z.#BL:56X7K>S=GE=#2];$
M\,L*G!+UMTIO@\4\U\2U-6F2YJ6[49K$L)AO^L#XR=BAKNH[9.IY>=^.KCK]
M\&A-EO_R/7R(JH<EUK+NS10Y*M+:M9@^,$J5DK^]VL0R_`2#!K[J"8("0R'G
M*BXD?OQ&][65F/G>.5PQX*W5DN,CLT,]*2708ISIL)QG$18^COOD_)<?W".0
MX7J'>[[RMM?_/*&/5-C[Q>G;)M9274HU2A!B+.>6-'\'CJX!_(*`V;FU&251
M;<G9X-BD."#E\=6$]VDV[;A.R<ASY!6D`)/D"$!$4;<^IH:A7"F:I&50BS3]
MA34>FWT5DED6`U2C!(A%.;BR5=QMGN#VM(?K7?-JXF.6#7LZ5QC$P01%3$T$
MI4Y5A:T9:SXW_"51+GE4JPP/*#NM1%YX:]M"$DC%3@,L3A\]G2E,^4(-0[W*
M-$C+HBY)MO7Y;&7V21ZS+":H21$0BXKPY#"_/ASW_@M$O0?/[@;>/3D!?.N$
M..+D<(1>2&+$/_ODB3FXO?KJ!-OP'I_I%W_'82B?_>@?,,*QY8\>WJRZ7"['
MZK:6E,$6TSZ-HYEJJ[HN9_.1V>LIU:*KM@6*\=MI^R#I`)`>WCS@+D"QC0N0
M]0+B;BX`Z:A4*@ZU1'V!%QB!O#?3#(Z2?<#OUN!4]A_5=6G-1^.1V5N7ZH77
MLNNI7`P;GUJE?P2;HA6!W_"_&8/SE`&.$W,@%RSY$RYG(?);ZA;0>F4QU+Y0
MCKMRHU./8S8S/-2JE_$8K#_4(I0N)RE++896;J``8Q!F<%@>U>LQ@_I\KWH<
M>#*WS'[GN:<1&;:7UBI;M^MV`8*\'HCS%K#9L;4'/[OQ___@/L.[R-_\N29$
MND4CD;Y.,)V-ZNY8>,_.-V)41JO)B)@4_!>J-L6L`"?J5'FIJN.`@YG9>ZI,
M<JCV&5C`V*@PP"7C_X/+`U(!Q#4`KL(9T,'&#6L\2$KGL)DY/3?[Z00F.>@Y
MO?4W)YR(A9A/==Q&H&QKM9KUQ.;%(,E<<:YHJL<187.SPZ'9!-'BRC!!DLME
M7/6S<X!QE-ER82G;V"GV),;D=LPI84NEK,EB8O9Q31U<U>Y!39\VX1+^(U>@
M6MIB&I^U7*@[Y2SW)8=23;C/297&-TT68[/=T7K`NHA5ZK5(+;XPK]HEWA5.
M`OU(,KJ]?<F+W#HO^$]DW??YA"WC>D=^#:].T1/Z2/%^_$3ADU_2\0H&OV@8
MOBQ*1GY?B]G8;,="F<S*HVX4`;>;-HM!H6WP\%+:5$[:CS>1+T#<!0[OB3L!
M>2_&&`\E&\#?C_&H+#44]#69S99FK['5":UE":,,OHW:.R"3$9(%#RH"@V<8
M'Q2Y87C">5<Y#,%#-]*'<Z3Q8BN\_@:#C1O&&6.CP/5"=T,2ZN"KJ?.1NA2M
MZH!+,`VZ!K1D(Q1U.I\8OL>L7G@M+H=*"63X'DE?%Z#0&WY*.^F/)XV61+G_
M#MW')WRR]0P#YQ%^@7A%Y7J/[WP$T-E$)V=_#X-#K$3JLG'U()$QYDK@$RBP
M8_1HYI.YX7=X^AN5`5D^1M'4F<04"$B0@`P**&`!&,R`S*6Z9=T/<\GZ"7HU
ME[/5=/K=.(3,PZ)O>=F/@'9:X8V36+<@LVZ;@G5#TAWP/E6\4(T)$0*8=ZQI
MOZHL,4RBF9`^OW<BN-[]BI],Q.>\J[IG"AM.IY6"Z6ECBG.<A#>IJ/K%W)N8
M'62M9P",W?MFD2+VO,#;=L_K;>)Y)>5*GE?J>*5^%TP#IG&/`'<)UCM`.C72
MS%"&=/VP,]4@,O4,G;[2G7&F`=`5MJ9%&CNQ#L@=B=P#?CIY@YK!$9UE[P1;
M&UA<R6&^@^@)@BTV*:CZ(VG62)M"%UCWPZ3(.U^CZ7<1<_"5'M6SC8#9)V],
MLMB9X\%SHT$6QO#&BV&2BQSEG7]RH*PNVDR'"&:8$\9!EFU5VKM?S*SO8UE$
M,PQ#61Q1R*)B<QJ&R/%)%DKI;53QTSMM&F966-$K-6/*G*/V[M&D.C/[[2NM
MXS`H1XE&(OOJ\3&`CW@1Y686YQF7:-PBUA;0F(A#_#OLZF4.8.!NX"?7<P^G
M`Q(0KQC)(J(NUX>BQ18-IGZM"^>HR;(N5-UC#EJO>P'&-`ZFNTDLPDC<2B;=
MQGO'^:XR[ADD78.D;Y/MDJ:-Y==FF.1O,V?]XVR=300V_+*4MC$8RF8SK4#V
M_1,$A\1JD"WC-V0#&6:;1L2N(->G:2>:5$*FR@F!@[>8<"FR?8T:WA0CP$-B
MUTA[FK>EV31,S^[T:[-+TI=C70R.-S@GK_L$C'X0!K$0HQ;'_E0T2;'1N"A:
MEY)EV>&GD9_U[PI]<KYAD#CH""M";99U1>:CT'6_5J)]#&09@V(OB"*3B=GI
M5%6(:_I:J`:SQ"5/TCIO)+)L@FM:O)BMY?*7(F<<FAK^GKH*<8>RP*C!;J=*
MF@;4-BP9-'O_M=S5X^2;K;_27?9"+[$G9[UN[[Q6WD$XXG7(*^J;J*M>;5V?
MHC!RO*WK/59/_F8&IGSIPMVOXK,,IRPST-+G8C8S.YF7<ME-=^.[!)`:[E'H
M3,;U;+5Z8F14QW#-CG3OHZ5/'`DY@'O32H4?A%_2*09+>(:?-Z;W\G)!"LH[
MBV-\<]92E\*S!XGZO;PLYQ/(NKS,A68^F9O]1D&/HZ+%B^I%-'7^E;&Y'H1T
MU<A<#]^7N92>ZX$/#?(/!G`JU-.PZ//^^A%0+-<#MZ=X_]7_?V%`_G^6__TF
MW?4^R\Y?MW?5L.],V:R8S>#'GNHY;0LX_[WA>5A815'M@##BL5%Y@`O'_Z?P
M!$Q62>2M`6:J4)Z/FLGSZKDFR]>8F;W1P"J*KO-(1EPVZG?6*\7I3A#-9'C%
M8Z-L(7[*Q/`M?&99M/A&K*BD$US4.:-)]FOD8FS(V9-+BJJT0^1%FZO6&B17
M;@34R\!Q=9$]N]W5GN@)W-9O]5_'3VE>SA;CJ;+=;#H,8MK-*V<ZHU+67\[,
M#I%A$4/UFH@!BYV5;7SW&B3EE=)?R81H(/TK#B5=_=C;F8Y>@0KDHFAQ)QE!
MV<213+1@4]0"R*,%5"\X)Q#1O]:[\S>:\>O-X4?7@S<1/(27UL)2E_]',E@Q
MO5(^<DQ/JC-T-)NMS-[84".PZCE-"6H[;14DS39.@A<@;QL[B7GK:9I2TC[X
M`_<`2!>,RTXY`GZ!1S^(,(CT8<*%57?;RB2+<8[9!,/1/8YR[4>E/[2P-3L+
MF%*YAV%-ZL%+-RH7(.X($-O"][#HK]"#@;._\K976WR+/8P"!V^4)?Y/NN\Y
MF:E;C%)!$--]3BE35::KOE@NS#X^9Q%#M:(Q8+&3LL#QMJ!<.EV"<N[HLM%"
MR5+4./)7%J)4U9-UDME;,8R2:%F&LF$JJ8)35@4^%?@"0XA&\`D!>`^?X=X_
MXFW3,C6FDZ6ZP%H*`&+TYY(P)3]-96NV7)J]LF.00K7=IX=BIT4)V0N%!8T^
M"Q^4F'RC&%\Q]Q25$W-D=A)/)CFTF'H61&7R;PODYSR[WCS![6D/USLY*YRW
M+_D:Y^J;&UY.YY;"JZ6*T0L>8VL?VRQ,6'7/UGQA>J(834.@>E[4)(>=]H.W
M%>3O1SR\E+<D<,\]6ZI[?$*/54CA.\`J()MEDQI&494ABKO#E#7\`I=*N8=F
M<HK@E=H9\`?IBB=\C^=F[><3=KC6._)K>/7LN'O<_0<_2!Z>FD\F=8G">[[?
MW@%;0NB>GL$4OMW>V>5B9AEN9A2+KMS2J,4OX\9GW!,V.G%?(.L,[/Q`Z_.2
MU"JR_&%O%`RF>GLS'TTGYH8*:Y&=WN(\P^#!UYY-@U(..S$63LE8Q"EWG0CY
M.\>([-:`R>@"8(7KY=$E#"P6B-!];)ZOTH2W)Z/!,'R2WTXJ]H7FME=J);ID
M-M8?Z0"NXB6W^'':N!MCK(=E_3`?<L9/H?V8K4:K[\Z`)$+36Y#X3==K;ZO9
MP^@2(74M"O>,#',ISC),E!ZYP%0?#\+1:)/"&/O!.-0*C$H[@L5L9/@QD=Z1
M&)`#0R&..K>FDE&K_!J;X:;-R'RFK].TJ7JKMAO!9#I^Y8\HL`Z%EF`9S4+9
MZ3,IL&B>^G:V/OC!#KK1*<@?WL4J,377L:I!W*^EH1M"65:EMK?%;&)VJ)Q"
MJ4UWA)JA2W5Z"MT`UTL.LPVR)7FX^P]C(CZ&2JW);#5:F'T!4*78%/9D%=L3
MC^1QZ6E7IT4$^YV#QGC?RY/W&9A?`S_$(8'CVA<7S=#^&L3]:C_=$$I]O?6\
MM\5T^DHC5;JE-MV5:(8NU96(N\F]"/P7U)5!UL3(;9%A61,U;T&?]S:96JO)
M]V=.$K$'L8W1(H!-?M/M1Q0RC.>'FO.5L5Y$!6^_6D\S?`J><\JC%!:O^T2X
M46;3O8<FX.I>,^DCI*2%_M;HA_F0,WX*[0=>PGYW!B01FC6DY"YR@J@?KZ%1
M"+OP"XXF^4_'.SG!"[#Z.-UH([.1\64#,@;2X\OJ*;4T.^&+.J$'$U_6*,*Y
M*>C[K+,`YXN_WW_P`_SCY70YGP]A<5'`;(Q5:!U'!8:AV!_R7L??C7&H$7Q`
MZXTJ>E6+#O`'[@LDG>FZOTNG&$;N6@[0P*A\E;K0WX)$[KSR"S)=H@]B"[-#
M"/O\YFUO5J$K$G$V"$?$W*!/_J%68$JZPIYGKSO&@G$D!N3-4(BC\87H/N/9
MF?7-^"W85V3;E&[7MD/`6X&O.Z*==2B&N;5+(YJI&[Z42F+Z-O!K,D@JMXP[
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M]9CFN7&KIYF^VW=B&^7[;\Q0<&C`*_?@>,=D&#X<IW2J4@]UP2TG,>A2DY7!
M_AN])#V;)Z$AEV:96%`LID,/2I,_&L;[:LPBR773JKF0S/+0>+303.?L51L^
M^2X9"PJ\PS+[8?G.AF,8CAB[8)Q9FR)_\^=-&)[@]OTI<+W'N$."+20_GNWN
MX;RD\\E4G2?%#$C0+L@8@$R].1I;K):&WPCB%DJYE\&+3,6[$P()F`4HJ"B_
M\H"4L"8[,D=K>!UK>%8!?JDH]%!*;F-NA+RG0._=<+/WPU,`U[NB&G^!>RP&
M>=.;=/]0F&;#JX<P"IQ-A'I7>/-6#)N8/LD>EU2SA-M=+B9F3W:2)%0]\\F!
M:1.E?/.V.@W^D19E#`;^Y'QS#Z?#)W+UXG(RGEK*]*O4E9BZ=*!.V5\N9EE3
MR^P0_5J\JIE9UZF=_!'\$?]9"JF4;&<H)U5E1^!LO*:K^=3L$Y1ZP%I6U;5=
MBY++]<J?2=TA0:DK07*UH\[(52J&E'%FN,6JPZO<8M5T:B=_E$HJ-19+-:FJ
M%JL\7M/%:F[V'=MZP'HL5EW7@N3Z@C<HKKZYX>746BZ46:NL&S%2M:!-"947
ML6;6RNR[/!6LJJW3>8<V^0-RT-&?A(FCQ"(I(T[%$A7&!FG6S.Q3WBI8+1:H
MTJTH@1);ACZ*.D^IT)$$$C4A+M$H-=%(R0;`HS):+3:HU&5*HO?^P7$]"312
M9XE4T:C>&A5G>K-][3JX^BQ2N6,A.MUMGN#VM(?K'?^IZSU^EO=R.E^.U!UL
MRH(I>-2B;K2R\Q=I75CSY<IL+9(NJ_(S4\F`[;3!+,^J4`P6^(,TWKL)4!,L
M]5I-0#7.21[+9M/YRNP=4?G":IF'I<,VPQ3P)J/XX+C![\[^!*_"\'1(#ZJ/
M<!/![7OWV=U";_O%B<B%V;'"^"?5^!6'42H87N'L,O1]+V8CL_>?M(V!<C]$
MDR`R0KUPEX#T"0J=XLBON%N0]@MPQ\;:*[/29;TZ>R4O&Q9]WY.IM33<.=(V
M"'J<)EWBV)E->7'AGN=BW4,WR@<6E/G=0()S/)V-ZW:`O6?G&S$6H]5D1$P%
M_HL.2!(LA?8Q*]D*Q;U;LY4U'D"^*4W#H,7#T2.+G3?4[..\37R<NJ56O8>3
M.SAYM[PNCB[-LL8_S)'`H.FV1Y,!7%#3-`ST]FCK;TZX)P+&6+N$9+*OP\@]
MX(AD$*#_B_>%=GF&@4N#S<CBAQ7A'S.-1F014VT`FS:ZQD'?,DB31';FA>2V
M@Y@3`\S'/0P.:/J<S4>*=X25`#?0MC0-J%*3DG0ZG\RM[\^.E(0?Y)JH*(&6
M[5[<H7G&1]WV[G=J?/3X,Z33>+(S_.:/#O&'Z[V4!<F=%H3S`'YV/?`"G2#\
MBP&G0[_[>]3,'E$K/<"P>LR,)BZ!@2=$G4.L](SHO/?%;&1X;@-]HS#(<^U:
M4;2X.GG/IIQM-ZG6<$ZW!VN]])QPG_>.ST/-3AJA<QB&>\I=+Y"=_]DXXY+<
M+,?Y_&;J$EGH$\1X4],\X!HM3@9B,;6^>[?I;#!>@?=4EJ@/)^H")!C,-WA#
M=:H&:_#Z<+$R$%-KM3([E4,/H_%:'*XSN0I^UP4XF&J/XD091#T&=N6B5A#S
M[5'C@.NT1RD(-$,/(#Q(ZV"\!@>L)%%/#EB,P7R#-U@';*@&KQ<'+`6!I^8?
M2\ZST7@U#EA9KK(#UKL]^N*&?WX((+SQT"C",,IV?M5E&%..WR#K0SF\2HQ.
M?=^+V6@`T4XZQF!0/E6+("I=*=PMP/V"M..^SP/;-<I\OVG0!DNMEU3?-PZL
M^8[.`5L'87@^49LX-O[QS0Y;%S>U+IP!WBKA%C9K%Y/A>D7F[8VS#;8VDU,X
M*?K>#<_94`S>8RK+TX/C9,(9()7:#=.1&JB-T^]6%4^%E@.X1:=S+%Z'DW4F
M59.O9<(A8"W\;(-VHOJ.G08Q3#=(C8.MSR#EIT/?4V8CBJ$8OM-5DJ<?I\O(
M??:*V@W4Z1JFC>O!Z2J<!/TP<N6Q>"5.5UFJ%J=+JT'ZZ'KP)H*'\'*ZG*W,
M\Z8R?#W9D);Q$38.>=MH_C/\'39Y0AKKM)PC%7='P!^X34`:U96T.GE0^5=4
M,`IOO/C!Y;]#]_$I@MNK9Q@XCY#\^!Y9F\QXD9RE!JH_GS0]V0II0R]L67B1
M+&;6*XWV%AL18VV6D%@RUEOK=($50T#.#(A!7(`4!DAPQ$4`1E)8I@W$+)JU
M_OJNS**\U1@O$GPF_4K=,\$A,7MM)B:<G99\XR0&;(>MUC/97/)W((S\S9\@
M_O`A>,3M0)ZLW#R27?_SA.AWXX510/)^ANOH"0;W3XZ7R)QDSH/;5&P2SSPV
MS\-CEZ0G,R9ER(5-&`^*Q?2U>G7\HV&L1\<MD@QO+NX<%'H'I'L0H?YS7R^#
MD+M[`[![9KEPWX7=D^>Z\:!`T_CBE>ZE"PR'V2X;OV#V%X@JN>1V7^R:[=*B
MAADGG.F<9OTS7BE\>]8((0TW:;P?2INUHP2XF,[-?L'<K($:O&_((JU^MQ&C
M,VQW4)%!&*;'^1U:;OU^*BW`T63TPW0SC-3K\&Z99!Z`XUO>@26!5D-T;<MB
MF&H".P=;O9$[A["8+E_IS7+.H1BNBUDKCT8G\OR<V703-S`?<-@F3J,?=PX!
M;T*]TC-BWK$8N"]6+U75VS+LY)<]SF(\&[XS-M@%J_CGTFWKJ':6K!_^'M-8
MO1:'D%;@'CW&H>T]<EN(0;N>WY]![\UYI8N(6_RPZ&R#]:K<7VJQC?>//_O>
M,X((MY]/AP<88/U;&OB4"ZL<IIK#[N%6;^XJ&!;3V?<:&-0P%L/U/^L%TNA?
M9@#0/PD$XRU=ON#X8>KTCG</M@Y/RXL?QJXT&/36[DB\GVMO:YI[UB":O3Y%
M8>1X6]=[!$X$[M#7@;@`F(PN`-9<\ZW3Z(=UZF>\^[%.\U>:9(Y[,%BMTUWD
M!-$0[!,2[MP^_:?CG9S@!5B&&J<O_G[_P0]P)9P!9(@7Z.ID,=Y(M8Z[1CM5
MQ&$M)JOO-1BO;4!>P=JQ*E6?"TA\NY@T&X(_,#*00-.50T9,30=V[/!JS*/&
M\X,Z'`OR?O?\NU]JU@[)P,\"6H6SSXV6<5:*[A!N-F3?;K#'I4(?2:.EHPML
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M0\`S]`\;5QJ+@;MJ]5)5+T''_IR9=HCN+:8A[G0RRCD,2\;SN72;.KHGZ,8_
M3"'+6+T6?Y!6X!X=QJ&%3W%;B$%[GM^?0>_-=Z4\\_U>WQGC':Q7Y?U2BRW'
M/7Z'_N!NG/U]X#K[=WZ(DQ5M3D$`MY?CA56;8-Q[=KX1HS5:34;$9.&_M+0D
M9D"8$*8:W5()AQ//S%X_4J!7[<9T0[#3(H"4`:002$O)9V'NO!E+PQPB'0_G
M<[--/05Z>AYN_0VQ?\1N2N8CAF+?^Q&BX29E9418N2&L=-.R\FFY,)Z5%7>G
MN=(B5N[90%F9P]?B$E``L>]K6,A(0G^/_LL/D-X\PX*_$5YYV\]H/!M^OD?_
M"IT-\3"NOKGAY6JU4K;Y)`FCH"XH&JA,;22U/YZ/#7<_I`JJW%.1B=8NM5;<
M(@F!XVUQO-:;37.1/W!+C$%9$O!_=#UX$\$#YJZZ+/0R@?:NZ<U#)E'=\T[&
M<\-?(%,@[0`4_PRRD/:#8L/@#]PT(&WKMP>?R/T`Q.RIR<8@1MF[)6@8+(EF
M(.EA/+?,SNLA6]0!&(`B7IG:_]X_.*['K/E>%*`F[F%PN!Q/%[.ZC-I-"\Q"
M75&5:D61ZT6A&'Y$<6;Z!%>#5SU#JYW:Z1\!_JL,AM#NC"FF2,WNU[GXAF>I
MK,6K;8>KIG/Y7*'<KE),E>J65*'8(I9^..8D!ZQGVZFNZYPI$3-3KK\=(3Y&
MJNYGH2\VM^KBQQMXT]R2&(N8$*:<:JEDS5:SB=F;,!3H5<]>W1#LM`BH.PR2
MST+*F:Y/&E9GP:YA-'M10(%>UPS9#24Y`X(I*^L.@QC/@'[UGV'@8="IA?T"
M-]!]=A[V\-(:3:;J-MS:NA8C,J-0*9-;JRU6<[,?MZ)`K]JB=D.P\R(@F]+S
M0BJXJR1ZK6_N5CS,MFH+;#^F*[,-,9T`6CQ0*BBY1QIPTO=O3^%;)]@Z:4,D
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MMN\DLOVCNX%>"*\>`T@B/?[N1D\?'S^Z.WBW<2'Z".''J,B:NBCK!L8S-"W&
M>C$94N:SM((_C66VK><11[5?PX')3NJ`K!+`M<#'1X#K@;0B0#5UJ@"EDV.V
M#E2='>8O9/9E&AYQ=#D]'-AJE.$K489?R\IP@;7A4J<ZT/E`9FM#Q1=B:"6>
MK0U_VXE+'BT^$0\R+<KPQ7]Q]M%+<N,]1*X6ZC-:[SZ<HE,`;P-_>]I$=\X>
MDAB)<=WCE@VZ0-^RF"H(29!JPB<7_1[Y'L3!Q_0MQM]J;O8>IK!L6C1$%*6=
MU`''I-(%.,;5V!3BUHF>?G<V&]>#=_[^5`HSG\XMAHP*S2V)$9X)84KPEDK$
MW)A]>$Z!7K5KWPW!QD5`4@9DA3@-,\U7IO31^R1BU0/O&,BQV<:4`KTN_[H;
MBGU[=?\WK8RD<PWZ)&1EZF^N%,\M8[./=FC@:YG`*8!(YJ,?(=UQG3WR!Y[=
M+=Q^.)%7EM:[ZV](#O1)TDC3]_`9[OUC'/$49OX$\0?K[E@VT5:T0T%V*Y`W
M4P+AMHD;9KBJ2!-2N;,A"ZF=M032ID#2%ECO0-I:'O]?:"])"77+Y47+XRJM
MD_-JE+/&91*G`\YG8W:V*GE":G/`9"&V[Y\@^B`0_PVG6?5WX)CI[3'5V]V)
MJ"WZ$:9JFUV0V!;4EN>:A$3Z4KJ`KT9=JPZE:-O)GH;9>ZT2I=3CGDK#6YA3
M=\E42J>3C#NS,(3H<SQ=>=L"HD+.`KR'_`$B@CC[8D1_(8_99X@=@<E(7=IZ
M.2`%-X!5#52JT-(Z6!D>[2I74-5.LE2T=MH:R152](*+64+(^4O2),C;O#C+
MGGH!4,/]:KN26V&O4=LKT[<\6J$NOA-U)Y)JF<;E8I:0WY/F4CF=2]SGM7=)
M6D#N;V?]X2YBKVGZ&A6A35B#=:$%=IX/@L=?Y3B'I]MW-3F2H.HLTC>"1WUF
M]OL_'-(H=_N8(66A`6F==$\3;X'&U4!2#Y"*ZHE/N:EI,O.KVY2L7\;L.ZD<
MTNC:>&2'5HF.`0[Z?VF$#-Z_V,5Z<$ST("2U&9]VVCS![6D/USL)J1WO24*(
MZ5SAYH5\O&):J&/\LC>3Y/=ES1>FOV:G3&C5DYXRY';:,K8!$C.HDCX8#_1_
M.R)=\*(D[#6Q;F3"88BZJVU$3"]I<:6Z55^>^-AF7ZEI!ZZ:XZV]V\FO(`V*
M3GZ7RC!*KTP_Q:J^5LM@F1W*V0Y<EP?5BD(+U^CVA/13K;(35%L^V3(PVX/O
M0*YECZ8=0\:T?<*T(P_3WCE'-W+V'Z&#>B!W9=U-X;M.)@QYR)N;$F,=&\8L
MKW!++3R$2[/O9]/`5SVK4F"PDS*`%`)I*3ZS1_6A*=-8]TK&:I+KYEJQ0B_-
M-H=4^+4811HD]B=D%Y_V+V!/2)GN6S!>]<1UD]SE\\F,X2)G6E&,:&W]4]`*
M1Z9X6[A=S>-A69E]&9E1DKZI5H/)CBT@>P[V8C?A>O<1AB&$U[L=W.!U\HV'
M6H1A],6)(&$"R[N\U"W+LXG,$M1QN:,1/.(+LY<J'-+HG,WI()4G]Q`?><2U
M0%8-I/4`KJB>^+0/GAC,_)K'4MB^S-+L8&P.:70MW=FAV3G3W93I`?H=;WEN
M$NT@7@;K^\(<Q&'W?$VC?JL#T]Y(XMP-QXNA%4>[*T,)K)GY7IGYPFXU9<8L
M96YU-=M55H;X=F8?3%7!JG8D*CTFKB_'0U4%6JX?]NXC,>OA.QQ+A];3\^FD
M+C6LI&<L6_N69QMIY*HSAS7UK-7*[&`X*OPZ_=PF$&?;5H5B%R`IJ(3)T_$K
MI?*TU:FM5IR.L?$83X?CRK;*0,'I5<QI#Z)&X%9\&F_#8^,)'KP!F_@'</0#
MDASSW&F5PG$<.9"S05W(36?W2HC>)ET'U0M5D=$Q^WX[K0@]&>]S'&WV.R^K
MBM[+5TWO)3.]E\3NS,P.4&&0@I[DSS!X\&4LRMH1V21\2IDQ#^/@ST^NYQY.
MAS0T]/T)7LXG2W6/W%%!D+A)02]E[?9$8W5K:?BC32QB:-V%;L=RMOU\D<;;
M)^7SD'Q40R7Y5]\%^5><Y$<6RO"[BFR",.S'X=M0$O;CNB#%3YLJ8/B-]\7?
MHYJ/5[L(!O^`3O#!?2:,J,MLI9'W]<`T:`/MB##I2$.CULKP%U'$A3-B,FE#
M2#O%7.`Y!K@>2)H"#FX+X,8`;DV_<BJYI#]HY6P_7&)E!S*]UBOPZCK$TW_X
MQ`?41H1=J%2RG$W3L67(Y->':C6/`Y]6%<SM?#A[O<QRF371E<%QSW%:9K<*
MX0R8V(Q0/,'IK&Q!!Q0LQRZ9@9/8.48\?\V5JQ&2`7E#*Z/F+X1)NQK5CH.`
M&N'VK)7ASSD)R67@_)6!$YR_4#M:%<^4^:MOQ9,Q?Q$.8`OZ.E4OD<S4^:N`
M$<]?,]5J=(\T!OL_<5HQ0R8P`DJW(C6,!+\FQ0U:*\/S>(L)9MXD5D`G-HN1
MAO3JGR'SF`'Z)V$F2XB`C>DKU<!$-$/GLA)(/)E-E2O35Q\OY?6$PU%#TJY(
M=:,@H$:H.6NU,#L@7T0L`Z>P%)O@!/;5UZEQIDQ>_6J<C(D+?WYL-E^ESB6"
MF3IIY1#QE#61K4#IM:\;;[,_;>'VQDM_P;&@JQYGKF9DJM6)94SHM:JE56ME
M^/TR"=+U/ZMU0:2?W++[[FE3>*I+?^Y!0]7?*!J@BK;?1F)M-KE7,QEZM!:5
MA!2Z*OLF$S_:])Z3<_!/.!`X@$=4!97!?F=Z:UFV4M[&7?SN[$]PO?L,H[/?
M+^>31=V]9EV:V85/M7ZRCP^]DG:V;2T'E-=-2,;^)U4ZH/13:](>(`WBZRVH
MR4JQWK2YIUL`@]%FCOL#W03"9G[HL2O44C(L0U7>/*#%:Z?Z^ISJJX?T]9#H
M*[F2QIEZKQOC%WAP7`^18KW[X(8;9X_7RWC#OL^)MQ:4:OVD'`EZI:QOT%K-
MAG[)ITVP_B?3%G3T,VC6"-;&N!GP@MK1JWX];;X:J'X<&[`-/,#;@,/)(,`C
MFB&;L*T@\3;LF$V9WL,'M(0-HX"DK7OKA&YXAQ:ISG;M_>X$+G[J@N1(6TPM
M=9?N*$&(*0NWI*ERT#8P,3T-')L@JN<>)C0V+@WRXA>`5`!Q#9S[+:W#D?"3
ME2%*)A(C=:$R4=`V@`S3?&)V[G!64;1,!(R@[)M2"D37`\YVZY(T')$/(AQ=
M\@8[6N"WR[O+PNO.($)MAJ?@A=03T98/S@9>D6U.1)JQNK1X3;W*U(<V6>H5
MH%!C,EL-B>\5Y'K-_7GW5?N.2X"XB&1^:C#?VOC98:`+-8C%,'O/JA-[#R:X
MBL)^ZP>!_Q4?Y>S=@TM>FMS[CB?"TAMO@PTRO$JLM[//.@G1MYZK2W9$CT,F
MD]GDK>=V:QN3^60^(*Y3R*+7/G<#JEKLM,X%R&N!O)IR_=!@UXW2CP[;W]J&
M-5F8GD>"0YH>Y@<:7+&JN`55<9-:V&-_D*0A>:[T]Z<`-1<_#8/8LE1W;XD.
M@US-H)6S22L:ZD_F\R'Y[QURZ)XMVL#4S12%QUE`7"-YHTVI#FB9(0S0@<Z9
MH:$^]G"G9H=],DK2RXS0CNELSV8;L_\HE?UW$0Z!0_UNT`_.(]DS^H*?M4Y.
M%1!39N,>9H4N7*JTA'T\NC6GL\W)?#RD]3:';/W-,G0`.V:>"Q`W`_)VXAF)
MM'21'F1K5TK-TY3Q2LDPG76V28RPV2$C$J3K>=JCQ6FGH2*EEYQ$].W\Z5M$
M(747AEJ[EJDUG5+5*\9YM<E\,J0#ZGKX>N><6@S5:47L?6FZCZUA5NB!PAVV
MO>9Y[[GAC_/0"="#A6Z`DKU*C4;2V[A'9\\9'EON+7O+KB[50,-;>M469%*P
M`5$]\=)WY.:&YWAJ0:W74A:[/C>0'$_PM7TZRL=V=;*I^GANP^B,AV2\2JCI
MZ23V&&XS!#M9KN&WS/&IZ[:\K<[XU&W;YZ1[TE8GP3KF25QX$9]0#^G<LPR[
MASFQ!,#^`I.9CU",\0%9W_&N'@,(2=1`T],9X^EL/JFYMM7TN"Q-HV*DX\7-
ME+MC12*5!Y]1H"0)`UL5/\B28>)YD07KPWLWW.S]$#5^]8`TP]D@YW"\G"A=
M.%?[%#>>-'(4[6==^=ER,8`%1@MR'6Y?<_?V9S^"(5X'DV#L/]+?_Y=2:TKY
M5+=QUK3ZQ#=5?:SNAM\U8!-$-6>9T-BX-,B*RWO>C9$<E,L<\UA=70S1C[_A
M+XFS":)KR<2$RH[#6?$"*KL4C0F?;OHP+J.H^JXF<,9DJ8MJ%2&YY$3CTB1C
MTH+Z7-<+LV.3!"4SPOPWPF.8#\"-<)I_4=;)G#4,4RC.>:7^PR[-7HP*2F;4
MS-,(LVLJ`@<GBL.C7`]$3Q#L4.7H"02)BD5?X?X9@@,^P`C1C_M]?"\#%]T[
M$3Y0?G`0[@T$X1.$$4C2<,&MYDF.;C]QB#I9V9?D:W`14\+LA;>H:%KV-P5!
M<KP(Q=YCG/8<<:@V.$.:=DC(T2]/-G[]R)/$+\S>VQ<5S3PWL(1/Q`_D>"A#
MF'K*/$$3]$J&+UCXNF8'ZHJ*9JXW6,+)[`Y&3VZP'8(W>$9>5>Z@"8HIP2$D
M+<8>R<+L.XK"LAGJ$I91<KRRQM'E5Y^0B"%<C*L3[>I1*Y>`<B2O+RQ>VUJI
M*)B!GF".3L@/9'UO1I!PZGS`GC5)BO^7?E.S,^B+"6:P[Y>C9/;\0HB&=ABN
M7Y&URAR_GK51AM/WU4\<CE<0V-`LF:D.7P$CQSN$W1U^AM^BI+][HJSDUD%(
M*%27-8Y;-1HZ4JT>]/+1JTA3F_@[&9ZL0ERX_EW`#H2T;B!N)G,"XX9`W))V
M'9/F#9JJ9#Q>8=MG-OQ)3W'AS/$..Y`R>X@>5CL#_<-.#LOR$4W540Y?L:'-
MQ&,Q._^\!.D,\1F[<'(\!MK=:7W>>TPFJ8'?"AYID"<;O:(TOQ(P&_I&>KMH
M_7N+K?AH?<7\H91U]E#*/Y@?2A%FGC0_T42UXO$1FS_N?.A[A^VBF>,?MN)D
M]@Z#XHM$)+(P?Y6HWC\L%H"HIGS/L(.WLOQ"$W62PR>L;3'V1>9##Y/JD,T0
M?[`=)<>;1._V3ABN=W]W@L#QHG7PQ7U\BJZ_P6#CAO`V<#<P^S%,?@TOYXNY
MN@>*>!")J9*<,<@N9_.T-IX9GD-`0"K5?B(_-)M4Q=-1\COZ`H`4N`!I`X"T
M4"@39H58G[(4H9F:A_2&I6K5)_1X6L.))Y9FWW@4DDO+3"6"T,Y4ZYBJUM>D
MJ`2%^GPZ/.#I\0YND/<9N3!\Y^SW</OVY=K9/)7+XE0O4X8]#>$.%2B/H+RM
MJL34-OZZAN\+RA.RESF-!VDRQ:WS*6Z=S%X@;@[_E#<(XA;!VQ>`VZQ4ZDU!
M*;='7H^&5K=,)''"[%`/>4+JVD:1AMB^QT%61[AQ=RY202]63S0[AKEZ1D].
M!"#6S*^YQQH0=?9/41@YWA;OH3RZSZ0P!$_^'N^XD/T74NSA%`'/C\A?_(>]
M^^BD3Q<>D:!/^($4S&?RNQN&)U09=>FDP#;QI'V!G_]$73_`G1]`]/,&!A%:
MF8(M?BFQ-RM!MU_S>HP$G4?,TG:<F,WP2V\2I>S/6^;":]\].:A#@*R5&^&)
M^HCT,S$%2K6N;E$VT[L'1`].JWYVCPRG<M;M69A]HBA'0,-\ZWJ4;5M'G[.9
MN^I8/[RHV4?BX*>^+:6A::[HM'K><&*^7[7RYC*:.*4VHK6O'A\#^(A?H`GC
MJ77C'P[(N0TC?_,GV*#Z)*DBTEO.32K27#QMW\+@-\^-_3>+8=NIVH2@GE!A
MRLA?4QJ/WMSPE60+;.533'/?=OP;2!PY]"O`/TLD%>U6B596U6QG-(V1V7D!
MVF!KVW)HQI`N$%QOLS]MD<.!UN1DOP#^\X2&$9QP68EDHUQQ:^5:=?JNEDXF
M`,//@=IPZYEF6Q"DEBR9-_%*],1LR:X)+6_"\(0CP5$7I*_D]??E:J9NC=G6
MLQ@YV61*2=I::[8<F6T6*="KGG2[(=AQ$9"6(8](Q3,QB,LI(*^295;/Y*U8
MV+9:B<$8+G]S`;387"HH=AR6PF=T;P-_`^$V_("^>MK/.KAS]G"]BWN_M*;3
M95T:13GT[08@1F(N`5,NTU3&SI;9R4`8I-#":GH\=EHT/HC:N@'<X##C'<31
MQ&Q,O\.K>-P=W!;?A8X=FL_P*_DIO+3F\W%=L@`Y;*<#(<9X;D%3UM,V@+^1
MV5$>C))H83\;)AO[V6%\_$I6<$(Z</4,`^<1DK[(K(%72K,Y_?Y3I0$QJM+@
M25E9+8N&:&'X@V[-H%6[P(T]V\DOB;-+?I/&(LH-)WTTJFXVU0_,Q.RKYLV@
M=6TT-2+(^)2%<#H@1)9IGVRCQW\IA+"@>9[LHY-M]3#^>>,?CH[W`K;Q-2$<
M<7(D9I%Q@ZJ%"73;4_J869EV*V47\1";?<6M!;66Z;2Y_XR8F'%A3$^N[4[,
MT]^=_0E>G:(G-/K_@EOR&1D>4&EN2<KF)QW"LSW0NDIXZ$:#V`EM0Z_I3*<%
M0G:T0XX.22&0EY+/0K:#GEYHV'CLTSB,9D_)%.@U'P*U0,DVZ`D?G>QWL/,#
MLKB(]T"W_GZ_=P+@Q'M\\GG*=$;4"TV;3HQJ*L4SC>&[\33P=9X?M0&Q?PW\
M$,_4R:9/@:=HY8NG<>)`XB9D4?,6?Z_LHBVA0=U]5F:BEMM51=M.]-TD/FL"
M?PG+[#4ULRS]N0/U@-J=`T`JY=E*5#-=V'7HE^HL;D7=YS![=<4L2_\N1STP
M*@<$6_EC`)]=_Q3&YMY)VV%]%Y.=2**N2;]JP."VE)N()U_+\%L>S,+T[-(T
MP&)P<"[BKY!L7CA\L\$GYQM.&1*?+5P].^X>[[Q]\,EA&\&(_Q&6^5079].@
M#:SMBVF%!&E2[6!NBGQ`LSU];IE4^T>\P.RD8AH@FU4%J"[`=1)?B53G]9CX
M647I.0U%2:J>%->'&YN]?<@MDR[/BA=@IBU)$*:3:<LNF49B]ZIF4F'TK?@I
M1N=C#45A*CX7:U.Q7S`V>Y^37R@M/A@W//NC>W!C'4V/)<.+1'FD.%\LD6=*
MPII-"JVK>&!4E6=+L]]9H!="M8]%C>0LI"XM"U*/"JE"7%X=V9>OG>Q+=K(O
M2<#7:NATS\6@)_PS#!Y\=;&D&:0SY@L<)Y`99;TK+/^O'L(H<#;8.9@R/?_;
MW)1@$"@3Q"SRDXQ;H=)[-]SL_?`4P*RZ-5LN#$]GSB*&+K>>`9--#/%Z!TKG
M!'EY\$=:XW_)YRW=QD^?M*VX$BV5R(B:O2"E0*_:>>B&8,=;+/X9)[F)6(@B
MG(]7ZC((RXKC:P6<\;!0:#$U/+M:%:QREIWW:'-'(-=]#C7W-13RIWKOHE!H
MLA@9?B.Y!JV6!7^UW]+9XD42AXROPY'%O-I;0FJLEH&WA*K6CK*!Q<KP^YYL
M@BBWDBQH['@:CHN#N#R(*UPDIR87`%6*2S"FJV%EB))EO8FJ4%G>TS60+$1?
M@S+DHFA:YC/"*D>;A/Z>,>3Z:KMUX\]P#SW'BVX.Q\!_)GO`5_AQ&KS+@,\!
MY@QOY]*T*<9C3M39_1.:ZGCS?&9VS!23'*K-.0L8.R\,XM*@4!QDY55RF?8"
MGV%DKKGF1SWP9J_3F.30M9G%`JK(ZBAFM5M@M:.#U91W_PPC=?6&($7U^'QS
M9G8\'YL@6I:53)#4</HC=$*X_>!LW#WZ6'?_/"'GYH/O1\YC3`J&P+R6IL08
MS(8Q>T^NI18>TJG93C$-?-6.!`4&.RX#TD(@+@628@K(2/M2::]LK'EQM&TL
M%U-K-F`Z)O!U>0(46`JO@X8Q(7=Q`?R7?4S9'6E@'[VP/NM)0P#*ISM[)6GU
M"<[F6LDT9/8M+2K\6F9V&B2IZ=REIK/,5,98F.2%S@]^4`Q/B/V*@G\\F2_&
MZH*_J$`(QL3P"IK%Q=`V,#$]Q1J3(*I]!28T=O;\.8X3_KD4)/.7=!^"<^^!
ME2!J,@P:J`G53(.4#6!S97;P#:,D6J8`-DRIP[([X8?&DS>P8CW@7-F==73C
M(5E@&'W!+V2-YTR99%J:$J,P&\:4MVVUK(4U69J]5TP#7[6UIL!@GYMAD)8"
MN)@",E*N[/IE8W5EUSF69F_VTL#7M;*CP**`EHT[H@Q)*E7MWC(A+#.R>8/<
M["`?"O1ZS&,;A)2&$@[+:#XQDVGLAX5-AK%Y%,W.XTN!7J]9;(.BF8YTNUM]
MLK&RV.D\83'[1B0-?"W+&@H@*1DE'$]]<D*$]0X&S^ZF<*'R'GZ+WJ+?_R1^
M6=V&5N,UW_;VQ(C)@3:_QMM1E;@_9E_5HI9!]?1-"\2."X*T9)[.`?R!"P-2
MFO&>`3T)J',YF,'9NEP-%..\,MO;I)9!UV1/"ZAG\M*F53"#NS5I$]JK+N)A
M-MM%I1="BVM`#:>%NE_=Z`F\<[;NWI'"W+^C]N+F\DM]B!0,SY]2-ZR$RU3X
M.TA=TP:9`,V..&`7IB>WHAD1'<^Y;S1R4$;,Y3"`\]1.2--7,?L@BUV8GMV2
M9F0MY/^[;/)G3=\B*9Z<$(:(,:M9W6TY&L97FY/(<RJLM>2NJ6DM)FC1/1Q*
MMXB@U7HWXSBC;8&U65%%1.6QS;TQM<,.-XROX4^WT8K0B\UMQF-WE%/$5XX5
M8&]T;5__56LNXK$U.P",6@;]J[\6-+8,7N8.2!PWL]ZE/]S[;^%MX#^[6[C]
MY'HX3Q_Q'AE>6.#O28D[S"=AAWM,TRARY*;+0>[>L4C7TZJ1`6*+)YU$C:UW
M^8_W/GB+$YS$38&D+?VZ)K;4'(2R42]&J3_V@/PC/NEZ7JXR0!VFU@EMRP]"
MZ6BW\BD:)3[)W/"<1S+$ZW/[GP6HG?P!H)$CFT(@3!4L\L$#?N\UKLAX)0`B
MY!C#_1.\>_*#:.?L]S&NZV\X,MOU'N^_^I_<_1Y]:;)J8$BRP=:ZF`()2Y+%
M_K,U1#9'S+[?S2F1:O>/#Y:=5,-S#*H(LIKIW)/5!:@R2&KKT0I*QVX(:E%U
MX'@^E]GG:)P2Z7+4^."9K!]T+M@0U*-Z8XRIH7C+Q_2K8YPB:7&I.,'AZY7D
M%98CJI*\-8&?MP\S+8D?VP4PTY((:<F!1TO.8"4]WW@?3OL]9M*(X9Y96UMB
M&L"(,L^.VE+-6HR7*[/O]E#A5^T!T8"P*P8\I?"-!W!!%:2D39??,RMK4N9W
MCJC9KCH5?ET."`V87NA)YT?TS<Z:C-+-U9(9:KA&,Q=`R_Q/!:5`3B>]1+[?
MOX!C7)J1FJ>'$/[SA+3I^AG?7L^B>F:CD<*4^0V]"A*86I:,NTTUK.7(\&N\
M7="5S_+M_=OY[R`NP/^0PUE/A<CX^7Q5MW&GAJ22@MA9Q&GB::$.&FVSTQ]T
M8M?-U',`=53EOE!!\775/"+1&UFK#D%SG<ET8?J3)9W@]3@"73"JI!5_W41-
M<GV%KYM4D^07"DU72^,=SPI:>G*)I;JO]&S?=KQH4OS#1_0O],?T3^C_/#@A
M1'_Y_P%02P,$%`````@`RX!I07AN2+:4.```&K`#`!4`'`!N=F%X+3(P,3(P
M.3,P7W!R92YX;6Q55`D``TUPG5!-<)U0=7@+``$$)0X```0Y`0``[%U;<^LX
MCG[?JOT/WLS+S$,<RY9O7=,[Z]Q.IS:)77'2/?.TQ<BTHVU9=.OBD_2O7Y"Z
MVI8L4A:MR]F7DYS$(8"/(`B`(/CW?WRNC=866[9.S)\OE';GHH5-C2QT<_7S
MQ=O\<C*_>7BX:-D.,A?((";^^<(D%__XSW__M[__Q^7EK/?/ZY?'RTO_O_XX
M+;6MM+O=5OCS#\?9_'1U]?W[]_:F]_EN&6V-K,/?;BRR<#6\:,%?=CM*]U)1
M+CNCUG^UQC_U1JW9D_=!0S=__XG^\XYLW`*N3?LG<XL^?[Z(C6Z2+8*?T>&O
MZ%"=<0\$\CY,Z2Z<\..,#6*MX'.=_I7WR_"CE,[.P-][[+/*>#R^8K\-/VKK
M21^$096K?SX]SK4/O$:7NDD!U##\E:W_9+,?/A(-.0SUV)_'N>I=A>*F?H+^
M[S+XV"7]T24`V%/:G_8B8/%`F&0B%X!RJ^7A;!$#O^!EBWY]>WE(Q9C^_NJ6
M:.X:F\[$7-R9CNY\/9A+8JV9<,`#&_##PDO0'/B[RV!>*(M_83]9(*P''W2^
M-J!BMK[>&(#655Z>KI%!\9Y_8.S87$QHVKLMDXD9L@"C#^SH&C*X.=H4S-+<
M072J[.ERNL$6FR)>>&Q2/"\.]KFY(>N-A3^P:>M;_$AL7J:THA5GARED?]P;
MY#LW0MKR'-R(:Y+M:,L-*IBWJ;5"IOXG_S('BU,T#X_Z'ZZ^`)/SA!P'-A\N
M/@Q]730?<W>]1M;7=#G75Z:^A(D!<ZAIQ`5[:*YFQ-`U'?-Q9]NH\$7/Q1W[
M^L7-XZ9P<\#%Y2MZ-P20=`J?:8=HOU_#=KF@)@OL%;_^V\X[THI&[6W^C8#;
M9;(->&5A[._$-\0PT#M!%K^)=^T5T@IF[P9M=`<9CY@Z&%Q6%!FX8!Z>B0/:
MC;ZHYG#Q8)+"C>5OR+)`GQ]U]*X;8*^X^/B.C,*W-X#7VV[7Q&2ZS*>Z1"O:
M.7I"IKM$FN-:L+H?057!&R'6%ZCN=`F+']\CC1^IM4&*WGKC6B-@=*CN%&YT
MXJM(@!>ZELYD`$7,\KM&"N<J[HS<@M"ZP<<,]4D6DIT2$7ZH;U(T/WP;ZS.U
M4`YXWR+LTBW6+(??>]V$X$I'QL2V(;P"NQ$85_CE$ZP4U\*+B7./=.L)6;]C
MYU=DN'AJ3EZPYEK4Z(`2ZT*30Z5=(F.]7&^M]W*D#C\UT6"N0,>FRT>\Q<8K
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M*_Z+$&Y1.99KS=BXFE&X5L1]_5PH4Z^_<)3C7$U6`-H*.;MPSV!SU_0-,@*L
MI^8=^)X;^OTC04*>,%.4#5JN-QN"C:)EV8]_13BC87#AANP@#A8R3T@KW'/@
MC8=%^*1A<?%\VA#4S+&U!:;L<"W_ICL?-V@!3AD?9W;AJ:9,QH20LXNWY7/W
MW<9_N,#3W98N5CY5<_%6,A]"F@_L<."RL;`-0[--]!%^$/R![ACP%YV.TKIL
M!<>&\6_!B+:\,\16PB$BY?[THTB/:_SIP+X(CBKC.N#;()K_*7`"L/'S!?S@
M?XX-.GD'CP=6;;NK]D:CMM)M#WAPY!ISEV&#'A<3*\"9B^-7^,MV%Y@ZY"M^
M"FYCK;TBVZL%UMFI.?V&\7S94?RSY+_`CW:&Y6(NK@83*V!T:9'U2<@ZY*B8
MQ`*'@]4R="Y:&TLG%HP,6G?1<FW@E3#/.CHY0Y9VH%B[)^3^)ZXV[.#M4OO0
M]_='^`37Q$R`W05E^=Y`J[:BJ@7-S,ZX59B:-$']N>E6<&X"B6<8V`*A%[?@
M;K65@5+PZMD9OPISE26X/V>]"LZ9)^X+7NE42M-Y1FO@?#0L:,J2AJ_"C&6(
M[4^86MD)NX%1+&0\P`;\^=_X"UA/VCKSS]C>^-69LG3!_3GK5W#.;ER+#G&O
MVQ`C_@LC*S01_7Y!TY9&H@HSQR&^/WF#"DY>('S$_CW\Q&YW.T49R10*59BZ
M;.']F1M6?N:\S3E@ORASF4JC>K.7#(`_?Z,*SI\G\KUNT.RG@U?$HO:^*(N9
M,'H5YNRXT/YLC2L[6[%\X/P#QK2GKL-*WW43HIAQ48%T-K'JS"4G)$'0W:G@
MW+Y:B'([_UJ_$Z.M#(O:^7;&K<*,I0D:.I?],N;F[U>).4&!=&&W==D*2Z'A
M^^O)X^3YYJXU_^7N[G7.GQY,O!4@G`_T"DY\MS"<E;ZW%(;I:K5$]CN#T+4O
M5PAM/-W"AF,'/]E7,O_'R13SIP=I)3D]ZH0O]+AH2T]^''OBW"#+^@+]8>?0
M[4&_/Y`F$1<+A2PIOMD*G7U1:,I*-H+82PPR+1Z]>4T=CPU&R]`P^R27@LPL
MO$'ZPB\`\;%K*VI7E:<1B31+T(!LV<M*KTB=\J,@C6M@U':&:_='0_4\G,M7
MT?&^BJ:*6E8225`S":T$X=?,O5*_.:UJ9%6>(0+CH<2]-XM\"39*"))PASJS
M\R?57$7%6S?$9&"]8`W#?@V@O)GONF'@Q61-BTKMMM+I]4;2]$.`DQ(T)2].
MX3E=DY1FZGQ@:]=X*CUEV)>F&X<$2U"!#*E#;Z9),QT5HO(Y]$J_IW:DJ8$@
M-R7HR"EXA?O+L-\<!?)O)-B1M7S&3KBYJGU%GK]QA'(9K@8G$.&&T6V2%GA7
MBR*,Y&T5NZ0*G.A4[A.CB01]:&B&@VRPY7S-#.1E6X.R:=!N"/8'XZ'$1$<Z
MZ7/..S<$9=5LE;"T):8+BLIP0+P_ZDCF5:(:IB0SXE(U,HOQC9#%=PBW:)2E
MR/,>`C+G-"2)HC4R@,QRDY^)J04A%GC(:FD11<3(.14A)SRAJC0I@(A%W7&Q
M>]VN/,\BD>8Y%2!;Z'"N1Z/FS'6L\<"^&]T=]^3%#.ET3W`R_'C/OW<817H#
M>2G49)J%**[(U.R'O.D0-#(D`K$M%R\.$6OW^WV)@6\:V3+G/QN(1@9%\1O'
M8:X8<.I)F_T$BJ7->Y;T9=V#*7OODA)HRMB[$E:LH@P\JWTF(<ZEO`=A=(;L
M-:E9$8NI;_VQ7^CQ)GS5P\3TL#^6YZZDDBW-<G$!$9JO)D7D\;XBTW=#7WE]
M6P+Q!VI/7KAUG'9IRL`/22-S--%:V&+3#3?RX6`H+^N63+,"YB`-@D:>UMUB
M2]^RUCT)F^&H([&:^1CE$K6`#XYP7VB2+L1$GIA>-[(/8H"@-LU'.E\Q^"06
M?O!R4;2."(J<[D,F:5DCDQ_"X,F.)T[7ERPY(3X8=N25=\<HE:/>QT*D'=EK
M$M>+Q4;TVI[N]4UE70U9=U5LTMZJ[<%(E5<O?81P1<P<)S0U"9G%[-P1O-3Q
M2)Z'5/F]CP^8FI0F%+OW46/94TK;]*JW>V2C5%9#$,GIMH2`(G;..U*Z\BH>
M,HA7Q(H(0!0E7]0JJ\A)R9>8Y,/!0)[/D4JV,FK!`4LCZ^@?B;FB;?SC9VL@
M;W<D+QF71+(B>I")1F@4>@TJCSD\G8@O@/Y0YJ:13KDB*L$+3J@9@W%S-"/E
MJ"*&P$"5>'4SDWQ%=$0(IJ@P9=`<10F;OTR7X;L_,V+K.WUQU'%?GJ[P<%"(
MNN03=;>:/J%0L^Y96[FPY5FCC:P`FP6#,PS\RYZJTI57`99`L:!UQ)_IBO5^
M.2I]W1=1:J;8;_#F=S<:273)]JF5-M?'Q&[DTIXL%KK']PSIBP?3]RK:_4%7
MW@EH"M'29IT#A)H<!XG>7'*0;N+%';),W5S9$TUSUZZ!V-MB2UW3Z94<M2^O
M6"J;@=)T0A";'_5<2$KR7\89=U)N?C`8#,\HQ+ET^>"4(D/VFIQ?B9U+<."D
M=NNBO*\6>[[U*^Z!#CN#CCPI#BF>2WLC>:(&ML>EKWBSHK&GOR9[J6\A=/4J
MV''8%4KZN*:%/[!IZUO\8&IDC1^);3]CB&Y?T2=X*QV)#>_$F"G/E<L/6JA&
M-3MJ.;V3<N]H)^767V=,@`],GT<V_A:((-A9>6>071@$VBPW*.?'D6H!S*86
M([A@=F^&+=9NG>8?!E*[[G(P48'$9@ZT&AG%[^+@=>2?N,X'"/<G7K!LE;SD
MS7'BE=.2H^@T,LQ/DO_!MEU/=HGA?3KABFI%`BJ-#.R39-]YP4-51O+2?QG4
M*ZH;:?C4)'K.G?Y/W54'HZ'$4_AL!BJ@)X(PU:0`-+>J'&RM(/OX'"I20:>#
M$Y:RGIH[KTKX^RK(+:]E3`K1*JK"(1QEO5AW7C6(;Z&#T>`LY\E5="]X@2GK
M93RI6K&3S?7$9^E<>98A@6(%E"`+A]+>SBL_'ZGNY2/GKY/7NZ>[Y]=Y:WK?
MFL[N7B:O#]-G@3?>8#1VM6^ZG&ZPY55*YLY!WA";71+T7X.*"NN4;D>F34NF
MFC_7&#W^X76$``+M8:<KKP@_@6`A"Y%_0B(+?%3T1I9TO0"(0(6V8+T%L0W"
M^GK[F+65?G<LKY[O*.V2=(`?CT;FC+]A$RRA`=)/%FO=U"E<](Y:"$"G.Y)G
MS3*HEZ02(I@T,E6<"9F44AD96]ONB.UA5Y%7ZK-/[3S:>U#F<TSHFJ2QQ6I\
MO//\T%.,ZO'[REC:9*<0S:^KOD=JKJ+RA+;2ZTA\SR&!8B$JRST?86OP#-$#
M/ZSJ.V^Q:BMEPRU<;;T!7]&G;VZN8>]<TJK8SF`D[UP@A>I9U/?`7>"!(%#A
M9B7]G[$37[+=X5!>*Y`=6N78J71Q@^FM>@)?S$(]$Y/LFF9?PT.H>FI?7K%A
M)OEREKL0*M'65<VJU'SK_C>LKSX<O)AL`8<5?G;7[]B:+EGZ,I;$OD:VKM&X
M6C=<AQ94#'L27\G+QU0Y.E0`@$$VHG:)80YW@MK7>T#7Z[_F`A)1OO8:+XF%
MPST7VT^ZR41_,($6MNES=;NC>$7#3]CY(/";+7R$)8'I_MR7'2"<19)R=L.R
MIBHPJ?V*FU2QO3:X8!84C.PO_=%`8M?Z#.+EV$@!1`*5&%=<)42S<-[IA.T?
M3]"C"9FE5KO4RIGT8S*'QS$UG60)8&5GMAO9QS_YS.:&&/`9XFT^[>Y@H";5
M-)M;],G60&?<Z[`50'_",V0Y*T)4UD:>4OG6`!R!?G\H[^&A@$PY#E6BD#5Y
MC4$T]1FX=AY(@3_85A2U)^]"4QK90J8[1[(D\J0YX*C[[G=BADG._>9B4DPI
M.NY-8GAHK"A>!;@<2?;(G5FE#V]K'Q6_XNU,\U[5_H9TDT:R4S/J]?M@`E0N
MBV*?L3.SL(,^(9Q5)+XXP\M&V68O%URAZC3ID>#]#0!$I[:_+Z\2*X%BV>J0
M!4(X\X->K6;^]$+8_M%"V)OIT^SE[I>[Y_G#KW>MQ^E<K"#6&]6>+G=Z)!P>
ML@E5QAYT6P@Z+40A:D?NG:`L!O)O["FG@'*.P`H_],PU-QD'H$TME4UK'?)F
M6A@9]`[7+\2@YS313C;'FFMYO4(MW89?W<)_S=4,-CBR"-N-*#U58HFX++;+
MU[^S3$@C$RBQ2RH>9.QUHP,@8_=5!O(*SP29.:7^,U79VH.QTI-8"II*N.@[
M1_FF,W8'C0>AFMQN%^T-EP]$V?V$"EL3LK0HZ2:CB%&OJ[-PNB<_..[)3^:_
MM.X?I[_E]>"1_7%OD._Y/??)XG]=_\S]E;Q@C9B:;N`=M^^54#(SBVQU&//Z
MZ\W&BP<S+.&=:!#&>_MMJ#82FXC(8#C_?G.+00$TW5MPYF*R)I:C_^F=T8PZ
MJLS'3%()%V(ISJ(7T;,G7"@V\F0SJ'3`S!"#0?7$5@9=B=J33+1^BL,!7DTN
MP(AV;Y<'LIS3BFJ9[5BTB`P\70)1(.-\S0QD.K0DC1VYTS3T6&+'8#XN*K\J
M#X^"\L`;7JNL9K(W[PD1X$O[/>!;['V-(>J_-A"5"0P4F2?AO'Q47M^2KN/D
MP+B1K7?$3]ADF[8SG$B69=Q$(*YX!'Q"KW(0ELY+S&>?+F]U6R.N]Z0ZH+'6
MW;4=K^[NJUYJ0)*OD8NI&JIB`>B'VVXUJ\WRZB4[-Z!/(@+4.Z?2;:7G]X26
MHWNIA&NH7IP@ABHT4IJD0NSQQ(?U!ND6J[^%4'.%8?&,>O)NM"73K+SJ)#\\
M>12[4&G4!CUXGL,1E54;6*BWSRDL;$=LVP'MPN`8L>>L.R.OG.=<<A[R4%1I
M=_Z938]3LA!KJ->8#H3_##I-`H-OX\*@T5NL%!J)E3?YF"I+NSB"8&%,P_QZ
M-8MTB[+);R9(;]!'UH-%!S!`L"8Q^\G%1)4-529F%:^A*<Y204`%;@U]"Y*1
M#8I=3>_9*>_%;5A5XY[$2PSYN*JR?HFC6O'#P`+SQ4$4YEJ4L3WCK4KM',7-
M2H6W04[\0GT:-SH@"598<-N:NIORBC4RZ5=8;XXA%2K+J$'*\HR=I/C?;W&>
M&/_W>A+;MXOSDS^8!2(:Q@O6DH2^TD"?+V07)()^_6U%527:VDSZQ=S5*6"&
MHZ>21!`+RTF;=(GK!#AE-<P[VX+AIT5OC:CR2LOY&2E["25U%\R#84U>DQ(K
MS8Z;DQ>(!;[\"M=GXN`@@P$6I=>3^3Q=-@MEZ]!1,\R%6VB)>PVRQ'$4]B17
MSZ0QM=&25'Q"S:AF1'VZ9L37QPL&S'0-8G-60Y]D<M6>Q'[&N?FJM&[E1SA4
MOB;EGN/0,)]XRL2P[SZQI>DV>W&VWY<70672K[0R92,6*DV3<C8GP"FI9<X9
MPXJX`7DDYNH56VL_A_-(TS+3=T-?>;U&Z4L]JL3^.@*LE+V,#C/LN7$,EU2S
MZL%2P/6JXM+`'9T]5#_"3^&A>@(M&F;VI#;TYV1$YH(2FO.,4#T+PT:&ZB?@
M>M8-2LIBFOEF]95,M#]<W<)`=>%2`C@XI>R-O,X2<H3-9*#LM7.X&0EB5O$;
M>R5L0><\7I&S:N)N/6*U2$_(H6U:OJ;+R1;I!LU&W!.+_C)JX$+3$Q*?&\G)
M5=D+['C0E!/=9B9_]@W/,3#`!$FLR!5@I6S]XC#@O#A6/*N3UY3O+[B]&ZZT
M07MTR57M=Y*ZDLLQ84<X*5NM,LT6+XJA?U!-I2HTZW/L\@4`*^^^L#@_)P6H
M->ZO6,3,-;_=XCE1E'S5J>*ESF>W/^?,%<FR/YRTV)(<54#HLBT7;X(L"\.:
M/*:>N\U@V*`MUE)/XH'?,<J%J(R8:.+*D63<F[[U%8HIIR=>]SWLK)ARGF37
MQ);E;B.<#J3LGL'Y;%FB/'0HVO04OM#H<@MQ)[TBR9I#[]\!:`_Z(WG/A8IP
M<C[;?=@O."=@36\@G`ZATJG[<IB`&;2L+[!XOR+#I=/J-3*2(QD7#^=;`9&0
MQY?`,9#J<>Z[88L80+$<@27@;C8&`Q$9`8@/YI)8:P_V`,Y^1Y7WF`TG$R6Z
MO#E@:F1#.KXEIS368DJ1K&H64SG18BJA\@^KK?R>Q;PS!<Z*;O&&V+ICWQ.+
M'9[!]ZQ)6W#6L7/,T555->F\.^4)6Y&QBU&'O,8_UND['QIU3P*DV!)6D<FZ
M'2QTQP7T'[Q[ZHMKUWDFSK^P,T/ZHCU0%7EE$+Q<5$.#\F!6]VS',>79*^<-
M5\_,M;0/VAF=+:.DF\LI1H5WW$JI@Q@*OCYT&E7L,L>.8_A[-;OC%6LJ1I\+
M3[K+E*("1X:JQJSSREK7E-SI[\X,.=^=:?UUQD3YP(ZN(>-O@3`YWZ'9&6P7
M&(%':6I\@'*T#FVZ9'>:@G8)-\1FM:_#H<0KJD=(EQ@><R-25[_OU!6L=!18
MM;23LT%L<'+@/U-KA<R]-WZREVG27PDOR/@@-\2TB:$O@M=Z9C$YIDO_K`09
MD7F(SDKZ`XEO8!;!X@DU!+3@%D^7_IDFNU?5'7;D=8PY)%C(<I8TT^$)VW&8
M?MS5WMU?[8\Z^+`0X'RUGI!#*?(O^?!/]_Y2>-GO#Q2UT5*3GRI/\2?3QLF_
MW/9'C*![!?FN#=I_B#*9Y"EP,IDP9"$K3`#48-6(2OOC+J/>_C*:N^LULKY:
M9-F:ZRM37X)C"@ZQWQM7-U>M&9@X+592Q>'Y>F."[Q*-&`VX/Y[XDXP'0T5V
M5>)]H'2R^9?I-;)UFV;W8DO"7!R%+=+H04>BM*=P5H@9$)CEP`P4A>:/:AZZ
MIY@'")3I=U\B$3*7G?"&_7]K$>KWWM!?WK\[FBSOW@,?#R5;``&$ZKK6CRK*
MFPTAQ)WMZ&N(/"""&'9[\@++76)ES?P1D1MYNG&/=(N=$C]A1&TU2^8G*OM8
M&<F[+L3-1EEZD0NGNJ;%CVK,$[)^QPX]`HANHZ;?4_70`3S4D;PRI3PLE:5(
M)\-7\;8->0]9DPI9=EO;)53'>N@,^@.9I_;Y.2M+QXI"LR:UQ6*J=H<L$\"D
MI=7L6?-]^ST:=N0Y.1G$RU(8`4SJ47(KJ!/^VP/T#BM$D%2"?024?E^1%^5E
MTB]+,<2`J4=QH?"-W>\QX"QBPK>:=PZ3[``JW:'4=D)B[)2E.2?!5M<2[5,S
M9[W3,F>O[,&PPC-GKPG/IOV8F;.Y]H$7+FVA$L:#7F<U\*9B#Q[Y,>)B:KY0
M3]X"'EA&B0$9-YU#15[+FD)Y+<N*R`.\D0F[$"0.;-Y,\FYCBQ7S/9@;UPDZ
M>.AL`F,)#74LKVY*!L>EYX@DH=_(!&1Z[B/"H#\>R0OP.1@H2Z$$L:EKNO'T
M<@3UP&NBU8Z7U[0BO75#UO252\%Z/C8"&R#I[X6=H(@[]GA7..`+-FA//%:0
MR4+O=THR*-L,-43QKW!)60&G\9;?F^*F>QVG&\M*J%4`)9FY0DQ&T4H3W@XK
M#OBZNE&GVYS^OLUY:\_;K6]DBRV370:8K"SL70M`)K5"!J@^V:LAS;9#;_-H
MR'!$FKSUQD-60DVJ@%UZLX\.[[.[4SN7M.92:OW$1L]O26+C;?'$LI"Y8J22
M"O@&(T5>?E>`D4(LQ,G3%QX9Y$/PQUW^@_WE[]^0:SW&&\EDK^_XQ;K<JSCE
MR9%PWD<=>1%<!NT3W`/\SE0Y-GZL(C>V'0U[0WD/B/%R4<AR%IW'Z+JW.%0_
M[M(=[B]==K6QM?>H8/;237^*4"0P@*F+F(E\MZ[$>HEDFJ>MU*2-8M@;R=MJ
M4X@6XWAS3DI\_64`\'_M75MSV[B2_BMZ/%MU1F7JKD?%L7.\Y5@NVYG4V9<M
M6H(L[M"D#TDY\?SZ!<"[")(`"9``S(?)))8%='_=C4NC+Y_7W%;GYO;31.>+
M8!2[R3[H32[Z:N&;#5)?H7RBT?+G(Y)'OBQ_FS1(B]>%['#YC!.6I'+B*%S,
M@A:TQ'M?S]#G-8MUP6=EVG`7<@^CL+G[*->/GL)AA;Y>T<N>Q3@*0^6$S5#D
MHGRD%F:">QADABQ)TUJ0PE4KZ*P;DX\)L4";V!$KQY_6JHR+<ZOZ;CJG`X3W
MA)Y>_CFZ#2^YKO>!O3+;P\':@=&UN6/<B'+#IH/"0W@XY/F(S#9(.T%6?8AA
MD"4:SSI^<WN]`[_BP?#-I$QY&1)=*8;D8JT<A)")AV%"X;.:\+3F>M8@RB5[
M3VL9RZ+#;2V-J4`C%T,D%N)\1553]W)QH\;B\YICM:.S@3EFO50MS5%+OV<F
MYNF$JGA\MQSK]?2*)XK?XJY=+^?L(VBNN)(H[0GLU5G*&=_/NS)01UTTB4PE
MAE^TW;V'((R*U>;J]<UV/P!X!-X[/-NF`0!9<C8V'AQ7)HJR`OZ&Y.!ZO9C&
MK)&L.EF$.-,M=>1&-])2=4FC5'0R5GC%V;Z%>TC8@.:CN.Q/N@C8;DJ@(JK+
M!7]5@QV9=31">//+]/99C%"D<2A$WS^]AC\KXD5\.1"GK\V)54YW.<E%RW3N
M.EM/4Y%#%SC"L,SHD5.,Y?F+W]3*J20/B%7-^6Y[G9E=U)2"'?WC*PA,RV:Y
MQ62_'WV[\>5EJ`U;A]!_NY83_`G'@L*#9]P=FNX%;'\YJ,7@-CA"G4&J3@P6
M*UE-*(;DLDH(+@?+BHR6F4:HU$7P\1T$1]11#[7OQ.6T(0B>?[3>4ES&J[7`
MGEK49*B@6(TP3:Z7BK6%:+_%3(I;3*'^<)-]IE"XMN5>(V]!8K:.5QU6!!+1
M%:Q!"6-F?+3T]90G3EZB#D9.,)ZOEWVDE$;3]Z4=3+AH>0@(?9_;PY/U"B*>
MDX>>=V#[EZ;S>/+AZNG<VZ8#ST?ACS.5]!&\Q-?^DC6P_8Q]:0MGK+3TV-7#
MNNIII[SWW!T`>_\:JD#<]R471#@VXE9=*Q&+8.W\':GUJJ#63,"HX9][!]ZS
MR_VX.BT>5UG*$=VAR&^43_A?#8ZT=*6)DBG:GG@U*E)$JC"Z]:P7>+^SHUB'
M[Z@]#-1C:"7S!4,^+\/07*R;4WU5&NZ3TXYBE]+FJF#^+H#!D/O",+24JE#!
M?:(*R[D^JK`Y[?"S@!EDRPN;8<$BS#Z#6[1RL+[$3<^AEB?1#41K;]DGM!NF
M_%_]WMDGN`6BPPYZ'CK%[K[SDJ^;5X3W>+XRQ'E.N)#8FWKQQE>-DR5KM=33
MZS/PM@>B,=XX(5@W3NHK1@\/<V)CSK+<#^89^M*8EEAHZ7^YM?X"MG5TW?W3
MT0R2BGD0I`?PYGH(WQ^.%=SXM\#WX:\X-X$?^RXC$YK,%BSZTG[&OO2',U:?
M]V5_6FS[R'*/35[&1F'M49PYF*GQ.(J+/([,8(3$-`I/GB,LKI'KC,Q14OUQ
MA,L_BKL1)\16U4G=8&T*J0QURMGDZU.*OT\O5+E/LU:>A;]PYSI>L1#MV%A/
M9L)8YT9F1\O=XGRY$X)S7\];+'KUY2/YZ[\LX,'O'S^P*WWSV_+'QFK=@=)4
MTL#!=C)MD_SB3%_=5]-RH-RF2_&LTI#"Q0::"KBJYQ05>'(H/34\_-?5`H+4
M$I`#.F'[$#P=@9L`O$*>U^$3A[1[44(J7UOL0-EXRZ>OBZ"P];VS%H+MUO=J
MCG'5=A\O(L9W@&[ZX\G%1%QP;<7$?"VDF2@+5E"-CY9A1R3>)RGOXARK%1/+
MKAL$?+1T?)%XGZ:\BPM&JYA8=MT@X*/ETXV8DX-8;>KL9,<8X)D0F+K[QO.U
MP'!@)E*D.<M6J$M]L&@-QEKN[1F(2>P;QF(I+DRH>G*5E(H!1E6/`3S>*UJU
M`<S\;ISPB?Z.M]31=!1NL.FCA>MT]SJ1_%9,V/:`R7J"UA+M_&4=L\2_2!@7
MRCU)9,Y</ZW@6.@JYN?;BOD/9_8:E5$.0V361KB$B\%!",T=O56DB%3Y9OE*
M0(WE[PWG"#P&IA<PA"KI$VS;5`]*U"!,N;AQ=AZN$0K"_X_7LU4'1WJ1+/05
M0]&Y?+2\H%*LD(;N%DNY<@O!0>F]T^AX[S14":T,]\XK9\_]^E"LS,AR?3BZ
M7O`'7"%>1YG0Q-&E;?H^_"(*<_)'B7/@CX/K_>&;ML`D'TS0$Z0G0TY*S<8_
M=U0,L4N$0DP5O63QL^9LOA3'&C49?<4>-<))XEB![^;_N=X3_(H?5K;>./NP
M5$?*#HY\F!HK<<%%E$2TR72KG2!Z=H!\BHLLHB:#BW8W%FV:%M4`-;5U_8P?
M(=<HOEI`Y/32]=Y0"PJ`QD^'C5[)#&,EL-IYU=1=Z769&-,FII3XZ'E)(Z69
M1+PO!#XP5\PKBV+00:.&QZU<*VI[3S4_##+L'>>;C\0[!PT@Z9O6;'$Q[?6$
M?,LU(I*#-C3&3^*(QF8\"2ZPS$LGJF,IX$W>SPW^S7-]_X?C`=-&=>._H35V
M/C/$E91F(J4S*Z@0=R%6@A7#9'74JM9`*91G:-S"?P'?&,_7`@_FK-1(J5<-
MD%3].,.H6IM7E!+[=UA2>[RX$+@P4Q*AAB*5XJ9JF58!V_M:A^V=*8Q/",?=
MATJV%'>[4,BU*@]1@8MJ.O)]A)H1:L>5M@=K5RF.V"J,6V4X3@T<A-P:^V\:
M5M)W"K5\?PE3`;Y\D'NF1'?+1>B4$WRI;DDFE[6(MR+1=@)I)`R)O3:HV.R=
M^0IBI]^*6`V&4Q'3W%S-#>;IE_L_P,/_7:/Z46C)NG%0;7SX+S1)G.DRFU\P
M%.&C'):+^M;!'JMC$U:US!C8.N#."O]+@`A[1)VAP%!XCV;,3J7-S*26M](8
MK=#WO5H:PK:T[$S-EZ,2Z0JEF.,3>#7<29WG4B8EWMP>T%:-^9J)#%E(IFFN
M0WB(R,`AK2NQM')<VBH@CE6GA#>)]28N;1S2/)W,Q,DC-Q4_B92I4O+T6,:A
MS%*)J@PG-(O;&')3=2B5,@[E>.*C]P]QO\B>;T/GFY7$:EN+11D4&5?::BZN
MO%![^C@[%X4I#U])##;I5AP!^GKOZ-8@Q40J=&.0?+&)RS/C3_W-*3A"B?\-
M]F-C,158IXH[O7S6,@$:UGH1HY*0EKZCQI!%3<BC8QE*FL$UQ4E)M64-M/E-
MK:]FUL"LI9.K+5C?X"\&7\T`7/T&WL[RP;UG[4!TK8LZQ2(4UPS-];J@27LM
M9A:,EN'S;5%,P,-9G:@?"()T>\#H8O@8&FT))49[A:87A2+Q&=UJ\O84^('I
M["WGY<8)/,OQK5V88PW/77,)3\9U=&NO\'024[4!2+VR/]=#]UP/W4]@O1P#
ML-^\`\]\`0\`O1O!GU^Z#@[!.)DV.NE-QL9\81ABS:!;CM0PD!ZE')G.8C"=
MXC:+7&V4H!H(5&*\@QRFTX`C[4VGK90CTUD.ID,&-;]AA]B)2]851_AG,H0J
MF25;A59I$YQN9/Z-$U[*GE#(>?&L.A47RMD%"VK80)=RC*QAI=7J?_7Z9KL?
M`#P"[]W:`3*H=RZN5@5W2X2?CX'*?H[BO>_<X-\@0%7.7AS\L+%:3<19@#"R
MI5?[3@06/T1=#+I.`UWDG'.]Z$?H]PR(IR$N;[-;7CZO5=2*-C85Y1YM>>3%
M%7O1EN;%E7YR]1O]G6.Z'/FGT31#"ET9;3Q2Z*C,<&/CP2W46O[<T#"-<<23
M(2[P5PC)BJ36"1*2Q$&@?#A.MR%C:?1\M*4GMKE91W.`/9F$:$$=SY<".P72
MT<#%\(0K29*!SXRKEG%A?/!^`&^N%R#4XZYL2T-<VP4Q-+=(7((J#25UW#C[
MKZCWC/N&=H-(@^)\A^E*W`,?!0$2&6>]LB11U6S`:FF@WX`#/-.&$&SVKY9C
MH1,&2GS.HS"9SL4M_U0D**E@S.#J&8?)^5#ZY2.50)@3L3#$99Z*IK[YOB!8
MFX6@V>/>2I_&TY6:,OFU6@E2CFM;UQ(H<3&(NBQ7"5P.`71Z;Y9X_6"[-TNF
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M%LQ"_FW='G'1XUK&E9G!L/CIPN>LWU>'Y[7K'8`5G#QJ1*,>!'):%R,[@WWQ
MU(>AKB!3):'"4C417`%'/!>?SYX$2%_?LFN<4_JE,!"VYRW1]WVDU->)4B](
MQ7?E6%#(-$M?/4*\J-1PT9=;OR;2:;!S?,[+>SN%E_Y1DG5Q$@UBV!T$G1<6
M:R4`#`F6[6!8K8L"UA.2W-18ZOM^C26*2O;G/^F7#=D!5&C9$/D:2I+;\.Y)
M]>CRS7-]'_FGB'V@Y%!X`L4JJ+R89CP5DAN.UNQ"FDUDU'CN>R1.P_']$]A_
M/7EPU%"%,`U^)FLC>3A"??06TYE`A)@I4L'D4ZP2FV^)O.3O<>O0IAWP@I(8
MN[-JP@,,VOYG$WEMFD"RHBHM6G:2OY#UI?.95Y+TP#N=R'M1*1"L@K[SOZC4
MR$V-AZQ^`S1)@EK)J/+2.#?.^B._FY:-%!`2%'8Z1"HXE0_&&K)56$!6W-8/
M%AFJT4KI'7C/KH"ZZ3/Z6C0;>!9_#04Y^H$^MIS1E1]8K^'G[F%T;5K>"+<K
M0?_"(T5E:_P1!A[L^96MR9"#J+EQ4EJV!T0))@3J0.:J$!$A26D;(2XC?4K;
MB/&HZ5C:IN@O$R$,/5NQ/"`@PDIXQDI<&]YDFN86AH>(*_X:*W%1LIF)N&AY
M!<1)E6,R;VJ\8#)J7-0#/N)V*C+>.3<5/UF6*6$LS5(.]92G^3O/K;@BY[FI
M.I1G&8=ZOIL,1?I$W[%OAYHR0TV9HEGW#2OY6')^<M%R$QOBY\6Y8RN3=?&'
M7^%M+W%9X&0-"9%LQHWV(?=MI#LL)5E`$XPRKKT'R__KV@.H.3B`2A(\0"RC
MZP7.OA77\:4K-O0UD#;RU/-F(1I)!*$ASHDEG/[!%G(2E#R$25(CB+P5.,!3
M7-OKKM@83((D3\D#G22P#-2^;8?>.JUW:P^<?;RX"&R1*IS^SV4+M1)4(_Y)
M!B/XT[7A,#:$)W_>G`CL&-D=(Y_3+.IEJD9DCWSV@<^@/19A:L_!8!%G4HQ,
M8368`N.RDIX]Y^*>=;MC9#`,LDPC^UCK9Q_/]5@^LV#Y!+Q7B-I\(=KU*H1P
M-?1?O,STC.43`EZ:=(5WU<EL/F%H/-8!29]3IRO$$BNW<L]J/`+ZYXV:RSX`
M/_`LA&L4MH_Q]T5VFTVGQ+\83BA9\UF](O2;FOC5?TY0)#<.)."$:=D&1^`]
M'4TG>@*_<YUW*$VPSV?US"6L-]J(%[EC_7L3ZQ"]T`S.VAB1,[PE=,6(8?:S
MVUE3Q1B")?BM:Y(5!!"W7_4%>I+)/UD92@,N0V4&7KK>X2)'DO]0<HZS8.6J
MVOH)%C%5`==@$>-75K>=_-6X#G5;;K<6T7ST/`X!%IC\WQ$;*IM3A_>>"MD/
M-QHF)/_$XLP@.5E)V)J#D8W!BMK*?H@?9T(R>E+*@ZFD$[O`R6!+'#1@"#KO
MT*VI[(V*N\-;6K%AXYCK+2Q5%LZ6-B;3(T=>K89;=?=JH:I'_E,NO=H*2^^E
MMX^G%T:U&EYE6KJTZ/!6W]_YN4VY-X\IFWH-+M46;C6ZLCXJ!FHQ\CE8<O_J
M-;AUFSCU4-<<JA5SK>*&S,+D8,,]*Y:JCN3V^2GS"^,\/^7'^'$\^N9"X!R$
M\FCSX@$LEY'IH(P5&RX2KH=']$<-TE#N70O*#O^9SI),LG'V^2G:9IYD1GL'
MV1*D<":HV;N2CY_@WWQSATFX35*JU@+7(IZ$-G>FI"*Y=!T<@?T`=L!ZQW59
MC8OI3!P`55-S62*%JD*\O%$#J(8CE;5[`Y0`G.4($?T*WH'MOF&C3L'\:07'
M:P`Y-^TL4CZZ1>U.B*P[@(+^IQ<"^REP(5(=E10@E.3(.]=(>>-4UDOX@;4S
M[2?/,FT,PW@R6QBD")Z2+./RD=31&DHTM+S\Q$NW_P#MQ8&GQ>6%0&?"^6SJ
MZ$@53LG^IM,2\>,-(NP$M]8.7EQ`=#M!]C`AG8M*5@?B(.H(O1X#5>]3U4<;
M]\.T@X\X0?$>>)#_8'NX/J$;Y[WG[D^[X-&T`5X?)Z0PM1)]H!]9'25IB)8:
M3UR,FG/OPMMJ`'=/R#8J';F_/N&>F]O#%;S'>I"?>(_-',_P3AO!AB$BE?<I
M4:C6$ZJC9WRQU;*"9[Q)HZI#D-LEL7!:B29EOZN.4I1RG)Q))G-]Y$N^WN6\
M:./)8C$CU:$OVY'JAU1'&UCQ21YF=5*2XBTNOMJ/)TN#F.-5MB24CJ2.2E"B
MD=QMESII0GN`H\:#Z[6XDH/<J&SN"O_7T?]B>GLSWDWP(U3$.CPT7##X@RJ&
MDL5H2F0:6PPM&%IZM6/FPW?&:]?;[/=6R$@8+Y`!@F&7I1Q6,0UA`4G+&*C(
M,9(\:2+O^NW+K74`CSL+.#O@WP99,$BMY4HTAF%H1;2F*5B)YNCD7;PW@^.?
MYFX'SR^/KGW*XH=<[@R'M/*1%-$+2BBT?(?B@"[ND;I>BVOERXG&YJ<S[BHH
M*TQRF2U1L5*_"W^9]'6@I'&\(`9RW8B%Z%`R37-CP4.<=9471RM'C:V`.-<3
MNLB;Q'H3]<:):)Y.9N+DD9N*GT3*5"F622F',DLE;$.1TFR(DTIVJ@ZE4L:A
M'/WER6'H25-Y#IM+W%W^0IS!\:>73W1X!S!R/`6<G3(D7C5$N*ME/8G>,H47
M:Z:2)"G)L6[*!#3QO-97)!A-/)=/DX.0%".?S&9A-?(S$RT+]&(:G8M5M68H
M2=,1JC7]6D[[O)E%,6_FTGRS`M,>W0+3!Z-_W)E>"$F35BW16'BH9*#6F3"9
M0;?/MO5RI@LK@94^:^9NX0;*#.QO#[?`]P&X.AP`:ER3[^0^F2VF+._<U"/S
M\<TP2B?9VIH!H.4[71:+\,W)VF7B4Z>D[O,4TC\;2AIQ5[&HY\L:XCH*ZEI,
MYPSO9O$7>Y4=F7Q5$RAX;**3FDTTC!8>1>ZDLT_CV.+1#[@!>F<?)F>?MMMO
M2$)$0<[ZHNGQ[-D/DJF'#;MNP\Z!&P/Z`%Y-"X&Z/5Q#W3#M?P/3&R]F!LG@
M^7/+0)0T.T%#(+7<).IQ^7J"YR)4J\!R7A`D3[]<B(K(!*\F)$FN7#4@JKJK
M\58MJ$8`F9RX\N\-B5)-O<Z!U#+'C!V7:_<$E_3IFI33T9=^(9H44Z]S&+7,
M0VL`B_6.C&XBE79!FE33KC,8]4PS8X)E<X##I]A,5P)3"9H3II">E0(:*=M2
M6V6KP'2MV=48"AR)MAO>2DGHTBK6C:PB"U*D_RO)]=]%3/'6_]E$,P.(WS-N
MG)U]VN."G=$G<'^=KKOAF96T+NTEY9[>8"A!C0QI+:DAK4-#<L`+:BO.\]QR
M'XH&UXW<'NY`</8Y7&V6\QZ7Y#KZ)%^O6>"-GRTO)%5"KJOY)<I(=@)DA,O.
M5_-H<GG6KAI@8LV0]46;Q_)4@=U*V8T^,S"*)DI%N^J:KW3Z+K5^1:GT9'!B
MM9?\#><=>,\N]P?D93$*Z\X-@(^>AE'$6<LH+#Q6-!2W**ROX#E(*4Z4P9BL
M2-$I?/2=/&=S\T7CI76XK\T=V+RZ)ZB8R]F$E/_.CPO2K%R,E58LL9'20*!E
MC%6>\2^F;_F/<$)SOW7^-#T+V0H.-EO.#'$N/4HB)-`,*H"T?(?/XY`-1'P,
MT!$HJK]FOF`XP@2F\.`/H1'8Y;<Y71*H4U,8M7R./X=FY^'PJZ3LR!?7\]Q?
MEO/B0R@6XF*EZ.F00H/H8-+R?;W<F+Z>/(A`U&1Z.5N)B]>@HT$*3:F'1\O'
MI3P,YU'6<%4E5>P1H1PB`L_;Z40%&(J\L[11A21VFQ0J6!)Z7AQ!`C$6&%&U
MC@X/'T(A"/W,A[!Y>?&PUVYT%HY^#]?$G?5FVFDHNNN,4)LJ7&%T=.N:3EN_
M0S)YWG4>SQQ/O'62:=&L@Y-B][\(AR04GR$^>C*;SQD2A1I.T\LBP`,2+9T:
M]<#<0>N)(FV>?@'['7QWG>#H8V@82CXVGDA2?:&!14OO1CTTI`!Y!`O#V:'1
M)))J2AT<6GHH&L""X]P1,"QE09M-HXJF%"#1TC?!#@P.6H>X$%U;W%2%6S2_
M>$TI`*)E&'\-CD*"D+H_G*,H3B1*$D]M=+L+52X$0;&SJTB*0"'.J?V%?%5\
MU/^)'M_1A=HRGRT;`M&D[W`T2#)&VSOR8^#N_HH&S1?48;@/$`=I;E;WGKL#
M8.]?0TV]\?V3Z>S`UD-MMK:'L'WVV)C-5N*>0NH)X&)_M-@GU:39<-'R+(HQ
M0\R#?=:;CWNMPWO<+_R1/S86"X&9T'1$]*(C#?#1\F9[Z;Z^ND[(-H3@AV/A
MRC(SIJYAA2%Z$6D=*UHV$;BT3=_?'B*8MMZ#]7(,[DZHYNOV\`AV4+<#"_B7
MIFV#_9>/*W-WS/\NAHBE5%+;"?O1#:XP:7DC#7?&>+^$!H0M*8IS6ZWGXNJQ
M5,W<B[;00J'EA9/15&)8HU_TQXOE0F#IGG;$J;#V5`&JR#V1@\)=_0;>SO+!
MO6?!P_N!!(K`'/(&%,FC6@S0:1G0\\VTG%L7XN)\A6?Z=S.LC!D'0\##?7#O
M@<#\/38NC+FXR"]:,GI1G$88:1KS$_,?^XK06AREWJPN!"I(U<R]*`4M%*JD
M90J('UH7W96XK?W(/8S"^^<(H][$98D'0@6X\346C=+::5D8,:<%:T+*79GG
MLG2DYNY+5A>,D.3`+EU4+-)HZJ=:J1*S0\H1;*W,E&YX$<J,!()/7%`6$X&M
MDM.).E/*HO.4S*R6#E*6QP0A*U17CRQ-5B=&<-1X:6%>F3*8X;(6FU-PA*S]
MC?K+SQ9SEBX$I2/U9^R4W&GI$RWG_1YQF#SR8R1(:SZSG//CRBCU"LZU](=&
M??3"$]?F'1[(4:3^M8N7.0P&!CB/"$.W`M;Q^].)5DAHZ;K<P+W"?`&9\Q!B
MF>0R*!%^88#^I%O-BZJ>PM97?N.B>.7_;CJG`T037\C^.;H-&V*YWL?(=/:C
M[>$`T1M=F[O&T4NY"=+A-\X^'#P>NZV#@':>K/HL2,GZI6L;V_@M0@Q1EO,^
M'N_Q/R>H5M>NBS+ED1X3GZ2JVL>0A^)BG1Q`S_68H>!:#9<`X^+[!!S3"6Y>
MWSSW/6Q\9]ON+W0%P;PSK,+E(\DF<$J>M;R)IS4,:E!@B,BD&5,V'6#&08UK
M-ZM?)@JEAL?/K!<BA"3%P9@NEN*JR]`1(9L"-8!.R]M]<TCI&L)V=_HY$UV^
M#^0B<M+0$5TQ5,]Z7&A:2\MU7VX)/C<0PR#</WS(ZN@1>.\0,3]M?S?Z907'
MT:6YAU=SEML&&BX>+1GL)QPK/U2#^T7-R*F4H;P88HZI!VYN4R53/$'VO\#/
M_\(D,]V%JL?C9%W-`4_=/`R,JWJS:.\7,$A^`0J[;.8/J!%K>T>`=H8:ANNB
M",OP@R?W"X#'G7<+(A+7S$/,,+CMF\\DNW&S@J6JV=>\X;M><#!M.T0CJLES
MXUR?;!MROR8V8"V+,:@82QIEH&982W]"5$MS>W@Z@C,DKGZC6Q$N<^)^MVP;
M<H?P8,GU9!M=&I5H`8J6;H8<I@FD]R=O=T0M+C``##5>:H:31@U8V%;5-]#^
M8E:H)?=X>O;!?T[HQ'?U#C+-6"BB/Y.OYK_)'O1Y-E`B[?G%A<"PM))96T34
MG8V8WC^,Q6(MKO!\Z;Q\GF:II9-LTE0XJ'H@:W\/FQ!"LL_-L%$X]AGNK8.Q
MZR0O)KZ9OUU^MK!M:KD-,=O%&U4Q4%B,/G`.H&&7.9E3-2Y.S'(EQOUFXXU0
MV.^,E%\B,"8Z.W]/6L"&BQH7)K9F3M$GZ(]G>%.`/_E_4$L#!!0````(`,N`
M:4%['(LT%!```/*R```1`!P`;G9A>"TR,#$R,#DS,"YX<V155`D``TUPG5!-
M<)U0=7@+``$$)0X```0Y`0``[5U;<]LV%G[?F?T/6#UY9U:6%"=IG(G;E6VI
MT8YL:2PY[>Y+!B)!"5,28`!0MOOK%P`OXDTT:3$5W?(A#D7B`.<#/AX<'(#`
MIY\>'1ML$>.8DHO.X+3?`8@8U,1D?=&Y7W2'BZO)I`.X@,2$-B7HHD-HYZ<?
M__ZW3__H=N=GOU[>3;O=X&>0#WA[.CA]\P9$]S="N!][O8>'AU/W[''%[%.#
M.M%3EU'3,Y`)I.2;_N!-=S#H]C^`?X/SCV<?P/S&3_C(S8_<V"`'`@'9&HE;
MZ"#N0D-J%,N?T"W<PD=50$]EUC\_4Y!LY"`BQI0YU\B"GBTN.M\\:&,+([,#
M9!T0_I%(N1)Y^8D5"IQ(K7%1MI9)^V<]3%25&2C*W'/R4YN"]<23BWHR!6+8
M"`4\WE6W>21E0;[2$N$3K5.W/^B>#:)2*"E1$"7=5&&R<A-"#V<ADD'OUYOI
M0M=[1S8#`+HA("%40"';6M\+[[HN)A8-;LF;-B:_?51_5I"C.V2!1WV'41L5
M5)UZW#.@;7BV+F*ZRZ`3Y+!AR))$E(W3#1OFJY0XE6C")`KJ18=CQ[51>`\R
M(U-V`'5P?G[>TZEZDH\N8@++&@YUC^I)W2@6#Y-F4B9![G+NU5)?)K(PP16J
M2PK\A:O+ABMDEZPIF?8O7%,N0UR:SBIOHA3Y4U28TG`IE0?JXOYNLK=ST!5U
M!5TLH#U%.B]L!K4BS1*JJDFD1ZC)[NW^<=!_#[K@&G/#IMQC2/X(2@:ZZ$^]
MM$0Z,X\C<T9^U-<I,QL(!RF*!)/VIKQ<FD[E):-7MKR(Y"9BTIU!^\6"NV%3
MU\:`L2=DX]S(.G(\)_Y@#I^4*\+OB8E8_,%PS9#V4JZ1@-CF*0Y9CF&[GF%#
MLTXVO>V_[[\IY!,X\:&``$OJ:0@':#RIAQ&D?YX$H/[9TK,1]+R%C$F06Y1/
M-E([R0;/D"Q2J*5*`ZAR2P7B\M6&*UO:)?D6KZ%(FK0YP\3`+K1#`S`CHV\>
M=M7UE$*RAU<NM!S7I<BNF6`_9*V8Q@`"$.`D@@%2]BQ"LK-E<B`:@0$*34O*
M!I`R;K^6JE'3[!*P3E*=/>-H@1-?B982QZ/$);15D&6Q04@DV&"L>)U<Z&OS
MLI"5J-T9>7TYG`YOKT9@\7DT6BY:"C2#`G,H2Q8;)+"LXQ0?W'H)<59("'"2
M4*6U$<<C2-1(?&9=44="W2#"I:<YI3QI,PQ<+T7>I2BR6`Z7HYO1K:3';`RN
M9C?SN]'GT>UB\F4$IK-%:T4:0A+(-V.;/B3)P0VK7G:\+V;'</$9C*>S7UI6
M')45`2=F+F(:8HH4M%Y.O"WDQ&P^NALN)[/;EA/'X\0U-3S5.D-BCHC`XFE"
M+,H<C37&#1.BFGL3'4$)"H]?0F("7Q,04Z5ER-$8,L7?/&S*]KB!0B`6MQ@V
M=FH=HPZR88^H=!`4WS*A,4S(!L44(6H.A;W)QEHSG`!M/.OX[+B!Q+.@(3R&
MR7H*5U1Z&)0]R8YE9EG80&-H8%LV6HPNCDUK]4('@WZ:*PFM_@5V>NF.QM<,
MA*JU[&D\>[(V1Y&H7ILSZ&=M3B4>M?:H$8SBLF]8(+:53<.CN=M?L-A<01/;
M,,XA#HUZ#5$.@90Z(-1G-YD,'J1&P%>II4MSZ9)C>21K:K8\@SS+4X(XK<5I
M`(7BT\PQFA#JUCQ*^J%P<KAE0",84+`F13&B[C4I/V0M1VK)0+LFI:E4R4S_
M*X+4/?U?;#3:Z?_C4V+&UI#@W].Q5]G0-?<?&4L1+[DE0",(D.TU%`]J[C2>
MH4+K53:`%`LHS;*>ZW<H60AJ_):EAAR(\)JI<9ZEAM8$4`OXN@"M3,N1)G!$
MM<2E;%13+0E!A&N40\X]Q]73O/?RT82,N,#^?-K,&D/,OD#;0S-+2\_\A#\S
M2`0R<RBV,BCTD+7E=%TSU=[JB>(DU91*78T(Q"&!DQ@HH%`!3,`.EV*G0@8T
M-/7+)VF`#@3P6@^XL:3-OSMZ5)<Y0RE%2V-EH-HIF9F)W$_)O4\"K5NV-99M
M!8-TQ:RZ!^EO<SK5O;1JQ^O-Y\_"<QS(GF;6'>*"84/V+3KA\`$RDP\-V7RY
MDU:*7)QQ6+=#_U:OTBQKMWSE52^Y4S_H,'T`($304K"Q%,P$CQ2WZ@X>57#0
MVCA2,WD2F2K?%RZT39S6;YC.7F28?&5;.]0H?F4B$G'V4*/6;Y4&_?-2<8B6
M#\?C0VA9%GA-L(4-.<8>&@;UB,!D/:<V-G"RA^*PUL^7!CG&96="8EJ!G5H@
MU*LE3L.),\8$$@-#>\@Y$GQ(S"F&*[702CZ\05"UN#D4*NQS`]EO2/AA+3*\
M0X;'U'HMV<?@G-6JBH86M!W+V;)5S?W=64X`H30EP4F$&?B@]2JS&&P0X@90
M^`$O'WH8]R(`@@@^T/C;KO/5,+XH*B$Y6W=4XBPG*E&!JVV<XO4Q3/__E.*5
M6^OG7V\.Z93!B:]ARZ2F,RE*%0[19M84;9&]W#"$)L3U1-1'STB9'IE#&SO?
MH3\^B(VQM"%.=:V1@C/@X]QURK+_;7O?5\OH#65BB9@S(5O$A?YD]LJ&G.OM
M58=\N)7MJ()<8\K44'0/C=5."="J>UH^+Q17A<<*6U=(<""&#NS@`<A!!+!K
M4=:5[V/;L[\>]F;#P9*,=8>##[*E;8#XZ$S*#1#'.2-6T*C5&QR4GT)HB7%$
M8N3L&[)O%R(N#*O>+QOZ>I%RF5U$V@V)FL,9;\71-T_"&VT5<^(,\="VWL_J
M<H)J8>G`+[YE0F.8D.,82T+4_,5<SOX`&4ZT:U0;P([[Q<]TBQC1N\V$WS`.
MB71!;*D\A4ROT(R1Q>/KFK_*S2Z.N3]=G(*=7K&/*U7`/5`MV"JIY<[1N#.G
M6+[&^F\AB8*6RAH>S:6:A^+OLI:G"IU:H]0`8OVBYBZ("&?6XA'Q!VC7NN75
MH/\A39>@]&ABK]V`I#E,R-H018B:3<B'K`G)<**U$[6RXU,O?;93<"=Y!I0^
M`0H[+F4"D-RCN?8=N^*?ZC6EALZL0$3]ZH9R776K.WC3/1N</JJ@<>]%:NS.
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M`_PS^_P[#I4F"[*GB7RB<CD0[.A1(&(B\^QMOR+NA&1^%<2QFAX+INDJ@%5?
M=9%U&:B>H;*[DV9TH5:NZ%6F<^A_(AX'5IRNL2VY10RNT6(#&9K+/C,!*?NL
M]M:0?;P2UV644#=^-M!L9>.U_Q%T>(C3W&/&1LV;QE"4%WEQ&[V(@14:*7&N
MH"X7&\$A5GN`9E*]"FQ<+9'C'*&192&UF@Q-B)"C62[4:[4'ZG-"SU.VVBL6
M,-:0$,K`4PN(9E80O)BQ.[S>".F?KA";63M#<05M&YF73R-H;))IXZ@/SZON
MR@@'ABJ+>X++U0@F:FIZR3"TKR@7?$)TYY]X:0L2-9?*_G=?RI3QN5\?<4AY
M3YO0'KNOU71?-?3$AC+\>[(]"A(UM6O;K[/LS"B+IB!*P4R+-!>T=%NAH9=I
M)H#%;W\GGRH4*J4F<]5\#[I&*S5-E>L]13OQ[.+`"4@OS:*I;:>`3&013!_X
MD6K!O(?';\=KY%*.!1_+E\.0+A77SOW,FOLG>JMMRB-/*P&FBEAC#7[1&3%#
M6:!ZX^*H2R5/HX7!DV,-@-1>/6K_BVR7'(-6E*BIK]OG#;^$S(2A;=0[>]P@
MY4[%D!6F^NYM12A1_J9)'8C+O(^AMO[N`.KUBL;;_I!@+[YG)1J']3]JU<,7
M^5L:]=D#08QOL#OW/7,Y;(UA?#;E<<<(<?5V6BE%I1<_$YO$V4)?2Z4^+B`]
M+C/#0Q\6WSSI\XXI3;5*8:KOU+7)JD-KQ,IB2/7!L7O'[WJGV%![J"4VY)^N
MI]A""P.K"6`^%=G7O9)4XU[Y*?X-V7A#97$;*&([-0[OD`H-RQY-CWJXB@C(
M)#)/.1QF[$D^&#HJI)NHBL,S._)[ECIW*L?GV)^D:7Y&YA"MR&-?HD=Q:2=V
M4\G@RDU=?[32YZL(BR@#BT(2O6W^D?3!B?3A,?37B3ARR?1-=:I*J3\A=]26
MGN+ZOPBR,?585?PY&?QY*D1_('Q0C00Y_(FJY($>5B%*_O56QZVT-P&:Y0.R
MM^A&#D8VO%*5[,WC]5;+'5)N@ZFBWV-I_J&MFKI2I>S)H:E54O8LN!P_H+IH
MT_P#?Q\?I=$NO#=C>(WE2/4&/JIFE;Z`>O"4P%U!ZOA.?:&Z/G>K@DQ+-0%D
M[$2QZ`4-)V)Y`M@S*9]Y4TVT.DYD<,^A:?ZP04W6^0^6]!+-&=UB$YE!0^U#
M7S&35U8Q>2[^\TF;X-\_>SQ>KC$N+=,\*ZQMIC^-F=[P0T^2Z4TH\R;7JHL>
M>^W/+7H(^T4=^BD>DI9*W03*ADL&<F?,)L2P/5,=BA';!R6.\@7"=4=)JL;R
M9@3=8O_?&&]1[%B/N;2'F1A9N>2-"X[-H=A\@88AU5Y06^?-,]B*$C4/D1\)
MFUG+#=(;]%C0MOWN;_1H(.F%J\$,O9%ZX_@V'5^K"GZO96TEXWC^1(O4%COH
M2J^#%=$*IRVR^14D"T^^(%@3D"#3OZUVK$:A6G'L!V?V?5[8"B[BG`KY`T,[
M=&S&'E&--K/4XE`F_=IPIO%::4_U3+&>;PR:/EXAA^=UW##O'>)R6&ILY&`M
MH6'LH]D8W%*I&SNE?D>?H"V>P@%Z]"+[PW?9@J;L=[2?$(=<0>BX3:F42!Y9
M5NA2E$O>!)\BN_5YCM];E*AICN["V"#34]6O'=;,IE"%YYKHG;QR&[3.7!O1
M[D@(_\;,TN>FWB$#X6WRI.>OA:D::XMT$ZTRA\>I%;5KG>[R:9<D,#ZZQ:*Y
MQ-B9;.$*&3G>L1!6=BFUIOD/*>W(CDX^Z;,8+],89R$L610.E[>/&76N):R9
MI4^O2]?E]ROG^"&T0P%J(`I3A%1]WQ%&QS,NU!]3W)&[Y@,Q!N&-U)*16G-M
M`N\2@ZG@C.P)&7NVG4!=E*RIL4G=Y09?3.2MI=CSO'&>2US-7"=D3X(F^!/^
M5X'1IX![OO\I3'7D/J[4YY^O\://Y0/]'V+Z7Q06FQ!5*_)7;B"MM$3C(D_W
MKL6HVO1&KY;+?FNWYWE3F^Z>E]D=+,?D514\HBWT=ZOQ/_26/_\/4$L!`AX#
M%`````@`RX!I0>M?`K%+H0``KOH&`!$`&````````0```*2!`````&YV87@M
M,C`Q,C`Y,S`N>&UL550%``--<)U0=7@+``$$)0X```0Y`0``4$L!`AX#%```
M``@`RX!I028)`<PI$@``2>0``!4`&````````0```*2!EJ$``&YV87@M,C`Q
M,C`Y,S!?8V%L+GAM;%54!0`#37"=4'5X"P`!!"4.```$.0$``%!+`0(>`Q0`
M```(`,N`:4%%D<,Q$10``*Y#`0`5`!@```````$```"D@0ZT``!N=F%X+3(P
M,3(P.3,P7V1E9BYX;6Q55`4``TUPG5!U>`L``00E#@``!#D!``!02P$"'@,4
M````"`#+@&E!2XJ3Z-%_``!2:`@`%0`8```````!````I(%NR```;G9A>"TR
M,#$R,#DS,%]L86(N>&UL550%``--<)U0=7@+``$$)0X```0Y`0``4$L!`AX#
M%`````@`RX!I07AN2+:4.```&K`#`!4`&````````0```*2!CD@!`&YV87@M
M,C`Q,C`Y,S!?<')E+GAM;%54!0`#37"=4'5X"P`!!"4.```$.0$``%!+`0(>
M`Q0````(`,N`:4%['(LT%!```/*R```1`!@```````$```"D@7&!`0!N=F%X
M+3(P,3(P.3,P+GAS9%54!0`#37"=4'5X"P`!!"4.```$.0$``%!+!08`````
..!@`&`!H"``#0D0$`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E5DAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Notes Payable (Aggregate Future Minimum Principal Payments on Equipment Loan)(Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Notes Payable [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear', window );">2012</a></td>
        <td class="nump">$ 39<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths', window );">2013</a></td>
        <td class="nump">157<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo', window );">2014</a></td>
        <td class="nump">157<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree', window );">2015</a></td>
        <td class="nump">157<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour', window );">2016</a></td>
        <td class="nump">40<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LoanAgreementFutureMinimumPaymentsDue', window );">Total</a></td>
        <td class="nump">$ 550<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LoanAgreementFutureMinimumPaymentsDue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum loan payments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LoanAgreementFutureMinimumPaymentsDue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum loan payments maturing in the fourth rolling twelve months following the latest balance sheet presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearFour</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum loan payments maturing in the third rolling twelve months following the latest balance sheet presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearThree</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum loan payments maturing in the second rolling twelve months following the latest balance sheet presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LoanAgreementFutureMinimumPaymentsDueInRollingYearTwo</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum loan payments maturing in the next rolling twelve months following the latest balance sheet presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LoanAgreementFutureMinimumPaymentsNextRollingTwelveMonths</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum loan payments maturing in the remainder of the fiscal year following the latest fiscal year ended.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LoanAgreementFutureMinimumPaymentsRemainderOfFiscalYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EQ1AG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>BALANCE SHEETS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 10,738<span></span></td>
        <td class="nump">$ 14,104<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesCurrent', window );">Short-term investments available-for-sale</a></td>
        <td class="nump">17,672<span></span></td>
        <td class="nump">4,205<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
        <td class="nump">838<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivables</a></td>
        <td class="nump">2,469<span></span></td>
        <td class="nump">1,965<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GovernmentContractReceivableUnbilledAmounts', window );">Unbilled receivables</a></td>
        <td class="nump">1,725<span></span></td>
        <td class="nump">1,836<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
        <td class="nump">2,807<span></span></td>
        <td class="nump">2,441<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
        <td class="nump">235<span></span></td>
        <td class="nump">1,558<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">36,484<span></span></td>
        <td class="nump">26,109<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">9,815<span></span></td>
        <td class="nump">6,857<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
        <td class="nump">33,141<span></span></td>
        <td class="nump">33,141<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
        <td class="nump">756<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
        <td class="nump">350<span></span></td>
        <td class="nump">469<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">80,546<span></span></td>
        <td class="nump">66,576<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">2,203<span></span></td>
        <td class="nump">2,645<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
        <td class="nump">6,031<span></span></td>
        <td class="nump">4,528<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
        <td class="nump">803<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Current portion of capital lease</a></td>
        <td class="nump">57<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
        <td class="nump">157<span></span></td>
        <td class="nump">20<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Warrant liability</a></td>
        <td class="nump">769<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Deferred rent</a></td>
        <td class="nump">421<span></span></td>
        <td class="nump">386<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">10,441<span></span></td>
        <td class="nump">7,579<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue</a></td>
        <td class="nump">2,500<span></span></td>
        <td class="nump">2,500<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Non-current portion of capital lease</a></td>
        <td class="nump">252<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Non-current portion of notes payable</a></td>
        <td class="nump">793<span></span></td>
        <td class="nump">300<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant liability</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">368<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent</a></td>
        <td class="nump">5,184<span></span></td>
        <td class="nump">1,980<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
        <td class="nump">19,170<span></span></td>
        <td class="nump">12,727<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 2,000,000 shares authorized; no shares issued and outstanding</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 200,000,000 shares authorized; and 136,003,676 shares issued and 135,548,246 shares outstanding at September 30, 2012 and 117,480,867 shares issued and 117,025,437 shares outstanding at December 31, 2011</a></td>
        <td class="nump">1,360<span></span></td>
        <td class="nump">1,175<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">411,558<span></span></td>
        <td class="nump">383,948<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="num">(350,128)<span></span></td>
        <td class="num">(329,656)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, 455,430 shares, cost basis</a></td>
        <td class="num">(2,450)<span></span></td>
        <td class="num">(2,450)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
        <td class="nump">1,036<span></span></td>
        <td class="nump">832<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
        <td class="nump">61,376<span></span></td>
        <td class="nump">53,849<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
        <td class="nump">$ 80,546<span></span></td>
        <td class="nump">$ 66,576<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsReceivableNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 130<br><br><br><br> -Paragraph 14, 17, 26<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e637-108580<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=SL7669686-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e681-108580<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Principles Board Opinion (APB)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 10<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Staff Position (FSP)<br><br><br><br> -Number FAS115-1/124-1<br><br><br><br> -Paragraph 15D<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Concepts (CON)<br><br><br><br> -Number 6<br><br><br><br> -Paragraph 25<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 4, 5<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 115<br><br><br><br> -Paragraph 12<br><br><br><br> -Subparagraph b<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 115<br><br><br><br> -Paragraph 16<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Staff Position (FSP)<br><br><br><br> -Number FAS115-1/124-1<br><br><br><br> -Paragraph 15C<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7534914&amp;loc=d3e22054-111558<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 115<br><br><br><br> -Paragraph 13, 17<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Staff Position (FSP)<br><br><br><br> -Number FAS115-1/124-1<br><br><br><br> -Paragraph 15D<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 133<br><br><br><br> -Paragraph 22<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid within one year (or one operating cycle, if longer) of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45023-112735<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 13<br><br><br><br> -Paragraph 7, 10, 13<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeaseObligationsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 22<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45023-112735<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 13<br><br><br><br> -Paragraph 7, 10, 13<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeaseObligationsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 8, 9<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 7, 26<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 7<br><br><br><br> -Footnote 1<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6952336&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 5<br><br><br><br> -Paragraph 8, 9<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Technical Bulletin (FTB)<br><br><br><br> -Number 85-3<br><br><br><br> -Paragraph 2<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39927-112707<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 13<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph b<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRentCreditCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Technical Bulletin (FTB)<br><br><br><br> -Number 85-3<br><br><br><br> -Paragraph 2<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.26(c))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39927-112707<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 13<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph b<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRentCreditNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 7, 8<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6600647&amp;loc=d3e214044-122780<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 7, 8<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 48<br><br><br><br> -Paragraph 6<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6600647&amp;loc=d3e214044-122780<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Staff Position (FSP)<br><br><br><br> -Number FIN39-1<br><br><br><br> -Paragraph 10A, 10B<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 7<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13433-108611<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 133<br><br><br><br> -Paragraph 4, 17<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13495-108611<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of after one year or beyond the normal operating cycle, if longer, net of the effects of master netting arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Staff Position (FSP)<br><br><br><br> -Number FIN39-1<br><br><br><br> -Paragraph 10A, 10B<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13433-108611<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 107<br><br><br><br> -Paragraph 10<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 7<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 133<br><br><br><br> -Paragraph 4, 17<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13495-108611<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 142<br><br><br><br> -Paragraph 45<br><br><br><br> -Subparagraph e<br><br><br><br> -Clause 1<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=14024403&amp;loc=d3e13816-109267<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 141R<br><br><br><br> -Paragraph 68<br><br><br><br> -Subparagraph l<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 141R<br><br><br><br> -Paragraph 34<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 142<br><br><br><br> -Paragraph 43<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 142<br><br><br><br> -Paragraph 45<br><br><br><br> -Subparagraph e<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 141R<br><br><br><br> -Paragraph 72<br><br><br><br> -Subparagraph d<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Goodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentContractReceivableUnbilledAmounts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unbilled amounts (net of unliquidated progress payments) of government contract receivables.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 912<br><br><br><br> -SubTopic 310<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6471842&amp;loc=d3e55376-109406<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GovernmentContractReceivableUnbilledAmounts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 22<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19, 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Principles Board Opinion (APB)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 10<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 129<br><br><br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6787-107765<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6386993&amp;loc=d3e5879-108316<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 4<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Assets<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (g)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph b, c<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Audit and Accounting Guide (AAG)<br><br><br><br> -Number AAG-BRD<br><br><br><br> -Paragraph 80<br><br><br><br> -Subparagraph Exhibit 4-8, 3<br><br><br><br> -IssueDate 2006-05-01<br><br><br><br> -Chapter 4<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Principles Board Opinion (APB)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 10<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph A3<br><br><br><br> -Appendix A<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Technical Bulletin (FTB)<br><br><br><br> -Number 85-6<br><br><br><br> -Paragraph 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TreasuryStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EWGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent Events (Details) (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="4">1 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1">32 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Oct. 31, 2012</div>
        </th>
        <th class="th">
          <div>May 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2008</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Nov. 07, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock sold</a></td>
        <td class="nump">12,385,321<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">700,000<span></span></td>
        <td class="nump">6,686,650<span></span></td>
        <td class="nump">8,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">24,957,715<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Price per share</a></td>
        <td class="nump">$ 2.18<span></span></td>
        <td class="nump">$ 1.22<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Amount raised through the sale of common stock</a></td>
        <td class="nump">$ 26,900<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 26,925<span></span></td>
        <td class="nump">$ 9,182<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EA2AG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STATEMENTS OF CASH FLOWS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (20,472)<span></span></td>
        <td class="num">$ (15,659)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Reconciliation of net loss to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Change in fair value of warrant liability</a></td>
        <td class="nump">401<span></span></td>
        <td class="num">(1,973)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">1,216<span></span></td>
        <td class="nump">1,197<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of net premiums on short-term investments</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">317<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of property and equipment</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">60<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on disposal of property and equipment</a></td>
        <td class="num">(26)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Deferred rent</a></td>
        <td class="nump">436<span></span></td>
        <td class="num">(254)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash stock-based compensation</a></td>
        <td class="nump">1,668<span></span></td>
        <td class="nump">1,677<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivables</a></td>
        <td class="num">(504)<span></span></td>
        <td class="nump">37<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInUnbilledReceivables', window );">Unbilled receivables</a></td>
        <td class="nump">111<span></span></td>
        <td class="num">(3,848)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
        <td class="num">(271)<span></span></td>
        <td class="num">(1,127)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
        <td class="num">(304)<span></span></td>
        <td class="num">(3,687)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
        <td class="nump">803<span></span></td>
        <td class="nump">2,500<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Lease incentives received</a></td>
        <td class="nump">2,803<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
        <td class="num">(14,139)<span></span></td>
        <td class="num">(20,760)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
        <td class="num">(2,202)<span></span></td>
        <td class="num">(414)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposal of property and equipment</a></td>
        <td class="nump">318<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturities of short-term investments</a></td>
        <td class="nump">2,500<span></span></td>
        <td class="nump">20,235<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities', window );">Purchases of short-term investments</a></td>
        <td class="num">(15,763)<span></span></td>
        <td class="num">(2,082)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
        <td class="num">(15,147)<span></span></td>
        <td class="nump">17,739<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Principal payments of capital lease</a></td>
        <td class="num">(90)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable', window );">Principal payments of notes payable</a></td>
        <td class="num">(20)<span></span></td>
        <td class="num">(60)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
        <td class="nump">650<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities', window );">Restricted cash</a></td>
        <td class="num">(1,594)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from sales of common stock, net of offering costs of $0.4 million and $0.2 million, respectively</a></td>
        <td class="nump">26,925<span></span></td>
        <td class="nump">9,182<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
        <td class="nump">49<span></span></td>
        <td class="nump">156<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
        <td class="nump">25,920<span></span></td>
        <td class="nump">9,278<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net (decrease) increase in cash and cash equivalents</a></td>
        <td class="num">(3,366)<span></span></td>
        <td class="nump">6,257<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
        <td class="nump">14,104<span></span></td>
        <td class="nump">8,061<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
        <td class="nump">10,738<span></span></td>
        <td class="nump">14,318<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of non-cash activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_CapitalLeaseObligationEquipmentPurchased', window );">Equipment acquired under a capital lease</a></td>
        <td class="nump">399<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_DepositsForAcquisitionOfPropertyAndEquipment', window );">Deposit applied towards the purchase of laboratory equipment</a></td>
        <td class="nump">500<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment purchases included in accounts payable and accrued expenses</a></td>
        <td class="nump">1,365<span></span></td>
        <td class="nump">168<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_SettlementOfNotesReceivable', window );">Settlement of notes receivable</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 1,522<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_CapitalLeaseObligationEquipmentPurchased">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Capital Lease Obligation Equipment Purchased</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_CapitalLeaseObligationEquipmentPurchased</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_DepositsForAcquisitionOfPropertyAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Deposits For Acquisition Of Property And Equipment</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_DepositsForAcquisitionOfPropertyAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_SettlementOfNotesReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Settlement Of Notes Receivable</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_SettlementOfNotesReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 144<br><br> -Paragraph 45, 46, 47<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=8077374&amp;loc=d3e2420-110228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetImpairmentCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalExpendituresIncurredButNotYetPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 8, 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7, 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7<br><br> -Footnote 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4A<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5618551-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDerivativeInstrumentsNetPretax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The difference between the sale price or salvage price and the book value of a property, plant, and equipment asset that was sold or retired during the reporting period. This element refers to the gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnSaleOfPropertyPlantEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInDeferredRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other noncurrent operating liabilities not separately disclosed in the statement of cash flows.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInUnbilledReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period of the amount of revenue for work performed for which billing has not occurred, net of uncollectible accounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInUnbilledReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from financing activity for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from investing activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNoncashIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 17<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 17<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireAvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 17<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireProductiveAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from a long-term borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromRepaymentsOfNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from cash and cash items that are not available for withdrawal or usage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the sale or maturity (principal being due) of securities not classified as either held-to-maturity securities or trading securities which are classified as available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 16<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 16<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 16<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph i<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26, 31<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E3LAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock-Based Compensation (Summary of Restricted Stock Awards Activity)(Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at January 1, 2012</a></td>
        <td class="nump">53,333<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock vested</a></td>
        <td class="nump">3,333<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Restricted stock forfeited</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at September 30, 2012</a></td>
        <td class="nump">50,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Per Share Weighted-Average Grant-Date Fair Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at January 1, 2012</a></td>
        <td class="nump">$ 1.63<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock granted</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock vested</a></td>
        <td class="nump">$ 5.21<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Restricted stock forfeited</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at September 30, 2012</a></td>
        <td class="nump">$ 1.39<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(2)(e)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(2)(c)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph c(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(2)(c)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(2)(b)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(2)(a)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(2)(b)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(2)(a)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(2)(d)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(2)(d)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E1AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company recorded stock-based compensation expense in the statements of operations and comprehensive loss as follows (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <table style="WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0" align="center"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Three Months Ended</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>September 30,</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Nine Months Ended</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>September 30,</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">2012</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">2011</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">2012</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">2011</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 48%">Research and development</td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">219</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">176</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">638</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">449</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">General and administrative</td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 274</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 366</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 1,030</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 1,228</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"> Total stock-based compensation expense</td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 493</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 542</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 1,668</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 1,677</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Option Activity</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following is a summary of option activity under the 2005 Plan and the 1995 Plan for the nine months ended September 30, 2012:</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <table style="WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="6" nowrap="nowrap">2005 Stock Incentive Plan</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="6" nowrap="nowrap">1995 Stock Option Plan</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none">&nbsp;</p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none">&nbsp;</p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Stock</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Options</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Weighted-</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Average</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Exercise</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Price</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none">&nbsp;</p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none">&nbsp;</p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Stock</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Options</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Weighted-</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Average</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Exercise</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Price</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="WIDTH: 48%">Outstanding at January 1, 2012</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">7,412,746</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">2.22</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">474,650</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">4.38</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td>Granted</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">3,483,000</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">1.29</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td>Exercised</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">(80,784</td> <td style="TEXT-ALIGN: left">)</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">0.61</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt">Canceled</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (1,546,562</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">)</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">$</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 2.26</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (184,750</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">)</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">$</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 4.01</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt">Outstanding at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 9,268,400</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 1.88</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 289,900</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 4.59</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"> Shares exercisable at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 3,503,043</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 2.38</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 289,900</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 4.59</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"> Shares available for grant at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 5,559,536</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Assumptions used to Estimate Grant Date Fair Value of Stock Options granted using Black-Scholes Option-Pricing Model</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The fair value of stock options granted was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <table style="WIDTH: 95%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"> <strong>Three Months Ended</strong></p> <p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"> <strong>September 30,</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"> <strong>Nine Months Ended</strong></p> <p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"> <strong>September 30,</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap">2012</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap">2011</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap">2012</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap">2011</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; TEXT-INDENT: -9pt; PADDING-LEFT: 9pt; WIDTH: 40%" nowrap="nowrap">Weighted-average fair value of stock options granted</td> <td style="WIDTH: 1%" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"> $1.09</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"> $0.78</td> <td style="TEXT-ALIGN: left; WIDTH: 1%" nowrap="nowrap">&nbsp;</td> <td style="WIDTH: 1%" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"> $0.71</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"> $1.19</td> <td style="TEXT-ALIGN: left; WIDTH: 1%" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left" nowrap="nowrap">Risk-free interest rate</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0.55%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0.48%-0.68%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0.55%-1.54%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0.48%-1.91%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left" nowrap="nowrap">Dividend yield</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td nowrap="nowrap">Volatility</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">76.60%-76.71%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">75.86%-80.40%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">75.47%-80.48%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">73.28%-80.48%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left" nowrap="nowrap">Expected term (in years)</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">4.24</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">3.49-4.21</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">3.34-7.09</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">3.26-4.47</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left" nowrap="nowrap">Expected forfeiture rate</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%-23.15%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%-23.15%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> <td nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%-23.15%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%-23.15%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock', window );">Summary of Restricted Stock Awards Activity</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following is a summary of restricted stock awards activity for the nine months ended September 30, 2012:</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none">&nbsp;</p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none">&nbsp;</p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none">&nbsp;</p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Number of</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Shares</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Per Share</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Weighted-</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Average</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Grant-Date</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Fair Value</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="WIDTH: 74%; FONT-WEIGHT: bold">Outstanding at January 1, 2012</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">53,333</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">1.63</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">Restricted stock granted</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">Restricted stock vested</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">3,333</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">5.21</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">Restricted stock forfeited</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">$</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; FONT-WEIGHT: bold">Outstanding at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 50,000</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 1.39</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Schedule Of Share Based Compensation, Restricted Stock Awards, Activity</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ScheduleOfShareBasedCompensationRestrictedStockAwardsActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph g(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ED4BG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>U.S. Government Agreement and Collaborations (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1">20 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="3"></th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2011</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2011

</div>
          <div>HHS BARDA Contract Award [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012

</div>
          <div>HHS BARDA Contract Award [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011

</div>
          <div>HHS BARDA Contract Award [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012

</div>
          <div>HHS BARDA Contract Award [Member]</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2011

</div>
          <div>HHS BARDA Option for Additional Period [Member]</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2011

</div>
          <div>License Agreement with LG Life Sciences, Ltd. [Member]</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2011

</div>
          <div>License Agreement with LG Life Sciences, Ltd. [Member]

</div>
          <div>Minimum [Member]</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2011

</div>
          <div>License Agreement with LG Life Sciences, Ltd. [Member]

</div>
          <div>Maximum [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012

</div>
          <div>PATH Vaccine Solutions [Member]</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2012

</div>
          <div>PATH Vaccine Solutions [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GovernmentContractReceivable', window );">Contract receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 179,000,000<span></span></td>
        <td class="nump">$ 97,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 82,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ContractTerm', window );">Contract term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">36 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">24 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractsRevenue', window );">Government contracts</a></td>
        <td class="nump">5,583,000<span></span></td>
        <td class="nump">5,008,000<span></span></td>
        <td class="nump">17,328,000<span></span></td>
        <td class="nump">8,843,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">16,900,000<span></span></td>
        <td class="nump">31,600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ResearchAndDevelopmentCollaboration', window );">Research and development collaboration</a></td>
        <td class="nump">182,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">182,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ExpectedClinicalTrialCosts', window );">Expected costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ClinicalTrialCostsIncurred', window );">Trial costs incurred</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_UpfrontLicensePayment', window );">Upfront license payment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_RoyaltyPaymentsPercentOfFutureProductSales', window );">Royalty payments, percent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10.00%<span></span></td>
        <td class="nump">20.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent', window );">Potential funding of external clinical development costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ClinicalTrialCostsIncurred">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total clinical trial costs incurred.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ClinicalTrialCostsIncurred</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ContractTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Contract Term</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ContractTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ExpectedClinicalTrialCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total expected clinical trial costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ExpectedClinicalTrialCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The precentage of potential provided fuding of external clinical development costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_PotentialProvidedFundingOfExternalClinicalDevelopmentCostsPercent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ResearchAndDevelopmentCollaboration">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Research And Development Collaboration</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ResearchAndDevelopmentCollaboration</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_RoyaltyPaymentsPercentOfFutureProductSales">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Royalty payments as a percent of future product sales.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_RoyaltyPaymentsPercentOfFutureProductSales</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_UpfrontLicensePayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Upfront License Payment</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_UpfrontLicensePayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractsRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period arising from products sold or services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts, construction contracts, and any other contract related to a particular project or product.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ContractsRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentContractReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of receivables that are derived from government contracts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 912<br><br> -SubTopic 310<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6471842&amp;loc=d3e55295-109406<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GovernmentContractReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Notes Payable [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Notes Payable</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Aggregate future minimum principal payments on the GE Equipment Loan at September 30, 2012 are as follows (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold"> Year</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">Amount</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 79%">2012</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 18%">39</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2013</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">157</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2014</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">157</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2015</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">157</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">2016</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 40</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDebtTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.1.0.1
 *
 */

var moreDialog = null;
var Show = {
    Default:'raw',

    more:function( obj ){
        var bClosed = false;
        if( moreDialog != null )
        {
			try
			{
				bClosed = moreDialog.closed;
			}
			catch(e)
			{
				//Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control
				// that somtimes causes it to throw when checking the closed property on a child window that has been
				//closed.  So if the exception occurs we assume the window is closed and move on from there.
				bClosed = true;
			}

			if( !bClosed ){
				moreDialog.close();
			}
        }

        obj = obj.parentNode.getElementsByTagName( 'pre' )[0];
		var hasHtmlTag = false;
		var objHtml = '';
		var raw = '';

		//Check for raw HTML
		var nodes = obj.getElementsByTagName( '*' );
		if( nodes.length ){
			objHtml = obj.innerHTML;
		}else{
			if( obj.innerText ){
				raw = obj.innerText;
			}else{
				raw = obj.textContent;
			}

			var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g );
			if( matches && matches.length ){
				objHtml = raw;

				//If there is an html node it will be 1st or 2nd,
				//   but we can check a little further.
				var n = Math.min( 5, matches.length );
				for( var i = 0; i < n; i++ ){
					var el = matches[ i ].toString().toLowerCase();
					if( el.indexOf( '<html' ) >= 0 ){
						hasHtmlTag = true;
						break;
					}
				}
			}
		}

        if( objHtml.length ){
			var html = '';

			if( hasHtmlTag ){
				html = objHtml;
			}else{
				html = '<html>'+
					"\n"+'<head>'+
					"\n"+'    <title>Report Preview Details</title>'+
					"\n"+'    <style type="text/css">'+
					"\n"+'    body {'+
					"\n"+'    }'+
					"\n"+'    table {'+
					"\n"+'    }'+
					"\n"+'    </style>'+
					"\n"+'</head>'+
					"\n"+'<body>'+
						objHtml +
					"\n"+'</body>'+
					"\n"+'</html>';
			}

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write( html );
			moreDialog.document.close();

			if( !hasHtmlTag ){
				moreDialog.document.body.style.margin = '0.5em';
			}
        }
        else
        {
			//default view logic
			var lines = raw.split( "\n" );
			var longest = 0;

			if( lines.length > 0 ){
				for( var p = 0; p < lines.length; p++ ){
					longest = Math.max( longest, lines[p].length );
				}
			}

			//Decide on the default view
			this.Default = longest < 120 ? 'raw' : 'formatted';

			//Build formatted view
			var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ;
			var formatted = '';

			if( text.length > 0 ){
				if( text.length == 1 ){
					text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ;
					formatted = "<p>"+ text.join( "<br /><br />\n" ) +"</p>";
				}else{
					for( var p = 0; p < text.length; p++ ){
						formatted += "<p>" + text[p] + "</p>\n";
					}
				}
			}else{
				formatted = '<p>' + raw + '</p>';
			}

			html = '<html>'+
				"\n"+'<head>'+
				"\n"+'    <title>Report Preview Details</title>'+
				"\n"+'    <style type="text/css">'+
				"\n"+'    body {'+
				"\n"+'       background-color: #f0f9ee;'+
				"\n"+'       font-family: Arial, san-serif; font-size: 0.8em;'+
				"\n"+'    }'+
				"\n"+'    table {'+
				"\n"+'       font-size: 1em;'+
				"\n"+'    }'+
				"\n"+'    </style>'+
				"\n"+'</head>'+
				"\n"+'<body>'+
				"\n"+'    <table border="0" width="100%">'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            formatted: <a href="javascript:void(0);" onclick="opener.Show.toggle( window, this );">'+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +'</a>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <div id="formatted" style="display: none;">'+formatted+'</div>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <pre id="raw" style="display: none; font-size: 1.2em;">'+raw+'</pre>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    </table>'+
				"\n"+'</body>'+
				"\n"+'</html>';

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write(html);
			moreDialog.document.close();

			this.toggle( moreDialog );
        }

		moreDialog.document.title = 'Report Preview Details';
    },

    toggle:function( win, domLink ){
        var domId = this.Default;

        var doc = win.document;
        var domEl = doc.getElementById( domId );
        domEl.style.display = 'block';

        this.Default = domId == 'raw' ? 'formatted' : 'raw';

        if( domLink ){
            domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed';
        }

        var domElOpposite = doc.getElementById( this.Default );
        domElOpposite.style.display = 'none';
    },

	LastAR : null,
	showAR : function ( link, id, win ){
		if( Show.LastAR ){
			Show.hideAR();
		}

		var ref = link;
		do {
			ref = ref.nextSibling;
		} while (ref && ref.nodeName != 'TABLE');

		if (!ref || ref.nodeName != 'TABLE') {
			var tmp = win ?
				win.document.getElementById(id) :
				document.getElementById(id);

			if( tmp ){
				ref = tmp.cloneNode(true);
				ref.id = '';
				link.parentNode.appendChild(ref);
			}
		}

		if( ref ){
			ref.style.display = 'block';
			Show.LastAR = ref;
		}
	},

	toggleNext : function( link ){
		var ref = link;

		do{
			ref = ref.nextSibling;
		}while( ref.nodeName != 'DIV' );

		if( ref.style &&
			ref.style.display &&
			ref.style.display == 'none' ){
			ref.style.display = 'block';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '+', '-' );
			}else{
				link.innerText = link.innerText.replace( '+', '-' );
			}
		}else{
			ref.style.display = 'none';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '-', '+' );
			}else{
				link.innerText = link.innerText.replace( '-', '+' );
			}
		}
	},

	hideAR : function(){
		Show.LastAR.style.display = 'none';
	}
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EGH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STATEMENTS OF CASH FLOWS (Parenthetical) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>STATEMENTS OF CASH FLOWS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Net proceeds from sales of common stock, offering costs</a></td>
        <td class="nump">$ 0.4<span></span></td>
        <td class="nump">$ 0.2<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for cost incurred directly with the issuance of an equity security.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18, 19, 20<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfStockIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StatementOfCashFlowsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAAAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>BALANCE SHEETS (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>BALANCE SHEETS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par or stated value per share</a></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump">2,000,000<span></span></td>
        <td class="nump">2,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">200,000,000<span></span></td>
        <td class="nump">200,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">136,003,676<span></span></td>
        <td class="nump">117,480,867<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">135,548,246<span></span></td>
        <td class="nump">117,025,437<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
        <td class="nump">455,430<span></span></td>
        <td class="nump">455,430<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StatementOfFinancialPositionAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TreasuryStockShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Manufacturing, Laboratory and Office Facility<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract', window );"><strong>Manufacturing Laboratory and Office Facility [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_NewFacilityLeaseDisclosureTextBlock', window );">Manufacturing, Laboratory and Office Facility</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 10 - Manufacturing, Laboratory and Office Facility</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In November 2011, the Company entered into lease agreements, under which the Company leases its new manufacturing, laboratory and office space in Gaithersburg, Maryland. The lease agreements provide that, among other things, as of January 1, 2012, the Company sublease from the current facility tenant, and subsequently lease directly from the landlord, approximately 74,000 total square feet, with rent payments for such space to the landlord commencing April 1, 2014. Under the terms of the arrangement, the Landlord will provide the Company with a tenant improvement allowance of $2.5 million and an additional tenant improvement allowance of $3 million (collectively, the "Improvement Allowance"). The additional tenant improvement allowance is to be paid back to the Landlord over the remaining term of the lease agreement with an effective interest rate of 8.0%. During the nine months ended September 30, 2012, the Company was funded $2.8 million under the Improvement Allowance. In addition, the Company purchased laboratory equipment under an agreement with the then current facility tenant. The Company is currently renovating the new facility and has started remarketing the Rockville, Maryland facility, which lease term ends January 31, 2017.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ManufacturingLaboratoryAndOfficeFacilityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_NewFacilityLeaseDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>New Facility Lease Disclosure</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_NewFacilityLeaseDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EPCAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Oct. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Sep. 30,
         2012<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">NOVAVAX INC.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001000694<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
        <td class="text">NVAX<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2012<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Accelerated Filer<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">147,941,442<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Trading symbol of an instrument as listed on an exchange.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_TradingSymbol</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Master Services Agreement with Cadila<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_MasterServicesAgreementWithCadilaAbstract', window );"><strong>Master Services Agreement with Cadila [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_MasterServicesAgreementTextBlock', window );">Master Services Agreement with Cadila</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 11 <font style="FONT-WEIGHT: normal">-</font> Master Services Agreement with Cadila</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In connection with the JV with Cadila, the Company entered into a master services agreement, which the Company and Cadila amended in July 2011 to extend the term by one year for which services can be provided by Cadila under this agreement. Under the revised terms, if by March 2013, the amount of services provided by Cadila under the master services agreement is less than $7.5 million, the Company will pay Cadila the portion of the shortfall amount that is less than or equal to $2.0 million and 50% of the portion of the shortfall amount that exceeds $2.0 million. Through September 30, 2012, the Company has purchased $0.4 million in services from Cadila pursuant to this agreement. The Company plans to explore with Cadila ways to potentially reduce its financial obligation and/or extend the time period during which the Company could utilize such services. The Company can provide no assurance, however, that these efforts will be successful. If the Company fails to negotiate a change in this arrangement, the Company expects that it will be obligated to spend a significant portion of its available cash and cash equivalents to pay Cadila for our shortfall in services purchased.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_MasterServicesAgreementTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Master Services Agreement [Text Block]</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_MasterServicesAgreementTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_MasterServicesAgreementWithCadilaAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_MasterServicesAgreementWithCadilaAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EPLAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STATEMENTS OF OPERATIONS (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>STATEMENTS OF OPERATIONS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractsRevenue', window );">Government contracts</a></td>
        <td class="nump">$ 5,583<span></span></td>
        <td class="nump">$ 5,008<span></span></td>
        <td class="nump">$ 17,328<span></span></td>
        <td class="nump">$ 8,843<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ResearchAndDevelopmentCollaboration', window );">Research and development collaboration</a></td>
        <td class="nump">182<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">182<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
        <td class="nump">5,765<span></span></td>
        <td class="nump">5,008<span></span></td>
        <td class="nump">17,510<span></span></td>
        <td class="nump">8,843<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractRevenueCost', window );">Cost of government contracts revenue</a></td>
        <td class="nump">3,838<span></span></td>
        <td class="nump">2,190<span></span></td>
        <td class="nump">12,740<span></span></td>
        <td class="nump">3,763<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump">6,395<span></span></td>
        <td class="nump">4,049<span></span></td>
        <td class="nump">16,649<span></span></td>
        <td class="nump">13,474<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
        <td class="nump">2,381<span></span></td>
        <td class="nump">2,737<span></span></td>
        <td class="nump">8,291<span></span></td>
        <td class="nump">8,926<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
        <td class="nump">12,614<span></span></td>
        <td class="nump">8,976<span></span></td>
        <td class="nump">37,680<span></span></td>
        <td class="nump">26,163<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
        <td class="num">(6,849)<span></span></td>
        <td class="num">(3,968)<span></span></td>
        <td class="num">(20,170)<span></span></td>
        <td class="num">(17,320)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
        <td class="nump">39<span></span></td>
        <td class="nump">22<span></span></td>
        <td class="nump">111<span></span></td>
        <td class="nump">106<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
        <td class="num">(6)<span></span></td>
        <td class="num">(2)<span></span></td>
        <td class="num">(12)<span></span></td>
        <td class="num">(6)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Change in fair value of warrant liability</a></td>
        <td class="num">(401)<span></span></td>
        <td class="nump">736<span></span></td>
        <td class="num">(401)<span></span></td>
        <td class="nump">1,973<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss from operations before income tax</a></td>
        <td class="num">(7,217)<span></span></td>
        <td class="num">(3,212)<span></span></td>
        <td class="num">(20,472)<span></span></td>
        <td class="num">(15,247)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">412<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (7,217)<span></span></td>
        <td class="num">$ (3,212)<span></span></td>
        <td class="num">$ (20,472)<span></span></td>
        <td class="num">$ (15,659)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share</a></td>
        <td class="num">$ (0.05)<span></span></td>
        <td class="num">$ (0.03)<span></span></td>
        <td class="num">$ (0.16)<span></span></td>
        <td class="num">$ (0.14)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average number of common shares outstanding</a></td>
        <td class="nump">134,178<span></span></td>
        <td class="nump">115,107<span></span></td>
        <td class="nump">127,246<span></span></td>
        <td class="nump">113,053<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ResearchAndDevelopmentCollaboration">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Research And Development Collaboration</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ResearchAndDevelopmentCollaboration</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractRevenueCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Costs incurred and are directly related to generating contract revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.2(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ContractRevenueCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractsRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period arising from products sold or services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts, construction contracts, and any other contract related to a particular project or product.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ContractsRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total costs of sales and operating expenses for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostsAndExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostsAndExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4A<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5618551-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDerivativeInstrumentsNetPretax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 1(i)<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeStatementAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 45<br><br> -Subparagraph a, b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 9<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher OTS<br><br> -Name Federal Regulation (FR)<br><br> -Number Title 12<br><br> -Section 563c.102<br><br> -Paragraph 9<br><br> -Chapter V<br><br> -Subsection II<br><br> -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy.  It will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 34<br><br> -Paragraph 21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-04.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents investment income derived from investments in debt and equity securities consisting of interest income earned from investments in debt securities and on cash and cash equivalents, dividend income from investments in equity securities, and income or expense derived from the amortization of investment related discounts or premiums, respectively, net of related investment expenses. This item does not include realized or unrealized gains or losses on the sale or holding of investments in debt and equity securities required to be included in earnings for the period or for other than temporary losses related to investments in debt and equity securities which are included in realized losses in the period recognized, and does not include investment income from real or personal property, such as rental income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS115-1/124-1<br><br> -Paragraph 13, 14, 15, 16<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 14, 16<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7(a),(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentIncomeNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpenseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 141<br><br> -Paragraph 51<br><br> -Subparagraph g<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 86<br><br> -Paragraph 11, 12<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 985<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 2<br><br> -Paragraph 12, 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>U.S. Government Agreement and Collaborations<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_UsGovernmentAgreementAndCollaborationsAbstract', window );"><strong>U.S. Government Agreement and Collaborations [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">U.S. Government Agreement and Collaboration</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 5 - U.S. Government Agreement and Collaborations</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em><br /> </em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>HHS BARDA Contract Award for Recombinant Influenza Vaccines</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In February 2011, the Company was awarded a contract from HHS BARDA valued at $97 million for the 36-month base-period, with an HHS BARDA option for an additional period of 24 months valued at $82 million, for a total contract value of up to $179 million. The HHS BARDA contract award provides significant funding for the Company&#39;s ongoing clinical development and product scale-up of both its seasonal and pandemic (H5N1) influenza vaccine candidates. This is a cost-plus-fixed-fee contract in which HHS BARDA will reimburse the Company for direct contract costs incurred plus allowable indirect costs and a fixed-fee earned in the further development of its multivalent seasonal and monovalent pandemic (H5N1) influenza vaccines. Billings under the contract are based on approved provisional indirect billing rates, which permit recovery of fringe benefits, overhead and general and administrative expenses not exceeding certain limits. These indirect rates are subject to audit by HHS BARDA on an annual basis. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly. Since the inception of the contract and during the nine months ended September 30, 2012, the Company has recognized revenue of approximately $31.6 million and $16.9 million, respectively.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Under certain circumstances HHS BARDA reimbursements may be delayed or even potentially withheld. In March 2012, the Company decided to conduct its Phase II dose-ranging clinical trial of its trivalent and quadrivalent seasonal influenza vaccine candidates (the "205 Trial") under its existing U.S. investigational new drug application ("IND") for its trivalent seasonal influenza vaccine candidate ("Trivalent IND") as opposed to waiting to conduct the 205 Trial under a new IND for its quadrivalent vaccine candidate ("Quadrivalent IND"). In July 2012, the Company reported that it expected to launch its next quadrivalent Phase II clinical trial in 2013 rather than in the second half of 2012; similarly, the filing of the Quadrivalent IND, which the Company had previously indicated was expected in the second half of 2012 will also be delayed. Based on discussions between HHS BARDA and the Company, because the 205 Trial includes its quadrivalent seasonal influenza vaccine candidate, the outside clinical trial costs for the 205 Trial will only be submitted for reimbursement to HHS BARDA and recorded as revenue by the Company after it submits the 205 Trial data to its Quadrivalent IND. Until then, the outside clinical trial costs of the 205 Trial will be expensed and included in cost of government contracts revenue. The financial impact of this delay in revenue recognition is based on the outside clinical trial costs of the 205 Trial that are expected to total approximately $3.1 million, of which $2.8 million was incurred through September 30, 2012.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em><br /> </em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>License Agreement with LG Life Sciences, Ltd.</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In February 2011, the Company entered into a license agreement with LG Life Sciences, Ltd. ("LGLS") that allows LGLS to use the Company&#39;s technology to develop and commercially sell influenza vaccines exclusively in South Korea and non-exclusively in certain other specified countries. At its own cost, LGLS is responsible for funding its clinical development of the influenza VLP vaccines and completing a manufacturing facility in South Korea. Under the license agreement, the Company is obligated to provide LGLS with information and materials related to the manufacture of the licensed products, provide on-going project management and regulatory support and conduct clinical trials of its influenza vaccines in order to obtain FDA approval in the U.S. The term of the license agreement is expected to terminate in 2027. Payments to the Company under the license agreement include an upfront payment of $2.5 million, reimbursements of certain development and product costs, payments related to the achievement of certain milestones and royalty payments at a rate between 10% and 20% from LGLS&#39;s future commercial sales of influenza VLP vaccines, which royalty rate is subject to reduction if certain timelines for regulatory licensure are not met. The upfront payment has been deferred and will be recognized when the previously mentioned obligations in the agreement are satisfied, which may not occur until the end of the term of the agreement. Payments for milestones under the agreement will be recognized on a straight-line basis over the remaining term of the research and development period upon achievement of such milestone. Any royalties under the agreement will be recognized as earned.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>PATH Vaccine Solutions</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In July 2012, the Company entered into a clinical development agreement with PATH Vaccine Solutions ("PATH") to develop its vaccine candidate to protect against RSV through maternal immunization in low-resource countries (the "RSV Collaboration Program"). The Company was awarded approximately $2.0 million by PATH for initial funding under the agreement to partially support its Phase II dose-ranging clinical trial in women of childbearing age, which was launched in October 2012. The agreement would expire July 31, 2013, unless the Company and PATH decide to continue the RSV Collaboration Program. The Company retains global rights to commercialize the product and has made a commitment to make the vaccine affordable and available in low-resource countries. To the extent PATH has continued to fund 50% of the Company&#39;s external clinical development costs for the RSV Collaboration Program, but the Company does not continue development, the Company would then grant PATH a fully-paid license to its RSV vaccine technology for use in pregnant women in such low-resource countries. During the three months ended September 30, 2012, the Company recognized revenue of approximately $0.2 million under the agreement. Revenue under this arrangement is being recognized under the proportional performance method and earned in proportion to the contract costs incurred in performance of the work as compared to total estimated contract costs. Costs incurred under this agreement represent a reasonable measurement of proportional performance of the work.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> <br /> </p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_UsGovernmentAgreementAndCollaborationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_UsGovernmentAgreementAndCollaborationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 808<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 07-1<br><br> -Paragraph 21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CollaborativeArrangementDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 4 - Stock-Based Compensation</strong></p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><br /> </strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company has granted equity awards under several plans. Under the 2005 Stock Incentive Plan (the "2005 Plan"), equity awards may be granted to officers, directors, employees, consultants and advisors to the Company and any present or future subsidiary. The 2005 Plan, approved in May 2005 and amended in June 2007, June 2011 and June 2012 by the Company&#39;s stockholders, currently authorizes the grant of equity awards for up to 18,312,192 shares of common stock, which included, at the time of approval of the 2005 Plan, a maximum 5,746,468 shares of common stock subject to stock options outstanding under the Company&#39;s 1995 Stock Option Plan (the "1995 Plan") that may revert to and become issuable under the 2005 Plan if such options should expire or otherwise terminate unexercised. The term of the Company&#39;s 1995 Plan has expired. Outstanding stock options remain in existence in accordance with their terms and no new awards will be made under the 1995 Plan.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Under the 2005 Plan and the 1995 Plan, incentive stock options, having a maximum term of 10 years, can be or were granted at no less than 100% of the fair value of the Company&#39;s common stock at the time of grant and are generally exercisable over periods ranging from six months to four years. There is no minimum exercise price for non-statutory stock options.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company recorded stock-based compensation expense in the statements of operations and comprehensive loss as follows (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <table style="WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0" align="center"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Three Months Ended</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>September 30,</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Nine Months Ended</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>September 30,</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">2012</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">2011</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">2012</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">2011</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 48%">Research and development</td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">219</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">176</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">638</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">449</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">General and administrative</td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 274</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 366</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 1,030</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 1,228</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"> Total stock-based compensation expense</td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 493</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 542</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 1,668</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 1,677</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> </tr> </table> <p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em><br /> </em></strong></p> <p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Stock Options Awards</em></strong></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following is a summary of option activity under the 2005 Plan and the 1995 Plan for the nine months ended September 30, 2012:</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><br /> </strong></p> <table style="WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="6" nowrap="nowrap">2005 Stock Incentive Plan</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="6" nowrap="nowrap">1995 Stock Option Plan</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong><br /> </strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong><br /> </strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Stock</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Options</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Weighted-</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Average</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Exercise</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Price</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong><br /> </strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong><br /> </strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Stock</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Options</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Weighted-</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Average</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Exercise</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Price</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="WIDTH: 48%">Outstanding at January 1, 2012</td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: right; WIDTH: 10%">7,412,746</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">2.22</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: right; WIDTH: 10%">474,650</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">4.38</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td>Granted</td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right">3,483,000</td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">1.29</td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td>Exercised</td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right">(80,784</td> <td style="TEXT-ALIGN: left">)</td> <td><br /> </td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">0.61</td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt">Canceled</td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (1,546,562</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">)</td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">$</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 2.26</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (184,750</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">)</td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">$</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 4.01</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt">Outstanding at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> <br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 9,268,400</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 1.88</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> <br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 289,900</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 4.59</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"> Shares exercisable at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> <br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 3,503,043</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 2.38</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> <br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 289,900</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 4.59</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right"><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right"><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right"><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right"><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -0.1in; PADDING-LEFT: 0.1in"> Shares available for grant at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> <br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 5,559,536</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The fair value of stock options granted was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><br /> </strong></p> <table style="WIDTH: 95%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"> <strong>Three Months Ended</strong></p> <p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"> <strong>September 30,</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="6" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"> <strong>Nine Months Ended</strong></p> <p style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; TEXT-DECORATION: none"> <strong>September 30,</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap">2012</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap">2011</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap">2012</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2" nowrap="nowrap">2011</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; TEXT-INDENT: -9pt; PADDING-LEFT: 9pt; WIDTH: 40%" nowrap="nowrap">Weighted-average fair value of stock options granted</td> <td style="WIDTH: 1%" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"> $1.09</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"> $0.78</td> <td style="TEXT-ALIGN: left; WIDTH: 1%" nowrap="nowrap"><br /> </td> <td style="WIDTH: 1%" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"> $0.71</td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center; WIDTH: 1%" nowrap="nowrap"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 12%" nowrap="nowrap"> $1.19</td> <td style="TEXT-ALIGN: left; WIDTH: 1%" nowrap="nowrap"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left" nowrap="nowrap">Risk-free interest rate</td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0.55%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0.48%-0.68%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap"><br /> </td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0.55%-1.54%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0.48%-1.91%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left" nowrap="nowrap">Dividend yield</td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap">&nbsp;</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td nowrap="nowrap">Volatility</td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">76.60%-76.71%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">75.86%-80.40%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap"><br /> </td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">75.47%-80.48%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">73.28%-80.48%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left" nowrap="nowrap">Expected term (in years)</td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">4.24</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">3.49-4.21</td> <td style="TEXT-ALIGN: left" nowrap="nowrap"><br /> </td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">3.34-7.09</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">3.26-4.47</td> <td style="TEXT-ALIGN: left" nowrap="nowrap"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left" nowrap="nowrap">Expected forfeiture rate</td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%-23.15%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%-23.15%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap"><br /> </td> <td nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%-23.15%</td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap"><br /> </td> <td style="TEXT-ALIGN: center" nowrap="nowrap">0%-23.15%</td> <td style="TEXT-ALIGN: left" nowrap="nowrap"><br /> </td> </tr> </table> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The aggregate intrinsic value and weighted-average remaining contractual term of stock options outstanding as of September 30, 2012 was approximately $4.6 million and 7.7 years, respectively. The aggregate intrinsic value and weighted-average remaining contractual term of stock options exercisable as of September 30, 2012 was approximately $1.0 million and 5.7 years, respectively. The aggregate intrinsic value represents the total intrinsic value (the difference between the Company&#39;s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 30, 2012. This amount is subject to change based on changes to the fair value of the Company&#39;s common stock. The aggregate intrinsic value of options exercised for the nine months ended September 30, 2012 and 2011 was less than $0.1 million and $0.2 million, respectively.</p> <p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em><br /> </em></strong></p> <p style="TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Restricted Stock Awards</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Under the 2005 Plan, the Company has granted restricted stock awards subject to certain performance-based and time-based vesting conditions which, if not met, would result in forfeiture of the shares and reversal of any previously recognized related stock-based compensation expense.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following is a summary of restricted stock awards activity for the nine months ended September 30, 2012:</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><br /> </strong></p> <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong><br /> </strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong><br /> </strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong><br /> </strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Number of</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 3.8pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Shares</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Per Share</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Weighted-</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Average</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Grant-Date</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px 0pt 5.25pt; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Fair Value</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="WIDTH: 74%; FONT-WEIGHT: bold">Outstanding at January 1, 2012</td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: right; WIDTH: 10%">53,333</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 10%">1.63</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">Restricted stock granted</td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">-</td> <td style="TEXT-ALIGN: left"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">Restricted stock vested</td> <td><br /> </td> <td style="TEXT-ALIGN: left"><br /> </td> <td style="TEXT-ALIGN: right">3,333</td> <td style="TEXT-ALIGN: left"><br /> </td> <td><br /> </td> <td style="TEXT-ALIGN: left">$</td> <td style="TEXT-ALIGN: right">5.21</td> <td style="TEXT-ALIGN: left"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">Restricted stock forfeited</td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">$</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; FONT-WEIGHT: bold">Outstanding at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> <br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 50,000</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 1.39</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> </tr> </table> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> As of September 30, 2012, there was approximately $3.6 million of total unrecognized compensation expense (net of estimated forfeitures) related to unvested options and restricted stock awards. This unrecognized compensation expense is expected to be recognized over a weighted-average period of 1.6 years. This estimate does not include the impact of other possible stock-based awards that may be made during future periods.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> <br /> </p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 93-6<br><br> -Paragraph 53<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64, 65, A240<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Capital Lease (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsAbstract', window );"><strong>Capital Lease [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock', window );">Schedule of Capital Lease Obligation</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"> Future minimum capital lease payments under the capital lease agreement at September 30, 2012 are as follows (in thousands):</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"> &nbsp;</p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td>&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">Amount</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 79%">2012</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 18%">12</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2013</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">76</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2014</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">76</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2015</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">76</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2016</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">76</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">2017</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 44</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">360</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">Less &#8213; amounts representing interest</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (51</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">)</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">Present value of net minimum lease payments</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">309</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">Less &#8213; current portion of capital lease</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (57</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">)</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">Non-current portion of capital lease</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 252</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> </table> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeaseObligationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent Events<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 12 - Subsequent Events</strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In October 2012, the Company sold 12,385,321 shares of its common stock to two affiliates of RA Capital Management, LLC, three affiliates of Camber Capital Management LLC and three affiliates of Ayer Capital Management LLC at a price of $2.18 per share, resulting in approximately $26.9 million in net proceeds. The shares were offered under an effective shelf registration statement previously filed with the SEC.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Warrant Liability<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_StockWarrantsAbstract', window );"><strong>Warrant Liability [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_StockWarrantsTextBlock', window );">Warrant Liability</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 8 - Warrant Liability</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.55in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.55in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In July 2008, the Company completed a registered direct offering of 6,686,650 units, raising approximately $17.5 million in net proceeds. Each unit consisted of one share of common stock and a warrant to purchase 0.5 shares of common stock (the "Warrants") at a price of $2.68 per unit. The Warrants represent the right to acquire an aggregate of 3,343,325 shares of common stock at an exercise price of $3.62 per share and are exercisable between January 31, 2009 and July 31, 2013.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.55in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.55in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="COLOR: black">During the nine months ended September 30, 2012 and 2011, the Company recorded as other income (expense)</font> in its statements of operations and comprehensive loss <font style="COLOR: black">a change in fair value of warrant liability of ($0.4) million and $2.0 million, respectively. As of September 30, 2012, the warrant liability recorded on the balance sheet was $0.8 million and all Warrants remain outstanding as of that date.</font></p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_StockWarrantsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_StockWarrantsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_StockWarrantsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock Warrant Disclosure</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_StockWarrantsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Capital Lease<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsAbstract', window );"><strong>Capital Lease [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock', window );">Capital Lease</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 6 - Capital Lease</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"> &nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"> In August 2012, the Company leased equipment under a capital lease with an effective interest rate of 6.5% with an advance payment and monthly payments of $6,325 starting August 2012 and over the next 59 months. The capital lease is recorded at the present value of the future minimum lease payments. Future minimum capital lease payments under the capital lease agreement at September 30, 2012 are as follows (in thousands):</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-WEIGHT: normal; MARGIN: 0pt 0px; TEXT-ALIGN: justify; TEXT-INDENT: 0.5in"> &nbsp;</p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td>&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">Amount</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 79%">2012</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 18%">12</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2013</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">76</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2014</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">76</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2015</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">76</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2016</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">76</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">2017</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 44</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">360</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">Less &#8213; amounts representing interest</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (51</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">)</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">Present value of net minimum lease payments</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">309</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">Less &#8213; current portion of capital lease</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (57</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">)</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">Non-current portion of capital lease</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 252</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> </table> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeaseObligationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Notes Payable<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Notes Payable [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 7 - Notes Payable</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In September 2012, the Company entered into a Master Security Agreement with General Electric Capital Corporation ("GE"), whereby the Company can borrow up to $2.0 million to finance the purchases of equipment ("Equipment Loan"). Each Equipment Loan bears interest at the three-year U.S. Government treasury rate plus 11.68%, provided that the rate shall not be less than 12.1%, and is to be repaid over forty-two (42) months. GE will maintain a security interest in all equipment financed under this facility. During the three months ended September 30, 2012, the Company financed $0.5 million at an interest rate of 12.1% with monthly principal payments of $13,089 starting October 2012. Interest accrues on the outstanding balance until paid in full.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Aggregate future minimum principal payments on the GE Equipment Loan at September 30, 2012 are as follows (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; FONT-WEIGHT: bold"> Year</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2">Amount</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 79%">2012</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 18%">39</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2013</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">157</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2014</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">157</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left">2015</td> <td>&nbsp;</td> <td style="TEXT-ALIGN: left">&nbsp;</td> <td style="TEXT-ALIGN: right">157</td> <td style="TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">2016</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 40</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 550</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> </table> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19,20,22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20, 22<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Sales of Common Stock<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_SalesOfCommonStockAbstract', window );"><strong>Sales of Common Stock [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_SaleOfCommonStockDisclosureTextBlock', window );">Sales of Common Stock</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 9 - Sales of Common Stock</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Board of Directors of the Company (the "Board") has appointed a standing Finance Committee (the "Committee") to assist the Board with its responsibilities to monitor, provide advice to senior management of the Company and approve all capital raising activities. The Committee has been authorized by the Board to approve all At Market Issuance sales transactions. In doing so, the Committee sets the amount of shares to be sold, the period of time during which such sales may occur and the minimum sales price per share. In September 2012, the Company entered into an At Market Issuance Sales Agreement, under which the Company may sell an aggregate of $50 million in gross proceeds of its common stock. This agreement replaces the previous sales agreement entered in March 2010, which also allowed for the sale of an aggregate of $50 million in gross proceeds of its common stock, but had recently met its limitation on sales of shares. The shares of common stock are being offered pursuant to a shelf registration statement previously filed with the SEC. For the nine months ended September 30, 2012, the Company sold 8.4 million shares at an average sales price of $1.70 per share, resulting in $14.0 million in net proceeds; this amount excludes $0.8 million received in early 2012 for 0.7 million shares traded in late December 2011. Since entering into the March 2010 sales agreement through November 7, 2012, the Company has sold 24,957,715 shares of its common stock and received gross proceeds of $49.9 million. No sales have occurred under the September 2012 sales agreement.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In May 2012, the Company sold 10,000,000 shares of its common stock to two affiliates of RA Capital Management, LLC at a price of $1.22 per share, resulting in $12.1 million in net proceeds. The shares were offered under an effective shelf registration statement previously filed with the SEC.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_SaleOfCommonStockDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sale Of Common Stock Disclosure</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_SaleOfCommonStockDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_SalesOfCommonStockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_SalesOfCommonStockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EVOAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock-Based Compensation (Assumptions Used in Estimation of Fair Value of Stock Options Granted)(Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of stock options granted</a></td>
        <td class="nump">$ 1.09<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="nump">$ 0.71<span></span></td>
        <td class="nump">$ 1.19<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.48%<span></span></td>
        <td class="nump">0.55%<span></span></td>
        <td class="nump">0.48%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
        <td class="nump">0.55%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.68%<span></span></td>
        <td class="nump">1.54%<span></span></td>
        <td class="nump">1.91%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility, minimum</a></td>
        <td class="nump">76.60%<span></span></td>
        <td class="nump">75.86%<span></span></td>
        <td class="nump">75.47%<span></span></td>
        <td class="nump">73.28%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility, maximum</a></td>
        <td class="nump">76.71%<span></span></td>
        <td class="nump">80.40%<span></span></td>
        <td class="nump">80.48%<span></span></td>
        <td class="nump">80.48%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
        <td class="text">4 years 2 months 27 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">3 years 5 months 27 days<span></span></td>
        <td class="text">3 years 4 months 2 days<span></span></td>
        <td class="text">3 years 3 months 4 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate', window );">Expected forfeiture rate</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">4 years 2 months 16 days<span></span></td>
        <td class="text">7 years 1 month 2 days<span></span></td>
        <td class="text">4 years 5 months 19 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate', window );">Expected forfeiture rate</a></td>
        <td class="nump">23.15%<span></span></td>
        <td class="nump">23.15%<span></span></td>
        <td class="nump">23.15%<span></span></td>
        <td class="nump">23.15%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Estimated rate of forfeitures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph e(2)(c)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iv)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph e(2)(d)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph c(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EKH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Assets and Liabilities Measured at Fair Market Value on Recurring Basis</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Financial assets and liabilities measured at fair market value on a recurring basis as of September 30, 2012 and December 31, 2011 are summarized below (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap">Fair Value at September 30, 2012</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap">Fair Value at December 31, 2011</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 1</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 2</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 3</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 1</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 2</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 3</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-LEFT: 9.45pt; TEXT-DECORATION: underline; TEXT-INDENT: -9.45pt"> Assets</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; PADDING-LEFT: 9.45pt; TEXT-ALIGN: left; TEXT-INDENT: -9.45pt; WIDTH: 34%"> Corporate debt and auction rate securities</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> 17,672</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> 4,205</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"> Liabilities</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> Warrant liability</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> 769</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> 368</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summarized Activity of Level 3 Inputs Measured on Recurring Basis</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table summarizes the activity of Level 3 inputs measured on a recurring basis as of September 30, 2012 (in thousands):</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Fair Value Measurements of</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Warrants Using Significant</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Unobservable Inputs</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>(Level 3)</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="WIDTH: 82%">Balance at December 31, 2011</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 15%">368</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">Change in fair value of Warrant liability</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 401</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt">Balance at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 769</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Short-term Investments Classified as Available-For-Sale</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Short-term investments classified as available-for-sale as of September 30, 2012 and December 31, 2011 were comprised of (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap">September 30, 2012</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap">December 31, 2011</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none">&nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Amortized</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Cost</strong></p> </td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Gains</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Losses</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap">Fair Value</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none">&nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Amortized</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Cost</strong></p> </td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Gains</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Losses</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap">Fair Value</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 20%">Auction rate securities</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">3,373</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">1,032</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">-</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">4,405</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">3,373</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">832</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">-</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">4,205</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> Corporate debt securities</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 13,263</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 4</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 13,267</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">Total</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 16,636</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 1,036</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 17,672</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 3,373</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 832</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 4,205</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> </tr> </table> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6872113&amp;loc=d3e27290-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6872113&amp;loc=d3e27198-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 03-1<br><br> -Paragraph 21<br><br> -Subparagraph a, b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62557-112803<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS115-1/124-1<br><br> -Paragraph 17<br><br> -Subparagraph a, b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6872113&amp;loc=d3e27337-111563<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 19, 20, 21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6872113&amp;loc=d3e27161-111563<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6872113&amp;loc=d3e27357-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19279-110258<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 157<br><br> -Paragraph 32<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19190-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EVNAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Liquidity Matters (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Oct. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_LiquidityMattersAbstract', window );"><strong>Liquidity Matters [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10,738<span></span></td>
        <td class="nump">$ 14,318<span></span></td>
        <td class="nump">$ 14,104<span></span></td>
        <td class="nump">$ 8,061<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesCurrent', window );">Short-term investments available-for-sale</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17,672<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,205<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Amount raised through the sale of common stock</a></td>
        <td class="nump">$ 26,900<span></span></td>
        <td class="nump">$ 26,925<span></span></td>
        <td class="nump">$ 9,182<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_LiquidityMattersAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_LiquidityMattersAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Section A<br><br> -Paragraph 4, 5<br><br> -Chapter 3<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 12<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 16<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS115-1/124-1<br><br> -Paragraph 15C<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7534914&amp;loc=d3e22054-111558<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 13, 17<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS115-1/124-1<br><br> -Paragraph 15D<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 133<br><br> -Paragraph 22<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 8, 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7, 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7<br><br> -Footnote 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E2XAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Warrant Liability (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="4">1 Months Ended</th>
        <th class="th" colspan="3">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1">32 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Oct. 31, 2012</div>
        </th>
        <th class="th">
          <div>May 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2008</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Nov. 07, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_StockWarrantsAbstract', window );"><strong>Warrant Liability [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Units issued in direct offering</a></td>
        <td class="nump">12,385,321<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">700,000<span></span></td>
        <td class="nump">6,686,650<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">24,957,715<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_CommonSharesPerUnit', window );">Common shares per unit</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from direct offering</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 12,100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 17,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 14,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 49,900,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Shares entitled per warrant</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.5<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuancePerShareAmount', window );">Price per unit</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2.68<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Aggregate shares common stock callable by warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,343,325<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Exercise price of warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3.62<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Change in fair value of warrant liability</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(401,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">736,000<span></span></td>
        <td class="num">(401,000)<span></span></td>
        <td class="nump">1,973,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Warrant liability</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 769,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 769,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The specified number of securities that each warrant or right outstanding gives the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_CommonSharesPerUnit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Shares included in each equity unit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_CommonSharesPerUnit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_StockWarrantsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_StockWarrantsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exercise price of each class of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The specified number of securities that each class of warrants or rights outstanding give the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FIN39-1<br><br> -Paragraph 10A, 10B<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Section A<br><br> -Paragraph 7<br><br> -Chapter 3<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13433-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 133<br><br> -Paragraph 4, 17<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13495-108611<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityIssuancePerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount per share assigned to the consideration received for shares issued.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 215<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityIssuancePerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4A<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5618551-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDerivativeInstrumentsNetPretax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOrSaleOfEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EMKAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STATEMENTS OF COMPREHENSIVE LOSS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (7,217)<span></span></td>
        <td class="num">$ (3,212)<span></span></td>
        <td class="num">$ (20,472)<span></span></td>
        <td class="num">$ (15,659)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on short-term investments available-for-sale</a></td>
        <td class="nump">96<span></span></td>
        <td class="nump">3<span></span></td>
        <td class="nump">204<span></span></td>
        <td class="nump">141<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
        <td class="num">$ (7,121)<span></span></td>
        <td class="num">$ (3,209)<span></span></td>
        <td class="num">$ (20,268)<span></span></td>
        <td class="num">$ (15,518)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph c(3)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=16317811<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e557-108580<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A5<br><br> -Appendix A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTaxAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net of tax amount of unrealized holding gain (loss) before reclassification adjustments and transfers on available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph c(3)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 24<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 17, 22<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e637-108580<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=SL7669646-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Note 3 - Summary of Significant Accounting Policies</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Basis of Presentation</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The accompanying unaudited financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The balance sheet as of September 30, 2012, statements of operations for the three and nine months ended September 30, 2012 and 2011 and the statements of cash flows for the nine months ended September 30, 2012 and 2011 are unaudited, but include all adjustments (consisting of normal recurring adjustments) that the Company considers necessary for a fair presentation of the financial position, operating results and cash flows, respectively, for the periods presented. Although the Company believes that the disclosures in these financial statements are adequate to make the information presented not misleading, certain information and footnote information normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC").</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Results for any interim period are not necessarily indicative of results for any future interim period or for the entire year. The accompanying unaudited financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#39;s Annual Report on Form 10-K for the year ended December 31, 2011.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Use of Estimates</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these estimates.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Fair Value Measurements</em></strong></p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company applies Accounting Standards Codification ("ASC") Topic 820, <em>Fair Value Measurements and Disclosures</em>, for financial and non-financial assets and liabilities.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> ASC 820 discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The statement utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: justify; WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"> &middot;</td> <td style="TEXT-ALIGN: justify">Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</td> </tr> </table> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: justify; WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"> &middot;</td> <td style="TEXT-ALIGN: justify">Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</td> </tr> </table> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: justify; WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"> &middot;</td> <td style="TEXT-ALIGN: justify">Level 3: Unobservable inputs that reflect the reporting entity&#39;s own assumptions.</td> </tr> </table> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Financial assets and liabilities measured at fair market value on a recurring basis as of September 30, 2012 and December 31, 2011 are summarized below (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap">Fair Value at September 30, 2012</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap">Fair Value at December 31, 2011</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 1</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 2</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 3</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 1</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 2</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 3</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-LEFT: 9.45pt; TEXT-DECORATION: underline; TEXT-INDENT: -9.45pt"> Assets</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; PADDING-LEFT: 9.45pt; TEXT-ALIGN: left; TEXT-INDENT: -9.45pt; WIDTH: 34%"> Corporate debt and auction rate securities</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> 17,672</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> 4,205</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"> Liabilities</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> Warrant liability</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> 769</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> 368</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table summarizes the activity of Level 3 inputs measured on a recurring basis as of September 30, 2012 (in thousands):</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Fair Value Measurements of</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Warrants Using Significant</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Unobservable Inputs</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>(Level 3)</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="WIDTH: 82%">Balance at December 31, 2011</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 15%">368</td> <td style="TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">Change in fair value of Warrant liability</td> <td style="PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 401</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt">Balance at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 769</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt">&nbsp;</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The amounts in the Company&#39;s balance sheet for accounts receivable, unbilled receivables and accounts payable approximate fair value due to their short-term nature. Based on borrowing rates available to the Company, the fair value of notes payable and capital lease approximates its carrying value.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"> Short-Term Investments</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Short-term investments at September 30, 2012 consist of investments in commercial paper, corporate notes and three auction rate securities. All marketable securities had original maturities greater than 90 days, but less than one year. The auction rate securities have a par value of $5.1 million. The Company has classified these securities as available-for-sale since the Company may need to liquidate these securities within the next year. The available-for-sale securities are carried at fair value and unrealized gains and losses, if determined to be temporary, on these securities are included in accumulated other comprehensive income (loss) in stockholders&#39; equity. Investments available for sale are evaluated periodically to determine whether a decline in value is "other-than-temporary." The term "other-than-temporary" is not intended to indicate a permanent decline in value. Rather, it means that the prospects for a near term recovery of value are not necessarily favorable, or that there is a lack of evidence to support fair values equal to, or greater than, the carrying value of the security. Management reviews criteria, such as the magnitude and duration of the decline, as well as the Company&#39;s ability to hold the securities until market recovery, to predict whether the loss in value is other-than-temporary. If a decline in value is determined to be other-than-temporary, the value of the security is reduced and the impairment is recorded in the statements of operations. The specific identification method is used in computing realized gains and losses on sale of the Company&#39;s securities.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Short-term investments classified as available-for-sale as of September 30, 2012 and December 31, 2011 were comprised of (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap">September 30, 2012</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap">December 31, 2011</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none">&nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Amortized</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Cost</strong></p> </td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Gains</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Losses</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap">Fair Value</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none">&nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Amortized</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Cost</strong></p> </td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Gains</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Losses</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap">Fair Value</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 20%">Auction rate securities</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">3,373</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">1,032</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">-</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">4,405</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">3,373</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">832</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">-</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">4,205</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> Corporate debt securities</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 13,263</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 4</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 13,267</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">Total</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 16,636</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 1,036</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 17,672</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 3,373</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 832</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 4,205</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> </tr> </table> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"> Restricted Cash</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company&#39;s noncurrent restricted cash with respect to its new manufacturing, laboratory and office space in Gaithersburg, Maryland functions as collateral for letters of credit, which serve as security deposits for the duration of the leases. In addition, the Company&#39;s restricted cash includes payments received under the PATH agreement (See Note 5) until such time the Company has paid for the work performed for the related Phase II RSV clinical trial.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Net Loss per Share</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Net loss per share is computed using the weighted average number of shares of common stock outstanding. All outstanding warrants, stock options and unvested restricted stock awards totaling 12,951,625 shares and 11,119,476 shares at September 30, 2012 and 2011, respectively, are excluded from the computation, as their effect is antidilutive.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Revenue Recognition</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company performs research and development for U.S. Government agencies and other collaborators under cost reimbursable and fixed price contracts, including license and clinical development agreements. The Company recognizes revenue under research contracts when a contract has been executed, the contract price is fixed and determinable, delivery of services or products has occurred and collection of the contract price is reasonably assured. Payments received in advance of work performed are recorded as deferred revenue and losses on contracts, if any, are recognized in the period in which they become known.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Under cost reimbursable contracts, the Company is reimbursed and recognizes revenue as allowable costs are incurred plus a portion of the fixed-fee earned. The Company considers fixed-fees under cost reimbursable contracts to be earned in proportion to the allowable costs incurred in performance of the work as compared to total estimated contract costs, with such costs incurred representing a reasonable measurement of the proportional performance of the work completed. Under its HHS BARDA contract, certain activities must be pre-approved by HHS BARDA in order for their costs to be deemed allowable direct costs. Direct costs incurred under cost reimbursable contracts are recorded as cost of government contracts revenue. The Company&#39;s government contracts, including its HHS BARDA contract, provide the U.S. government (or agency) the ability to terminate the contract for convenience or to terminate for default if the Company fails to meet its obligations as set forth in the statement of work. The Company believes that if the government were to terminate one of its contracts for convenience, including the HHS BARDA contract, the costs incurred through the effective date of such termination and any settlement costs resulting from such termination would be allowable costs. Payments to the Company under cost reimbursable contracts with agencies of the U.S. Government, including its contract with HHS BARDA, are provisional payments subject to adjustment upon annual audit by the government. No such audit has been completed as of September 30, 2012; however, management believes that revenue for periods subject to audit has been recorded in amounts that are expected to be realized upon final audit and settlement.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company&#39;s collaborative research and development agreements may include an upfront payment, payments for research and development services, milestone payments and royalties. Agreements with multiple deliverables are evaluated to determine if the deliverables can be divided into more than one unit of accounting. A deliverable can generally be considered a separate unit of accounting if both of the following criteria are met: (1) the delivered item(s) has value to the customer on a stand-alone basis; and (2) if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable and substantially in control of the Company. Deliverables that cannot be divided into separate units are combined with other units of accounting, as appropriate. Consideration received is allocated among the separate units of accounting based on the relative selling price method. Deliverables under these arrangements typically include rights to intellectual property, research and development services and involvement by the parties in steering committees. Historically, deliverables under the Company&#39;s collaborative research and development agreements have been deemed to have no stand-alone value and as a result been treated as a single unit of accounting. In addition, the Company analyzes its contracts and collaborative agreements to determine whether the payments received should be recorded as revenue or as a reduction to research and development expenses. In reaching this determination, management considers a number of factors, including whether the Company is principal under the arrangement, and whether the arrangement is significant to, and part of, the Company&#39;s core operations. Historically, payments received under its contracts and collaborative agreements have been recognized as revenue since the Company acts as a principal in the arrangement, and the activities are core to its operations.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> When the performance under a fixed price contract can be reasonably estimated, revenue for fixed price contracts is recognized under the proportional performance method and earned in proportion to the contract costs incurred in performance of the work as compared to total estimated contract costs. Costs incurred under fixed price contracts represent a reasonable measurement of proportional performance of the work. Direct costs incurred under collaborative research and development agreements are recorded as research and development expenses. If the performance under a fixed price contract cannot be reasonably estimated, the Company recognizes the revenue on a straight-line basis over the contract term</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Revenue associated with upfront payments under arrangements is recognized over the contract term or when all obligations associated with the upfront payment have been satisfied.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Revenue from the achievement of research and development milestones, if deemed substantive, is recognized as revenue when the milestones are achieved, and the milestone payments are due and collectible. If not deemed substantive, the Company would recognize such milestone as revenue upon its achievement on a straight-line basis over the remaining expected term of the research and development period. Milestones are considered substantive if all of the following conditions are met: (1) the milestone is non-refundable; (2) there is substantive uncertainty of achievement of the milestone at the inception of the arrangement; (3) substantive effort is involved to achieve the milestone and such achievement relates to past performance; and (4) the amount of the milestone appears reasonable in relation to the effort expended and all of the deliverables and payment terms in the arrangement.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Recent Accounting Pronouncements</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In June 2011, the FASB issued ASU 2011-05, <em>Comprehensive Income (Topic 220): Presentation of Comprehensive Income</em> ("ASU 2011-05"). This guidance is intended to increase the prominence of other comprehensive income in financial statements by presenting it in either a single-statement or two-statement approach. This ASU was effective for the Company beginning January 1, 2012. This presentation requirement was adopted January 1, 2012 and is reflected on the accompanying statements of operations and comprehensive loss for the periods ended September 30, 2012 and 2011.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In September 2011, the FASB issued ASU 2011-08, <em>Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for Impairment</em> ("ASU 2011-08")<em>,</em> to give both public and nonpublic entities the option to qualitatively determine whether they can bypass the two-step goodwill impairment test. Under the new guidance, if an entity chooses to perform a qualitative assessment and determines that it is more likely than not (a more than 50 percent likelihood) that the fair value of a reporting unit is less than its carrying amount, it would then perform Step 1 of the annual goodwill impairment test in ASC 350-20 and, if necessary, proceed to Step 2. Otherwise, no further evaluation would be necessary. The decision to perform a qualitative assessment is made at the reporting unit level, and an entity with multiple reporting units may utilize a mix of qualitative assessments and quantitative tests among its reporting units. The amended guidance was effective for interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, although early adoption was permitted. The adoption of ASU 2011-08 on January 1, 2012 did not have a material effect on the Company&#39;s financial statements.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E2HAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Narrative)(Details) (USD $)<br>In Millions, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_NumberOfAuctionRateSecuritiesIncludedInInvestments', window );">Number of auction rate securities</a></td>
        <td class="nump">3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_MarketableSecuritiesOriginalMinimumMaturity', window );">Marketable securities, original minimum maturity</a></td>
        <td class="text">90 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_MarketableSecuritiesOriginalMaximumMaturity', window );">Marketable securities, original maximum maturity</a></td>
        <td class="text">1 year<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvax_AuctionRateSecuritiesParValue', window );">Auction rate securities, par value</a></td>
        <td class="nump">$ 5.1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Number of shares excluded from the computation of net loss per share</a></td>
        <td class="nump">12,951,625<span></span></td>
        <td class="nump">11,119,476<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_AuctionRateSecuritiesParValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of par or stated value of auction rate securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_AuctionRateSecuritiesParValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_MarketableSecuritiesOriginalMaximumMaturity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Marketable Securities Original Maximum Maturity</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_MarketableSecuritiesOriginalMaximumMaturity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_MarketableSecuritiesOriginalMinimumMaturity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Marketable Securities Original Minimum Maturity</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_MarketableSecuritiesOriginalMinimumMaturity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvax_NumberOfAuctionRateSecuritiesIncludedInInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of Auction Rate Securities Included In Investments</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>nvax_NumberOfAuctionRateSecuritiesIncludedInInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>nvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 07-4<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 171<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 13, 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.4.0.6</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>73</ContextCount>
  <ElementCount>240</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>15</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>002 - Statement - BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/BalanceSheets</Role>
      <ShortName>BALANCE SHEETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>003 - Statement - BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>BALANCE SHEETS (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>004 - Statement - STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StamentsOfOperations</Role>
      <ShortName>STATEMENTS OF OPERATIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>005 - Statement - STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StatementsOfComprehensiveLoss</Role>
      <ShortName>STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>006 - Statement - STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StatementsOfCashFlows</Role>
      <ShortName>STATEMENTS OF CASH FLOWS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>007 - Statement - STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StatementsOfCashFlowsParenthetical</Role>
      <ShortName>STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>101 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>102 - Disclosure - Liquidity Matters</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/LiquidityMatters</Role>
      <ShortName>Liquidity Matters</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>103 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>104 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>105 - Disclosure - U.S. Government Agreement and Collaborations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/USGovernmentAgreementAndCollaboartions</Role>
      <ShortName>U.S. Government Agreement and Collaborations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>106 - Disclosure - Capital Lease</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/CapitalLease</Role>
      <ShortName>Capital Lease</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>107 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.novavax.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>108 - Disclosure - Warrant Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/WarrantLiability</Role>
      <ShortName>Warrant Liability</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>109 - Disclosure - Sales of Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SalesOfCommonStock</Role>
      <ShortName>Sales of Common Stock</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>110 - Disclosure - Manufacturing, Laboratory and Office Facility</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacility</Role>
      <ShortName>Manufacturing, Laboratory and Office Facility</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>111 - Disclosure - Master Services Agreement with Cadila</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/MasterServicesAgreementWithCadila</Role>
      <ShortName>Master Services Agreement with Cadila</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>112 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>203 - Disclosure - Summary of Significant Accounting Policies (Policy)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesPolicy</Role>
      <ShortName>Summary of Significant Accounting Policies (Policy)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>303 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>304 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>306 - Disclosure - Capital Lease (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/CapitalLeaseTables</Role>
      <ShortName>Capital Lease (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>307 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.novavax.com/role/NotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>40101 - Disclosure - Organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/OrganizationDetails</Role>
      <ShortName>Organization (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Liquidity Matters (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/LiquidityMattersDetails</Role>
      <ShortName>Liquidity Matters (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>40301 - Disclosure - Summary of Significant Accounting Policies (Narrative)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Narrative)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>40302 - Disclosure - Summary of Significant Accounting Policies (Financial Assets and Liabilities Measured at Fair Market Value on a Recurring Basis)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesFinancialAssetsAndLiabilitiesMeasuredAtFairMarketValueOnARecurringBasisDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Financial Assets and Liabilities Measured at Fair Market Value on a Recurring Basis)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>40303 - Disclosure - Summary of Significant Accounting Policies (Summary of Activity of Level 3 Inputs Measured on Recurring Basis)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfActivityOfLevelThreeInputsMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Summary of Activity of Level 3 Inputs Measured on Recurring Basis)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>40304 - Disclosure - Summary of Significant Accounting Policies (Short-term Investments Classified as Available-for-sale)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SummaryOfSignificantAccountingPoliciesShortTermInvestmentsClassifiedAsAvailableForSaleDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Short-term Investments Classified as Available-for-sale)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>40401 - Disclosure - Stock-Based Compensation (Narrative)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation (Narrative)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>40402 - Disclosure - Stock-Based Compensation (Stock-Based Compensation Expense)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation (Stock-Based Compensation Expense)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>40403 - Disclosure - Stock-Based Compensation (Summary of Option Activity)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StockBasedCompensationSummaryOfOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation (Summary of Option Activity)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>40404 - Disclosure - Stock-Based Compensation (Assumptions Used in Estimation of Fair Value of Stock Options Granted)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StockBasedCompensationAssumptionsUsedInEstimationOfFairValueOfStockOptionsGrantedDetails</Role>
      <ShortName>Stock-Based Compensation (Assumptions Used in Estimation of Fair Value of Stock Options Granted)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>40405 - Disclosure - Stock-Based Compensation (Summary of Restricted Stock Awards Activity)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/StockBasedCompensationSummaryOfRestrictedStockAwardsActivityDetails</Role>
      <ShortName>Stock-Based Compensation (Summary of Restricted Stock Awards Activity)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>40501 - Disclosure - U.S. Government Agreement and Collaborations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/PointsPointGovernmentAgreementAndCollaborationsDetails</Role>
      <ShortName>U.S. Government Agreement and Collaborations (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Capital Lease (Narrative)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/CapitalLeaseNarrativeDetails</Role>
      <ShortName>Capital Lease (Narrative)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>40602 - Disclosure - Capital Lease (Future Minimum Capital Lease Payments Under Capital Lease Agreement)(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/CapitalLeaseFutureMinimumCapitalLeasePaymentsUnderCapitalLeaseAgreementDetails</Role>
      <ShortName>Capital Lease (Future Minimum Capital Lease Payments Under Capital Lease Agreement)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>40701 - Disclosure - Notes Payable (Narrative)(Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.novavax.com/role/NotesPayableNarrativeDetails</Role>
      <ShortName>Notes Payable (Narrative)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>40702 - Disclosure - Notes Payable (Aggregate Future Minimum Principal Payments on Equipment Loan)(Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.novavax.com/role/NotesPayableAggregateFutureMinimumPrincipalPaymentsOnEquipmentLoanDetails</Role>
      <ShortName>Notes Payable (Aggregate Future Minimum Principal Payments on Equipment Loan)(Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>40801 - Disclosure - Warrant Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/WarrantLiabilityDetails</Role>
      <ShortName>Warrant Liability (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>40901 - Disclosure - Sales of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SalesOfCommonStockDetails</Role>
      <ShortName>Sales of Common Stock (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>41001 - Disclosure - Manufacturing, Laboratory and Office Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/ManufacturingLaboratoryAndOfficeFacilityDetails</Role>
      <ShortName>Manufacturing, Laboratory and Office Facility (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>41101 - Disclosure - Master Services Agreement with Cadila (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/MasterServicesAgreementWithCadilaDetails</Role>
      <ShortName>Master Services Agreement with Cadila (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>41201 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.novavax.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element nvax_ResearchAndDevelopmentCollaboration had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">Element nvax_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate had a mix of decimals attribute values: 4 8.</Log>
    <Log type="Info">Element us-gaap_ContractsRevenue had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">'Monetary' elements on report '40501 - Disclosure - U.S. Government Agreement and Collaborations (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '40701 - Disclosure - Notes Payable (Narrative)(Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '40801 - Disclosure - Warrant Liability (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - BALANCE SHEETS</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Sep. 30, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2010'</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - BALANCE SHEETS (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 004 - Statement - STATEMENTS OF OPERATIONS</Log>
    <Log type="Info">Process Flow-Through: 005 - Statement - STATEMENTS OF COMPREHENSIVE LOSS</Log>
    <Log type="Info">Process Flow-Through: 006 - Statement - STATEMENTS OF CASH FLOWS</Log>
    <Log type="Info">Process Flow-Through: 007 - Statement - STATEMENTS OF CASH FLOWS (Parenthetical)</Log>
  </Logs>
  <InputFiles>
    <File>nvax-20120930.xml</File>
    <File>nvax-20120930.xsd</File>
    <File>nvax-20120930_cal.xml</File>
    <File>nvax-20120930_def.xml</File>
    <File>nvax-20120930_lab.xml</File>
    <File>nvax-20120930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EADAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Capital Lease (Future Minimum Capital Lease Payments Under Capital Lease Agreement)(Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsAbstract', window );"><strong>Capital Lease [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">2012</a></td>
        <td class="nump">$ 12<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo', window );">2013</a></td>
        <td class="nump">76<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree', window );">2014</a></td>
        <td class="nump">76<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour', window );">2015</a></td>
        <td class="nump">76<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive', window );">2016</a></td>
        <td class="nump">76<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive', window );">2017</a></td>
        <td class="nump">44<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
        <td class="nump">360<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments', window );">Less - amounts representing interest</a></td>
        <td class="num">(51)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments', window );">Present value of net minimum lease payments</a></td>
        <td class="nump">309<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Less - current portion of capital lease</a></td>
        <td class="num">(57)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Non-current portion of capital lease</a></td>
        <td class="nump">$ 252<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeaseObligationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid within one year (or one operating cycle, if longer) of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45023-112735<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 7, 10, 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeaseObligationsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45023-112735<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 7, 10, 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeaseObligationsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum lease payments for capital leases.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 16<br><br> -Subparagraph a(ii)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeasesFutureMinimumPaymentsDue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum lease payments maturing after the fifth rolling twelve months following the latest balance sheet presented for capital leases.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum lease payments maturing in the fifth rolling twelve months following the latest balance sheet presented for capital leases.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum lease payments maturing in the fourth rolling twelve months following the latest balance sheet presented for capital leases.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum lease payments maturing in the third rolling twelve months following the latest balance sheet presented for capital leases.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum lease payments maturing in the second rolling twelve months following the latest balance sheet presented for capital leases.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount necessary to reduce net minimum lease payments to present value for capital leases.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 7<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 16<br><br> -Subparagraph a(ii)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Present value of minimum lease payments for capital leases net of executory costs, including amounts paid by the lessee to the lessor for insurance, maintenance and taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 16<br><br> -Subparagraph a(ii)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of minimum lease payments maturing in the remainder of the fiscal year following the latest fiscal year ended for capital leases.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EWGAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policy)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Basis of Presentation</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The accompanying unaudited financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The balance sheet as of September 30, 2012, statements of operations for the three and nine months ended September 30, 2012 and 2011 and the statements of cash flows for the nine months ended September 30, 2012 and 2011 are unaudited, but include all adjustments (consisting of normal recurring adjustments) that the Company considers necessary for a fair presentation of the financial position, operating results and cash flows, respectively, for the periods presented. Although the Company believes that the disclosures in these financial statements are adequate to make the information presented not misleading, certain information and footnote information normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC").</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Results for any interim period are not necessarily indicative of results for any future interim period or for the entire year. The accompanying unaudited financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#39;s Annual Report on Form 10-K for the year ended December 31, 2011.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Use of Estimates</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these estimates.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Fair Value Measurements</em></strong></p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company applies Accounting Standards Codification ("ASC") Topic 820, <em>Fair Value Measurements and Disclosures</em>, for financial and non-financial assets and liabilities.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> ASC 820 discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The statement utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: justify; WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"> &middot;</td> <td style="TEXT-ALIGN: justify">Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</td> </tr> </table> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: justify; WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"> &middot;</td> <td style="TEXT-ALIGN: justify">Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</td> </tr> </table> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: justify; WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: justify; WIDTH: 0.25in"> &middot;</td> <td style="TEXT-ALIGN: justify">Level 3: Unobservable inputs that reflect the reporting entity&#39;s own assumptions.</td> </tr> </table> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Financial assets and liabilities measured at fair market value on a recurring basis as of September 30, 2012 and December 31, 2011 are summarized below (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap">Fair Value at September 30, 2012</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="10" nowrap="nowrap">Fair Value at December 31, 2011</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold" nowrap="nowrap"> <br /> </td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 1</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 2</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 3</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 1</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 2</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" colspan="2" nowrap="nowrap">Level 3</td> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt" nowrap="nowrap"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; PADDING-LEFT: 9.45pt; TEXT-DECORATION: underline; TEXT-INDENT: -9.45pt"> Assets</td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; PADDING-LEFT: 9.45pt; TEXT-ALIGN: left; TEXT-INDENT: -9.45pt; WIDTH: 34%"> Corporate debt and auction rate securities</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> 17,672</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> 4,205</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; WIDTH: 1%"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left; WIDTH: 1%"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right; WIDTH: 8%"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; WIDTH: 1%"> <br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"> Liabilities</td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: right"><br /> </td> <td style="FONT-SIZE: 9pt; TEXT-ALIGN: left"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> Warrant liability</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> 769</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> <br /> </td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 9pt; TEXT-ALIGN: right"> 368</td> <td style="FONT-SIZE: 9pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> <br /> </td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table summarizes the activity of Level 3 inputs measured on a recurring basis as of September 30, 2012 (in thousands):</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <table style="WIDTH: 70%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Fair Value Measurements of</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Warrants Using Significant</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>Unobservable Inputs</strong></p> <p style="TEXT-ALIGN: center; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; TEXT-DECORATION: none"> <strong>(Level 3)</strong></p> </td> <td style="PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold; TEXT-DECORATION: none" nowrap="nowrap"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="WIDTH: 82%">Balance at December 31, 2011</td> <td style="WIDTH: 1%"><br /> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="TEXT-ALIGN: right; WIDTH: 15%">368</td> <td style="TEXT-ALIGN: left; WIDTH: 1%"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt">Change in fair value of Warrant liability</td> <td style="PADDING-BOTTOM: 1pt"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"><br /> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 401</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"><br /> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt">Balance at September 30, 2012</td> <td style="PADDING-BOTTOM: 2.5pt"><br /> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 769</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"><br /> </td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> </p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The amounts in the Company&#39;s balance sheet for accounts receivables, unbilled receivables and accounts payable approximate fair value due to their short-term nature. Based on borrowing rates available to the Company, the fair value of capital lease and notes payable approximates their carrying value.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAvailableForSaleSecuritiesPolicy', window );">Short-Term Investments</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"> Short-Term Investments</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Short-term investments at September 30, 2012 consist of investments in commercial paper, corporate notes and three auction rate securities. All marketable securities had original maturities greater than 90 days, but less than one year. The auction rate securities have a par value of $5.1 million. The Company has classified these securities as available-for-sale since the Company may need to liquidate these securities within the next year. The available-for-sale securities are carried at fair value and unrealized gains and losses, if determined to be temporary, on these securities are included in accumulated other comprehensive income (loss) in stockholders&#39; equity. Investments available for sale are evaluated periodically to determine whether a decline in value is "other-than-temporary." The term "other-than-temporary" is not intended to indicate a permanent decline in value. Rather, it means that the prospects for a near term recovery of value are not necessarily favorable, or that there is a lack of evidence to support fair values equal to, or greater than, the carrying value of the security. Management reviews criteria, such as the magnitude and duration of the decline, as well as the Company&#39;s ability to hold the securities until market recovery, to predict whether the loss in value is other-than-temporary. If a decline in value is determined to be other-than-temporary, the value of the security is reduced and the impairment is recorded in the statements of operations. The specific identification method is used in computing realized gains and losses on sale of the Company&#39;s securities.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Short-term investments classified as available-for-sale as of September 30, 2012 and December 31, 2011 were comprised of (in thousands):</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap">September 30, 2012</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="14" nowrap="nowrap">December 31, 2011</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom; TEXT-DECORATION: none"> <td style="FONT-SIZE: 7pt; TEXT-DECORATION: none" nowrap="nowrap"> &nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none">&nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Amortized</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Cost</strong></p> </td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Gains</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Losses</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap">Fair Value</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none">&nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Amortized</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; FONT-SIZE: 7pt; MARGIN: 0pt 0px; TEXT-ALIGN: center; TEXT-DECORATION: none"> <strong>Cost</strong></p> </td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Gains</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap"><strong>Gross</strong><br /> <strong>Unrealized</strong><br /> <strong>Losses</strong></td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; FONT-WEIGHT: bold; TEXT-ALIGN: center; TEXT-DECORATION: none" colspan="2" nowrap="nowrap">Fair Value</td> <td style="FONT-SIZE: 7pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 1pt; TEXT-DECORATION: none" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 20%">Auction rate securities</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">3,373</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">1,032</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">-</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">4,405</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">3,373</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">832</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">-</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">$</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: right; WIDTH: 7%">4,205</td> <td style="FONT-SIZE: 7pt; TEXT-ALIGN: left; WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> Corporate debt securities</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 13,263</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 4</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 13,267</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">Total</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 16,636</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 1,036</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 17,672</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 3,373</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 832</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: left"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; FONT-SIZE: 7pt; TEXT-ALIGN: right"> 4,205</td> <td style="FONT-SIZE: 7pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> &nbsp;</td> </tr> </table> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: bold italic 10pt Times New Roman, Times, Serif"> Restricted Cash</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company&#39;s noncurrent restricted cash with respect to its new manufacturing, laboratory and office space in Gaithersburg, Maryland functions as collateral for letters of credit, which serve as security deposits for the duration of the leases. In addition, the Company&#39;s restricted cash includes payments received under the PATH agreement (See Note 5) until such time the Company has paid for the work performed for the related Phase II RSV clinical trial.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Net Loss per Share</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Net loss per share is computed using the weighted average number of shares of common stock outstanding. All outstanding warrants, stock options and unvested restricted stock awards totaling 12,951,625 shares and 11,119,476 shares at September 30, 2012 and 2011, respectively, are excluded from the computation, as their effect is antidilutive.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Revenue Recognition</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company performs research and development for U.S. Government agencies and other collaborators under cost reimbursable and fixed price contracts, including license and clinical development agreements. The Company recognizes revenue under research contracts when a contract has been executed, the contract price is fixed and determinable, delivery of services or products has occurred and collection of the contract price is reasonably assured. Payments received in advance of work performed are recorded as deferred revenue and losses on contracts, if any, are recognized in the period in which they become known.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Under cost reimbursable contracts, the Company is reimbursed and recognizes revenue as allowable costs are incurred plus a portion of the fixed-fee earned. The Company considers fixed-fees under cost reimbursable contracts to be earned in proportion to the allowable costs incurred in performance of the work as compared to total estimated contract costs, with such costs incurred representing a reasonable measurement of the proportional performance of the work completed. Under its HHS BARDA contract, certain activities must be pre-approved by HHS BARDA in order for their costs to be deemed allowable direct costs. Direct costs incurred under cost reimbursable contracts are recorded as cost of government contracts revenue. The Company&#39;s government contracts, including its HHS BARDA contract, provide the U.S. government (or agency) the ability to terminate the contract for convenience or to terminate for default if the Company fails to meet its obligations as set forth in the statement of work. The Company believes that if the government were to terminate one of its contracts for convenience, including the HHS BARDA contract, the costs incurred through the effective date of such termination and any settlement costs resulting from such termination would be allowable costs. Payments to the Company under cost reimbursable contracts with agencies of the U.S. Government, including its contract with HHS BARDA, are provisional payments subject to adjustment upon annual audit by the government. No such audit has been completed as of September 30, 2012; however, management believes that revenue for periods subject to audit has been recorded in amounts that are expected to be realized upon final audit and settlement.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company&#39;s collaborative research and development agreements may include an upfront payment, payments for research and development services, milestone payments and royalties. Agreements with multiple deliverables are evaluated to determine if the deliverables can be divided into more than one unit of accounting. A deliverable can generally be considered a separate unit of accounting if both of the following criteria are met: (1) the delivered item(s) has value to the customer on a stand-alone basis; and (2) if the arrangement includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable and substantially in control of the Company. Deliverables that cannot be divided into separate units are combined with other units of accounting, as appropriate. Consideration received is allocated among the separate units of accounting based on the relative selling price method. Deliverables under these arrangements typically include rights to intellectual property, research and development services and involvement by the parties in steering committees. Historically, deliverables under the Company&#39;s collaborative research and development agreements have been deemed to have no stand-alone value and as a result been treated as a single unit of accounting. In addition, the Company analyzes its contracts and collaborative agreements to determine whether the payments received should be recorded as revenue or as a reduction to research and development expenses. In reaching this determination, management considers a number of factors, including whether the Company is principal under the arrangement, and whether the arrangement is significant to, and part of, the Company&#39;s core operations. Historically, payments received under its contracts and collaborative agreements have been recognized as revenue since the Company acts as a principal in the arrangement, and the activities are core to its operations.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> When the performance under a fixed price contract can be reasonably estimated, revenue for fixed price contracts is recognized under the proportional performance method and earned in proportion to the contract costs incurred in performance of the work as compared to total estimated contract costs. Costs incurred under fixed price contracts represent a reasonable measurement of proportional performance of the work. Direct costs incurred under collaborative research and development agreements are recorded as research and development expenses. If the performance under a fixed price contract cannot be reasonably estimated, the Company recognizes the revenue on a straight-line basis over the contract term</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Revenue associated with upfront payments under arrangements is recognized over the contract term or when all obligations associated with the upfront payment have been satisfied.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Revenue from the achievement of research and development milestones, if deemed substantive, is recognized as revenue when the milestones are achieved, and the milestone payments are due and collectible. If not deemed substantive, the Company would recognize such milestone as revenue upon its achievement on a straight-line basis over the remaining expected term of the research and development period. Milestones are considered substantive if all of the following conditions are met: (1) the milestone is non-refundable; (2) there is substantive uncertainty of achievement of the milestone at the inception of the arrangement; (3) substantive effort is involved to achieve the milestone and such achievement relates to past performance; and (4) the amount of the milestone appears reasonable in relation to the effort expended and all of the deliverables and payment terms in the arrangement.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Recent Accounting Pronouncements</em></strong></p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In June 2011, the FASB issued ASU 2011-05, <em>Comprehensive Income (Topic 220): Presentation of Comprehensive Income</em> ("ASU 2011-05"). This guidance is intended to increase the prominence of other comprehensive income in financial statements by presenting it in either a single-statement or two-statement approach. This ASU was effective for the Company beginning January 1, 2012. This presentation requirement was adopted January 1, 2012 and is reflected on the accompanying statements of operations and comprehensive loss for the periods ended September 30, 2012 and 2011.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In September 2011, the FASB issued ASU 2011-08, <em>Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for Impairment</em> ("ASU 2011-08")<em>,</em> to give both public and nonpublic entities the option to qualitatively determine whether they can bypass the two-step goodwill impairment test. Under the new guidance, if an entity chooses to perform a qualitative assessment and determines that it is more likely than not (a more than 50 percent likelihood) that the fair value of a reporting unit is less than its carrying amount, it would then perform Step 1 of the annual goodwill impairment test in ASC 350-20 and, if necessary, proceed to Step 2. Otherwise, no further evaluation would be necessary. The decision to perform a qualitative assessment is made at the reporting unit level, and an entity with multiple reporting units may utilize a mix of qualitative assessments and quantitative tests among its reporting units. The amended guidance was effective for interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, although early adoption was permitted. The adoption of ASU 2011-08 on January 1, 2012 did not have a material effect on the Company&#39;s financial statements.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccountingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 305<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122427<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.1(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Subparagraph a<br><br> -Article 9<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Financial Reporting Release (FRR)<br><br> -Number 203<br><br> -Paragraph 02-03<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 6, 8-16, 60<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144384<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for fair value measurements, which may include, but is not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 35<br><br> -Paragraph 18G<br><br> -URI http://asc.fasb.org/extlink&amp;oid=15229074&amp;loc=SL7494712-110257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueMeasurementPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAvailableForSaleSecuritiesPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for investments in debt and equity securities that are classified as available-for-sale. This policy also may describe the entity's accounting treatment for transfers between investment categories, how the entity determines whether impairments of available-for-sale securities are other than temporary, and how the fair values of such securities are determined.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 2, 12<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 10, 11<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 12, 13, 14, 15, 16<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2196929<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section M<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS115-1/124-1<br><br> -Paragraph 7, 8, 9, 13, 14, 15, 16, 17<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesAvailableForSaleSecuritiesPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of the adoption of new accounting pronouncements that may impact the entity's financial reporting.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6600647&amp;loc=d3e214044-122780<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 22<br><br> -Paragraph 8, 12, 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18823-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section B<br><br> -Paragraph Question 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 94-6<br><br> -Paragraph 11, 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
